FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Lee, EK
   Tian, HZ
   Nakaya, HI
AF Lee, Eva K.
   Tian, Haozheng
   Nakaya, Helder, I
TI Antigenicity prediction and vaccine recommendation of human influenza
   virus A (H3N2) using convolutional neural networks
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Article; Early Access
DE Convolution neural networks; Influenza A; particle swarm optimization;
   antigenicity; machine learning; deep learning; flu vaccine strain
   selection
ID VARIANTS; HEMAGGLUTININ
AB The rapid evolution of influenza A viruses poses a great challenge to vaccine development. Analytical and machine learning models have been applied to facilitate the process of antigenicity determination. In this study, we designed deep convolutional neural networks (CNNs) to predict Influenza antigenicity. Our model is the first that systematically analyzed 566 amino acid properties and 141 amino acid substitution matrices for their predictability. We then optimized the structure of the CNNs using particle swarm optimization. The optimal neural networks outperform other predictive models with a blind validation accuracy of 95.8%. Further, we applied our model to vaccine recommendations in the period 1997 to 2011 and contrasted the performance of previous vaccine recommendations using traditional experimental approaches. The results show that our model outperforms the WHO recommendation and other existing models and could potentially improve the vaccine recommendation process. Our results show that WHO often selects virus strains with small variation from year to year and learns slowly and recovers once coverage dips very low. In contrast, the influenza strains selected via our CNN model can differ quite drastically from year to year and exhibit consistently good coverage. In summary, we have designed a comprehensive computational pipeline for optimizing a CNN in the modeling of Influenza A antigenicity and vaccine recommendation. It is more cost and time-effective when compared to traditional hemagglutination inhibition assay analysis. The modeling framework is flexible and can be adopted to study other type of viruses.
C1 [Lee, Eva K.; Tian, Haozheng] Georgia Inst Technol, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA.
   [Lee, Eva K.; Tian, Haozheng] Georgia Inst Technol, Ctr Computat Biol & Bioinformat, Atlanta, GA 30332 USA.
   [Lee, Eva K.; Tian, Haozheng] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.
   [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Atlanta, GA 30332 USA.
   [Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
RP Lee, EK (corresponding author), Georgia Inst Technol, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA.
EM evalee-gatech@pm.me
RI Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder/0000-0001-5297-9108
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U19 AI090023];
   U.S. Department of Health and Human Services; Centers for Disease
   Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA
FX The work is partially supported by a grant from by the U.S. National
   Institutes of Health (U19 AI090023), the U.S. Department of Health and
   Human Services and the Centers for Disease Control and Prevention.
   Findings and conclusions in this paper are those of the authors and do
   not necessarily reflect the views of the National Institutes of Health,
   U.S. Department of Health and Human Services and the Centers for Disease
   Control and Prevention.
CR Abdel-Hamid O, 2012, INT CONF ACOUST SPEE, P4277, DOI 10.1109/ICASSP.2012.6288864
   Albelwi S, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19060242
   Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399
   Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07
   Bedford T, 2014, ELIFE, V3, DOI 10.7554/eLife.01914
   Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861
   Bergstra J., 2011, ADV NEURAL INFORM PR, P2546, DOI DOI 10.5555/2986459.2986743
   Bergstra J, 2012, J MACH LEARN RES, V13, P281
   Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058
   BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069
   CDC, 2001, 2000 2001 INFL SEAS
   Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P393
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P8
   Chan CM, 2016, VIROLOGY, V494, P78, DOI 10.1016/j.virol.2016.04.008
   Chollet F., 2015, KERAS
   Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51
   Conn AR, 1997, APPROXIMATION THEORY, P83
   Cruz-Roa A, 2014, SPIE MED IMAGING
   De A, 2015, INSIGHT SEGMENT BASE, DOI [10.3390/MOL2NET-1-b015, DOI 10.3390/M0L2NET-1-B015]
   Dennis Jr JE, 1987, NEW COMPUTING ENV MI, P116
   Dou Q, 2016, IEEE T MED IMAGING, V35, P1182, DOI 10.1109/TMI.2016.2528129
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018
   Fletcher R., 2013, PRACTICAL METHODS OP
   Garro BA, 2015, COMPUT INTEL NEUROSC, DOI 10.1155/2015/369298
   Georgiev AG, 2009, J COMPUT BIOL, V16, P703, DOI 10.1089/cmb.2008.0173
   GHAFOORIAN M, 2016, BIOM IM ISBI 2016 IE, P1414, DOI DOI 10.1109/ISBI.2016.7493532
   Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300
   Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59
   Kageyama T, 2013, EUROSURVEILLANCE, V18, P7
   Karaboga D, 2007, LECT NOTES ARTIF INT, V4617, P318
   Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223
   Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998
   KENNEDY J, 1995, ENCY MACHINE LEARNIN, P1942, DOI DOI 10.1007/978-0-387-30164-8_630
   Kennedy J, 2006, IEEE T SYST MAN CY C, V36, P515, DOI 10.1109/TSMCC.2006.875410
   Kim J., 2017, INT C DAT MIN DMIN 1, P24
   Kim Y, 2014, ARXIV14085882
   Krizhevsky A., 2012, ADV NEURAL INFORM PR, V25, P1097, DOI [10.1145/3065386., DOI 10.1145/3065386]
   Lee EK, 2016, INTERFACES, V46, P368, DOI 10.1287/inte.2016.0862
   Lee MS, 2007, VACCINE, V25, P8133, DOI 10.1016/j.vaccine.2007.09.039
   Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107
   Lees WD, 2010, BIOINFORMATICS, V26, P1403, DOI 10.1093/bioinformatics/btq160
   Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638
   Martens James, 2010, P 27 INT C MACH LEAR, P735, DOI DOI 10.1155/2011/176802
   MENDOZA H, 2016, WORKSH AUT MACH LEAR, V64, P58
   Neher RA, 2016, P NATL ACAD SCI USA, V113, pE1701, DOI 10.1073/pnas.1525578113
   Nocedal J., 2006, SEQUENTIAL QUADRATIC
   Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105
   Peng DP, 2007, VET IMMUNOL IMMUNOP, V117, P17, DOI 10.1016/j.vetimm.2007.01.022
   POWELL MJD, 1964, COMPUT J, V7, P155, DOI 10.1093/comjnl/7.2.155
   Qiu JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31156
   Quang D, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw226
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ren XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126742
   Saito R, 2002, INFECT CONT HOSP EP, V23, P82, DOI 10.1086/502011
   Sarraf S., 2016, ARXIV160308631
   Saxena S., 2016, ADV NEURAL INFORM PR, P4053
   Simard PY, 2003, PROC INT CONF DOC, P958
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   Snoek Jasper, 2012, ADV NEURAL INFORM PR, P2951, DOI DOI 10.1094/PDIS-11-11-0999-PDN
   Steinbruk L, 2014, J VIROL, V88, P12123, DOI 10.1128/JVI.01861-14
   Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408
   Straeter TA, 1971, EXTENSION DAVIDSON B
   Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13
   van Westen GJP, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-42
   Veljkovic V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01456
   Wang HB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.034003
   Wang T, 2012, INT C PATT RECOG, P3304
   WHO, 2014, INFL SEAS
   WHO, 2007, DESCR PROC SEAS H5N1, DOI [10.1094/PDIS-91-4-0467B, DOI 10.1094/PDIS-91-4-0467B]
   Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219
   Yao YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01699-z
   Young SM, 2015, PHYS REV APPL, V4, DOI 10.1103/PhysRevApplied.4.054004
   Yu JB, 2007, NEURAL PROCESS LETT, V26, P217, DOI 10.1007/s11063-007-9053-x
   Zhang Y, 2017, NUCLEIC ACIDS RES, V45, pD466, DOI 10.1093/nar/gkw857
   Zhong S, 2016, INT C GISCI P, V1, DOI [10.21433/B3113969C18V, DOI 10.21433/B3113969C18V]
   Zoph Barret, 2016, ARXIV161101578
NR 77
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
DI 10.1080/21645515.2020.1734397
EA JUL 2020
PG 19
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA MU4EO
UT WOS:000555623500001
PM 32750260
OA Bronze
DA 2020-12-17
ER

PT J
AU Dos-Santos, JCK
   Silva, JL
   Judice, CC
   Kayano, ACAV
   Aliberti, J
   Khouri, R
   de Lima, DS
   Nakaya, H
   Lacerda, MVG
   De Paula, EV
   Lopes, SCP
   Costa, FTM
AF Dos-Santos, Joao Conrado Khouri
   Silva-Filho, Joao Luiz
   Judice, Carla C.
   Kayano, Ana Carolina Andrade Vitor
   Aliberti, Julio
   Khouri, Ricardo
   de Lima, Diogenes S.
   Nakaya, Helder
   Lacerda, Marcus Vinicius Guimaraes
   De Paula, Erich Vinicius
   Lopes, Stefanie Costa Pinto
   Costa, Fabio Trindade Maranhao
TI Platelet disturbances correlate with endothelial cell activation in
   uncomplicatedPlasmodium vivaxmalaria
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PLASMODIUM-VIVAX MALARIA; POTENTIAL ROLE; CD40 LIGAND; P-SELECTIN;
   FALCIPARUM; THROMBOCYTOPENIA; THROMBOPOIESIS; COMPLICATIONS;
   CYTOADHESION; DYSFUNCTION
AB Author summary Endothelial cell activation is a key process in the pathogenesis ofPlasmodium vivaxmalaria. Platelets are classically involved in endothelial cell activation in several diseases, but their role in the context of vivax malaria remains unclear. Thrombocytopenia is the most common hematological disturbance inP.vivax-infected patients, and platelets have been implicated in parasitemia control. In this work, we studied the activation of platelets in association with endothelial cell activation in vivax malaria. Platelets retrieved from infected peripheral blood were non-activated when analyzed by flow cytometry; however, they displayed higher mean volume and significantly reduced counts. We also found higher levels of circulating factors associated with platelet activation (especially soluble CD40L), thrombopoiesis and endothelial cell activation in infected patients. Further, through pair-wise correlation and clustering analysis, we found a subgroup of patients showing significant associations between markers of platelet and endothelial activation in a pattern different from that of endemic controls. Collectively, our findings indicate a role of platelets in endothelial cell activation in vivax malaria and indicate a heterogeneous host response in the setting of uncomplicated disease, a finding to be further explored in future studies.
   Platelets drive endothelial cell activation in many diseases. However, if this occurs inPlasmodium vivaxmalaria is unclear. As platelets have been reported to be activated and to play a role in inflammatory response during malaria, we hypothesized that this would correlate with endothelial alterations during acute illness. We performed platelet flow cytometry of PAC-1 and P-selectin. We measured platelet markers (CXCL4, CD40L, P-selectin, Thrombopoietin, IL-11) and endothelial activation markers (ICAM-1, von Willebrand Factor and E-selectin) in plasma with a multiplex-based assay. The values of each mediator were used to generate heatmaps, K-means clustering and Principal Component analysis. In addition, we determined pair-wise Pearson's correlation coefficients to generate correlation networks. Platelet counts were reduced, and mean platelet volume increased in malaria patients. The activation of circulating platelets in flow cytometry did not differ between patients and controls. CD40L levels (Median [IQ]: 517 [406-651] vs. 1029 [732-1267] pg/mL,P= 0.0001) were significantly higher in patients, while P-selectin and CXCL4 showed a nonsignificant trend towards higher levels in patients. The network correlation approach demonstrated the correlation between markers of platelet and endothelial activation, and the heatmaps revealed a distinct pattern of activation in two subsets ofP.vivaxpatients when compared to controls. Although absolute platelet activation was not strong in uncomplicated vivax malaria, markers of platelet activity and production were correlated with higher endothelial cell activation, especially in a specific subset of patients.
C1 [Dos-Santos, Joao Conrado Khouri; Silva-Filho, Joao Luiz; Judice, Carla C.; Kayano, Ana Carolina Andrade Vitor; Costa, Fabio Trindade Maranhao] Univ Estadual Campinas, Inst Biol, Lab Doencas Trop Prof Luiz Jacintho da Silva, Campinas, Brazil.
   [Dos-Santos, Joao Conrado Khouri] Univ Estadual Campinas, Fac Ciencias Med, Posgrad Fisiopatol Med, Campinas, Brazil.
   [Aliberti, Julio] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Khouri, Ricardo] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [de Lima, Diogenes S.; Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Lacerda, Marcus Vinicius Guimaraes] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Lacerda, Marcus Vinicius Guimaraes; Lopes, Stefanie Costa Pinto] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [De Paula, Erich Vinicius] Univ Estadual Campinas, Ctr Hematol & Hemoterapia Hemoctr, Campinas, Brazil.
RP Costa, FTM (corresponding author), Univ Estadual Campinas, Inst Biol, Lab Doencas Trop Prof Luiz Jacintho da Silva, Campinas, Brazil.
EM fabiotmc72@gmail.com
RI Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/16525-2,
   2017/18611-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES; FAPESPFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2916/12855-9]
FX This worked was funded by the Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP under grants #2012/16525-2 and #2017/18611-7 received
   by FTMC. JCKS has a scholarship from Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) as an MD/PhD Student. JLSF has a
   scholarship from FAPESP (#2916/12855-9) as a Pos-Doctoral researcher.
   HN, MVGL, EVP and FTMC are Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) research fellows. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR ABDALLA SH, 1990, BLOOD CELLS, V16, P401
   Barber BE, 2016, J INFECT DIS, V214, P1557, DOI 10.1093/infdis/jiw427
   Barber BE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004558
   Barbier M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019651
   BESSMAN JD, 1981, AM J CLIN PATHOL, V76, P289
   BESSMAN JD, 1984, AM J HEMATOL, V16, P161, DOI 10.1002/ajh.2830160208
   Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021
   Brouwers J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064850
   Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815
   Coelho HCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063410
   Cruz LAB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006306
   de Mast Q, 2010, BRIT J HAEMATOL, V151, P495, DOI 10.1111/j.1365-2141.2010.08399.x
   Eto K, 2016, BLOOD, V127, P1234, DOI 10.1182/blood-2015-07-607903
   FACER CA, 1994, MICROBIOL IMMUNOL, V38, P727, DOI 10.1111/j.1348-0421.1994.tb01848.x
   Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC
   Gomes LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109246
   Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960
   Lacerda MVG, 2011, MEM I OSWALDO CRUZ, V106, P52, DOI 10.1590/S0074-02762011000900007
   Hanson J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0324-5
   Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   INYANG AL, 1987, BRIT J HAEMATOL, V66, P375, DOI 10.1111/j.1365-2141.1987.tb06926.x
   JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665
   Karanikas G, 2004, THROMB HAEMOSTASIS, V91, P553
   Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720
   Kho S, 2018, BLOOD, V132, P1332, DOI 10.1182/blood-2018-05-849307
   Kim MJ, 2014, BLOOD COAGUL FIBRIN, V25, P221, DOI 10.1097/MBC.0000000000000027
   Kraakman MJ, 2017, J CLIN INVEST, V127, P2133, DOI 10.1172/JCI92450
   KUTER DJ, 1994, P NATL ACAD SCI USA, V91, P11104, DOI 10.1073/pnas.91.23.11104
   Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615
   Lacerda MVG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-12
   Lee SP, 2006, ARTERIOSCL THROM VAS, V26, P1626, DOI 10.1161/01.ATV.0000220374.00602.a2
   Leligdowicz A, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2372-2
   Martinez-Salazar EL, 2014, REV SOC BRAS MED TRO, V47, P341, DOI 10.1590/0037-8682-0078-2014
   Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029
   Lopes SCP, 2014, J INFECT DIS, V209, P1403, DOI 10.1093/infdis/jiu018
   Martin JF, 2012, NAT REV CARDIOL, V9, P658, DOI 10.1038/nrcardio.2012.131
   McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892
   Millar FR, 2016, THORAX, V71, P462, DOI 10.1136/thoraxjnl-2015-207461
   Nhek S, 2017, ARTERIOSCL THROM VAS, V37, P707, DOI 10.1161/ATVBAHA.116.308126
   Nishimura S, 2015, J CELL BIOL, V209, P453, DOI 10.1083/jcb.201410052
   Obaldia N, 2018, MBIO, V9, DOI 10.1128/mBio.00625-18
   Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0
   Proenca-Ferreira R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089012
   Raza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081363
   Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361
   Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686
   Sun G, 2003, INFECT IMMUN, V71, P6553, DOI 10.1128/IAI.71.11.6553-6561.2003
   Supanaranond W, 1992, Platelets, V3, P195, DOI 10.3109/09537109209013183
   Turner GDH, 1998, AM J PATHOL, V152, P1477
   TURNER GDH, 1994, AM J PATHOL, V145, P1057
   Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216
   Val F, 2017, AM J TROP MED HYG, V97, P733, DOI 10.4269/ajtmh.17-0131
   Verma SK, 2015, SEMIN NEPHROL, V35, P96, DOI 10.1016/j.semnephrol.2015.01.010
   Wang JY, 2017, HEMATOLOGY, V22, P630, DOI 10.1080/10245332.2017.1333274
   Wassmer SC, 2004, J INFECT DIS, V189, P180, DOI 10.1086/380761
   Yeo TW, 2010, J INFECT DIS, V202, P109, DOI 10.1086/653211
NR 57
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2020
VL 14
IS 7
AR e0007656
DI 10.1371/journal.pntd.0007656
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA MR9ON
UT WOS:000553918800003
PM 32687542
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Aguiar, RS
   Pohl, F
   Morais, GL
   Nogueira, FCS
   de Carvalho, JB
   Guida, L
   Arge, LWP
   Melo, A
   Moreira, MEL
   Cunha, DP
   Gomes, L
   Portari, EA
   Velasquez, E
   Melani, RD
   Pezzuto, P
   de Castro, FL
   Geddes, VEV
   Gerber, AL
   Azevedo, GS
   Schamber-Reis, BL
   Goncalves, AL
   Junqueira-de-Azevedo, I
   Nishiyama, MY
   Ho, P
   Schanoski, A
   Schuch, V
   Tanuri, A
   Chimelli, L
   Vasconcelos, ZFM
   Domont, GB
   Vasconcelos, ATR
   Nakaya, HI
AF Aguiar, Renato S.
   Pohl, Fabio
   Morais, Guilherme L.
   Nogueira, Fabio C. S.
   de Carvalho, Joseane B.
   Guida, Leticia
   Arge, Luis W. P.
   Melo, Adriana
   Moreira, Maria E. L.
   Cunha, Daniela P.
   Gomes, Leonardo
   Portari, Elyzabeth A.
   Velasquez, Erika
   Melani, Rafael D.
   Pezzuto, Paula
   de Castro, Fernanda L.
   Geddes, Victor E. V.
   Gerber, Alexandra L.
   Azevedo, Girlene S.
   Schamber-Reis, Bruno L.
   Goncalves, Alessandro L.
   Junqueira-de-Azevedo, Inacio
   Nishiyama Jr, Milton Y.
   Ho, Paulo
   Schanoski, Alessandra
   Schuch, Viviane
   Tanuri, Amilcar
   Chimelli, Leila
   Vasconcelos, Zilton F. M.
   Domont, Gilberto B.
   Vasconcelos, Ana T. R.
   Nakaya, Helder, I
TI Molecular alterations in the extracellular matrix in the brains of
   newborns with congenital Zika syndrome
SO SCIENCE SIGNALING
LA English
DT Article
ID VIRUS-INFECTION; RNA-SEQ; COLLAGEN; MUTATIONS; DATABASE; VISUALIZATION;
   POLYMORPHISM; DISRUPTION; PROTEINS; REGIONS
AB Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.
C1 [Aguiar, Renato S.; Pezzuto, Paula; de Castro, Fernanda L.; Geddes, Victor E. V.; Goncalves, Alessandro L.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
   [Pohl, Fabio; Schuch, Viviane; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Morais, Guilherme L.; de Carvalho, Joseane B.; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.
   [Nogueira, Fabio C. S.; Velasquez, Erika; Melani, Rafael D.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.
   [Nogueira, Fabio C. S.] Univ Fed Rio de Janeiro, Inst Chem, LADETEC, Lab Prote, Rio De Janeiro, Brazil.
   [Guida, Leticia; Moreira, Maria E. L.; Cunha, Daniela P.; Gomes, Leonardo; Portari, Elyzabeth A.; Vasconcelos, Zilton F. M.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Melo, Adriana; Azevedo, Girlene S.] Inst Pesquisa Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Schamber-Reis, Bruno L.] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [Junqueira-de-Azevedo, Inacio; Nishiyama Jr, Milton Y.] Butantan Inst, Special Lab Appl Toxinol, Sao Paulo, Brazil.
   [Ho, Paulo; Schanoski, Alessandra] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.; Vasconcelos, ATR (corresponding author), LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.; Domont, GB (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.; Vasconcelos, ZFM (corresponding author), Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
EM chimelli@hucff.ufrj.br; zilton.vasconcelos@iff.fiocruz.br;
   gilbertodomont@gmail.com; atrv@lncc.br; hnakaya@usp.br
RI Junqueira-de-Azevedo, Inacio L. M./H-5239-2011; Nakaya, Helder
   I/A-1397-2010; NOGUEIRA, FABIO CESAR SOUSA/G-9580-2011; Center of
   Toxins, Immune-response/J-5731-2015; Junior, Milton Y
   Nishiyama/H-4002-2013; Nakaya, Helder/AAF-1738-2020; Aguiar,
   Renato/G-3542-2015
OI Junqueira-de-Azevedo, Inacio L. M./0000-0003-4491-0180; Nakaya, Helder
   I/0000-0001-5297-9108; NOGUEIRA, FABIO CESAR SOUSA/0000-0001-5507-7142;
   Junior, Milton Y Nishiyama/0000-0002-2410-0562; Nakaya,
   Helder/0000-0001-5297-9108; Pohl, Fabio/0000-0003-1695-4936;
   /0000-0002-2034-0294; Guida, Leticia/0000-0003-3543-1532; Geddes,
   Victor/0000-0002-0723-3873; Arge, Luis Willian
   Pacheco/0000-0002-0109-4809; Aguiar, Renato/0000-0001-5180-3717
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440900/2016-6, 313662/2017-7, 440613/2016-7, 303170/2017-4]; CAPESCAPES
   [88881.130757/2016-01, 001, 88887.130697]; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [01.16.0078.00]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/50137-3, 2012/19278-6, 2018/14933-2, 2018/21934-5, 2013/08216-2];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/202.650/2018, 26/202.903/20]
FX This research was supported by CNPq (grant no. 440900/2016-6), CAPES
   (grant no. 88881.130757/2016-01), and FINEP (grant no. 01.16.0078.00).
   H.I.N. is supported by CNPq (313662/2017-7) and the Sao Paulo Research
   Foundation (FAPESP; grants 2017/50137-3, 2012/19278-6, 2018/14933-2,
   2018/21934-5, and 2013/08216-2). F.L.d.C., V.E.V.G., J.B.C., and
   L.W.P.A. are funded by CAPES (grant 001). G.B.D. has financial support
   from grants 88887.130697 (CAPES) and 440613/2016-7 (CNPq). F.C.S.N. is
   supported by FAPERJ (E-26/202.650/2018). A.T.R.V. is supported by CNPq
   (303170/2017-4) and FAPERJ (26/202.903/20).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274
   Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954
   Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen Y, 2017, INT J CLIN EXP MED, V10, P14904
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckx S, 2016, FASEB J, V30, P2651, DOI 10.1096/fj.201500096R
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dittrich R, 2007, NEUROLOGY, V68, P2120, DOI 10.1212/01.wnl.0000264892.92538.a9
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faqeih E, 2009, AM J MED GENET A, V149A, P461, DOI 10.1002/ajmg.a.32653
   Fernandez-Calle R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0823-8
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gorshkov V, 2015, ANAL CHEM, V87, P6319, DOI 10.1021/acs.analchem.5b01166
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HIPC-CHI Signatures Project Team; HIPC-I Consortium, 2017, SCI IMMUNOL, V2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797
   Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larroche J.-C., 1977, DEV PATHOLOGY NEONAT, Vxviii
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024
   Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026
   Maness PF, 2007, NAT NEUROSCI, V10, P263, DOI 10.1038/nn0207-263b
   Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703
   Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007
   Plotkin Horacio, 2004, BMC Pediatr, V4, P16, DOI 10.1186/1471-2431-4-16
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004
   Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907
   Schiela B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02177
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   Useche YM, 2019, J INFECT PUBLIC HEAL, V12, P43, DOI 10.1016/j.jiph.2018.08.009
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   van der Velde KJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1141-7
   Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weng YC, 2012, ANN NEUROL, V71, P470, DOI 10.1002/ana.22682
   Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114
   Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443
   Zhu Zhe, 2017, J Exp Med, V214, P3145, DOI 10.1084/jem.2017109309122017c
   Zou YQ, 2014, HUM MOL GENET, V23, P2339, DOI 10.1093/hmg/ddt627
NR 86
TC 1
Z9 1
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JUN 9
PY 2020
VL 13
IS 635
AR eaay6736
DI 10.1126/scisignal.aay6736
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LY4UD
UT WOS:000540523900001
PM 32518143
DA 2020-12-17
ER

PT J
AU Dias, TL
   Schuch, V
   Beltrao-Braga, PCB
   Martins-de-Souza, D
   Brentani, HP
   Franco, GR
   Nakaya, HI
AF Dias, Thomaz Luscher
   Schuch, Viviane
   Baleeiro Beltrao-Braga, Patricia Cristina
   Martins-de-Souza, Daniel
   Brentani, Helena Paula
   Franco, Gloria Regina
   Nakaya, Helder Imoto
TI Drug repositioning for psychiatric and neurological disorders through a
   network medicine approach
SO TRANSLATIONAL PSYCHIATRY
LA English
DT Article
ID INFLAMMATORY-BOWEL-DISEASE; ALZHEIMERS-DISEASE; CIRCADIAN-RHYTHM;
   SCHIZOPHRENIA; PREVALENCE; DEPRESSION; RISK; NEUROPATHOLOGY;
   ASSOCIATION; HUNTINGTIN
AB Psychiatric and neurological disorders (PNDs) affect millions worldwide and only a few drugs achieve complete therapeutic success in the treatment of these disorders. Due to the high cost of developing novel drugs, drug repositioning represents a promising alternative method of treatment. In this manuscript, we used a network medicine approach to investigate the molecular characteristics of PNDs and identify novel drug candidates for repositioning. Using IBM Watson for Drug Discovery, a powerful machine learning text-mining application, we built knowledge networks containing connections between PNDs and genes or drugs mentioned in the scientific literature published in the past 50 years. This approach revealed several drugs that target key PND-related genes, which have never been used to treat these disorders to date. We validate our framework by detecting drugs that have been undergoing clinical trial for treating some of the PNDs, but have no published results in their support. Our data provides comprehensive insights into the molecular pathology of PNDs and offers promising drug repositioning candidates for follow-up trials.
C1 [Dias, Thomaz Luscher; Franco, Gloria Regina] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Schuch, Viviane; Nakaya, Helder Imoto] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
   [Baleeiro Beltrao-Braga, Patricia Cristina; Nakaya, Helder Imoto] Sci Platform Pasteur USP, Sao Paulo, Brazil.
   [Martins-de-Souza, Daniel] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Lab Neuroprote, Campinas, Brazil.
   [Martins-de-Souza, Daniel] Conselho Nacl Desenvolvimento Cient & Tecnol, Inst Nacl Biomarcadores Neuropsiquiatria, Sao Paulo, Brazil.
   [Martins-de-Souza, Daniel] Univ Estadual Campinas, Expt Med Res Cluster EMRC, Campinas, Brazil.
   [Martins-de-Souza, Daniel] DOr Inst Reasearch & Educ IDOR, Sao Paulo, Brazil.
   [Brentani, Helena Paula] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Inst Psiquiatria, Sao Paulo, Brazil.
   [Brentani, Helena Paula] Natl Inst Dev Psychiat Children & Adolescents INP, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.; Nakaya, HI (corresponding author), Sci Platform Pasteur USP, Sao Paulo, Brazil.
EM hnakaya@usp.br
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010;
   Martins-de-Souza, Daniel/E-7021-2010; Beltrao-Braga,
   Patricia/D-6450-2013
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Martins-de-Souza, Daniel/0000-0003-3595-5846;
   Beltrao-Braga, Patricia/0000-0003-0004-1091
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research
   Foundation) [2019/00098-7, 2018/03673-0, 2018/16748-8, 2017/25588-1,
   2014/10068-4] Funding Source: Medline; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (Brazilian Federal Agency for the Support and
   Evaluation of Graduate Education) [001] Funding Source: Medline
CR Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757
   ASADURRAHMAN FNU, 2016, CUREUS, V8, P8, DOI DOI 10.18605/2175-7275/cereus.v8nespp8
   Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P840, DOI 10.1016/j.bbi.2010.09.002
   Baio J, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6706a1
   Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Boloc D, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0330-4
   Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038
   Bradley AJ, 2017, PSYCHOL MED, V47, P1678, DOI 10.1017/S0033291717000186
   Bugarski-Kirola D, 2016, LANCET PSYCHIAT, V3, P1115, DOI 10.1016/S2215-0366(16)30344-3
   Bulut M, 2019, PSYCHIAT RES, V272, P73, DOI 10.1016/j.psychres.2018.12.073
   Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012
   Carvalho-Silva D, 2019, NUCLEIC ACIDS RES, V47, pD1056, DOI 10.1093/nar/gky1133
   Cassoli JS, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.34
   Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104
   Chen Y, 2016, CLIN THER, V38, P688, DOI 10.1016/j.clinthera.2015.12.001
   Chiarini A, 2015, CURR PHARM BIOTECHNO, V16, P696, DOI 10.2174/1389201016666150505123813
   Cipriani A, 2018, LANCET, V391, P1357, DOI 10.1016/S0140-6736(17)32802-7
   D'Souza DC, 2018, BIOL PSYCHIAT, V84, P413, DOI 10.1016/j.biopsych.2017.12.019
   Dal Pra I, 2014, NEUROMOL MED, V16, P645, DOI 10.1007/s12017-014-8315-9
   de Baumont A, 2015, SCHIZOPHR RES, V161, P215, DOI 10.1016/j.schres.2014.10.055
   Dong Y, 2018, ANN NEUROL, V83, P387, DOI 10.1002/ana.25159
   Doshi-Velez F, 2015, INFLAMM BOWEL DIS, V21, P2281, DOI 10.1097/MIB.0000000000000502
   Gandal MJ, 2018, SCIENCE, V362, P1265, DOI 10.1126/science.aat8127
   Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469
   Gitlin MJ, 2018, INT J BIPOLAR DISORD, V6, DOI 10.1186/s40345-018-0133-9
   Gomez AF, 2018, EXPERT OPIN PHARMACO, V19, P883, DOI 10.1080/14656566.2018.1472767
   Hogg E, 2018, J PARKINSON DIS, V8, P259, DOI 10.3233/JPD-181305
   Holohan Kelly N., 2013, Frontiers in Genetics, V3, P323, DOI 10.3389/fgene.2012.00323
   Igoumenou A, 2012, HEART ASIA, V4, P44, DOI 10.1136/heartasia-2012-010099
   Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379
   Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200
   Jablensky Assen, 2010, Dialogues Clin Neurosci, V12, P271
   Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9
   Jauhar S, 2019, INT J BIPOLAR DISORD, V7, DOI 10.1186/s40345-019-0145-0
   Kahn RS, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.67
   Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44
   Kang DW, 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2
   Kelmendi B, 2011, NEUROSCI LETT, V496, P195, DOI 10.1016/j.neulet.2011.04.026
   Kim J, 2017, MOL CELLS, V40, P450, DOI 10.14348/molcells.2017.0065
   Koh MT, 2018, SCHIZOPHR RES, V193, P119, DOI 10.1016/j.schres.2017.06.027
   Kohler-Forsberg O, 2017, BRAIN BEHAV IMMUN, V62, P344, DOI 10.1016/j.bbi.2017.02.020
   Ku SM, 2017, NEUROTHERAPEUTICS, V14, P698, DOI 10.1007/s13311-017-0538-7
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Ledonne A, 2018, PHARMACOL RES, V130, P12, DOI 10.1016/j.phrs.2018.02.003
   Malik M, 2015, HUM MOL GENET, V24, P3557, DOI 10.1093/hmg/ddv092
   Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013
   Martins-de-Souza D, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.129
   Martins-de-Souza D, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.13
   Martins-de-Souza D, 2020, EUR ARCH PSY CLIN N, V270, P127, DOI 10.1007/s00406-019-01002-3
   Mistry S, 2019, J AFFECT DISORDERS, V246, P633, DOI 10.1016/j.jad.2018.12.091
   Mizuno M, 2010, J PHARMACOL SCI, V114, P320, DOI 10.1254/jphs.10099FP
   Naglieri Jack A., 2000, DIAGNOSTIC STAT MANU, P84
   Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379
   Palmese LB, 2011, SCHIZOPHR RES, V133, P238, DOI 10.1016/j.schres.2011.07.030
   Palmieri O, 2015, CHRONOBIOL INT, V32, P903, DOI 10.3109/07420528.2015.1050726
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016
   Sastry PSRK, 2004, MED HYPOTHESES, V62, P542, DOI 10.1016/j.mehy.2003.11.026
   Schroll H, 2016, MOVEMENT DISORD, V31, P1591, DOI 10.1002/mds.26719
   Simon NG, 2017, PROG NEUROBIOL, V152, P1, DOI 10.1016/j.pneurobio.2017.04.001
   So H.-c., 2018, PSYCHOL MED, V49, P2692
   Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x
   Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176
   Tian Z, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0658-7
   Uher R, 2014, AM J PSYCHIAT, V171, P1278, DOI 10.1176/appi.ajp.2014.14010094
   van Dam S, 2017, BRIEF BIOINFORM, V19, pbbw139
   Wehr MC, 2017, EMBO MOL MED, V9, P1448, DOI 10.15252/emmm.201707691
   Wehr TA, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0203-x
   Weingarden AR, 2017, GUT MICROBES, V8, P238, DOI 10.1080/19490976.2017.1290757
   Who, 2017, DEPR OTH COMM MENT D, V24
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   World Health Organization, 2001, WORLD HLTH REPORT 20
   Zahid I, 2018, INDIAN HEART J, V70, pS199, DOI 10.1016/j.ihj.2018.10.410
   Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029
   Zenaro E, 2015, NAT MED, V21, P880, DOI 10.1038/nm.3913
   Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336
NR 77
TC 1
Z9 1
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2158-3188
J9 TRANSL PSYCHIAT
JI Transl. Psychiatr.
PD MAY 12
PY 2020
VL 10
IS 1
DI 10.1038/s41398-020-0827-5
PG 10
WC Psychiatry
SC Psychiatry
GA LR6OP
UT WOS:000535812300008
PM 32398742
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Trevisan, CM
   Naslavsky, MS
   Monfardini, F
   Wang, JQ
   Zatz, M
   Peluso, C
   Pellegrino, R
   Mafra, F
   Hakonarson, H
   Ferreira, FM
   Nakaya, H
   Christofolini, DM
   Montagna, E
   Crandall, KA
   Barbosa, CP
   Bianco, B
AF Trevisan, Camila Martins
   Naslavsky, Michel Satya
   Monfardini, Frederico
   Wang, Jaqueline
   Zatz, Mayana
   Peluso, Carla
   Pellegrino, Renata
   Mafra, Fernanda
   Hakonarson, Hakon
   Ferreira, Frederico Moraes
   Nakaya, Helder
   Christofolini, Denise Maria
   Montagna, Erik
   Crandall, Keith A.
   Barbosa, Caio Parente
   Bianco, Bianca
TI Variants in the Kisspeptin-GnRH Pathway Modulate the Hormonal Profile
   and Reproductive Outcomes
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE kisspeptin; in vitro fertilization; single nucleotide variation; KISS1;
   KISS1R; GNRHR
ID PROTEIN-COUPLED RECEPTOR; HYPOGONADOTROPIC HYPOGONADISM;
   LUTEINIZING-HORMONE; ARCUATE NUCLEUS; GENE; EXPRESSION; KISS-1;
   POLYMORPHISMS; SYSTEM; GPR54
AB Kisspeptin has been identified as a key regulatory protein in the release of gonadotropin-releasing hormone (GnRH), which subsequently increases gonadotropin secretion during puberty to establish reproductive function and regulate the hypothalamic-pituitary-gonadal axis. The effects of variants in the KISS1, KISS1R, and GNRHR genes and their possible association with assisted reproduction outcomes remain to be elucidated. In this study, we used next-generation sequencing to investigate the associations of the genetic diversity at the candidate loci for KISS1, KISS1R, and GNRHR with the hormonal profiles and reproductive outcomes in 86 women who underwent in vitro fertilization treatments. Variants in the KISS1 and KISS1R genes were associated with luteinizing hormone (rs35431622:T>C), anti-Mullerian hormone (rs71745629delT), follicle-stimulating hormone (rs73507529:C>A), and estradiol (rs73507527:G>A, rs350130:A>G, and rs73507529:C>A) levels, as well as with reproductive outcomes such as the number of oocytes retrieved (s35431622:T>C), metaphasis II oocytes (rs35431622:T>C), and embryos (rs1132506:G>C). Additionally, variants in the GNRHR UTR3 ' (rs1038426:C>A, rs12508464:A>C, rs13150734:C>A, rs17635850:A>G, rs35683646:G>A, rs35610027:C>G, rs35845954:T>C, rs17635749:C>T, and rs7666201:C>T) were associated with low prolactin levels. A conjoint analysis of clinical, hormonal, and genetic variables using a generalized linear model identified two variants of the KISS1 gene (rs71745629delT and rs1132506:G>C) that were significantly associated with hormonal variations and reproductive outcomes. The findings suggest that variants in KISS1, KISS1R, and GNRHR genes can modulate hormone levels and reproductive outcomes.
C1 [Trevisan, Camila Martins; Peluso, Carla; Christofolini, Denise Maria; Barbosa, Caio Parente; Bianco, Bianca] FMABC, Ctr Univ Saude ABC, Dept Collect Hlth, Discipline Sexual & Reprod Hlth & Populat Genet, Santo Andre 09060870, SP, Brazil.
   [Naslavsky, Michel Satya; Monfardini, Frederico; Wang, Jaqueline; Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Sao Paulo, Brazil.
   [Pellegrino, Renata; Mafra, Fernanda; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.
   [Ferreira, Frederico Moraes; Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Montagna, Erik] FMABC, Ctr Univ Saude ABC, Postgrad Program Hlth Sci Res & Innovat, Santo Andre, SP, Brazil.
   [Crandall, Keith A.] George Washington Univ, Milken Inst Sch Publ Hlth, Computat Biol Inst, Washington, DC USA.
RP Bianco, B (corresponding author), FMABC, Ctr Univ Saude ABC, Dept Collect Hlth, Discipline Sexual & Reprod Hlth & Populat Genet, Santo Andre 09060870, SP, Brazil.
EM bianca.bianco@fmabc.br
RI Trevisan, Camila Martins/H-3557-2015; Nakaya, Helder I/A-1397-2010;
   Nakaya, Helder/AAF-1738-2020; BIANCO, BIANCA/C-2488-2012; Montagna,
   Erik/B-9473-2014
OI Trevisan, Camila Martins/0000-0003-2125-5566; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Bianco,
   Bianca/0000-0001-8669-3562; Montagna, Erik/0000-0001-6834-0261; Barbosa,
   Caio/0000-0002-2922-0264
FU Sao Paulo Research Foundation -FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/06177-2, 2016/25953-9]
FX This work was supported by grants from Sao Paulo Research Foundation
   -FAPESP #2014/06177-2 and #2016/25953-9.
CR [Anonymous], 2019, Obstet Gynecol, V133, pe377, DOI 10.1097/AOG.0000000000003271
   Balaban B, 2011, HUM REPROD, V26, pI24
   Balasch J, 2006, REPROD BIOMED ONLINE, V12, P406, DOI 10.1016/S1472-6483(10)61991-8
   Barbosa CP, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-11
   BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883
   Beneduzzi D, 2014, FERTIL STERIL, V102, P838, DOI 10.1016/j.fertnstert.2014.05.044
   Boehm U, 2015, NAT REV ENDOCRINOL, V11, P547, DOI 10.1038/nrendo.2015.112
   Broekmans FJM, 2010, FERTIL STERIL, V94, P1044, DOI 10.1016/j.fertnstert.2009.04.040
   Roman AC, 2012, FERTIL STERIL, V97, P1213, DOI 10.1016/j.fertnstert.2012.02.021
   Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8
   Chen WY, 2017, J HUM GENET, V62, P1065, DOI 10.1038/jhg.2017.85
   Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001
   Rodrigues NPD, 2019, ARCH GYNECOL OBSTET, V300, P1423, DOI 10.1007/s00404-019-05307-5
   de Mattos CS, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0114-2
   de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100
   Di Paola R, 2018, ARCH GYNECOL OBSTET, V298, P1029, DOI 10.1007/s00404-018-4906-2
   Fernandois D, 2016, J ENDOCRINOL, V228, P161, DOI 10.1530/JOE-15-0429
   Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039
   Freeman ME, 2000, PHYSIOL REV, V80, P1523
   Garcia-Ortega J, 2014, HUM REPROD, V29, P2736, DOI 10.1093/humrep/deu247
   Gutierrez-Pascual E, 2007, J NEUROENDOCRINOL, V19, P521, DOI 10.1111/j.1365-2826.2007.01558.x
   Hu KL, 2019, REPROD SCI, V26, P1429, DOI 10.1177/1933719118818899
   Hu KL, 2018, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00365
   Kaya C, 2019, GYNECOL ENDOCRINOL, V35, P228, DOI 10.1080/09513590.2018.1519792
   KNOBIL E, 1980, SCIENCE, V207, P1371, DOI 10.1126/science.6766566
   Knobil E, 1974, Recent Prog Horm Res, V30, P1
   Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200
   La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037
   LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444
   Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078
   Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Matoulkova E, 2012, RNA BIOL, V9, P563, DOI 10.4161/rna.20231
   Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102
   Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443
   Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Navarro VM, 2004, ENDOCRINOLOGY, V145, P4565, DOI 10.1210/en.2004-0413
   Noel SD, 2011, MOL CELL ENDOCRINOL, V346, P91, DOI 10.1016/j.mce.2011.06.022
   Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005
   Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135
   Peluso C, 2014, CLIN CHIM ACTA, V437, P175, DOI 10.1016/j.cca.2014.07.029
   Peng J, 2013, FERTIL STERIL, V99, P1436, DOI 10.1016/j.fertnstert.2012.12.008
   Penzias A, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.02.107
   Pfeifer S, 2015, FERTIL STERIL, V103, pE44, DOI 10.1016/j.fertnstert.2015.03.019
   Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365
   Ponomarenko JV, 2002, HUM MUTAT, V20, P239, DOI 10.1002/humu.10116
   R Core Team, 2018, R LANG ENV STAT COMP
   Richard N, 2009, PEPTIDES, V30, P123, DOI 10.1016/j.peptides.2008.09.015
   Rometo AM, 2007, J CLIN ENDOCR METAB, V92, P2744, DOI 10.1210/jc.2007-0553
   Sadee W, 2011, CLIN PHARMACOL THER, V89, P355, DOI 10.1038/clpt.2010.314
   Sebert ME, 2010, DOMEST ANIM ENDOCRIN, V38, P289, DOI 10.1016/j.domaniend.2010.01.001
   Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322
   Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421
   Simoni M, 1995, REPROD MED REV, V4, P163
   Smith JT, 2011, ENDOCRINOLOGY, V152, P1001, DOI 10.1210/en.2010-1225
   Teles MG, 2011, MOL CELL ENDOCRINOL, V346, P84, DOI 10.1016/j.mce.2011.05.019
   Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184
   Trevisan CM, 2018, CELL PHYSIOL BIOCHEM, V49, P1259, DOI 10.1159/000493406
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   Varikasuvu SR, 2019, REPROD BIOMED ONLINE, V39, P685, DOI 10.1016/j.rbmo.2019.04.018
   Vaziri H., 2017, GENE CELL TISSUE, V4, pe12355
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   West A, 1998, GENOMICS, V54, P145, DOI 10.1006/geno.1998.5566
   World Health Organisation, 2010, EX PROC HUM SEM
   Zhai JY, 2017, GYNECOL ENDOCRINOL, V33, P560, DOI 10.1080/09513590.2017.1296129
NR 66
TC 1
Z9 1
U1 1
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD JUN 1
PY 2020
VL 39
IS 6
BP 1012
EP 1022
DI 10.1089/dna.2019.5165
EA APR 2020
PG 11
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA LU4AJ
UT WOS:000530002100001
PM 32352843
DA 2020-12-17
ER

PT J
AU Sorgi, S
   Bonezi, V
   Dominguez, MR
   Gimenez, AM
   Dobrescu, I
   Boscardin, S
   Nakaya, HI
   Bargieri, DY
   Soares, IS
   Silveira, ELV
AF Sorgi, Sara
   Bonezi, Vivian
   Dominguez, Mariana R.
   Gimenez, Alba Marina
   Dobrescu, Irina
   Boscardin, Silvia
   Nakaya, Helder I.
   Bargieri, Daniel Y.
   Soares, Irene S.
   Silveira, Eduardo L. V.
TI Sao Paulo School of Advanced Sciences on Vaccines: an overview
SO JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
LA English
DT Review
DE Vaccine history; WHO priorities and challenges; Immune responses;
   Antigen search; Delivery systems and strategies
ID T-CELL RESPONSES; DENDRITIC CELLS; ZIKA VIRUS; SCHISTOSOMA-MANSONI;
   TRYPANOSOMA-CRUZI; PROTECTIVE IMMUNITY; BINDING-PROTEIN; WHOLE-GENOME;
   SEROGROUP-B; IN-VITRO
AB Two years ago, we held an exciting event entitled the Sao Paulo School of Advanced Sciences on Vaccines (SPSASV). Sixty-eight Ph.D. students, postdoctoral fellows and independent researchers from 37 different countries met at the Mendes Plaza Hotel located in the city of Santos, SP - Brazil to discuss the challenges and the new frontiers of vaccinology. The SPSASV provided a critical and comprehensive view of vaccine research from basics to the current state-of-the-art techniques performed worldwide. For 10 days, we discussed all the aspects of vaccine development in 36 lectures, 53 oral presentations and 2 poster sessions. At the end of the course, participants were further encouraged to present a model of a grant proposal related to vaccine development against individual pathogens. Among the targeted pathogens were viruses (Chikungunya, HIV, RSV, and Influenza), bacteria (Mycobacterium tuberculosis and Streptococcus pyogenes), parasites (Plasmodium falciparum or Plasmodium vivax), and the worm Strongyloides stercoralis. This report highlights some of the knowledge shared at the SPSASV.
C1 [Sorgi, Sara; Bonezi, Vivian; Dominguez, Mariana R.; Gimenez, Alba Marina; Nakaya, Helder I.; Soares, Irene S.; Silveira, Eduardo L. V.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.
   [Sorgi, Sara] Univ Siena, Dipartimento Biotecnol Med, Siena, Italy.
   [Dobrescu, Irina; Boscardin, Silvia; Bargieri, Daniel Y.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, SP, Brazil.
RP Silveira, ELV (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.
EM eduardosilveira@usp.br
RI Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020; Soares,
   Irene Silva/C-5974-2012; Silveira, Eduardo L V/E-5733-2014; Gimenez,
   Alba Marina/I-3456-2018; Dominguez, Mariana R/E-8407-2017
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Soares, Irene Silva/0000-0002-3336-6856;
   Silveira, Eduardo L V/0000-0001-8333-2884; Gimenez, Alba
   Marina/0000-0001-8251-1346; Dominguez, Mariana/0000-0002-3517-3599
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/17349-7]; Brazilian Society of Immunology; National Institute of
   Science and Technology for Vaccines
FX The financial support of the event Sao Paulo School of Advanced Sciences
   on Vaccines was provided mostly by FAPESP (grant number 2017/17349-7) as
   well as the Brazilian Society of Immunology, and the National Institute
   of Science and Technology for Vaccines. The School of Pharmaceutical
   Sciences (USP), Pro-reitoria de Pesquisa (USP), Biomedical Sciences
   Institute (USP), BD Biosciences, Eppendorf and Synapse also contributed
   to this event.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ackerman ME, 2018, NAT MED, V24, P1590, DOI 10.1038/s41591-018-0161-0
   Aguiar JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136109
   Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009
   Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114
   Bear JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31272-1
   Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639
   Butkeviciute E, 2018, FUTURE MICROBIOL, V13, P1193, DOI 10.2217/fmb-2018-0026
   Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297
   Byberg S, 2017, VACCINE, V35, P33, DOI 10.1016/j.vaccine.2016.11.049
   Calvert AE, 2016, ANTIVIR RES, V131, P92, DOI 10.1016/j.antiviral.2016.04.013
   Campi-Azevedo AC, 2019, EMERG INFECT DIS, V25, P1511, DOI 10.3201/eid2508.181432
   Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711
   de Paiva RMC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005296
   Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815
   Christopher M. E., 2011, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V10, P327
   Clemente T, 2013, METHODS, V61, P105, DOI 10.1016/j.ymeth.2013.02.007
   Clemente T, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.506
   Coventry BJ, 2002, BRIT J CANCER, V86, P546, DOI 10.1038/sj.bjc.6600132
   Cox Manon M J, 2015, Ther Adv Vaccines, V3, P97, DOI 10.1177/2051013615595595
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030
   Dall'Oglio Marcos, 2003, Int. braz j urol., V29, P517, DOI 10.1590/S1677-55382003000600006
   Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672
   Damasceno L, 2017, PROTEIN EXPRES PURIF, V134, P72, DOI 10.1016/j.pep.2017.04.002
   de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08
   Denapoli PMA, 2017, FRONT PARASITOL, P531
   Dillon PM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0295-5
   Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011
   Duarte-Neto AN, 2019, HISTOPATHOLOGY, V75, P638, DOI 10.1111/his.13904
   Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652
   Eickhoff CS, 2019, VACCINE, V37, P5364, DOI 10.1016/j.vaccine.2019.07.034
   Exner M, 2017, GMS HYG INFECT CONTR, V12, DOI 10.3205/dgkh000290
   Farrington CP, 2009, TROP MED INT HEALTH, V14, P977, DOI 10.1111/j.1365-3156.2009.02302.x
   Farrington CP, 2014, BMJ-BRIT MED J, V311, P484
   Favorov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032567
   Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095
   Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f
   France MM, 2017, J CELL SCI, V130, P307, DOI 10.1242/jcs.193482
   Freyne B, 2015, T ROY SOC TROP MED H, V109, P52, DOI 10.1093/trstmh/tru197
   Freyne B, 2014, ARCH DIS CHILD, V99, P182, DOI 10.1136/archdischild-2013-305655
   Gimenez AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01275
   Grimaldi G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002853
   Halle S, 2017, TRENDS IMMUNOL, V38, P432, DOI 10.1016/j.it.2017.04.002
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Holscher C, 1998, INFECT IMMUN, V66, P1208
   Huang CJ, 2011, APPL MICROBIOL BIOT, V90, P235, DOI 10.1007/s00253-011-3118-5
   INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849
   Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927
   INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631
   Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0
   Junqueira C, 2018, NAT MED, V24, P1330, DOI 10.1038/s41591-018-0117-4
   Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC
   Kallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2
   Kanoi BN, 2017, VACCINE, V35, P873, DOI 10.1016/j.vaccine.2017.01.001
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Lage SL, 2013, P NATL ACAD SCI USA, V110, pE3321, DOI 10.1073/pnas.1305316110
   Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li Y, 2011, J GENE MED, V13, P60, DOI 10.1002/jgm.1536
   Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811
   Lopes SCP, 2014, J INFECT DIS, V209, P1403, DOI 10.1093/infdis/jiu018
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Luiz WB, 2015, INFECT IMMUN, V83, P4555, DOI 10.1128/IAI.00858-15
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Martins KAO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089735
   Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502
   Matarrese P, 2005, J BIOL CHEM, V280, P6969, DOI 10.1074/jbc.M409752200
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009
   Meyer-Hermann M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02020
   Morita M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46086
   Moriyama M, 2017, VACCINE, V35, P6620, DOI 10.1016/j.vaccine.2017.10.038
   Nagato T, 2014, CLIN CANCER RES, V20, P1223, DOI 10.1158/1078-0432.CCR-13-2781
   Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b
   Nankabirwa V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1497-8
   Ntege EH, 2016, VACCINE, V34, P5612, DOI 10.1016/j.vaccine.2016.09.028
   Nussenzweig MC, 2012, P NATL ACAD SCI US
   Oliveira AC, 2017, ELIFE, V6, DOI [10.7554/eLife.30883, 10.7554/elife.30883]
   Oliveira AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000870
   Owczarek B, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4216060
   Pinho MP, 2016, CYTOTHERAPY, V18, P570, DOI 10.1016/j.jcyt.2016.01.005
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Pollard AJ, 2017, ARCH DIS CHILD, V102, P1077, DOI 10.1136/archdischild-2015-310282
   Polonio CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0131-x
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960
   Regina-Silva S, 2016, VACCINE, V34, P2233, DOI 10.1016/j.vaccine.2016.03.019
   Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09
   Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC
   ROSA DS, 2011, J VACCINES VACCIN, V6, DOI DOI 10.1371/JOURNAL.PONE.0016921
   Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Santos PM, 2018, J IMMUNOL, V200, P443, DOI 10.4049/jimmunol.1701024
   Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033
   Shao BZ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00320
   Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09
   SMITHERS SR, 1989, PARASITE IMMUNOL, V11, P301, DOI 10.1111/j.1365-3024.1989.tb00669.x
   STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142
   Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x
   Tagliabue A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01068
   Tendler M, 1996, P NATL ACAD SCI USA, V93, P269, DOI 10.1073/pnas.93.1.269
   Thomas R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00947
   Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005
   Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07
   Uthayakumar D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02869
   Vasconcelos JR, 2014, HUM GENE THER, V25, P350, DOI 10.1089/hum.2013.218
   Vasconcelos JR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002699
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032
   Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040
   Wang YM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00374
   World Health Organization, 2019, WORLD MAL REP 2018
   World Health Organization, DIS SPEC AR WORK
   World Health Organization, GLOB VACC ACT PLAN
   Yau HL, 2017, BIORXIV
   Zufferey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077334
NR 120
TC 0
Z9 0
U1 1
U2 1
PU CEVAP-SAO PAULO STATE UNIV-UNESP
PI BOTUCATU
PA CENTER STUDY VENOMS & VENOMOUS, SUA JOSE BARROS, BOTUCATU, SP 18610-307,
   BRAZIL
EI 1678-9199
J9 J VENOM ANIM TOXINS
JI J. Venom. Anim. Toxins Trop. Dis.
PD APR 6
PY 2020
VL 26
AR E20190061
DI 10.1590/1678-9199-JVATITD-2019-0061
PG 14
WC Toxicology; Tropical Medicine; Zoology
SC Toxicology; Tropical Medicine; Zoology
GA LC5DA
UT WOS:000525344000001
PM 32362926
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bonezi, V
   Cataneo, AHD
   Branquinho, MSF
   Silva, MBB
   Gonzalez-Dias, P
   Pereira, SS
   Ferreira, LCD
   Nakaya, HI
   Campa, A
   Wowk, PF
   Silveira, ELV
AF Bonezi, Vivian
   Cataneo, Allan H. D.
   Branquinho, Maryana S. F.
   Silva, Maysa B. B.
   Gonzalez-Dias, Patricia
   Pereira, Samuel S.
   de Souza Ferreira, Luis C.
   Nakaya, Helder, I
   Campa, Ana
   Wowk, Pryscilla F.
   Silveira, Eduardo L., V
TI Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting
   Cells in Humans Is Associated With the Activation of the Tryptophan
   Metabolism
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Dengue virus; B cell differentiation; antibody-secreting cells;
   tryptophan metabolism; flaviviruses
ID DENGUE VIRUS-INFECTION; HUMAN MONOCLONAL-ANTIBODIES; INDOLEAMINE
   2,3-DIOXYGENASE; INTERFERON-GAMMA; PLASMABLAST RESPONSE; IMMUNE
   ACTIVATION; SERUM; LYMPHOCYTES; DEFICIENCY; INHIBITION
AB Patients infected with the Dengue virus (DENV) often present with a massive generation of DENV-specific antibody-secreting cells (ASCs) in the blood. In some cases, these ASCs represent more than 50% of the circulating B cells, a higher magnitude than those induced by other infections, vaccinations, and plasma cell lymphomas. However, it remains unclear how the DENV infection elicits this colossal response. To address this issue, we utilised an in vitro strategy to induce human PBMCs of healthy individuals incubated with DENV particles (DENV4 TVP/360) to differentiate into ASCs. As controls, PBMCs were incubated with a mitogen cocktail or supernatants of uninfected C6/36 cells (mock). The ASC phenotype and function were increasingly detected in the DENV and mitogen-cultured PBMCs as compared to mock-treated cells. In contrast to the in vivo condition, secreted IgG derived from the PBMC-DENV culture was not DENV-specific. Lower ASC numbers were observed when inactivated viral particles or purified B cells were added to the cultures. The physical contact was essential between B cells and the remaining PBMCs for the DENV-mediated ASC response. Considering the evidence for the activation of the tryptophan metabolism detected in the serum of Dengue patients, we assessed its relevance in the DENV-mediated ASC differentiation. For this, tryptophan and its respective metabolites were quantified in the supernatants of cell cultures through mass spectrophotometry. Tryptophan depletion and kynurenine accumulation were found in the supernatants of PBMC-DENV cultures, which presented enhanced detection of indoleamine 2,3-dioxygenase 1 and 2 transcripts as compared to controls. In PBMC-DENV cultures, tryptophan and kynurenine levels strongly correlated to the respective ASC numbers, while the kynurenine levels were directly proportional to the secreted IgG titers. Contrastingly, PBMCs incubated with Zika or attenuated Yellow Fever viruses showed no correlation between their kynurenine concentrations and ASC numbers. Therefore, our data revealed the existence of distinct pathways for the DENV-mediated ASC differentiation and suggest the involvement of the tryptophan metabolism in this cellular process triggered by flavivirus infections.
C1 [Bonezi, Vivian; Branquinho, Maryana S. F.; Silva, Maysa B. B.; Gonzalez-Dias, Patricia; Nakaya, Helder, I; Campa, Ana; Silveira, Eduardo L., V] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Cataneo, Allan H. D.; Wowk, Pryscilla F.] Fiocruz Parana, Lab Virol Mol, ICC, Curitiba, Parana, Brazil.
   [Gonzalez-Dias, Patricia; Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
   [Pereira, Samuel S.; de Souza Ferreira, Luis C.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
RP Silveira, ELV (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
EM eduardosilveira@usp.br
RI Nakaya, Helder/AAF-1738-2020; Silveira, Eduardo L V/E-5733-2014; Nakaya,
   Helder I/A-1397-2010; Wowk, Pryscilla Fanini/AAR-7230-2020
OI Nakaya, Helder/0000-0001-5297-9108; Silveira, Eduardo L
   V/0000-0001-8333-2884; Nakaya, Helder I/0000-0001-5297-9108; Wowk,
   Pryscilla/0000-0002-8976-2647
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [420616/2016-0]; FapespFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2017/11931-6]; Programa de Apoio aos Novos Docentes
   (University of Sao Paulo)
FX This study was supported by CNPq (Grant No. 420616/2016-0), Fapesp
   (Grant No. 2017/11931-6), and Programa de Apoio aos Novos Docentes
   (University of Sao Paulo). VB was a Capes and CNPq fellow during
   different periods of her graduation.
CR Adam I, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1486353
   Appanna R, 2016, EBIOMEDICINE, V12, P178, DOI 10.1016/j.ebiom.2016.09.003
   Arnold J, 2016, CELL DEATH DIFFER, V23, P853, DOI 10.1038/cdd.2015.149
   Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025
   Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938
   Barnes NA, 2009, J IMMUNOL, V183, P5768, DOI 10.4049/jimmunol.0803480
   Becerra A, 2009, J GEN VIROL, V90, P810, DOI 10.1099/vir.0.004416-0
   Buckner CM, 2013, J VIROL, V87, P5800, DOI 10.1128/JVI.00094-13
   Yam-Puc JC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00188
   CASTELLA A, 1985, AM J CLIN PATHOL, V84, P423
   Cepok S, 2007, ANN NEUROL, V62, P458, DOI 10.1002/ana.21195
   Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550
   CHESS Q, 1984, DIAGN CLIN IMMUNOL, V2, P148
   Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533
   Finger E, 2017, BLOOD, V130
   Fornecker LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37273-4
   Garcia M, 2017, IMMUNOLOGY, V151, P122, DOI 10.1111/imm.12713
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Gawoski JM, 2003, ARCH PATHOL LAB MED, V127, P1026
   Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846
   Haltaufderhyde K, 2018, J INFECT DIS, V218, P1675, DOI 10.1093/infdis/jiy360
   Harrington L, 2008, INFECT IMMUN, V76, P3045, DOI 10.1128/IAI.00193-08
   Heine G, 2014, EUR J IMMUNOL, V44, P1615, DOI 10.1002/eji.201343822
   Huengsberg M, 1998, CLIN CHEM, V44, P858
   Human Protein Atlas, 2019, BLOOD ATL WARS MON S
   Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Khetarpal N, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6803098
   Kuczera D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0548-9
   KURANE I, 1986, J GEN VIROL, V67, P1653, DOI 10.1099/0022-1317-67-8-1653
   KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457
   KURANE I, 1988, J GEN VIROL, V69, P445, DOI 10.1099/0022-1317-69-2-445
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803
   Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marchevsky RS, 2006, BIOLOGICALS, V34, P191, DOI 10.1016/j.biologicals.2005.09.005
   Matsushita N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31266
   McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   MIZUMA H, 1987, CLIN EXP IMMUNOL, V68, P5
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363
   Ninomiya S, 2008, BLOOD, V112, P971
   Nivarthi UK, 2019, EBIOMEDICINE, V41, P465, DOI 10.1016/j.ebiom.2019.02.060
   OLESKE J, 1983, JAMA-J AM MED ASSOC, V249, P2345, DOI 10.1001/jama.249.17.2345
   Pone EJ, 2015, AUTOIMMUNITY, V48, P1, DOI 10.3109/08916934.2014.993027
   Price MJ, 2018, CELL REP, V23, P3152, DOI 10.1016/j.celrep.2018.05.053
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   RIZVI N, 1989, IMMUNOLOGY, V67, P38
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Romano A, 2018, BLOOD, V132, P4511, DOI [10.1182/blood-2018-99-116447, DOI 10.1182/BLOOD-2018-99-116447]
   Shinde R, 2015, J IMMUNOL, V195, P2374, DOI 10.4049/jimmunol.1402854
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Silveira GF, 2018, J VIROL, V92, DOI [10.1128/JVI.02181-17, 10.1128/jvi.02181-17]
   Sinclair LV, 2018, NAT COMMUN, V9, DOI [10.1038/S41467-018-04366-7, 10.1038/s41467-018-04366-7]
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Spudich SS, 2016, CURR OPIN HIV AIDS, V11, P226, DOI 10.1097/COH.0000000000000243
   Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439
   TAYLOR MW, 1991, FASEB J, V5, P2516
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Utay NS, 2016, CURR OPIN HIV AIDS, V11, P131, DOI 10.1097/COH.0000000000000242
   Correa ARV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143391
   WERNER ER, 1988, BIOL CHEM H-S, V369, P337, DOI 10.1515/bchm3.1988.369.1.337
   World Health Organization, 2019, FACT SHEET DENG SEV
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Yoshikawa T, 2010, EUR J HAEMATOL
   Zhang Y, 2015, INT IMMUNOL, V27, P521, DOI 10.1093/intimm/dxv034
NR 75
TC 0
Z9 0
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD FEB 11
PY 2020
VL 11
AR 20
DI 10.3389/fimmu.2020.00020
PG 13
WC Immunology
SC Immunology
GA KR5CK
UT WOS:000517636300001
PM 32117223
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Fabris, AL
   Nunes, AV
   Schuch, V
   de Paula-Silva, M
   Rocha, GHO
   Nakaya, HI
   Ho, PL
   Silveira, ELV
   Farsky, SHP
AF Fabris, Andre Luis
   Nunes, Andre Vinicius
   Schuch, Viviane
   de Paula-Silva, Marina
   Rocha, G. H. O.
   Nakaya, Helder I.
   Ho, Paulo Lee
   Silveira, Eduardo L. V.
   Poliselli Farsky, Sandra Helena
TI Hydroquinone exposure alters the morphology of lymphoid organs in
   vaccinated C57Bl/6 mice
SO ENVIRONMENTAL POLLUTION
LA English
DT Article
DE Environmental toxicology; Oxidative stress; Humoral response; Influenza
   vaccine; Gene expression; Neutrophils
ID CIGARETTE-SMOKE; LUNG INFLAMMATION; BONE-MARROW; REACTIVE METABOLITE;
   INDUCED APOPTOSIS; IN-VITRO; BENZENE; CELLS; INFLUENZA; NEUTROPHILS
AB The influenza is a common viral infection that can be fatal, especially in high-risk groups such as children, pregnant women, elderly, and immune-deficient individuals. Vaccination is the most efficient approach to prevent the spreading of viral infection and promote individual and public health. In contrast, exposure to environmental pollutants such as cigarette smoke reduces the efficacy of vaccination. We investigated whether chronic exposure to hydroquinone (HQ), the most abundant compound of the tobacco particulate phase, could impair the adaptive immune responses elicited by influenza vaccination. For this, adult male C57BL/6 mice were daily exposed to either nebulized HQ or PBS for 1 h for a total of eight weeks. At weeks 6 and 8, the mice were primed and boosted with the trivalent influenza vaccine via IM respectively. Although the HQ exposure did not alter the body weight of the mice and the biochemical and hematological parameters, the pollutant increased the oxidative stress in splenocytes of immunized animals, modified the morphology of spleen follicles, and augmented the size of their lymph nodes. The lymphoid organs of HQ-exposed mice presented a similar number of vaccine-specific IgG-secreting cells, titers of vaccine-specific total IgG, and respective subclasses. Transcriptome studies with HQ benzene, or cigarette smoke exposure were also analyzed. The genes up-regulated upon pollutant exposure were associated with neutrophil migration and were shown to be co-expressed with antibody-secreting cell genes. Therefore, these findings suggest that HQ exposure may trigger an immune-compensatory mechanism that enhances the humoral responses induced by influenza vaccination. (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Fabris, Andre Luis; de Paula-Silva, Marina; Rocha, G. H. O.; Poliselli Farsky, Sandra Helena] Univ Sao Paulo, Sch Pharmaceut Sci, Lab Expt Toxicol, Sao Paulo, Brazil.
   [Nunes, Andre Vinicius; Silveira, Eduardo L. V.] Univ Sao Paulo, Sch Pharmaceut Sci, Lab Immunol, Sao Paulo, Brazil.
   [Schuch, Viviane; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Computat Syst Biol Lab, Sao Paulo, Brazil.
   [Ho, Paulo Lee] Butantan Inst, BioInd Div, Bacteriol Serv, Sao Paulo, Brazil.
RP Farsky, SHP (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Av Prof Lineu Prestes 580,Bl 13B,Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil.
EM sfarsky@usp.br
RI Nakaya, Helder/AAF-1738-2020; Silveira, Eduardo L V/E-5733-2014; Nakaya,
   Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Silveira, Eduardo L
   V/0000-0001-8333-2884; Nakaya, Helder I/0000-0001-5297-9108; Rocha,
   Gustavo/0000-0001-9158-1194
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/07328-4,
   2016/24134-4]
FX The study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP; research grant 2014/07328-4 and 2016/24134-4, Master
   Fellow A.L.F.). S.H.P.F, H.T.I.N. and P.L.H. are fellows of Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The
   Institute Butantan donated the vaccines used in this study.
CR Abplanalp WT, 2019, TOXICOL SCI, V167, P426, DOI 10.1093/toxsci/kfy252
   Bodnar JA, 2012, REGUL TOXICOL PHARM, V64, P35, DOI 10.1016/j.yrtph.2012.05.011
   Shimada ALB, 2012, TOXICOLOGY, V296, P20, DOI 10.1016/j.tox.2012.02.012
   Shimada ALB, 2012, TOXICOL LETT, V211, P10, DOI 10.1016/j.toxlet.2012.02.016
   Chen LP, 2019, J BIOL CHEM, V294, P2486, DOI 10.1074/jbc.RA118.006319
   Cho JY, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/298010
   Choi JM, 2008, ARCH PHARM RES, V31, P337, DOI 10.1007/s12272-001-1161-1
   Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012
   Coquery CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102284
   de Almeida CMC, 2008, TOXICON, V52, P293, DOI 10.1016/j.toxicon.2008.05.022
   EASTMOND DA, 1987, TOXICOL APPL PHARM, V91, P85, DOI 10.1016/0041-008X(87)90196-7
   Elmore SA, 2010, METHODS MOL BIOL, V598, P323, DOI 10.1007/978-1-60761-401-2_22
   Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719
   Arlant LHF, 2016, J PEDIAT INF DIS SOC, V5, P1, DOI 10.1093/jpids/piv107
   Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10
   Figueres C, 2018, LANCET, V392, P1502, DOI 10.1016/S0140-6736(18)32740-5
   FINKLEA JF, 1971, AM REV RESPIR DIS, V104, P368, DOI 10.1164/arrd.1971.104.3.368
   Frazer-Abel AA, 2007, MOL IMMUNOL, V44, P488, DOI 10.1016/j.molimm.2006.02.013
   Godoy P, 2018, EUR J PUBLIC HEALTH, V28, P150, DOI 10.1093/eurpub/ckx130
   Grohskopf LA, 2018, MMWR RECOMM REP, V67, DOI 10.15585/mmwr.rr6703a1
   Heluany CS, 2018, CHEM-BIOL INTERACT, V291, P120, DOI 10.1016/j.cbi.2018.06.016
   Heluany CS, 2018, TOXICOLOGY, V408, P22, DOI 10.1016/j.tox.2018.06.010
   Heluany CS., 2019, ARCH TOXICOL
   Henschler R, 1996, ENVIRON HEALTH PERSP, V104, P1271, DOI 10.2307/3433174
   Horobin RW, 2011, BIOTECH HISTOCHEM, V86, P36, DOI 10.3109/10520295.2010.515491
   Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760
   KARK JD, 1982, NEW ENGL J MED, V307, P1042, DOI 10.1056/NEJM198210213071702
   Kim E, 2005, IMMUNOL LETT, V99, P24, DOI 10.1016/j.imlet.2004.11.025
   Kim H, 2017, ENVIRON TOXICOL, V32, P2481, DOI 10.1002/tox.22461
   Kreitinger JM, 2016, J IMMUNOL, V196, P3217, DOI 10.4049/jimmunol.1502149
   Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118
   Landrigan PJ, 2019, SCI TOTAL ENVIRON, V650, P2389, DOI 10.1016/j.scitotenv.2018.09.375
   Landrigan PJ, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP3141
   Lee JY, 2007, MOL CELLS, V23, P198
   Lee JS, 2012, MOL BIOL REP, V39, P6737, DOI 10.1007/s11033-012-1498-y
   Li JQ, 2018, TOXICOL IN VITRO, V46, P361, DOI 10.1016/j.tiv.2017.08.018
   Li J, 2018, ENVIRON POLLUT, V234, P127, DOI 10.1016/j.envpol.2017.11.042
   Liu JX, 2017, MOL MED REP, V16, P8076, DOI 10.3892/mmr.2017.7643
   Lugade AA, 2014, J IMMUNOL, V192, P5226, DOI 10.4049/jimmunol.1302584
   Luster MI, 2014, J IMMUNOTOXICOL, V11, P197, DOI 10.3109/1547691X.2013.837121
   Macedo SMD, 2007, TOXICOLOGY, V241, P47, DOI 10.1016/j.tox.2007.08.085
   Macedo SMD, 2006, TOXICOLOGY, V220, P126, DOI 10.1016/j.tox.2005.12.008
   Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659
   Mazur DM, 2017, ENVIRON POLLUT, V222, P242, DOI 10.1016/j.envpol.2016.12.049
   McGregor D, 2007, CRIT REV TOXICOL, V37, P887, DOI 10.1080/10408440701638970
   Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771
   Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562
   Musich T, 2018, J IMMUNOL, V201, P2287, DOI 10.4049/jimmunol.1800677
   Paddock CD, 2012, J INFECT DIS, V205, P895, DOI 10.1093/infdis/jir861
   Peng C, 2013, CELL BIOL TOXICOL, V29, P213, DOI 10.1007/s10565-013-9247-0
   Piade JJ, 2013, FOOD CHEM TOXICOL, V55, P329, DOI 10.1016/j.fct.2013.01.016
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Pons M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016722
   Pons M, 2010, AM J PATHOL, V177, P1198, DOI 10.2353/ajpath.2010.091108
   Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194
   Ramirez C, 2013, NEUROTOXICOLOGY, V39, P102, DOI 10.1016/j.neuro.2013.08.004
   Romberg N, 2019, J ALLERGY CLIN IMMUN, V143, P258, DOI 10.1016/j.jaci.2018.06.012
   Roseman C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3923
   Scapini P, 2005, BLOOD, V105, P830, DOI 10.1182/blood-2004-02-0564
   Scapini P, 2008, IMMUNOL LETT, V116, P1, DOI 10.1016/j.imlet.2007.11.009
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   SMITH MT, 1989, ENVIRON HEALTH PERSP, V82, P23, DOI 10.2307/3430757
   Snyder R, 2004, DRUG METAB REV, V36, P531, DOI 10.1081/DMR-200033445
   Stabbert R, 2017, TOXICOL IN VITRO, V42, P222, DOI 10.1016/j.tiv.2017.04.003
   Tan Q, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22269
   Ribeiro ALT, 2011, TOXICOLOGY, V288, P1, DOI 10.1016/j.tox.2011.05.009
   Vaidyanathan B, 2017, J EXP MED, V214, P197, DOI 10.1084/jem.20160789
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   WARD CO, 1985, AM J IND MED, V7, P457, DOI 10.1002/ajim.4700070510
   Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544
   Wei CX, 2017, ARCH TOXICOL, V91, P921, DOI 10.1007/s00204-016-1760-5
   Wilson KM, 2013, J PEDIATR-US, V162, P16, DOI 10.1016/j.jpeds.2012.06.043
   Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213
   Wu HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162570
   Yang EJ, 2011, TOXICOL IN VITRO, V25, P131, DOI 10.1016/j.tiv.2010.10.004
   Zaheen A, 2009, BLOOD, V114, P547, DOI 10.1182/blood-2009-03-211763
   Zelnik V, 2004, J VET MED B, V51, P61, DOI 10.1111/j.1439-0450.2004.00728.x
   Zhu JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053196
NR 78
TC 1
Z9 1
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0269-7491
EI 1873-6424
J9 ENVIRON POLLUT
JI Environ. Pollut.
PD FEB
PY 2020
VL 257
AR 113554
DI 10.1016/j.envpol.2019.113554
PG 11
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA KN3NG
UT WOS:000514746800062
PM 31767231
DA 2020-12-17
ER

PT J
AU Peron, JPS
   Nakaya, H
AF Schatzmann Peron, Jean Pierre
   Nakaya, Helder
TI Susceptibility of the Elderly to SARS-CoV-2 Infection: ACE-2
   Overexpression, Shedding, and Antibody-dependent Enhancement (ADE)
SO CLINICS
LA English
DT Review
DE SARS-CoV-2; Immunopathology; ACE-2
ID ANGIOTENSIN-CONVERTING ENZYME-2; FUNCTIONAL RECEPTOR; SARS CORONAVIRUS;
   SPIKE PROTEIN; VIRUS; DENGUE; COV; ANGIOTENSIN-CONVERTING-ENZYME-2;
   INHIBITION
AB The world is currently facing a serious SARS-CoV-2 infection pandemic. This virus is a new isolate of coronavirus, and the current infection crisis has surpassed the SARS and MERS epidemics that occurred in 2002 and 2013, respectively. SARS-CoV-2 has currently infected more than 142,000 people, causing 5,000 deaths and spreading across more than 130 countries worldwide. The spreading capacity of the virus clearly demonstrates the potential threat of respiratory viruses to human health, thereby reiterating to the governments around the world that preventive health policies and scientific research are pivotal to overcoming the crisis. Coronavirus disease (COVID-19) causes flu-like symptoms in most cases. However, approximately 15% of the patients need hospitalization, and 5% require assisted ventilation, depending on the cohorts studied. What is intriguing, however, is the higher susceptibility of the elderly, especially individuals who are older than 60 years of age, and have comorbidities, including hypertension, diabetes, and heart disease. In fact, the death rate in this group may be up to 10-12%. Interestingly, children are somehow less susceptible and are not considered as a risk group.
   Therefore, in this review, we discuss some possible molecular and cellular mechanisms by virtue of which the elderly subjects may be more susceptible to severe COVID-19. Toward this, we raise two main points, i) increased ACE-2 expression in pulmonary and heart tissues in users of chronic angiotensin 1 receptor (AT1R) blockers; and ii) antibody-dependent enhancement (ADE) after previous exposure to other circulating coronaviruses. We believe that these points are pivotal for a better understanding of the pathogenesis of severe COVID-19, and must be carefully addressed by physicians and scientists in the field.
C1 [Schatzmann Peron, Jean Pierre] Univ Sao Paulo, Dept Imunol ICB 4, Lab Interacoes Neuroimunes, Sao Paulo, SP, Brazil.
   [Schatzmann Peron, Jean Pierre; Nakaya, Helder] Univ Sao Paulo, Plataforma Cient Pasteur USP, Sao Paulo, SP, Brazil.
   [Schatzmann Peron, Jean Pierre] Univ Sao Paulo, Programa Pos Grad Alergia & Imunopatol, Fac Med FMUSP, Sao Paulo, SP, Brazil.
RP Peron, JPS (corresponding author), Univ Sao Paulo, Dept Imunol ICB 4, Lab Interacoes Neuroimunes, Sao Paulo, SP, Brazil.; Peron, JPS (corresponding author), Univ Sao Paulo, Plataforma Cient Pasteur USP, Sao Paulo, SP, Brazil.; Peron, JPS (corresponding author), Univ Sao Paulo, Programa Pos Grad Alergia & Imunopatol, Fac Med FMUSP, Sao Paulo, SP, Brazil.
EM jeanpierre@usp.br
RI Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/50137-3, 2012/19278-6, 2018/14933-2, 2018/21934-5, 2013/08216-2,
   2017/26170-0, 2017/22504-1]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [313662/2017-7, 301287/2016-3]
FX JPSP is funded by FAPESP (grant numbers: #2017/26170-0 and 2017/22504-1)
   and CNPq (301287/2016-3). HN is funded by FAPESP (grant numbers:
   #2017/50137-3, 2012/19278-6, 2018/14933-2, 2018/21934-5, and
   2013/08216-2) and CNPq (313662/2017-7).
CR Agata J, 2006, HYPERTENS RES, V29, P865, DOI 10.1291/hypres.29.865
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101
   Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262
   Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088
   Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105
   Haga S, 2010, ANTIVIR RES, V85, P551, DOI 10.1016/j.antiviral.2009.12.001
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Huang ML, 2010, CLIN EXP PHARMACOL P, V37, pe1, DOI 10.1111/j.1440-1681.2009.05302.x
   Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a
   Jia HP, 2009, AM J PHYSIOL-LUNG C, V297, pL84, DOI 10.1152/ajplung.00071.2009
   Jiang F, 2014, NAT REV CARDIOL, V11, P413, DOI 10.1038/nrcardio.2014.59
   Johansen ME, 2020, J AM BOARD FAM MED, V33, P143, DOI 10.3122/jabfm.2020.01.190134
   Kuczera D, 2018, J INTERF CYTOK RES, V38, P69, DOI 10.1089/jir.2017.0037
   Kuzmina NA, 2018, CELL REP, V24, P1802, DOI 10.1016/j.celrep.2018.07.035
   Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158
   Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang QD, 2016, ACS INFECT DIS, V2, P361, DOI 10.1021/acsinfecdis.6b00006
   Wang X, 2020, LANCET GLOB HEALTH, V8, pE497, DOI 10.1016/S2214-109X(19)30545-5
   Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16
   World Health Organization (WHO), 2020, SIT REP
   Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Xu JX, 2017, CIRC RES, V121, P43, DOI 10.1161/CIRCRESAHA.116.310509
   Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204
   Zhang LQ, 2006, J MED VIROL, V78, P1, DOI 10.1002/jmv.20499
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 38
TC 10
Z9 11
U1 68
U2 68
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2020
VL 75
AR e1912
DI 10.6061/clinics/2020/e1912
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA LT4PI
UT WOS:000537053800001
PM 32428113
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Gonzalez-Dias, P
   Lee, EK
   Sorgi, S
   de Lima, DS
   Urbanski, AH
   Silveira, EL
   Nakaya, HI
AF Gonzalez-Dias, Patricia
   Lee, Eva K.
   Sorgi, Sara
   de Lima, Diogenes S.
   Urbanski, Alysson H.
   Silveira, Eduardo Lv
   Nakaya, Helder I.
TI Methods for predicting vaccine immunogenicity and reactogenicity
SO HUMAN VACCINES & IMMUNOTHERAPEUTICS
LA English
DT Review
DE Systems vaccinology; machine learning; vaccine immunogenicity; vaccine
   reactogenicity; artificial intelligence
ID YELLOW-FEVER VACCINE; INFLUENZA VACCINATION; SYSTEMS-ANALYSIS; SEASONAL
   INFLUENZA; FEATURE-SELECTION; IMMUNE-RESPONSES; BIOLOGY; REVEALS; GENE
AB Subjects receiving the same vaccine often show different levels of immune responses and some may even present adverse side effects to the vaccine. Systems vaccinology can combine omics data and machine learning techniques to obtain highly predictive signatures of vaccine immunogenicity and reactogenicity. Currently, several machine learning methods are already available to researchers with no background in bioinformatics. Here we described the four main steps to discover markers of vaccine immunogenicity and reactogenicity: (1) Preparing the data; (2) Selecting the vaccinees and relevant genes; (3) Choosing the algorithm; (4) Blind testing your model. With the increasing number of Systems Vaccinology datasets being generated, we expect that the accuracy and robustness of signatures of vaccine reactogenicity and immunogenicity will significantly improve.
C1 [Gonzalez-Dias, Patricia; de Lima, Diogenes S.; Urbanski, Alysson H.; Silveira, Eduardo Lv; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.
   [Lee, Eva K.] Georgia Inst Technol, Ctr Operat Res Med & HealthCare, Atlanta, GA 30332 USA.
   [Sorgi, Sara] Univ Siena, Dept Med Biotechnol, Siena, Italy.
   [Nakaya, Helder I.] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.
EM hnakaya@usp.br
RI Silveira, Eduardo L V/E-5733-2014; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020
OI Silveira, Eduardo L V/0000-0001-8333-2884; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108;
   Gonzalez-Dias, Patricia/0000-0002-6434-3841
FU Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) under the
   VSV-EBOPLUS [116068]; Sao Paulo Research Foundation (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/14933-2,
   2018/21934-5, 2013/08216-2]
FX This work was supported by grants from the Innovative Medicines
   Initiative 2 Joint Undertaking (IMI2 JU) under the VSV-EBOPLUS [grant
   number 116068] project and from the Sao Paulo Research Foundation
   (FAPESP); grants [2018/14933-2, 2018/21934-5 and 2013/08216-2].
CR Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x
   Avey S, 2017, BIOINFORMATICS, V33, pI208, DOI 10.1093/bioinformatics/btx260
   BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224
   Beyer WEP, 1996, EUR J CLIN MICROBIOL, V15, P65, DOI 10.1007/BF01586187
   Blohmke CJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01276
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Cai J, 2018, NEUROCOMPUTING, V300, P70, DOI 10.1016/j.neucom.2017.11.077
   Camacho DM, 2018, CELL, V173, P1581, DOI 10.1016/j.cell.2018.05.015
   Campbell-Tofte J, 2019, CELL MOL LIFE SCI, V76, P67, DOI 10.1007/s00018-018-2925-6
   Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294
   Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8
   Cook IF, 2008, HUM VACCINES, V4, P67, DOI 10.4161/hv.4.1.4747
   Darst BF, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0633-8
   Davis MM, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028886
   de Fortuny EJ, 2019, BIG DATA-US, V7, P83, DOI 10.1089/big.2013.0037.correx
   Demsar J, 2013, J MACH LEARN RES, V14, P2349
   Eraslan G, 2019, NAT REV GENET, V20, P389, DOI 10.1038/s41576-019-0122-6
   Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8
   Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111
   GODFREY K, 1985, NEW ENGL J MED, V313, P1629, DOI 10.1056/NEJM198512263132604
   Gradin R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212669
   Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797
   Hu YL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3317-7
   Huttner A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1701
   Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054
   Jochems SP, 2018, NAT IMMUNOL, V19, P1299, DOI 10.1038/s41590-018-0231-y
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Kim SJ, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-20
   Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9
   Lai CM, 2016, NEUROCOMPUTING, V218, P331, DOI 10.1016/j.neucom.2016.08.089
   Langley P., 1996, ELEMENTS MACHINE LEA
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Lever M, 2017, CURR ISSUES MOL BIOL, V22, P1, DOI 10.21775/cimb.022.001
   Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982
   Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nakaya HI, 2015, EXPERT REV VACCINES, V14, P777, DOI 10.1586/14760584.2015.1040395
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nakayama T, 2019, VACCINE, V37, P366, DOI 10.1016/j.vaccine.2018.11.045
   Nichol KL, 1996, ARCH INTERN MED, V156, P1546, DOI 10.1001/archinte.156.14.1546
   Pereira RB, 2018, ARTIF INTELL REV, V49, P57, DOI 10.1007/s10462-016-9516-4
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344
   Scherer A editor, 2009, J WILEY, DOI [10.1002/9780470685983, DOI 10.1002/9780470685983]
   Tomic A, 2019, J IMMUNOL, V203, P749, DOI 10.4049/jimmunol.1900033
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   Witten IH, 2017, DATA MINING: PRACTICAL MACHINE LEARNING TOOLS AND TECHNIQUES, 4TH EDITION, pCP1
   Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18
NR 52
TC 3
Z9 4
U1 3
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 2164-5515
EI 2164-554X
J9 HUM VACC IMMUNOTHER
JI Human Vaccines Immunother.
PY 2020
VL 16
IS 2
BP 269
EP 276
DI 10.1080/21645515.2019.1697110
EA DEC 2019
PG 8
WC Biotechnology & Applied Microbiology; Immunology
SC Biotechnology & Applied Microbiology; Immunology
GA LS9ZU
UT WOS:000504141400001
PM 31869262
OA Other Gold, Green Published
DA 2020-12-17
ER

PT J
AU Prow, NA
   Hirata, TDC
   Tang, B
   Larcher, T
   Mukhopadhyay, P
   Alves, TL
   Le, TT
   Gardner, J
   Poo, YS
   Nakayama, E
   Lutzky, VP
   Nakaya, HI
   Suhrbier, A
AF Prow, Natalie A.
   Hirata, Thiago D. C.
   Tang, Bing
   Larcher, Thibaut
   Mukhopadhyay, Pamela
   Alves, Tiago Lubiana
   Le, Thuy T.
   Gardner, Joy
   Poo, Yee Suan
   Nakayama, Eri
   Lutzky, Viviana P.
   Nakaya, Helder, I
   Suhrbier, Andreas
TI Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High
   Fiber Diet and Butyrate
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE chikungunya; immunopathology; arthritis; fiber; diet
ID CHAIN FATTY-ACIDS; REGULATORY T-CELLS; HISTONE DEACETYLASE INHIBITOR;
   SODIUM-BUTYRATE; GUT MICROBIOTA; NEUTROPHIL MIGRATION;
   MONOCLONAL-ANTIBODIES; MOLECULAR-MECHANISMS; ENDOTHELIAL-CELLS; EDEMA
   FORMATION
AB Chikungunya virus (CHIKV) is a mosquito transmitted alphavirus associated with a robust systemic infection and an acute inflammatory rheumatic disease. A high fiber diet has been widely promoted for its ability to ameliorate inflammatory diseases. Fiber is fermented in the gut into short chain fatty acids such as acetate, propionate, and butyrate, which enter the circulation providing systemic anti-inflammatory activities. Herein we show that mice fed a high fiber diet show a clear exacerbation of CHIKV arthropathy, with increased edema and neutrophil infiltrates. RNA-Seq analyses illustrated that a high fiber diet, in this setting, promoted a range of pro-neutrophil responses including Th17/IL-17. Gene Set Enrichment Analyses demonstrated significant similarities with mouse models of inflammatory psoriasis and significant depression of macrophage resolution phase signatures in the CHIKV arthritic lesions from mice fed a high fiber diet. Supplementation of the drinking water with butyrate also increased edema after CHIKV infection. However, the mechanisms involved were different, with modulation of AP-1 and NF-kappa B responses identified, potentially implicating deoptimization of endothelial barrier repair. Thus, neither fiber nor short chain fatty acids provided benefits in this acute infectious disease setting, which is characterized by widespread viral cytopathic effects and a need for tissue repair.
C1 [Prow, Natalie A.; Tang, Bing; Mukhopadhyay, Pamela; Le, Thuy T.; Gardner, Joy; Poo, Yee Suan; Nakayama, Eri; Lutzky, Viviana P.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Immunol Dept, Brisbane, Qld, Australia.
   [Prow, Natalie A.; Suhrbier, Andreas] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
   [Hirata, Thiago D. C.; Alves, Tiago Lubiana; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Computat Syst Biol Lab, Sao Paulo, SP, Brazil.
   [Larcher, Thibaut] INRA, Unite Mixte Rech 703, Nantes, France.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Immunol Dept, Brisbane, Qld, Australia.; Suhrbier, A (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
EM andreas.suhrbier@qimrberghofer.edu.au
RI Hirata, Thiago Dominguez Crespo/AAP-1903-2020; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia
   [APP1078468]; Australian Infectious Disease Research Center; Queensland
   Government, Australia; National Health and Medical Research Council of
   AustraliaNational Health and Medical Research Council of Australia;
   Daiichi Sankyo Foundation of Life Science; FAPESP (Sao Paulo Research
   Foundation)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX This work was supported by a project grant from the National Health and
   Medical Research Council (NHMRC) of Australia (APP1078468) and
   intramural seed funding from the Australian Infectious Disease Research
   Center. NP was supported by an Advance Queensland Research Fellowship
   from the Queensland Government, Australia. AS holds a Principal Research
   Fellowship from the National Health and Medical Research Council of
   Australia. EN was supported in part by the Daiichi Sankyo Foundation of
   Life Science. TH was supported by FAPESP (Sao Paulo Research
   Foundation).
CR Amin M, 2018, J DERMATOL TREAT, V29, P347, DOI 10.1080/09546634.2017.1395796
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113
   Bazzoni F, 2010, EUR J IMMUNOL, V40, P2360, DOI 10.1002/eji.200940294
   Bejjani F, 2019, BBA-REV CANCER, V1872, P11, DOI 10.1016/j.bbcan.2019.04.003
   Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409
   Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3
   Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995
   Blottiere HM, 2003, P NUTR SOC, V62, P101, DOI 10.1079/PNS2002215
   Bootun R, 2013, INT WOUND J, V10, P98, DOI 10.1111/j.1742-481X.2012.00950.x
   Bultman SJ, 2018, NAT MICROBIOL, V3, P1332, DOI 10.1038/s41564-018-0299-z
   Carpentier KS, 2018, CURR OPIN VIROL, V28, P53, DOI 10.1016/j.coviro.2017.11.006
   Chang S, 2018, ANIM BIOTECHNOL, V29, P212, DOI 10.1080/10495398.2017.1358734
   Chen GX, 2018, EBIOMEDICINE, V30, P317, DOI 10.1016/j.ebiom.2018.03.030
   Chen JZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051026
   Chen L, 2019, INFLAMM BOWEL DIS, V25, P1450, DOI 10.1093/ibd/izz046
   Chen WQ, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8549329
   Chen WQ, 2017, NAT MICROBIOL, V2, P1435, DOI 10.1038/s41564-017-0015-4
   Clemente JC, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5145
   Coccia EM, 2001, BIOCHEM J, V360, P285, DOI 10.1042/0264-6021:3600285
   Coradini D, 2000, CELL PROLIFERAT, V33, P139, DOI 10.1046/j.1365-2184.2000.00173.x
   Cosorich I, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700492
   Cullen EM, 2010, MOL IMMUNOL, V47, P1701, DOI 10.1016/j.molimm.2010.03.003
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Souza BDE, 2019, AN BRAS DERMATOL, V94, P116, DOI 10.1590/abd1806-4841.20197987
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217
   Di Caro V, 2019, SHOCK, V51, P526, DOI 10.1097/SHK.0000000000001180
   Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2
   Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413
   Folkerts J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01067
   FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x
   Friedman AD, 2003, BLOOD CELL MOL DIS, V31, P338, DOI 10.1016/S1079-9796(03)00135-9
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gasque P, 2015, VECTOR-BORNE ZOONOT, V15, P241, DOI 10.1089/vbz.2014.1710
   Gavin PG, 2019, CURR OPIN ENDOCRINOL, V26, P207, DOI 10.1097/MED.0000000000000483
   George SMC, 2015, CLIN EXP DERMATOL, V40, P717, DOI 10.1111/ced.12715
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gharbi C, 2014, CLIN KIDNEY J, V7, P115, DOI 10.1093/ckj/sfu001
   Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90
   Goh LYH, 2015, J GEN VIROL, V96, P507, DOI 10.1099/jgv.0.000002
   Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004
   Greer A, 2016, J DENT RES, V95, P946, DOI 10.1177/0022034516641036
   Haase S, 2018, IMMUNOLOGY, V154, P230, DOI 10.1111/imm.12933
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   Hashimoto M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070073
   Hinnebusch BF, 2002, J NUTR, V132, P1012
   Hitomi T, 2003, FEBS LETT, V554, P347, DOI 10.1016/S0014-5793(03)01186-4
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887
   Hui WP, 2019, INT IMMUNOPHARMACOL, V68, P226, DOI 10.1016/j.intimp.2019.01.018
   Huits R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196630
   Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   Jefferson A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00033
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Keeshan K, 2003, BLOOD, V102, P1267, DOI 10.1182/blood-2003-02-0477
   Keeter WC, 2018, J IMMUNOL, V200
   Kespohl M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01036
   Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014
   Kim DS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01525
   Kim K, 2019, MOL MED REP, V20, P1569, DOI 10.3892/mmr.2019.10431
   Kim SY, 2019, IMMUNOL CELL BIOL, V97, P258, DOI 10.1111/imcb.12236
   Knudsen KEB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101499
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Kulkarni SP, 2017, EUR J CLIN MICROBIOL, V36, P2475, DOI 10.1007/s10096-017-3087-4
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Le TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153975
   Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535
   Lee WWL, 2015, J VIROL, V89, P7893, DOI 10.1128/JVI.00998-15
   Li M, 2018, EUR J PHARMACOL, V831, P52, DOI 10.1016/j.ejphar.2018.05.003
   Li YG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-114
   Liu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05543
   Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x
   Lokireddy S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-31
   Long Kristin M, 2015, Curr Trop Med Rep, V2, P13
   Lucas S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02490-4
   Luo AN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00417
   Luu M, 2019, EUR J IMMUNOL, V49, P842, DOI 10.1002/eji.201848009
   Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734
   Mao SZ, 2015, ARTERIOSCL THROM VAS, V35, P1635, DOI 10.1161/ATVBAHA.115.305519
   Mao SZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111087
   Marques FZ, 2017, CIRCULATION, V135, P964, DOI [10.1161/CIRCULATIONAHA.116.024545, 10.1161/circulationaha.116.024545]
   Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530
   Matt SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01832
   Matusali G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020175
   Meng X, 2019, AUTOIMMUN REV, V18, P455, DOI 10.1016/j.autrev.2019.03.006
   Michlmayr D, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177862
   Miles JP, 2017, INFLAMM BOWEL DIS, V23, P1133, DOI 10.1097/MIB.0000000000001155
   Moots RJ, 2017, RHEUMATOLOGY, V56, P541, DOI 10.1093/rheumatology/kew370
   Morikawa A, 2004, J ENDOTOXIN RES, V10, P33, DOI 10.1177/09680519040100010401
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Motse K G, 2016, SAMJ, S. Afr. med. j., V106, P886, DOI [10.7196/SAMJ.2016.v106i9.10636, 10.7196/samj.2016.v106i9.11061]
   Nakajima A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179696
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002
   Nepelska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052869
   Nguyen C, 2003, P NATL ACAD SCI USA, V100, P1169, DOI 10.1073/pnas.0437889100
   Niki Y, 2001, J CLIN INVEST, V107, P1127, DOI 10.1172/JCI11530
   O'Rielly Darren D, 2019, J Rheumatol Suppl, V95, P46, DOI 10.3899/jrheum.190119
   Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277
   Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44
   Park JW, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e9
   Park J, 2016, J IMMUNOL, V196, P2388, DOI 10.4049/jimmunol.1502046
   Park JH, 2016, BIOTECHNOL J, V11, P487, DOI 10.1002/biot.201500327
   Parsonage G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2406
   Patil DR, 2012, MICROBES INFECT, V14, P457, DOI 10.1016/j.micinf.2011.12.008
   Petitdemange C, 2015, J ALLERGY CLIN IMMUN, V135, P846, DOI 10.1016/j.jaci.2015.01.039
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Prasad Kedar N, 2018, Mech Ageing Dev, DOI 10.1016/j.mad.2018.10.003
   Price PJR, 2014, J VIROL, V88, P10840, DOI 10.1128/JVI.01524-14
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Prow NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006788
   Qi Y, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160342
   Reichel CA, 2006, J LEUKOCYTE BIOL, V79, P114, DOI 10.1189/jlb.0605337
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rivero JA, 1996, BIOCHEM BIOPH RES CO, V224, P796, DOI 10.1006/bbrc.1996.1102
   Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720
   ROSENGREN S, 1990, AM J PHYSIOL, V259, pH1288, DOI 10.1152/ajpheart.1990.259.4.H1288
   ROYALL JA, 1989, AM J PHYSIOL, V257, pL399
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Sa-Caputo D, 2017, TRICHOL COSMETOL OPE, V1, P25, DOI [10.17140/TCOJ-1-106, DOI 10.17140/TCOJ-1-106]
   Saidane O, 2019, JOINT BONE SPINE, V86, P411, DOI 10.1016/j.jbspin.2018.10.010
   Sakanoi Y, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101417
   Salem I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01459
   Sangfelt O, 1999, ONCOGENE, V18, P2798, DOI 10.1038/sj.onc.1202609
   Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187
   Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018
   Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423
   Sergushichev A.A., 2016, 060012 BIORXIV, DOI [10.1101/060012v1., DOI 10.1101/060012]
   SHIGA Y, 1991, NEUROSCI LETT, V125, P110, DOI 10.1016/0304-3940(91)90003-C
   Silva JPB, 2018, CURR PHARM DESIGN, V24, P4154, DOI 10.2174/1381612824666181001153605
   Soares-Schanoski A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007880
   Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E
   Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779
   Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800
   Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x
   Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330
   Suhrbier A, 2019, NAT REV RHEUMATOL, V15, P597, DOI 10.1038/s41584-019-0276-9
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Sun B, 2018, J AGR FOOD CHEM, V66, P7633, DOI 10.1021/acs.jafc.8b01189
   Suo J, 2014, J LEUKOCYTE BIOL, V96, P133, DOI 10.1189/jlb.3A1213-628R
   Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266
   Tegeder I, 2001, FASEB J, V15, P595, DOI 10.1096/fasebj.15.3.595
   Telle-Hansen VH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111783
   Thackray LB, 2018, CELL REP, V22, P3440, DOI 10.1016/j.celrep.2018.03.001
   Theiler A, 2019, J ALLERGY CLIN IMMUN, V144, P764, DOI 10.1016/j.jaci.2019.05.002
   Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320
   Van Hung T, 2018, J NUTR, V148, P552, DOI 10.1093/jn/nxy008
   Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022
   Trop-Steinberg S, 2017, AM J MED SCI, V353, P474, DOI 10.1016/j.amjms.2017.01.019
   Valamparampil JJ, 2009, INDIAN J PEDIATR, V76, P151, DOI 10.1007/s12098-009-0045-x
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Veronese N, 2018, AM J CLIN NUTR, V107, P436, DOI 10.1093/ajcn/nqx082
   Vieira AT, 2017, J LEUKOCYTE BIOL, V101, P275, DOI [10.1189/jlb.3A1015-453RRR, 10.1189/jlb.3a1015-453rrr]
   Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205
   Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624
   Wang AS, 2013, AM J SURG, V206, P410, DOI 10.1016/j.amjsurg.2012.11.018
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wang J, 2016, DNA CELL BIOL, V35, P203, DOI 10.1089/dna.2015.3037
   Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7
   Weger-Lucarelli J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006247
   Williams AE, 2017, THORAX, V72, P66, DOI 10.1136/thoraxjnl-2016-208597
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   Wu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16355
   Xu YH, 2018, J ENDOCRINOL, V238, P231, DOI 10.1530/JOE-18-0137
   Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607
   Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016
   Zenobia C, 2015, PERIODONTOL 2000, V69, P142, DOI 10.1111/prd.12083
   Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963
   Zhang YY, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01929
   Zhao-Fleming H, 2018, BURNS TRAUMA, V6, DOI 10.1186/s41038-018-0128-x
   Zhu XJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4377
   Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133
   Zimmerman MA, 2012, AM J PHYSIOL-GASTR L, V302, pG1405, DOI 10.1152/ajpgi.00543.2011
NR 177
TC 4
Z9 4
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 26
PY 2019
VL 10
AR 2736
DI 10.3389/fimmu.2019.02736
PG 20
WC Immunology
SC Immunology
GA KA1LP
UT WOS:000505560600001
PM 31849947
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Goncalves, ANA
   Lever, M
   Russo, PST
   Gomes-Correia, B
   Urbanski, AH
   Pollara, G
   Noursadeghi, M
   Maracaja-Coutinho, V
   Nakaya, HI
AF Goncalves, Andre N. A.
   Lever, Melissa
   Russo, Pedro S. T.
   Gomes-Correia, Bruno
   Urbanski, Alysson H.
   Pollara, Gabriele
   Noursadeghi, Mahdad
   Maracaja-Coutinho, Vinicius
   Nakaya, Helder, I
TI Assessing the Impact of Sample Heterogeneity on Transcriptome Analysis
   of Human Diseases Using MDP Webtool
SO FRONTIERS IN GENETICS
LA English
DT Article
DE heterogeneity; transcriptome analysis; gene expression profiling;
   infectious diseases; inflammatory diseases
ID GENE-EXPRESSION PATTERNS; ARTHRITIS; IMMUNITY
AB Transcriptome analyses have increased our understanding of the molecular mechanisms underlying human diseases. Most approaches aim to identify significant genes by comparing their expression values between healthy subjects and a group of patients with a certain disease. Given that studies normally contain few samples, the heterogeneity among individuals caused by environmental factors or undetected illnesses can impact gene expression analyses. We present a systematic analysis of sample heterogeneity in a variety of gene expression studies relating to inflammatory and infectious diseases and show that novel immunological insights may arise once heterogeneity is addressed. The perturbation score of samples is quantified using nonperturbed subjects (i.e., healthy subjects) as a reference group. Such a score allows us to detect outlying samples and subgroups of diseased patients and even assess the molecular perturbation of single cells infected with viruses. We also show how removal of outlying samples can improve the "signal" of the disease and impact detection of differentially expressed genes. The method is made available via the mdp Bioconductor R package and as a user-friendly webtool, webMDP, available at http://mdp.sysbio.tools.
C1 [Goncalves, Andre N. A.; Lever, Melissa; Russo, Pedro S. T.; Urbanski, Alysson H.; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.
   [Gomes-Correia, Bruno; Maracaja-Coutinho, Vinicius] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago, Chile.
   [Pollara, Gabriele; Noursadeghi, Mahdad] UCL, Div Infect & Immun, London, England.
   [Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, SP, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, SP, Brazil.
EM hnakaya@usp.br
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/19278-6, 2013/08216-2, 2018/14933-2]; CNPqNational Council for
   Scientific and Technological Development (CNPq) [313662/2017-7];
   FONDECYT-CONICYTComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDECYT [11161020]; PAI-CONICYT
   [PAI79170021]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-Brasil (CAPES)CAPES [001]; Wellcome TrustWellcome Trust;
   National Institute for Health Research Biomedical Research Centre at
   University College London Hospitals
FX This work was supported by grants from FAPESP (2012/19278-6,
   2013/08216-2, 2018/14933-2), CNPq (313662/2017-7), FONDECYT-CONICYT
   (11161020), and PAI-CONICYT (PAI79170021). This study was financed in
   part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-Brasil (CAPES)-Finance Code 001. MN and GP were supported by
   the Wellcome Trust and National Institute for Health Research Biomedical
   Research Centre at University College London Hospitals.
CR Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891
   Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406
   BELL LCK, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PPAT.1005469
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Best MG, 2015, CANCER CELL, V28, P666, DOI 10.1016/j.ccell.2015.09.018
   Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147
   Brown RA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02995
   De Hertogh B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-17
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Garg N, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.362
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383
   Hersh AO, 2015, J AUTOIMMUN, V64, P113, DOI 10.1016/j.jaut.2015.08.002
   Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274
   Jochems SP, 2018, NAT IMMUNOL, V19, P1299, DOI 10.1038/s41590-018-0231-y
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019
   Mo A, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0558-x
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127
   Pollara G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169271
   Prada-Medina CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01767-4
   Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Wang Y, 2008, BRIT J CANCER, V98, P1023, DOI 10.1038/sj.bjc.6604207
   Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499
   Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
NR 29
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD OCT 24
PY 2019
VL 10
AR 971
DI 10.3389/fgene.2019.00971
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA JO2QV
UT WOS:000497428400001
PM 31708960
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Zimmermann, P
   Perrett, KP
   Ritz, N
   Flanagan, KL
   Robins-Browne, R
   van der Klis, FRM
   Curtis, N
   Abruzzo, V
   Allen, K
   Bonnici, R
   Casalaz, D
   Elborough, H
   Freyne, B
   Gardiner, K
   Germano, S
   Kollmann, T
   Messina, N
   Morrison, C
   Nakaya, H
   Ponsonby, AL
   Shann, F
   South, M
   Vuillermin, P
AF Zimmermann, Petra
   Perrett, Kirsten P.
   Ritz, Nicole
   Flanagan, Katie L.
   Robins-Browne, Roy
   van der Klis, Fiona R. M.
   Curtis, Nigel
   Abruzzo, Veronica
   Allen, Katie
   Bonnici, Rhian
   Casalaz, Dan
   Elborough, Hannah
   Freyne, Bridget
   Gardiner, Kaya
   Germano, Susie
   Kollmann, Tobias
   Messina, Nicole
   Morrison, Clare
   Nakaya, Helder
   Ponsonby, Anne Louise
   Shann, Frank
   South, Mike
   Vuillermin, Peter
CA MIS BAIR Grp
TI Biological sex influences antibody responses to routine vaccinations in
   the first year of life
SO ACTA PAEDIATRICA
LA English
DT Article; Early Access
DE antibodies; humoral; immunisation; immunoglobulin; infant; titre
ID HEPATITIS-B; TETANUS; VACCINE; DIPHTHERIA; IMMUNITY; PROTECTION;
   MODULATION; ADULTS; POLIO; MILK
AB Aim We investigated the effect of early-life factors, namely sex, delivery mode, feeding method and antibiotic exposure, on antibody responses to routine vaccinations administered during the first year of life. Methods One and seven months after the primary course of routine vaccines and 1 month after routine vaccines at 12 months of age, antibodies against 26 vaccine antigens were measured in 398 healthy infants. The geometric mean concentration (GMC) of antibodies (adjusted for effect modifiers with multiple linear regression) and the seroprotection rate for each vaccine were compared for each early-life factor. Results Sex had an influence on GMCs. Antibody concentrations were significantly lower at 7 months of age in females for tetanus and filamentous haemagglutinin and at 13 months of age for pertactin. In contrast, at 13 months of age, antibody concentrations were significantly higher in females for polio type 3, pneumococcal serotype 6A and measles. Sex did not have an influence on seroprotection rates. Delivery mode, feeding method and antibiotic exposure did not exert a substantial influence on vaccine antibody concentrations. Conclusion There is a difference between males and females in the humoral response to routine vaccinations in the first year of life.
C1 [Zimmermann, Petra; Ritz, Nicole; Curtis, Nigel] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia.
   [Zimmermann, Petra; Robins-Browne, Roy; Curtis, Nigel] Murdoch Childrens Res Inst, Infect Dis Res Grp, Parkville, Vic, Australia.
   [Zimmermann, Petra; Curtis, Nigel] Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Vic, Australia.
   [Zimmermann, Petra] Univ Fribourg, Fribourg Hosp HFR, Dept Paediat, Fribourg, Switzerland.
   [Zimmermann, Petra] Univ Fribourg, Fac Sci & Med, Fribourg, Switzerland.
   [Perrett, Kirsten P.] Murdoch Childrens Res Inst, Food Allergy Res Grp, Parkville, Vic, Australia.
   [Perrett, Kirsten P.] Murdoch Childrens Res Inst, Melbourne Childrens Trial Ctr, Parkville, Vic, Australia.
   [Perrett, Kirsten P.] Royal Childrens Hosp, Dept Allergy & Immunol, Parkville, Vic, Australia.
   [Perrett, Kirsten P.] Royal Childrens Hosp, Dept Gen Med, Parkville, Vic, Australia.
   [Perrett, Kirsten P.] Univ Melbourne, Sch Populat & Global Hlth, Parkville, Vic, Australia.
   [Ritz, Nicole] Univ Basel, Infect Dis Unit, Childrens Hosp, Basel, Switzerland.
   [Flanagan, Katie L.] Univ Tasmania, Launceston, Tas, Australia.
   [Flanagan, Katie L.] Monash Univ, Clayton, Vic, Australia.
   [Robins-Browne, Roy] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic, Australia.
   [van der Klis, Fiona R. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis, Bilthoven, Netherlands.
RP Curtis, N (corresponding author), Univ Melbourne, Dept Paediat, Royal Childrens Hosp Melbourne, Parkville, Vic 3052, Australia.
EM nigel.curtis@rch.org.au
RI Ritz, Nicole/L-1452-2019; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020; Zimmermann, Petra/I-4670-2019; Robinsbrowne,
   Roy/ABF-8434-2020; Ponsonby, Anne-Louise/AAE-4351-2019; perrett,
   kirsten/P-8813-2019
OI Ritz, Nicole/0000-0002-1498-1685; Nakaya, Helder I/0000-0001-5297-9108;
   Nakaya, Helder/0000-0001-5297-9108; Zimmermann,
   Petra/0000-0002-2388-4318; Robinsbrowne, Roy/0000-0001-9179-7884;
   perrett, kirsten/0000-0002-5683-996X; Kollmann,
   Tobias/0000-0003-2403-9762; Messina, Nicole/0000-0001-8404-4462;
   Ponsonby, Anne-Louise/0000-0002-6581-3657
FU Australian National Health and Medical Research Council (NHMRC)National
   Health and Medical Research Council of Australia [GNT1051228,
   GNT1099680]; University of MelbourneUniversity of Melbourne; European
   Society of Paediatric Infectious Diseases (ESPID)
FX This work was supported by the Australian National Health and Medical
   Research Council (NHMRC) (grants GNT1051228 and GNT1099680), the
   University of Melbourne (International Research Scholarship to PZ) and
   the European Society of Paediatric Infectious Diseases (ESPID)
   (fellowship to PZ).
CR Chilengi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150100
   Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394
   Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00754
   Freidl GS, 2018, VACCINE, V36, P1664, DOI 10.1016/j.vaccine.2018.01.079
   Garcia-Gomez E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928290
   GERGEN P, 1995, NEW ENGL J MED, V332, P761, DOI 10.1056/NEJM199503233321201
   Glass R I, 1991, Adv Exp Med Biol, V310, P249
   HAHNZORIC M, 1990, ACTA PAEDIATR SCAND, V79, P1137
   Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085
   Han K, 2012, HUM VACC IMMUNOTHER, V8, P1845, DOI 10.4161/hv.21818
   Harris VC, 2018, CELL HOST MICROBE, V24, P197, DOI 10.1016/j.chom.2018.07.005
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea
   Omenaca F, 2007, PEDIATRICS, V119, pE179, DOI 10.1542/peds.2005-2907
   PABST HF, 1990, LANCET, V336, P269, DOI 10.1016/0140-6736(90)91802-H
   PICHICHERO ME, 1990, J INFECT DIS, V162, P753, DOI 10.1093/infdis/162.3.753
   Pickering LK, 1998, PEDIATRICS, V101, P242, DOI 10.1542/peds.101.2.242
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Ritz N, 2013, VACCINE, V31, P3098, DOI 10.1016/j.vaccine.2013.03.059
   Schepp RM, 2017, J VIROL METHODS, V241, P15, DOI 10.1016/j.jviromet.2016.12.006
   Silfverdal SA, 2002, PEDIATR INFECT DIS J, V21, P816, DOI 10.1097/00006454-200209000-00006
   Stark K, 1999, VACCINE, V17, P844, DOI 10.1016/S0264-410X(98)00269-2
   Vemuri R, 2019, SEMIN IMMUNOPATHOL, V41, P265, DOI 10.1007/s00281-018-0716-7
   Voysey M, 2017, JAMA PEDIATR, V171, P637, DOI 10.1001/jamapediatrics.2017.0638
   Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18
   Zimmermann P, 2018, VACCINE, V36, P4433, DOI 10.1016/j.vaccine.2018.04.066
   Zimmermann P, 2018, PEDIATR INFECT DIS J, V37, pE315, DOI 10.1097/INF.0000000000002103
NR 27
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
DI 10.1111/apa.14932
EA OCT 2019
PG 11
WC Pediatrics
SC Pediatrics
GA JC7UN
UT WOS:000489483700001
PM 31610635
DA 2020-12-17
ER

PT J
AU Hirako, I
   Assis, P
   Hojo-Souza, N
   Reed, G
   Nakaya, H
   Golenbock, D
   Coimbra, R
   Gazzinelli, R
AF Hirako, I.
   Assis, P.
   Hojo-Souza, N.
   Reed, G.
   Nakaya, H.
   Golenbock, D.
   Coimbra, R.
   Gazzinelli, R.
TI Daily pattern of feeding and rhythmic oscillation of TNFa production
   regulate synchrony of Plasmodium chabaudi stages with host circadian
   cycle
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 17th International Congress of Immunology of the
   International-Union-of-Immunological-Societies (IUIS)
CY OCT 19-23, 2019
CL Beijing, PEOPLES R CHINA
SP Int Union Immunol Soc
C1 [Hirako, I.; Hojo-Souza, N.; Coimbra, R.; Gazzinelli, R.] Fundacao Oswaldo Cruz, Belo Horizonte, MG, Brazil.
   [Assis, P.; Reed, G.; Golenbock, D.] Univ Massachusetts, Sch Med, Worcester, MA USA.
   [Nakaya, H.] Univ Sao Paulo, Sao Paulo, Brazil.
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2019
VL 49
SU 3
SI SI
MA P0976
BP 1297
EP 1297
PG 1
WC Immunology
SC Immunology
GA JD5MK
UT WOS:000490026904169
DA 2020-12-17
ER

PT J
AU Schroder, WA
   Hirata, TD
   Le, TT
   Gardner, J
   Boyle, GM
   Ellis, J
   Nakayama, E
   Pathirana, D
   Nakaya, HI
   Suhrbier, A
AF Schroder, Wayne A.
   Hirata, Thiago D.
   Le, Thuy T.
   Gardner, Joy
   Boyle, Glen M.
   Ellis, Jonathan
   Nakayama, Eri
   Pathirana, Dilan
   Nakaya, Helder I.
   Suhrbier, Andreas
TI SerpinB2 inhibits migration and promotes a resolution phase signature in
   large peritoneal macrophages
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PLASMINOGEN-ACTIVATOR INHIBITOR; NF-KAPPA-B; ALPHA-INDUCED APOPTOSIS;
   TUMOR-NECROSIS-FACTOR; CANCER-CELL SURVIVAL; PLG-R-KT; GENE-EXPRESSION;
   ALTERNATIVE ACTIVATION; BREAST-CANCER; COLON-CANCER
AB SerpinB2 (plasminogen activator inhibitor type 2) has been called the "undecided serpin" with no clear consensus on its physiological role, although it is well described as an inhibitor of urokinase plasminogen activator (uPA). In macrophages, pro-inflammatory stimuli usually induce SerpinB2; however, expression is constitutive in Gata6+ large peritoneal macrophages (LPM). Interrogation of expression data from human macrophages treated with a range of stimuli using a new bioinformatics tool, CEMiTool, suggested that SerpinB2 is most tightly co- and counter-regulated with genes associated with cell movement. Using LPM from SerpinB2(-/-) and SerpinB2(R)(380A) (active site mutant) mice, we show that migration on Matrigel was faster than for their wild-type controls. Confocal microscopy illustrated that SerpinB2 and F-actin staining overlapped in focal adhesions and lamellipodia. Genes associated with migration and extracellular matrix interactions were also identified by RNA-Seq analysis of migrating RPM from wild-type and SerpinB2(R)(380A) mice. Subsequent gene set enrichment analyses (GSEA) suggested SerpinB2 counter-regulates many Gata6-regulated genes associated with migration. These data argue that the role of SerpinB2 in macrophages is inhibition of uPA-mediated plasmin generation during cell migration. GSEA also suggested that SerpinB2 expression (likely via ensuing modulation of uPA-receptor/integrin signaling) promotes the adoption of a resolution phase signature.
C1 [Schroder, Wayne A.; Le, Thuy T.; Gardner, Joy; Boyle, Glen M.; Ellis, Jonathan; Pathirana, Dilan; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia.
   [Hirata, Thiago D.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld 4029, Australia.
EM Andreas.Suhrbier@qimrberghofer.edu.au
RI Boyle, Glen/G-1347-2013; Hirata, Thiago Dominguez Crespo/AAP-1903-2020;
   Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020
OI Boyle, Glen/0000-0002-1385-529X; Nakaya, Helder I/0000-0001-5297-9108;
   Nakaya, Helder/0000-0001-5297-9108; Pathirana,
   Dilan/0000-0001-7000-2659; Hirata, Thiago/0000-0002-3967-8121; Nakayama,
   Eri/0000-0002-0826-3513
FU National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia; Sao
   Paulo Research Foundation FAPESPFundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [2014/24162-2, 2017/17345-1]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PROEX)CAPES [001];
   NHMRCNational Health and Medical Research Council of Australia
FX The work was supported by a Project grant from the National Health and
   Medical Research Council (NHMRC) of Australia, and Sao Paulo Research
   Foundation FAPESP Grant No. 2014/24162-2 and 2017/17345-1. Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/PROEX) - Finance
   Code 001 provided a PhD scholarship for T.D.H.A.S. holds a Principle
   Research Fellowship from the NHMRC. The authors would like to thank the
   QIMRB animal house and IT staff for their assistance.
CR Aisina R B, 2014, Bioorg Khim, V40, P642
   Al-Ejeh F, 2004, EXP CELL RES, V297, P259, DOI 10.1016/j.yexcr.2004.03.030
   Al-Horani Rami A., 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V12, P91
   ANTALIS TM, 1992, EUR J BIOCHEM, V205, P203, DOI 10.1111/j.1432-1033.1992.tb16769.x
   Bae SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32258
   Belaguli NS, 2010, NEOPLASIA, V12, P856, DOI 10.1593/neo.10224
   Besch R, 2007, CELL DEATH DIFFER, V14, P818, DOI 10.1038/sj.cdd.4402065
   Beuling E, 2012, MOL CELL BIOL, V32, P3392, DOI 10.1128/MCB.00070-12
   Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001
   Blom K, 2017, IMMUNOPHARM IMMUNOT, V39, P199, DOI 10.1080/08923973.2017.1320671
   Booth NA, 1999, BEST PRACT RES CL HA, V12, P423, DOI 10.1053/beha.1999.0034
   Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107
   Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107
   Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789
   Cabrera-Ortega AA, 2017, CRIT REV IMMUNOL, V37, P1, DOI 10.1615/CritRevImmunol.2017019636
   Carlson S, 2017, J MOL CELL CARDIOL, V108, P42, DOI 10.1016/j.yjmcc.2016.05.016
   CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893
   Carriero MV, 2011, CURR PHARM DESIGN, V17, P1944
   Cha BH, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700289
   Chistiakov DA, 2017, IMMUNOBIOLOGY, V223, P101, DOI 10.1016/j.imbio.2017.10.005
   Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110
   Cochran BJ, 2011, J BIOL CHEM, V286, P24467, DOI 10.1074/jbc.M111.225706
   Corsetti JP, 2016, ATHEROSCLEROSIS, V250, P1, DOI 10.1016/j.atherosclerosis.2016.04.017
   Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400
   D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550
   Daniels MJD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010102
   Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109
   Deng L, 2015, INT J CLIN EXP MED, V8, P1862
   Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259
   DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894
   Doeuvre L, 2010, BIOCHEM J, V432, P365, DOI 10.1042/BJ20100561
   Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686
   Draxler DF, 2017, SEMIN THROMB HEMOST, V43, P143, DOI 10.1055/s-0036-1586227
   Eblen ST, 2018, ADV CANCER RES, V138, P99, DOI 10.1016/bs.acr.2018.02.004
   Elsafadi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10983-x
   ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783
   Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013
   Fan J, 2004, ACTA BIOCH BIOPH SIN, V36, P42, DOI 10.1093/abbs/36.1.42
   Farrehi PM, 1998, CIRCULATION, V97, P1002
   Fish RJ, 2006, EXP CELL RES, V312, P350, DOI 10.1016/j.yexcr.2005.11.003
   Fleetwood AJ, 2014, J IMMUNOL, V192, P3540, DOI 10.4049/jimmunol.1302864
   Foley JH, 2017, SEMIN THROMB HEMOST, V43, P135, DOI 10.1055/s-0036-1592302
   Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654
   Gardiner EE, 2014, J THROMB HAEMOST, V12, P1703, DOI 10.1111/jth.12704
   Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Genua M, 2016, INFLAMM BOWEL DIS, V22, P2390, DOI 10.1097/MIB.0000000000000896
   Genua M, 2015, GUT, V64, P589, DOI 10.1136/gutjnl-2013-305933
   Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009
   Guller S, 2011, PLACENTA, V32, P63, DOI 10.1016/j.placenta.2010.10.011
   HAMILTON JA, 1992, BLOOD, V80, P121
   Harris NLE, 2017, ONCOGENE, V36, P4288, DOI 10.1038/onc.2017.63
   Hildenbrand R, 2008, HISTOL HISTOPATHOL, V23, P227, DOI 10.14670/HH-23.227
   Hsieh HH, 2017, J CELL SCI, V130, P3272, DOI 10.1242/jcs.204974
   Hume D. A., 2016, DIFFERENTIATION MICR, V4, P1
   Jensen PH, 1996, J BIOL CHEM, V271, P26892, DOI 10.1074/jbc.271.43.26892
   Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kan XH, 2016, ARCH BIOCHEM BIOPHYS, V591, P150, DOI 10.1016/j.abb.2015.12.013
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Keller N, 2018, SEMIN CELL DEV BIOL, V82, P105, DOI 10.1016/j.semcdb.2018.01.009
   Kindzelskii AL, 2004, HISTOCHEM CELL BIOL, V121, P299, DOI 10.1007/s00418-004-0639-3
   KINNBY B, 1991, FIBRINOLYSIS, V5, P239, DOI 10.1016/0268-9499(91)90006-P
   Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007
   LAUG WE, 1993, CANCER RES, V53, P6051
   Lee JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130136
   Lee NH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0748-x
   Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050
   Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016483
   Longhin E, 2018, ARCH TOXICOL, V92, P2923, DOI 10.1007/s00204-018-2259-z
   Lu HX, 2018, J LEUKOCYTE BIOL, V103, P719, DOI 10.1002/JLB.3A0617-264RR
   Lv PC, 2018, EXPERT OPIN THER PAT, V28, P139, DOI 10.1080/13543776.2018.1414183
   Mahmood N, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00024
   Mahony D, 1999, EUR J BIOCHEM, V263, P765, DOI 10.1046/j.1432-1327.1999.00552.x
   Major L, 2011, EXP CELL RES, V317, P338, DOI 10.1016/j.yexcr.2010.10.016
   Major LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057343
   Marenholz I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01220-0
   Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865
   Maurer F, 1996, J BIOL CHEM, V271, P26074, DOI 10.1074/jbc.271.42.26074
   Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x
   Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7
   Meznarich J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057837
   Miles LA, 2017, J THROMB HAEMOST, V15, P155, DOI 10.1111/jth.13532
   Miles LA, 2014, INT REV CEL MOL BIO, V309, P259, DOI 10.1016/B978-0-12-800255-1.00005-3
   Mills CD, 2014, J INNATE IMMUN, V6, P716, DOI 10.1159/000364945
   Mitchell JW, 2006, BLOOD, V107, P4383, DOI 10.1182/blood-2005-07-2872
   Munakata S, 2015, GASTROENTEROLOGY, V148, P565, DOI 10.1053/j.gastro.2014.12.001
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Nguyen DHD, 2000, J BIOL CHEM, V275, P19382, DOI 10.1074/jbc.M909575199
   O'Connell PA, 2010, BLOOD, V116, P1136, DOI 10.1182/blood-2010-01-264754
   Oh MH, 2017, CELL REP, V20, P2439, DOI 10.1016/j.celrep.2017.08.046
   Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016
   Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043
   Paland N, 2013, ATHEROSCLEROSIS, V231, P29, DOI 10.1016/j.atherosclerosis.2013.08.016
   Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010
   Pavet V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.5
   Peng J, 2015, INT J CANCER, V137, P848, DOI 10.1002/ijc.29485
   POLLANEN J, 1988, J CELL BIOL, V106, P87, DOI 10.1083/jcb.106.1.87
   Praus M, 1999, GENE THER, V6, P227, DOI 10.1038/sj.gt.3300802
   Prow NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006788
   Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304
   Ramnefjell M, 2017, ONCOTARGET, V8, P90706, DOI 10.18632/oncotarget.21456
   Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488
   Reichel CA, 2012, TRENDS CARDIOVAS MED, V22, P192, DOI 10.1016/j.tcm.2012.07.019
   Ritchie H, 1999, THROMB HAEMOSTASIS, V81, P96
   Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414
   Roy S, 2015, NUCLEIC ACIDS RES, V43, P6969, DOI 10.1093/nar/gkv646
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Santibanez Juan F, 2013, ISRN Dermatol, V2013, P597927, DOI 10.1155/2013/597927
   Schroder WA, 2010, PARASITE IMMUNOL, V32, P764, DOI 10.1111/j.1365-3024.2010.01241.x
   Schroder WA, 2019, PLATELETS, V30, P658, DOI 10.1080/09537104.2018.1535702
   Schroder WA, 2016, AM J PATHOL, V186, P1511, DOI 10.1016/j.ajpath.2016.02.017
   Schroder WA, 2014, CANCER MED-US, V3, P500, DOI 10.1002/cam4.229
   Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20
   Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187
   Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429
   Shay T, 2013, TRENDS IMMUNOL, V34, P602, DOI 10.1016/j.it.2013.03.004
   Shea-Donohue T, 2014, GUT MICROBES, V5, P254, DOI 10.4161/gmic.28093
   Shen F, 2013, ONCOL REP, V30, P1355, DOI 10.3892/or.2013.2544
   Siefert SA, 2014, J THROMB HAEMOST, V12, P1706, DOI 10.1111/jth.12657
   Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821
   Song YC, 2015, EXP MOL PATHOL, V99, P617, DOI 10.1016/j.yexmp.2015.10.005
   Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sugimoto MA, 2017, BLOOD, V129, P2896, DOI 10.1182/blood-2016-09-742825
   Suwa D, 2008, ANTICANCER RES, V28, P693
   Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056
   Teoh SSY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4164
   Tian F, 2013, EUR J CANCER, V49, P1771, DOI 10.1016/j.ejca.2012.12.015
   Tian L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01214
   Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850
   Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040
   Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711
   VONHEIJNE G, 1991, J BIOL CHEM, V266, P15240
   Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009
   Wiesner C, 2014, CELL ADHES MIGR, V8, P179, DOI 10.4161/cam.28116
   Wolff C, 2011, J PATHOL, V223, P54, DOI 10.1002/path.2791
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yang H, 2015, MOL MED, V21, pS6, DOI 10.2119/molmed.2015.00087
   YE RD, 1988, J BIOL CHEM, V263, P4869
   Yu H, 2002, BLOOD, V99, P2810, DOI 10.1182/blood.V99.8.2810
   Zeng P, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/379538
   Zhang S, 2015, EXP CELL RES, V332, P278, DOI 10.1016/j.yexcr.2015.02.006
   Zhang YL, 2018, CANCER RES, V78, P2305, DOI 10.1158/0008-5472.CAN-17-2867
   Zhao AP, 2013, J IMMUNOL, V190, P5779, DOI 10.4049/jimmunol.1200293
   Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696
NR 148
TC 6
Z9 6
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 27
PY 2019
VL 9
AR 12421
DI 10.1038/s41598-019-48741-w
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IT2UQ
UT WOS:000482709400032
PM 31455834
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Lima, DS
   Cardozo, LE
   Maracaja-Coutinho, V
   Suhrbier, A
   Mane, K
   Jeffries, D
   Silveira, ELV
   Amaral, PP
   Rappuoli, R
   de Silva, TI
   Nakaya, HI
AF de Lima, Diogenes S.
   Cardozo, Lucas E.
   Maracaja-Coutinho, Vinicius
   Suhrbier, Andreas
   Mane, Karim
   Jeffries, David
   Silveira, Eduardo L. V.
   Amaral, Paulo P.
   Rappuoli, Rino
   de Silva, Thushan I.
   Nakaya, Helder I.
TI Long noncoding RNAs are involved in multiple immunological pathways in
   response to vaccination
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE systems biology; vaccination; transcriptome; long noncoding RNAs
ID YELLOW-FEVER VACCINE; INFLUENZA VACCINATION; IMMUNE-RESPONSES;
   SYSTEMS-ANALYSIS; GENE-EXPRESSION; TRANSCRIPTION; PHENOTYPES; SIGNATURE;
   INVASION; PROGRAM
AB Understanding the mechanisms of vaccine-elicited protection contributes to the development of new vaccines. The emerging field of systems vaccinology provides detailed information on host responses to vaccination and has been successfully applied to study the molecular mechanisms of several vaccines. Long noncoding RNAs (lncRNAs) are crucially involved in multiple biological processes, but their role in vaccine-induced immunity has not been explored. We performed an analysis of over 2,000 blood transcriptome samples from 17 vaccine cohorts to identify lncRNAs potentially involved with antibody responses to influenza and yellow fever vaccines. We have created an online database where all results from this analysis can be accessed easily. We found that lncRNAs participate in distinct immunological pathways related to vaccine-elicited responses. Among them, we showed that the expression of lncRNA FAM30A was high in B cells and correlates with the expression of immunoglobulin genes located in its genomic vicinity. We also identified altered expression of these lncRNAs in RNA-sequencing (RNA-seq) data from a cohort of children following immunization with intranasal live attenuated influenza vaccine, suggesting a common role across several diverse vaccines. Taken together, these findings provide evidence that lncRNAs have a significant impact on immune responses induced by vaccination.
C1 [de Lima, Diogenes S.; Cardozo, Lucas E.; Silveira, Eduardo L. V.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.
   [Maracaja-Coutinho, Vinicius] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago 8380492, Chile.
   [Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Lab, Brisbane, Qld 4029, Australia.
   [Mane, Karim; Jeffries, David; de Silva, Thushan I.] Gambia LSHTM, Vaccines & Immun Theme Med Res Council Unit, Banjul, Gambia.
   [Amaral, Paulo P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.
   [Rappuoli, Rino] GlaxoSmithKline, I-53100 Siena, Italy.
   [Rappuoli, Rino] Imperial Coll London, Dept Infect Dis, London W12 ONN, England.
   [de Silva, Thushan I.] Imperial Coll London, Dept Med, Ctr Int Child Hlth, Paediat Sect, London W2 1PG, England.
   [de Silva, Thushan I.] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield S10 2RX, S Yorkshire, England.
   [Nakaya, Helder I.] Univ Sao Paulo, Sci Platform Pasteur, BR-05508210 Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.; Rappuoli, R (corresponding author), GlaxoSmithKline, I-53100 Siena, Italy.; Rappuoli, R (corresponding author), Imperial Coll London, Dept Infect Dis, London W12 ONN, England.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, BR-05508210 Sao Paulo, Brazil.
EM rino.r.rappuoli@gsk.com; hnakaya@usp.br
RI Nakaya, Helder I/A-1397-2010; Silveira, Eduardo L V/E-5733-2014; Nakaya,
   Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Silveira, Eduardo L
   V/0000-0001-8333-2884; Nakaya, Helder/0000-0001-5297-9108
FU Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2017/50137-3, 2013/08216-2, 2012/19278-6];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil
   (CAPES)CAPES [001]; Fondo Nacional de Desarrollo Cientifico y
   Tecnologico-Comision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT) [11161020]; Programa de Atraccion e Insercion de Capital
   Humano Avanzado-CONICYT [PAI79170021]; Wellcome Trust Intermediate
   Clinical Fellowship award [110058/Z/15/Z]; Fondo de Financiamiento de
   Centros de Investigacion en Areas PrioritariasCONICYT [15130011]
FX H.I.N. is supported by the Sao Paulo Research Foundation (grants
   2017/50137-3, 2013/08216-2, and 2012/19278-6). This study was financed
   in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-Brasil (CAPES)-Finance Code 001; Fondo Nacional de Desarrollo
   Cientifico y Tecnologico-Comision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT) (11161020), Programa de Atraccion e Insercion de
   Capital Humano Avanzado-CONICYT (PAI79170021), and Fondo de
   Financiamiento de Centros de Investigacion en Areas PrioritariasCONICYT
   (15130011), and by a Wellcome Trust Intermediate Clinical Fellowship
   award to T.I.d.S. (110058/Z/15/Z).
CR Adams D, 2012, NAT BIOTECHNOL, V30, P224, DOI 10.1038/nbt.2153
   Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068
   Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156
   de Candia P, 2016, EUR J IMMUNOL, V46, P725, DOI 10.1002/eji.201545787
   de Candia P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00043
   de Candia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075348
   Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Goyal A, 2017, NUCLEIC ACIDS RES, V45, P12496, DOI 10.1093/nar/gkx952
   Guo M, 2018, J IMMUNOL, V200, P1039, DOI 10.4049/jimmunol.1701470
   Hou J, 2017, J IMMUNOL, V199, P1476, DOI 10.4049/jimmunol.1700083
   Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009
   Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9
   Jia J, 2016, ONCOTARGET, V7, P37868, DOI 10.18632/oncotarget.9350
   Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202. Article published online before March 2002
   Koff WC, 2014, NAT IMMUNOL, V15, P589, DOI 10.1038/ni.2871
   Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011
   Kuwahara K, 2000, BLOOD, V95, P2321, DOI 10.1182/blood.V95.7.2321.007k33_2321_2328
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Li ZW, 2017, CELL DEATH DIFFER, V24, P59, DOI 10.1038/cdd.2016.95
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Lin HN, 2018, BIOINFORMATICS, V34, P190, DOI 10.1093/bioinformatics/btx558
   Mao ZQ, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171070
   Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942
   McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042
   Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rajaiya J, 2012, BIOCHEMISTRY-US, V51, P5695, DOI 10.1021/bi3007127
   Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093
   Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Romero-Barrios N, 2018, NUCLEIC ACIDS RES, V46, P2169, DOI 10.1093/nar/gky095
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Signal B, 2016, TRENDS GENET, V32, P620, DOI 10.1016/j.tig.2016.08.004
   Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328
   Sun C, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0427-3
   Thakar J, 2015, AGING-US, V7, P38, DOI 10.18632/aging.100720
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   Verma-Gaur J, 2012, P NATL ACAD SCI USA, V109, P17004, DOI 10.1073/pnas.1208398109
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456
   Wang Y, 2015, P NATL ACAD SCI USA, V112, pE3883, DOI 10.1073/pnas.1501662112
   Wu XS, 2017, EMBO REP, V18, P1837, DOI 10.15252/embr.201744147
   YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2
   Zemmour D, 2017, P NATL ACAD SCI USA, V114, pE3472, DOI 10.1073/pnas.1700946114
   Zeng HF, 2018, ONCOL RES, V26, P335, DOI 10.3727/096504017X14907375885605
   Zhang H, 2013, J ALLERGY CLIN IMMUN, V132, P1005, DOI 10.1016/j.jaci.2013.05.033
   Zhang J, 2015, TUMOR BIOL, V36, P7465, DOI 10.1007/s13277-015-3460-9
   Zhang XQ, 2012, NEUROBIOL DIS, V48, P1, DOI 10.1016/j.nbd.2012.06.004
   Zhao FJ, 2015, ONCOTARGET, V6, P1064, DOI 10.18632/oncotarget.2833
   Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045
NR 60
TC 10
Z9 10
U1 1
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 20
PY 2019
VL 116
IS 34
BP 17121
EP 17126
DI 10.1073/pnas.1822046116
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IS1SW
UT WOS:000481935500069
PM 31399544
OA Other Gold, Green Accepted, Green Published
DA 2020-12-17
ER

PT J
AU Mastelic-Gavillet, B
   Vono, M
   Gonzalez-Dias, P
   Ferreira, FM
   Cardozo, L
   Lambert, PH
   Nakaya, HI
   Siegrist, CA
AF Mastelic-Gavillet, Beatris
   Vono, Maria
   Gonzalez-Dias, Patricia
   Ferreira, Frederico Moraes
   Cardozo, Lucas
   Lambert, Paul-Henri
   Nakaya, Helder, I
   Siegrist, Claire-Anne
TI Neonatal T Follicular Helper Cells Are Lodged in a Pre-T Follicular
   Helper Stage Favoring Innate Over Adaptive Germinal Center Responses
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE T follicular helper cells; neonates; vaccines; adjuvant; transcriptional
   profile analysis
ID CENTER B-CELL; TRANSCRIPTION FACTOR STAT3; BCL6 EXPRESSION;
   GENE-EXPRESSION; DENDRITIC CELLS; PPAR-GAMMA; C-MAF; RXR-ALPHA; FH
   CELLS; DIFFERENTIATION
AB T follicular helper (T-fh) cells have emerged as a critical limiting factor for controlling the magnitude of neonatal germinal center (GC) reactions and primary vaccine antibody responses. We compared the functional attributes of neonatal and adult T-fh cells at the transcriptomic level and demonstrated that the T-fh cell program is well-initiated in neonates although the T-f(h) gene-expression pattern (i.e., CXCR5, IL-21, BCL6, TBK1, STAT4, ASCL2, and c-MAF) is largely underrepresented as compared to adult T-fh cells. Importantly, we identified a TH2-bias of neonatal T-fh cells, with preferential differentiation toward short-lived pre-T-fh effector cells. Remarkably, adjuvantation with CpG-ODNs redirect neonatal pre-T-fh cells toward committed GC-T-fh cells, as illustrated by increased expression of T-fh signature genes and reduced expression of TH2-related genes.
C1 [Mastelic-Gavillet, Beatris; Vono, Maria; Lambert, Paul-Henri; Siegrist, Claire-Anne] Univ Geneva, WHO Collaborating Ctr Vaccine Immunol, Dept Pathol Immunol, Geneva, Switzerland.
   [Mastelic-Gavillet, Beatris; Vono, Maria; Lambert, Paul-Henri; Siegrist, Claire-Anne] Univ Geneva, WHO Collaborating Ctr Vaccine Immunol, Dept Pediat, Geneva, Switzerland.
   [Gonzalez-Dias, Patricia; Cardozo, Lucas; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Ferreira, Frederico Moraes] Univ Sao Paulo, Heart Inst, Sch Med, Lab Immunol, Sao Paulo, Brazil.
   [Mastelic-Gavillet, Beatris] Univ Lausanne, Ludwig Ctr Canc Res, Ctr Expt Therapeut, Dept Oncol, Lausanne, Switzerland.
RP Mastelic-Gavillet, B (corresponding author), Univ Geneva, WHO Collaborating Ctr Vaccine Immunol, Dept Pathol Immunol, Geneva, Switzerland.; Mastelic-Gavillet, B (corresponding author), Univ Geneva, WHO Collaborating Ctr Vaccine Immunol, Dept Pediat, Geneva, Switzerland.; Mastelic-Gavillet, B (corresponding author), Univ Lausanne, Ludwig Ctr Canc Res, Ctr Expt Therapeut, Dept Oncol, Lausanne, Switzerland.
EM beatris.mastelic-gavillet@chuv.ch
RI Nakaya, Helder I/A-1397-2010; Ferreira, Frederico Moraes/A-4622-2013;
   Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Gonzalez-Dias, Patricia/0000-0002-6434-3841
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310000-111926/1, 310030-165960]; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19278-6, 2017/50137-3];
   Center for Vaccinology and Neonatal Immunology
FX This study was supported by the Swiss National Science Foundation (grant
   numbers 310000-111926/1 and 310030-165960 to C-AS) and by research
   grants of the Center for Vaccinology and Neonatal Immunology. HN was
   supported by FAPESP (grant numbers: 2012/19278-6 and 2017/50137-3).
CR Adkins B, 2003, J IMMUNOL, V170, P4548, DOI 10.4049/jimmunol.170.9.4548
   Akram Afia, 2010, Mol Neurodegener, V5, P36, DOI 10.1186/1750-1326-5-36
   Andris F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00480
   Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675
   Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012
   Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483
   Baumjohann D, 2011, J IMMUNOL, V187, P2089, DOI 10.4049/jimmunol.1101393
   Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690
   Bollig N, 2012, P NATL ACAD SCI USA, V109, P8664, DOI 10.1073/pnas.1205834109
   Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545
   Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147
   Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010
   Chakarov S, 2014, EMBO MOL MED, V6, P590, DOI 10.1002/emmm.201403841
   Chen NX, 1995, TRANSPLANTATION, V60, P1187
   Chen X, 2015, PROTEIN CELL, V6, P825, DOI 10.1007/s13238-015-0210-0
   Chevrier S, 2009, P NATL ACAD SCI USA, V106, P3895, DOI 10.1073/pnas.0809736106
   Choi JM, 2012, MOL CELLS, V33, P217, DOI 10.1007/s10059-012-2297-y
   Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226
   Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963
   Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023
   David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x
   Debock I, 2013, J IMMUNOL, V191, P1231, DOI 10.4049/jimmunol.1203288
   Du X, 2005, EUR J IMMUNOL, V35, P3414, DOI 10.1002/eji.200535366
   Eddahri F, 2009, BLOOD, V113, P2426, DOI 10.1182/blood-2008-04-154682
   Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI 10.1093/nar/gkx1132
   Furmanski AL, 2013, J IMMUNOL, V190, P2641, DOI 10.4049/jimmunol.1202541
   Galindo-Albarran AO, 2016, CELL REP, V17, P2151, DOI 10.1016/j.celrep.2016.10.056
   Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798
   Gatto D, 2011, J IMMUNOL, V187, P4621, DOI 10.4049/jimmunol.1101542
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Gavillet BM, 2015, J IMMUNOL, V194, P4836, DOI 10.4049/jimmunol.1402071
   Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020
   Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380
   Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099
   Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819
   HSU HL, 1991, MOL CELL BIOL, V11, P3037, DOI 10.1128/MCB.11.6.3037
   Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037
   Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024
   Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025
   Kubo M, 2015, NAT IMMUNOL, V16, P900, DOI 10.1038/ni.3254
   Leber A, 2016, J THEOR BIOL, V398, P74, DOI 10.1016/j.jtbi.2016.02.036
   Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010
   Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013
   Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075
   Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038
   Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910
   Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219
   Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205
   Mastelic B, 2012, J IMMUNOL, V189, P5764, DOI 10.4049/jimmunol.1201143
   Moriyama S, 2014, J EXP MED, V211, P1297, DOI 10.1084/jem.20131666
   Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012
   Nemajerova A, 2010, J CLIN INVEST, V120, P2070, DOI 10.1172/JCI40331
   Nobs SP, 2017, J EXP MED, V214, P3015, DOI 10.1084/jem.20162069
   Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676
   Ono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111405
   Opiela SJ, 2008, BLOOD, V112, P1530, DOI 10.1182/blood-2007-08-106500
   Park HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099127
   Pedros C, 2016, NAT IMMUNOL, V17, P825, DOI 10.1038/ni.3463
   Pihlgren M, 2003, J IMMUNOL, V170, P2824, DOI 10.4049/jimmunol.170.6.2824
   Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651
   Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430
   Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005
   Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rookhuizen DC, 2014, P NATL ACAD SCI USA, V111, pE3224, DOI 10.1073/pnas.1323985111
   Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005
   Sanda T, 2017, EXP HEMATOL, V53, P7, DOI 10.1016/j.exphem.2017.06.001
   Saubermann LJ, 2002, INFLAMM BOWEL DIS, V8, P330, DOI 10.1097/00054725-200209000-00004
   Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016
   Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508
   Smith NL, 2014, J IMMUNOL, V193, P177, DOI 10.4049/jimmunol.1400553
   Stauss D, 2016, EMBO J, V35, P881, DOI 10.15252/embj.201591459
   Stone EL, 2015, IMMUNITY, V42, P239, DOI 10.1016/j.immuni.2015.01.017
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tanaka Y, 2005, BLOOD, V106, P1286, DOI 10.1182/blood-2004-10-4074
   Vaeth M, 2014, J EXP MED, V211, P545, DOI 10.1084/jem.20130604
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605
   Vono M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00381
   Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145
   Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112
   Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406
   Weber JP, 2015, J EXP MED, V212, P217, DOI 10.1084/jem.20141432
   Weinmann AS, 2014, IMMUNOL CELL BIOL, V92, P34, DOI 10.1038/icb.2013.49
   Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554
   Whittaker E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00532
   Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129
   Wood N, 2011, CURR OPIN INFECT DIS, V24, P190, DOI 10.1097/QCO.0b013e328345d563
   Wu H, 2015, J IMMUNOL, V195, P2080, DOI 10.4049/jimmunol.1500335
   Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443
   Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058
   Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229
   Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002
   Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777
NR 99
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 13
PY 2019
VL 10
AR 1845
DI 10.3389/fimmu.2019.01845
PG 12
WC Immunology
SC Immunology
GA IQ1YV
UT WOS:000480547100001
PM 31456798
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Soares-Schanoski, A
   Baptista Cruz, N
   de Castro-Jorge, LA
   de Carvalho, RVH
   dos Santos, CA
   da Ros, N
   Oliveira, U
   Costa, DD
   dos Santos, CLS
   Cunha, MD
   Oliveira, MLS
   Alves, JC
   Ocea, RADC
   Ribeiro, DR
   Goncalves, ANA
   Gonzalez-Dias, P
   Suhrbier, A
   Zanotto, PMD
   de Azevedo, IJ
   Zamboni, DS
   Almeida, RP
   Ho, PL
   Kalil, J
   Nishiyama, MY
   Nakaya, HI
AF Soares-Schanoski, Alessandra
   Baptista Cruz, Natalia
   de Castro-Jorge, Luiza Antunes
   Homem de Carvalho, Renan Villanova
   dos Santos, Cliomar Alves
   da Ros, Nancy
   Oliveira, Ursula
   Costa, Danuza Duarte
   Simoes dos Santos, Cecilia Luiza
   Cunha, Marielton dos Passos
   Sarno Oliveira, Maria Leonor
   Alves, Juliana Cardoso
   de Lucena Couto Ocea, Regina Adalva
   Ribeiro, Danielle Rodrigues
   Aquime Goncalves, Andre Nicolau
   Gonzalez-Dias, Patricia
   Suhrbier, Andreas
   de Andrade Zanotto, Paolo Marinho
   de Azevedo, Inacio Junqueira
   Zamboni, Dario S.
   Almeida, Roque Pacheco
   Ho, Paulo Lee
   Kalil, Jorge
   Nishiyama, Milton Yutaka
   Nakaya, Helder I.
TI Systems analysis of subjects acutely infected with the Chikungunya virus
SO PLOS PATHOGENS
LA English
DT Article
ID DISEASE; NEUTROPHILS; POPULATION; EVOLUTION; MONOCYTES; ARTHRITIS;
   REVEALS; BIOLOGY
AB The largest ever recorded epidemic of the Chikungunya virus (CHIKV) broke out in 2004 and affected four continents. Acute symptomatic infections are typically associated with the onset of fever and often debilitating polyarthralgia/polyarthritis. In this study, a systems biology approach was adopted to analyze the blood transcriptomes of adults acutely infected with the CHIKV. Gene signatures that were associated with viral RNA levels and the onset of symptoms were identified. Among these genes, the putative role of the Eukaryotic Initiation Factor (eIF) family genes and apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC3A) in the CHIKV replication process were displayed. We further compared these signatures with signatures induced by the Dengue virus infection and rheumatoid arthritis. Finally, we demonstrated that the CHIKV in vitro infection of murine bone marrow-derived macrophages induced IL-1 beta production in a mechanism that is significantly dependent on the inflammasome NLRP3 activation. The observations provided valuable insights into virus-host interactions during the acute phase and can be instrumental in the investigation of new and effective therapeutic interventions.
   Author summary The Chikungunya virus (CHIKV) has infected millions of people worldwide and presents a serious public health issue. Acute symptomatic infections caused by contracting this mosquito-transmitted arbovirus are typically associated with an abrupt onset of fever and often debilitating polyarthralgia/ polyarthritis, as well as prolonged periods of disability in some patients. These dramatic effects call for a careful evaluation of the molecular mechanisms involved in this puzzling infection. By analyzing the blood transcriptome of adults acutely infected with CHIKV, we were able to provide a detailed picture of the early molecular events induced by the infection. Additionally, the systems biology approach revealed genes that can be investigated extensively as probable therapeutic targets for the disease.
C1 [Soares-Schanoski, Alessandra; Sarno Oliveira, Maria Leonor] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
   [Baptista Cruz, Natalia; Aquime Goncalves, Andre Nicolau; Gonzalez-Dias, Patricia; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [de Castro-Jorge, Luiza Antunes; Homem de Carvalho, Renan Villanova; Zamboni, Dario S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular Mol & Bioagentes Patogen, Ribeirao Preto, Brazil.
   [dos Santos, Cliomar Alves; Costa, Danuza Duarte] State Secretary Hlth, Cent Lab Publ Hlth LACEN SE, Hlth Fdn Parreiras Horta, Sergipe, Brazil.
   [da Ros, Nancy; Oliveira, Ursula; Nishiyama, Milton Yutaka] Butantan Inst, Special Lab Appl Toxinol, Sao Paulo, Brazil.
   [Simoes dos Santos, Cecilia Luiza] Adolfo Lutz Inst, Virol Ctr, Resp Dis Div, Sao Paulo, Brazil.
   [Cunha, Marielton dos Passos; de Andrade Zanotto, Paolo Marinho] Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Lab Mol Evolut & Bioinformat, Sao Paulo, Brazil.
   [Alves, Juliana Cardoso; de Lucena Couto Ocea, Regina Adalva; Ribeiro, Danielle Rodrigues] Univ Fed Sergipe, Univ Hosp EBSERH, Div Immunol & Mol Biol Lab, Sergipe, Brazil.
   [Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Ho, Paulo Lee] Butantan Inst, Bioind Div, Bacteriol Serv, Sao Paulo, Brazil.
   [Kalil, Jorge] Univ Sao Paulo, Fac Med, Heart Inst, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
EM hnakaya@usp.br
RI Oliveira, Maria Leonor S/F-4988-2012; Junior, Milton Y
   Nishiyama/H-4002-2013; de A. Zanotto, Paolo M./B-9286-2019; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010;
   Junqueira-de-Azevedo, Inacio L. M./H-5239-2011; Center of Toxins,
   Immune-response/J-5731-2015; de Carvalho, Renan V. H./AAC-7673-2019;
   Zamboni, Dario S/D-3024-2012; Soares Schanoski, Alessandra/H-8144-2014
OI Junior, Milton Y Nishiyama/0000-0002-2410-0562; de A. Zanotto, Paolo
   M./0000-0002-8167-0625; Nakaya, Helder/0000-0001-5297-9108; Nakaya,
   Helder I/0000-0001-5297-9108; Junqueira-de-Azevedo, Inacio L.
   M./0000-0003-4491-0180; de Carvalho, Renan V. H./0000-0001-5740-0652;
   Zamboni, Dario S/0000-0002-7856-7512; Gonzalez-Dias,
   Patricia/0000-0002-6434-3841; Baptista-Cruz,
   Natalia/0000-0002-8864-4139; Soares Schanoski,
   Alessandra/0000-0002-6514-8458
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2017/50137-3, 2012/19278-6, 2013/08216-2,
   CEPID 2013/07467-1]; Butantan Foundation; CNPqNational Council for
   Scientific and Technological Development (CNPq) [443371/2016-4,
   306992/2014-0]; Brazilian Health Ministry; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [0116005600]; CAPESCAPES [001]; FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/25055-8]; 
   [FAPESP -2016/08204-2]
FX H.I.N. is supported by the Sao Paulo Research Foundation (FAPESP; grants
   2017/50137-3, 2012/19278-6, and 2013/08216-2). A.S.S. is supported by
   Butantan Foundation, CNPq (Grant 443371/2016-4) and Brazilian Health
   Ministry. R. A. is supported by FINEP Grant 0116005600. D. R. R. has a
   postdoctoral fellowship from CNPq. J.C.A. has a postdoctoral fellowship
   from CAPES - Finance Code 001. M.P.C. has a PhD fellowship from FAPESP
   -2016/08204-2. I.J.A is supported by Sao Paulo Research Foundation
   (FAPESP; grant: CEPID 2013/07467-1). P.L.H is supported by Butantan
   Foundation, CNPq 306992/2014-0 and Fapesp 2015/25055-8. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bastos MLA, 2018, BRAZ J INFECT DIS, V22, P248, DOI 10.1016/j.bjid.2018.05.002
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Carrasco L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020070
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P585, DOI 10.1002/art.40383
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P578, DOI 10.1002/art.40384
   Chen WQ, 2017, NAT MICROBIOL, V2, P1435, DOI 10.1038/s41564-017-0015-4
   Chirathaworn C, 2013, ASIAN PAC J TROP MED, V6, P631, DOI 10.1016/S1995-7645(13)60108-X
   Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753
   Cunha MD, 2017, J CLIN VIROL, V97, P44, DOI 10.1016/j.jcv.2017.10.015
   David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275
   Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417
   Gabriel C, 2013, DNA CELL BIOL, V32, P665, DOI 10.1089/dna.2013.2211
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018
   Guaraldo L, 2018, EXPERT REV ANTI-INFE, V16, P333, DOI 10.1080/14787210.2018.1450629
   Gunn BM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002586
   Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181
   Hochedez P, 2006, EMERG INFECT DIS, V12, P1565, DOI 10.3201/eid1210.060495
   Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004
   Hossain MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006561
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   Jakobs C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131702
   Jianying Li PRB, 2009, PRINCIPAL VARIANCE C
   Joubert PE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005091
   Karasu E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00543
   Khadivjam B, 2017, J VIROL, V91, DOI 10.1128/JVI.02411-16
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kirschfink M, 1999, MOL IMMUNOL, V36, P225, DOI 10.1016/S0161-5890(99)00048-6
   KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Lian JQ, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.18892
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263
   Michlmayr D, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177862
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Figueiredo LTM, 2017, REV SOC BRAS MED TRO, V50, P583, DOI 10.1590/0037-8682-0397-2017
   Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Nanjappa SG, 2011, BLOOD, V117, P5123, DOI 10.1182/blood-2010-12-323154
   Naumenko V, 2018, CELL TISSUE RES, V371, P505, DOI 10.1007/s00441-017-2763-0
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Patkar C, 2013, AM J TROP MED HYG, V88, P89, DOI 10.4269/ajtmh.2012.12-0474
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Prow NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006788
   Rayamajhi Manira, 2013, Methods Mol Biol, V1040, P85, DOI 10.1007/978-1-62703-523-1_7
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Sanfilippo C, 2017, INFLAMM RES, V66, P1107, DOI 10.1007/s00011-017-1091-x
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Simarmata D, 2016, SCI REP-UK, V6, DOI 10.1038/srep26097
   Spalinger MR, 2017, AUTOPHAGY, V13, P1590, DOI 10.1080/15548627.2017.1341453
   SVS-MS, 2018, MON CAS DENG FEBR CH
   Swanson KV, 2019, NAT REV IMMUNOL, DOI [10.1038/s41577-019-0165-031036962, DOI 10.1038/S41577-019-0165-031036962]
   Tan Y, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006670
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
NR 67
TC 6
Z9 6
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUN
PY 2019
VL 15
IS 6
AR e1007880
DI 10.1371/journal.ppat.1007880
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA IO1PP
UT WOS:000479154700054
PM 31211814
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Oliveira-de-Souza, D
   Vinhaes, CL
   Arriaga, MB
   Kumar, NP
   Cubillos-Angulo, JM
   Shi, RR
   Wei, W
   Yuan, X
   Zhang, GL
   Cai, Y
   Barry, CE
   Via, LE
   Sher, A
   Babu, S
   Mayer-Barber, KD
   Nakaya, HI
   Fukutani, KF
   Andrade, BB
AF Oliveira-de-Souza, Deivide
   Vinhaes, Caian L.
   Arriaga, Maria B.
   Kumar, Nathella Pavan
   Cubillos-Angulo, Juan M.
   Shi, Ruiru
   Wei, Wang
   Yuan, Xing
   Zhang, Guolong
   Cai, Ying
   Barry, Clifton E., III
   Via, Laura E.
   Sher, Alan
   Babu, Subash
   Mayer-Barber, Katrin D.
   Nakaya, Helder I.
   Fukutani, Kiyoshi F.
   Andrade, Bruno B.
TI Molecular degree of perturbation of plasma inflammatory markers
   associated with tuberculosis reveals distinct disease profiles between
   Indian and Chinese populations
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; HEME OXYGENASE-1; PULMONARY; EXPRESSION;
   INDUCTION; IMMUNITY; INNATE; RISK
AB Tuberculosis (TB) is a chronic inflammatory disease caused by Mycobacterium tuberculosis infection which causes tremendous morbidity and mortality worldwide. Clinical presentation of TB patients is very diverse and disease heterogeneity is associated with changes in biomarker signatures. Here, we compared at the molecular level the extent of individual inflammatory perturbation of plasma protein and lipid mediators associated with TB in patients in China versus India. We performed a cross-sectional study analyzing the overall degree of inflammatory perturbation in treatment-naive pulmonary TB patients and uninfected individuals from India (TB: n =97, healthy: n = 20) and China (TB: n = 100, healthy: n =11). We employed the molecular degree of perturbation (MDP) adapted to plasma biomarkers to examine the overall changes in inflammation between these countries. M. tuberculosis infection caused a significant degree of molecular perturbation in patients from both countries, with higher perturbation detected in India. Interestingly, there were differences in biomarker perturbation patterns and the overall degree of inflammation. Patients with severe TB exhibited increased MDP values and Indian patients with this condition exhibited even higher degree of perturbation compared to Chinese patients. Network analyses identified IFN-alpha, IFN-beta, IL-1RI and TNF-alpha as combined biomarkers that account for the overall molecular perturbation in the entire study population. Our results delineate the magnitude of the systemic inflammatory perturbation in pulmonary TB and reveal qualitative changes in inflammatory profiles between two countries with high disease prevalence.
C1 [Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Arriaga, Maria B.; Cubillos-Angulo, Juan M.; Fukutani, Kiyoshi F.; Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Arriaga, Maria B.; Cubillos-Angulo, Juan M.; Fukutani, Kiyoshi F.; Andrade, Bruno B.] Fundacao Jose Silveira, Multinat Org Network Sponsoring Translat & Epidem, BR-40210320 Salvador, BA, Brazil.
   [Oliveira-de-Souza, Deivide; Vinhaes, Caian L.; Fukutani, Kiyoshi F.; Andrade, Bruno B.] FTC, Curso Med, BR-40290150 Salvador, BA, Brazil.
   [Kumar, Nathella Pavan; Babu, Subash] Natl Inst Res TB, Natl Inst Hlth, Int Ctr Excellence Res, Chennai 600031, Tamil Nadu, India.
   [Shi, Ruiru; Wei, Wang; Yuan, Xing] Henan Chest Hosp, Zhengzhou 450000, Henan, Peoples R China.
   [Zhang, Guolong] Sino US Int Res Ctr TB, Zhengzhou 450000, Henan, Peoples R China.
   [Zhang, Guolong] Henan Publ Hlth Ctr, Zhengzhou 450000, Henan, Peoples R China.
   [Cai, Ying; Barry, Clifton E., III; Via, Laura E.; Mayer-Barber, Katrin D.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Sher, Alan] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-05508 Sao Paulo, Brazil.
   [Andrade, Bruno B.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37232 USA.
   [Andrade, Bruno B.] Laureate Univ, Univ Salvador UNIFACS, BR-41720200 Salvador, BA, Brazil.
RP Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, Multinat Org Network Sponsoring Translat & Epidem, BR-40210320 Salvador, BA, Brazil.; Andrade, BB (corresponding author), FTC, Curso Med, BR-40290150 Salvador, BA, Brazil.; Andrade, BB (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37232 USA.; Andrade, BB (corresponding author), Laureate Univ, Univ Salvador UNIFACS, BR-41720200 Salvador, BA, Brazil.
EM bruno.andrade@fiocruz.br
RI Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020; Fukutani,
   Kiyoshi/T-1630-2019; Andrade, Bruno/AAI-2248-2020; Barry, Clifton
   E/ABE-7992-2020; Barry, Clifton E/H-3839-2012
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Barry, Clifton E/0000-0002-2927-270X; Barry,
   Clifton E/0000-0002-2927-270X; Andrade, Bruno/0000-0001-6833-3811; Via,
   Laura/0000-0001-6074-9521; Cubillos Angulo, Juan
   Manuel/0000-0002-3877-5077
FU Intramural Research Program of the NIAIDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES [001];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U01AI115940, R01AI069923-08,
   R01AI20790-02]; Intramural Program of Fundacao Oswaldo Cruz; Brazilian
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa da Bahia (FAPESB); Organization of
   American States - Partnerships Program for Education and Training
   (OAS-PAEC); Fundacao Jose Silveira; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [ZIAAI001065, U01AI115940,
   ZIAAI000843, U01AI115940, ZIAAI001065, ZIAAI001044, ZIAAI001081,
   ZIAAI001044, ZIAAI001065, U01AI115940, U01AI115940, ZIAAI000843,
   ZIAAI001207, ZIAAI001044, ZIAAI001065, ZIAAI001081, ZIAAI001207,
   ZIAAI001044, ZIAAI001081, ZIAAI001207, ZIAAI001207, ZIAAI001081,
   ZIAAI000843] Funding Source: NIH RePORTER
FX Acknowledgements The authors acknowledge study participants. This
   project was supported by the Intramural Research Program of the NIAID to
   K.D.M.-B. and C.E.B. This study was also financed in part by Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Finance Code
   001). The work of B.B.A. was supported by grants from the NIH
   (U01AI115940, R01AI069923-08, R01AI20790-02), by Intramural Program of
   Fundacao Oswaldo Cruz, Fundacao Jose Silveira and by the Brazilian
   National Council for Scientific and Technological Development (CNPq).
   D.O.-de.-S. and M.B.A. receive fellowships from the Fundacao de Amparo a
   Pesquisa da Bahia (FAPESB). C.L.V. is a research fellow from CNPq.
   J.M.C.-A. was supported by the Organization of American States -
   Partnerships Program for Education and Training (OAS-PAEC).
CR Albert MA, 2007, NUTR REV, V65, pS234, DOI 10.1301/nr.2007.dec.S234-S238
   Amaral EP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004188
   Andrade BB, 2014, CHEST, V145, P1244, DOI 10.1378/chest.13-1799
   Bastian M., 2009, INT AAAI C WEBL SOC
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767
   Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011
   Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468
   Devi KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145860
   Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758
   Doroshenko A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1112-9
   Ferguson JF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-63
   Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0
   Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198
   Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Kathirvel M, 2016, EPIGENOMICS-UK, V8, P537, DOI 10.2217/epi.16.1
   Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051
   Lai TC, 2016, OCCUP ENVIRON MED, V73, P56, DOI 10.1136/oemed-2015-102995
   Liang L, 2017, INT J TUBERC LUNG D, V21, P1145, DOI 10.5588/ijtld.16.0880
   Manion M, 2017, J VIRUS ERAD, V3, P24
   Mayer-Barber KD, 2015, IMMUNOL REV, V264, P264, DOI 10.1111/imr.12249
   Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489
   Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002
   Mesquita EDD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1736-3
   Miller MA, 2007, CURR MED CHEM, V14, P1409, DOI 10.2174/092986707780831131
   Moreira-Teixeira L, 2018, J EXP MED, V215, P1273, DOI 10.1084/jem.20180325
   Murray M, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P64, DOI 10.5588/ijtld.10.0535
   Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76
   Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127
   Prada-Medina CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01767-4
   Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242
   Rockwood N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00542
   Romagnoli A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0640-8
   Rousu J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003018
   Sharma P, 2017, TUBERCULOSIS, V105, P60, DOI 10.1016/j.tube.2017.04.003
   Singh J, 2015, J INFECTION, V71, P207, DOI 10.1016/j.jinf.2015.04.028
   Trauner A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1196-0
   Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10
   World Health Organization, 2018, GLOB TUB REP
   Wypych TP, 2017, ANN AM THORAC SOC, V14, pS339, DOI 10.1513/AnnalsATS.201703-255AW
   2010, TREATM TUB GUID 4 ED, P1
NR 43
TC 10
Z9 10
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 29
PY 2019
VL 9
AR 8002
DI 10.1038/s41598-019-44513-8
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IA1KB
UT WOS:000469318000015
PM 31142816
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Cardozo, LE
   Russo, PST
   Gomes-Correia, B
   Araujo-Pereira, M
   Sepulveda-Hermosilla, G
   Maracaja-Coutinho, V
   Nakaya, HI
AF Cardozo, Lucas E.
   Russo, Pedro S. T.
   Gomes-Correia, Bruno
   Araujo-Pereira, Mariana
   Sepulveda-Hermosilla, Gonzalo
   Maracaja-Coutinho, Vinicius
   Nakaya, Helder, I
TI webCEMiTool: Co-expression Modular Analysis Made Easy
SO FRONTIERS IN GENETICS
LA English
DT Article
DE co-expression analysis; systems biology; transcriptomics; web tool; data
   integration
AB Co-expression analysis has been widely used to elucidate the functional architecture of genes under different biological processes. Such analysis, however, requires substantial knowledge about programming languages and/or bioinformatics skills. We present webCEMiTool,(1) a unique online tool that performs comprehensive modular analyses in a fully automated manner. The webCEMiTool not only identifies co-expression gene modules but also performs several functional analyses on them. In addition, webCEMiTool integrates transcriptomic data with interactome information (i.e., protein-protein interactions) and identifies potential hubs on each network. The tool generates user-friendly html reports that allow users to search for specific genes in each module, as well as check if a module contains genes overrepresented in specific pathways or altered in a specific sample phenotype. We used webCEMiTool to perform a modular analysis of single-cell RNA-seq data of human cells infected with either Zika virus or dengue virus.
C1 [Cardozo, Lucas E.; Russo, Pedro S. T.; Araujo-Pereira, Mariana; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Gomes-Correia, Bruno; Maracaja-Coutinho, Vinicius] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago, Chile.
   [Sepulveda-Hermosilla, Gonzalo] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
EM hnakaya@usp.br
RI Nakaya, Helder I/A-1397-2010; Maracaja-Coutinho, Vinicius/R-5256-2019;
   Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Maracaja-Coutinho,
   Vinicius/0000-0002-8873-9381; Nakaya, Helder/0000-0001-5297-9108
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/19278-6, 2013/08216-2, 2017/05762-7, 2018/10748-6]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [313662/2017-7]; FONDECYT-CONICYTComision Nacional de Investigacion
   Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [11161020];
   PAI-CONICYT [PAI79170021]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES)CAPES [001]
FX This work was supported by grants from FAPESP (2012/19278-6,
   2013/08216-2, 2017/05762-7, 2018/10748-6); CNPq (313662/2017-7);
   FONDECYT-CONICYT (11161020); and PAI-CONICYT (PAI79170021). This study
   was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Beins E, 2016, GLIA, V64, P1007, DOI 10.1002/glia.22979
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Desai AP, 2017, PEERJ, V5, DOI 10.7717/peerj.3678
   Janova H, 2016, GLIA, V64, P635, DOI 10.1002/glia.22955
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Sharma Ankush, 2017, Front Immunol, V8, P918, DOI 10.3389/fimmu.2017.00918
   Tzfadia O, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01194
   Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110
   Wang J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004892
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
NR 12
TC 3
Z9 3
U1 1
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD MAR 6
PY 2019
VL 10
AR 146
DI 10.3389/fgene.2019.00146
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA HO4DL
UT WOS:000460872200001
PM 30894872
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Jochems, SP
   Marcon, F
   Carniel, BF
   Holloway, M
   Mitsi, E
   Smith, E
   Gritzfeld, JF
   Solorzano, C
   Reine, J
   Pojar, S
   Nikolaou, E
   German, EL
   Hyder-Wright, A
   Hill, H
   Hales, C
   Piters, WAAD
   Bogaert, D
   Adler, H
   Zaidi, S
   Connor, V
   Gordon, SB
   Rylance, J
   Nakaya, HI
   Ferreira, DM
AF Jochems, Simon P.
   Marcon, Fernando
   Carniel, Beatriz F.
   Holloway, Mark
   Mitsi, Elena
   Smith, Emma
   Gritzfeld, Jenna F.
   Solorzano, Carla
   Reine, Jesus
   Pojar, Sherin
   Nikolaou, Elissavet
   German, Esther L.
   Hyder-Wright, Angie
   Hill, Helen
   Hales, Caz
   Piters, Wouter A. A. de Steenhuijsen
   Bogaert, Debby
   Adler, Hugh
   Zaidi, Seher
   Connor, Victoria
   Gordon, Stephen B.
   Rylance, Jamie
   Nakaya, Helder I.
   Ferreira, Daniela M.
TI Inflammation induced by influenza virus impairs human innate immune
   control of pneumococcus
SO NATURE IMMUNOLOGY
LA English
DT Article
ID STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; INTERFERON INDUCTION;
   SEASONAL INFLUENZA; ANTIBODY-RESPONSES; SYSTEMS-ANALYSIS; COINFECTION;
   VACCINATION; INFECTION; TRANSMISSION
AB Colonization of the upper respiratory tract by pneumococcus is important both as a determinant of disease and for transmission into the population. The immunological mechanisms that contain pneumococcus during colonization are well studied in mice but remain unclear in humans. Loss of this control of pneumococcus following infection with influenza virus is associated with secondary bacterial pneumonia. We used a human challenge model with type 6B pneumococcus to show that acquisition of pneumococcus induced early degranulation of resident neutrophils and recruitment of monocytes to the nose. Monocyte function was associated with the clearance of pneumococcus. Prior nasal infection with live attenuated influenza virus induced inflammation, impaired innate immune function and altered genome-wide nasal gene responses to the carriage of pneumococcus. Levels of the cytokine CXCL10, promoted by viral infection, at the time pneumococcus was encountered were positively associated with bacterial load.
C1 [Jochems, Simon P.; Carniel, Beatriz F.; Holloway, Mark; Mitsi, Elena; Smith, Emma; Gritzfeld, Jenna F.; Solorzano, Carla; Reine, Jesus; Pojar, Sherin; Nikolaou, Elissavet; German, Esther L.; Hyder-Wright, Angie; Hill, Helen; Hales, Caz; Adler, Hugh; Zaidi, Seher; Connor, Victoria; Gordon, Stephen B.; Rylance, Jamie; Ferreira, Daniela M.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.
   [Marcon, Fernando; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil.
   [Hyder-Wright, Angie; Hill, Helen; Hales, Caz; Connor, Victoria] Royal Liverpool & Broadgreen Univ Hosp, Liverpool, Merseyside, England.
   [Piters, Wouter A. A. de Steenhuijsen; Bogaert, Debby] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland.
   [Piters, Wouter A. A. de Steenhuijsen; Bogaert, Debby] Univ Med Ctr Utrecht, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands.
   [Piters, Wouter A. A. de Steenhuijsen; Bogaert, Debby] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.
   [Gordon, Stephen B.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.
RP Jochems, SP; Ferreira, DM (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Analyses, Sao Paulo, Brazil.
EM simon.jochems@lstmed.ac.uk; hnakaya@usp.br;
   daniela.ferreira@lstmed.ac.uk
RI Passos, Fernando Marcon/AAI-3922-2020; Nakaya, Helder I/A-1397-2010;
   Nakaya, Helder/AAF-1738-2020; Hales, Caz/AAS-1820-2020; de Steenhuijsen
   Piters, Wouter/AAI-9952-2020
OI Passos, Fernando Marcon/0000-0001-5128-1410; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Hales,
   Caz/0000-0002-3197-1657; de Steenhuijsen Piters,
   Wouter/0000-0002-1144-4067; Rylance, Jamie/0000-0002-2323-3611;
   Solorzano, Carla/0000-0001-9129-5569; Ferreira, Daniela
   M/0000-0002-0594-0902; Jochems, Simon/0000-0002-4835-1032; Reine,
   Jesus/0000-0001-7462-2054; Pojar, Sherin/0000-0002-7746-3279
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MR/M011569/1]; Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation [OPP1117728]; National Institute for Health Research Local
   Comprehensive Research Network; Royal Society of Tropical Medicine and
   Hygiene; Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/08216-2, 2012/19278-6];
   Wellcome Trust Multi-User Equipment GrantWellcome Trust [104936/Z/14/Z]
FX S.B.G. and D.M.F. are supported by the Medical Research Council (grant
   MR/M011569/1), the Bill and Melinda Gates Foundation (grant OPP1117728)
   and the National Institute for Health Research Local Comprehensive
   Research Network. Flow cytometric acquisition was performed on a BD LSR
   II funded by a Wellcome Trust Multi-User Equipment Grant
   (104936/Z/14/Z). S.P.J. received support from the Royal Society of
   Tropical Medicine and Hygiene for NanoString analysis. H.I.N. is
   supported by the Sao Paulo Research Foundation (FAPESP; grants
   2013/08216-2 and 2012/19278-6). We thank all volunteers for
   participating in this study, and R. Robinson, C. Lowe, L. Lazarova, K.
   Piddock and I. Wheeler for clinical support. We also acknowledge M. Mina
   for his input in study design.
CR Albrich WC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005953
   Alpkvist H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140112
   Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001
   Cox MA, 2017, CURR OPIN IMMUNOL, V48, P61, DOI 10.1016/j.coi.2017.07.016
   CRAFT AW, 1976, BRIT MED J, V1, P1570, DOI 10.1136/bmj.1.6025.1570
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Ferreira DM, 2013, AM J RESP CRIT CARE, V187, P855, DOI 10.1164/rccm.201212-2277OC
   Gerszten RE, 1999, NATURE, V398, P718
   Glennie S, 2016, MUCOSAL IMMUNOL, V9, P56, DOI 10.1038/mi.2015.35
   Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524
   Gritzfeld JF, 2014, CLIN MICROBIOL INFEC, V20, pO1145, DOI 10.1111/1469-0691.12752
   Gritzfeld JF, 2013, JOVE-J VIS EXP, DOI 10.3791/50115
   Hoffmann J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38532
   Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06
   Jochems SP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006665
   Jochems SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169805
   Karppinen S, 2017, AM J RESP CRIT CARE, V196, P1172, DOI 10.1164/rccm.201702-0357OC
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159
   Lu YJ, 2010, VACCINE, V28, P7468, DOI 10.1016/j.vaccine.2010.09.031
   Luo H, 2012, EXP THER MED, V3, P76, DOI 10.3892/etm.2011.350
   Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077
   Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100
   McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576
   Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980
   Mina MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01040-13
   Mina MJ, 2014, LANCET RESP MED, V2, P750, DOI 10.1016/S2213-2600(14)70131-6
   Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708
   Morton B, 2016, SHOCK, V46, P635, DOI 10.1097/SHK.0000000000000715
   Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Paixao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121042
   Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Rylance J., 2018, BIORXIV, DOI [10.1101/343319, DOI 10.1101/343319]
   Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15
   Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653
   Seyoum B, 2011, VACCINE, V29, P8002, DOI 10.1016/j.vaccine.2011.08.064
   Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005
   Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/erv.12.53, 10.1586/ERV.12.53]
   Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765
   Thors V, 2016, AM J RESP CRIT CARE, V193, P1401, DOI 10.1164/rccm.201510-2000OC
   Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x
   Wolter N, 2014, J INFECT DIS, V210, P1649, DOI 10.1093/infdis/jiu326
   Wu WX, 2015, VIROLOGY, V482, P181, DOI 10.1016/j.virol.2015.03.048
   Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157
   Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681
   Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731
NR 58
TC 36
Z9 36
U1 1
U2 14
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD DEC
PY 2018
VL 19
IS 12
BP 1299
EP +
DI 10.1038/s41590-018-0231-y
PG 11
WC Immunology
SC Immunology
GA HD9HQ
UT WOS:000452873000011
PM 30374129
OA Green Accepted, Green Published
DA 2020-12-17
ER

PT J
AU van der Heijden, YF
   Abdullah, F
   Andrade, BB
   Andrews, JR
   Christopher, DJ
   Croda, J
   Ewing, H
   Haas, DW
   Hatherill, M
   Horsburgh, CR
   Mave, V
   Nakaya, HI
   Rolla, V
   Srinivasan, S
   Sugiyono, RI
   Ugarte-Gil, C
   Hamilton, C
AF van der Heijden, Yuri F.
   Abdullah, Fareed
   Andrade, Bruno B.
   Andrews, Jason R.
   Christopher, Devasahayam J.
   Croda, Julio
   Ewing, Heather
   Haas, David W.
   Hatherill, Mark
   Horsburgh, C. Robert, Jr.
   Mave, Vidya
   Nakaya, Helder I.
   Rolla, Valeria
   Srinivasan, Sudha
   Sugiyono, Retna Indah
   Ugarte-Gil, Cesar
   Hamilton, Carol
TI Building capacity for advances in tuberculosis research; proceedings of
   the third RePORT international meeting
SO TUBERCULOSIS
LA English
DT Review
DE Transmission; Pharmacogenomics; Incipient tuberculosis; HIV; Diabetes;
   Biomarkers
ID INDUCED LIVER-INJURY; DRUG-RESISTANT TUBERCULOSIS; TYPE-2
   DIABETES-MELLITUS; MYCOBACTERIUM-TUBERCULOSIS; NAT2 GENOTYPE; TB;
   TRANSMISSION; RIFAMPIN; PHARMACOKINETICS; EFAVIRENZ
AB RePORT International is a global network of research sites in India, Brazil, Indonesia, South Africa, China, and the Philippines dedicated to collaborative tuberculosis research in the context of HIV. A standardized research protocol (the Common Protocol) guides the enrollment of participants with active pulmonary tuberculosis and contacts into observational cohorts. The establishment of harmonized clinical data and bio-repositories will allow cutting-edge, large-scale advances in the understanding of tuberculosis, including identification of novel biomarkers for progression to active tuberculosis and relapse after treatment. The RePORT International infrastructure aims to support research capacity development through enabling globally-diverse collaborations. To that end, representatives from the RePORT International network sites, funding agencies, and other stakeholders gathered together in Brazil in September 2017 to present updates on relevant research findings and discuss ideas for collaboration. Presenters emphasized research involving biomarker identification for incipient tuberculosis, host immunity and pharmacogenomics, co-morbidities such as HIV and type 2 diabetes mellitus, and tuberculosis transmission in vulnerable and high-risk populations. Currently, 962 active TB participants and 670 household contacts have contributed blood, sputum, urine and microbes to in-country biorepositories. Cross-consortium collaborations have begun sharing data and specimens to analyze molecular and cytokine predictive patterns.
C1 [van der Heijden, Yuri F.] Vanderbilt Univ, Sch Med, Vanderbilt TB Ctr, Nashville, TN 37212 USA.
   [van der Heijden, Yuri F.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.
   [Abdullah, Fareed] South African Med Res Council, Off AIDS & TB Res, Pretoria, South Africa.
   [Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Andrade, Bruno B.] Jose Silveira Fdn, Multinat Org Network Sponsoring Translat & Epidem, BR-45204040 Salvador, BA, Brazil.
   [Andrade, Bruno B.] Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Afr, ZA-7925 Cape Town, South Africa.
   [Andrade, Bruno B.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37232 USA.
   [Andrade, Bruno B.] Laureate Univ, Univ Salvador UNIFACS, BR-41720200 Salvador, BA, Brazil.
   [Andrade, Bruno B.] Escola Bahiana Med & Saude Publ, BR-40290000 Salvador, BA, Brazil.
   [Andrews, Jason R.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA USA.
   [Christopher, Devasahayam J.] Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India.
   [Croda, Julio] Univ Fed Mato Grosso do Sul, Sch Med, Campo Grande, Brazil.
   [Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
   [Ewing, Heather] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.
   [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.
   [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.
   [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA.
   [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Microbiol, Nashville, TN 37212 USA.
   [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Immunol, Nashville, TN 37212 USA.
   [Haas, David W.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.
   [Hatherill, Mark] Univ Cape Town, South African TB Vaccine Initiat, Inst Infect Dis & Mol Med, Cape Town, South Africa.
   [Hatherill, Mark] Univ Cape Town, Div Immunol, Dept Pathol, Cape Town, South Africa.
   [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA.
   [Mave, Vidya] Johns Hopkins Univ, Byramjee Jeejeebhoy Govt Med Coll, Clinical Res Site, Pune, Maharashtra, India.
   [Mave, Vidya] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Rolla, Valeria] Natl Inst Infect Dis Evandro Chagas, Clin Res Lab Mycobacteria, Fiocruz, Brazil.
   [Srinivasan, Sudha] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA.
   [Sugiyono, Retna Indah] Minist Hlth, Natl Inst Hlth Res & Dev, RESPOND, INA, South Jakarta, Indonesia.
   [Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru.
   [Ugarte-Gil, Cesar] London Sch Hyg & Trop Med, TB Ctr, London, England.
   [Ugarte-Gil, Cesar] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Hamilton, Carol] FHI 360, Durham, NC 27701 USA.
   [Hamilton, Carol] Duke Univ, Durham, NC 27708 USA.
RP Hamilton, C (corresponding author), FHI 360, Durham, NC 27701 USA.; Hamilton, C (corresponding author), Duke Univ, Durham, NC 27708 USA.
EM yuri.vanderheijden@vanderbilt.edu; fareed.abdullah@mrc.ac.za;
   bruno.andrade@bahia.fiocruz.br; jasonandr@gmail.com;
   djchris@cmcvellore.ac.in; julio.croda@fiocruz.br;
   heather.m.ewing@vanderbilt.edu; david.haas@vanderbilt.edu;
   Mark.hatherill@uct.ac.za; rhorsbu@bu.edu; vidyamave@gmail.com;
   hnakaya@usp.br; valeria.rolla@ini.fiocruz.br; sudha.srinivasan@nih.gov;
   retnaindah.sugiyono@ina-respond.net; cesar.ugarte@upch.pe;
   carol.hamilton@duke.edu
RI Andrade, Bruno/AAI-2248-2020; Nakaya, Helder/AAF-1738-2020;
   SOUNDRARAJAN, JOYSON/I-1779-2019; Ugarte-Gil, Cesar/E-6074-2013; Croda,
   Julio/I-5172-2013; Christopher, DJ/R-1479-2019; Nakaya, Helder
   I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Ugarte-Gil,
   Cesar/0000-0002-2833-9087; Croda, Julio/0000-0002-6665-6825; Nakaya,
   Helder I/0000-0001-5297-9108; Horsburgh, C./0000-0001-6838-7895;
   Andrade, Bruno/0000-0001-6833-3811
FU Division of AIDS (DAIDS), National Institute of Allergy and Infectious
   Diseases (NIAID) at the National Institutes of Health (NIH); NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; The Indian Department of Biotechnology (DBT);
   Ministry of Science and Technology; Indian Council of Medical Research
   (ICMR)Indian Council of Medical Research (ICMR); The Ministry of Health;
   Department of Science and Technology (Departamento de Ciencia e
   Tecnologia do Ministerio da Sande [DECIT]), Secretaria de Ciencia,
   Tecnologia e Insumos Estrategicos (SCTIE), Ministerio da Sande; National
   Institute of Health Research and Development (NIHRD), Ministry of Health
   (Indonesia); South African Medical Research Council (SAMRC); South
   African Department of Science and Technology (DST); Department of Health
   (DOH); China Innovation Alliance on Tuberculosis Diagnosis and Treatment
   (Beijing); China Ministry of Science and TechnologyMinistry of Science
   and Technology, China; University of the Philippines, Manila Philippines
   National Institutes of Health; National Institutes of Health (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [K08 AI106420]; U.S. Civilian Research and
   Development Foundation (CRDF) [OISE-16-62061-1]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI077505, P30 AI110527, R01AI130058, U01AI14018, R01AI20790];
   CRDF Global [OISE-16-62054-1, DAA3-17-63145-1]; Fundacao de Amparo a
   Pesquisa do Estado da Bahia (FAPESB); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), BrazilNational Council
   for Scientific and Technological Development (CNPq) [028/2010,
   401824/2016-0, 420672/2017-6]; South African Medical Research Council
   (SAMRC Collaborating Centre for TB and HIV); Providence/Boston Center
   for AIDS Research [P30AI042853]; Boston University/Rutgers Tuberculosis
   Research Unit [U19AI111276]; U.S.-India Vaccine Action Program (VAP)
   Initiative on Tuberculosis (CRDF Global/NIAID); Indo (DBT)-US (NIH)
   [USB1-31147-XX-13 CRDF/NIH]; NIAID at NIH [HHSN261200800001E,
   HHSN261201500003I]; TANDEM project - European Union [305279];
   NIH/NIAID/DAIDSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); Johns Hopkins
   Baltimore-Washington-India Clinical Trials Unit for NIAID Networks
   [U01AI069497]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P30AI110527, U19AI111276, P30AI110527,
   P30AI042853, P30AI042853, P30AI042853, P30AI110527, P30AI110527,
   U19AI111276, P30AI110527, P30AI042853, U19AI111276, P30AI042853,
   U19AI111276, U19AI111276, U19AI111276, R01AI130058, U19AI111276,
   U19AI111276, P30AI110527, R01AI130058, U19AI111276, U19AI111276,
   P30AI042853, R01AI077505, P30AI042853, K08AI106420, P30AI042853,
   R01AI077505, U19AI111276, P30AI042853, P30AI110527, P30AI042853,
   U19AI111276, P30AI042853, P30AI110527, P30AI042853, P30AI042853,
   P30AI042853, U19AI111276, P30AI042853, P30AI110527, P30AI042853,
   U19AI111276, P30AI042853, U19AI111276, U19AI111276, P30AI110527,
   P30AI042853, P30AI042853, P30AI110527, P30AI042853, P30AI110527,
   R01AI077505, P30AI110527, P30AI042853, U19AI111276, P30AI110527,
   U19AI111276, P30AI110527, U19AI111276, P30AI110527, P30AI042853,
   U19AI111276, P30AI110527, P30AI110527, U19AI111276, P30AI042853,
   P30AI110527, U19AI111276, P30AI110527, U19AI111276, K08AI106420,
   P30AI110527, P30AI110527, U19AI111276, P30AI042853, P30AI042853,
   P30AI110527, U19AI111276, R01AI130058, P30AI042853, P30AI110527,
   P30AI110527, U19AI111276, U19AI111276, U19AI111276, P30AI110527,
   R01AI077505, P30AI110527, R01AI130058, U19AI111276, U19AI111276,
   P30AI110527, P30AI110527, U19AI111276] Funding Source: NIH RePORTER
FX RePORT International is funded by the Division of AIDS (DAIDS), National
   Institute of Allergy and Infectious Diseases (NIAID) at the National
   Institutes of Health (NIH), and serves all the consortia. The NIH and
   local governments jointly fund the individual RePORT consortia in a
   bilateral manner. Country-specific co-funders include:; RePORT India:
   The Indian Department of Biotechnology (DBT), the Ministry of Science
   and Technology, and the Indian Council of Medical Research (ICMR).;
   RePORT Brazil: The Ministry of Health and Department of Science and
   Technology (Departamento de Ciencia e Tecnologia do Ministerio da Sande
   [DECIT]), Secretaria de Ciencia, Tecnologia e Insumos Estrategicos
   (SCTIE), Ministerio da Sande.; RePORT Indonesia: National Institute of
   Health Research and Development (NIHRD), Ministry of Health
   (Indonesia).; RePORT South Africa: South African Medical Research
   Council (SAMRC), with support from the South African Department of
   Science and Technology (DST) and Department of Health (DOH).; RePORT
   China: China Innovation Alliance on Tuberculosis Diagnosis and Treatment
   (Beijing), and China Ministry of Science and Technology, with co-funding
   from six China Clinical Trials Consortuim (CTCTC) member centers.;
   RePORT Philippines: University of the Philippines, Manila Philippines
   National Institutes of Health.; This work was supported as follows: Dr.
   van der Heijden was supported by the National Institutes of Health (NIH)
   [K08 AI106420] and the U.S. Civilian Research and Development Foundation
   (CRDF) [OISE-16-62061-1]. Dr. Andrade was supported by the NIH
   [U01AI14018, R01AI20790], CRDF Global [DAA3-17-63145-1], Fundacao de
   Amparo a Pesquisa do Estado da Bahia (FAPESB), and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [028/2010]. Drs.
   Andrews and Croda were supported by the NIH [R01AI130058], and Dr. Croda
   was also supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Brazil [401824/2016-0 and 420672/2017-6]. Dr. Haas
   was supported by the NIH [R01AI077505, P30 AI110527]. Dr. Hatherill was
   supported by CRDF Global [OISE-16-62054-1] and the South African Medical
   Research Council (SAMRC Collaborating Centre for TB and HIV). Dr.
   Horsburgh was supported by the Providence/Boston Center for AIDS
   Research [P30AI042853], the Boston University/Rutgers Tuberculosis
   Research Unit [U19AI111276], and the U.S.-India Vaccine Action Program
   (VAP) Initiative on Tuberculosis (CRDF Global/NIAID). Dr. Mave was
   supported by the Indo (DBT)-US (NIH) [USB1-31147-XX-13 CRDF/NIH], and
   the Johns Hopkins Baltimore-Washington-India Clinical Trials Unit for
   NIAID Networks [U01AI069497]. Dr. Sugiyono was supported by the NIAID at
   NIH [contract numbers HHSN261200800001E and HHSN261201500003I]. Dr.
   Ugarte-Gil was supported by the TANDEM project, which is funded by the
   European Union's Seventh Framework Programme (FP7/2007-2013) [305279].;
   NIH/NIAID/DAIDS (sponsor) representatives contributed to an
   agenda-setting process that was led by the RePORT Brazil site and the
   RePORT International Coordinating Center at FHI 360.
CR Alisjahbana B, 2016, 47 UN WORLD C LUNG H
   Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841
   Andrade BB, 2014, CHEST, V145, P1244, DOI 10.1378/chest.13-1799
   Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951
   [Anonymous], 2017, PROTOCOLO CLIN DIRET
   Azuma J, 2013, EUR J CLIN PHARMACOL, V69, P1091, DOI 10.1007/s00228-012-1429-9
   Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949
   Basu S, 2011, AM J TROP MED HYG, V84, P30, DOI 10.4269/ajtmh.2011.10-0472
   Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381
   Bourdillon PM, 2017, EMERG INFECT DIS, V23, P496, DOI 10.3201/eid2303.161006
   Buu TN, 2010, EMERG INFECT DIS, V16, P1466, DOI 10.3201/eid1609.100281
   Cai Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047769
   Chigutsa E, 2011, ANTIMICROB AGENTS CH, V55, P4122, DOI 10.1128/AAC.01833-10
   Darboe F, 2018, PRESENTED AT THE KEY
   Darboe F, 2018, TUBERCULOSIS, V108, P124, DOI 10.1016/j.tube.2017.11.001
   Das Roy P, 2008, PHARMACOGENOMICS, V9, P311, DOI 10.2217/14622416.9.3.311
   Degner NR, 2018, CLIN INFECT DIS, V66, P198, DOI 10.1093/cid/cix819
   di Iulio J, 2009, PHARMACOGENET GENOM, V19, P300, DOI 10.1097/FPC.0b013e328328d577
   Dooley KE, 2015, J INFECT DIS, V211, P197, DOI 10.1093/infdis/jiu429
   Dooley KE, 2013, JAIDS-J ACQ IMM DEF, V62, P21, DOI 10.1097/QAI.0b013e318276cda9
   Dowdy DW, 2014, CLIN INFECT DIS, V59, P1123, DOI 10.1093/cid/ciu506
   Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109
   Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023
   Filgueiras LR, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005568
   Geadas C, 2017, TUBERCULOSIS, V102, P55, DOI 10.1016/j.tube.2016.11.006
   Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427
   Glynn JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132840
   Grandjean L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001843
   Hamilton CD, 2015, CLIN INFECT DIS, V61, pS155, DOI 10.1093/cid/civ611
   Hardwick JP, 2013, ADV PHARMACOL, V66, P157, DOI 10.1016/B978-0-12-404717-4.00005-6
   Heysell SK, 2010, EMERG INFECT DIS, V16, P1546, DOI 10.3201/eid1610.100374
   Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144
   Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102
   International Diabetes Federation, 2013, IDF DIAB ATLT, P2013
   Horna-Campos OJ, 2011, OCCUP ENVIRON MED, V68, P163, DOI 10.1136/oem.2009.051128
   Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x
   Jeremiah K, 2014, ANTIMICROB AGENTS CH, V58, P3468, DOI 10.1128/AAC.02307-13
   Kim RB, 2003, EUR J CLIN INVEST, V33, P1, DOI 10.1046/j.1365-2362.33.s2.5.x
   Knight GM, 2015, CLIN INFECT DIS, V61, pS147, DOI 10.1093/cid/civ579
   Kumar AKH, 2017, EUR J CLIN PHARMACOL, V73, P65, DOI 10.1007/s00228-016-2132-z
   Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112108
   Kumar NP, 2014, J INFECT DIS, V210, P1670, DOI 10.1093/infdis/jiu329
   Kwara A, 2011, AIDS, V25, P388, DOI 10.1097/QAD.0b013e3283427e05
   Laurence Y, 2017, 48 UN WORLD C LUNG H
   Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3
   Luetkemeyer AF, 2015, CLIN INFECT DIS, V60, P1860, DOI 10.1093/cid/civ155
   Luo PC, 2011, PROSTAG OTH LIPID M, V95, P1, DOI 10.1016/j.prostaglandins.2011.06.001
   Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790
   Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489
   Medelln-Garibay SE, 2015, ANTIMICROB AGENTS CH, V59, P7707, DOI 10.1128/AAC.01067-15
   Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403
   Middelkoop K, 2014, INT J EPIDEMIOL, V43, P1114, DOI 10.1093/ije/dyu044
   Nijland HMJ, 2006, CLIN INFECT DIS, V43, P848, DOI 10.1086/507543
   Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0
   Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1
   Pan SC, 2015, LANCET DIABETES ENDO, V3, P323, DOI 10.1016/S2213-8587(15)00042-X
   Pedrazzoli D, 2017, INT J TUBERC LUNG D, V21, P957, DOI 10.5588/ijtld.16.0906
   Penn-Nicholson A, 2016, S Afr Med J, V107, P4, DOI 10.7196/SAMJ.2016.v107.i1.12230
   Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016
   Ramachandran G, 2012, PHARMACOGN PERS MED, V5, P89, DOI 10.2147/PGPM.S15454
   Ramesh K, 2016, INT J TUBERC LUNG D, V20, P1231, DOI 10.5588/ijtld.15.1007
   Reis-Santos B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100082
   Ruslami R, 2010, ANTIMICROB AGENTS CH, V54, P1068, DOI 10.1128/AAC.00447-09
   Sacchi FPC, 2015, EMERG INFECT DIS, V21, P452, DOI 10.3201/eid2103.140896
   Sen Tiyas, 2009, J Assoc Physicians India, V57, P660
   Shah NS, 2017, NEW ENGL J MED, V376, P243, DOI 10.1056/NEJMoa1604544
   Slam K, 2007, INT J TUBERC LUNG D, V11, P1049
   Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5
   Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105
   Suliman S, 2018, AM J RESP CRIT CARE, V197, P1198, DOI 10.1164/rccm.201711-2340OC
   Sun F, 2008, INT J TUBERC LUNG D, V12, P994
   Thompson EG, 2017, TUBERCULOSIS, V107, P48, DOI 10.1016/j.tube.2017.08.004
   Ugarte-Gil C, 2016, 47 UN WORLD C LUNG H
   van Crevel R, 2017, LANCET DIABETES ENDO, V5, P457, DOI 10.1016/S2213-8587(16)30081-X
   Wang JY, 2015, CHEST, V147, P520, DOI 10.1378/chest.14-0918
   Wang PY, 2012, INT J TUBERC LUNG D, V16, P589, DOI 10.5588/ijtld.11.0377
   Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601
   World Health Organization, 2018, TOP 10 CAUS DEATH
   World Health Organization (Producer), WHOHTMTB201529
   World Health Organization (Producer), 2017, WHOHTMTB201623
   Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5
   Ypma RJF, 2013, EPIDEMIOLOGY, V24, P395, DOI 10.1097/EDE.0b013e3182878e19
   Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1
NR 83
TC 3
Z9 3
U1 0
U2 1
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD DEC
PY 2018
VL 113
BP 153
EP 162
DI 10.1016/j.tube.2018.09.009
PG 10
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA HC4IJ
UT WOS:000451766300019
PM 30514497
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Fukutani, KF
   Nascimento-Carvalho, CM
   Bouzas, ML
   Oliveira, JR
   Barral, A
   Dierckx, T
   Khouri, R
   Nakaya, HI
   Andrade, BB
   Van Weyenbergh, J
   de Oliveira, CI
AF Fukutani, Kiyoshi F.
   Nascimento-Carvalho, Cristiana M.
   Bouzas, Maiara L.
   Oliveira, Juliana R.
   Barral, Aldina
   Dierckx, Tim
   Khouri, Ricardo
   Nakaya, Helder I.
   Andrade, Bruno B.
   Van Weyenbergh, Johan
   de Oliveira, Camila I.
TI In situ Immune Signatures and Microbial Load at the Nasopharyngeal
   Interface in Children With Acute Respiratory Infection
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE network analysis; ARI; immune response; nCounter; interferon; viral
   load; innate immunity; adaptive immunity
ID HAEMOPHILUS-INFLUENZAE; STREPTOCOCCUS-PNEUMONIAE; MORAXELLA-CATARRHALIS;
   EPITHELIAL-CELLS; SYNCYTIAL VIRUS; INDUCTION; BACTERIAL; PROTEIN;
   INTERFERONS; SYMPTOMS
AB Acute respiratory infection (ARI) is the most frequent cause for hospitalization in infants and young children. Using multiplexed nCounter technology to digitally quantify 600 human mRNAs in parallel with 14 virus- and 5 bacterium-specific RNAs, we characterized viral and bacterial presence in nasopharyngeal aspirates (NPA) of 58 children with ARI and determined the corresponding in situ immune profiles. NPA contained different groups of organisms and these were classified into bacterial (n = 27), viral (n = 5), codetection [containing both viral and bacterial transcripts (n = 21), or indeterminate intermediate where microbial load is below threshold (n = 5)]. We then identified differentially expressed immune transcripts (DEITs) comparing NPAs from symptomatic children vs. healthy controls, and comparing children presenting NPAs with detectable microbial load vs. indeterminate. We observed a strong innate immune response in NPAs, due to the presence of evolutionarily conserved type I Interferon (IFN)-stimulated genes (ISG), which was correlated with total bacterial and/or viral load. In comparison with indeterminate NPAs, adaptive immunity transcripts discriminated among viral, bacterial, and codetected microbial profiles. In viral NPAs, B cell transcripts were significantly enriched among DEITs, while only type III IFN was correlated with viral load. In bacterial NPAs, myeloid cells and coinhibitory transcripts were enriched and significantly correlated with bacterial load. In conclusion, digital nCounter transcriptomics provide a microbial and immunological in situ "snapshot" of the nasopharyngeal interface in children with ARI. This enabled discrimination among viral, bacterial, codetection, and indeterminate transcripts in the samples using non-invasive sampling.
C1 [Fukutani, Kiyoshi F.; Barral, Aldina; Khouri, Ricardo; Andrade, Bruno B.; de Oliveira, Camila I.] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Nascimento-Carvalho, Cristiana M.; Bouzas, Maiara L.; Oliveira, Juliana R.; Barral, Aldina; Khouri, Ricardo; de Oliveira, Camila I.] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   [Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Sch Med, Dept Pediat, Salvador, BA, Brazil.
   [Dierckx, Tim; Van Weyenbergh, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Andrade, Bruno B.] Fdn Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil.
RP de Oliveira, CI (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.; de Oliveira, CI (corresponding author), Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.; Van Weyenbergh, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium.
EM j.vw@live.be; camila@bahia.fiocruz.br
RI Khouri, Ricardo/M-3184-2018; de Oliveira, Camila I/B-4358-2009; Andrade,
   Bruno/AAI-2248-2020; Fukutani, Kiyoshi/T-1630-2019; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Fukutani,
   Kiyoshi/N-7905-2016; Van Weyenbergh, Johan/Q-3829-2019; Van Weyenbergh,
   Johan/B-4187-2009
OI Khouri, Ricardo/0000-0001-5664-4436; de Oliveira, Camila
   I/0000-0002-7868-5164; Nakaya, Helder/0000-0001-5297-9108; Nakaya,
   Helder I/0000-0001-5297-9108; Fukutani, Kiyoshi/0000-0003-2223-0918; Van
   Weyenbergh, Johan/0000-0003-3234-8426; Van Weyenbergh,
   Johan/0000-0003-3234-8426; Dierckx, Tim/0000-0002-1969-7974; Andrade,
   Bruno/0000-0001-6833-3811
FU Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)
   [PNX0019/2009]; Belgian FWOFWO [G0D6817N]; Science without Borders (PVE
   Anne-Mieke Vandamme); Institute for the Promotion of Innovation through
   Science and Technology Flanders (IWT-Vlaanderen)Institute for the
   Promotion of Innovation by Science and Technology in Flanders (IWT)
   [141614]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2012/19278-6, 2017/50137-3]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U01AI115940]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI115940,
   U01AI115940, U01AI115940, U01AI115940, U01AI115940, U01AI115940] Funding
   Source: NIH RePORTER
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado da
   Bahia (FAPESB; Grant PNX0019/2009 to AB) and Belgian FWO (Grant
   G0D6817N). KF was supported by a fellowship from Science without Borders
   (PVE Anne-Mieke Vandamme). TD was supported by the Institute for the
   Promotion of Innovation through Science and Technology Flanders
   (IWT-Vlaanderen), project 141614. CN-C, AB, and CO were senior
   investigators from Conselho Nacional de Pesquisa Cientifica (CNPq). HN
   was supported by FAPESP (Grant Nos. 2012/19278-6 and 2017/50137-3). BA
   was supported by the National Institutes of Health (U01AI115940).
CR Andrade DC, 2016, PEDIATR INFECT DIS J, V35, P683, DOI 10.1097/INF.0000000000001126
   Andreakos E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01232
   Andris F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00480
   Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006
   Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008
   Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035
   Bouzas ML, 2018, J CLIN VIROL, V106, P34, DOI 10.1016/j.jcv.2018.07.003
   Bouzas ML, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005142
   Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84
   Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Fukutani KF, 2015, J CLIN VIROL, V69, P190, DOI 10.1016/j.jcv.2015.06.005
   Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385
   Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359
   Heinonen S, 2016, AM J RESP CRIT CARE, V193, P772, DOI 10.1164/rccm.201504-0749OC
   HOWARD AJ, 1988, EPIDEMIOL INFECT, V100, P193, DOI 10.1017/S0950268800067327
   Ishizuka S, 2003, J INFECT DIS, V188, P1928, DOI 10.1086/379833
   Jogdand GM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00520
   Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x
   Liquet B, 2016, BIOINFORMATICS, V32, P35, DOI 10.1093/bioinformatics/btv535
   Maler MD, 2017, MBIO, V8, DOI 10.1128/mBio.00670-17
   Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549
   Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970
   Moens B, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-171
   Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Nascimento-Carvalho CM, 2016, PEDIATR INFECT DIS J, V35, P338, DOI 10.1097/INF.0000000000001032
   Nascimento-Carvalho CM, 2013, SCAND J INFECT DIS, V45, P478, DOI 10.3109/00365548.2012.754106
   Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020
   Nolan VG, 2018, J INFECT DIS, V218, P179, DOI 10.1093/infdis/jix641
   Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598
   Parnell GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11477
   R Core Team, 2013, R LANG ENV STAT COMP
   Ruohola A, 2013, J INFECTION, V66, P247, DOI 10.1016/j.jinf.2012.12.002
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Shaw AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004086
   Shoemaker JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-460
   Skevaki CL, 2015, PEDIATR INFECT DIS J, V34, P1296, DOI 10.1097/INF.0000000000000872
   Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004
   Suarez NM, 2015, J INFECT DIS, V212, P213, DOI 10.1093/infdis/jiv047
   Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369
   Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165
   Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09
   Uitti JM, 2015, PEDIATR INFECT DIS J, V34, P1056, DOI 10.1097/INF.0000000000000800
   Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188
   Wiertsema SP, 2011, J MED VIROL, V83, P2008, DOI 10.1002/jmv.22221
   Zhai YJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004869
NR 47
TC 1
Z9 1
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 9
PY 2018
VL 9
AR 2475
DI 10.3389/fmicb.2018.02475
PG 13
WC Microbiology
SC Microbiology
GA GZ7DP
UT WOS:000449637600001
PM 30473680
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Bittencourt, NC
   Leite, JA
   Silva, ABIE
   Pimenta, TS
   Silva, JL
   Cassiano, GC
   Lopes, SCP
   dos-Santos, JCK
   Bourgard, C
   Nakaya, HI
   Ventura, AMRD
   Lacerda, MVG
   Ferreira, MU
   Machado, RLD
   Albrecht, L
   Costa, FTM
AF Bittencourt, Najara C.
   Leite, Juliana A.
   Silva, Ana Beatriz I. E.
   Pimenta, Tamirys S.
   Silva-Filho, Joao Luiz
   Cassiano, Gustavo C.
   Lopes, Stefanie C. P.
   dos-Santos, Joao C. K.
   Bourgard, Catarina
   Nakaya, Helder I.
   Revoredo da Silva Ventura, Ana Maria
   Lacerda, Marcus V. G.
   Ferreira, Marcelo U.
   Machado, Ricardo L. D.
   Albrecht, Letusa
   Costa, Fabio T. M.
TI Genetic sequence characterization and naturally acquired immune response
   to Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2)
SO MALARIA JOURNAL
LA English
DT Article
DE Genetic diversity; RON2; Plasmodium vivax; Immunogenicity; Malaria
ID APICAL MEMBRANE ANTIGEN-1; MEROZOITE SURFACE PROTEIN-1; HOST-CELL
   INVASION; VACCINE CANDIDATE; ANTIBODY-RESPONSE; FALCIPARUM; DIVERSITY;
   SELECTION; MALARIA; POLYMORPHISM
AB BackgroundThe genetic diversity of malaria antigens often results in allele variant-specific immunity, imposing a great challenge to vaccine development. Rhoptry Neck Protein 2 (PvRON2) is a blood-stage antigen that plays a key role during the erythrocyte invasion of Plasmodium vivax. This study investigatesthe genetic diversity of PvRON2 and the naturally acquired immune response to P. vivax isolates.ResultsHere, the genetic diversity of PvRON2(1828-2080) and the naturally acquired humoral immune response against PvRON2(1828-2080) in infected and non-infected individuals from a vivax malaria endemic area in Brazil was reported. The diversity analysis of PvRON2(1828-2080) revealed that the protein is conserved in isolates in Brazil and worldwide. A total of 18 (19%) patients had IgG antibodies to PvRON2(1828-2080). Additionally, the analysis of the antibody response in individuals who were not acutely infected with malaria, but had been infected with malaria in the past indicated that 32 patients (33%) exhibited an IgG immune response against PvRON2.ConclusionsPvRON2 was conserved among the studied isolates. The presence of naturally acquired antibodies to this protein in the absence of the disease suggests that PvRON2 induces a long-term antibody response. These results indicate that PvRON2 is a potential malaria vaccine candidate.
C1 [Bittencourt, Najara C.; Leite, Juliana A.; Silva-Filho, Joao Luiz; Cassiano, Gustavo C.; dos-Santos, Joao C. K.; Bourgard, Catarina; Costa, Fabio T. M.] Univ Campinas UNICAMP, Dept Genet Evolut Microbiol & Immunol, Lab Trop Dis Prof Dr Luiz Jacintho da Silva, Campinas, SP, Brazil.
   [Silva, Ana Beatriz I. E.; Albrecht, Letusa] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, PR, Brazil.
   [Pimenta, Tamirys S.; Revoredo da Silva Ventura, Ana Maria; Machado, Ricardo L. D.] Inst Evandro Chagas SVS MS, Lab Ensaios Clin & Imunogenet Malaria, Ananindeua, PA, Brazil.
   [Lopes, Stefanie C. P.; Lacerda, Marcus V. G.] Fiocruz MS, Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, AM, Brazil.
   [Lopes, Stefanie C. P.; Lacerda, Marcus V. G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, AM, Brazil.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
RP Costa, FTM (corresponding author), Univ Campinas UNICAMP, Dept Genet Evolut Microbiol & Immunol, Lab Trop Dis Prof Dr Luiz Jacintho da Silva, Campinas, SP, Brazil.; Albrecht, L (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Inst Carlos Chagas, Curitiba, PR, Brazil.
EM letusa.albrecht@fiocruz.br; costaftm@unicamp.br
RI Bourgard, Catarina/N-3630-2019; Nakaya, Helder I/A-1397-2010; Cassiano,
   Gustavo C/G-5728-2013; Bourgard, Catarina/AAF-8186-2020; Albrecht,
   Letusa/I-1837-2012; Machado, Ricardo Luiz Dantas Dantas/P-1288-2014;
   Silva-Filho, Joao Luiz/I-5704-2016; Pimenta, Tamirys
   Simao/AAT-1853-2020; Nakaya, Helder/AAF-1738-2020; Ferreira, Marcelo
   U/G-8289-2011; ventura, ana maria r s/E-4027-2017; Costa,
   Fabio/E-1181-2012
OI Nakaya, Helder I/0000-0001-5297-9108; Cassiano, Gustavo
   C/0000-0002-6971-5974; Bourgard, Catarina/0000-0003-3469-703X; Albrecht,
   Letusa/0000-0001-6406-2057; Machado, Ricardo Luiz Dantas
   Dantas/0000-0002-8955-3204; Silva-Filho, Joao Luiz/0000-0003-4762-2205;
   Pimenta, Tamirys Simao/0000-0001-7588-6203; Nakaya,
   Helder/0000-0001-5297-9108; Ferreira, Marcelo U/0000-0002-5293-9090;
   ventura, ana maria r s/0000-0002-4737-1533; Costa,
   Fabio/0000-0001-9969-7300; Lopes, Stefanie/0000-0002-6981-2192
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/16525-2];
   Evandro Chagas core grant;  [2015/02808-0];  [2013/25807-4]; 
   [2016/12855-9];  [2015/20774-6];  [2013/20509-5]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) Grant 2012/16525-2, and fellowships grants
   2015/02808-0 (to NB), 2013/25807-4 (to JAL), 2016/12855-9 (to JLS-F),
   2015/20774-6 (to GCC), 2013/20509-5 (to CB). Evandro Chagas core grant
   (to RLDM). MUF, MVGL and FTMC are Conselho Nacional do Desenvolvimento
   Cientifico e Tecnologico (CNPq) research fellows.2
CR Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017
   Amoah LE, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2338-7
   Arevalo-Pinzon G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-60
   Arnott A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-233
   Arnott A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002506
   Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814
   Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366
   Bargieri DY, 2010, VACCINE, V28, P2818, DOI 10.1016/j.vaccine.2010.02.004
   Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359
   Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063
   Bermudez M, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12835
   Buitrago SP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1563-4
   Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358
   Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005
   Chenet SM, 2013, INFECT GENET EVOL, V20, P239, DOI 10.1016/j.meegid.2013.09.011
   Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4
   Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273
   Cortes A, 2003, INFECT IMMUN, V71, P1416, DOI 10.1128/IAI.71.3.1416-1426.2003
   de Cassan SC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00348
   de Sousa TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022944
   Dias S, 2013, GENE, V518, P381, DOI 10.1016/j.gene.2013.01.003
   Escalante AA, 2001, MOL BIOCHEM PARASIT, V113, P279, DOI 10.1016/S0166-6851(01)00229-8
   Ferreira MU, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1335-1
   Ferreira MU, 1998, MEM I OSWALDO CRUZ, V93, P631, DOI 10.1590/S0074-02761998000500013
   Garg S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-154
   Garzon-Ospina D, 2015, INFECT GENET EVOL, V33, P182, DOI 10.1016/j.meegid.2015.05.001
   Garzon-Ospina D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045962
   Garzon-Ospina D, 2010, INFECT GENET EVOL, V10, P261, DOI 10.1016/j.meegid.2009.12.004
   Gentil F, 2010, VACCINE, V28, P6183, DOI 10.1016/j.vaccine.2010.07.017
   Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012
   Gomez A, 2006, PARASITOLOGY, V133, P661, DOI 10.1017/S0031182006001168
   Goncalves R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048469
   Gonzalez-Ceron L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1266-7
   Gunasekera AM, 2007, MOL BIOL EVOL, V24, P939, DOI 10.1093/molbev/msm013
   Gutierrez A, 2000, EXP PARASITOL, V95, P215, DOI 10.1006/expr.2000.4534
   Khosravi A, 2011, PARASITE IMMUNOL, V33, P145, DOI 10.1111/j.1365-3024.2010.01260.x
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Lopez C, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00156
   MARQUES AC, 1987, PARASITOL TODAY, V3, P166, DOI 10.1016/0169-4758(87)90170-0
   Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x
   MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315
   Mehrizi AA, 2016, INFECT GENET EVOL, V43, P50, DOI 10.1016/j.meegid.2016.05.015
   Moll K., 2008, METHODS MALARIA RES
   Moon SU, 2010, ACTA TROP, V114, P71, DOI 10.1016/j.actatropica.2010.01.006
   Mueller I, 2015, VACCINE, V33, P7489, DOI 10.1016/j.vaccine.2015.09.060
   Mueller I, 2013, ADV PARASIT, V81, P77, DOI 10.1016/B978-0-12-407826-0.00003-5
   Ord RL, 2016, INFECT IMMUN, V84, P1574, DOI 10.1128/IAI.00107-16
   Patel P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182674
   Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449
   Prajapati SK, 2010, J VECTOR DIS, V47, P85
   Putaporntip C, 2001, GENE, V268, P97, DOI 10.1016/S0378-1119(01)00425-5
   Putaporntip C, 2009, INFECT GENET EVOL, V9, P821, DOI 10.1016/j.meegid.2009.04.017
   Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6
   Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778
   Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27
   Rodrigues-da-Silva RN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00077
   Rouhani M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0547-0
   Sambrook J., 2006, CSH PROTOC, V2006, P1, DOI DOI 10.1101/PDB.PR0T3944
   Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189
   Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254
   Srinivasan P, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0015-7
   Srinivasan P, 2014, P NATL ACAD SCI USA, V111, P10311, DOI 10.1073/pnas.1409928111
   Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261
   Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108
   Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002
   Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257
   Tang JX, 2012, PARASITOLOGY, V139, P709, DOI 10.1017/S0031182011002447
   Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406
   Thakur A, 2008, GENE, V419, P35, DOI 10.1016/j.gene.2008.04.012
   Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115
   Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988
   Vallejo AF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1104-1
   Vicentin EC, 2014, INFECT IMMUN, V82, P1296, DOI 10.1128/IAI.01169-13
   Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755
   Vulliez-LeNormand B, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.018319828817634, DOI 10.1371/JOURNAL.PONE.0183198]
   Weaver R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33094
   Yeom JS, 2008, J PARASITOL, V94, P1410, DOI 10.1645/GE-1484.1
   Zakeri S, 2006, TROP MED INT HEALTH, V11, P729, DOI 10.1111/j.1365-3156.2006.01613.x
   Zeyrek FY, 2006, PARASITE IMMUNOL, V28, P201, DOI 10.1111/j.1365-3024.2006.00822.x
NR 79
TC 3
Z9 3
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2875
J9 MALARIA J
JI Malar. J.
PD OCT 31
PY 2018
VL 17
AR 401
DI 10.1186/s12936-018-2543-7
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GZ1FO
UT WOS:000449112600001
PM 30382855
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Hirako, IC
   Assis, PA
   Hojo-Souza, NS
   Reed, G
   Nakaya, H
   Golenbock, DT
   Coimbra, RS
   Gazzinelli, RT
AF Hirako, Isabella Cristina
   Assis, Patricia Aparecida
   Hojo-Souza, Natalia Satchiko
   Reed, George
   Nakaya, Helder
   Golenbock, Douglas Taylor
   Coimbra, Roney Santos
   Gazzinelli, Ricardo Tostes
TI Daily Rhythms of TNF alpha Expression and Food Intake Regulate Synchrony
   of Plasmodium Stages with the Host Circadian Cycle
SO CELL HOST & MICROBE
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; IMMUNE-RESPONSE; DENDRITIC CELLS; GLUCOSE-UPTAKE;
   SEVERE MALARIA; PPAR-GAMMA; IN-VIVO; CHABAUDI; CLOCK; GENE
AB The Plasmodium cell cycle, wherein millions of parasites differentiate and proliferate, occurs in synchrony with the vertebrate host's circadian cycle. The underlying mechanisms are unknown. Here we addressed this question in a mouse model of Plasmodium chabaudi infection. Inflammatory gene expression and carbohydrate metabolism are both enhanced in interferon-gamma (IFN gamma)-primed leukocytes and liver cells from P. chabaudi-infected mice. Tumor necrosis factor alpha (TNF alpha) expression oscillates across the host circadian cycle, and increased TNFa alpha correlates with hypoglycemia and a higher frequency of non-replicative ring forms of trophozoites. Conversely, parasites proliferate and acquire biomass during food intake by the host. Importantly, cyclic hypoglycemia is attenuated and synchronization of P. chabaudi stages is disrupted in IFN gamma(-/-), TNF receptor(-/-), or diabetic mice. Hence, the daily rhythm of systemic TNF alpha production and host food intake set the pace for Plasmodium synchronization with the host's circadian cycle. This mechanism indicates that Plasmodium parasites take advantage of the host's feeding
C1 [Hirako, Isabella Cristina; Hojo-Souza, Natalia Satchiko; Golenbock, Douglas Taylor; Coimbra, Roney Santos; Gazzinelli, Ricardo Tostes] Fundacao Oswaldo Cruz Minas, Lab Immunopathol, BR-30190002 Belo Horizonte, MG, Brazil.
   [Hirako, Isabella Cristina; Assis, Patricia Aparecida; Golenbock, Douglas Taylor; Gazzinelli, Ricardo Tostes] Univ Massachusetts, Med Sch, Div Infect Dis & Immunol, 364 Plantat St, Worcester, MA 01605 USA.
   [Reed, George] Univ Massachusetts, Med Sch, Div Prevent & Behav Med, Worcester, MA 01605 USA.
   [Nakaya, Helder] Univ Sao Paulo, Escola Ciencias Farmaceut, BR-05508000 Sao Paulo, Brazil.
   [Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Gazzinelli, Ricardo Tostes] Fundacao Oswaldo Cruz, Fac Med Ribeirao Preto, Plataforma Med Translac, BR-14049900 Ribeirao Preto, SP, Brazil.
RP Gazzinelli, RT (corresponding author), Fundacao Oswaldo Cruz Minas, Lab Immunopathol, BR-30190002 Belo Horizonte, MG, Brazil.; Gazzinelli, RT (corresponding author), Univ Massachusetts, Med Sch, Div Infect Dis & Immunol, 364 Plantat St, Worcester, MA 01605 USA.; Gazzinelli, RT (corresponding author), Univ Fed Minas Gerais, Dept Bioquim & Imunol, BR-31270901 Belo Horizonte, MG, Brazil.; Gazzinelli, RT (corresponding author), Fundacao Oswaldo Cruz, Fac Med Ribeirao Preto, Plataforma Med Translac, BR-14049900 Ribeirao Preto, SP, Brazil.
EM ricardo.gazzinelli@umassmed.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Coimbra, Roney/0000-0002-9204-0573
FU US NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01NS098747, R01AI079293, U19AI089681,
   R21AI131632, 5U2C-DK093000]; Brazilian National Institute of Science and
   Technology for Vaccines (INCT/CNPq); Fundacao de Pesquisa do Estado de
   Minas Gerais [465293/2014-0]; Fundacao de Amparo de Pesquisa do Estado
   de Sao Paulo [2016/23618-8]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI089681, U19AI089681,
   R01AI079293, U19AI089681, R01AI079293, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, R01AI079293,
   R01AI079293, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, R01AI079293,
   R01AI079293, U19AI089681, U19AI089681, U19AI089681, R21AI131632,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, R01AI079293, U19AI089681,
   U19AI089681, R21AI131632, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, R01AI079293,
   R01AI079293, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, R01AI079293, R01AI079293, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681, U19AI089681, U19AI089681, U19AI089681, U19AI089681,
   U19AI089681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000,
   U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000,
   U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000,
   U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000, U2CDK093000] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS098747, R01NS098747, R01NS098747,
   R01NS098747, R01NS098747] Funding Source: NIH RePORTER
FX We thank Dr. David Weaver for helpful discussions and Prof. Sarah Reece,
   Dr. Kim Prior, and a third anonymous reviewer for constructive
   critiques. We are grateful to Dr. Danielle Durso for preparing figures
   and submitting RNA-sequencing and microarray data to NCBI and to Melanie
   Trombly for comments and edition of the final version of the manuscript.
   This work was supported by the US NIH (R01NS098747, R01AI079293,
   U19AI089681, R21AI131632, and 5U2C-DK093000), a Brazilian National
   Institute of Science and Technology for Vaccines (INCT/CNPq), Fundacao
   de Pesquisa do Estado de Minas Gerais (465293/2014-0), and Fundacao de
   Amparo de Pesquisa do Estado de Sao Paulo (2016/23618-8).
CR Antonelli LRV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004393
   Ataide MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003885
   Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002
   Danquah I, 2010, EMERG INFECT DIS, V16, P1601, DOI 10.3201/eid1610.100399
   DAVID PH, 1978, P NATL ACAD SCI USA, V75, P5081, DOI 10.1073/pnas.75.10.5081
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012
   Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034
   ELASED K, 1994, INFECT IMMUN, V62, P5157, DOI 10.1128/IAI.62.11.5157-5160.1994
   Emanueli C, 2004, DIABETES, V53, P1096, DOI 10.2337/diabetes.53.4.1096
   Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191
   FALANGA PB, 1987, EUR J IMMUNOL, V17, P599, DOI 10.1002/eji.1830170504
   Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106
   GAUTRET P, 1994, PARASITE, V1, P235, DOI 10.1051/parasite/1994013235
   Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742
   Gordon EB, 2015, MBIO, V6, DOI 10.1128/mBio.00725-15
   HAWKING F, 1970, SCI AM, V222, P123, DOI 10.1038/scientificamerican0670-123
   Hirako IC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13277
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Hotta CT, 2000, NAT CELL BIOL, V2, P466
   Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537
   Kalantari P, 2014, CELL REP, V6, P196, DOI 10.1016/j.celrep.2013.12.014
   KWIATKOWSKI D, 1991, P NATL ACAD SCI USA, V88, P5111, DOI 10.1073/pnas.88.12.5111
   KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357
   LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287
   Li C, 2003, INFECT IMMUN, V71, P4850, DOI 10.1128/IAI.71.9.4850-4856.2003
   Lima Wania Rezende, 2016, Genes Cancer, V7, P323, DOI 10.18632/genesandcancer.118
   Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001
   Mancio-Silva L, 2017, NATURE, V547, P213, DOI 10.1038/nature23009
   Mejia P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7050
   Mideo N, 2013, TRENDS PARASITOL, V29, P10, DOI 10.1016/j.pt.2012.10.006
   Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   MONS B, 1985, PARASITOLOGY, V91, P423, DOI 10.1017/S0031182000062673
   MURRAY MJ, 1975, LANCET, V1, P653
   OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183
   Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06
   Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298
   Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104
   Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808
   Prior KF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006900
   Reece SE, 2017, J BIOL RHYTHM, V32, P516, DOI 10.1177/0748730417718904
   Sakurai Y, 1996, AM J PHYSIOL-ENDOC M, V270, pE864
   Salcedo-Sora JE, 2014, TRENDS PARASITOL, V30, P170, DOI 10.1016/j.pt.2014.02.001
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Schaecher K, 2005, INFECT IMMUN, V73, P6091, DOI 10.1128/IAI.73.9.6091-6100.2005
   Sexton AC, 2004, J INFECT DIS, V189, P1245, DOI 10.1086/382596
   Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016
   Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559
   SPOLARICS Z, 1991, J LEUKOCYTE BIOL, V49, P309
   Srivastava A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006094
   Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006
   Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Vallon-Christersson J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-330
   VOGEL SN, 1991, INFECT IMMUN, V59, P2494, DOI 10.1128/IAI.59.7.2494-2498.1991
   Wu J, 2014, P NATL ACAD SCI USA, V111, pE511, DOI 10.1073/pnas.1316467111
   Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zijlmans W, 2008, AM J TROP MED HYG, V79, P605, DOI 10.4269/ajtmh.2008.79.605
NR 62
TC 27
Z9 27
U1 2
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 13
PY 2018
VL 23
IS 6
BP 796
EP +
DI 10.1016/j.chom.2018.04.016
PG 19
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GM7WT
UT WOS:000438408600018
PM 29805094
OA Bronze, Green Accepted
DA 2020-12-17
ER

PT J
AU Peres, RS
   Donate, PB
   Talbot, J
   Cecilio, NT
   Lobo, PR
   Machado, CC
   Lima, KWA
   Oliveira, RD
   Carregaro, V
   Nakaya, HI
   Cunha, TM
   Alves, JC
   Liew, FY
   Louzada, P
   Cunha, FQ
AF Peres, Raphael S.
   Donate, Paula B.
   Talbot, Jhimmy
   Cecilio, Nerry T.
   Lobo, Patricia R.
   Machado, Caio C.
   Lima, Kalil W. A.
   Oliveira, Rene D.
   Carregaro, Vanessa
   Nakaya, Helder, I
   Cunha, Thiago M.
   Alves-Filho, Jose Carlos
   Liew, Foo Y.
   Louzada-Junior, Paulo
   Cunha, Fernando Q.
TI TGF-beta signalling defect is linked to low CD39 expression on
   regulatory T cells and methotrexate resistance in rheumatoid arthritis
SO JOURNAL OF AUTOIMMUNITY
LA English
DT Article
DE Regulatory T cells; CD39; Methotrexate; TGF-beta signalling; Rheumatoid
   arthritis
ID ANTIINFLAMMATORY MECHANISM; TRANSDUCTION PATHWAYS; AMERICAN-COLLEGE;
   BINDING-PROTEIN; INFLAMMATION; ACTIVATION; FOXP3; SMAD; ADENOSINE;
   RELEASE
AB Rheumatoid arthritis (RA) is an autoimmune arthropathy characterized by chronic articular inflammation. Methotrexate (MTX) remains the first-line therapy for RA and its anti-inflammatory effect is associated with the maintenance of high levels of extracellular adenosine (ADO). Nonetheless, up to 40% of RA patients are resistant to MTX treatment and this is linked to a reduction of CD39 expression, an ectoenzyme involved in the generation of extracellular ADO by ATP metabolism, on circulating regulatory T cells (Tregs). However, the mechanism mediating the reduction of CD39 expression on Tregs is unknown. Here we demonstrated that the impairment in TGF-beta signalling lead to the reduction of CD39 expression on Tregs that accounts for MTX resistance. TGF-beta increases CD39 expression on Tregs via the activation of TGFBRII/TGFBRI, SMAD2 and the transcription factor CREB, which is activated in a p38-dependent manner and induces CD39 expression by promoting ENTPDI gene transcription. Importantly, unresponsive patients to MTX (UR-MTX) show reduced expression of TGFBR2 and CREBI and decreased levels of p-SMAD2 and p-CREB in Tregs compared to MTX-responsive patients (R-MTX). Furthermore, RA patients carrying at least one mutant allele for rs1431131 (AT or AA) of the TGFBR2 gene are significantly (p = 0.0006) associated with UR-MTX. Therefore, we have uncovered a molecular mechanism for the reduced CD39 expression on Tregs, and revealed potential targets for therapeutic intervention for MTX resistance. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Peres, Raphael S.; Donate, Paula B.; Talbot, Jhimmy; Cecilio, Nerry T.; Lima, Kalil W. A.; Cunha, Thiago M.; Alves-Filho, Jose Carlos; Cunha, Fernando Q.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, Brazil.
   [Peres, Raphael S.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England.
   [Lobo, Patricia R.; Machado, Caio C.; Oliveira, Rene D.; Louzada-Junior, Paulo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil.
   [Carregaro, Vanessa] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Biochem & Immunol, Ribeirao Preto, Brazil.
   [Nakaya, Helder, I] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Liew, Foo Y.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Liew, Foo Y.] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou 215006, Peoples R China.
RP Cunha, FQ (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Ribeirao Preto, Brazil.; Louzada, P (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, Brazil.; Liew, FY (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
EM foo.liew@glasgow.ac.uk; plouzada@fmrp.usp.br; fdqcunha@fmrp.usp.br
RI Nakaya, Helder/AAF-1738-2020; Alves-Filho, Jose Carlos/B-5814-2008;
   Cunha, Thiago M/B-7729-2012; Oliveira, Rene/C-4467-2012; Nakaya, Helder
   I/A-1397-2010; Carregaro, Vanessa/D-2913-2012; Cunha, Fernando
   Q/M-3090-2014; Louzada-Junior, Paulo/E-4132-2012; Cecilio,
   Nerry/L-2378-2016
OI Nakaya, Helder/0000-0001-5297-9108; Alves-Filho, Jose
   Carlos/0000-0002-9918-8714; Cunha, Thiago M/0000-0003-1084-0065;
   Oliveira, Rene/0000-0003-0229-6864; Nakaya, Helder
   I/0000-0001-5297-9108; Louzada-Junior, Paulo/0000-0003-2585-3870;
   Carregaro, Vanessa/0000-0002-8435-0766; Sanches Peres,
   Raphael/0000-0002-0417-779X; Cecilio, Nerry Tatiana/0000-0001-5465-5238;
   Cunha, Fernando Queiroz/0000-0003-4755-1670
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2009/54014-7, 2011/19670, 2012/10438-0,
   2013/08216-2]; University of Sao Paulo (NAP-DIN) [11.1.21625.01.0]
FX The research received funding from Sao Paulo Research Foundation
   (FAPESP, 2009/54014-7, 2011/19670, 2012/10438-0 and 2013/08216-2, Center
   for Research in Inflammatory Diseases) and from the University of Sao
   Paulo (NAP-DIN, 11.1.21625.01.0).
CR Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584
   Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005
   Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200
   Bansard C, 2009, RHEUMATOLOGY, V48, P1021, DOI 10.1093/rheumatology/kep112
   Birkenkamp KU, 2000, BRIT J PHARMACOL, V131, P99, DOI 10.1038/sj.bjp.0703534
   Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175
   Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019
   Cottrez F, 2001, J IMMUNOL, V167, P773, DOI 10.4049/jimmunol.167.2.773
   Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3
   CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904
   Herbst KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005642
   Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490
   JACOBSON KA, 1993, FEBS LETT, V323, P141, DOI 10.1016/0014-5793(93)81466-D
   Kamiya K, 2007, MOL CELL BIOL, V27, P3489, DOI 10.1128/MCB.00665-06
   Kochetkova I, 2011, J IMMUNOL, V187, P4654, DOI 10.4049/jimmunol.1100530
   Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905
   Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051
   Meinig JM, 2015, ACS CHEM BIOL, V10, P570, DOI 10.1021/cb500856c
   Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643
   Ohta A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00190
   Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506
   Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112
   Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701
   Rissiek A, 2015, J AUTOIMMUN, V58, P12, DOI 10.1016/j.jaut.2014.12.007
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   Shevach EM, 2008, EUR J IMMUNOL, V38, P915, DOI 10.1002/eji.200738111
   Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480
   Steven A, 2016, ONCOTARGET, V7, P35454, DOI 10.18632/oncotarget.7721
   Warner DR, 2004, BIOCHEM BIOPH RES CO, V324, P70, DOI 10.1016/j.bbrc.2004.09.017
   Warner DR, 2003, CELL SIGNAL, V15, P235, DOI 10.1016/S0898-6568(02)00082-7
   Wolf J, 2005, ANN RHEUM DIS, V64, P564, DOI 10.1136/ard.2003.014985
   Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959
   Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018
   Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458
NR 36
TC 13
Z9 14
U1 0
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0896-8411
EI 1095-9157
J9 J AUTOIMMUN
JI J. Autoimmun.
PD JUN
PY 2018
VL 90
BP 49
EP 58
DI 10.1016/j.jaut.2018.01.004
PG 10
WC Immunology
SC Immunology
GA GH7PJ
UT WOS:000433645600004
PM 29426578
DA 2020-12-17
ER

PT J
AU Barros, JBD
   da Silva, PAN
   Koga, RDR
   Gonzalez-Dias, P
   Carmo, JR
   Nagib, PRA
   Coelho, V
   Nakaya, HI
   Fonseca, SG
   Pfrimer, IAH
AF de Sousa Barros, Jessica Barletto
   Neves da Silva, Paulo Alex
   Rocha Koga, Rosemary de Carvalho
   Gonzalez-Dias, Patricia
   Carmo Filho, Jose Rodrigues
   Alo Nagib, Patricia Resende
   Coelho, Veronica
   Nakaya, Helder I.
   Fonseca, Simone Goncalves
   Hoffmann Pfrimer, Irmtraut Araci
TI Acute Zika Virus Infection in an Endemic Area Shows Modest
   Proinflammatory Systemic Immunoactivation and Cytokine-Symptom
   Associations
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE acute Zika virus infection; cytokines; chemokines; symptoms; immune
   response; low viremia; immunoactivation
ID SERUM-LEVELS; CCL3/MIP-1-ALPHA; MONOCYTES; MIGRAINE; TARGET; CELLS
AB An early immune response to Zika virus (ZIKV) infection may determine its clinical manifestation and outcome, including neurological effects. However, low-grade and transient viremia limits the prompt diagnosis of acute ZIKV infection. We have investigated the plasma cytokine, chemokine, and growth factor profiles of 36 individuals from an endemic area displaying different symptoms such as exanthema, headache, myalgia, arthralgia, fever, hyperemia, swelling, itching, and nausea during early-phase infection. These profiles were then associated with symptoms, revealing important aspects of the immunopathophysiology of ZIKV infection. The levels of some cytokines/chemokines were significantly higher in acute ZIKV-infected individuals compared to healthy donors, including interferon (IFN) gamma-induced protein 10 (IP-10), regulated on activation, normal T cell expressed and secreted (RANTES), IFN-gamma interleukin (IL)-9, IL-7, IL-5, and IL-1ra, including some with predominantly immunoregulatory activity. Of note, we found that higher levels of IP-10 and IL-5 in ZIKV-infected individuals were strongly associated with exanthema and headache, respectively. Also, higher levels of IL-1ra were associated with subjects with arthralgia, whereas those with fever showed lower levels of granulocytecolony stimulating factor (G-CSF). No correlation was observed between the number of symptoms and ZIKV viral load. Interestingly, only IP-10 showed significantly decreased levels in the recovery phase. In conclusion, our results indicate that acute ZIKV infection in a larger cohort resident to an endemic area displays a modest systemic immune activation profile, involving both proinflammatory and immunoregulatory cytokines and chemokines that could participate of virus control. In addition, we showed that differential cytokine/chemokine levels are related to specific clinical symptoms, suggesting their participation in underlying mechanisms.
C1 [de Sousa Barros, Jessica Barletto; Rocha Koga, Rosemary de Carvalho; Carmo Filho, Jose Rodrigues; Hoffmann Pfrimer, Irmtraut Araci] Pontifical Catholic Univ Goias, Sch Med Pharmaceut & Biomed Sci, Dept Master Environm Sci & Hlth, Goiania, Go, Brazil.
   [Neves da Silva, Paulo Alex; Alo Nagib, Patricia Resende; Fonseca, Simone Goncalves] Univ Fed Goias, Dept Microbiol Immunol Parasitol & Pathol, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
   [Gonzalez-Dias, Patricia; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, Sao Paulo, Brazil.
   [Coelho, Veronica] Univ Sao Paulo, Sch Med, Immunol Lab, Heart Inst InCor, Sao Paulo, Brazil.
   [Coelho, Veronica; Fonseca, Simone Goncalves] INCT, Iii, Natl Inst Sci & Technol, Sao Paulo, Brazil.
RP Pfrimer, IAH (corresponding author), Pontifical Catholic Univ Goias, Sch Med Pharmaceut & Biomed Sci, Dept Master Environm Sci & Hlth, Goiania, Go, Brazil.; Fonseca, SG (corresponding author), Univ Fed Goias, Dept Microbiol Immunol Parasitol & Pathol, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, Sao Paulo, Brazil.; Fonseca, SG (corresponding author), INCT, Iii, Natl Inst Sci & Technol, Sao Paulo, Brazil.
EM hnakaya@usp.br; fonseca.simone@gmail.com; araci@pfrimer.com.br
RI Nakaya, Helder/AAF-1738-2020; FONSECA, SIMONE GONCALVES/U-9278-2019;
   Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Araci Holffman Pfrimer,
   Irmtraut/0000-0002-3737-0027; Coelho, Veronica/0000-0002-0989-2581;
   Gonzalez-Dias, Patricia/0000-0002-6434-3841
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/08216-2]
FX This work was funded by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) fellowship (to JB), and research fellowships from
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to VC
   and HN). The research leading to these results received funding from the
   Sao Paulo Research Foundation (FAPESP) under grant agreement no.
   2013/08216-2 (Center for Research in Inflammatory Diseases-CRID) (to
   HN).
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Bockowski L, 2010, PHARMACOL REP, V62, P287
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   BRASIL - Secretaria de Vigilancia em Saude Ministerio da Saude (SVS-MS, 2018, B EPIDEMIOLOGICO, V49, P5
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117
   Chalan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26021
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cutolo M, 2004, Reumatismo, V56, P41
   Dayer JM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00293
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Domingues RB, 2016, ARQ NEURO-PSIQUIAT, V74, P626, DOI 10.1590/0004-282X20160096
   Duarte H, 2015, NEUROL SCI, V36, P203, DOI 10.1007/s10072-014-1931-1
   Fallahi P, 2016, CLIN TER, V167, pE186, DOI 10.7417/CT.2016.1966
   Fernandez TD, 2009, CURR OPIN INFECT DIS, V22, P272, DOI 10.1097/QCO.0b013e3283298e62
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Genin P, 2000, REV IMMUNOGENET, V2, P3
   Glass WG, 2003, CURR OPIN ALLERGY CL, V3, P467, DOI 10.1097/01.all.0000104448.09202.91
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Konno S, 2002, AM J RESP CELL MOL, V26, P594, DOI 10.1165/ajrcmb.26.5.4438
   Koraka P, 2003, J MED VIROL, V70, P91, DOI 10.1002/jmv.10358
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706
   Maciel IJ, 2008, REV PATOLOGIA TROPIC, V37, P2, DOI [10.5216/rpt.v37i2.4998, DOI 10.5216/RPT.V37I2.4998]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munno I, 1998, HEADACHE, V38, P465, DOI 10.1046/j.1526-4610.1998.3806465.x
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Vazquez S, 2005, J CLIN VIROL, V33, P132, DOI 10.1016/j.jcv.2004.10.013
   Vazquez S, 2014, J MED VIROL, V86, P1576, DOI 10.1002/jmv.23833
   Wang F, 2016, ASIAN PAC J ALLERGY, V34, P236, DOI 10.12932/AP0679
   Zhu X, 2012, CURR ONCOL, V19, pE239, DOI 10.3747/co.19.948
NR 49
TC 10
Z9 10
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 3
PY 2018
VL 9
AR 821
DI 10.3389/fimmu.2018.00821
PG 11
WC Immunology
SC Immunology
GA GE6JS
UT WOS:000431333200001
PM 29774022
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ferreira, GR
   Nakaya, HI
   Costa, LD
AF Ferreira, Gustavo Rodrigues
   Nakaya, Helder Imoto
   Costa, Luciano da Fontoura
TI Gene regulatory and signaling networks exhibit distinct topological
   distributions of motifs
SO PHYSICAL REVIEW E
LA English
DT Article
ID DIFFERENTIAL EXPRESSION; CELL; PATTERNS; DURATION
AB The biological processes of cellular decision making and differentiation involve aplethora of signaling pathways and gene regulatory circuits. These networks in turn exhibit a multitude of motifs playing crucial parts in regulating network activity. Here we compare the topological placement of motifs in gene regulatory and signaling networks and observe that it suggests different evolutionary strategies in motif distribution for distinct cellular subnetworks.
C1 [Ferreira, Gustavo Rodrigues; Costa, Luciano da Fontoura] Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil.
   [Nakaya, Helder Imoto] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
RP Costa, LD (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, Sao Carlos, SP, Brazil.
EM ldfcosta@gmail.com
RI Nakaya, Helder/AAF-1738-2020; da F. Costa, Luciano/H-5475-2011; Nakaya,
   Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; da F. Costa,
   Luciano/0000-0001-5203-4366; Nakaya, Helder I/0000-0001-5297-9108
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2015/22308-2, 2012/19278-6, 2014/19323-7]
FX The authors acknowledge financial support from FAPESP Grants No.
   2015/22308-2, No. 2012/19278-6, and No. 2014/19323-7.
CR ALBERTS B, 2015, MOL BIOL CELL, P1
   Alon U, 2007, INTRO SYSTEMS BIOL D
   Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Biggs N., 1994, ALGEBRAIC GRAPH THEO
   Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403
   Buchana M., 2010, NETWORKCELL BIOL
   Caldarelli G, 2004, EUR PHYS J B, V38, P183, DOI 10.1140/epjb/e2004-00020-6
   Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015
   Costa LD, 2006, J STAT PHYS, V125, P845, DOI 10.1007/s10955-006-9130-y
   Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210
   de Silva E, 2005, J R SOC INTERFACE, V2, P419, DOI 10.1098/rsif.2005.0067
   Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Fujii K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14443
   Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948
   Ghaffarizadeh A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S7
   Giraud C, 2015, INTRO HIGH DIMENSION
   Gkantsidis C., 2003, P 5 WORKSH ALG ENG E
   Guan Y, 2009, STAT PROBABIL LETT, V79, P1621, DOI 10.1016/j.spl.2009.04.010
   Hu GQ, 2013, NAT IMMUNOL, V14, P1190, DOI 10.1038/ni.2712
   Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4
   Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615
   Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102
   Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838
   Kramer F, 2013, BIOINFORMATICS, V29, P520, DOI 10.1093/bioinformatics/bts710
   Liu DB, 2017, NUCLEIC ACIDS RES, V45, P7078, DOI 10.1093/nar/gkx485
   Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040
   Liu ZP, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav095
   Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876
   Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051
   Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824
   Navlakha S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0283
   Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785
   Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795
   Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014
   PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075
   Sah P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-220
   Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126
   Shin YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012785
   Silva FN, 2016, INFORM SCIENCES, V333, P61, DOI 10.1016/j.ins.2015.11.014
   Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983
   Xiao YH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066108
   Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660
NR 46
TC 1
Z9 1
U1 1
U2 5
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2470-0045
EI 2470-0053
J9 PHYS REV E
JI Phys. Rev. E
PD APR 27
PY 2018
VL 97
IS 4
AR 042417
DI 10.1103/PhysRevE.97.042417
PG 6
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA GG8RZ
UT WOS:000432967700005
PM 29758668
DA 2020-12-17
ER

PT J
AU Silva, MC
   Davoli-Ferreira, M
   Medina, TS
   Sesti-Costa, R
   Silva, GK
   Lopes, CD
   Cardozo, LE
   Gava, FN
   Lyroni, K
   Dias, FC
   Frade, AF
   Baron, M
   Nakaya, HI
   Figueiredo, F
   Alves, JC
   Cunha, FQ
   Tsatsanis, C
   Chevillard, C
   Cunha, E
   Hirsch, E
   Silva, JS
   Cunha, TM
AF Silva, Maria C.
   Davoli-Ferreira, Marcela
   Medina, Tiago S.
   Sesti-Costa, Renata
   Silva, Grace K.
   Lopes, Carla D.
   Cardozo, Lucas E.
   Gava, Fabio N.
   Lyroni, Konstantina
   Dias, Fabricio C.
   Frade, Amanda F.
   Baron, Monique
   Nakaya, Helder I.
   Figueiredo, Florencio
   Alves-Filho, Jose C.
   Cunha, Fernando Q.
   Tsatsanis, Christos
   Chevillard, Christophe
   Cunha-Neto, Edecio
   Hirsch, Emilio
   Silva, Joao S.
   Cunha, Thiago M.
TI Canonical PI3K gamma signaling in myeloid cells restricts Trypanosoma
   cruzi infection and dampens chagasic myocarditis
SO NATURE COMMUNICATIONS
LA English
DT Article
ID PHOSPHOINOSITIDE 3-KINASE; NITRIC-OXIDE; PHOSPHATIDYLINOSITOL 3-KINASES;
   AMERICAN TRYPANOSOMIASIS; INDUCED COLITIS; HEART-FAILURE; DISEASE; MICE;
   PROTEIN; HOST
AB Chagas disease is caused by infection with the protozoan Trypanosoma cruzi (T. cruzi) and is an important cause of severe inflammatory heart disease. However, the mechanisms driving Chagas disease cardiomyopathy have not been completely elucidated. Here, we show that the canonical PI3K gamma pathway is upregulated in both human chagasic hearts and hearts of acutely infected mice. PI3K gamma-deficient mice and mutant mice carrying catalytically inactive PI3K gamma are more susceptible to T. cruzi infection. The canonical PI3K gamma signaling in myeloid cells is essential to restrict T. cruzi heart parasitism and ultimately to avoid myocarditis, heart damage, and death of mice. Furthermore, high PIK3CG expression correlates with low parasitism in human Chagas' hearts. In conclusion, these results indicate an essential role of the canonical PI3K gamma signaling pathway in the control of T. cruzi infection, providing further insight into the molecular mechanisms involved in the pathophysiology of chagasic heart disease.
C1 [Silva, Maria C.; Davoli-Ferreira, Marcela; Alves-Filho, Jose C.; Cunha, Fernando Q.; Cunha, Thiago M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Bandeirantes Ave 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Silva, Maria C.; Davoli-Ferreira, Marcela; Medina, Tiago S.; Sesti-Costa, Renata; Silva, Grace K.; Lopes, Carla D.; Dias, Fabricio C.; Silva, Joao S.] Univ Sao Paulo, Ribeirao Preto Med Sch, Fiocruz Bi Inst Translat Med Plataform, Dept Biochem & Immunol, Bandeirantes Ave 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Cardozo, Lucas E.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, SP, Brazil.
   [Gava, Fabio N.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Bandeirantes Ave 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Lyroni, Konstantina; Tsatsanis, Christos] Univ Crete, Sch Med, Lab Clin Chem, Iraklion 71003, Greece.
   [Frade, Amanda F.; Baron, Monique; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Immunol, BR-05403900 Sao Paulo, SP, Brazil.
   [Figueiredo, Florencio] Univ Brasilia, Sch Med, Lab Pathol, Campus Univ Darcy Ribeiro, BR-70910900 Brasilia, DF, Brazil.
   [Chevillard, Christophe] Aix Marseille Univ AMU, TAGC INSERM U1090, Parc Sci Luminy Case 928,163 Ave Luminy, F-13288 Marseille 09, France.
   [Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, BR-05403900 Sao Paulo, SP, Brazil.
   [Cunha-Neto, Edecio] Inst Invest Immunol Iii INCT, BR-05403900 Sao Paulo, SP, Brazil.
   [Hirsch, Emilio] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Mol Biotechnol Ctr, I-10126 Turin, Italy.
   [Silva, Maria C.] Univ Catolica Dom Bosco, Post Grad Program Biotechnol, Campo Grande, MS, Brazil.
   [Frade, Amanda F.] Brazil Univ, Dept Bioengn, Rua Carolina Fonseca 234 Campus II, BR-08230030 Sao Paulo, SP, Brazil.
RP Cunha, TM (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Bandeirantes Ave 3900, BR-14049900 Ribeirao Preto, SP, Brazil.; Silva, JS (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Fiocruz Bi Inst Translat Med Plataform, Dept Biochem & Immunol, Bandeirantes Ave 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM jsdsilva@fmrp.usp.br; thicunha@fmrp.usp.br
RI Silva, Maria Claudia/P-8430-2018; chevillard, christophe/A-7087-2015;
   Cunha, Fernando Q/M-3090-2014; Silva, Joao S/A-4484-2008; Cunha-Neto,
   Edecio/B-4157-2009; Nakaya, Helder/AAF-1738-2020; Medina, Tiago
   S/B-3084-2018; Frade, Amanda F/O-3322-2017; Cunha, Thiago M/B-7729-2012;
   Sesti-Costa, Renata/H-9115-2012; Nakaya, Helder I/A-1397-2010;
   Alves-Filho, Jose Carlos/B-5814-2008; Hirsch, Emilio/F-4848-2013
OI chevillard, christophe/0000-0002-5269-8813; Silva, Joao
   S/0000-0002-3410-3927; Cunha-Neto, Edecio/0000-0002-3699-3345; Nakaya,
   Helder/0000-0001-5297-9108; Medina, Tiago S/0000-0001-8674-8842; Frade,
   Amanda F/0000-0002-9004-8811; Cunha, Thiago M/0000-0003-1084-0065;
   Sesti-Costa, Renata/0000-0002-7098-2850; Nakaya, Helder
   I/0000-0001-5297-9108; Alves-Filho, Jose Carlos/0000-0002-9918-8714;
   Duque Lopes, Carla/0000-0003-0702-5043; Cunha, Fernando
   Queiroz/0000-0003-4755-1670; Hirsch, Emilio/0000-0002-9073-6024
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2012/14524-9, 2013/08216-2]; University of
   Sao Paulo NAP-DIN [11.1.21625.01.0]; CAPESCAPES [88881.068044/20 14-01];
   Sao Paulo Research FoundationFundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2011/09488-0]; Institut National de la Sante et de
   la Recherche Medicale (INSERM)Institut National de la Sante et de la
   Recherche Medicale (Inserm); Aix-Marseille University (Direction des
   Relations Internationales); USP-COFECUB program; ARCUS II PACA Bresil
   program; Laboratoire d'Excellence (LabEx) ParaFrap [ANR-11-LABX-0024];
   French (ANR)French National Research Agency (ANR); Brazilian
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX The authors gratefully acknowledge the technical assistance of Cristiane
   Maria Milanezi, Wander Ribeiro, Ieda R. Schivo, Giuliana Bertozi, and
   Sergio Rosa. We also thank Julio Anselmo Siqueira for supervising the
   animal facility as well as providing all animals used in this study. The
   research leading to these results received funding from the Sao Paulo
   Research Foundation (FAPESP) under grant agreements no. 2012/14524-9
   (Thematic Project to J.S.S.), 2013/08216-2 (Center for Research in
   Inflammatory Disease), from the University of Sao Paulo NAP-DIN under
   grant agreement no. 11.1.21625.01.0; and a CAPES Visiting Professor
   Grant no. 88881.068044/20 14-01. M.C.S. was supported by doctoral
   fellowship from the Sao Paulo Research Foundation Grant 2011/09488-0. C.
   C. was supported by the Institut National de la Sante et de la Recherche
   Medicale (INSERM), Aix-Marseille University (Direction des Relations
   Internationales), the USP-COFECUB program, the ARCUS II PACA Bresil
   program, and from the Laboratoire d'Excellence (LabEx) ParaFrap
   ANR-11-LABX-0024. E.C.N. and C. C. were recipient for an international
   program (Br-Fr-Chagas) funded by the French (ANR) and the Brazilian
   (FAPESP) science funding agencies.
CR Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996
   Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109
   Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291
   Basile L, 2011, EUROSURVEILLANCE, V16, P14, DOI 10.2807/ese.16.37.19968-en
   Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6
   BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0
   Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284
   Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Chuenkova MV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000374
   Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018
   Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Dutra RC, 2011, BRIT J PHARMACOL, V163, P358, DOI 10.1111/j.1476-5381.2011.01226.x
   Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879
   GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764
   Gruen M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-63
   Guedes PMM, 2010, BRIT J PHARMACOL, V160, P270, DOI 10.1111/j.1476-5381.2009.00576.x
   Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617
   HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665
   Holscher C, 1998, INFECT IMMUN, V66, P1208
   Imai K, 2015, PARASITOL INT, V64, P240, DOI 10.1016/j.parint.2015.02.005
   Imai K, 2014, EMERG INFECT DIS, V20, P146, DOI 10.3201/eid2001.131071
   Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834
   Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024
   Koberle F., 1968, Advances in Parasitology, V6, P63, DOI 10.1016/S0065-308X(08)60472-8
   Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443
   Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263
   Martin EL, 2010, AM J RESP CRIT CARE, V182, P762, DOI 10.1164/rccm.201001-0088OC
   Maya JD, 2007, COMP BIOCHEM PHYS A, V146, P601, DOI 10.1016/j.cbpa.2006.03.004
   Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248
   Ndongson-Dongmo B, 2015, CARDIOVASC RES, V108, P243, DOI 10.1093/cvr/cvv217
   Nogueira LG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/914326
   Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017
   Pereira-da Silva L. H., 1953, Folia Clinica et Biologica Sao Paulo, V20, P191
   Rajappa M, 2005, ANGIOLOGY, V56, P677, DOI 10.1177/000331970505600605
   Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205
   Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002
   Rogers N, 2015, NAT MED, V21, P1108, DOI 10.1038/nm1015-1108
   Roman-Campos D, 2013, INT J CARDIOL, V167, P3011, DOI 10.1016/j.ijcard.2012.09.020
   ROSSI MA, 1990, AM HEART J, V120, P233, DOI 10.1016/0002-8703(90)90191-Y
   ROTTENBERG ME, 1993, INFECT IMMUN, V61, P5129, DOI 10.1128/IAI.61.12.5129-5133.1993
   Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040
   Silva GK, 2013, J IMMUNOL, V191, P3373, DOI 10.4049/jimmunol.1203293
   SUN J, 1993, AM J TROP MED HYG, V48, P161, DOI 10.4269/ajtmh.1993.48.161
   TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0
   Todorov AG, 2000, J BIOL CHEM, V275, P32182, DOI 10.1074/jbc.M909440199
   van Dop WA, 2010, IMMUNOL LETT, V131, P33, DOI 10.1016/j.imlet.2010.03.008
   VESPA GNR, 1994, INFECT IMMUN, V62, P5177, DOI 10.1128/IAI.62.11.5177-5182.1994
   Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451
   Wilkowsky SE, 2001, EXP CELL RES, V264, P211, DOI 10.1006/excr.2000.5123
NR 51
TC 8
Z9 8
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR 17
PY 2018
VL 9
AR 1513
DI 10.1038/s41467-018-03986-3
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD0MZ
UT WOS:000430196200008
PM 29666415
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Amaral, PP
   Leonardi, T
   Han, N
   Vire, E
   Gascoigne, DK
   Arias-Carrasco, R
   Buscher, M
   Pandolfini, L
   Zhang, AD
   Pluchino, S
   Maracaja-Coutinho, V
   Nakaya, HI
   Hemberg, M
   Shiekhattar, R
   Enright, AJ
   Kouzarides, T
AF Amaral, Paulo P.
   Leonardi, Tommaso
   Han, Namshik
   Vire, Emmanuelle
   Gascoigne, Dennis K.
   Arias-Carrasco, Raul
   Buscher, Magdalena
   Pandolfini, Luca
   Zhang, Anda
   Pluchino, Stefano
   Maracaja-Coutinho, Vinicius
   Nakaya, Helder, I
   Hemberg, Martin
   Shiekhattar, Ramin
   Enright, Anton J.
   Kouzarides, Tony
TI Genomic positional conservation identifies topological anchor point RNAs
   linked to developmental loci
SO GENOME BIOLOGY
LA English
DT Article
DE lncRNAs; Development; Chromatin architecture; Topology; Zinc finger;
   Cancer
ID LONG NONCODING RNAS; NATURAL ANTISENSE TRANSCRIPT; HUMAN CELL-TYPES;
   GENE-EXPRESSION; MESENCHYMAL TRANSITION; CHROMATIN STATE; X-CHROMOSOME;
   EVOLUTION; LNCRNA; DIFFERENTIATION
AB Background: The mammalian genome is transcribed into large numbers of long noncoding RNAs (lncRNAs), but the definition of functional lncRNA groups has proven difficult, partly due to their low sequence conservation and lack of identified shared properties. Here we consider promoter conservation and positional conservation as indicators of functional commonality.
   Results: We identify 665 conserved lncRNA promoters in mouse and human that are preserved in genomic position relative to orthologous coding genes. These positionally conserved lncRNA genes are primarily associated with developmental transcription factor loci with which they are coexpressed in a tissue-specific manner. Over half of positionally conserved RNAs in this set are linked to chromatin organization structures, overlapping binding sites for the CTCF chromatin organiser and located at chromatin loop anchor points and borders of topologically associating domains (TADs). We define these RNAs as topological anchor point RNAs (tapRNAs). Characterization of these noncoding RNAs and their associated coding genes shows that they are functionally connected: they regulate each other's expression and influence the metastatic phenotype of cancer cells in vitro in a similar fashion. Furthermore, we find that tapRNAs contain conserved sequence domains that are enriched in motifs for zinc finger domain-containing RNA-binding proteins and transcription factors, whose binding sites are found mutated in cancers.
   Conclusions: This work leverages positional conservation to identify lncRNAs with potential importance in genome organization, development and disease. The evidence that many developmental transcription factors are physically and functionally connected to lncRNAs represents an exciting stepping-stone to further our understanding of genome regulation.
C1 [Amaral, Paulo P.; Han, Namshik; Gascoigne, Dennis K.; Buscher, Magdalena; Pandolfini, Luca; Hemberg, Martin; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.
   [Leonardi, Tommaso] European Bioinformat Inst, European Mol Biol Lab, Welcome Genome Campus, Cambridge CB10 1SD, England.
   [Leonardi, Tommaso; Pluchino, Stefano] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Leonardi, Tommaso; Pluchino, Stefano] Univ Cambridge, NIHR Biomed Res Ctr, Cambridge, England.
   [Arias-Carrasco, Raul; Maracaja-Coutinho, Vinicius] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago, Chile.
   [Zhang, Anda; Shiekhattar, Ramin] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Human Genet, Biomed Res Bldg, Miami, FL 33136 USA.
   [Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Av Prof Lineu Prestes 580, BR-05508 Sao Paulo, Brazil.
   [Hemberg, Martin] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.
   [Enright, Anton J.] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.
   [Vire, Emmanuelle] UCL Inst Neurol, MRC Prion Unit, Queen Sq House,Queen Sq, London WC1N 3BG, England.
   [Maracaja-Coutinho, Vinicius] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago, Chile.
   [Han, Namshik] Univ Cambridge, Milner Therapeut Inst, Tennis Court Rd, Cambridge CB2 1QN, England.
RP Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.
EM t.kouzarides@gurdon.cam.ac.uk
RI Pluchino, Stefano/AAE-9037-2019; Nakaya, Helder/AAF-1738-2020; Nakaya,
   Helder I/A-1397-2010; Maracaja-Coutinho, Vinicius/R-5256-2019; Enright,
   Anton/F-3094-2011
OI Pluchino, Stefano/0000-0002-6267-9472; Nakaya,
   Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108;
   Maracaja-Coutinho, Vinicius/0000-0002-8873-9381; Enright,
   Anton/0000-0002-6090-3100; Arias-Carrasco, Raul/0000-0003-1698-9282;
   Kouzarides, Tony/0000-0002-8918-4162; Leonardi,
   Tommaso/0000-0002-4449-1863; Pandolfini, Luca/0000-0003-1444-8167;
   Buescher, Magdalena/0000-0002-2215-3329; Vire,
   Emmanuelle/0000-0002-7868-9923
FU Cancer Research UKCancer Research UK [C6/A18796, C6946/A14492]; European
   Research Council CRIPTON Grant [268569]; University of
   CambridgeUniversity of Cambridge; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/50308-4]; Wellcome TrustWellcome
   Trust [092096]; PAI-CONICYT grant [PAI79170021]; FONDECYT-CONICYT
   grantComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [11161020]; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM078455, R01GM078455,
   R01GM078455, R01GM078455, R01GM078455, R01GM078455, R01GM078455,
   R01GM078455, R01GM078455] Funding Source: NIH RePORTER
FX This work was funded by programme grants from Cancer Research UK
   (C6/A18796) and European Research Council CRIPTON Grant (268569), and
   supported by a University of Cambridge and FAPESP grant (2014/50308-4)
   and Institutional funding by a Wellcome Trust Core Grant (092096) and
   Cancer Research UK Grant (C6946/A14492). VMC was supported by a
   PAI-CONICYT grant (PAI79170021) and a FONDECYT-CONICYT grant (11161020).
CR Akerman I, 2017, CELL METAB, V25, P400, DOI 10.1016/j.cmet.2016.11.016
   Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951
   Amaral PP, 2013, BRIEF FUNCT GENOMICS, V12, P254, DOI 10.1093/bfgp/elt016
   Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309
   Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7
   Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787
   Arnes L, 2016, GENE DEV, V30, P502, DOI 10.1101/gad.273821.115
   Balbin OA, 2015, GENOME RES, V25, P1068, DOI 10.1101/gr.180596.114
   Ballester B, 2014, ELIFE, V3, DOI 10.7554/eLife.02626
   Basseres DS, 2012, LUNG CANCER, V77, P31, DOI 10.1016/j.lungcan.2012.01.011
   Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep26657
   Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708
   Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532
   BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72
   Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034
   Delpretti S, 2013, CELL REP, V5, P137, DOI 10.1016/j.celrep.2013.09.002
   Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44
   Deng CW, 2016, CELL REP, V14, P103, DOI 10.1016/j.celrep.2015.12.007
   Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111
   Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368
   Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108
   Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030
   Down TA, 2011, BIOINFORMATICS, V27, P889, DOI 10.1093/bioinformatics/btr020
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149
   Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047
   Enright AJ, 2018, ARRAYEXPRESS
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Fabre PJ, 2015, P NATL ACAD SCI USA, V112, P13964, DOI 10.1073/pnas.1517972112
   Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106
   Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014
   Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015
   Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428
   Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114
   Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114
   Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63
   Hezroni H, 2015, CELL REP, V11, P1110, DOI 10.1016/j.celrep.2015.04.023
   Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024
   Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284
   Isoda T, 2017, CELL, V171, P103, DOI 10.1016/j.cell.2017.09.001
   Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192
   Jiang W, 2015, CELL REP, V11, P137, DOI 10.1016/j.celrep.2015.03.008
   Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009
   Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451
   Kanduri C, 2016, BBA-GENE REGUL MECH, V1859, P102, DOI 10.1016/j.bbagrm.2015.05.006
   Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335
   Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249
   Kung JT, 2015, MOL CELL, V57, P361, DOI 10.1016/j.molcel.2014.12.006
   Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884
   Leonardi T, 2018, TAPRNAS V1 0
   Leonardi T, 2018, FIGSHARE
   Li T, 2016, ONCOGENE, V35, P1575, DOI 10.1038/onc.2015.223
   Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111
   Lonfat N, 2014, SCIENCE, V346, P1004, DOI 10.1126/science.1257493
   Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110
   Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024
   Luo ZJ, 2015, MOL CELL, V57, P685, DOI 10.1016/j.molcel.2015.01.007
   Mas-Ponte D, 2017, RNA, V23, P1080, DOI 10.1261/rna.060814.117
   Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176
   Mele M, 2016, MOL CELL, V62, P657, DOI 10.1016/j.molcel.2016.05.011
   Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105
   Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743
   Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088
   Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943
   Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004
   O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043
   Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059
   Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003
   Quagliata L, 2014, HEPATOLOGY, V59, P911, DOI 10.1002/hep.26740
   Quinn JJ, 2016, GENE DEV, V30, P191, DOI 10.1101/gad.272187.115
   Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021
   Rinn J, 2014, SCIENCE, V345, P1240, DOI 10.1126/science.1252966
   Romito A, 2011, BIOCHIMIE, V93, P1935, DOI 10.1016/j.biochi.2011.07.009
   Saldana-Meyer R, 2014, GENE DEV, V28, P723, DOI 10.1101/gad.236869.113
   Sawyer IA, 2017, CHROMOSOMA, V126, P541, DOI 10.1007/s00412-017-0632-y
   Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346
   Skalska L, 2017, NAT REV MOL CELL BIO, V18, P1, DOI 10.1038/nrm.2017.12
   Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803
   Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126
   Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055
   Van Nostrand E. L., 2017, BIORXIV
   Wan LD, 2016, J CELL MOL MED, V20, P2036, DOI 10.1111/jcmm.12892
   Wang J, 2014, CARCINOGENESIS, V35, P2576, DOI 10.1093/carcin/bgu180
   Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112
   Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819
   Wang XQD, 2017, NUCLEIC ACIDS RES, V45, P1091, DOI 10.1093/nar/gkw966
   Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764
   Werner MS, 2017, NAT STRUCT MOL BIOL, V24, P596, DOI 10.1038/nsmb.3424
   Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701
   Wiles Elizabeth T, 2013, Genes Cancer, V4, P486, DOI 10.1177/1947601913506115
   Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043
   Yu M, 2017, ANNU REV CELL DEV BI, V33, P265, DOI 10.1146/annurev-cellbio-100616-060531
   Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164
   Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252
   Zhuang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11924
NR 101
TC 43
Z9 44
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PD MAR 15
PY 2018
VL 19
AR 32
DI 10.1186/s13059-018-1405-5
PG 21
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA FZ9CF
UT WOS:000427906500001
PM 29540241
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Caires, LC
   Goulart, E
   Melo, US
   Araujo, BHS
   Alvizi, L
   Soares-Schanoski, A
   de Oliveira, DF
   Kobayashi, GS
   Griesi-Oliveira, K
   Musso, CM
   Amaral, MS
   daSilva, LF
   Astray, RM
   Suarez-Patino, SF
   Ventini, DC
   da Silva, SG
   Yamamoto, GL
   Ezquina, S
   Naslavsky, MS
   Telles-Silva, KA
   Weinmann, K
   van der Linden, V
   van der Linden, H
   de Oliveira, JRM
   Arrais, NMR
   Melo, A
   Figueiredo, T
   Santos, S
   Meira, JGC
   Passos, SD
   de Almeida, RP
   Bispo, AJB
   Cavalheiro, EA
   Kalil, J
   Cunha-Neto, E
   Nakaya, H
   Andreata-Santos, R
   Ferreira, LCD
   Verjovski-Almeida, S
   Ho, PL
   Passos-Bueno, MR
   Zatz, M
AF Caires-Junior, Luiz Carlos
   Goulart, Ernesto
   Melo, Uira Souto
   Silva Araujo, Bruno Henrique
   Alvizi, Lucas
   Soares-Schanoski, Alessandra
   de Oliveira, Danyllo Felipe
   Kobayashi, Gerson Shigeru
   Griesi-Oliveira, Karina
   Musso, Camila Manso
   Amaral, Murilo Sena
   daSilva, Lucas Ferreira
   Astray, Renato Mancini
   Suarez-Patino, Sandra Fernanda
   Ventini, Daniella Cristina
   da Silva, Sergio Gomes
   Yamamoto, Guilherme Lopes
   Ezquina, Suzana
   Naslavsky, Michel Satya
   Telles-Silva, Kayque Alves
   Weinmann, Karina
   van der Linden, Vanessa
   van der Linden, Helio
   Mendes de Oliveira, Joao Ricardo
   Rodrigues Arrais, Nivia Maria
   Melo, Adriana
   Figueiredo, Thalita
   Santos, Silvana
   Castro Meira, Joanna Goes
   Passos, Saulo Duarte
   de Almeida, Roque Pacheco
   Barreto Bispo, Ana Jovina
   Cavalheiro, Esper Abrao
   Kalil, Jorge
   Cunha-Neto, Edecio
   Nakaya, Helder
   Andreata-Santos, Robert
   de Souza Ferreira, Luis Carlos
   Verjovski-Almeida, Sergio
   Ho, Paulo Lee
   Passos-Bueno, Maria Rita
   Zatz, Mayana
TI Discordant congenital Zika syndrome twins show differential in vitro
   viral susceptibility of neural progenitor cells (vol 9, 2018)
SO NATURE COMMUNICATIONS
LA English
DT Correction
C1 [Caires-Junior, Luiz Carlos; Goulart, Ernesto; Melo, Uira Souto; Alvizi, Lucas; de Oliveira, Danyllo Felipe; Kobayashi, Gerson Shigeru; Griesi-Oliveira, Karina; Musso, Camila Manso; Yamamoto, Guilherme Lopes; Ezquina, Suzana; Naslavsky, Michel Satya; Telles-Silva, Kayque Alves; Weinmann, Karina; Figueiredo, Thalita; Passos-Bueno, Maria Rita; Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
   [Silva Araujo, Bruno Henrique] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.
   [Silva Araujo, Bruno Henrique; Cavalheiro, Esper Abrao] Fed Univ Sao Paulo UNIFESP, EPM, Dept Neurol & Neurosurg, Neurosci Lab, BR-04039002 Sao Paulo, SP, Brazil.
   [Soares-Schanoski, Alessandra; Amaral, Murilo Sena; Astray, Renato Mancini; Suarez-Patino, Sandra Fernanda; Ventini, Daniella Cristina; Kalil, Jorge; Verjovski-Almeida, Sergio; Ho, Paulo Lee] Butantan Inst, BR-05503900 Sao Paulo, SP, Brazil.
   [Griesi-Oliveira, Karina; da Silva, Sergio Gomes] Albert Einstein Hosp, BR-05652900 Sao Paulo, SP, Brazil.
   [daSilva, Lucas Ferreira; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, SP, Brazil.
   [da Silva, Sergio Gomes] Univ Mogi das Cruzes, BR-08780911 Mogi Das Cruzes, SP, Brazil.
   [van der Linden, Vanessa] AACD, BR-50080810 Recife, PE, Brazil.
   [van der Linden, Helio] Rehabil Ctr Dr Henrique Santillo, BR-74653230 Goiania, Go, Brazil.
   [Mendes de Oliveira, Joao Ricardo] Fed Univ Pernambuco UFPE, Neuropsychiat Dept, BR-50670901 Recife, PE, Brazil.
   [Mendes de Oliveira, Joao Ricardo] Fed Univ Pernambuco UFPE, KeizoAsami Lab, BR-50670901 Recife, PE, Brazil.
   [Rodrigues Arrais, Nivia Maria] Fed Univ Rio Grande do Norte UFRN, Dept Pediat, BR-59010180 Natal, RN, Brazil.
   [Melo, Adriana] ISEA, BR-58400220 Campina Grande, PB, Brazil.
   [Santos, Silvana] Paraiba State Univ UEPB, Dept Biol, BR-58429500 Campina Grande, PB, Brazil.
   [Castro Meira, Joanna Goes] Fed Univ Bahia UFBA, BR-40170115 Salvador, BA, Brazil.
   [Passos, Saulo Duarte] Med Sch Jundiai, Infect Pediat Lab, BR-40170115 Jundiai, SP, Brazil.
   [de Almeida, Roque Pacheco; Barreto Bispo, Ana Jovina] Fed Univ Sergipe UFS, Div Immunol, BR-49100000 Aracaju, SP, Brazil.
   [de Almeida, Roque Pacheco; Barreto Bispo, Ana Jovina] Fed Univ Sergipe UFS, Mol Biol Lab, BR-49100000 Aracaju, SP, Brazil.
   [Cunha-Neto, Edecio] Univ Sao Paulo, Fac Med, Heart Inst, BR-05403900 Sao Paulo, SP, Brazil.
   [Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, SP, Brazil.
   [Andreata-Santos, Robert; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Vaccine Dev Lab, BR-05508900 Sao Paulo, SP, Brazil.
RP Zatz, M (corresponding author), Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
EM mayazatz@usp.br
RI Kobayashi, Gerson Shigeru/AAB-9113-2019; Cunha-Neto, Edecio/B-4157-2009;
   KALIL, JORGE/C-8029-2012; Zatz, Mayana/M-5338-2015; Santos,
   Silvana/ABF-5893-2020; Melo, Adriana S O/H-5650-2016; Goulart,
   Ernesto/AAC-3713-2020; Kobayashi, Gerson/H-4017-2013; Schanoski,
   Alessandra/H-8144-2014; Verjovski-Almeida, Sergio/E-4082-2012; Amaral,
   Murilo S/G-5769-2013; Nakaya, Helder/AAF-1738-2020; Passos-Bueno, Maria
   Rita/I-6796-2016; Cavalheiro, Esper/I-3084-2016; Naslavsky,
   Michel/L-1772-2015
OI Kobayashi, Gerson Shigeru/0000-0002-6520-5774; Cunha-Neto,
   Edecio/0000-0002-3699-3345; KALIL, JORGE/0000-0001-8415-4274; Zatz,
   Mayana/0000-0003-3970-8025; Santos, Silvana/0000-0002-5252-0206;
   Kobayashi, Gerson/0000-0002-6520-5774; Schanoski,
   Alessandra/0000-0002-6514-8458; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Nakaya, Helder/0000-0001-5297-9108;
   Passos-Bueno, Maria Rita/0000-0002-9248-3008; Cavalheiro,
   Esper/0000-0002-0854-3582; Goulart, Ernesto/0000-0001-9526-8701;
   Naslavsky, Michel/0000-0002-9068-1713
FU CAPESCAPES; DECIT-MS
FX Financial support from CAPES and DECIT-MS
CR CAIRESJUNIOR LC, 2018, NAT COMM, V0009
NR 1
TC 5
Z9 5
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR 13
PY 2018
VL 9
AR 1114
DI 10.1038/s41467-018-03497-1
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ0HK
UT WOS:000427248800003
PM 29535311
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Russo, PST
   Ferreira, GR
   Cardozo, LE
   Burger, MC
   Arias-Carrasco, R
   Maruyama, SR
   Hirata, TDC
   Lima, DS
   Passos, FM
   Fukutani, KF
   Lever, M
   Silva, JS
   Maracaja-Coutinho, V
   Nakaya, HI
AF Russo, Pedro S. T.
   Ferreira, Gustavo R.
   Cardozo, Lucas E.
   Buerger, Matheus C.
   Arias-Carrasco, Raul
   Maruyama, Sandra R.
   Hirata, Thiago D. C.
   Lima, Diogenes S.
   Passos, Fernando M.
   Fukutani, Kiyoshi F.
   Lever, Melissa
   Silva, Joao S.
   Maracaja-Coutinho, Vinicius
   Nakaya, Helder I.
TI CEMiTool: a Bioconductor package for performing comprehensive modular
   co-expression analyses
SO BMC BIOINFORMATICS
LA English
DT Article
DE Co-expression modules; Gene networks; Modular analysis; Leishmaniasis;
   Transcriptomics
ID NETWORK ANALYSIS; GENE-EXPRESSION; HEPATITIS-C; R PACKAGE; PSORIASIS;
   PROFILES; GENOMICS; CLUSTERS; CELLS; MODEL
AB Background: The analysis of modular gene co-expression networks is a well-established method commonly used for discovering the systems-level functionality of genes. In addition, these studies provide a basis for the discovery of clinically relevant molecular pathways underlying different diseases and conditions.& para;& para;Results: In this paper, we present a fast and easy-to-use Bioconductor package named CEMiTool that unifies the discovery and the analysis of co-expression modules. Using the same real datasets, we demonstrate that CEMiTool outperforms existing tools, and provides unique results in a user-friendly html report with high quality graphs. Among its features, our tool evaluates whether modules contain genes that are over-represented by specific pathways or that are altered in a specific sample group, as well as it integrates transcriptomic data with interactome information, identifying the potential hubs on each network. We successfully applied CEMiTool to over 1000 transcriptome datasets, and to a new RNA-seq dataset of patients infected with Leishmania, revealing novel insights of the disease's physiopathology.& para;& para;Conclusion: The CEMiTool R package provides users with an easy-to-use method to automatically implement gene co-expression network analyses, obtain key information about the discovered gene modules using additional downstream analyses and retrieve publication-ready results via a high-quality interactive report.
C1 [Russo, Pedro S. T.; Ferreira, Gustavo R.; Cardozo, Lucas E.; Buerger, Matheus C.; Hirata, Thiago D. C.; Lima, Diogenes S.; Passos, Fernando M.; Lever, Melissa; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, SP, Brazil.
   [Arias-Carrasco, Raul; Maracaja-Coutinho, Vinicius] Univ Chile, Adv Ctr Chron Dis ACCDiS, Fac Ciencias Quim & Farmaceut, Santiago, Chile.
   [Maruyama, Sandra R.; Fukutani, Kiyoshi F.; Silva, Joao S.] Univ Sao Paulo, Dept Biochem Immunol & Cell Biol, Ribeirao Preto, SP, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, SP, Brazil.
EM hnakaya@usp.br
RI Hirata, Thiago Dominguez Crespo/AAP-1903-2020; Silva, Joao
   S/A-4484-2008; Maruyama, Sandra R/G-1171-2012; Maracaja-Coutinho,
   Vinicius/R-5256-2019; Passos, Fernando Marcon/AAI-3922-2020; Fukutani,
   Kiyoshi/T-1630-2019; Nakaya, Helder/AAF-1738-2020; Russo,
   Pedro/K-8746-2019; Nakaya, Helder I/A-1397-2010
OI Silva, Joao S/0000-0002-3410-3927; Maracaja-Coutinho,
   Vinicius/0000-0002-8873-9381; Passos, Fernando
   Marcon/0000-0001-5128-1410; Nakaya, Helder/0000-0001-5297-9108; Russo,
   Pedro/0000-0002-4615-7498; Nakaya, Helder I/0000-0001-5297-9108;
   Arias-Carrasco, Raul/0000-0003-1698-9282; Hirata,
   Thiago/0000-0002-3967-8121; /0000-0001-6807-1452
FU FAPESP grants [2012/19278-6, 2013/08216-2, 2015/20897-0, 2017/05762-7,
   2014/19323-7, 2014/24162-2, 2015/25825-8]; CNPq grantsNational Council
   for Scientific and Technological Development (CNPq) [443719/2014-4];
   CAPES grants [1496888, 1572872]; PAI-CONICYT grant [PAI79170021];
   FONDECYT-CONICYT grantComision Nacional de Investigacion Cientifica y
   Tecnologica (CONICYT)CONICYT FONDECYT [11161020]
FX FAPESP grants No 2012/19278-6, 2013/08216-2, 2015/20897-0, 2017/05762-7,
   2014/19323-7, 2014/24162-2, 2015/25825-8;& para;& para;CNPq grants
   443719/2014-4;& para;& para; CAPES grants No. 1496888 and No. 1572872 &
   para;& para;FONDECYT-CONICYT grant 11161020 & para;& para;PAI-CONICYT
   grant PAI79170021
CR Afshar M, 2013, J EUR ACAD DERMATOL, V27, P771, DOI 10.1111/j.1468-3083.2012.04582.x
   Apostol TM, 1991, CALCULUS, P1967
   Ballouz S, 2015, BIOINFORMATICS, V31, P2123, DOI 10.1093/bioinformatics/btv118
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Chiu DS, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-017-1996-y
   Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018
   Desai AP, 2017, PEERJ, V5, DOI 10.7717/peerj.3678
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Guan Y, 2009, STAT PROBABIL LETT, V79, P1621, DOI 10.1016/j.spl.2009.04.010
   Ha MJ, 2015, BIOINFORMATICS, V31, P3413, DOI 10.1093/bioinformatics/btv406
   Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5
   Keermann M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1508-2
   Kim GW, 2013, ANN DERMATOL, V25, P479, DOI 10.5021/ad.2013.25.4.479
   Langfelder P, 2014, WGCNA PACKAGE FREQUE
   Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Liu J, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0217-3
   Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121
   Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103
   Petereit J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0298-8
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sergushichev AA, 2016, BIORXIV
   Silva-Barrios S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00014
   Subramaniam S, 2012, NAT IMMUNOL, V13, P199, DOI 10.1038/ni.2244
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497
   Tsoi LC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0570-4
   Varma N, 2010, INDIAN J HEMATOL BLO, V26, P78, DOI 10.1007/s12288-010-0027-1
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Watson M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-509
   Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
NR 37
TC 33
Z9 34
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD FEB 20
PY 2018
VL 19
AR 56
DI 10.1186/s12859-018-2053-1
PG 13
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA FX3SO
UT WOS:000425992800001
PM 29458351
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Arias-Carrasco, R
   Vasquez-Moran, Y
   Nakaya, HI
   Maracaja-Coutinho, V
AF Arias-Carrasco, Raul
   Vasquez-Moran, Yessenia
   Nakaya, Helder I.
   Maracaja-Coutinho, Vinicius
TI StructRNAfinder: an automated pipeline and web server for RNA families
   prediction
SO BMC BIOINFORMATICS
LA English
DT Article
DE RNA family; RNA structure; Noncoding RNAs; Covariance models; Web
   server; Tool; Pipeline
ID NONCODING RNAS; IDENTIFICATION; HAYSTACK; RFAM
AB Background: The function of many noncoding RNAs (ncRNAs) depend upon their secondary structures. Over the last decades, several methodologies have been developed to predict such structures or to use them to functionally annotate RNAs into RNA families. However, to fully perform this analysis, researchers should utilize multiple tools, which require the constant parsing and processing of several intermediate files. This makes the large-scale prediction and annotation of RNAs a daunting task even to researchers with good computational or bioinformatics skills. Results: We present an automated pipeline named StructRNAfinder that predicts and annotates RNA families in transcript or genome sequences. This single tool not only displays the sequence/structural consensus alignments for each RNA family, according to Rfam database but also provides a taxonomic overview for each assigned functional RNA. Moreover, we implemented a user-friendly web service that allows researchers to upload their own nucleotide sequences in order to perform the whole analysis. Finally, we provided a stand-alone version of StructRNAfinder to be used in large-scale projects. The tool was developed under GNU General Public License (GPLv3) and is freely available at http//structrnafinder.integrativebioinformatics.me. Conclusions: The main advantage of StructRNAfinder relies on the large-scale processing and integrating the data obtained by each tool and database employed along the workflow, of which several files are generated and displayed in user-friendly reports, useful for downstream analyses and data exploration.
C1 [Arias-Carrasco, Raul; Vasquez-Moran, Yessenia; Maracaja-Coutinho, Vinicius] Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago 8580745, Chile.
   [Arias-Carrasco, Raul] Univ Mayor, Programa Doctorado Genom Integrat, Vicerrectoria Invest, Santiago 8580745, Chile.
   [Nakaya, Helder I.] Univ Sao Paulo, Fac Ciencias Farmaceut, BR-05508900 Sao Paulo, Brazil.
   [Maracaja-Coutinho, Vinicius] Inst Vandique, BR-58000000 Joao Pessoa, Paraiba, Brazil.
   [Maracaja-Coutinho, Vinicius] Beagle Bioinformat, Santiago 8320000, Chile.
   [Maracaja-Coutinho, Vinicius] Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago 8380492, Chile.
RP Maracaja-Coutinho, V (corresponding author), Univ Mayor, Fac Ciencias, Ctr Genom & Bioinformat, Santiago 8580745, Chile.; Nakaya, HI (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, BR-05508900 Sao Paulo, Brazil.; Maracaja-Coutinho, V (corresponding author), Inst Vandique, BR-58000000 Joao Pessoa, Paraiba, Brazil.; Maracaja-Coutinho, V (corresponding author), Beagle Bioinformat, Santiago 8320000, Chile.; Maracaja-Coutinho, V (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Adv Ctr Chron Dis ACCDiS, Santiago 8380492, Chile.
EM hnakaya@uso.br; viniciusmaracaja@integrativebioinformatics.me
RI Maracaja-Coutinho, Vinicius/R-5256-2019; Nakaya, Helder/AAF-1738-2020;
   Nakaya, Helder I/A-1397-2010
OI Maracaja-Coutinho, Vinicius/0000-0002-8873-9381; Nakaya,
   Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108;
   Arias-Carrasco, Raul/0000-0003-1698-9282
FU Programa Becas Iberoamerica, Jovenes Profesores e Investigadores,
   Santander Universidades, Chile; Vicerrectoria de Investigation,
   Universidad Mayor, Chile; Fondecyt Iniciacion, Comision National de
   Investigacion Cientifica y Tecnologica (CONICYT), Chile [11161020];
   Fondo de Financiamiento de Centro de Investigacion en Areas Prioritarias
   (FONDAP), CONICYT [15130011]; Programa Nacional de Insercion de Capital
   Humano Avanzado en la Academia, PAI-CONICYT, Chile [PAI79170021];
   Programa de Bienes Publicos Estrategicos para la Competitividad,
   Corporacion de Fomento de la Produccion (CORFO), Chile [16BPE-62321];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP),
   BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [12/19278-6]; Subsidio Semilia de Asignacion Flexible (SSAF), CORFO
   [14-SSAF-27061-]
FX This work was supported by the Programa Becas Iberoamerica, Jovenes
   Profesores e Investigadores, Santander Universidades, Chile; Fondecyt
   Iniciacion, Comision National de Investigacion Cientifica y Tecnologica
   (CONICYT), Chile, grant 11161020; Programa Nacional de Insercion de
   Capital Humano Avanzado en la Academia, PAI-CONICYT, Chile, grant
   PAI79170021; Fondo de Financiamiento de Centro de Investigacion en Areas
   Prioritarias (FONDAP), CONICYT, grant 15130011; Programa de Bienes
   Publicos Estrategicos para la Competitividad, Corporacion de Fomento de
   la Produccion (CORFO), Chile, grant 16BPE-62321; Subsidio Semilia de
   Asignacion Flexible (SSAF), CORFO, grant 14-SSAF-27061-9; and Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil, grant
   12/19278-6. RAC received a PhD fellowship from Vicerrectoria de
   Investigation, Universidad Mayor, Chile..
CR Aguiar RR, GENET MOL RES, V15
   An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187
   CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.bi.55.070186.003123
   DANDEKAR T, 1995, TRENDS GENET, V11, P45, DOI 10.1016/S0168-9525(00)88996-9
   Eggenhofer F, 2016, NUCLEIC ACIDS RES, V44, P8433, DOI 10.1093/nar/gkw558
   Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081
   Hertel J, 2008, BIOINFORMATICS, V24, P158, DOI 10.1093/bioinformatics/btm464
   Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Machado-Lima A, 2008, J MATH BIOL, V56, P15, DOI 10.1007/s00285-007-0122-6
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   Mattei E, 2015, NUCLEIC ACIDS RES, V43, pW493, DOI 10.1093/nar/gkv489
   Mattick JS, 2010, AN ACAD BRAS CIENC, V82, P933, DOI 10.1590/S0001-37652010000400016
   Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063
   Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385
   Paschoal AR, 2012, RNA BIOL, V9, P274, DOI 10.4161/rna.19352
   Saetrom P, 2005, NUCLEIC ACIDS RES, V33, P3263, DOI 10.1093/nar/gki644
   Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316
   Torres F, 2017, DATABASE, V2017
   Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102
NR 21
TC 5
Z9 5
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD FEB 17
PY 2018
VL 19
AR 55
DI 10.1186/s12859-018-2052-2
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA FX3RQ
UT WOS:000425990400001
PM 29454313
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Caires, LC
   Goulart, E
   Melo, U
   Araujo, BSH
   Alvizi, L
   Schanoski, AS
   de Oliveira, DF
   Kobayashi, GS
   Griesi-Oliveira, K
   Musso, CM
   Amaral, M
   dasilva, LF
   Astray, RM
   Suarez-Patino, SF
   Ventini, DC
   da Silva, SG
   Yamamoto, GL
   Ezquina, S
   Naslavsky, MS
   Silva, KTA
   Weinmann, K
   Van der Linden, V
   Van der Linden, H
   de Oliveira, JMR
   Arrais, NRM
   Melo, A
   Figueiredo, T
   Santos, S
   Meira, JCG
   Passos, SD
   de Almeida, RP
   Bispo, AJ
   Cavalheiro, E
   Kalil, J
   Cunha-Neto, E
   Nakaya, H
   Santos, RA
   Ferreira, LCD
   Verjovski-Almeida, S
   Ho, PL
   Passos-Bueno, MR
   Zatz, M
AF de Caires, Luiz Carlos, Jr.
   Goulart, Ernesto
   Melo, UiraSouto
   Henrique Araujo, Bruno Silva
   Alvizi, Lucas
   Schanoski, Alessandra Soares
   de Oliveira, Danyllo Felipe
   Kobayashi, Gerson Shigeru
   Griesi-Oliveira, Karina
   Musso, Camila Manso
   Amaral, MuriloSena
   dasilva, Lucas Ferreira
   Astray, Renato Mancini
   Suarez-Patino, Sandra Fernanda
   Ventini, Daniella Cristina
   da Silva, Sergio Gomes
   Yamamoto, Guilherme Lopes
   Ezquina, Suzana
   Naslavsky, Michel Satya
   Alves Silva, Kayque Telles
   Weinmann, Karina
   Van der Linden, Vanessa
   Van der Linden, Helio
   Ricardo de Oliveira, Joao Mendes
   Maria Arrais, Nivia Rodrigues
   Melo, Adriana
   Figueiredo, Thalita
   Santos, Silvana
   Goes Meira, Joanna Castro
   Passos, Saulo Duarte
   de Almeida, Roque Pacheco
   Bispo, Ana JovinaBarreto
   Cavalheiro, EsperAbrao
   Kalil, Jorge
   Cunha-Neto, Edecio
   Nakaya, Helder
   Santos, Robert Andreata
   de Souza Ferreira, Luis Carlos
   Verjovski-Almeida, Sergio
   Ho, Paulo Lee
   Passos-Bueno, Maria Rita
   Zatz, Mayana
TI Discordant congenital Zika syndrome twins show differential in vitro
   viral susceptibility of neural progenitor cells
SO NATURE COMMUNICATIONS
LA English
DT Article
ID VIRUS-INFECTION; STEM-CELLS; MENTAL-RETARDATION; GENETIC-VARIANTS;
   SEQUENCING DATA; ASSOCIATION; IDENTIFICATION; FLAVIVIRUSES; INTEGRATION;
   EXPRESSION
AB Congenital Zika syndrome (CZS) causes early brain development impairment by affecting neural progenitor cells (NPCs). Here, we analyze NPCs from three pairs of dizygotic twins discordant for CZS. We compare by RNA-Seq the NPCs derived from CZS-affected and CZS-unaffected twins. Prior to Zika virus (ZIKV) infection the NPCs from CZS babies show a significantly different gene expression signature of mTOR and Wnt pathway regulators, key to a neurodevelopmental program. Following ZIKV in vitro infection, cells from affected individuals have significantly higher ZIKV replication and reduced cell growth. Whole-exome analysis in 18 affected CZS babies as compared to 5 unaffected twins and 609 controls excludes a monogenic model to explain resistance or increased susceptibility to CZS development. Overall, our results indicate that CZS is not a stochastic event and depends on NPC intrinsic susceptibility, possibly related to oligogenic and/or epigenetic mechanisms.
C1 [de Caires, Luiz Carlos, Jr.; Goulart, Ernesto; Melo, UiraSouto; Alvizi, Lucas; de Oliveira, Danyllo Felipe; Kobayashi, Gerson Shigeru; Griesi-Oliveira, Karina; Musso, Camila Manso; Yamamoto, Guilherme Lopes; Ezquina, Suzana; Naslavsky, Michel Satya; Alves Silva, Kayque Telles; Weinmann, Karina; Figueiredo, Thalita; Passos-Bueno, Maria Rita; Zatz, Mayana] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
   [Henrique Araujo, Bruno Silva] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.
   [Henrique Araujo, Bruno Silva; Cavalheiro, EsperAbrao] Fed Univ Sao Paulo Univ UNIFESP EPM, Dept Neurol & Neurosurg, Neurosci Lab, BR-04039002 Sao Paulo, SP, Brazil.
   [Schanoski, Alessandra Soares; Amaral, MuriloSena; Astray, Renato Mancini; Suarez-Patino, Sandra Fernanda; Ventini, Daniella Cristina; Kalil, Jorge; Verjovski-Almeida, Sergio; Ho, Paulo Lee] Butantan Inst, BR-05503900 Sao Paulo, SP, Brazil.
   [Griesi-Oliveira, Karina; da Silva, Sergio Gomes] Albert Einstein Hosp, BR-05652900 Sao Paulo, SP, Brazil.
   [dasilva, Lucas Ferreira; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Chem, Dept Biochem, BR-05508900 Sao Paulo, SP, Brazil.
   [da Silva, Sergio Gomes] Univ Mogi das Cruzes, BR-08780911 Mogi Das Cruzes, SP, Brazil.
   [Van der Linden, Vanessa] AACD, BR-50080810 Recife, PE, Brazil.
   [Van der Linden, Helio] Rehabil Ctr Dr Henrique Santillo, BR-74653230 Goiania, Go, Brazil.
   [Ricardo de Oliveira, Joao Mendes] Fed Univ Pernambuco UFPE, Neuropsychiat Dept, BR-50670901 Recife, PE, Brazil.
   [Ricardo de Oliveira, Joao Mendes] Fed Univ Pernambuco UFPE, KeizoAsami Lab, BR-50670901 Recife, PE, Brazil.
   [Maria Arrais, Nivia Rodrigues] Fed Univ Rio Grande Norte UFRN, Dept Pediat, BR-59010180 Natal, RN, Brazil.
   [Melo, Adriana] ISEA, BR-58400220 Campina Grande, PB, Brazil.
   [Figueiredo, Thalita] Paraiba State Univ UEPB, Dept Biol, BR-58429500 Campina Grande, PB, Brazil.
   [Goes Meira, Joanna Castro] Fed Univ Bahia UFBA, BR-40170115 Salvador, BA, Brazil.
   [Passos, Saulo Duarte] Med Sch Jundiai, Infect Pediat Lab, BR-13202550 Jundiai, SP, Brazil.
   [de Almeida, Roque Pacheco; Bispo, Ana JovinaBarreto] Fed Univ Sergipe UFS, Div Immunol, BR-49100000 Aracaju, SP, Brazil.
   [de Almeida, Roque Pacheco; Bispo, Ana JovinaBarreto] Fed Univ Sergipe UFS, Mol Biol Lab, BR-49100000 Aracaju, SP, Brazil.
   [Cunha-Neto, Edecio] Univ Sao Paulo, Fac Med, Heart Inst, BR-05403900 Sao Paulo, SP, Brazil.
   [Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508900 Sao Paulo, SP, Brazil.
   [Santos, Robert Andreata; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Vaccine Dev Lab, BR-05508900 Sao Paulo, SP, Brazil.
RP Zatz, M (corresponding author), Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508900 Sao Paulo, SP, Brazil.
EM mayazatz@usp.br
RI Araujo, Bruno/B-8741-2013; Astray, Renato Mancini/N-6627-2013;
   Naslavsky, Michel/L-1772-2015; Verjovski-Almeida, Sergio/AAI-2728-2020;
   Goulart, Ernesto/AAC-3713-2020; Araujo, Bruno/P-9975-2019; Cunha-Neto,
   Edecio/B-4157-2009; Zatz, Mayana/M-5338-2015; Passos-Bueno, Maria
   Rita/I-6796-2016; Cavalheiro, Esper A/I-3084-2016; KALIL,
   JORGE/C-8029-2012; Melo, Adriana S O/H-5650-2016; Kobayashi, Gerson
   Shigeru/AAB-9113-2019; Naslavsky, Michel/U-6595-2019; Schanoski,
   Alessandra/H-8144-2014; Amaral, Murilo S/G-5769-2013; Nakaya, Helder
   I/A-1397-2010; Kobayashi, Gerson/H-4017-2013; Verjovski-Almeida,
   Sergio/E-4082-2012; Nakaya, Helder/AAF-1738-2020; da Silva, Sergio
   Gomes/F-1847-2013; Santos, Silvana/ABF-5893-2020; Passos,
   Saulo/C-5166-2012
OI Araujo, Bruno/0000-0003-0012-4217; Astray, Renato
   Mancini/0000-0002-6983-5298; Naslavsky, Michel/0000-0002-9068-1713;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Araujo,
   Bruno/0000-0003-0012-4217; Cunha-Neto, Edecio/0000-0002-3699-3345; Zatz,
   Mayana/0000-0003-3970-8025; Passos-Bueno, Maria
   Rita/0000-0002-9248-3008; Cavalheiro, Esper A/0000-0002-0854-3582;
   KALIL, JORGE/0000-0001-8415-4274; Kobayashi, Gerson
   Shigeru/0000-0002-6520-5774; Schanoski, Alessandra/0000-0002-6514-8458;
   Nakaya, Helder I/0000-0001-5297-9108; Kobayashi,
   Gerson/0000-0002-6520-5774; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Nakaya, Helder/0000-0001-5297-9108; da
   Silva, Sergio Gomes/0000-0002-9650-809X; Santos,
   Silvana/0000-0002-5252-0206; Andreata-Santos,
   Robert/0000-0002-4506-3756; VAN DER LINDEN JUNIOR,
   HELIO/0000-0002-3123-2264; Goulart, Ernesto/0000-0001-9526-8701;
   Alexandrasmello@gmail.com, Alexandra/0000-0002-7996-873X; Alves Telles
   Silva, Kayque/0000-0002-2994-609X; Passos, Saulo/0000-0002-0908-2677
FU FAPESP (CEPID)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2013/08028-1]; FAPESP (INCT) [14/50931-3]; FAPESP (Thematic
   grant) [2014/03620-2]; CNPq (INCT)National Council for Scientific and
   Technological Development (CNPq) [465355/2014-5]; AACD (Recife-PE);
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [440770/2016-5]
FX This study was supported by grants from FAPESP (CEPID number
   2013/08028-1 and INCT number 14/50931-3 to M.Z. and Thematic grant
   number 2014/03620-2 to S.V.-A.) and CNPq (INCT number 465355/2014-5 to
   M.Z.); Luiz Carlos de Caires Junior is a fellow of FAPESP
   (2017/16283-2); Ernesto Goulart is a fellow of FAPESP (2015/14821-1);
   Bruno Araujo is a fellow of FAPESP (2014/08049-1); Vanessa van der
   Linden Mota is supported by AACD (Recife-PE); Joao Ricardo de Oliveira
   is supported by CNPq (440770/2016-5). We are extremely grateful to Dr.
   S. Raia, D. Bertola, M. Vibranoski, P. Cunha, E.L. Durigon, W. Cumpady,
   P. Zanotto, C.R.S. Maia, A.N. Melo, M.T.A.L. Bezerra, D.A.M. de Araujo,
   A. Tanuri, R.S. de Aguiar, and T.R. Gollop for scientific discussions
   and sample collections. L. Suzuki and E. Amaro-Junior for helping with
   CT analysis. N. Lourenco, and M. Aguena for technical support in exome
   sequencing and MLPA assay.
CR Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Araujo B. H. S., 2017, MOL NEUROBIOL
   Barbier A, 2013, PEDIATRICS, V131, pE1158, DOI 10.1542/peds.2011-3846
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109
   Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Alves RPD, 2016, CLIN VACCINE IMMUNOL, V23, P460, DOI 10.1128/CVI.00081-16
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Homem CCF, 2015, NAT REV NEUROSCI, V16, P647, DOI 10.1038/nrn4021
   Hou PS, 2013, NUCLEIC ACIDS RES, V41, P7753, DOI 10.1093/nar/gkt567
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089
   Jehee FS, 2011, EUR J MED GENET, V54, pE425, DOI 10.1016/j.ejmg.2011.03.007
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Joubert PE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005091
   Kassai H, 2014, CELL REP, V7, P1626, DOI 10.1016/j.celrep.2014.04.048
   Kortum F, 2011, J MED GENET, V48, P396, DOI 10.1136/jmg.2010.087528
   Kumamoto T, 2017, DEV GROWTH DIFFER, V59, P258, DOI 10.1111/dgd.12367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293
   Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 45
TC 11
Z9 12
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD FEB 2
PY 2018
VL 9
AR 475
DI 10.1038/s41467-017-02790-9
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU7VL
UT WOS:000424060700001
PM 29396410
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ferreira, LRP
   Ferreira, FM
   Laugier, L
   Cabantous, S
   Navarro, IC
   Candido, DD
   Rigaud, VC
   Real, JM
   Pereira, GV
   Pereira, IR
   Ruivo, L
   Pandey, RP
   Savoia, M
   Kalil, J
   Lannes-Vieira, J
   Nakaya, H
   Chevillard, C
   Cunha-Neto, E
AF Pinto Ferreira, Ludmila Rodrigues
   Ferreira, Frederico Moraes
   Laugier, Laurie
   Cabantous, Sandrine
   Navarro, Isabela Cunha
   Candido, Darlan da Silva
   Rigaud, Vagner Carvalho
   Real, Juliana Monte
   Pereira, Glaucia Vilar
   Pereira, Isabela Resende
   Ruivo, Leonardo
   Pandey, Ramendra Pati
   Savoia, Marilda
   Kalil, Jorge
   Lannes-Vieira, Joseli
   Nakaya, Helder
   Chevillard, Christophe
   Cunha-Neto, Edecio
TI Integration of miRNA and gene expression profiles suggest a role for
   miRNAs in the pathobiological processes of acute Trypanosoma cruzi
   infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TISSUE-DAMAGE CONTROL; CHAGAS-DISEASE; INTERFERON-GAMMA; MESSENGER-RNA;
   IFN-GAMMA; MICRORNAS; CARDIOMYOPATHY; NRF2; GLOBALIZATION; DEFICIENCY
AB Chagas disease, caused by the parasite Trypanosoma cruzi, is endemic in Latin America. Its acute phase is associated with high parasitism, myocarditis and profound myocardial gene expression changes. A chronic phase ensues where 30% develop severe heart lesions. Mouse models of T. cruzi infection have been used to study heart damage in Chagas disease. The aim of this study was to provide an interactome between miRNAs and their targetome in Chagas heart disease by integrating gene and microRNA expression profiling data from hearts of T. cruzi infected mice. Gene expression profiling revealed enrichment in biological processes and pathways associated with immune response and metabolism. Pathways, functional and upstream regulator analysis of the intersections between predicted targets of differentially expressed microRNAs and differentially expressed mRNAs revealed enrichment in biological processes and pathways such as IFN gamma, TNF alpha, NF-kappa B signaling signatures, CTL-mediated apoptosis, mitochondrial dysfunction, and Nrf2-modulated antioxidative responses. We also observed enrichment in other key heart disease-related processes like myocarditis, fibrosis, hypertrophy and arrhythmia. Our correlation study suggests that miRNAs may be implicated in the pathophysiological processes taking place the hearts of acutely T. cruzi-infected mice.
C1 [Pinto Ferreira, Ludmila Rodrigues; Ferreira, Frederico Moraes; Navarro, Isabela Cunha; Candido, Darlan da Silva; Rigaud, Vagner Carvalho; Pandey, Ramendra Pati; Savoia, Marilda; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Immunol, Sao Paulo, Brazil.
   [Pinto Ferreira, Ludmila Rodrigues; Navarro, Isabela Cunha; Candido, Darlan da Silva; Rigaud, Vagner Carvalho; Pandey, Ramendra Pati; Savoia, Marilda; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
   [Pinto Ferreira, Ludmila Rodrigues; Ferreira, Frederico Moraes; Navarro, Isabela Cunha; Candido, Darlan da Silva; Rigaud, Vagner Carvalho; Pandey, Ramendra Pati; Savoia, Marilda; Kalil, Jorge; Cunha-Neto, Edecio] Iii INCT, Inst Invest Immunol, Sao Paulo, Brazil.
   [Pinto Ferreira, Ludmila Rodrigues] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil.
   [Laugier, Laurie; Cabantous, Sandrine; Chevillard, Christophe] Aix Marseille Univ, INSERM, Fac Med, U1108, Marseille, France.
   [Real, Juliana Monte] Santa Marcelina Hosp, Dept Pediat Oncol, TUCCA Assoc Children & Adolescents Canc, Sao Paulo, Brazil.
   [Real, Juliana Monte] Univ Sao Paulo, Inst Canc Estado Sao Paulo, Ctr Invest Translac Oncol, Sao Paulo, Brazil.
   [Pereira, Glaucia Vilar; Pereira, Isabela Resende; Ruivo, Leonardo; Lannes-Vieira, Joseli] Fiocruz MS, Oswaldo Cruz Inst, Lab Biol Interact, Rio De Janeiro, Brazil.
   [Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-077010 Sao Paulo, Brazil.
   [Nakaya, Helder] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Chevillard, Christophe] Aix Marseille Univ, UMR1090, INSERM, Parc Sci Luminy Case 928,163 Ave Luminy, Marseille, France.
RP Ferreira, LRP (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Immunol, Sao Paulo, Brazil.; Ferreira, LRP (corresponding author), Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.; Ferreira, LRP (corresponding author), Iii INCT, Inst Invest Immunol, Sao Paulo, Brazil.; Ferreira, LRP (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil.; Chevillard, C (corresponding author), Aix Marseille Univ, INSERM, Fac Med, U1108, Marseille, France.; Chevillard, C (corresponding author), Aix Marseille Univ, UMR1090, INSERM, Parc Sci Luminy Case 928,163 Ave Luminy, Marseille, France.
EM lucamargo@gmail.com; christophe.chevillard@univ-amu.fr
RI chevillard, christophe/A-7087-2015; Navarro, Isabela Cunha/V-7182-2017;
   Rigaud, Vagner Oliveira Carvalho/I-4124-2013; KALIL, JORGE/C-8029-2012;
   Ferreira, Ludmila Rodrigues Pinto/B-4955-2015; Nakaya,
   Helder/AAF-1738-2020; Cunha-Neto, Edecio/B-4157-2009; Ferreira,
   Frederico Moraes/A-4622-2013; Nakaya, Helder I/A-1397-2010
OI chevillard, christophe/0000-0002-5269-8813; Navarro, Isabela
   Cunha/0000-0002-6844-2361; Rigaud, Vagner Oliveira
   Carvalho/0000-0002-1194-9380; KALIL, JORGE/0000-0001-8415-4274;
   Ferreira, Ludmila Rodrigues Pinto/0000-0001-9944-6691; Nakaya,
   Helder/0000-0001-5297-9108; Cunha-Neto, Edecio/0000-0002-3699-3345;
   Nakaya, Helder I/0000-0001-5297-9108; Pandey,
   Ramendrapati/0000-0002-5196-6468; da Silva Candido,
   Darlan/0000-0002-5080-3130
FU Institut National de la Sante et de la Recherche Medicale
   (INSERM)Institut National de la Sante et de la Recherche Medicale
   (Inserm); Aix-Marseille University (Direction des Relations
   Internationales); USP-COFECUB; ARCUS II PACA; CNPq (Brazilian National
   Council for Scientific and Technological Development)National Council
   for Scientific and Technological Development (CNPq); FAPESP (Sao Paulo
   State Research Funding Agency-Brazil)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/50302-3]; plan << Laboratoire
   d'Excellence (LabEx) ParaFrap >> [ANR-11-LABX-0024]; French (Agence
   Nationale de Recherche-ANR)French National Research Agency (ANR);
   Brazilian (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by the Institut National de la Sante et de la
   Recherche Medicale (INSERM), Aix-Marseille University (Direction des
   Relations Internationales), the USP-COFECUB program, the ARCUS II PACA
   Bresil program, CNPq (the Brazilian National Council for Scientific and
   Technological Development), and FAPESP (Sao Paulo State Research Funding
   Agency-Brazil) << grant 2013/50302-3 >>. This work is supported by the
   plan << Laboratoire d'Excellence (LabEx) ParaFrap ANR-11-LABX-0024 >>.
   ECN and CC were recipients for an international program (Br-Fr-Chagas)
   funded by the French (Agence Nationale de Recherche-ANR) and the
   Brazilian (FAPESP) science funding agencies. ECN and JK are recipients
   of CNPq productivity awards.
CR Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Andrade DV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003010
   BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Cardoso MS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002369
   Carod-Artal FJ, 2009, NEUROLOGIA, V24, P431
   Castaldi A, 2014, CIRC RES, V115, P273, DOI 10.1161/CIRCRESAHA.115.303252
   Cheng XH, 2013, FREE RADICAL BIO MED, V64, P4, DOI 10.1016/j.freeradbiomed.2013.07.025
   Chistiakov DA, 2016, J MOL CELL CARDIOL, V94, P107, DOI 10.1016/j.yjmcc.2016.03.015
   Coura J. R., 2014, MEM I O CRUZ
   Cunha-Neto E, 2005, AM J PATHOL, V167, P305, DOI 10.1016/S0002-9440(10)62976-8
   Cunha-Neto E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/683230
   Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Ferreira LRP, 1999, J LEUKOCYTE BIOL, V66, P593
   Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475
   Garg N, 2003, BBA-MOL BASIS DIS, V1638, P106, DOI 10.1016/S0925-4439(03)00060-7
   Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365
   Healy Chris, 2015, Card Electrophysiol Clin, V7, P251, DOI 10.1016/j.ccep.2015.03.016
   Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498
   Hua YN, 2012, J CELL MOL MED, V16, P83, DOI 10.1111/j.1582-4934.2011.01307.x
   Kalil R, 2015, J AM COLL CARDIOL, V66, P1190, DOI 10.1016/j.jacc.2015.07.024
   Katz MG, 2016, AM J PHYSIOL-HEART C, V310, pH528, DOI 10.1152/ajpheart.00181.2015
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Keating SM, 2015, INT J CARDIOL, V199, P451, DOI 10.1016/j.ijcard.2015.07.040
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999
   Mensah GA, 2015, GLOB HEART, V10, P203, DOI 10.1016/j.gheart.2015.08.001
   Min PK, 2015, EUR J CLIN INVEST, V45, P860, DOI 10.1111/eci.12475
   Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016
   Mukherjee S, 2003, PARASITOL RES, V91, P187, DOI 10.1007/s00436-003-0937-z
   Muraoka N, 2014, EMBO J, V33, P1565, DOI 10.15252/embj.201387605
   Navarro IC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003828
   Nogueira LG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/914326
   Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688
   Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525
   Pall ML, 2013, INT J MOL SCI, V14, P22274, DOI 10.3390/ijms141122274
   Perez-Molina JA, 2015, LANCET INFECT DIS, V15, P1347, DOI 10.1016/S1473-3099(15)00243-1
   Dias JCP, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/789758
   Ferreira LRP, 2014, WORLD J CARDIOL, V6, P782, DOI 10.4330/wjc.v6.i8.782
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Ropert C, 2002, MICROBES INFECT, V4, P1015, DOI 10.1016/S1286-4579(02)01609-X
   Satoh M, 2010, J CARD FAIL, V16, P404, DOI 10.1016/j.cardfail.2010.01.002
   Scalbert E, 2008, CURR OPIN PHARMACOL, V8, P181, DOI 10.1016/j.coph.2007.12.013
   Seeger T, 2016, J PHYSIOL-LONDON, V594, P2085, DOI 10.1113/JP270557
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Soares MP, 2015, BIOCHEM SOC T, V43, P663, DOI 10.1042/BST20150054
   Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001
   Soares MBP, 2011, CELL CYCLE, V10, P1448, DOI 10.4161/cc.10.9.15487
   Stephanou A, 2000, J BIOL CHEM, V275, P10002, DOI 10.1074/jbc.275.14.10002
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Talvani A, 2000, MICROBES INFECT, V2, P851, DOI 10.1016/S1286-4579(00)00388-9
   Tanowitz HB, 2015, EXPERT REV CARDIOVAS, V13, P1393, DOI 10.1586/14779072.2015.1103648
   Teixeira PC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001205
   Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156
   Urbina JA, 2016, NEW ENGL J MED, V374, P189, DOI 10.1056/NEJMc1514453
   Vannucchi V, 2015, J CARDIOVASC MED, V16, P817, DOI 10.2459/JCM.0000000000000045
   Wan XX, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005954
   Wan XX, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003855
   Yu H, 2014, CURR DRUG TARGETS, V15, P817
NR 61
TC 8
Z9 8
U1 1
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 21
PY 2017
VL 7
AR 17990
DI 10.1038/s41598-017-18080-9
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FQ7SE
UT WOS:000418562100030
PM 29269773
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Prow, NA
   Tang, B
   Gardner, J
   Le, TT
   Taylor, A
   Poo, YS
   Nakayama, E
   Hirata, TDC
   Nakaya, HI
   Slonchak, A
   Mukhopadhyay, P
   Mahalingam, S
   Schroder, WA
   Klimstra, W
   Suhrbier, A
AF Prow, Natalie A.
   Tang, Bing
   Gardner, Joy
   Le, Thuy T.
   Taylor, Adam
   Poo, Yee S.
   Nakayama, Eri
   Hirata, Thiago D. C.
   Nakaya, Helder I.
   Slonchak, Andrii
   Mukhopadhyay, Pamela
   Mahalingam, Suresh
   Schroder, Wayne A.
   Klimstra, William
   Suhrbier, Andreas
TI Lower temperatures reduce type I interferon activity and promote
   alphaviral arthritis
SO PLOS PATHOGENS
LA English
DT Article
ID HEMORRHAGIC SEPTICEMIA VIRUS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED
   PROTEIN RESPONSE; COMMON COLD VIRUS; CHIKUNGUNYA VIRUS; VIRAL
   REPLICATION; AEDES-ALBOPICTUS; INNATE IMMUNITY; MOUSE MODEL; RIG-I
AB Chikungunya virus (CHIKV) belongs to a group of mosquito-borne alphaviruses associated with acute and chronic arthropathy, with peripheral and limb joints most commonly affected. Using a mouse model of CHIKV infection and arthritic disease, we show that CHIKV replication and the ensuing foot arthropathy were dramatically reduced when mice were housed at 30 degrees C, rather than the conventional 22 degrees C. The effect was not associated with a detectable fever, but was dependent on type I interferon responses. Bioinformatics analyses of RNA-Seq data after injection of poly(I:C)/jetPEI suggested the unfolded protein response and certain type I interferon responses are promoted when feet are slightly warmer. The ambient temperature thus appears able profoundly to effect anti-viral activity in the periphery, with clear consequences for alphaviral replication and the ensuing arthropathy. These observations may provide an explanation for why alphaviral arthropathies are largely restricted to joints of the limbs and the extremities.
C1 [Prow, Natalie A.; Tang, Bing; Gardner, Joy; Le, Thuy T.; Poo, Yee S.; Nakayama, Eri; Hirata, Thiago D. C.; Mukhopadhyay, Pamela; Schroder, Wayne A.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Prow, Natalie A.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
   [Taylor, Adam; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Gold Coast, NSW, Australia.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan.
   [Hirata, Thiago D. C.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Slonchak, Andrii] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.
   [Klimstra, William] Univ Pittsburgh, Dept Microbiol & Mol Genet, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Suhrbier, A (corresponding author), Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
EM Andreas.Suhrbier@qimrberghofer.edu.au
RI Nakaya, Helder/AAF-1738-2020; Hirata, Thiago Dominguez
   Crespo/AAP-1903-2020; Nakaya, Helder I/A-1397-2010; Slonchak,
   Andrii/Y-4162-2019
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Slonchak, Andrii/0000-0003-3258-0508; Taylor,
   Adam/0000-0002-7159-3961; Hirata, Thiago/0000-0002-3967-8121
FU National Health and Medical Research Council (NHMRC) of
   AustraliaNational Health and Medical Research Council of Australia
   [APP1078468]; Australian Infectious Disease Research Center;
   NHMRCNational Health and Medical Research Council of Australia;
   Queensland Government; Daiichi Sankyo Foundation of Life Science; FAPESP
   (Sao Paulo Research Foundation)Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP); Queensland Tropical Health Alliance; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI095436, R01AI095436, R01AI095436, R01AI095436, R01AI095436,
   R01AI095436, R01AI095436] Funding Source: NIH RePORTER
FX The work was supported by a project grant from the National Health and
   Medical Research Council (NHMRC) of Australia (APP1078468) and
   intramural seed funding from the Australian Infectious Disease Research
   Center. AS hold a Principle Research Fellowship from the NHMRC. NAP was
   supported in part by an Advance Queensland Research Fellowship from the
   Queensland Government. EN was supported in part by the Daiichi Sankyo
   Foundation of Life Science. TDCH was supported by FAPESP (Sao Paulo
   Research Foundation). BSL3 equipment was funded by the Queensland
   Tropical Health Alliance (www.qtha.org.au), and donations from Prof Ed
   Westaway (Royal Australian Air Force Association) and Dr Jim Aylward
   (Oncolin Pty Ltd). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdelnabi R, 2017, ANTIVIRAL RES
   Adebajo AO, 1996, BRIT J RHEUMATOL, V35, P909
   Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239
   Avunje S, 2013, FISH SHELLFISH IMMUN, V34, P1236, DOI 10.1016/j.fsi.2013.02.012
   Avunje S, 2012, FISH SHELLFISH IMMUN, V32, P1162, DOI 10.1016/j.fsi.2012.03.025
   Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113
   Beisel C, 2017, CYTOKINE, V94, P55, DOI 10.1016/j.cyto.2017.04.006
   Bhattacharyya S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00292
   Boonarkart C, 2017, ARCH VIROL
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   BUCKLER CE, 1971, P SOC EXP BIOL MED, V136, P394
   Cannon JG, 2013, COMPLEMENT THER MED, V21, pS54, DOI 10.1016/j.ctim.2011.08.002
   Cho JA, 2013, CELL HOST MICROBE, V13, P558, DOI 10.1016/j.chom.2013.03.011
   Clavarino G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002708
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Dalet A, 2017, EMBO J, V36, P761, DOI 10.15252/embj.201695000
   David RYS, 2016, ELIFE, V5, DOI 10.7554/eLife.11275
   De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784
   Deal DN, 2002, J BONE JOINT SURG AM, V84A, P1573, DOI 10.2106/00004623-200209000-00009
   Disanto G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034866
   Earn DJD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2570
   Elsinga J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005987
   Foxman EF, 2016, P NATL ACAD SCI USA, V113, P8496, DOI 10.1073/pnas.1601942113
   Foxman EF, 2015, P NATL ACAD SCI USA, V112, P827, DOI 10.1073/pnas.1411030112
   Fros JJ, 2015, J GEN VIROL, V96, P580, DOI 10.1099/vir.0.071845-0
   GAHLINGER PM, 1986, AM J TROP MED HYG, V35, P601, DOI 10.4269/ajtmh.1986.35.601
   Galluzzi L, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0020
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Goh LYH, 2015, J GEN VIROL, V96, P507, DOI 10.1099/jgv.0.000002
   Golden J, 2010, NURS HIST REV, V18, P189, DOI 10.1891/1062-8061.18.189
   Gunes UY, 2008, J CLIN NURS, V17, P2284, DOI 10.1111/j.1365-2702.2007.02272.x
   Gustin KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125874
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Holland R, 2013, AUST FAM PHYSICIAN, V42, P770
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Hu FL, 2011, EUR J IMMUNOL, V41, P1086, DOI 10.1002/eji.201040831
   Hugo LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1838-1
   HUSSEINI RH, 1982, J INFECT DIS, V145, P520, DOI 10.1093/infdis/145.4.520
   Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005
   Ikaheimo TM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090244
   Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Konig I, 2015, NAT METHODS, V12, P773, DOI [10.1038/nmeth.3475, 10.1038/NMETH.3475]
   Kokolus KM, 2013, P NATL ACAD SCI USA, V110, P20176, DOI 10.1073/pnas.1304291110
   KRAMER MS, 1991, LANCET, V337, P591, DOI 10.1016/0140-6736(91)91648-E
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Labzin LI, 2015, J IMMUNOL, V195, P4446, DOI 10.4049/jimmunol.1500204
   Lamech LT, 2015, J CELL BIOL, V209, P781, DOI 10.1083/jcb.201503107
   Lancaster KZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000791
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Lencer WI, 2015, TRENDS IMMUNOL, V36, P401, DOI 10.1016/j.it.2015.05.006
   LEPOCK JR, 1993, J CELL BIOL, V122, P1267, DOI 10.1083/jcb.122.6.1267
   Li T, 2017, FISH SHELLFISH IMMUN, V67, P667, DOI 10.1016/j.fsi.2017.06.055
   Liu YP, 2012, J IMMUNOL, V189, P4630, DOI 10.4049/jimmunol.1102737
   Long Kristin M, 2015, Curr Trop Med Rep, V2, P13
   Lu SH, 2010, J CLIN NURS, V19, P4, DOI 10.1111/j.1365-2702.2009.02945.x
   Magnusson M, 2006, ARTHRITIS RHEUM-US, V54, P148, DOI 10.1002/art.21517
   Martinon F., 2017, JOINT BONE SPINE
   McCarthy MK, 2017, CURR OPIN VIROL
   Mimuro J, 1991, Rinsho Ketsueki, V32, P487
   Morrison CR, 2016, MICROBIOL SPECTR, P4
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Mylonas AD, 2002, MED J AUSTRALIA, V177, P356, DOI 10.5694/j.1326-5377.2002.tb04837.x
   Oppewal S R, 1997, Image J Nurs Sch, V29, P83
   Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195
   Perera N, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12734
   Pincus D, 2017, CURR GENET, V63, P175, DOI 10.1007/s00294-016-0638-7
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682
   Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x
   Ryti NRI, 2016, ENVIRON HEALTH PERSP, V124, P12, DOI 10.1289/ehp.1408104
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Savan R, 2014, J INTERF CYTOK RES, V34, P318, DOI 10.1089/jir.2013.0117
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Scroggie DA, 2000, J RHEUMATOL, V27, P2444
   Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009
   Shi L, 2007, CLIN PHARMACOL THER, V81, P259, DOI 10.1038/sj.clpt.6100055
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E
   Solet J. L., 2007, PLOS BIOL, V77, P727
   Soonthornvacharin S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.22
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005
   Sun H., 2017, MULT SCLER
   Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540
   Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579
   Talbot FB, 1931, AM J DIS CHILD, V42, P965
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   TINGLE AJ, 1983, INFECT IMMUN, V40, P22, DOI 10.1128/IAI.40.1.22-28.1983
   Truttmann MC, 2017, P NATL ACAD SCI USA, V114, pE152, DOI 10.1073/pnas.1619234114
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052
   Zhang JL, 2017, FISH SHELLFISH IMMUN, V68, P260, DOI 10.1016/j.fsi.2017.07.029
   Zhao J, 2016, CONSERV GENET RESOUR, V8, P17, DOI 10.1007/s12686-015-0514-7
NR 110
TC 16
Z9 16
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD DEC
PY 2017
VL 13
IS 12
AR e1006788
DI 10.1371/journal.ppat.1006788
PG 25
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA FR4EZ
UT WOS:000419019800034
PM 29281739
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Oliveira, EA
   de Lima, DS
   Cardozo, LE
   de Souza, GF
   de Souza, N
   Alves-Fernandes, DK
   Faiao-Flores, F
   Quincoces, JAP
   Barros, SBD
   Nakaya, HI
   Monteiro, G
   Maria-Engler, SS
AF de Oliveira, Erica Aparecida
   de Lima, Diogenes Saulo
   Cardozo, Lucas Esteves
   de Souza, Garcia Ferreira
   de Souza, Nayane
   Alves-Fernandes, Debora Kristina
   Faiao-Flores, Fernanda
   Pablo Quincoces, Jose Agustin
   de Moraes Barros, Silvia Berlanga
   Nakaya, Helder I.
   Monteiro, Gisele
   Maria-Engler, Silvya Stuchi
TI Toxicogenomic and bioinformatics platforms to identify key molecular
   mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Curcumin-analogue; DM-1; Toxicogenomic; Bioinformatics; Melanoma; TOP1;
   ADK
ID PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; ADENOSINE KINASE;
   TOPOISOMERASE-I; BREAST-CANCER; INHIBITOR RESISTANCE; ANOXIC
   HEPATOCYTES; COLORECTAL-CANCER; DRUG-RESISTANCE; GENE-EXPRESSION;
   DOWN-REGULATION
AB Melanoma is a highly invasive and metastatic cancer with high mortality rates and chemoresistance. Around 50% of melanomas are driven by activating mutations in BRAF that has led to the development of potent anti-BRAF inhibitors. However resistance to anti-BRAF therapy usually develops within a few months and consequently there is a need to identify alternative therapies that will bypass BRAF inhibitor resistance. The curcumin analogue DM-1 (sodium 4-[5-(4-hydroxy-3-methoxy-phenyl)-3-oxo-penta-1,4-dieny1]-2-methoxy-phenolate) has substantial anti-tumor activity in melanoma, but its mechanism of action remains unclear. Here we use a synthetic lethal genetic screen in Saccharomyces cerevisiae to identify 211 genes implicated in sensitivity to DM-1 toxicity. From these 211 genes, 74 had close human orthologues implicated in oxidative phosphorylation, insulin signaling and iron and RNA metabolism. Further analysis identified 7 target genes (ADIC, ATP6V0B, PEMT, TOP1, ZFP36, ZFP36L1, ZFP36L2) with differential expression during melanoma progression implicated in regulation of tumor progression, cell differentiation, and epithelial-mesenchymal transition. Of these TOP1 and ADK were regulated by DM-1 in treatment-naive and vemurafenib-resistant melanoma cells respectively. These data reveal that the anticancer effect of curcumin analogues is likely to be mediated via multiple targets and identify several genes that represent candidates for combinatorial targeting in melanoma. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [de Oliveira, Erica Aparecida; de Souza, Nayane; Alves-Fernandes, Debora Kristina; Faiao-Flores, Fernanda; de Moraes Barros, Silvia Berlanga; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Sch Pharmaceut Sci, Skin Biol Grp, Clin Chem & Toxicol Dept,FCF USP, Sao Paulo, Brazil.
   [de Lima, Diogenes Saulo; Cardozo, Lucas Esteves; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Computat Syst Biol Lab, FCF USP, Sao Paulo, Brazil.
   [de Souza, Garcia Ferreira; Pablo Quincoces, Jose Agustin] Anhanguera Univ Sao Paulo, Lab Organ Synth, UNIAN, Sao Paulo, Brazil.
   [Monteiro, Gisele] Univ Sao Paulo, Sch Pharmaceut Sci, Biochem Pharmaceut Technol Dept, FCF USP, Sao Paulo, Brazil.
RP Maria-Engler, SS (corresponding author), Univ Sao Paulo, Dept Clin Chem & Toxicol, Fac Pharmaceut Sci, 580 Prof Lineu Prestes Ave, BR-05508000 Sao Paulo, Brazil.
EM silvya@usp.br
RI Nakaya, Helder I/A-1397-2010; Alves-Fernandes, Debora
   Kristina/AAQ-3385-2020; Alves-Fernandes, Debora Kristina/AAC-5983-2019;
   Maria-Engler, Silvya/ABC-2016-2020; Monteiro, Gisele/E-5897-2012;
   Barros, Silvia B M/H-1090-2012; Faiao-Flores, Fernanda/F-7111-2012;
   Oliveira, Erica A/M-6305-2015; Barros, Silvia B M/K-6856-2014; Nakaya,
   Helder/AAF-1738-2020; Engler, Silvya Stuchi Maria/K-5936-2016
OI Nakaya, Helder I/0000-0001-5297-9108; Alves-Fernandes, Debora
   Kristina/0000-0002-0917-9292; Maria-Engler, Silvya/0000-0003-4771-6041;
   Monteiro, Gisele/0000-0002-3385-047X; Faiao-Flores,
   Fernanda/0000-0003-3449-9930; Oliveira, Erica A/0000-0002-1624-4021;
   Nakaya, Helder/0000-0001-5297-9108; Engler, Silvya Stuchi
   Maria/0000-0003-4771-6041
FU PNPD/CAPESCAPES; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2014/24400-0]
FX Pos-Doc Fellowship grant PNPD/CAPES and FAPESP grant (2014/24400-0).
CR Afshari CA, 2011, TOXICOL SCI, V120, pS225, DOI 10.1093/toxsci/kfq373
   Baenke F, 2016, MOL ONCOL, V10, P73, DOI 10.1016/j.molonc.2015.08.003
   Balabanov S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019164
   Boison D, 2013, PHARMACOL REV, V65, P906, DOI 10.1124/pr.112.006361
   BONTEMPS F, 1983, P NATL ACAD SCI-BIOL, V80, P2829, DOI 10.1073/pnas.80.10.2829
   BONTEMPS F, 1993, BIOCHEM J, V290, P671, DOI 10.1042/bj2900671
   BONTEMPS F, 1993, BIOCHEM J, V290, P679, DOI 10.1042/bj2900679
   Chen J., 2017, BIOMED RES INT, V2017
   Chen YL, 2013, MOL BIOL REP, V40, P2867, DOI 10.1007/s11033-012-2302-8
   Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029
   Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823
   de Sousa GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145377
   Faiao-Flores F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118702
   Faiao-Flores F, 2013, TUMOR BIOL, V34, P1119, DOI 10.1007/s13277-013-0653-y
   Faiao-Flores F, 2013, TUMOR BIOL, V34, P1235, DOI 10.1007/s13277-013-0666-6
   Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218
   Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620
   Giglioni S, 2008, NUCLEOS NUCLEOT NUCL, V27, P750, DOI 10.1080/15257770802145629
   Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   GOLDWASSER F, 1995, CANCER RES, V55, P2116
   Grob JJ, 2015, LANCET ONCOL, V16, P1389, DOI 10.1016/S1470-2045(15)00087-X
   Guerreiro A, 2012, AMYLOID, V19, P74, DOI 10.3109/13506129.2012.668500
   Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003
   Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003
   Hutton JE, 2016, MOL CELL PROTEOMICS, V15, P2924, DOI 10.1074/mcp.M116.058925
   Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770
   Kang HB, 2015, MOL CELL, V59, P345, DOI 10.1016/j.molcel.2015.05.037
   Kaushik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142443
   Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609
   Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lelli D, 2017, BIOMED PHARMACOTHER, V88, P832, DOI 10.1016/j.biopha.2017.01.078
   Li D, 2014, ONCOTARGET, V5, P1315, DOI 10.18632/oncotarget.1800
   Lin JR, 2009, JNCI-J NATL CANCER I, V101, P1423, DOI 10.1093/jnci/djp309
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loewe R, 2004, J INVEST DERMATOL, V123, P733, DOI 10.1111/j.0022-202X.2004.23402.x
   Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004
   Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645
   Meo-Evoli N, 2015, ONCOTARGET, V6, P28057, DOI 10.18632/oncotarget.4812
   Michaelis Martin, 2014, BMC Res Notes, V7, P710, DOI 10.1186/1756-0500-7-710
   Nagarajah J, 2015, J NUCL MED, V56, P662, DOI 10.2967/jnumed.114.150607
   Naniwa J, 2007, INT J GYNECOL CANCER, V17, P76, DOI 10.1111/j.1525-1438.2006.00752.x
   Navarro FJ, 2012, CURR OPIN CELL BIOL, V24, P833, DOI 10.1016/j.ceb.2012.10.015
   Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626
   Nguyen TA, 2013, J DRUGS DERMATOL, V12, P1131
   Nieves-Neira W, 1999, INT J CANCER, V82, P396, DOI 10.1002/(SICI)1097-0215(19990730)82:3<396::AID-IJC13>3.0.CO;2-Z
   Pal HC, 2016, MINI-REV MED CHEM, V16, P953, DOI 10.2174/1389557516666160211120157
   Paraiso KHT, 2013, BIOCHEM PHARMACOL, V85, P1033, DOI 10.1016/j.bcp.2013.01.018
   Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891
   Rao S, 2017, ONCOTARGET, V8, P37923, DOI 10.18632/oncotarget.13544
   Read J, 2016, J MED GENET, V53, P1, DOI 10.1136/jmedgenet-2015-103150
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122
   Ross CR, 2012, AGEING RES REV, V11, P473, DOI 10.1016/j.arr.2012.02.005
   Roth GN, 1998, J NAT PROD, V61, P542, DOI 10.1021/np970459f
   Rozzo C, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-37
   Ryan D, 2010, PIGM CELL MELANOMA R, V23, P542, DOI 10.1111/j.1755-148X.2010.00720.x
   Ryu J, 2015, MOL CELLS, V38, P156, DOI 10.14348/molcells.2015.2259
   Sandri S, 2016, PHARMACOL RES, V111, P523, DOI 10.1016/j.phrs.2016.07.017
   Seo JH, 2010, CANCER LETT, V288, P50, DOI 10.1016/j.canlet.2009.06.023
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009
   Siwak DR, 2005, CANCER-AM CANCER SOC, V104, P879, DOI 10.1002/cncr.21216
   Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005
   Tang C, 2011, LEUKEMIA LYMPHOMA, V52, P2139, DOI 10.3109/10428194.2011.591013
   Tessitore L, 2003, ONCOLOGY-BASEL, V65, P152, DOI 10.1159/000072341
   Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112
   Vanacloig-Pedros E, 2016, TOXINS, V8, DOI 10.3390/toxins8100273
   Vannoni D, 2004, NUCLEOS NUCLEOT NUCL, V23, P1455, DOI 10.1081/NCN-200027676
   Vannoni D, 2004, MED ONCOL, V21, P187, DOI 10.1385/MO:21:2:187
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Xu Y, 2015, BIOMOLECULES, V5, P1652, DOI 10.3390/biom5031652
   Yasokawa D, 2010, J BIOSCI BIOENG, V110, P511, DOI 10.1016/j.jbiosc.2010.06.003
   Yoon NA, 2016, ONCOTARGET, V7, P8931, DOI 10.18632/oncotarget.7094
   Yu T, 2013, BIOCHEM BIOPH RES CO, V441, P53, DOI 10.1016/j.bbrc.2013.10.008
   Yue X, 2017, BIOCHEM PHARMACOL, V137, P29, DOI 10.1016/j.bcp.2017.04.032
   Zhao M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134929
   Zinrajh D, 2014, ONCOL LETT, V7, P2175, DOI 10.3892/ol.2014.2035
NR 79
TC 10
Z9 10
U1 0
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
J9 PHARMACOL RES
JI Pharmacol. Res.
PD NOV
PY 2017
VL 125
BP 178
EP 187
DI 10.1016/j.phrs.2017.08.018
PN B
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FL3GH
UT WOS:000414110400008
PM 28882690
DA 2020-12-17
ER

PT J
AU Blohmke, CJ
   Hill, J
   Darton, TC
   Carvalho-Burger, M
   Eustace, A
   Jones, C
   Schreiber, F
   Goodier, MR
   Dougan, G
   Nakaya, HI
   Pollard, AJ
AF Blohmke, Christoph J.
   Hill, Jennifer
   Darton, Thomas C.
   Carvalho-Burger, Matheus
   Eustace, Andrew
   Jones, Claire
   Schreiber, Fernanda
   Goodier, Martin R.
   Dougan, Gordon
   Nakaya, Helder I.
   Pollard, Andrew J.
TI Induction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral
   Vaccines against Typhoid Fever
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE typhoid; typhoid vaccines; functional genomics; vaccine immunity; Ty21a;
   NK cell; cell cycle regulation
ID ENTERICA SEROVAR TYPHI; SALMONELLA PATHOGENICITY ISLAND-2;
   IMMUNE-RESPONSES; IMMUNIZATION; ANTIGEN; STRAIN; VACCINATION;
   PATHOGENESIS; ACTIVATION; REGULATORS
AB The mechanisms by which oral, live-attenuated vaccines protect against typhoid fever are poorly understood. Here, we analyze transcriptional responses after vaccination with Ty21a or vaccine candidate, M01ZH09. Alterations in response profiles were related to vaccine-induced immune responses and subsequent outcome after wild-type Salmonella Typhi challenge. Despite broad genetic similarity, we detected differences in transcriptional responses to each vaccine. Seven days after M01ZH09 vaccination, marked cell cycle activation was identified and associated with humoral immunogenicity. By contrast, vaccination with Ty21a was associated with NK cell activity and validated in peripheral blood mononuclear cell stimulation assays confirming superior induction of an NK cell response. Moreover, transcriptional signatures of amino acid metabolism in Ty21a recipients were associated with protection against infection, including increased incubation time and decreased severity. Our data provide detailed insight into molecular immune responses to typhoid vaccines, which could aid the rational design of improved oral, live-attenuated vaccines against enteric pathogens.
C1 [Blohmke, Christoph J.; Hill, Jennifer; Darton, Thomas C.; Eustace, Andrew; Jones, Claire; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, NIHR Oxford Biomed Res Ctr, Oxford, England.
   [Darton, Thomas C.] Univ Sheffield, Med Sch, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.
   [Carvalho-Burger, Matheus; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Schreiber, Fernanda; Dougan, Gordon] Wellcome Trust Sanger Inst, Microbial Pathogenesis Grp, Hinxton, England.
   [Goodier, Martin R.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London, England.
RP Darton, TC (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, NIHR Oxford Biomed Res Ctr, Oxford, England.; Darton, TC (corresponding author), Univ Sheffield, Med Sch, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.
EM thomas.darton@paediatrics.ox.ac.uk
RI Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020; Darton,
   Thomas/H-2816-2017
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Darton, Thomas/0000-0003-2209-9956; GOODIER,
   MARTIN/0000-0002-8963-4768
FU Wellcome Trust Strategic Translational Award [092661]; Emergent
   BioSolutions; Newton Fund through the Medical Research Council
   [MR/M02637X/1]; Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19278-6, 2014/50828-8];
   FP7 program of the European Union; National Institute of Health Research
   (ACL) [3557]; Oxford Martin School; Medical Research CouncilMedical
   Research Council UK (MRC) [MR/M02637X/1] Funding Source: researchfish;
   National Institute for Health ResearchNational Institute for Health
   Research (NIHR) [CL-2014-04-001] Funding Source: researchfish
FX This work was funded by a Wellcome Trust Strategic Translational Award
   (#092661 to AP), Emergent BioSolutions (challenge strain manufacture,
   vaccine/placebo supply, and labelling), the Newton Fund through the
   Medical Research Council (MR/M02637X/1), and the Sao Paulo Research
   Foundation (FAPESP, # 2012/19278-6 and 2014/50828-8). CB is Marie Curie
   Fellow supported by the FP7 program of the European Union. Additional
   support was received from the National Institute of Health Research (ACL
   # 3557 to TD) and the Oxford Martin School.
CR Antillon M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005376
   Anwar E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub3
   Bao S, 2000, IMMUNOLOGY, V99, P464, DOI 10.1046/j.1365-2567.2000.00955.x
   Begier EM, 2004, CLIN INFECT DIS, V38, P771, DOI 10.1086/381548
   Blohmke CJ, 2016, J EXP MED, V213, P1061, DOI 10.1084/jem.20151025
   Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401
   Carreno JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178669
   Choi JM, 2012, MOL CELLS, V33, P217, DOI 10.1007/s10059-012-2297-y
   Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132
   Clutterbuck EA, 2008, CLIN VACCINE IMMUNOL, V15, P182, DOI 10.1128/CVI.00336-07
   Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541
   Darton TC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004926
   de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933
   Dougan G, 2014, ANNU REV MICROBIOL, V68, P317, DOI 10.1146/annurev-micro-091313-103739
   DRAGUNSKY EM, 1989, J BIOL STAND, V17, P353, DOI 10.1016/S0092-1157(89)80006-X
   Feenstra B, 2014, NAT GENET, V46, P1274, DOI 10.1038/ng.3129
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553
   Goodier MR, 2016, J IMMUNOL, V197, P313, DOI 10.4049/jimmunol.1502049
   Hall LJ, 2010, J IMMUNOL, V184, P4327, DOI 10.4049/jimmunol.0903357
   Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002
   Horowitz A, 2010, J IMMUNOL, V185, P2808, DOI 10.4049/jimmunol.1000844
   Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207
   Kampmann B, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0148
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Kirkpatrick BD, 2006, VACCINE, V24, P116, DOI 10.1016/j.vaccine.2005.08.008
   LEVINE MM, 1987, LANCET, V1, P1049
   LEVINE MM, 1989, REV INFECT DIS, V11, pS552
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117
   Lyon CE, 2010, VACCINE, V28, P3602, DOI 10.1016/j.vaccine.2010.02.017
   MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956
   Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047
   McArthur MA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004914
   Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322
   Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113
   O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70
   Pennington SH, 2016, J INFECT DIS, V213, P1809, DOI 10.1093/infdis/jiw030
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165
   Salerno-Goncalves R, 2002, J IMMUNOL, V169, P2196, DOI 10.4049/jimmunol.169.4.2196
   Salerno-Goncalves R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00398
   Salerno-Goncalves R, 2010, CLIN VACCINE IMMUNOL, V17, P1305, DOI 10.1128/CVI.00234-10
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M
   Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556
   Sizemore DR, 1997, INFECT IMMUN, V65, P309, DOI 10.1128/IAI.65.1.309-312.1997
   Subramaniam KS, 2015, J INFECT DIS, V212, P1322, DOI 10.1093/infdis/jiv217
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sztein MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00516
   Toapanta FR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003837
   Waddington CS, 2014, CLIN INFECT DIS, V58, P1230, DOI 10.1093/cid/ciu078
   Waickman AT, 2012, J IMMUNOL, V188, P4721, DOI 10.4049/jimmunol.1103143
NR 54
TC 6
Z9 5
U1 0
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD OCT 12
PY 2017
VL 8
AR 1276
DI 10.3389/fimmu.2017.01276
PG 13
WC Immunology
SC Immunology
GA FJ4SV
UT WOS:000412733300001
PM 29075261
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-12-17
ER

PT J
AU Racioppi, L
   Lento, W
   Huang, W
   Arvai, S
   Doan, PL
   Harris, JR
   Marcon, F
   Nakaya, HI
   Liu, YP
   Chao, N
AF Racioppi, Luigi
   Lento, William
   Huang, Wei
   Arvai, Stephanie
   Doan, Phuong L.
   Harris, Jeffrey R.
   Marcon, Fernando
   Nakaya, Helder I.
   Liu, Yaping
   Chao, Nelson
TI Calcium/calmodulin-dependent kinase kinase 2 regulates hematopoietic
   stem and progenitor cell regeneration
SO CELL DEATH & DISEASE
LA English
DT Article
ID QUIESCENCE; P53; AMPK; METABOLISM; IMPAIRS; CANCER; GROWTH; CYCLE;
   MACROPHAGES; HOMEOSTASIS
AB Hematopoietic stem and progenitor cells (HSPCs) are predominantly quiescent in adults, but proliferate in response to bone marrow (BM) injury. Here, we show that deletion of Ca2+/calmodulin (CaM)-dependent protein kinase kinase 2 (CaMKK2) promotes HSPC regeneration and hematopoietic recovery following radiation injury. Using Camkk2-enhanced green fluorescent protein (EGFP) reporter mice, we found that Camkk2 expression is developmentally regulated in HSPC. Deletion of Camkk2 in HSPC results in a significant downregulation of genes affiliated with the quiescent signature. Accordingly, HSPC from Camkk2 null mice have a high proliferative capability when stimulated in vitro in the presence of BM-derived endothelial cells. In addition, Camkk2 null mice are more resistant to radiation injury and show accelerated hematopoietic recovery, enhanced HSPC regeneration and ultimately a prolonged survival following sublethal or lethal total body irradiation. Mechanistically, we propose that CaMKK2 regulates the HSPC response to hematopoietic damage by coupling radiation signaling to activation of the anti-proliferative AMP-activated protein kinase. Finally, we demonstrated that systemic administration of the small molecule CaMKK2 inhibitor, STO-609, to irradiated mice enhanced HSPC recovery and improved survival. These findings identify CaMKK2 as an important regulator of HSPC regeneration and demonstrate CaMKK2 inhibition is a novel approach to promoting hematopoietic recovery after BM injury.
C1 [Racioppi, Luigi; Lento, William; Huang, Wei; Arvai, Stephanie; Doan, Phuong L.; Harris, Jeffrey R.; Liu, Yaping; Chao, Nelson] Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, 905 S,LaSalle St,2006 GSRB1, Durham, NC 27710 USA.
   [Racioppi, Luigi] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.
   [Marcon, Fernando; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, Sao Paulo, Brazil.
RP Racioppi, L (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, 905 S,LaSalle St,2006 GSRB1, Durham, NC 27710 USA.
EM luigi.racioppi@dm.duke.edu
RI Passos, Fernando Marcon/AAI-3922-2020; Nakaya, Helder/AAF-1738-2020;
   Doan, Phuong L./Q-2093-2019; Nakaya, Helder I/A-1397-2010
OI Passos, Fernando Marcon/0000-0001-5128-1410; Nakaya,
   Helder/0000-0001-5297-9108; Doan, Phuong L./0000-0003-1361-2068; Nakaya,
   Helder I/0000-0001-5297-9108
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [5U19AI067798-12, W81XWH-15-1-0443]; Opportunity Funds Management Core
   of the Centers for Medical Countermeasures against Radiation, National
   Institute of Allergy and Infectious Diseases [U19AI067773]; NATIONAL
   CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [K08CA184552, K08CA184552, K08CA184552, K08CA184552,
   K08CA184552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI067798, U19AI067773,
   U19AI067773, U19AI067773, U19AI067773, U19AI067773, U19AI067773,
   U19AI067798, U19AI067773, U19AI067773, U19AI067798, U19AI067798,
   U19AI067798, U19AI067798, U19AI067773, U19AI067773, U19AI067798,
   U19AI067773, U19AI067773, U19AI067798, U19AI067798, U19AI067798,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798, U19AI067773,
   U19AI067773, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067798, U19AI067798, U19AI067773, U19AI067773, U19AI067798,
   U19AI067798, U19AI067798, U19AI067773, U19AI067798, U19AI067798,
   U19AI067773, U19AI067798, U19AI067773, U19AI067798, U19AI067798,
   U19AI067773, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067773, U19AI067798, U19AI067773, U19AI067773, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798, U19AI067773,
   U19AI067798, U19AI067773, U19AI067773, U19AI067773, U19AI067798,
   U19AI067798, U19AI067773, U19AI067798, U19AI067798, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067773, U19AI067798, U19AI067773, U19AI067798, U19AI067798,
   U19AI067798, U19AI067773, U19AI067798, U19AI067773, U19AI067798,
   U19AI067798, U19AI067773, U19AI067773, U19AI067798, U19AI067773,
   U19AI067773, U19AI067798, U19AI067773, U19AI067798, U19AI067773,
   U19AI067798, U19AI067773, U19AI067798, U19AI067773, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067773, U19AI067773,
   U19AI067798, U19AI067773, U19AI067798, U19AI067773, U19AI067773,
   U19AI067773, U19AI067798, U19AI067798, U19AI067773, U19AI067773,
   U19AI067798, U19AI067798, U19AI067773, U19AI067773, U19AI067798,
   U19AI067773, U19AI067798, U19AI067798, U19AI067798, U19AI067798,
   U19AI067773, U19AI067773, U19AI067798, U19AI067798, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067773, U19AI067773,
   U19AI067798, U19AI067773, U19AI067773, U19AI067773, U19AI067773,
   U19AI067773, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067798, U19AI067773, U19AI067798, U19AI067773, U19AI067773,
   U19AI067773, U19AI067773, U19AI067773, U19AI067798, U19AI067773,
   U19AI067798, U19AI067798, U19AI067773, U19AI067773, U19AI067798,
   U19AI067798, U19AI067773, U19AI067773, U19AI067773, U19AI067798,
   U19AI067798, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067798, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067773, U19AI067798, U19AI067798, U19AI067798, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798, U19AI067798,
   U19AI067798, U19AI067773, U19AI067798, U19AI067798, U19AI067798,
   U19AI067773, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067798, U19AI067773, U19AI067798, U19AI067798, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798, U19AI067798,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798, U19AI067798,
   U19AI067798, U19AI067773, U19AI067798, U19AI067798, U19AI067773,
   U19AI067773, U19AI067798, U19AI067798, U19AI067798, U19AI067798,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798, U19AI067798,
   U19AI067773, U19AI067773, U19AI067798, U19AI067798, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067773, U19AI067798,
   U19AI067773, U19AI067773, U19AI067773, U19AI067773, U19AI067773,
   U19AI067773, U19AI067798, U19AI067773, U19AI067798, U19AI067773,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798, U19AI067773,
   U19AI067798, U19AI067773, U19AI067773, U19AI067798, U19AI067798,
   U19AI067773, U19AI067798, U19AI067798, U19AI067798, U19AI067773,
   U19AI067773, U19AI067773, U19AI067773, U19AI067798, U19AI067798,
   U19AI067798, U19AI067798, U19AI067773, U19AI067798, U19AI067773,
   U19AI067798, U19AI067773, U19AI067798, U19AI067798, U19AI067773,
   U19AI067773, U19AI067773, U19AI067798, U19AI067773, U19AI067798,
   U19AI067773, U19AI067798, U19AI067798, U19AI067773, U19AI067773,
   U19AI067773, U19AI067798, U19AI067773, U19AI067773, U19AI067773,
   U19AI067773, U19AI067798, U19AI067798, U19AI067798, U19AI067798,
   U19AI067798, U19AI067773, U19AI067798, U19AI067773, U19AI067773,
   U19AI067773, U19AI067773, U19AI067798, U19AI067798, U19AI067798,
   U19AI067798, U19AI067798, U19AI067798, U19AI067798] Funding Source: NIH
   RePORTER
FX We would like to thank Dr. Anthony Means for Camkk2<SUP>-/-</SUP> and
   reporter mice and Drs. Mike Cook and Bin Li for flow cytometry
   expertise. We also would like to thank all members of Chao's lab. This
   work was supported by funding from the National Institutes of Health
   (NIH) 5U19AI067798-12 and W81XWH-15-1-0443 awarded to NC; pilot grant
   from the Opportunity Funds Management Core of the Centers for Medical
   Countermeasures against Radiation, National Institute of Allergy and
   Infectious Diseases; grant number U19AI067773 awarded to LR.
CR Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247
   Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011
   Baba M, 2016, STEM CELLS, V34, P1068, DOI 10.1002/stem.2293
   Bonizzi G, 2012, TRENDS MOL MED, V18, P6, DOI 10.1016/j.molmed.2011.08.002
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Cary RL, 2013, J BONE MINER RES, V28, P1599, DOI 10.1002/jbmr.1890
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804
   Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591
   Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Doan PL, 2013, NAT MED, V19, P295, DOI 10.1038/nm.3070
   Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160
   Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595
   Ghosh SP, 2012, J RADIAT RES, V53, P526, DOI 10.1093/jrr/rrs001
   Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572
   Himburg HA, 2017, NAT MED, V23, P91, DOI 10.1038/nm.4251
   Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627
   Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Kelly RM, 2010, BLOOD, V115, P1088, DOI 10.1182/blood-2009-05-223198
   Lee CL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9477
   Lento W, 2014, GENE DEV, V28, P995, DOI 10.1101/gad.231944.113
   Liao EC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.220
   Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006
   Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155
   Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158
   Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014
   Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513
   Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014
   Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485
   Racioppi L, 2012, J BIOL CHEM, V287, P11579, DOI 10.1074/jbc.M111.336032
   Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006
   Sanli T, 2012, RADIOTHER ONCOL, V102, P459, DOI 10.1016/j.radonc.2011.11.014
   Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041
   Teng EC, 2011, J LEUKOCYTE BIOL, V90, P897, DOI 10.1189/jlb.0311152
   Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200
   Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301
   Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534
   Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703
   Zannella VE, 2011, RADIOTHER ONCOL, V99, P293, DOI 10.1016/j.radonc.2011.05.049
   Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003
NR 50
TC 3
Z9 3
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD OCT
PY 2017
VL 8
AR e3076
DI 10.1038/cddis.2017.474
PG 12
WC Cell Biology
SC Cell Biology
GA FL2CV
UT WOS:000414022900083
PM 28981105
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Chen, WQ
   Foo, SS
   Zaid, A
   Teng, TS
   Herrero, LJ
   Wolf, S
   Tharmarajah, K
   Vu, LD
   van Vreden, C
   Taylor, A
   Freitas, JR
   Li, RW
   Woodruff, TM
   Gordon, R
   Ojcius, DM
   Nakaya, HI
   Kanneganti, TD
   O'Neill, LAJ
   Robertson, AAB
   King, NJ
   Suhrbier, A
   Cooper, MA
   Ng, LFP
   Mahalingam, S
AF Chen, Weiqiang
   Foo, Suan-Sin
   Zaid, Ali
   Teng, Terk-Shin
   Herrero, Lara J.
   Wolf, Stefan
   Tharmarajah, Kothila
   Vu, Luan D.
   van Vreden, Caryn
   Taylor, Adam
   Freitas, Joseph R.
   Li, Rachel W.
   Woodruff, Trent M.
   Gordon, Richard
   Ojcius, David M.
   Nakaya, Helder I.
   Kanneganti, Thirumala-Devi
   O'Neill, Luke A. J.
   Robertson, Avril A. B.
   King, Nicholas J.
   Suhrbier, Andreas
   Cooper, Matthew A.
   Ng, Lisa F. P.
   Mahalingam, Suresh
TI Specific inhibition of NLRP3 in chikungunya disease reveals a role for
   inflammasomes in alphavirus-induced inflammation
SO NATURE MICROBIOLOGY
LA English
DT Article
ID ROSS-RIVER-VIRUS; WEST-NILE-VIRUS; MOUSE MODEL; ARTHRITOGENIC
   ALPHAVIRUSES; ARTHRITIS; INFECTION; BINDARIT; DIFFERENTIATION;
   SUSCEPTIBILITY; PRECURSORS
AB Mosquito-borne viruses can cause severe inflammatory diseases and there are limited therapeutic solutions targeted specifically at virus-induced inflammation. Chikungunya virus (CHIKV), a re-emerging alphavirus responsible for several outbreaks worldwide in the past decade, causes debilitating joint inflammation and severe pain. Here, we show that CHIKV infection activates the NLRP3 inflammasome in humans and mice. Peripheral blood mononuclear cells isolated from CHIKV-infected patients showed elevated NLRP3, caspase-1 and interleukin-18 messenger RNA expression and, using a mouse model of CHIKV infection, we found that high NLRP3 expression was associated with peak inflammatory symptoms. Inhibition of NLRP3 activation using the small-molecule inhibitor MCC950 resulted in reduced CHIKV-induced inflammation and abrogated osteoclastogenic bone loss and myositis, but did not affect in vivo viral replication. Mice treated with MCC950 displayed lower expression levels of the cytokines interleukin-6, chemokine ligand 2 and tumour necrosis factor in joint tissue. Interestingly, MCC950 treatment abrogated disease signs in mice infected with a related arthritogenic alphavirus, Ross River virus, but not in mice infected with West Nile virus-a flavivirus. Here, using mouse models of alphavirus-induced musculoskeletal disease, we demonstrate that NLRP3 inhibition in vivo can reduce inflammatory pathology and that further development of therapeutic solutions targeting inflammasome function could help treat arboviral diseases.
C1 [Chen, Weiqiang; Foo, Suan-Sin; Zaid, Ali; Herrero, Lara J.; Wolf, Stefan; Tharmarajah, Kothila; Taylor, Adam; Freitas, Joseph R.; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Emerging Viruses & Inflammat Res Grp, Gold Coast, Qld 4222, Australia.
   [Teng, Terk-Shin; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore 138632, Singapore.
   [Teng, Terk-Shin; Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
   [Vu, Luan D.; van Vreden, Caryn; King, Nicholas J.] Univ Sydney, Bosch Inst, Sydney Med Sch, Sch Med Sci,Discipline Pathol,Charles Perkins Ctr, Camperdown, NSW 2006, Australia.
   [Li, Rachel W.] Australian Natl Univ, Med Sch, Acton, ACT 2601, Australia.
   [Li, Rachel W.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Acton, ACT 2601, Australia.
   [Woodruff, Trent M.; Gordon, Richard] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia.
   [Ojcius, David M.] Univ Pacific, Dept Biomed Sci, San Francisco, CA 94103 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-05508000 Sao Paulo, Brazil.
   [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.
   [O'Neill, Luke A. J.] Univ Dublin, Trinity Biomed Sci Inst, Trinity Coll Dublin, Dublin 2, Ireland.
   [Robertson, Avril A. B.; Cooper, Matthew A.] Univ Queensland, Inst Mol Biocsci, St Lucia, Qld 4072, Australia.
   [Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Lab, Herston, Qld 4006, Australia.
   [Chen, Weiqiang; Foo, Suan-Sin] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
RP Mahalingam, S (corresponding author), Griffith Univ, Inst Glyc, Emerging Viruses & Inflammat Res Grp, Gold Coast, Qld 4222, Australia.
EM s.mahalingam@griffith.edu.au
RI W, T/ABF-1428-2020; Gordon, Richard/E-8222-2016; Ojcius,
   David/ABE-6557-2020; King, Nicholas JC/C-4138-2011; Cooper, Matthew
   A/C-7988-2009; Woodruff, Trent/AAS-4629-2020; Kanneganti,
   Thirumala-Devi/Y-2503-2019; Nakaya, Helder I/A-1397-2010; Kanneganti,
   Thirumala-Devi/M-9435-2018; Woodruff, Trent M./B-4861-2009; Li, Rachel
   Wei/T-2261-2019; Nakaya, Helder/AAF-1738-2020; Robertson,
   Avril/A-4043-2012; VU, LUAN/AAO-4951-2020; Herrero, Lara/A-4628-2015
OI W, T/0000-0003-1382-911X; Gordon, Richard/0000-0003-2478-4607; King,
   Nicholas JC/0000-0002-3877-9772; Woodruff, Trent/0000-0003-1382-911X;
   Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Nakaya, Helder
   I/0000-0001-5297-9108; Kanneganti, Thirumala-Devi/0000-0002-6395-6443;
   Woodruff, Trent M./0000-0003-1382-911X; Li, Rachel
   Wei/0000-0001-7053-7928; Nakaya, Helder/0000-0001-5297-9108; Robertson,
   Avril/0000-0002-9652-8357; VU, LUAN/0000-0001-8493-1811; Ng,
   Lisa/0000-0003-4071-5222; Zaid, Ali/0000-0002-2528-2783; Herrero,
   Lara/0000-0002-5661-9828; Mahalingam, Suresh/0000-0003-3141-8410;
   O'Neill, Luke/0000-0002-4333-2748; Ojcius, David/0000-0003-1461-4495;
   Taylor, Adam/0000-0002-7159-3961
FU Australian National Health and Medical Research Council (NHMRC)National
   Health and Medical Research Council of Australia [APP1079086];
   NHMRCNational Health and Medical Research Council of Australia
   [APP1059167, APP1058391]
FX We thank S. Masters (the Walter and Eliza Hall Institute of Medical
   Research) for kindly providing the caspase-1<SUP>-/-</SUP> and
   ASC<SUP>-/-</SUP> mice. This study was supported by grants from the
   Australian National Health and Medical Research Council (NHMRC) to S.M.
   (APP1079086). S.M. is the recipient of an NHMRC Senior Research
   Fellowship (APP1059167) and A.S. is the recipient of an NHMRC Principal
   Research Fellowship (APP1058391).
CR Bonar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035979
   Cao Y, 2005, CANCER RES, V65, P1124, DOI 10.1158/0008-5472.CAN-04-2128
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chakrabarti A, 2015, CELL HOST MICROBE, V17, P466, DOI 10.1016/j.chom.2015.02.010
   Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007
   Chen WQ, 2015, TRENDS MICROBIOL, V23, P35, DOI 10.1016/j.tim.2014.09.005
   Chen WQ, 2015, J VIROL, V89, P581, DOI 10.1128/JVI.02034-14
   Chen W, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0189-9
   Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Ekchariyawat P, 2015, INFECT GENET EVOL, V32, P401, DOI 10.1016/j.meegid.2015.03.025
   Enomoto H, 2003, J BIOL CHEM, V278, P23971, DOI 10.1074/jbc.M302457200
   Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Griffin D. E., 2002, ALPHAVIRUSES ENCY MO
   Gubler DJ, 2001, ANN NY ACAD SCI, V951, P13
   Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893
   Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113
   Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667
   Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13
   Kanneganti TD, 2010, NAT REV IMMUNOL, V10, P688, DOI 10.1038/nri2851
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330
   Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Qu C, 2015, FASEB J, V29, P1269, DOI 10.1096/fj.14-264804
   Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039
   Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470
   Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682
   Ryman KD, 2014, P NATL ACAD SCI USA, V111, P5767, DOI 10.1073/pnas.1404206111
   Seregin SS, 2017, MUCOSAL IMMUNOL, V10, P434, DOI 10.1038/mi.2016.55
   Shepard D. S., 2010, DENGUE B, V34, P1
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Taylor A, 2015, J GEN VIROL, V96, P221, DOI 10.1099/vir.0.071282-0
   Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Wikan N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-96
   Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x
   Zou L, 2015, STEM CELL REP, V4, P190, DOI 10.1016/j.stemcr.2015.01.008
NR 52
TC 34
Z9 34
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD OCT
PY 2017
VL 2
IS 10
BP 1435
EP 1445
DI 10.1038/s41564-017-0015-4
PG 11
WC Microbiology
SC Microbiology
GA FM7PO
UT WOS:000415272500011
PM 28848230
DA 2020-12-17
ER

PT J
AU Oliveira, AC
   Gomes-Neto, JF
   Barbosa, CHD
   Granato, A
   Reis, BS
   Santos, BM
   Fucs, R
   Canto, FB
   Nakaya, HI
   Nobrega, A
   Bellio, M
AF Oliveira, Ana-Carolina
   Gomes-Neto, Joao F.
   Barbosa, Carlos-Henrique D.
   Granato, Alessandra
   Reis, Bernardo S.
   Santos, Bruno M.
   Fucs, Rita
   Canto, Fabio B.
   Nakaya, Helder I.
   Nobrega, Alberto
   Bellio, Maria
TI Crucial role for T cell-intrinsic IL-18R-MyD88 signaling in cognate
   immune response to intracellular parasite infection
SO ELIFE
LA English
DT Article
ID TRYPANOSOMA-CRUZI INFECTION; LEISHMANIA-MAJOR INFECTION; TOLL-LIKE
   RECEPTOR; INTERFERON-GAMMA; IFN-GAMMA; MYCOBACTERIUM-TUBERCULOSIS;
   LISTERIA-MONOCYTOGENES; TRANSCRIPTION FACTOR; TOXOPLASMA-GONDII;
   HOST-RESISTANCE
AB MyD88 is the main adaptor molecule for TLR and IL-1R family members. Here, we demonstrated that T-cell intrinsic MyD88 signaling is required for proliferation, protection from apoptosis and expression of activation/memory genes during infection with the intracellular parasite Trypanosoma cruzi, as evidenced by transcriptome and cytometry analyses in mixed bone-marrow ( BM) chimeras. The lack of direct IL-18R signaling in T cells, but not of IL-1R, phenocopied the absence of the MyD88 pathway, indicating that IL-18R is a critical MyD88-upstream pathway involved in the establishment of the Th1 response against an in vivo infection, a presently controvert subject. Accordingly, Il18r1(-/-) mice display lower levels of Th1 cells and are highly susceptible to infection, but can be rescued from mortality by the adoptive transfer of WT CD4(+) T cells. Our findings establish the T-cell intrinsic IL18R/MyD88 pathway as a crucial element for induction of cognate Th1 responses against an important human pathogen.
C1 [Oliveira, Ana-Carolina; Gomes-Neto, Joao F.; Barbosa, Carlos-Henrique D.; Granato, Alessandra; Santos, Bruno M.; Canto, Fabio B.; Nobrega, Alberto; Bellio, Maria] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941902 Rio de Janeiro, RJ, Brazil.
   [Oliveira, Ana-Carolina] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio de Janeiro, RJ, Brazil.
   [Reis, Bernardo S.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.
   [Fucs, Rita] Univ Fed Fluminense, Inst Biol, Niteroi, RJ, Brazil.
   [Nakaya, Helder I.] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, SP, Brazil.
   [Nakaya, Helder I.; Bellio, Maria] CNPq MCT, INCTV, Brasilia, DF, Brazil.
   [Nakaya, Helder I.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Bellio, M (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21941902 Rio de Janeiro, RJ, Brazil.; Bellio, M (corresponding author), CNPq MCT, INCTV, Brasilia, DF, Brazil.
EM mariabellioufrj@gmail.com
RI Nakaya, Helder/AAF-1738-2020; Nobrega, Alberto/U-1161-2019; Nakaya,
   Helder I/A-1397-2010; Maia, Bruno/E-2192-2019; Oliveira, Ana
   Carolina/O-6791-2014; BELLIO, MARIA/N-8525-2018
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Maia, Bruno/0000-0002-4675-8488; Oliveira, Ana
   Carolina/0000-0002-0036-3720; Gomes Neto, Joao
   Francisco/0000-0002-1990-9703; BELLIO, MARIA/0000-0002-3360-2740; Canto,
   Fabio/0000-0001-7574-2613; Nobrega, Alberto/0000-0002-9840-0103
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Conselho Nacional de Pesquisas
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); National Institute for Vaccine Development and Technology
   (INCTV-CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq); CSF program; FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de
   Pesquisas (CNPq) and by The National Institute for Vaccine Development
   and Technology (INCTV-CNPq). AG and FBC received PhD fellowships from
   CNPq. AG and FBC received post-doc fellowship from CSF program, CNPq.
   JFG and CDB received MSc fellowships from FAPERJ and CNPq, respectively.
   AN, ACO and MB received PQ fellowship from CNPq and AN and MB received
   CNE fellowship from FAPERJ.
CR Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098
   Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496
   Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515
   Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106
   Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x
   Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911
   Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711
   Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2
   Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007
   Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8
   Frazer LC, 2013, J IMMUNOL, V191, P4269, DOI 10.4049/jimmunol.1301547
   Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027
   Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010
   Graefe SEB, 2003, MICROBES INFECT, V5, P833, DOI 10.1016/S1286-4579(03)00176-X
   Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106
   Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377
   Haring JS, 2009, INFECT IMMUN, V77, P1894, DOI 10.1128/IAI.01315-08
   Holscher C, 2000, INFECT IMMUN, V68, P4075, DOI 10.1128/IAI.68.7.4075-4083.2000
   Kano SI, 2008, NAT IMMUNOL, V9, P34, DOI 10.1038/ni1538
   LaRosa DF, 2008, P NATL ACAD SCI USA, V105, P3855, DOI 10.1073/pnas.0706663105
   Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2
   Monteforte GM, 2000, J IMMUNOL, V164, P5890, DOI 10.4049/jimmunol.164.11.5890
   Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237
   Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423
   Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103
   Nish SA, 2014, ELIFE, V3, DOI 10.7554/eLife.01949
   O'Donnell H, 2014, IMMUNITY, V40, P213, DOI 10.1016/j.immuni.2013.12.013
   Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688
   Oliveira AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000870
   Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508
   Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7
   Rodrigues Mauricio M., 2012, Journal of Parasitology Research, P507874, DOI 10.1155/2012/507874
   Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997
   SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567
   Schenten D, 2014, IMMUNITY, V40, P78, DOI 10.1016/j.immuni.2013.10.023
   Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583
   Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863
   Smeltz RB, 2002, J IMMUNOL, V168, P6165, DOI 10.4049/jimmunol.168.12.6165
   Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9
   Tomita T, 2008, J IMMUNOL, V180, P5291, DOI 10.4049/jimmunol.180.8.5291
   Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004
   Zhou SH, 2009, J VIROL, V83, P1625, DOI 10.1128/JVI.01770-08
NR 42
TC 6
Z9 6
U1 0
U2 2
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD SEP 12
PY 2017
VL 6
AR e30883
DI 10.7554/eLife.30883
PG 62
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA FH8XI
UT WOS:000411488200001
PM 28895840
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Li, SZ
   Sullivan, NL
   Rouphael, N
   Yu, TW
   Banton, S
   Maddur, MS
   McCausland, M
   Chiu, C
   Canniff, J
   Dubey, S
   Liu, K
   Tran, V
   Hagan, T
   Duraisingham, S
   Wieland, A
   Mehta, AK
   Whitaker, JA
   Subramaniam, S
   Jones, DP
   Sette, A
   Vora, K
   Weinberg, A
   Mulligan, MJ
   Nakaya, HI
   Levin, M
   Ahmed, R
   Pulendran, B
AF Li, Shuzhao
   Sullivan, Nicole L.
   Rouphael, Nadine
   Yu, Tianwei
   Banton, Sophia
   Maddur, Mohan S.
   McCausland, Megan
   Chiu, Christopher
   Canniff, Jennifer
   Dubey, Sheri
   Liu, Ken
   ViLinh Tran
   Hagan, Thomas
   Duraisingham, Sai
   Wieland, Andreas
   Mehta, Aneesh K.
   Whitaker, Jennifer A.
   Subramaniam, Shankar
   Jones, Dean P.
   Sette, Alessandro
   Vora, Kalpit
   Weinberg, Adriana
   Mulligan, Mark J.
   Nakaya, Helder I.
   Levin, Myron
   Ahmed, Rafi
   Pulendran, Bali
TI Metabolic Phenotypes of Response to Vaccination in Humans
SO CELL
LA English
DT Article
ID VARICELLA-ZOSTER-VIRUS; YELLOW-FEVER VACCINE; IMMUNE CELL-FUNCTION;
   SYSTEMS BIOLOGY; SEASONAL INFLUENZA; GENE-EXPRESSION; IMMUNOLOGY;
   INNATE; MACROPHAGES; ACTIVATION
AB Herpes zoster (shingles) causes significant morbidity in immune compromised hosts and older adults. Whereas a vaccine is available for prevention of shingles, its efficacy declines with age. To help to understand the mechanisms driving vaccinal responses, we constructed a multiscale, multifactorial response network (MMRN) of immunity in healthy young and older adults immunized with the live attenuated shingles vaccine Zostavax. Vaccination induces robust antigen-specific antibody, plasmablasts, and CD4+ T cells yet limited CD8+ T cell and antiviral responses. The MMRN reveals striking associations between orthogonal datasets, such as transcriptomic and metabolomics signatures, cell populations, and cytokine levels, and identifies immune and metabolic correlates of vaccine immunity. Networks associated with inositol phosphate, glycerophospholipids, and sterol metabolism are tightly coupled with immunity. Critically, the sterol regulatory binding protein 1 and its targets are key integrators of antibody and T follicular cell responses. Our approach is broadly applicable to study human immunity and can help to identify predictors of efficacy as well as mechanisms controlling immunity to vaccination.
C1 [Li, Shuzhao; Rouphael, Nadine; Banton, Sophia; Liu, Ken; ViLinh Tran; Mehta, Aneesh K.; Whitaker, Jennifer A.; Jones, Dean P.; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30303 USA.
   [Sullivan, Nicole L.; Maddur, Mohan S.; McCausland, Megan; Chiu, Christopher; Hagan, Thomas; Duraisingham, Sai; Wieland, Andreas; Ahmed, Rafi; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
   [Rouphael, Nadine; Mulligan, Mark J.] Emory Vaccine Ctr, Hope Clin, Decatur, GA 30030 USA.
   [Yu, Tianwei] Emory Univ, Rollins Sch Publ Hlth, Dept Bioinformat & Biostat, Atlanta, GA 30030 USA.
   [Canniff, Jennifer; Weinberg, Adriana] Univ Colorado, Anschutz Med Campus, Aurora, CO 80045 USA.
   [Dubey, Sheri; Vora, Kalpit] Dept Infect Dis & Vaccines, West Point, PA USA.
   [Dubey, Sheri; Vora, Kalpit] Merck & Co Inc, Merck Res Labs, Kenilworth, NJ 07033 USA.
   [Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, Dept Nanoengn, Dept Bioengn,Dept Chem & Biochem, La Jolla, CA 92093 USA.
   [Sette, Alessandro] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA.
   [Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Whitaker, Jennifer A.] Mayo Clin & Mayo Grad Sch Med, Dept Med, Div Infect Dis, 200 First St SW, Rochester, MN 55902 USA.
RP Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.; Pulendran, B (corresponding author), Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder I/A-1397-2010; Mulligan, Mark/V-9275-2019; Nakaya,
   Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Li, Shuzhao/0000-0002-7386-2539; Rouphael,
   Nadine/0000-0002-2512-7919
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI090023, U19AI057266, S10OD18006];
   Medical Research CouncilMedical Research Council UK (MRC) [G0902266]
   Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R37AI048638, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, T32AI007290,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, R37AI048638, U19AI057266,
   U19AI090023, R37AI048638, U19AI090023, U19AI057266, U19AI057266,
   R37AI048638, U19AI090023, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, R37AI048638, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   R37AI048638, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, T32AI007290, U19AI090023, U19AI090023, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, T32AI007290, T32AI007290,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, R37AI048638, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI090023, U19AI090023, T32AI007290,
   U19AI090023, R37AI048638, U19AI090023, U19AI057266, U19AI057266,
   R37AI048638, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI090023, R37AI048638, U19AI090023, U19AI057266,
   R37AI048638, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R01DK057665, R01DK057665,
   R01DK057665, R01DK057665, R01DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R01DK057665, R37DK057665,
   R37DK057665, R37DK057665, R01DK057665, R01DK057665, R01DK057665,
   R01DK057665, R37DK057665, R37DK057665, R01DK057665] Funding Source: NIH
   RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132] Funding Source: NIH RePORTER
FX We are grateful to Mary Bower, Ildefonzo Tellez, Srilatha Edugupanti,
   David Rimland, and the Hope Clinic staff, who assisted with the clinical
   work. We also thank Emory Immunology/Flow Cytometry Core for technical
   assistance. This work was supported by NIH grants U19AI090023 (to B.P.),
   U19AI057266 (to R.A. and B.P.), and S10OD18006 (to D.P.J.).
CR Abendroth A, 2010, CURR TOP MICROBIOL, V342, P155, DOI 10.1007/82_2010_41
   Bartel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005274
   Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274
   Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052
   Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191
   Chiu C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004008
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003
   Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101
   Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299
   Frey CR, 2003, J INFECT DIS, V188, P40, DOI 10.1086/375828
   Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610
   Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317
   Gomi Y, 2002, J VIROL, V76, P11447, DOI 10.1128/JVI.76.22.11447-11459.2002
   Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017
   Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123
   Mehmood T, 2012, CHEMOMETR INTELL LAB, V118, P62, DOI 10.1016/j.chemolab.2012.07.010
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Mooney M, 2013, CURR OPIN IMMUNOL, V25, P551, DOI 10.1016/j.coi.2013.09.014
   Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302
   Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nath Artika Praveeta, 2012, Frontiers in Genetics, V3, P243, DOI 10.3389/fgene.2012.00243
   Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946
   Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Qi Q, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005892
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834
   Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637
   Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328
   Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045
   Yu TW, 2013, J PROTEOME RES, V12, P1419, DOI 10.1021/pr301053d
   Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505
   Zak DE, 2015, VACCINE, V33, P5241, DOI 10.1016/j.vaccine.2015.05.098
   Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109
   Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x
   Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283
NR 54
TC 85
Z9 87
U1 0
U2 62
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 18
PY 2017
VL 169
IS 5
BP 862
EP +
DI 10.1016/j.cell.2017.04.026
PG 33
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EV1OM
UT WOS:000401515900012
PM 28502771
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Prada-Medina, CA
   Fukutani, KF
   Kumar, NP
   Gil-Santana, L
   Babu, S
   Lichtenstein, F
   West, K
   Sivakumar, S
   Menon, PA
   Viswanathan, V
   Andrade, BB
   Nakaya, HI
   Kornfeld, H
AF Prada-Medina, Cesar A.
   Fukutani, Kiyoshi F.
   Kumar, Nathella Pavan
   Gil-Santana, Leonardo
   Babu, Subash
   Lichtenstein, Flavio
   West, Kim
   Sivakumar, Shanmugam
   Menon, Pradeep A.
   Viswanathan, Vijay
   Andrade, Bruno B.
   Nakaya, Helder I.
   Kornfeld, Hardy
TI Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals
   Signatures of Disease Complications
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PULMONARY TUBERCULOSIS; BAYESIAN NETWORKS; SEVERITY; PLASMA; CARE; TB;
   COINCIDENT; EXPRESSION; DIAGNOSIS; EPIDEMIC
AB Comorbid diabetes mellitus (DM) increases tuberculosis (TB) risk and adverse outcomes but the pathological interactions between DM and TB remain incompletely understood. We performed an integrative analysis of whole blood gene expression and plasma analytes, comparing South Indian TB patients with and without DM to diabetic and non-diabetic controls without TB. Luminex assay of plasma cytokines and growth factors delineated a distinct biosignature in comorbid TBDM in this cohort. Transcriptional profiling revealed elements in common with published TB signatures from cohorts that excluded DM. Neutrophil count correlated with the molecular degree of perturbation, especially in TBDM patients. Body mass index and HDL cholesterol were negatively correlated with molecular degree of perturbation. Diabetic complication pathways including several pathways linked to epigenetic reprogramming were activated in TBDM above levels observed with DM alone. Our data provide a rationale for trials of host-directed therapies in TBDM, targeting neutrophilic inflammation and diabetic complication pathways to address the greater morbidity and mortality associated with this increasingly prevalent dual burden of communicable and non-communicable diseases.
C1 [Prada-Medina, Cesar A.; Lichtenstein, Flavio; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-05508 Sao Paulo, Brazil.
   [Fukutani, Kiyoshi F.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Imunoparasitol, Salvador, BA, Brazil.
   [Kumar, Nathella Pavan; Babu, Subash] Natl Inst Hlth, NIRT, Int Ctr Excellence Res, Madras, Tamil Nadu, India.
   [Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Unidade Med Invest, Lab Integrado Microbiol & Imunorregulacao, Salvador, BA, Brazil.
   [Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Jose Silveira, Inst Brasileiro Invest TB, Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil.
   [Gil-Santana, Leonardo; Andrade, Bruno B.] Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil.
   [West, Kim; Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.
   [Sivakumar, Shanmugam; Menon, Pradeep A.] Natl Inst Res TB, Madras, Tamil Nadu, India.
   [Viswanathan, Vijay] Prof M Viswanathan Diabet Res Ctr, Chennai, Tamil Nadu, India.
   [Andrade, Bruno B.] Univ Salvador UNIFACS, Laureate Univ, Salvador, BA, Brazil.
   [Andrade, Bruno B.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-05508 Sao Paulo, Brazil.; Kornfeld, H (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA.
EM hnakaya@usp.br; Hardy.Kornfeld@umassmed.edu
RI Fukutani, Kiyoshi/N-7905-2016; Nakaya, Helder I/A-1397-2010; Andrade,
   Bruno/AAI-2248-2020; Nakaya, Helder/AAF-1738-2020; Fukutani,
   Kiyoshi/T-1630-2019; Lichtenstein, Flavio/Z-5001-2019
OI Fukutani, Kiyoshi/0000-0003-2223-0918; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Prada-Medina,
   Cesar Augusto/0000-0003-1939-2297; Andrade, Bruno/0000-0001-6833-3811
FU Indian Department of Biotechnology [USB1-31149-XX-13]; National
   Institute for Allergy and Infectious Diseases, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/08216-2]; CNPq research
   fellowshipNational Council for Scientific and Technological Development
   (CNPq); Indian Council of Medical ResearchIndian Council of Medical
   Research (ICMR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [ZIAAI001065, ZIAAI001065, ZIAAI001065,
   ZIAAI001065, ZIAAI001065, ZIAAI001065, ZIAAI001065, ZIAAI001065,
   ZIAAI001065, ZIAAI001065, ZIAAI001065] Funding Source: NIH RePORTER
FX We thank the EDOTS study volunteers who participated in this study, the
   staff of the Prof. M. Viswanathan Diabetes Research Centre, the M.V.
   Hospital for Diabetes, the National Institute for Research in
   Tuberculosis and the District Tuberculosis Officer Dr. J. Lavanya and
   staff of the Revised National Tuberculosis Control Program in Chennai,
   India. This work was supported by the following funding sources: grant
   #USB1-31149-XX-13 (to V. Viswanathan and H. Kornfeld) jointly sponsored
   by the Indian Department of Biotechnology, the Indian Council of Medical
   Research and the National Institute for Allergy and Infectious Diseases,
   National Institutes of Health, and administered by CRDF Global.; FAPESP
   grant # 2013/08216-2 (to H. Nakaya). H. Nakaya receives a CNPq research
   fellowship.
CR Abakay O, 2015, INFLAMMATION, V38, P691, DOI 10.1007/s10753-014-9978-y
   Andrade BB, 2014, CHEST, V145, P1244, DOI 10.1378/chest.13-1799
   [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005
   Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Blankley S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0427
   Cetin MS, 2016, HEART LUNG CIRC, V25, P1077, DOI 10.1016/j.hlc.2016.02.023
   Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183
   Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x
   De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20
   Deffur A, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.04.12
   Deforche K, 2006, BIOINFORMATICS, V22, P2975, DOI 10.1093/bioinformatics/btl508
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P196
   Ghosh P, 2015, ENDOCR REV, V36, P272, DOI 10.1210/er.2014-1099
   Guo XY, 2015, EUR J ENDOCRINOL, V173, P217, DOI 10.1530/EJE-15-0176
   Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503
   Hartemink A J, 2001, Pac Symp Biocomput, P422
   Hesar A. S., 2012, STRUCTURE LEARNING B
   HOLM S, 1979, SCAND J STAT, V6, P65
   Kaji H, 2013, J LIPIDS, V2013, DOI 10.1155/2013/684903
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Kim Bong-Joon, 2016, J Cardiovasc Ultrasound, V24, P115, DOI 10.4250/jcu.2016.24.2.115
   Kornfeld H, 2016, CHEST, V149, P1501, DOI 10.1016/j.chest.2016.02.675
   Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC
   Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241
   Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10
   Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034
   Liquet B, 2016, BIOINFORMATICS, V32, P35, DOI 10.1093/bioinformatics/btv535
   Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3
   Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308
   Lou MQ, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0002-9
   Lowe DM, 2012, TRENDS IMMUNOL, V33, P14, DOI 10.1016/j.it.2011.10.003
   Luna P, 2016, J CARDIOTHOR VASC AN, V30, P1369, DOI 10.1053/j.jvca.2016.02.008
   Maertzdorf J, 2016, EMBO MOL MED, V8, P86, DOI 10.15252/emmm.201505790
   Mahajan K, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1166
   Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC
   Martinez N, 2016, J INFECT DIS, V214, P1629, DOI 10.1093/infdis/jiw436
   Martinez N, 2014, J IMMUNOL, V193, P4457, DOI 10.4049/jimmunol.1401125
   Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301
   McAuley AK, 2014, J DIABETES COMPLICAT, V28, P419, DOI 10.1016/j.jdiacomp.2013.09.010
   Nickerson HD, 2012, J CARDIOVASC TRANSL, V5, P375, DOI 10.1007/s12265-012-9388-1
   Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127
   Peiris-Pages Maria, 2015, Oncoscience, V2, P696
   Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242
   Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x
   Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044
   Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088
   Su CW, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-6
   Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369
   Tatsch E, 2015, MUTAT RES-FUND MOL M, V782, P17, DOI 10.1016/j.mrfmmm.2015.10.003
   Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567
   Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304
   van den Berg SM, 2015, INT J OBESITY, V39, P782, DOI 10.1038/ijo.2014.198
   Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Wong TY, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.12
   World Health Organization, 2006, DEFINITION AND DIAGN
   World Health Organization, 2015, GLOB TUB REP 2015
   Yilmaz MI, 2014, AM J NEPHROL, V40, P208, DOI 10.1159/000366169
   Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1
   Zbidi H, 2011, PLATELETS, V22, P284, DOI 10.3109/09537104.2010.528813
   Zhan YQ, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0274-7
NR 65
TC 38
Z9 39
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 17
PY 2017
VL 7
AR 1999
DI 10.1038/s41598-017-01767-4
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV1MS
UT WOS:000401511100006
PM 28515464
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Costa, VV
   Del Sarto, JL
   Rocha, RF
   Silva, FR
   Doria, JG
   Olmo, IG
   Marques, RE
   Queiroz, CM
   Foureaux, G
   Araujo, JMS
   Cramer, A
   Real, ALCV
   Ribeiro, LS
   Sardi, SI
   Ferreira, AJ
   Machado, FS
   de Oliveira, AC
   Teixeira, AL
   Nakaya, HI
   Souza, DG
   Ribeiro, FM
   Teixeira, MM
AF Costa, Vivian V.
   Del Sarto, Juliana L.
   Rocha, Rebeca F.
   Silva, Flavia R.
   Doria, Juliana G.
   Olmo, Isabella G.
   Marques, Rafael E.
   Queiroz-Junior, Celso M.
   Foureaux, Giselle
   Araujo, Julia Maria S.
   Cramer, Allysson
   Real, Ana Luiza C. V.
   Ribeiro, Lucas S.
   Sardi, Silvia I.
   Ferreira, Anderson J.
   Machado, Fabiana S.
   de Oliveira, Antonio C.
   Teixeira, Antonio L.
   Nakaya, Helder I.
   Souza, Danielle G.
   Ribeiro, Fabiola M.
   Teixeira, Mauro M.
TI N-Methyl-D-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death
   Induced by Zika Virus Infection
SO MBIO
LA English
DT Article
DE NMDA receptor; Zika virus; intraocular pressure; memantine;
   microgliosis; mouse model; neuronal death
ID METABOTROPIC GLUTAMATE RECEPTORS; ALZHEIMERS-DISEASE;
   HUNTINGTONS-DISEASE; HOST-RESISTANCE; MOUSE MODEL; IFN-GAMMA; IN-VITRO;
   MEMANTINE; MICE; TRANSMISSION
AB Zika virus (ZIKV) infection is a global health emergency that causes significant neurodegeneration. Neurodegenerative processes may be exacerbated by N-methyl-D-aspartate receptor (NMDAR)-dependent neuronal excitoxicity. Here, we have exploited the hypothesis that ZIKV-induced neurodegeneration can be rescued by blocking NMDA overstimulation with memantine. Our results show that ZIKV actively replicates in primary neurons and that virus replication is directly associated with massive neuronal cell death. Interestingly, treatment with memantine or other NMDAR blockers, including dizocilpine (MK-801), agmatine sulfate, or ifenprodil, prevents neuronal death without interfering with the ability of ZIKV to replicate in these cells. Moreover, in vivo experiments demonstrate that therapeutic memantine treatment prevents the increase of intraocular pressure (IOP) induced by infection and massively reduces neurodegeneration and microgliosis in the brain of infected mice. Our results indicate that the blockade of NMDARs by memantine provides potent neuroprotective effects against ZIKV-induced neuronal damage, suggesting it could be a viable treatment for patients at risk for ZIKV infection-induced neurodegeneration.
   IMPORTANCE Zika virus (ZIKV) infection is a global health emergency associated with serious neurological complications, including microcephaly and Guillain-Barre syndrome. Infection of experimental animals with ZIKV causes significant neuronal damage and microgliosis. Treatment with drugs that block NMDARs prevented neuronal damage both in vitro and in vivo. These results suggest that overactivation of NMDARs contributes significantly to the neuronal damage induced by ZIKV infection, and this is amenable to inhibition by drug treatment.
C1 [Costa, Vivian V.; Del Sarto, Juliana L.; Rocha, Rebeca F.; Marques, Rafael E.; Cramer, Allysson; Ribeiro, Lucas S.; Machado, Fabiana S.; Souza, Danielle G.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Immunopharmacol Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Costa, Vivian V.; Araujo, Julia Maria S.; Ribeiro, Lucas S.; Souza, Danielle G.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Host Interact Microorganism Lab, Dept Microbiol, Belo Horizonte, MG, Brazil.
   [Silva, Flavia R.; Doria, Juliana G.; Olmo, Isabella G.; Real, Ana Luiza C. V.; Ribeiro, Fabiola M.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Biochem & Immunol, Neurobiochem Lab, Belo Horizonte, MG, Brazil.
   [Queiroz-Junior, Celso M.; Foureaux, Giselle; Ferreira, Anderson J.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Morphol, Cardiac Biol Lab, Belo Horizonte, MG, Brazil.
   [Cramer, Allysson; Machado, Fabiana S.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Immunoregulat Infect Dis Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.
   [Sardi, Silvia I.] Univ Fed Bahia UFBA, Dept Virol, Virol Lab, Salvador, BA, Brazil.
   [de Oliveira, Antonio C.] Univ Fed Minas Gerais, Inst Biol Sci ICB, Neuropharmacol Lab, Dept Pharmacol, Belo Horizonte, MG, Brazil.
   [Teixeira, Antonio L.] Univ Texas Houston, Hlth Sci Ctr Houston, McGovern Med Houston, Dept Psychiat & Behav Sci, Houston, TX USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Dept Clin Anal & Toxicol, Sch Pharmaceut Sci, Metabol Appl Hlth Lab, Sao Paulo, Brazil.
RP Teixeira, MM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci ICB, Immunopharmacol Lab, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil.; Ribeiro, FM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci ICB, Dept Biochem & Immunol, Neurobiochem Lab, Belo Horizonte, MG, Brazil.
EM fmribeiro@icb.ufmg.br; mmtex.ufmg@gmail.com
RI Costa, Vivian VVC/I-2499-2018; Teixeira, Antonio L/N-3315-2014; de
   Oliveira, Antonio CP/F-1661-2013; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020; Rodrigues, Dra. Flavia/A-9986-2018; Marques,
   Rafael Elias/R-4890-2016; Olmo, Isabella Guimaraes/W-5050-2019;
   Queiroz-Junior, Celso/L-5438-2013; Ribeiro, Fabiola/E-8831-2013; sardi,
   silvia ines/P-9349-2016; de Paiva Froes Rocha, Rebeca/B-2477-2018
OI Costa, Vivian VVC/0000-0002-0175-642X; Teixeira, Antonio
   L/0000-0002-9621-5422; de Oliveira, Antonio CP/0000-0003-3217-4294;
   Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Rodrigues, Dra. Flavia/0000-0003-3007-9795;
   Marques, Rafael Elias/0000-0002-6949-0947; Olmo, Isabella
   Guimaraes/0000-0002-0007-3280; Queiroz-Junior,
   Celso/0000-0002-7884-7709; Ribeiro, Fabiola/0000-0001-7042-9433; sardi,
   silvia ines/0000-0002-2002-8436; Secchim Ribeiro,
   Lucas/0000-0001-8876-3827; de Paiva Froes Rocha,
   Rebeca/0000-0002-5678-4006; Simao Machado, Fabiana/0000-0001-9272-5209
FU National Institute of Science and Technology in Dengue (INCT dengue);
   Brazilian National Science Council (CNPq, Brazil); Minas Gerais
   Foundation for Science (FAPEMIG, Brazil); Financiadora de Estudos e
   Pesquisa (FINEP, Brazil); Comissao de Apoio a Pessoal de Ensino Superior
   (CAPES, Brazil)
FX This work has received financial support from the National Institute of
   Science and Technology in Dengue (INCT dengue), a program funded by The
   Brazilian National Science Council (CNPq, Brazil) and Minas Gerais
   Foundation for Science (FAPEMIG, Brazil). This work also received
   financial support from Financiadora de Estudos e Pesquisa (FINEP,
   Brazil) and Comissao de Apoio a Pessoal de Ensino Superior (CAPES,
   Brazil).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Anderson ER, 2004, J NEUROSCI, V24, P7194, DOI 10.1523/JNEUROSCI.1933-04.2004
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8
   CHEN HSV, 1992, J NEUROSCI, V12, P4427
   Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909
   Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205
   Costa VV, 2014, MED MICROBIOL IMMUN, V203, P231, DOI 10.1007/s00430-014-0334-5
   Costa VV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001663
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L
   Esposito Z, 2013, CNS NEUROSCI THER, V19, P549, DOI 10.1111/cns.12095
   Fagundes CT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001449
   FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z
   Foureaux G, 2013, INVEST OPHTH VIS SCI, V54, P4296, DOI 10.1167/iovs.12-11427
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268
   Li C, 2016, ACTA ASTRONAUT, V129, P74, DOI 10.1016/j.actaastro.2016.08.032
   Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008
   Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958
   LIPTON SA, 1992, NEUROLOGY, V42, P1403, DOI 10.1212/WNL.42.7.1403
   Lopez-Valdes HE, 2014, STROKE, V45, P2093, DOI 10.1161/STROKEAHA.113.004476
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Minkeviciene R, 2004, J PHARMACOL EXP THER, V311, P677, DOI 10.1124/jpet.104.071027
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7
   Moretti Morgana, 2014, Front Biosci (Elite Ed), V6, P341
   MULLER WEG, 1992, EUR J PHARM-MOLEC PH, V226, P209, DOI 10.1016/0922-4106(92)90063-2
   Murugan M, 2013, CNS NEUROL DISORD-DR, V12, P773, DOI 10.2174/18715273113126660174
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0
   Ott BR, 2007, J NEUROL, V254, P351, DOI 10.1007/s00415-006-0374-x
   Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   RYTIK PG, 1991, AIDS RES HUM RETROV, V7, P89, DOI 10.1089/aid.1991.7.89
   Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054
   Silva ACSE, 2016, NEUROPSYCH DIS TREAT, V12, P1747, DOI 10.2147/NDT.S113037
   TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wang YC, 2017, J CEREBR BLOOD F MET, V37, P980, DOI 10.1177/0271678X16648971
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010
   Young AB, 2003, J CLIN INVEST, V111, P299, DOI 10.1172/JCI200317742
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 69
TC 41
Z9 43
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAR-APR
PY 2017
VL 8
IS 2
AR e00350-17
DI 10.1128/mBio.00350-17
PG 16
WC Microbiology
SC Microbiology
GA ET8TW
UT WOS:000400575700017
PM 28442607
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Kazmin, D
   Nakaya, HI
   Lee, EK
   Johnson, MJ
   van der Most, R
   van den Berg, RA
   Ballou, WR
   Jongert, E
   Wille-Reece, U
   Ockenhouse, C
   Aderem, A
   Zak, DE
   Sadoff, J
   Hendriks, J
   Wrammert, J
   Ahmed, R
   Pulendran, B
AF Kazmin, Dmitri
   Nakaya, Helder I.
   Lee, Eva K.
   Johnson, Matthew J.
   van der Most, Robbert
   van den Berg, Robert A.
   Ballou, W. Ripley
   Jongert, Erik
   Wille-Reece, Ulrike
   Ockenhouse, Christian
   Aderem, Alan
   Zak, Daniel E.
   Sadoff, Jerald
   Hendriks, Jenny
   Wrammert, Jens
   Ahmed, Rafi
   Pulendran, Bali
TI Systems analysis of protective immune responses to RTS, S malaria
   vaccination in humans
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE malaria; vaccine; systems vaccinology; systems biology; immune
ID YELLOW-FEVER VACCINE; CIRCUMSPOROZOITE-PROTEIN; CELL RESPONSES;
   IMMUNOGENICITY; EFFICACY; BIOLOGY; SAFETY; RTS,S/AS01B; EXPRESSION;
   CANDIDATE
AB RTS,S is an advanced malaria vaccine candidate and confers significant protection against Plasmodium falciparum infection in humans. Little is known about the molecular mechanisms driving vaccine immunity. Here, we applied a systems biology approach to study immune responses in subjects receiving three consecutive immunizations with RTS, S (RRR), or in those receiving two immunizations of RTS, S/AS01 following a primary immunization with adenovirus 35 (Ad35) (ARR) vector expressing circumsporozoite protein. Subsequent controlled human malaria challenge (CHMI) of the vaccinees with Plasmodium-infected mosquitoes, 3 wk after the final immunization, resulted in similar to 50% protection in both groups of vaccinees. Circumsporozoite protein (CSP)-specific antibody titers, prechallenge, were associated with protection in the RRR group. In contrast, ARR-induced lower antibody responses, and protection was associated with polyfunctional CD4(+) T-cell responses 2 wk after priming with Ad35. Molecular signatures of B and plasma cells detected in PBMCs were highly correlated with antibody titers prechallenge and protection in the RRR cohort. In contrast, early signatures of innate immunity and dendritic cell activation were highly associated with protection in the ARR cohort. For both vaccine regimens, natural killer (NK) cell signatures negatively correlated with and predicted protection. These results suggest that protective immunity against P. falciparum can be achieved via multiple mechanisms and highlight the utility of systems approaches in defining molecular correlates of protection to vaccination.
C1 [Kazmin, Dmitri; Wrammert, Jens; Ahmed, Rafi; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil.
   [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Atlanta, GA 30332 USA.
   [Johnson, Matthew J.] Univ Minnesota, Ctr Genome Engn, St Paul, MN 55108 USA.
   [van der Most, Robbert; Jongert, Erik] GSK Vaccines, B-1330 Rixensart, Belgium.
   [van den Berg, Robert A.; Ballou, W. Ripley] GSK Vaccines, Rockville, MD 20850 USA.
   [Wille-Reece, Ulrike; Ockenhouse, Christian] Program Appropriate Technol Hlth Malaria Vaccine, Washington, DC 20001 USA.
   [Aderem, Alan; Zak, Daniel E.] Ctr Infect Dis Res, Seattle, WA 98109 USA.
   [Sadoff, Jerald; Hendriks, Jenny] Crucell, NL-2333 Leiden, Netherlands.
   [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Ahmed, R; Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.; Pulendran, B (corresponding author), Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
EM rahmed@emory.edu; bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; van den
   Berg, Robert A./N-1217-2019
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; van den Berg, Robert A./0000-0003-2708-7890
FU MVI-Path; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [U19AI090023, U19AI057266]; National Science FoundationNational Science
   Foundation (NSF) [NSF-1516074, NSF-1361532]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, R37AI048638, U19AI090023,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, R37AI048638, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, R37AI048638, U19AI057266, R37AI048638, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI057266, U19AI057266, R37AI048638, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, R37AI048638, U19AI057266, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, R37AI048638,
   U19AI090023, U19AI090023, U19AI057266, R37AI048638, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, R37AI048638, R37AI048638, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, R37AI048638, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR,
   NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132] Funding Source: NIH RePORTER
FX The clinical study was performed at the Walter Reed Army Institute of
   Research Malaria Vaccine Branch, which provided the PBMCs for this
   study. We thank Dr. Matthew Woodruff for critically reading the
   manuscript. This work was supported by a research grant from MVI-Path
   (to B.P.), National Institutes of Health Grants U19AI090023 (to B.P.)
   and U19AI057266 (to R.A.), and National Science Foundation Grants
   NSF-1516074 and NSF-1361532 (to E.K.L.).
CR Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773
   Agnandji ST, 2015, FUTURE MICROBIOL, V10, P1553, DOI 10.2217/fmb.15.90
   Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685
   Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287
   Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1
   Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6
   Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381
   Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4
   Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033
   Clinical RTSS, 2015, LANCET, V386, P31
   Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677
   Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948
   Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548
   Filtjens J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087463
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889
   GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576
   Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991
   Ockenhouse CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131571
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Roland J, 2006, J IMMUNOL, V177, P1229, DOI 10.4049/jimmunol.177.2.1229
   Rydyznski C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7375
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06
   Strategic Advisory Group of Experts, 2011, WKLY EPIDEMIOL REC, V90, P681
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   World Health Organization, 2015, WORLD MALARIA REPORT
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109
NR 38
TC 111
Z9 113
U1 2
U2 17
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 28
PY 2017
VL 114
IS 9
BP 2425
EP 2430
DI 10.1073/pnas.1621489114
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EM1TZ
UT WOS:000395101200083
PM 28193898
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Geraldo, MV
   Nakaya, HI
   Kimura, ET
AF Geraldo, Murilo Vieira
   Nakaya, Helder Imoto
   Kimura, Edna Teruko
TI Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for
   miR-654-3p in papillary thyroid cancer
SO ONCOTARGET
LA English
DT Article
DE microRNA; papillary thyroid carcinoma; 14q32 region; microTranscriptome;
   metastasis
ID TYPE-3 DEIODINASE EXPRESSION; ACUTE MYELOID-LEUKEMIA; GENOMIC REGION;
   CARCINOMA; MICRORNA; CELLS; PROLIFERATION; BRAF(V600E); INVASION;
   CLUSTER
AB Papillary thyroid carcinoma (PTC) is the most prevalent malignant neoplasia of the thyroid gland. A fraction of PTC cases show loss of differentiation and aggressive behavior, with radioiodine therapy resistance and metastasis. Although microRNAs (miRNAs) emerged as promising molecular markers for PTC, their role in the loss of differentiation observed during PTC progression remains to be fully understood. We performed the large-scale analysis of miRNA expression during PTC progression in BRAFT1799A-transgenic animals (Tg-Braf) and thyroid cancer cell lines and identified the marked downregulation of several miRNAs from the region 14q32. Data from The Cancer Genome Atlas (TCGA) confirmed the global downregulation of miRNAs from the 14q32 region in human PTC. The regulatory network potentially suppressed by these miRNAs suggests that key cancer-related biological processes such as cell proliferation, adhesion, migration and angiogenesis. Among the downregulated miRNAs, we observed that miR-654-3p levels decrease with long-term PTC progression in Tg-Braf mice and inversely correlate with EMT. The in vitro restoration of miR-654-3p decreased cell proliferation and migration and induced reprogramming of metastasis-related genes, suggesting a tumor suppressor role for this miRNA. In conclusion, we show global downregulation of 14q32-encoded miRNAs in an in vivo model of PTC progression. The potential circuitry in which these miRNAs are involved suggests that these miRNAs could play a key role in the pathophysiology of PTC and therefore be relevant for the development of new therapeutic strategies.
C1 [Geraldo, Murilo Vieira; Kimura, Edna Teruko] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.
   [Nakaya, Helder Imoto] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin Anal & Toxicol, Sao Paulo, Brazil.
   [Geraldo, Murilo Vieira] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil.
RP Geraldo, MV; Kimura, ET (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.; Geraldo, MV (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil.
EM murilovg@unicamp.br; etkimura@usp.br
RI Geraldo, Murilo V/F-7211-2013; Nakaya, Helder/AAF-1738-2020; Nakaya,
   Helder I/A-1397-2010; Kimura, Edna/D-7334-2012
OI Geraldo, Murilo V/0000-0002-9418-6103; Nakaya,
   Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108;
   Kimura, Edna/0000-0001-8403-4459
FU Sao Paulo Research Foundation: FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [11/52051-2, 2011/50732-2]; National
   Council for Scientific and Technological Development: CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [308527/2013-5, 458505/2014-5]
FX This study was funded by the Sao Paulo Research Foundation
   (http://fapesp.br/): FAPESP grants 11/52051-2 (MVG) and 2011/50732-2
   (ETK); and National Council for Scientific and Technological Development
   (http://cnpq.br/): CNPq grants 308527/2013-5; 458505/2014-5 (ETK).
CR Anaya-Ruiz M, 2013, ASIAN PAC J CANCER P, V14, P3757, DOI 10.7314/APJCP.2013.14.6.3757
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8
   Benetatos L, 2012, CRIT REV EUKAR GENE, V22, P1
   Cahill S, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-21
   Cahill S, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-70
   Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051
   Chen LC, 2012, INT J BIOCHEM CELL B, V44, P1711, DOI 10.1016/j.biocel.2012.06.027
   Chien WW, 2011, ONCOGENE, V30, P1880, DOI 10.1038/onc.2010.570
   Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141
   Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10
   Formosa A, 2014, ONCOGENE, V33, P5173, DOI 10.1038/onc.2013.451
   Froehlich E, 2014, CANCER TREAT REV, V40, P665, DOI 10.1016/j.ctrv.2014.01.002
   Fugazzola L, 2006, ENDOCR-RELAT CANCER, V13, P455, DOI 10.1677/erc.1.01086
   Geraldo MV, 2012, ONCOGENE, V31, P1910, DOI 10.1038/onc.2011.381
   Geraldo MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141726
   Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045
   Gu YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102602
   He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102
   Ioannides Y, 2014, J MED GENET, V51, P495, DOI 10.1136/jmedgenet-2014-102396
   Kelly L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064102
   Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44
   Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047
   Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271
   Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254
   Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003
   Lim L, 2014, HEPATOLOGY, V59, P202, DOI 10.1002/hep.26662
   Lima CR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2146-z
   Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696
   Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838
   Niu CS, 2013, INT J ONCOL, V42, P1533, DOI 10.3892/ijo.2013.1844
   Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Riesco-Eizaguirre G, 2006, ENDOCR-RELAT CANCER, V13, P257, DOI 10.1677/erc.1.01119
   Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248
   Romitti M, 2012, THYROID, V22, P897, DOI 10.1089/thy.2012.0031
   Romitti M, 2016, ENDOCR-RELAT CANCER, V23, P135, DOI 10.1530/ERC-15-0162
   Saiselet Manuel, 2012, Front Endocrinol (Lausanne), V3, P133, DOI 10.3389/fendo.2012.00133
   Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102
   Severi G, 2016, AM J MED GENET A, V170, P162, DOI 10.1002/ajmg.a.37346
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Sun M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.225
   Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564
   Yang ZL, 2013, MOL MED REP, V8, P1353, DOI 10.3892/mmr.2013.1699
   Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44
   Zhang J, 2013, INT J MED SCI, V10, P585, DOI 10.7150/ijms.5794
   Zhang XL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-56
NR 47
TC 18
Z9 18
U1 0
U2 4
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 7
PY 2017
VL 8
IS 6
BP 9597
EP 9607
DI 10.18632/oncotarget.14162
PG 11
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EK8NX
UT WOS:000394181800058
PM 28030816
OA Other Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ferreira, LRP
   Ferreira, FM
   Nakaya, HI
   Deng, XT
   Cndido, DD
   de Oliveira, LC
   Billaud, JN
   Lanteri, MC
   Rigaud, VOC
   Seielstad, M
   Kalil, J
   Fernandes, F
   Ribeiro, ALP
   Sabino, EC
   Cunha-Neto, E
AF Pinto Ferreira, Ludmila Rodrigues
   Ferreira, Frederico Moraes
   Nakaya, Helder Imoto
   Deng, Xutao
   Cndido, Darlan da Silva
   de Oliveira, Lea Campos
   Billaud, Jean-Noel
   Lanteri, Marion C.
   Rigaud, Vagner Oliveira-Carvalho
   Seielstad, Mark
   Kalil, Jorge
   Fernandes, Fabio
   Ribeiro, Antonio Luiz P.
   Sabino, Ester Cerdeira
   Cunha-Neto, Edecio
TI Blood Gene Signatures of Chagas Cardiomyopathy With or Without
   Ventricular Dysfunction
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Chagas disease; whole-blood transcriptome; Cardiomyopathy; NK cells
ID TRYPANOSOMA-CRUZI INFECTION; SET ENRICHMENT ANALYSIS; T-CELLS;
   HEART-DISEASE; NK CELLS; LYMPHOCYTES; BIOMARKERS; MICROARRAY; MORBIDITY;
   FAILURE
AB Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects 7 million people in Latin American areas of endemicity. About 30% of infected patients will develop chronic Chagas cardiomyopathy (CCC), an inflammatory cardiomyopathy characterized by hypertrophy, fibrosis, and myocarditis. Further studies are necessary to understand the molecular mechanisms of disease progression. Transcriptome analysis has been increasingly used to identify molecular changes associated with disease outcomes. We thus assessed the whole-blood transcriptome of patients with Chagas disease. Microarray analysis was performed on blood samples from 150 subjects, of whom 30 were uninfected control patients and 120 had Chagas disease (1 group had asymptomatic disease, and 2 groups had CCC with either a preserved or reduced left ventricular ejection fraction [LVEF]). Each Chagas disease group displayed distinct gene expression and functional pathway profiles. The most different expression patterns were between CCC groups with a preserved or reduced LVEF. A more stringent analysis indicated that 27 differentially expressed genes, particularly those related to natural killer (NK)/CD8(+) T-cell cytotoxicity, separated the 2 groups. NK/CD8(+) T-cell cytotoxicity could play a role in determining Chagas disease progression. Understanding genes associated with disease may lead to improved insight into CCC pathogenesis and the identification of prognostic factors for CCC progression.
C1 [Pinto Ferreira, Ludmila Rodrigues; Ferreira, Frederico Moraes; Cndido, Darlan da Silva; Rigaud, Vagner Oliveira-Carvalho; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Inst Heart, Immunol Lab, Sao Paulo, Brazil.
   [Kalil, Jorge; Fernandes, Fabio] Univ Sao Paulo, Inst Heart, Cardiomyopathy Unit, Sao Paulo, Brazil.
   [Pinto Ferreira, Ludmila Rodrigues; Ferreira, Frederico Moraes; Cndido, Darlan da Silva; Rigaud, Vagner Oliveira-Carvalho; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
   [Nakaya, Helder Imoto] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, Sao Paulo, Brazil.
   [de Oliveira, Lea Campos; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Trop Med, Dept Infect Dis, Sao Paulo, Brazil.
   [Cndido, Darlan da Silva; Rigaud, Vagner Oliveira-Carvalho; Kalil, Jorge; Cunha-Neto, Edecio] Natl Inst Sci & Technol, Inst Invest Immunol, Berhampur, Orissa, India.
   [Pinto Ferreira, Ludmila Rodrigues; Ferreira, Frederico Moraes] Univ Santo Amaro, Sao Paulo, Brazil.
   [Ribeiro, Antonio Luiz P.] Univ Fed Minas Gerais, Hosp Clin, Minas Gerais, Brazil.
   [Ribeiro, Antonio Luiz P.] Univ Fed Minas Gerais, Fac Med, Minas Gerais, Brazil.
   [Nakaya, Helder Imoto] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Deng, Xutao; Lanteri, Marion C.; Seielstad, Mark] Blood Syst Res Inst, Berhampur, Orissa, India.
   [Deng, Xutao] Dept Lab Med, San Francisco, CA USA.
   [Lanteri, Marion C.; Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, Dept Lab Med, San Francisco, CA 94143 USA.
   [Billaud, Jean-Noel] Qiagen, Dept BioInformat, Redwood City, CA USA.
RP Cunha, E (corresponding author), Heart Inst InCor, Immunol Lab, Ave Dr Eneas Carvalho Aguiar 44,Bloco II,9 Andar, BR-05403900 Sao Paulo, Brazil.
EM ede-cunha@usp.br
RI Ferreira, Frederico Moraes/A-4622-2013; Nakaya, Helder/AAF-1738-2020;
   Sabino, Ester Cerdeira/F-7750-2010; Rigaud, Vagner Oliveira
   Carvalho/I-4124-2013; Cunha-Neto, Edecio/B-4157-2009; Nakaya, Helder
   I/A-1397-2010; Ribeiro, Antonio L/C-2707-2009; Ferreira, Ludmila
   Rodrigues Pinto/B-4955-2015; Seielstad, Mark/T-7841-2019; Candido,
   Darlan/F-7209-2017; KALIL, JORGE/C-8029-2012
OI Nakaya, Helder/0000-0001-5297-9108; Sabino, Ester
   Cerdeira/0000-0003-2623-5126; Rigaud, Vagner Oliveira
   Carvalho/0000-0002-1194-9380; Cunha-Neto, Edecio/0000-0002-3699-3345;
   Nakaya, Helder I/0000-0001-5297-9108; Ribeiro, Antonio
   L/0000-0002-2740-0042; Ferreira, Ludmila Rodrigues
   Pinto/0000-0001-9944-6691; KALIL, JORGE/0000-0001-8415-4274; Seielstad,
   Mark/0000-0001-5783-1401; da Silva Candido, Darlan/0000-0002-5080-3130
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI098461]; National Heart, Lung, and Blood InstituteUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Heart Lung & Blood Institute (NHLBI)
   [HHSN268200417175C]; Sao Paulo (Brazil) Research Foundation (FAPESP)
   [2013/50302-3]; Brazilian National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI098461, P50AI098461,
   P50AI098461, P50AI098461, P50AI098461, U19AI098461, P50AI098461,
   U19AI098461, P50AI098461, P50AI098461, U19AI098461, P50AI098461,
   U19AI098461, P50AI098461, U19AI098461, P50AI098461, U19AI098461,
   U19AI098461, P50AI098461, U19AI098461, U19AI098461, P50AI098461,
   P50AI098461, P50AI098461, P50AI098461, P50AI098461, U19AI098461,
   P50AI098461, U19AI098461, U19AI098461, P50AI098461, P50AI098461,
   U19AI098461, P50AI098461, U19AI098461, P50AI098461, U19AI098461,
   U19AI098461, P50AI098461, U19AI098461, U19AI098461, P50AI098461,
   P50AI098461, P50AI098461] Funding Source: NIH RePORTER
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases (grant P50AI098461), the National Heart, Lung, and
   Blood Institute (grant HHSN268200417175C), the Sao Paulo (Brazil)
   Research Foundation (FAPESP) (grant 2013/50302-3 to E. C.- N.), and the
   Brazilian National Council for Scientific and Technological Development
   (CNPq) (research productivity awards to H. I. N., A. L. R., E. C.- N.,
   E. S., and J. K.).
CR Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523
   Araujo FF, 2007, FRONT BIOSCI-LANDMRK, V12, P2797, DOI 10.2741/2273
   Bilate AMB, 2003, MICROBES INFECT, V5, P1116, DOI 10.1016/j.micinf.2003.07.001
   Bjorkstrom NK, 2012, BLOOD, V120, P3455, DOI 10.1182/blood-2012-03-416867
   Brodskyn CI, 1996, CLIN EXP IMMUNOL, V105, P450, DOI 10.1046/j.1365-2249.1996.d01-785.x
   Cardillo F, 1996, INFECT IMMUN, V64, P128, DOI 10.1128/IAI.64.1.128-134.1996
   Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P275, DOI 10.1590/0074-0276150001
   Cunha-Neto E, 2006, AUTOIMMUNITY, V39, P41, DOI 10.1080/08916930500485002
   Cunha-Neto E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/683230
   Dotiwala F, 2016, NAT MED, V22, P210, DOI 10.1038/nm.4023
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Ferreira RC, 2003, MEM I OSWALDO CRUZ, V98, P407, DOI 10.1590/S0074-02762003000300021
   Gascon J, 2014, EXPERT REV ANTI-INFE, V12, P393, DOI 10.1586/14787210.2014.896194
   Giraldo NA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002038
   Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003
   Hidron A, 2010, CLIN MICROBIOL REV, V23, P324, DOI 10.1128/CMR.00054-09
   Higuchi M L, 1995, Arq Bras Cardiol, V64, P251
   HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665
   Abel LCJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/345659
   Kalil R, 2015, J AM COLL CARDIOL, V66, P1190, DOI 10.1016/j.jacc.2015.07.024
   Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354
   Keating SM, 2015, INT J CARDIOL, V199, P451, DOI 10.1016/j.ijcard.2015.07.040
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003
   Lieke T, 2006, CLIN EXP IMMUNOL, V145, P357, DOI 10.1111/j.1365-2249.2006.03118.x
   Longhi SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002906
   Maciejak A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0149-z
   Marin-Neto JA, 2009, REV ESP CARDIOL, V62, P1211, DOI 10.1016/S0300-8932(09)73071-4
   Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296
   Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999
   Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Padilla AM, 2009, CURR OPIN IMMUNOL, V21, P385, DOI 10.1016/j.coi.2009.07.006
   Pedrotty DM, 2012, PROG CARDIOVASC DIS, V55, P64, DOI 10.1016/j.pcad.2012.06.003
   Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046
   Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
   Rassi A, 2009, MEM I OSWALDO CRUZ, V104, P152, DOI 10.1590/S0074-02762009000900021
   REIS DD, 1993, AM J TROP MED HYG, V48, P637, DOI 10.4269/ajtmh.1993.48.637
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Sabino EC, 2015, EUR J HEART FAIL, V17, P416, DOI 10.1002/ejhf.220
   Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Silva CP, 2008, ARQ BRAS CARDIOL, V91, P358
   Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369
   Talvani A, 2004, MEM I OSWALDO CRUZ, V99, P645, DOI 10.1590/S0074-02762004000600020
   Vitelli-Avelar DM, 2006, CLIN EXP IMMUNOL, V145, P81, DOI 10.1111/j.1365-2249.2006.03123.x
   Vitelli-Avelar DM, 2005, SCAND J IMMUNOL, V62, P297, DOI 10.1111/j.1365-3083.2005.01668.x
NR 49
TC 16
Z9 16
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD FEB 1
PY 2017
VL 215
IS 3
BP 387
EP 395
DI 10.1093/infdis/jiw540
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP2HT
UT WOS:000397204700008
PM 28003350
OA Green Published
DA 2020-12-17
ER

PT J
AU Kasturi, SP
   Kozlowski, PA
   Nakaya, HI
   Burger, MC
   Russo, P
   Pham, M
   Kovalenkov, Y
   Silveira, ELV
   Havenar-Daughton, C
   Burton, SL
   Kilgore, KM
   Johnson, MJ
   Nabi, R
   Legere, T
   Sher, ZJ
   Chen, XM
   Amara, RR
   Hunter, E
   Bosinger, SE
   Spearman, P
   Crotty, S
   Villinger, F
   Derdeyn, CA
   Wrammert, J
   Pulendran, B
AF Kasturi, Sudhir Pai
   Kozlowski, Pamela A.
   Nakaya, Helder I.
   Burger, Matheus C.
   Russo, Pedro
   Pham, Mathew
   Kovalenkov, Yevgeniy
   Silveira, Eduardo L. V.
   Havenar-Daughton, Colin
   Burton, Samantha L.
   Kilgore, Katie M.
   Johnson, Mathew J.
   Nabi, Rafiq
   Legere, Traci
   Sher, Zarpheen Jinnah
   Chen, Xuemin
   Amara, Rama R.
   Hunter, Eric
   Bosinger, Steven E.
   Spearman, Paul
   Crotty, Shane
   Villinger, Francois
   Derdeyn, Cynthia A.
   Wrammert, Jens
   Pulendran, Bali
TI Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like
   Receptor Ligands Encapsulated in Nanoparticles Induces Persistent
   Antibody Responses and Enhanced Protection in TRIM5 alpha Restrictive
   Macaques
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE SIV; vaccine; rhesus macaques; TLR ligands; adjuvants; HIV vaccines;
   antibody responses; plasma cells; plasmablasts
ID HUMAN MONOCLONAL-ANTIBODIES; VAGINAL SHIV CHALLENGE; RHESUS MACAQUES;
   INNATE IMMUNITY; CELLULAR-IMMUNITY; HIV-1 VACCINE; NONNEUTRALIZING
   ANTIBODIES; SYNERGISTICALLY TRIGGER; HUMORAL IMMUNITY; SIV CHALLENGES
AB Our previous work has shown that antigens adjuvanted with ligands specific for Toll-like receptor 4 (TLR4) and TLR7/8 encapsulated in poly(lactic-co-glycolic) acid (PLGA)-based nanoparticles (NPs) induce robust and durable immune responses in mice and macaques. We investigated the efficacy of these NP adjuvants in inducing protective immunity against simian immunodeficiency virus (SIV). Rhesus macaques (RMs) were immunized with NPs containing TLR4 and TLR7/8 agonists mixed with soluble recombinant SIVmac239-derived envelope (Env) gp140 and Gag p55 (protein) or with virus-like particles (VLPs) containing SIVmac239 Env and Gag. NPadjuvanted vaccines induced robust innate responses, antigen-specific antibody responses of a greater magnitude and persistence, and enhanced plasmablast responses compared to those achieved with alum-adjuvanted vaccines. NP-adjuvanted vaccines induced antigen-specific, long-lived plasma cells (LLPCs), which persisted in the bone marrow for several months after vaccination. NP-adjuvanted vaccines induced immune responses that were associated with enhanced protection against repeated low-dose, intravaginal challenges with heterologous SIVsmE660 in animals that carried TRIM5 alpha restrictive alleles. The protection induced by immunization with protein-NP correlated with the prechallenge titers of Env-specific IgG antibodies in serum and vaginal secretions. However, no such correlate was apparent for immunization with VLP-NP or alum as the adjuvant. Transcriptional profiling of peripheral blood mononuclear cells isolated within the first few hours to days after primary vaccination revealed that NP-adjuvanted vaccines induced a molecular signature similar to that induced by the live attenuated yellow fever viral vaccine. This systems approach identified early blood transcriptional signatures that correlate with Envspecific antibody responses in vaginal secretions and protection against infection. These results demonstrate the adjuvanticity of the NP adjuvant in inducing persistent and protective antibody responses against SIV in RMs with implications for the design of vaccines against human immunodeficiency virus (HIV).
   IMPORTANCE The results of the RV144 HIV vaccine trial, which demonstrated a rapid waning of protective immunity with time, have underscored the need to develop strategies to enhance the durability of protective immune responses. Our recent work in mice has highlighted the capacity of nanoparticle-encapsulated TLR ligands (NP) to induce potent and durable antibody responses that last a lifetime in mice. In the present study, we evaluated the ability of these NP adjuvants to promote robust and durable protective immune responses against SIV in nonhuman primates. Our results demonstrate that immunization of rhesus macaques with NP adjuvants mixed with soluble SIV Env or a virus-like particle form of Env (VLP) induces potent and durable Env-specific antibody responses in the serum and in vaginal secretions. These responses were superior to those induced by alum adjuvant, and they resulted in enhanced protection against a low-dose intravaginal challenge with a heterologous strain of SIV in animals with TRIM5a restrictive alleles. These results highlight the potential for such NP TLR L adjuvants in promoting robust and durable antibody responses against HIV in the next generation of HIV immunogens currently being developed.
C1 [Kasturi, Sudhir Pai; Nakaya, Helder I.; Pham, Mathew; Kovalenkov, Yevgeniy; Silveira, Eduardo L. V.; Burton, Samantha L.; Kilgore, Katie M.; Johnson, Mathew J.; Legere, Traci; Sher, Zarpheen Jinnah; Amara, Rama R.; Hunter, Eric; Bosinger, Steven E.; Spearman, Paul; Villinger, Francois; Derdeyn, Cynthia A.; Wrammert, Jens; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Kozlowski, Pamela A.; Nabi, Rafiq] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.
   [Nakaya, Helder I.; Burger, Matheus C.; Russo, Pedro; Silveira, Eduardo L. V.] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Havenar-Daughton, Colin; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA.
   [Chen, Xuemin; Spearman, Paul; Wrammert, Jens] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.
   [Amara, Rama R.] Emory Univ, Rollins Res Ctr, Div Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Hunter, Eric; Derdeyn, Cynthia A.; Pulendran, Bali] Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Villinger, Francois] Univ Louisiana Lafayette, New Iberia Res Ctr, New Iberia, LA USA.
RP Pulendran, B (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Pulendran, B (corresponding author), Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
EM bpulend@emory.edu
RI Crotty, Shane/AAE-8446-2019; Russo, Pedro/K-8746-2019; Crotty,
   Shane/AAC-6703-2019; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020; Silveira, Eduardo L V/E-5733-2014
OI Russo, Pedro/0000-0002-4615-7498; Crotty, Shane/0000-0002-6484-6262;
   Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Silveira, Eduardo L V/0000-0001-8333-2884
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P30 A050509, P51-RR000165,
   P51-OD011132]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P01-AI096187, R01-AI58706]; Bill and Melinda Gates FoundationBill &
   Melinda Gates Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P30AI050409, U19AI096187, P30AI050409,
   P30AI050409, P30AI050409, P30AI050409, R01AI048638, U19AI096187,
   P30AI050409, P30AI050409, U19AI096187, P30AI050409, P30AI050409,
   U19AI096187, P30AI050409, P30AI050409, UM1AI124436, U19AI096187,
   P30AI050409, R01AI048638, P30AI050409, P30AI050409, P30AI050409,
   R01AI058706, R37AI048638, R01AI048638, P30AI050409, P30AI050409,
   R01AI048638, P30AI050409, P30AI050409, P30AI050409, U19AI096187,
   U19AI096187, P30AI050409, P30AI050409, P30AI050409, U19AI096187,
   P30AI050409, U19AI096187, P30AI050409, P30AI050409, P30AI050409,
   U19AI096187, P30AI050409, P30AI050409, R01AI058706, P30AI050409,
   R37AI048638, P30AI050409, U19AI096187, P30AI050409, R01AI058706,
   P30AI050409, P30AI050409, U19AI096187, U19AI096187, U19AI096187,
   P30AI050409, R37AI048638, R01AI048638, P30AI050409, P30AI050409,
   P30AI050409, P30AI050409, UM1AI124436, R37AI048638, P30AI050409,
   R37AI048638, P30AI050409, U19AI096187, P30AI050409, U19AI096187,
   P30AI050409, R01AI058706, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409, P30AI050409, U19AI096187, P30AI050409, P30AI050409,
   U19AI096187, R01AI058706, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409, U19AI096187, P30AI050409, R37AI048638, P30AI050409,
   R01AI058706, P30AI050409, U19AI096187, P30AI050409, R37AI048638,
   P30AI050409, U19AI096187, R01AI058706, P30AI050409, P30AI050409,
   P30AI050409, P30AI050409, P30AI050409, R37AI048638, P30AI050409,
   P30AI050409, U19AI096187, P30AI050409, P30AI050409, UM1AI124436,
   R01AI058706, U19AI096187, P30AI050409, UM1AI124436, P30AI050409,
   R01AI048638, P30AI050409, U19AI096187, R01AI058706, P30AI050409,
   R01AI058706, R01AI058706, P30AI050409, P30AI050409, R01AI058706,
   U19AI096187, P30AI050409, U19AI096187, R37AI048638, P30AI050409,
   P30AI050409, U19AI096187, R01AI058706, R37AI048638, P30AI050409,
   P30AI050409, UM1AI124436, R37AI048638, U19AI096187, U19AI096187,
   U19AI096187, U19AI096187, P30AI050409, U19AI096187, U19AI096187,
   P30AI050409, P30AI050409, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409, P30AI050409, U19AI096187, P30AI050409, R01AI048638,
   P30AI050409, U19AI096187, P30AI050409, R01AI058706, R01AI048638,
   U19AI096187, U19AI096187, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409, U19AI096187, P30AI050409, P30AI050409, P30AI050409,
   U19AI096187, P30AI050409, P30AI050409, P30AI050409, P30AI050409,
   U19AI096187, P30AI050409, P30AI050409, U19AI096187, U19AI096187,
   P30AI050409, U19AI096187, U19AI096187, P30AI050409, U19AI096187,
   P30AI050409, P30AI050409, P30AI050409, U19AI096187, P30AI050409,
   P30AI050409, P30AI050409, U19AI096187, P30AI050409, P30AI050409,
   U19AI096187, P30AI050409, U19AI096187, U19AI096187, R01AI048638,
   P30AI050409, P30AI050409, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR,
   NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51OD011132,
   U24OD011023, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, U24OD011023, P51OD011132, U24OD011023, P51OD011132,
   P51OD011132, U24OD011023, P51OD011132, U24OD011023, P51OD011132,
   P51OD011132, P51OD011132, U24OD011023, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132] Funding Source: NIH
   RePORTER
FX The CFAR Immunology/Emory Vaccine Center Flow Cytometry Core is
   supported by an NIH grant (P30 A050509). This work was supported by
   grants NIH P51-RR000165 and P51-OD011132 to the Yerkes National Primate
   Research Center. Studies were also supported by grants P01-AI096187
   (principal investigator, Eric Hunter) and R01-AI58706 (principal
   investigator, Cynthia A. Derdeyn) from the National Institutes of Health
   and a Collaboration for AIDS Vaccine Discovery (CAVD) grant (principal
   investigator, Bali Pulendran) from the Bill and Melinda Gates
   Foundation.
CR Ackerman ME, 2012, ANNU REV MED, V63, P113, DOI 10.1146/annurev-med-050310-085221
   Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016
   Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157
   Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915
   Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259
   Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886
   Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061
   Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766
   Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015
   Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108
   Burton SL, 2015, P NATL ACAD SCI USA, V112, P10780, DOI 10.1073/pnas.1509731112
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Excler JL, 2013, CURR OPIN HIV AIDS, V8, P421, DOI 10.1097/COH.0b013e3283632c26
   Fox CB, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-17
   Francica JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7565
   Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677
   Goff PH, 2015, J VIROL, V89, P3221, DOI 10.1128/JVI.03337-14
   Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016
   Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425
   Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3
   Institute for Vaccine Safety, 2016, EXC 5
   Jensen K, 2016, J VIROL, V90, P7285, DOI 10.1128/JVI.00481-16
   Kannanganat S, 2010, J IMMUNOL, V185, P7262, DOI 10.4049/jimmunol.1000751
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Kilgore KM, 2015, J VIROL, V89, P8130, DOI 10.1128/JVI.01221-14
   Kim JH, 2015, ANNU REV MED, V66, P423, DOI 10.1146/annurev-med-052912-123749
   Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297
   Kwa S, 2014, J VIROL, V88, P9579, DOI 10.1128/JVI.00975-14
   Kwissa M, 2007, J EXP MED, V204, P2733, DOI 10.1084/jem.20071211
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579
   Lai L, 2007, VIROLOGY, V369, P153, DOI 10.1016/j.virol.2007.07.017
   Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199
   Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Lopalco L, 2011, EXPERT REV VACCINES, V10, P1253, DOI [10.1586/ERV.11.98, 10.1586/erv.11.98]
   Manrique M, 2013, J VIROL, V87, P4738, DOI 10.1128/JVI.03531-12
   McKay PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148984
   Moldt B, 2016, AIDS, V30, P1543, DOI 10.1097/QAD.0000000000001102
   Monie A, 2008, BIOL-TARGETS THER, V2, P107
   Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23
   Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223
   Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Reynolds MR, 2011, J VIROL, V85, P9637, DOI 10.1128/JVI.05074-11
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson HL, 2013, EXPERT OPIN BIOL TH, V13, P197, DOI 10.1517/14712598.2012.743527
   Santra S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005042
   Sholukh AM, 2015, VACCINE, V33, P2086, DOI 10.1016/j.vaccine.2015.02.020
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sui Yongjun, 2013, Curr Protoc Immunol, V102, DOI 10.1002/0471142735.im1214s102
   Sundling C, 2010, J EXP MED, V207, P2003, DOI 10.1084/jem.20100025
   Taaffe JE, 2012, J MED PRIMATOL, V41, P24, DOI 10.1111/j.1600-0684.2011.00521.x
   Tuero I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005101
   Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105
   Vecchi S, 2012, J PHARM SCI-US, V101, P17, DOI 10.1002/jps.22759
   Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Xiao P, 2012, J VIROL, V86, P4644, DOI 10.1128/JVI.06812-11
   Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10
NR 68
TC 39
Z9 40
U1 0
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2017
VL 91
IS 4
AR e01844
DI 10.1128/JVI.01844-16
PG 25
WC Virology
SC Virology
GA EK4FU
UT WOS:000393883300015
PM 27928002
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Lever, M
   Silveira, EL
   Nakaya, HI
AF Lever, Melissa
   Silveira, Eduardo L.
   Nakaya, Helder I.
TI Systems Vaccinology Applied to DNA Vaccines: Perspective and Challenges
SO CURRENT ISSUES IN MOLECULAR BIOLOGY
LA English
DT Review
ID ADAPTIVE IMMUNE-RESPONSES; SEASONAL INFLUENZA; MOLECULAR SIGNATURES;
   ANTIBODY-RESPONSES; INNATE IMMUNITY; VACCINATION; EXPRESSION; BIOLOGY;
   ACTIVATION; KNOWLEDGE
AB DNA vaccination represents a new milestone in our technological efforts to avoid infectious diseases. Although this method of vaccination has had success in providing protection in animals, these vaccines suffer from low immunogenicity in humans. Questions remain over the molecular mechanism of DNA vaccination, the best ways in which to safely increase vaccine reactogenecity, and what biomarkers can be used as correlates of protection. Systems vaccinology, which utilizes modern experimental and computational approaches to provide an integrated view of the vaccination process, offers the potential to answer these questions. In this review we discuss the current tools utilized in systems vaccinology, the ways in which they have and can be applied to DNA vaccinology, and challenges faced in the field.
C1 [Lever, Melissa; Silveira, Eduardo L.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-05508 Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-05508 Sao Paulo, Brazil.
EM hnakaya@usp.br
RI Silveira, Eduardo L V/E-5733-2014; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020
OI Silveira, Eduardo L V/0000-0001-8333-2884; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108
CR Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356
   Applequist SE, 2005, J IMMUNOL, V175, P3882, DOI 10.4049/jimmunol.175.6.3882
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010
   Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1
   Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042
   Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156
   Carlisle A, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-3758
   Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84
   Coban C, 2013, HUM VACC IMMUNOTHER, V9, P2216, DOI 10.4161/hv.25893
   Coban C, 2011, CURR GENE THER, V11, P479, DOI 10.2174/156652311798192815
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Dolinski K, 2015, MOL BIOL CELL, V26, P2575, DOI 10.1091/mbc.E13-12-0756
   Esterhuyse MM, 2015, MBIO, V6, DOI 10.1128/mBio.01187-15
   Faurez F, 2010, VACCINE, V28, P3888, DOI 10.1016/j.vaccine.2010.03.040
   Flo J, 2000, IMMUNOLOGY, V100, P259, DOI 10.1046/j.1365-2567.2000.00041.x
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049
   Gunawardena J, 2014, MOL BIOL CELL, V25, P3441, DOI 10.1091/mbc.E14-02-0717
   Hagan T, 2015, VACCINE, V33, P5294, DOI 10.1016/j.vaccine.2015.03.072
   Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540
   Hasson Sidgi Syed Anwer Abdo, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P344, DOI 10.1016/S2221-1691(15)30366-X
   Hofherr SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017076
   Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750
   Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159
   Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Klinman DM, 1997, SPRINGER SEMIN IMMUN, V19, P245, DOI 10.1007/BF00870272
   Kobiyama K, 2013, VACCINES, V1, P278, DOI 10.3390/vaccines1030278
   Kohl P, 2010, CLIN PHARMACOL THER, V88, P25, DOI 10.1038/clpt.2010.92
   Kojima Y, 2002, VACCINE, V20, P2857, DOI 10.1016/S0264-410X(02)00238-4
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Lambert SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051618
   Larocca RA, 2016, NATURE
   Legat A, 2016, CLIN CANCER RES, V22, P1330, DOI 10.1158/1078-0432.CCR-15-1212
   Lewis DJM, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/909406
   Li F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000292
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326
   Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55
   Ma C, 2014, PLANT CELL, V26, P520, DOI 10.1105/tpc.113.121913
   Mann CJ, 2012, GENE THER, V19, P1177, DOI 10.1038/gt.2011.198
   Mastelic B, 2013, BIOLOGICALS, V41, P458, DOI 10.1016/j.biologicals.2013.08.006
   Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824
   Mizukami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101835
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nakaya HI, 2011, WILEY INTERDISCIP RE, V4, P193, DOI DOI 10.1002/WSBM.163
   Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224
   Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Olafsdottir T, 2015, VACCINE, V33, P5302, DOI 10.1016/j.vaccine.2015.04.099
   Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210
   Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448
   Penfold CA, 2011, INTERFACE FOCUS, V1, P857, DOI 10.1098/rsfs.2011.0053
   Pereiro P, 2012, FISH SHELLFISH IMMUN, V32, P1088, DOI 10.1016/j.fsi.2012.03.004
   Pereiro P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104509
   Plotkin S, 2014, P NATL ACAD SCI USA, V111, P12283, DOI 10.1073/pnas.1400472111
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Raha D., 2010, MOL BIOL
   Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829
   Reif DM, 2009, GENES IMMUN, V10, P112, DOI 10.1038/gene.2008.80
   Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]
   Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015
   Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328
   Soon WW, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.61
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013
   Takeshita F, 2006, J VIROL, V80, P6218, DOI 10.1128/JVI.00121-06
   Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39
   Wang S, 2013, NAT PROTOC, V8, P2502, DOI 10.1038/nprot.2013.150
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Xu HQ, 2010, J GENE MED, V12, P97, DOI 10.1002/jgm.1412
   Yang F, 2008, J PROTEOME RES, V7, P741, DOI 10.1021/pr700663q
   Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109
   Zarate-Blades CR, 2009, J GENE MED, V11, P66, DOI 10.1002/jgm.1269
   Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644
NR 88
TC 3
Z9 3
U1 0
U2 10
PU HORIZON SCIENTIFIC PRESS
PI POOLE
PA UNIT 7570, PO BOX 7169, WAREHAM RD, POOLE BH15 9EL, ENGLAND
SN 1467-3037
EI 1467-3045
J9 CURR ISSUES MOL BIOL
JI Curr. Issues Mol. Biol.
PY 2017
VL 22
BP 1
EP 16
DI 10.21775/cimb.022.001
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EN4FK
UT WOS:000395963200001
PM 27648510
DA 2020-12-17
ER

PT J
AU Ellebedy, AH
   Jackson, KJL
   Kissick, HT
   Nakaya, HI
   Davis, CW
   Roskin, KM
   McElroy, AK
   Oshansky, CM
   Elbein, R
   Thomas, S
   Lyon, GM
   Spiropoulou, CF
   Mehta, AK
   Thomas, PG
   Boyd, SD
   Ahmed, R
AF Ellebedy, Ali H.
   Jackson, Katherine J. L.
   Kissick, Haydn T.
   Nakaya, Helder I.
   Davis, Carl W.
   Roskin, Krishna M.
   McElroy, Anita K.
   Oshansky, Christine M.
   Elbein, Rivka
   Thomas, Shine
   Lyon, George M.
   Spiropoulou, Christina F.
   Mehta, Aneesh K.
   Thomas, Paul G.
   Boyd, Scott D.
   Ahmed, Rafi
TI Defining antigen-specific plasmablast and memory B cell subsets in human
   blood after viral infection or vaccination
SO NATURE IMMUNOLOGY
LA English
DT Article
ID INFLUENZA INFECTION; VIRUS-INFECTION; GENERATION; ANTIBODIES; RESPONSES;
   NETWORKS
AB Antigen-specific B cells bifurcate into antibody-secreting cells (ASCs) and memory B cells (MBCs) after infection or vaccination. ASCs (plasmablasts) have been extensively studied in humans, but less is known about B cells that become activated but do not differentiate into plasmablasts. Here we have defined the phenotype and transcriptional program of a subset of antigen-specific B cells, which we have called 'activated B cells' (ABCs), that were distinct from ASCs and were committed to the MBC lineage. We detected ABCs in humans after infection with Ebola virus or influenza virus and also after vaccination. By simultaneously analyzing antigen-specific ASCs and ABCs in human blood after vaccination against influenza virus, we investigated the clonal overlap and extent of somatic hypermutation (SHM) in the ASC (effector) and ABC (memory) lineages. Longitudinal tracking of vaccination-induced hemagglutinin (HA)-specific clones revealed no overall increase in SHM over time, which suggested that repeated annual immunization might have limitations in enhancing the quality of influenza-virus-specific antibody.
C1 [Ellebedy, Ali H.; Davis, Carl W.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA.
   [Ellebedy, Ali H.; Kissick, Haydn T.; Davis, Carl W.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Jackson, Katherine J. L.; Roskin, Krishna M.; Boyd, Scott D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.
   [Kissick, Haydn T.] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA.
   [Nakaya, Helder I.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [McElroy, Anita K.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.
   [McElroy, Anita K.; Spiropoulou, Christina F.] US Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA USA.
   [Oshansky, Christine M.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.
   [Elbein, Rivka; Thomas, Shine; Lyon, George M.; Mehta, Aneesh K.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA.
RP Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.; Boyd, SD (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.
EM sboyd1@stanford.edu; rahmed@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Jackson, Katherine/AAE-4326-2019; Thomas,
   Paul G./H-1063-2018; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Thomas, Paul G./0000-0001-7955-0256;
   Nakaya, Helder I/0000-0001-5297-9108; McElroy,
   Anita/0000-0001-6764-7536; Jackson, Katherine/0000-0002-9952-7069
FU National Institute of Allergy and Infectious Diseases of the US National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN266200700006C,
   1P01AI097092, U19AI117891, T32AI074492, U19AI09525801, UM1AI100663,
   U01AI104342]; Advanced Immunization Technologies [280873]; European
   UnionEuropean Union (EU); National Center for Advancing Translational
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR000454]; National Council for
   Scientific and Technological Development of BrazilNational Council for
   Scientific and Technological Development (CNPq); NATIONAL CENTER FOR
   ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR000454,
   UL1TR000454, UL1TR000454, UL1TR000454, UL1TR000454, UL1TR000454,
   UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [UM1AI100663, P01AI097092,
   U19AI117891, UM1AI100663, P01AI097092, U19AI117891, P01AI097092,
   UM1AI100663, U01AI104342, U19AI117891, UM1AI100663, P01AI097092,
   U19AI117891, UM1AI100663, P01AI097092, UM1AI100663, U19AI117891,
   P01AI097092, P01AI097092, UM1AI100663, UM1AI100663, P01AI097092,
   P01AI097092, P01AI097092, T32AI074492, P01AI097092, UM1AI100663,
   U19AI117891, T32AI074492, P01AI097092, UM1AI100663, UM1AI100663,
   U01AI104342, T32AI074492, U19AI117891, UM1AI100663, T32AI074492,
   P01AI097092, UM1AI100663, UM1AI100663, UM1AI100663, UM1AI100663,
   P01AI097092, P01AI097092, UM1AI100663, UM1AI100663, P01AI097092,
   P01AI097092, UM1AI100663, UM1AI100663, UM1AI100663, T32AI074492,
   P01AI097092, UM1AI100663, P01AI097092, UM1AI100663, U01AI104342,
   UM1AI100663, U19AI117891, U19AI117891, UM1AI100663, UM1AI100663,
   T32AI074492, UM1AI100663, UM1AI100663, UM1AI100663, P01AI097092,
   P01AI097092, UM1AI100663, P01AI097092, T32AI074492, UM1AI100663,
   UM1AI100663, P01AI097092, T32AI074492, P01AI097092, T32AI074492,
   UM1AI100663, T32AI074492, U19AI117891, U01AI104342, UM1AI100663,
   U01AI104342, P01AI097092, U19AI117891, P01AI097092, UM1AI100663,
   UM1AI100663, UM1AI100663, UM1AI100663, T32AI074492, UM1AI100663,
   U19AI117891, U19AI117891, UM1AI100663, P01AI097092, UM1AI100663,
   UM1AI100663, P01AI097092, P01AI097092, P01AI097092, U19AI117891,
   U19AI117891, P01AI097092, UM1AI100663, P01AI097092, P01AI097092,
   T32AI074492, UM1AI100663, P01AI097092, P01AI097092, UM1AI100663,
   UM1AI100663, P01AI097092, UM1AI100663, P01AI097092, P01AI097092,
   T32AI074492, U19AI117891, T32AI074492, UM1AI100663, UM1AI100663,
   UM1AI100663, U01AI104342, P01AI097092, P01AI097092, UM1AI100663,
   P01AI097092, P01AI097092, UM1AI100663, U19AI117891, P01AI097092,
   U19AI117891, UM1AI100663, UM1AI100663, UM1AI100663, T32AI074492,
   U19AI117891, T32AI074492, UM1AI100663, P01AI097092, P01AI097092,
   UM1AI100663, U19AI117891, UM1AI100663] Funding Source: NIH RePORTER
FX We thank R. Karaffa and S. Durham for technical assistance. Supported by
   the National Institute of Allergy and Infectious Diseases of the US
   National Institutes of Health (HHSN266200700006C, 1P01AI097092 and
   U19AI117891 to R.A.; T32AI074492 to A.E.; and U19AI09525801, UM1AI100663
   and U01AI104342 to S.D.B.), Advanced Immunization Technologies (280873),
   the European Union (R.A.), the National Center for Advancing
   Translational Sciences (UL1TR000454 to A.K.M.) and The National Council
   for Scientific and Technological Development of Brazil (H.I.N.). The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institute of
   Allergy and Infectious Diseases or the National Institutes of Health or
   that of the Centers for Disease Control and Prevention.
CR Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092
   Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669
   Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969
   Frolich D, 2010, J IMMUNOL, V185, P3103, DOI 10.4049/jimmunol.1000911
   Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109
   Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112
   McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128
   Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nutt SL, 1999, NATURE, V401, P556
   Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010
   Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507
   Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC
   Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129
   Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740
   Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]
   Singh H, 2014, TRENDS IMMUNOL, V35, P211, DOI 10.1016/j.it.2014.03.006
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117
   Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716
   Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531
   Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087
   Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
   Xu HP, 2015, NAT IMMUNOL, V16, P1274, DOI 10.1038/ni.3287
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
NR 32
TC 106
Z9 107
U1 0
U2 19
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD OCT
PY 2016
VL 17
IS 10
BP 1226
EP +
DI 10.1038/ni.3533
PG 11
WC Immunology
SC Immunology
GA DX3VD
UT WOS:000384302900014
PM 27525369
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Im, SJ
   Hashimoto, M
   Gerner, MY
   Lee, J
   Kissick, HT
   Urger, MCB
   Shan, Q
   Hale, JS
   Lee, J
   Nasti, TH
   Sharpe, AH
   Freeman, GJ
   Germain, RN
   Nakaya, HI
   Xue, HH
   Ahmed, R
AF Im, Se Jin
   Hashimoto, Masao
   Gerner, Michael Y.
   Lee, Junghwa
   Kissick, Haydn T.
   Urger, Matheus C. B.
   Shan, Qiang
   Hale, J. Scott
   Lee, Judong
   Nasti, Tahseen H.
   Sharpe, Arlene H.
   Freeman, Gordon J.
   Germain, Ronald N.
   Nakaya, Helder I.
   Xue, Hai-Hui
   Ahmed, Rafi
TI Defining CD8(+) T cells that provide the proliferative burst after PD-1
   therapy
SO NATURE
LA English
DT Article
ID CHRONIC VIRAL-INFECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS;
   TRANSCRIPTION FACTOR; LYMPHOID ORGANS; MEMORY; PERSISTENCE; EFFECTOR;
   FH; DIFFERENTIATION; EXHAUSTION
AB Chronic viral infections are characterized by a state of CD8(+) T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor(1-4). A better understanding of the mechanisms that regulate CD8(+) T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8(+) T cells. Here we identify a population of virus-specific CD8(+) T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8(+) T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8(+) T-cell subset was characterized by a unique gene signature that was related to that of CD4(+) T follicular helper (T-FH) cells, CD8(+) T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4(+) T(H)1 cells and CD8(+) terminal effectors. This CD8(+) T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8(+) T cells. These PD-1(+) CD8(+) T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8(+) T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8(+) T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8(+) T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.
C1 [Im, Se Jin; Hashimoto, Masao; Lee, Junghwa; Kissick, Haydn T.; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Im, Se Jin; Hashimoto, Masao; Lee, Junghwa; Kissick, Haydn T.; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Gerner, Michael Y.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Gerner, Michael Y.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98109 USA.
   [Kissick, Haydn T.] Emory Univ, Dept Urol, Sch Med, Atlanta, GA 30322 USA.
   [Urger, Matheus C. B.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil.
   [Shan, Qiang; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.
   [Sharpe, Arlene H.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA.
   [Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.
   [Freeman, Gordon J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Dept Med, Boston, MA 02115 USA.
   [Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA.
RP Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
EM rahmed@emory.edu
RI Germain, Ronald/ABE-7090-2020; Hashimoto, Masao/AAC-9225-2020; Freeman,
   Gordon/AAC-5380-2019; Germain, Ronald N./Z-1945-2019; Nakaya, Helder
   I/A-1397-2010; Nakaya, Helder/AAF-1738-2020
OI Hashimoto, Masao/0000-0002-7120-1390; Freeman,
   Gordon/0000-0002-7210-5616; Nakaya, Helder I/0000-0001-5297-9108;
   Nakaya, Helder/0000-0001-5297-9108; Xue, Hai-Hui/0000-0002-9163-7669
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI30048, P01
   AI056299, R01 AI112579, R01 AI121080]; Intramural Research Program of
   NIAID, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); Prostate Cancer Foundation; Swim Across
   America; CNPqNational Council for Scientific and Technological
   Development (CNPq); NATIONAL CANCER INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Cancer Institute (NCI) [P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P01AI080192, P01AI080192, P01AI080192, P01AI056299,
   P01AI056299, ZIAAI001034, P01AI056299, R01AI121080, P01AI056299,
   P01AI056299, P01AI056299, P01AI056299, P01AI080192, ZIAAI001034,
   P01AI056299, R01AI121080, P01AI080192, P01AI056299, P01AI080192,
   P01AI080192, P01AI080192, P01AI056299, ZIAAI001034, P01AI080192,
   P01AI080192, P01AI056299, ZIAAI001034, ZIAAI001034, P01AI080192,
   P01AI056299, P01AI056299, P01AI080192, ZIAAI001034, R01AI121080,
   P01AI080192, P01AI056299, P01AI056299, P01AI080192, P01AI080192,
   P01AI056299, R01AI112579, P01AI056299, P01AI056299, P01AI056299,
   R01AI030048, P01AI080192, P01AI056299, P01AI056299, P01AI080192,
   P01AI080192, P01AI056299, R01AI030048, P01AI080192, P01AI056299,
   R01AI030048, R01AI030048, P01AI080192, P01AI056299, P01AI056299,
   P01AI056299, P01AI056299, P01AI056299, R01AI030048, P01AI056299,
   P01AI056299, P01AI056299, P01AI056299, P01AI080192, P01AI056299,
   P01AI056299, P01AI056299, P01AI056299, P01AI056299, P01AI056299,
   R01AI030048, P01AI056299, P01AI056299, P01AI056299, P01AI056299,
   P01AI080192, P01AI056299, P01AI080192, P01AI056299, P01AI080192,
   R01AI121080, P01AI056299, P01AI080192, P01AI056299, ZIAAI001034,
   P01AI056299, P01AI056299, P01AI080192, P01AI056299, P01AI056299,
   P01AI080192, P01AI056299, P01AI056299, P01AI056299, P01AI080192,
   P01AI056299, P01AI080192, P01AI056299, P01AI056299, P01AI056299,
   R01AI030048, P01AI056299, R01AI030048, R01AI030048, P01AI056299,
   P01AI080192, ZIAAI001034, ZIAAI001034, R01AI030048, P01AI056299,
   P01AI056299, R01AI030048, R01AI112579, P01AI056299, P01AI080192,
   R01AI030048, P01AI056299, P01AI056299, R01AI112579, P01AI080192,
   R01AI121080, P01AI056299, P01AI080192, P01AI056299, P01AI056299,
   P01AI080192, P01AI056299, P01AI080192, P01AI056299, R01AI112579,
   P01AI080192, P01AI056299, P01AI056299, P01AI056299, P01AI056299,
   P01AI056299, R01AI030048, P01AI080192, P01AI056299, P01AI056299,
   P01AI056299, R01AI030048, R01AI030048, P01AI080192, ZIAAI001034,
   P01AI080192, P01AI056299, P01AI056299, ZIAAI001034, P01AI056299,
   P01AI080192, R01AI030048, R01AI030048, P01AI056299, P01AI056299,
   P01AI056299, P01AI056299, P01AI056299, P01AI056299, R01AI030048,
   R01AI112579] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health grants R01
   AI30048 (R.A.), P01 AI056299 (R.A. and A.H.S.), R01 AI112579 (H.H.X.)
   and R01 AI121080 (H.-H.X.) and also by the Intramural Research Program
   of NIAID, NIH (R.N.G. and M.Y.G.). H.T.K. is supported by funding from
   the Prostate Cancer Foundation and Swim Across America. H.I.N. receives
   a CNPq research fellowship. The authors acknowledge technical support
   from R. Karaffa and S. Durham for cell sorting.
CR Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100
   Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679
   Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105
   Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226
   Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400
   Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021
   Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383
   Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011
   Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099
   Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823
   Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107
   Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870
   Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010
   Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948
   Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370
   Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858
   MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994
   MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993
   Miyazaki M, 2015, GENE DEV, V29, P409, DOI 10.1101/gad.255331.114
   Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a
   Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104
   Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7
   Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620
   Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097
   Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172
   Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003
   Wu JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002565
   Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229
   Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798
   Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158
   Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205
NR 37
TC 450
Z9 459
U1 10
U2 101
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD SEP 15
PY 2016
VL 537
IS 7620
BP 417
EP +
DI 10.1038/nature19330
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV7EC
UT WOS:000383098000057
PM 27501248
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Lee, EK
   Nakaya, HI
   Yuan, F
   Querec, TD
   Burel, G
   Pietz, FH
   Benecke, BA
   Pulendran, B
AF Lee, Eva K.
   Nakaya, Helder I.
   Yuan, Fan
   Querec, Troy D.
   Burel, Greg
   Pietz, Ferdinand H.
   Benecke, Bernard A.
   Pulendran, Bali
TI Machine Learning for Predicting Vaccine Immunogenicity
SO INTERFACES
LA English
DT Article
DE machine learning; multiple-group classification; vaccine immunogenicity
   prediction; influenza; yellow fever; malaria; health security;
   prophylactic medical countermeasures; hypothesis generation; vaccine
   design for emerging infections
ID PROTEIN-KINASE-IV; INFLUENZA VACCINATION; SEASONAL INFLUENZA; SYSTEMS
   BIOLOGY; SENSOR GCN2; IMMUNITY; CLASSIFICATION; RESPONSES;
   DIFFERENTIATION; IMMUNIZATION
AB ability to predict how different individuals will respond to vaccination and to understand what best protects individuals from infection greatly facilitates developing next-generation vaccines. It facilitates both the rapid design and evaluation of new and emerging vaccines and identifies individuals unlikely to be protected by vaccine. We describe a general-purpose machine-learning framework, DAMIP, for discovering gene signatures that can predict vaccine immunity and efficacy. DAMIP is a multiple-group, concurrent classifier that offers unique features not present in other models: a nonlinear data transformation to manage the curse of dimensionality and noise; a reserved-judgment region that handles fuzzy entities; and constraints on the allowed percentage of misclassifications.
   Using DAMIP, implemented results for yellow fever demonstrated that, for the first time, a vaccine's ability to immunize a patient could be successfully predicted (with accuracy of greater than 90 percent) within one week after vaccination. A gene identified by DAMIP, EIF2AK4, decrypted a seven-decade-old mystery of vaccination. Results for flu vaccine demonstrated DAMIP's applicability to both live-attenuated and inactivated vaccines. Results in a malaria study enabled targeted delivery to individual patients.
   Our project's methods and findings permit highlighting and probabilistically prioritizing hypothesis design to enhance biological discovery. Moreover, they guide the rapid development of better vaccines to fight emerging infections, and improve monitoring for poor responses in the elderly, infants, or others with weakened immune systems. In addition, the project's work should help with universal flu-vaccine design.
C1 [Lee, Eva K.; Yuan, Fan] NSF Whitaker Ctr Operat Res Med & HealthCare, Atlanta, GA 30332 USA.
   [Lee, Eva K.; Yuan, Fan] NSF I UCRC Ctr Hlth Org Transformat, Atlanta, GA 30332 USA.
   [Lee, Eva K.; Yuan, Fan] Georgia Inst Technol, Ind & Syst Engn & Comp Sci, Atlanta, GA 30332 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA.
   [Querec, Troy D.] Ctr Dis Control & Prevent, Chron Viral Dis Branch, Atlanta, GA 30322 USA.
   [Burel, Greg; Pietz, Ferdinand H.] Ctr Dis Control & Prevent, Strateg Natl Stockpile, Atlanta, GA 30322 USA.
   [Benecke, Bernard A.] Ctr Dis Control & Prevent, Global Dis Detect & Emergency Response, Atlanta, GA 30322 USA.
   [Pulendran, Bali] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30329 USA.
RP Lee, EK (corresponding author), NSF Whitaker Ctr Operat Res Med & HealthCare, Atlanta, GA 30332 USA.; Lee, EK (corresponding author), NSF I UCRC Ctr Hlth Org Transformat, Atlanta, GA 30332 USA.; Lee, EK (corresponding author), Georgia Inst Technol, Ind & Syst Engn & Comp Sci, Atlanta, GA 30332 USA.
EM eva.lee@gatech.edu; hnakaya@gmail.com
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU National Science FoundationNational Science Foundation (NSF) [0832390,
   1361532, 1516074]; National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [U19
   AI 057266, U19 AI090023-01]; Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [200-2011-38339]
FX The work is partially supported by grants from the National Science
   Foundation [Grants 0832390, 1361532, 1516074], National Institutes of
   Health [Grants U19 AI 057266, U19 AI090023-01], and Centers for Disease
   Control and Prevention [Grant no. 200-2011-38339]. The findings and
   conclusions in this paper are those of the authors and do not
   necessarily represent the official position of the funding agencies.
CR Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002
   Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x
   Brooks JP, 2014, INFORMS J COMPUT, V26, P567, DOI 10.1287/ijoc.2013.0584
   Brooks JP, 2010, ANN OPER RES, V174, P147, DOI 10.1007/s10479-008-0424-0
   Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x
   Cancro MP, 2006, ANN RHEUM DIS, V65, P34, DOI 10.1136/ard.2006.058412
   Chen GL, 2010, VIROLOGY, V398, P109, DOI 10.1016/j.virol.2009.12.003
   Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681
   Deaglio S, 2001, LEUKEMIA RES, V25, P1, DOI 10.1016/S0145-2126(00)00093-X
   Diaz-Uriarte R, 2006, GENE SELECTION CLASS
   Easton T, 2003, MATH PROGRAM, V98, P177, DOI 10.1007/s10107-003-0401-y
   Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100
   Fessenden M, 2015, NATURE, V525, P409, DOI 10.1038/525409a
   Fiore AE, 2010, PREVENTION CONTROL I
   Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173
   International Society of Vaccines, 2016, ISV PAP YEAR 2011
   Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968
   Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968
   Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200
   Koczor CA, 2013, PHYSIOL GENOMICS, V45, P597, DOI 10.1152/physiolgenomics.00013.2013
   Krebs J, 1997, BIOCHEM BIOPH RES CO, V241, P383, DOI 10.1006/bbrc.1997.7823
   Lee EK, 2004, IEEE T BIO-MED ENG, V51, P82, DOI 10.1109/TBME.2003.820323
   Lee EK, 2003, INFORMS J COMPUT, V15, P23, DOI 10.1287/ijoc.15.1.23.15158
   Lee EK, 2002, PHYS MED BIOL, V47, P1891, DOI 10.1088/0031-9155/47/11/305
   Lee EK, 2012, OPTIMIZATION DATA AN, P83
   Lee EK, 2016, SIAM J OPTI IN PRESS
   Lee EK, 2008, AIP C P DAT MIN SYST, P1
   Lee EK, 2007, AIP CONF PROC, V953, P1, DOI 10.1063/1.2817343
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Lee EK, 2015, INTERFACES, V45, P58, DOI 10.1287/inte.2014.0788
   Lee Eva K, 2012, AMIA Annu Symp Proc, V2012, P495
   Lee EK, 2009, SPRINGER SER OPTIM A, V26, P381, DOI 10.1007/978-0-387-09770-1_12
   Lee KK, 2009, LECT NOTES COMPUT SC, V5547, P1, DOI 10.1007/978-3-642-01929-6_1
   Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003
   Lorenzetti L., 2015, WORLDS 1 MALARIA VAC
   McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Monath TP, 2008, VACCINES, P959
   Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186
   Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829
   Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06
   Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975
   Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515
   Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2
   Steinwart I, 2005, IEEE T INFORM THEORY, V51, P128, DOI 10.1109/TIT.2004.839514
   Sturm JJ, 2010, ACAD PEDIATR, V10, P70, DOI 10.1016/j.acap.2009.10.001
   Thomas R, 2010, CLIN REV ALLERG IMMU, V38, P159, DOI 10.1007/s12016-009-8148-8
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   US Food and Drug Administration Center for Biologics Evaluation and Research, 2007, GUID IND CLIN DAT NE
   Wang SL, 2001, CELL GROWTH DIFFER, V12, P351
   Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b
NR 59
TC 3
Z9 3
U1 1
U2 15
PU INFORMS
PI CATONSVILLE
PA 5521 RESEARCH PARK DR, SUITE 200, CATONSVILLE, MD 21228 USA
SN 0092-2102
EI 1526-551X
J9 INTERFACES
JI Interfaces
PD SEP-OCT
PY 2016
VL 46
IS 5
SI SI
BP 368
EP 389
DI 10.1287/inte.2016.0862
PG 22
WC Management; Operations Research & Management Science
SC Business & Economics; Operations Research & Management Science
GA EF3XU
UT WOS:000390259300002
DA 2020-12-17
ER

PT J
AU da Silva, FP
   Munoz, M
   de Lima, TM
   Severino, P
   Machado, MCC
   Reis, EM
   Nakaya, H
   Irineu, V
AF Pinheiro da Silva, F.
   Munoz, M.
   Martins de Lima, T.
   Severino, P.
   Cerqueira Cesar Machado, M.
   Moraes Reis, E.
   Nakaya, H.
   Irineu, V
TI Cathelicidin binds to transcriptional complexes in cancer cells
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT International Congress of Immunology (ICI)
CY AUG 21-26, 2016
CL Melbourne, AUSTRALIA
C1 [Pinheiro da Silva, F.; Martins de Lima, T.; Cerqueira Cesar Machado, M.; Irineu, V] Univ Sao Paulo, Emergency Med, Sao Paulo, Brazil.
   [Munoz, M.; Nakaya, H.] Univ Sao Paulo, Pharmacol, Sao Paulo, Brazil.
   [Severino, P.] Hosp Albert Einstein, Sao Paulo, Brazil.
   [Moraes Reis, E.] Univ Sao Paulo, Chem, Sao Paulo, Brazil.
RI Severino, Patricia/H-2013-2012; da Silva, Fabiano Pinheiro/F-3464-2011;
   machado, marcel/E-2129-2012; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020
OI Severino, Patricia/0000-0002-6682-9343; da Silva, Fabiano
   Pinheiro/0000-0003-2673-2202; machado, marcel/0000-0002-0729-1635;
   Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108
NR 0
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD AUG
PY 2016
VL 46
SU 1
SI SI
MA 1310
BP 1214
EP 1214
PG 1
WC Immunology
SC Immunology
GA DW4KA
UT WOS:000383610402843
DA 2020-12-17
ER

PT J
AU Schroder, WA
   Anraku, I
   Le, TT
   Hirata, TDC
   Nakaya, HI
   Major, L
   Ellis, JJ
   Suhrbier, A
AF Schroder, Wayne A.
   Anraku, Itaru
   Le, Thuy T.
   Hirata, Thiago D. C.
   Nakaya, Helder I.
   Major, Lee
   Ellis, Jonathan J.
   Suhrbier, Andreas
TI SerpinB2 Deficiency Results in a Stratum Corneum Defect and Increased
   Sensitivity to Topically Applied Inflammatory Agents
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID PLASMINOGEN-ACTIVATOR INHIBITOR; NF-KAPPA-B; HUMAN
   EPIDERMAL-KERATINOCYTES; DIFFERENTIAL GENE-EXPRESSION; ALLERGIC
   CONTACT-DERMATITIS; CHIKUNGUNYA VIRUS ARTHRITIS; CORNIFIED
   CELL-ENVELOPE; SKIN TUMOR PROMOTION; ATOPIC-DERMATITIS; TYPE-2 PAI-2
AB SerpinB2 (plasminogen activator inhibitor type 2) is constitutively expressed at high levels by differentiating keratinocytes in mice and humans; however, the physiological function of keratinocyte SerpinB2 remains unclear. Herein, we show that SerpinB2(-/-) mice are more susceptible to contact dermatitis after topical application of dinitrofluorobenzene, and show enhanced inflammatory lesions after topical applications of phorbol ester. Untreated SerpinB2(-/-) mice showed no overt changes in epithelial structure, and we were unable to find evidence for a role for keratinocyte SerpinB2 in regulating immunity, apoptosis, IL-1 beta production, proteasomal activity, or wound healing. Instead, the phenotype was associated with impaired skin barrier function and a defective stratum corneum, with SerpinB2(-/-) mice showing increased transepidermal water Loss, increased overt Loss of stratum corneum in inflammatory lesions, and impaired stratum corneum thickening after phorbol ester treatment. Immunoblotting suggested that SerpinB2 (cross-linked into the cornified envelope) is present in the stratum corneum and retains the ability to form covalent inhibitory complexes with urokinase. Data suggest that the function of keratinocyte SerpinB2 is protection of the stratum corneum from proteolysis via inhibition of urokinase, thereby maintaining the integrity and barrier function of the stratum corneum, particularly during times of skin inflammation. Implications for studies involving genetically modified mice treated with topical agents and human dermatological conditions, such as contact dermatitis, are discussed.
C1 [Schroder, Wayne A.; Anraku, Itaru; Le, Thuy T.; Major, Lee; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol Grp, Brisbane, Qld, Australia.
   [Hirata, Thiago D. C.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Ellis, Jonathan J.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld, Australia.
RP Suhrbier, A (corresponding author), Royal Brisbane Hosp, QIMR Berghofer, Locked Bag 2000, Brisbane, Qld 4029, Australia.
EM andreas.suhrbier@gimrberghofer.edu.au
RI Hirata, Thiago Dominguez Crespo/AAP-1903-2020; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Ellis, Jonathan
   J/F-2920-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Ellis, Jonathan J/0000-0003-0410-5064; Ellis,
   Jonathan/0000-0003-0218-546X; Hirata, Thiago/0000-0002-3967-8121
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia [APP1043104]
FX Supported by grant APP1043104, National Health and Medical Research
   Council of Australia (W.A.S. and A.S.).
CR Bechtel MJ, 1996, BRIT J DERMATOL, V134, P411, DOI 10.1046/j.1365-2133.1996.24759.x
   Bechtel MJ, 1998, BRIT J DERMATOL, V138, P22
   Boncela J, 2011, J BIOL CHEM, V286, P43164, DOI 10.1074/jbc.M111.245647
   Botta A, 2012, J CELL SCI, V125, P4241, DOI 10.1242/jcs.096289
   Braungart E, 2001, J INVEST DERMATOL, V116, P778, DOI 10.1046/j.1523-1747.2001.01310.x
   Brem R, 2001, ONCOGENE, V20, P2854, DOI 10.1038/sj.onc.1204403
   Busse D, 2014, J INVEST DERMATOL, V134, P2823, DOI 10.1038/jid.2014.273
   Christensen AD, 2014, IMMUN INFLAMM DIS, V2, P21, DOI 10.1002/iid3.16
   Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x
   Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110
   Cochran BJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-43
   COHEN RL, 1989, J BIOL CHEM, V264, P8375
   Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133
   de Veer SJ, 2014, PROTEOM CLIN APPL, V8, P389, DOI 10.1002/prca.201300081
   Dear AE, 2000, BBA-GENE STRUCT EXPR, V1492, P15, DOI 10.1016/S0167-4781(00)00041-5
   Delhase M, 2012, P NATL ACAD SCI USA, V109, pE177, DOI 10.1073/pnas.1119296109
   Denda M, 2014, J INVEST DERMATOL, V134, P2677, DOI 10.1038/jid.2014.229
   Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259
   Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686
   Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010
   Elias PM, 2014, J ALLERGY CLIN IMMUN, V134, P781, DOI 10.1016/j.jaci.2014.05.048
   Fan J, 2004, ACTA BIOCH BIOPH SIN, V36, P42, DOI 10.1093/abbs/36.1.42
   Fernandez-Soria V, 2006, INT J ONCOL, V28, P143
   Fish RJ, 2006, EXP CELL RES, V312, P350, DOI 10.1016/j.yexcr.2005.11.003
   Fleetwood AJ, 2014, J IMMUNOL, V192, P3540, DOI 10.4049/jimmunol.1302864
   FURSTENBERGER G, 1981, P NATL ACAD SCI-BIOL, V78, P7722, DOI 10.1073/pnas.78.12.7722
   Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654
   Gardiner EE, 2014, J THROMB HAEMOST, V12, P1703, DOI 10.1111/jth.12704
   Gaspari A. A., 2001, CURR PROTOC IMMUNOL
   GISSLER HM, 1993, BRIT J DERMATOL, V128, P612, DOI 10.1111/j.1365-2133.1993.tb00254.x
   Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012
   Gliozzi M, 2013, J AUTOIMMUN, V40, P122, DOI 10.1016/j.jaut.2012.09.003
   Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009
   Grinberg-Bleyer Y, 2015, J IMMUNOL, V194, P2472, DOI 10.4049/jimmunol.1402608
   Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031
   Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023
   Hanson JL, 2004, CANCER RES, V64, P7248, DOI 10.1158/0008-5472.CAN-03-3898
   Hayashi K, 2015, ONCOGENE, V34, P4647, DOI 10.1038/onc.2014.398
   Heda GD, 2008, J AM PODIAT MED ASSN, V98, P345, DOI 10.7547/0980345
   Heinrich J, 2000, J MOL MED-JMM, V78, P380, DOI 10.1007/s001090000116
   Hibino T, 1999, J INVEST DERMATOL, V112, P85, DOI 10.1046/j.1523-1747.1999.00466.x
   Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113
   Jang S, 2010, J DERMATOL SCI, V59, P25, DOI 10.1016/j.jdermsci.2010.04.012
   JENSEN PH, 1994, BRIT J CANCER, V70, P834, DOI 10.1038/bjc.1994.407
   JENSEN PJ, 1995, EXP CELL RES, V217, P65, DOI 10.1006/excr.1995.1064
   Judex MO, 2005, AM J PATHOL, V166, P645, DOI 10.1016/S0002-9440(10)62285-7
   Kalinin A, 2001, J CELL SCI, V114, P3069
   Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150
   Kessler-Becker D, 2004, EXP DERMATOL, V13, P708, DOI 10.1111/j.0906-6705.2004.00222.x
   Kielar D, 2003, J INVEST DERMATOL, V121, P465, DOI 10.1046/j.1523-1747.2003.12404.x
   Kiss A, 2016, MOL CARCINOGEN, V55, P563, DOI 10.1002/mc.22303
   Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041
   Kottner J, 2013, ARCH DERMATOL RES, V305, P315, DOI 10.1007/s00403-012-1313-6
   KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007
   Kubo A, 2013, AM J HUM GENET, V93, P945, DOI 10.1016/j.ajhg.2013.09.015
   Lammers G, 2012, MACROMOL BIOSCI, V12, P675, DOI 10.1002/mabi.201100443
   Lavker RM, 1998, J INVEST DERMATOL, V110, P917, DOI 10.1046/j.1523-1747.1998.00223.x
   Li QT, 2011, CARCINOGENESIS, V32, P1782, DOI 10.1093/carcin/bgr207
   Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016483
   Lian XH, 2004, BIOL CELL, V96, P109, DOI 10.1016/j.biolcel.2003.09.007
   Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173
   Lund LR, 1996, J INVEST DERMATOL, V106, P622, DOI 10.1111/1523-1747.ep12345425
   Lyons-Giordano B, 1994, Exp Dermatol, V3, P85, DOI 10.1111/j.1600-0625.1994.tb00052.x
   LYONSGIORDANO B, 1994, HISTOCHEMISTRY, V101, P105, DOI 10.1007/BF00269356
   Mahony D, 1999, EUR J BIOCHEM, V263, P765, DOI 10.1046/j.1432-1327.1999.00552.x
   Major L, 2011, EXP CELL RES, V317, P338, DOI 10.1016/j.yexcr.2010.10.016
   Major LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057343
   McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973
   Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x
   Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7
   Melino G, 2005, CELL DEATH DIFFER, V12, P1457, DOI 10.1038/sj.cdd.4401781
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Norling LV, 2013, CURR OPIN PHARMACOL, V13, P570, DOI 10.1016/j.coph.2013.05.008
   Oji V, 2006, BRIT J DERMATOL, V154, P860, DOI 10.1111/j.1365-2133.2005.07109.x
   Park JY, 2010, MOL CELL TOXICOL, V6, P79, DOI 10.1007/s13273-010-0011-8
   PARKINSON FK, 1983, CARCINOGENESIS, V4, P857, DOI 10.1093/carcin/4.7.857
   Pedersen MB, 2007, J INVEST DERMATOL, V127, P2585, DOI 10.1038/sj.jid.5700902
   Peng W, 2015, CLIN EXP ALLERGY, V45, P566, DOI 10.1111/cea.12495
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Reinartz J, 1996, EXP CELL RES, V223, P91, DOI 10.1006/excr.1996.0061
   Riggs PK, 2005, MOL CARCINOGEN, V44, P122, DOI 10.1002/mc.20127
   Risse BC, 1998, HISTOCHEM CELL BIOL, V110, P559, DOI 10.1007/s004180050318
   Risse BC, 2000, J CELL PHYSIOL, V182, P281, DOI 10.1002/(SICI)1097-4652(200002)182:2<281::AID-JCP17>3.0.CO;2-D
   Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035
   Rundhaug Joyce E, 2010, Cancers (Basel), V2, P436, DOI 10.3390/cancers2020436
   Rushworth LK, 2014, P NATL ACAD SCI USA, V111, P18267, DOI 10.1073/pnas.1420159112
   Schaefer BM, 1996, AUTOIMMUNITY, V23, P155, DOI 10.3109/08916939608995339
   Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455
   Schroder WA, 2010, PARASITE IMMUNOL, V32, P764, DOI 10.1111/j.1365-3024.2010.01241.x
   Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013
   Schroder WA, 2014, CANCER MED-US, V3, P500, DOI 10.1002/cam4.229
   Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20
   Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187
   SCHROEDER LM, 1992, J CHEM ECOL, V18, P1583, DOI 10.1007/BF00993231
   Schuliga M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/437695
   Schulze A, 2004, MOL BIOL CELL, V15, P3450, DOI 10.1091/mbc.E03-11-0807
   SCHUSTER WA, 1994, FIBRINOLYSIS, V8, P113, DOI 10.1016/S0268-9499(05)80028-1
   Simone TM, 2014, ADV WOUND CARE, V3, P281, DOI 10.1089/wound.2013.0512
   Sivaprasad U, 2015, J INVEST DERMATOL, V135, P160, DOI 10.1038/jid.2014.353
   Stacey MC, 2000, CARDIOVASC SURG, V8, P381, DOI 10.1016/S0967-2109(00)00028-4
   STANLEY PL, 1991, SKIN PHARMACOL, V4, P262, DOI 10.1159/000210960
   Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124
   Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850
   Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107
   Varro A, 2004, CANCER RES, V64, P1695, DOI 10.1158/0008-5472.CAN-03-2399
   Voegeli R., 2007, International Journal of Cosmetic Science, V29, P191, DOI 10.1111/j.1467-2494.2007.00386.x
   VONHEIJNE G, 1991, J BIOL CHEM, V266, P15240
   Warbrick EV, 2002, J APPL TOXICOL, V22, P1, DOI 10.1002/jat.830
   Watanabe H, 2007, J INVEST DERMATOL, V127, P1956, DOI 10.1038/sj.jid.5700819
   Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408
   Zhang CY, 2015, J CELL BIOL, V209, P289, DOI 10.1083/jcb.201409032
   Zhang EY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007703
   Zhang S, 2015, EXP CELL RES, V332, P278, DOI 10.1016/j.yexcr.2015.02.006
   Zhao AP, 2013, J IMMUNOL, V190, P5779, DOI 10.4049/jimmunol.1200293
   Zhou HM, 2001, CANCER RES, V61, P970
NR 115
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JUN
PY 2016
VL 186
IS 6
BP 1511
EP 1523
DI 10.1016/j.ajpath.2016.02.017
PG 13
WC Pathology
SC Pathology
GA DN7DZ
UT WOS:000377236800010
PM 27109612
OA Bronze
DA 2020-12-17
ER

PT J
AU Ravindran, R
   Loebbermann, J
   Nakaya, HI
   Khan, N
   Ma, HL
   Gama, L
   Machiah, DK
   Lawson, B
   Hakimpour, P
   Wang, YC
   Li, SZ
   Sharma, P
   Kaufman, RJ
   Martinez, J
   Pulendran, B
AF Ravindran, Rajesh
   Loebbermann, Jens
   Nakaya, Helder I.
   Khan, Nooruddin
   Ma, Hualing
   Gama, Leonardo
   Machiah, Deepa K.
   Lawson, Benton
   Hakimpour, Paul
   Wang, Yi-chong
   Li, Shuzhao
   Sharma, Prachi
   Kaufman, Randal J.
   Martinez, Jennifer
   Pulendran, Bali
TI The amino acid sensor GCN2 controls gut inflammation by inhibiting
   inflammasome activation
SO NATURE
LA English
DT Article
ID EIF2-ALPHA KINASE; OXIDATIVE STRESS; DENDRITIC CELLS; PROTEIN;
   TRANSLATION; AUTOPHAGY; PHOSPHORYLATION; DIFFERENTIATION; DEPRIVATION;
   HOMEOSTASIS
AB The integrated stress response (ISR) is a homeostatic mechanism by which eukaryotic cells sense and respond to stress-inducing signals, such as amino acid starvation. General controlled non-repressed (GCN2) kinase is a key orchestrator of the ISR, and modulates protein synthesis in response to amino acid starvation. Here we demonstrate in mice that GCN2 controls intestinal inflammation by suppressing inflammasome activation. Enhanced activation of ISR was observed in intestinal antigen presenting cells (APCs) and epithelial cells during amino acid starvation, or intestinal inflammation. Genetic deletion of Gcn2 (also known as Eif2ka4) in CD11c(+) APCs or intestinal epithelial cells resulted in enhanced intestinal inflammation and T helper 17 cell (T(H)17) responses, owing to enhanced inflammasome activation and interleukin (IL)-1 beta production. This was caused by reduced autophagy in Gcn2(-/-) intestinal APCs and epithelial cells, leading to increased reactive oxygen species (ROS), a potent activator of inflammasomes(1). Thus, conditional ablation of Atg5 or Atg7 in intestinal APCs resulted in enhanced ROS and T(H)17 responses. Furthermore, in vivo blockade of ROS and IL-1 beta resulted in inhibition of T(H)17 responses and reduced inflammation in Gcn2(-/-) mice. Importantly, acute amino acid starvation suppressed intestinal inflammation via a mechanism dependent on GCN2. These results reveal a mechanism that couples amino acid sensing with control of intestinal inflammation via GCN2.
C1 [Ravindran, Rajesh; Loebbermann, Jens; Ma, Hualing; Hakimpour, Paul; Wang, Yi-chong; Li, Shuzhao; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.; Gama, Leonardo] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil.
   [Khan, Nooruddin] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India.
   [Machiah, Deepa K.; Sharma, Prachi] Yerkes Natl Primate Res Ctr, Div Pathol, 954 Gatewood Rd, Atlanta, GA 30329 USA.
   [Lawson, Benton] Emory Vaccine Ctr, Virol Core, 954 Gatewood Rd, Atlanta, GA 30329 USA.
   [Lawson, Benton] Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
   [Kaufman, Randal J.] Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Martinez, Jennifer] NIEHS, Mail Drop D2-01, Res Triangle Pk, NC 27709 USA.
RP Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Martinez, Jennifer/C-3740-2019; Ma, Huailiang/C-3403-2017; Khan,
   Nooruddin/AAF-5417-2019; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020
OI Martinez, Jennifer/0000-0002-3060-2518; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Li,
   Shuzhao/0000-0002-7386-2539
FU US National Institutes of Health (NIH)United States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R37 DK057665,
   R37 AI048638, U19 AI090023, U19 AI057266]; Bill & Melinda Gates
   FoundationBill & Melinda Gates Foundation; NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   DK088227, R37 DK042394, R01 DK103185]; Crohn's & Colitis Foundation of
   America Senior Fellow Award [3800]; Center for AIDS Research core at
   Yerkes Primate Research Center [P30-AI-50409]; NATIONAL HEART, LUNG, AND
   BLOOD INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [R01HL052173, R01HL052173, R01HL052173,
   R01HL052173, R01HL052173, R01HL052173, R01HL052173, R01HL052173,
   R01HL052173, R01HL052173, R01HL052173, R01HL052173, R01HL052173,
   R01HL052173, R01HL052173, R01HL052173, R01HL052173] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, P30AI050409, U19AI090023, U19AI090023,
   P30AI050409, U19AI090023, U19AI057266, P30AI050409, R01AI048638,
   P30AI050409, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   P30AI050409, P30AI050409, P30AI050409, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, P30AI050409, P30AI050409,
   U19AI057266, U19AI057266, P30AI050409, P30AI050409, U19AI057266,
   P30AI050409, U19AI090023, P30AI050409, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   P30AI050409, P30AI050409, R37AI048638, U19AI090023, U19AI090023,
   R37AI048638, P30AI050409, U19AI057266, U19AI090023, P30AI050409,
   R37AI048638, U19AI057266, U19AI090023, P30AI050409, P30AI050409,
   U19AI057266, P30AI050409, P30AI050409, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI090023, P30AI050409,
   U19AI057266, R01AI048638, P30AI050409, U19AI057266, R56AI048638,
   U19AI090023, U19AI057266, P30AI050409, U19AI057266, P30AI050409,
   U19AI090023, U19AI090023, U19AI057266, P30AI050409, U19AI057266,
   U19AI057266, U19AI057266, R01AI048638, U19AI057266, U19AI057266,
   P30AI050409, P30AI050409, R37AI048638, U19AI057266, U19AI090023,
   P30AI050409, U19AI057266, P30AI050409, U19AI090023, R37AI048638,
   U19AI057266, P30AI050409, P30AI050409, P30AI050409, R37AI048638,
   P30AI050409, P30AI050409, U19AI057266, P30AI050409, U19AI057266,
   P30AI050409, U19AI057266, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409, U19AI057266, P30AI050409, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, P30AI050409, P30AI050409,
   R01AI048638, P30AI050409, U19AI057266, P30AI050409, P30AI050409,
   U19AI090023, U19AI090023, P30AI050409, U19AI057266, U19AI057266,
   P30AI050409, P30AI050409, U19AI057266, U19AI057266, U19AI090023,
   R01AI048638, P30AI050409, U19AI057266, P30AI050409, P30AI050409,
   U19AI057266, U19AI090023, P30AI050409, P30AI050409, U19AI057266,
   R37AI048638, P30AI050409, P30AI050409, R01AI048638, P30AI050409,
   R01AI048638, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   P30AI050409, U19AI090023, U19AI090023, P30AI050409, P30AI050409,
   P30AI050409, P30AI050409, U19AI057266, U19AI090023, P30AI050409,
   P30AI050409, P30AI050409, P30AI050409, U19AI057266, U19AI057266,
   U19AI090023, R37AI048638, U19AI090023, P30AI050409, R01AI048638,
   P30AI050409, P30AI050409, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, P30AI050409, U19AI057266, P30AI050409,
   P30AI050409, P30AI050409, U19AI057266, P30AI050409, P30AI050409,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI090023, U19AI057266, P30AI050409, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, P30AI050409, U19AI057266, P30AI050409,
   P30AI050409, P30AI050409, U19AI057266, R01AI048638, P30AI050409,
   U19AI057266, P30AI050409, U19AI057266, U19AI057266, U19AI090023,
   P30AI050409, P30AI050409, U19AI090023, P30AI050409, U19AI057266,
   P30AI050409, P30AI050409, U19AI057266, U19AI057266, U19AI090023,
   P30AI050409, P30AI050409, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   P30AI050409, P30AI050409, U19AI090023, U19AI090023, P30AI050409,
   U19AI057266, U19AI090023, U19AI057266, P30AI050409, U19AI057266,
   U19AI090023, U19AI090023, U19AI057266, P30AI050409, P30AI050409,
   U19AI057266, U19AI057266, U19AI057266, P30AI050409, U19AI090023,
   U19AI057266, U19AI057266, R37AI048638, U19AI057266, U19AI090023,
   U19AI057266, P30AI050409, U19AI090023, U19AI090023, U19AI057266,
   P30AI050409, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, P30AI050409, U19AI090023, P30AI050409, U19AI090023,
   U19AI090023, P30AI050409, U19AI057266, U19AI057266, U19AI057266,
   P30AI050409, P30AI050409, U19AI057266, U19AI057266, P30AI050409,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI090023,
   P30AI050409, P30AI050409, R37AI048638, U19AI090023, U19AI090023,
   P30AI050409, U19AI090023, U19AI090023, P30AI050409, U19AI090023,
   P30AI050409, P30AI050409, U19AI057266, U19AI090023, P30AI050409,
   U19AI057266, U19AI090023, U19AI090023, R37AI048638, P30AI050409,
   U19AI057266, U19AI090023, U19AI057266, P30AI050409, U19AI057266,
   U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK042394, R01DK103185, R37DK042394, R37DK057665, R37DK042394,
   R37DK057665, R37DK057665, R37DK057665, R01DK088227, R01DK103185,
   R01DK088227, R37DK057665, R37DK042394, R01DK103185, R01DK088227,
   R37DK042394, R37DK042394, R37DK042394, R01DK088227, R01DK103185,
   R37DK042394, R37DK057665, R01DK088227, R37DK042394, R37DK057665,
   R01DK103185, R37DK042394, R37DK057665, R37DK057665, R37DK042394,
   R37DK042394, R37DK057665, R37DK042394, R01DK088227] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Environmental Health
   Sciences (NIEHS) [ZIAES103286, ZIAES103286, ZIAES103286, ZIAES103286,
   ZIAES103286] Funding Source: NIH RePORTER
FX This work was supported by grants from the US National Institutes of
   Health (NIH; grants R37 DK057665, R37 AI048638, U19 AI090023, U19
   AI057266) and from the Bill & Melinda Gates Foundation to B.P. R.J.K.
   was supported by NIH grants R01 DK088227, R37 DK042394, R01 DK103185 and
   the Crohn's & Colitis Foundation of America Senior Fellow Award 3800. We
   thank B. Cervasi and K. P. Gill for help with sorting and D. Levesque,
   D. Hampton, S. Weismann and colleagues for animal husbandry and
   veterinary support. We thank the Center for AIDS Research core at Yerkes
   Primate Research Center for help with qPCR (grant P30-AI-50409) and the
   Integrated Cellular Imaging Center at Winship Cancer Center, Emory
   University for help with confocal microscopy. We also thank the Yerkes
   Pathology Core for performing the immunofluorescence and histology
   analysis. We thank S. Virgin for his advice and review of the autophagy
   experiments.
CR Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200
   Ariyasinghe A, 2006, J PARASITOL, V92, P531, DOI 10.1645/GE-551R1.1
   Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002
   Brubacher JL, 2001, J IMMUNOL METHODS, V251, P81, DOI 10.1016/S0022-1759(01)00308-8
   Cao SS, 2014, INFLAMM BOWEL DIS, V20, P712, DOI 10.1097/MIB.0000000000000010
   Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648
   Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x
   Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6
   Funke B, 2009, GUT, V58, P483, DOI 10.1136/gut.2008.148908
   Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909
   Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882
   Harding HP, 1999, NATURE, V397, P271
   Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8
   Hu JF, 1997, ONCOGENE, V15, P2795, DOI 10.1038/sj.onc.1201444
   Julian D, 2005, J EXP BIOL, V208, P4109, DOI 10.1242/jeb.01867
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   KLEENE SJ, 1977, J BIOL CHEM, V252, P3214
   Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203
   Li CC, 2004, CELL IMMUNOL, V231, P96, DOI 10.1016/j.cellimm.2004.12.005
   Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200
   Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7
   Oarada M, 2009, NUTRITION, V25, P954, DOI 10.1016/j.nut.2009.02.004
   Peng W., 2012, SCI TRANSL MED, V4
   Pulendran B, 2015, ANNU REV IMMUNOL, V33, P563, DOI 10.1146/annurev-immunol-020711-075049
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829
   Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383
   Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638
   Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012
   Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002
   Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 35
TC 112
Z9 117
U1 2
U2 68
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR 24
PY 2016
VL 531
IS 7595
BP 523
EP +
DI 10.1038/nature17186
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH3QK
UT WOS:000372701300045
PM 26982722
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Schons-Fonseca, L
   da Silva, JB
   Milanez, JS
   Domingos, RH
   Smith, JL
   Nakaya, HI
   Grossman, AD
   Ho, PL
   da Costa, RMA
AF Schons-Fonseca, Luciane
   da Silva, Josefa B.
   Milanez, Juliana S.
   Domingos, Renan H.
   Smith, Janet L.
   Nakaya, Helder I.
   Grossman, Alan D.
   Ho, Paulo L.
   da Costa, Renata M. A.
TI Analysis of LexA binding sites and transcriptomics in response to
   genotoxic stress in Leptospira interrogans
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID ESCHERICHIA-COLI; SOS RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; ANTIBIOTIC
   CIPROFLOXACIN; STAPHYLOCOCCUS-AUREUS; PATHOGENIC LEPTOSPIRA; DNA-DAMAGE;
   VIRULENCE; PROTEIN; IDENTIFICATION
AB We determined the effects of DNA damage caused by ultraviolet radiation on gene expression in Leptospira interrogans using DNA microarrays. These data were integrated with DNA binding in vivo of LexA1, a regulator of the DNA damage response, assessed by chromatin immunoprecipitation and massively parallel DNA sequencing (ChIP-seq). In response to DNA damage, Leptospira induced expression of genes involved in DNA metabolism, in mobile genetic elements and defective prophages. The DNA repair genes involved in removal of photodamage (e.g. nucleotide excision repair uvrABC, recombinases recBCD and resolvases ruvABC) were not induced. Genes involved in various metabolic pathways were down regulated, including genes involved in cell growth, RNA metabolism and the tricarboxylic acid cycle. From ChIP-seq data, we observed 24 LexA1 binding sites located throughout chromosome 1 and one binding site in chromosome 2. Expression of many, but not all, genes near those sites was increased following DNA damage. Binding sites were found as far as 550 bp upstream from the start codon, or 1 kb into the coding sequence. Our findings indicate that there is a shift in gene expression following DNA damage that represses genes involved in cell growth and virulence, and induces genes involved in mutagenesis and recombination.
C1 [Schons-Fonseca, Luciane; da Silva, Josefa B.; Milanez, Juliana S.; Domingos, Renan H.; Ho, Paulo L.] Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil.
   [Schons-Fonseca, Luciane] Univ Sao Paulo, Inst Quim, BR-05508000 Sao Paulo, Brazil.
   [Schons-Fonseca, Luciane; Smith, Janet L.; Grossman, Alan D.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Milanez, Juliana S.; Nakaya, Helder I.] Univ Sao Paulo, Fac Ciencias Farmaceut, BR-05508000 Sao Paulo, Brazil.
   [da Costa, Renata M. A.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, BR-09210580 Sao Paulo, Brazil.
RP Ho, PL (corresponding author), Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil.; da Costa, RMA (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, BR-09210580 Sao Paulo, Brazil.
EM paulo.ho@butantan.gov.br; renata.costa@ufabc.edu.br
RI Ho, Paulo/P-8267-2015; da Silva, Josefa Bezerra/I-3515-2015; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Ho, Paulo/0000-0003-3652-241X; Nakaya, Helder/0000-0001-5297-9108;
   Nakaya, Helder I/0000-0001-5297-9108
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   Fundacao Butantan; National Institute of General Medical Sciences of the
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [GM41934]; NATIONAL INSTITUTE OF
   GENERAL MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R37GM041934, R01GM041934,
   R37GM041934, R01GM041934, R37GM041934, R37GM041934, R01GM041934,
   R01GM041934, R01GM041934, R37GM041934, R01GM041934, R37GM041934,
   R01GM041934, R01GM041934, R37GM041934, R01GM041934, R37GM041934,
   R01GM041934, R01GM041934, R01GM041934, R01GM041934, R01GM041934,
   R01GM041934, R01GM041934, R37GM041934, R01GM041934, R37GM041934] Funding
   Source: NIH RePORTER
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao
   Butantan; National Institute of General Medical Sciences of the National
   Institutes of Health [Award number GM41934 to A.D.G., in part]. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the funding agencies.
   Funding for open access charge: Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP).
CR Abela-Ridder B, 2013, PRINC MAH AW C 2013
   Abella M, 2007, J BACTERIOL, V189, P8855, DOI 10.1128/JB.01213-07
   Baharoglu Z, 2014, FEMS MICROBIOL REV, V38, P1126, DOI 10.1111/1574-6976.12077
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011
   Bensing BA, 2001, INFECT IMMUN, V69, P6186, DOI 10.1128/IAI.69.10.6186-6192.2001
   Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200
   Bos J, 2015, P NATL ACAD SCI USA, V112, P178, DOI 10.1073/pnas.1420702111
   Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6
   Butala M., 2011, NUCLEIC ACIDS RES, P1
   Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004
   Ching ATC, 2012, BIOCHEM BIOPH RES CO, V427, P774, DOI 10.1016/j.bbrc.2012.09.137
   Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06
   Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06
   Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1
   Cune J, 2005, J BACTERIOL, V187, P5841, DOI 10.1128/JB.187.16.5841-5845.2005
   da Rocha RP, 2008, J BACTERIOL, V190, P1209, DOI 10.1128/JB.01419-07
   da Silva JB, 2012, MICROB PATHOGENESIS, V52, P206, DOI 10.1016/j.micpath.2012.01.002
   ELLINGHAUSEN HC, 1967, J BACTERIOL, V94, P27
   Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x
   Eshghi A, 2012, INFECT IMMUN, V80, P3892, DOI 10.1128/IAI.00466-12
   Evangelista KV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003215
   Faine S., 1998, BACTERIAL INFECT HUM, P395
   Faine S, 1999, LEPTOSPIRA LEPTOSPIR, P296
   Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129
   Fonseca LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076419
   FRANZ B, 1995, EMBO J, V14, P397, DOI 10.1002/j.1460-2075.1995.tb07014.x
   Friedberg E.C., 2006, DNA REPAIR MUTAGENES
   Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108
   Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363
   Goranov AI, 2006, J BACTERIOL, V188, P5595, DOI 10.1128/JB.00342-06
   Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914
   Gutekunst K, 2005, MOL MICROBIOL, V58, P810, DOI 10.1111/j.1365-2958.2005.04867.x
   Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11
   Haydel S. E., 2006, J BACTERIOL, V188, P150
   HEWAT EA, 1991, EMBO J, V10, P2695, DOI 10.1002/j.1460-2075.1991.tb07813.x
   Hiasa H, 2000, J BIOL CHEM, V275, P34780, DOI 10.1074/jbc.M001608200
   Ji H., 2011, CURR PROTOC BIOINFOR, V33, P2131
   King AM, 2014, INFECT IMMUN, V82, P1123, DOI 10.1128/IAI.01546-13
   Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lehmann JS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002468
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253
   Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6
   LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375
   Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Marcsisin R. A., 2013, J MED MICROBIOL
   Martins-Pinheiro M, 2016, MOL GENET GENOMICS, V291, P703, DOI 10.1007/s00438-015-1135-2
   Mellies JL, 2007, J BACTERIOL, V189, P2863, DOI 10.1128/JB.01859-06
   Murray GL, 2010, MOL MICROBIOL, V78, P701, DOI 10.1111/j.1365-2958.2010.07360.x
   Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08
   Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7
   Pinne M, 2012, J BACTERIOL, V194, P6074, DOI 10.1128/JB.01119-12
   Qin JH, 2008, INFECT IMMUN, V76, P2411, DOI 10.1128/IAI.01730-07
   Ratet G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003359
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000
   Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37
   Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339
   Smollett KL, 2012, J BIOL CHEM, V287, P22004, DOI 10.1074/jbc.M112.357715
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Toma C, 2014, CELL MICROBIOL, V16, P1366, DOI 10.1111/cmi.12296
   Toshima H, 2007, APPL ENVIRON MICROB, V73, P7582, DOI 10.1128/AEM.01326-07
   Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u
   Ubeda C, 2007, MOL MICROBIOL, V65, P41, DOI 10.1111/j.1365-2958.2007.05758.x
   van der Veen S, 2010, MICROBIOL-SGM, V156, P374, DOI 10.1099/mic.0.035196-0
   Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605
   Zhong Y, 2011, CELL RES, V21, P1210, DOI 10.1038/cr.2011.46
NR 73
TC 4
Z9 4
U1 0
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB 18
PY 2016
VL 44
IS 3
BP 1179
EP 1191
DI 10.1093/nar/gkv1536
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DF3ST
UT WOS:000371268700025
PM 26762976
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Clutterbuck, E
   Kazmin, D
   Wang, LL
   Cortese, M
   Bosinger, SE
   Patel, NB
   Zak, DE
   Aderemg, A
   Dong, T
   Del Giudice, G
   Rappuoli, R
   Cerundolo, V
   Pollard, AJ
   Pulendran, B
   Siegrist, CA
AF Nakaya, Helder I.
   Clutterbuck, Elizabeth
   Kazmin, Dmitri
   Wang, Lili
   Cortese, Mario
   Bosinger, Steven E.
   Patel, Nirav B.
   Zak, Daniel E.
   Aderemg, Alan
   Dong, Tao
   Del Giudice, Giuseppe
   Rappuoli, Rino
   Cerundolo, Vincenzo
   Pollard, Andrew J.
   Pulendran, Bali
   Siegrist, Claire-Anne
TI Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted
   trivalent seasonal influenza vaccines in early childhood
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE systems biology; influenza vaccine; MF59; adjuvant; children
ID SET ENRICHMENT ANALYSIS; CHILDREN; IMMUNOGENICITY; VACCINATION;
   RESPONSES; CORRELATE; ADJUVANT; HUMANS; AGE
AB The dynamics and molecular mechanisms underlying vaccine immunity in early childhood remain poorly understood. Here we applied systems approaches to investigate the innate and adaptive responses to trivalent inactivated influenza vaccine (TIV) and MF59-adjuvanted TIV (ATIV) in 90 14- to 24-mo-old healthy children. MF59 enhanced the magnitude and kinetics of serum antibody titers following vaccination, and induced a greater frequency of vaccine specific, multicytokine-producing CD4(+) T cells. Compared with transcriptional responses to TIV vaccination previously reported in adults, responses to TIV in infants were markedly attenuated, limited to genes regulating antiviral and antigen presentation pathways, and observed only in a subset of vaccinees. In contrast, transcriptional responses to ATIV boost were more homogenous and robust. Interestingly, a day 1 gene signature characteristic of the innate response (antiviral IFN genes, dendritic cell, and monocyte responses) correlated with hemagglutination at day 28. These findings demonstrate that MF59 enhances the magnitude, kinetics, and consistency of the innate and adaptive response to vaccination with the seasonal influenza vaccine during early childhood, and identify potential molecular correlates of antibody responses.
C1 [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, BR-05508 Sao Paulo, Brazil.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Clutterbuck, Elizabeth; Pollard, Andrew J.] Univ Oxford, Dept Pediat, Oxford Vaccine Grp, Oxford OX3 9DU, England.
   [Clutterbuck, Elizabeth; Pollard, Andrew J.] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford OX3 9DU, England.
   [Kazmin, Dmitri; Cortese, Mario; Bosinger, Steven E.; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Wang, Lili; Dong, Tao; Cerundolo, Vincenzo] Univ Oxford, Radcliffe Dept Med, Med Res Council Human Immunol Unit, Oxford OX3 9DU, England.
   [Bosinger, Steven E.; Patel, Nirav B.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Div Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Zak, Daniel E.; Aderemg, Alan] Ctr Infect Dis Res, Seattle, WA 98109 USA.
   [Del Giudice, Giuseppe; Rappuoli, Rino] Novartis Vaccines, Res Ctr, I-53100 Siena, Italy.
   [Siegrist, Claire-Anne] Univ Geneva, Dept Pathol Immunol, WHO Collaborat Ctr Vaccine Immunol, CH-1211 Geneva, Switzerland.
   [Siegrist, Claire-Anne] Univ Geneva, Dept Pediat, WHO Collaborat Ctr Vaccine Immunol, CH-1211 Geneva, Switzerland.
RP Pulendran, B (corresponding author), Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.; Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.; Rappuoli, R (corresponding author), Novartis Vaccines, Res Ctr, I-53100 Siena, Italy.; Siegrist, CA (corresponding author), Univ Geneva, Dept Pathol Immunol, WHO Collaborat Ctr Vaccine Immunol, CH-1211 Geneva, Switzerland.; Siegrist, CA (corresponding author), Univ Geneva, Dept Pediat, WHO Collaborat Ctr Vaccine Immunol, CH-1211 Geneva, Switzerland.
EM rino.r.rappuoli@gsk.com; bpulend@emory.edu;
   Claire-Anne.Siegrist@unige.ch
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU European Commission FP7European CommissionEuropean Commission Joint
   Research Centre; National Institute for Health Research Oxford
   Biomedical Research CentreNational Institute for Health Research (NIHR);
   Medical Research CouncilMedical Research Council UK (MRC); National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U19AI090023,
   R37AI48638, R37DK057665, U19AI057266, AI100663-02]; CNPqNational Council
   for Scientific and Technological Development (CNPq); Cancer Research
   UKCancer Research UK [17722] Funding Source: researchfish; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L018942/1,
   MC_UU_12010/1, G1001046, G1000800, G0600520, G1000800e] Funding Source:
   researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI090023, UM1AI100663, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI057266, U19AI090023, UM1AI100663, U19AI057266,
   U19AI057266, UM1AI100663, U19AI090023, UM1AI100663, UM1AI100663,
   U19AI090023, U19AI090023, U19AI090023, R37AI048638, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, UM1AI100663,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, UM1AI100663, U19AI057266, UM1AI100663,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, R37AI048638,
   UM1AI100663, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, UM1AI100663, UM1AI100663, U19AI090023,
   R37AI048638, UM1AI100663, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, UM1AI100663, U19AI057266, UM1AI100663, UM1AI100663,
   U19AI057266, UM1AI100663, U19AI057266, U19AI090023, U19AI090023,
   UM1AI100663, U19AI057266, R37AI048638, U19AI057266, U19AI090023,
   U19AI057266, UM1AI100663, UM1AI100663, U19AI057266, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   R37AI048638, U19AI057266, UM1AI100663, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   UM1AI100663, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   UM1AI100663, U19AI057266, UM1AI100663, U19AI057266, U19AI090023,
   U19AI057266, UM1AI100663, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, UM1AI100663,
   U19AI057266, U19AI057266, UM1AI100663, U19AI090023, U19AI090023,
   U19AI057266, UM1AI100663, U19AI090023, U19AI057266, R37AI048638,
   U19AI090023, U19AI057266, U19AI090023, UM1AI100663, UM1AI100663,
   U19AI090023, U19AI057266, U19AI057266, UM1AI100663, U19AI057266,
   U19AI057266, UM1AI100663, U19AI057266, R37AI048638, U19AI057266,
   UM1AI100663, U19AI090023, U19AI090023, UM1AI100663, U19AI057266,
   UM1AI100663, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, UM1AI100663, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, UM1AI100663, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, UM1AI100663,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, R37AI048638,
   U19AI090023, UM1AI100663, U19AI090023, U19AI090023, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   UM1AI100663, U19AI057266, UM1AI100663, U19AI057266, UM1AI100663,
   U19AI057266, UM1AI100663, U19AI090023, UM1AI100663, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, UM1AI100663, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, UM1AI100663,
   U19AI057266, U19AI057266, UM1AI100663, U19AI057266, U19AI057266,
   UM1AI100663, U19AI090023, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, UM1AI100663, UM1AI100663,
   U19AI057266, UM1AI100663, U19AI057266, UM1AI100663, U19AI090023,
   UM1AI100663, UM1AI100663, UM1AI100663, UM1AI100663, UM1AI100663,
   UM1AI100663, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, UM1AI100663, U19AI057266, U19AI090023,
   U19AI090023, R37AI048638, U19AI090023, U19AI090023, U19AI057266,
   R37AI048638, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   R37AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665] Funding Source: NIH RePORTER
FX We thank Dr. Angus Goodson, Elizabeth Davies, Hannah Robinson, and
   Richard Sewell for assisting with the clinical trial; Amber Thompson,
   Jaclyn Bowman, Susan Ndimah, Karlijn De Nie, and Rebecca Sie for
   assisting with laboratory evaluation; and the families who participated
   in this study. This study was supported in part by European Commission
   FP7 Grant "Advanced Immunisation Technologies"; the National Institute
   for Health Research Oxford Biomedical Research Centre; and the Medical
   Research Council ( to the Human Immunology Unit). Work in B.P.'s
   laboratory was supported by National Institutes of Health Grants
   U19AI090023, R37AI48638, R37DK057665, U19AI057266, and AI100663-02.
   H.I.N. is the recipient of a CNPq research fellowship.
CR Black S, 2011, PEDIATR INFECT DIS J, V30, P1081, DOI 10.1097/INF.0b013e3182367662
   Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090
   Cao RG, 2014, J INFECT DIS, V210, P224, DOI 10.1093/infdis/jiu079
   Esposito S, 2011, PEDIATRICS, V127, pE1161, DOI 10.1542/peds.2010-1920
   Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299
   Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15
   Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106
   Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3
   Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354
   Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336
   Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/ERV.12.140, 10.1586/erv.12.140]
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369
   Tan Y, 2014, EUR J IMMUNOL, V44, P285, DOI 10.1002/eji.201343657
   Vesikari T, 2009, VACCINE, V27, P6291, DOI [10.1016/j.vaccine.2009.02.004, 10.1016/j.vaccine.2009.09.115]
   Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331
   Wong KK, 2013, PEDIATRICS, V132, P796, DOI 10.1542/peds.2013-1493
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Zedda L, 2015, PEDIATR INFECT DIS J, V34, P73, DOI 10.1097/INF.0000000000000465
NR 25
TC 79
Z9 79
U1 0
U2 15
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 16
PY 2016
VL 113
IS 7
BP 1853
EP 1858
DI 10.1073/pnas.1519690113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD9BF
UT WOS:000370220000053
PM 26755593
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Okada, SS
   de Oliveira, EM
   de Araujo, TH
   Rodrigues, MR
   Albuquerque, RC
   Mortara, RA
   Taniwaki, NN
   Nakaya, HI
   Campa, A
   Moreno, ACR
AF Okada, Sabrina Sayori
   de Oliveira, Edson Mendes
   de Araujo, Tomaz Henrique
   Rodrigues, Maria Rita
   Albuquerque, Renata Chaves
   Mortara, Renato Arruda
   Taniwaki, Noemi Nosomi
   Nakaya, Helder Imoto
   Campa, Ana
   Ramos Moreno, Ana Carolina
TI Myeloperoxidase in human peripheral blood lymphocytes: Production and
   subcellular localization
SO CELLULAR IMMUNOLOGY
LA English
DT Article
DE Electron microscopy; FACS; Fluorescence microscopy; Moonlighting
   protein; Subcellular localization
ID PEROXIDE CHLORIDE SYSTEM; HUMAN NEUTROPHILS EMPLOY; ALPHA-AMINO-ACIDS;
   GENE-EXPRESSION; HYPOCHLOROUS ACID; MESSENGER-RNA; REACTIVE ALDEHYDES;
   CELLS; OXIDATION; MELATONIN
AB Myeloperoxidase (MPO) is an important enzyme in the front-line protection against microorganisms. In peripheral blood, it is accepted that MPO is only produced by myeloid-lineage cells. Thus, MPO presence is unexpected in lymphocytes. We showed recently that BI-lymphocytes from mice have MPO. Here, we showed that subsets of human peripheral B, CD4(+) and CD8(+) T lymphocytes express MPO. The content of MPO in lymphocytes was very low compared to neutrophils/monocytes with a preferential distribution in the nucleus and perinuclear region. Also, we performed a MPO mRNA expression analysis from human blood cells derived from microarray raw data publicly available, showing that MPO is modulated in infectious disease. MPO was increased in CD4(+) T lymphocytes from HIV chronic infection and in CD8(+) T lymphocytes from HCV-positive patients. Our study points out MPO as a multifunctional protein due to its subcellular localization and expression modulation in lymphocytes indicating alternative unknown functions for MPO in lymphocytes. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Okada, Sabrina Sayori; de Oliveira, Edson Mendes; Albuquerque, Renata Chaves; Nakaya, Helder Imoto; Campa, Ana; Ramos Moreno, Ana Carolina] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508 Sao Paulo, SP, Brazil.
   [de Araujo, Tomaz Henrique] Univ Fed Alfenas, Dept Ciencias Biol, BR-37130 Alfenas, MG, Brazil.
   [Rodrigues, Maria Rita] Univ Fed Alfenas, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-37130 Alfenas, MG, Brazil.
   [Mortara, Renato Arruda] Univ Fed Sao Paulo, Dept Microbiol Imunobiol & Parasitol, BR-04023 Sao Paulo, SP, Brazil.
   [Taniwaki, Noemi Nosomi] Adolfo Lutz Inst, Nucleo Microscopia Eletron, BR-01246 Sao Paulo, SP, Brazil.
   [Nakaya, Helder Imoto] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
RP Moreno, ACR (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, SP, Brazil.
EM carol@usp.br
RI de Oliveira, Edson M/C-9885-2014; Nakaya, Helder/AAF-1738-2020;
   Rodrigues, Maria Rita/ABE-1097-2020; Nakaya, Helder I/A-1397-2010;
   Campa, Ana/D-4669-2012; Mortara, Renato A./C-1864-2012
OI de Oliveira, Edson M/0000-0002-7330-7826; Nakaya,
   Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Campa,
   Ana/0000-0002-6183-3378; Mortara, Renato A./0000-0002-2311-8349
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/14632-3,
   2008/54474-5, 06/50641-9, 2010/18498-7]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPqNational Council for
   Scientific and Technological Development (CNPq) [47151012010-6]
FX This work was supported by grants from the Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo - FAPESP (FAPESP 2009/14632-3) and the Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (CNPq
   47151012010-6). Similarly, we acknowledge the scholarship from FAPESP to
   A.C.R. Moreno (2008/54474-5), S.S. Okada (06/50641-9) and E.M. Oliveira
   (2010/18498-7).
CR ALBRICH JM, 1986, J CLIN INVEST, V78, P177, DOI 10.1172/JCI112548
   Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403
   BENNETT JM, 1991, BRIT J HAEMATOL, V78, P325, DOI 10.1111/j.1365-2141.1991.tb04444.x
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   de Araujo TH, 2013, CELL IMMUNOL, V281, P27, DOI 10.1016/j.cellimm.2013.01.002
   DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542
   Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830
   Gomes MM, 2012, FORENSIC TOXICOL, V30, P87, DOI 10.1007/s11419-011-0131-4
   Green PS, 2004, J NEUROCHEM, V90, P724, DOI 10.1111/j.1471-4159.2004.02527.x
   HARRISON JE, 1976, J BIOL CHEM, V251, P1371
   Hazen SL, 1996, J BIOL CHEM, V271, P23080, DOI 10.1074/jbc.271.38.23080
   Hazen SL, 1998, BIOCHEMISTRY-US, V37, P6864, DOI 10.1021/bi972449j
   Hazen SL, 1998, J BIOL CHEM, V273, P4997, DOI 10.1074/jbc.273.9.4997
   Himmelfarb J, 2001, FREE RADICAL BIO MED, V31, P1163, DOI 10.1016/S0891-5849(01)00697-9
   HU ZB, 1993, BLOOD, V82, P1599
   Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022
   Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06
   Johansson MW, 1997, J CELL SCI, V110, P1133
   Kern W, 2006, CANCER, V107, P2401, DOI 10.1002/cncr.22251
   KETTLE AJ, 1994, J BIOL CHEM, V269, P17146
   Kindzelskii AL, 2006, EUR J IMMUNOL, V36, P1619, DOI 10.1002/eji.200535391
   Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349
   KLEBANOFF SJ, 1967, J CLIN INVEST, V46, P1078
   Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210
   Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200
   La Rocca G, 2009, BASIC RES CARDIOL, V104, P307, DOI 10.1007/s00395-008-0761-9
   NAUSEEF WM, 1986, BLOOD, V67, P1504
   Nauseef WM, 2001, INT J HEMATOL, V74, P125, DOI 10.1007/BF02981994
   Ozgen O, 2003, LEUKEMIA RES, V27, P1109, DOI 10.1016/S0145-2126(03)00098-5
   Peskin AV, 2003, FREE RADICAL BIO MED, V35, P1252, DOI 10.1016/S0891-5849(03)00502-1
   Rodrigues MR, 2003, J PINEAL RES, V34, P69, DOI 10.1034/j.1600-079X.2003.02944.x
   Rodrigues MR, 2002, BIOCHEM BIOPH RES CO, V292, P869, DOI 10.1006/bbrc.2002.6724
   ROSEN H, 1990, P NATL ACAD SCI USA, V87, P10048, DOI 10.1073/pnas.87.24.10048
   SAGOH T, 1988, ARCH BIOCHEM BIOPHYS, V262, P599, DOI 10.1016/0003-9861(88)90411-0
   SAVENKOVA MI, 1994, J BIOL CHEM, V269, P20394
   Schoonbroodt S, 1997, BIOCHEM J, V321, P777, DOI 10.1042/bj3210777
   Serrano J, 1999, LEUKEMIA, V13, P175, DOI 10.1038/sj.leu.2401305
   Silva SO, 2000, BIOCHEM BIOPH RES CO, V279, P657, DOI 10.1006/bbrc.2000.3993
   Silva SO, 2004, J PINEAL RES, V37, P171, DOI 10.1111/j.1600-079X.2004.00149.x
   TOBLER A, 1988, J CELL PHYSIOL, V136, P215, DOI 10.1002/jcp.1041360203
   Tourino MC, 2013, CELL BIOCHEM FUNCT, V31, P361, DOI 10.1002/cbf.2980
   Vile GF, 1998, ARCH BIOCHEM BIOPHYS, V359, P51, DOI 10.1006/abbi.1998.0881
   YAMADA M, 1984, J BIOL CHEM, V259, P3021
   Zhao B.-B., 2013, PLOS ONE, V8
   ZHOU MX, 1993, LEUKEMIA, V7, P1180
NR 45
TC 9
Z9 9
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0008-8749
EI 1090-2163
J9 CELL IMMUNOL
JI Cell. Immunol.
PD FEB
PY 2016
VL 300
BP 18
EP 25
DI 10.1016/j.cellimm.2015.11.003
PG 8
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA DF2RN
UT WOS:000371191600003
PM 26632272
DA 2020-12-17
ER

PT J
AU Munoz, M
   Craske, M
   Severino, P
   de Lima, TM
   Labhart, P
   Chammas, R
   Velasco, IT
   Machado, MCC
   Egan, B
   Nakaya, HI
   da Silva, FP
AF Munoz, Mindy
   Craske, Madeleine
   Severino, Patricia
   de Lima, Thais Martins
   Labhart, Paul
   Chammas, Roger
   Velasco, Irineu Tadeu
   Cesar Machado, Marcel Cerqueira
   Egan, Brian
   Nakaya, Helder I.
   da Silva, Fabiano Pinheiro
TI Antimicrobial peptide LL-37 participates in the transcriptional
   regulation of melanoma cells
SO JOURNAL OF CANCER
LA English
DT Article
DE LL-37; transcription factors; antimicrobial peptides; cancer
ID CATHELICIDIN LL-37; GENE-EXPRESSION; GROWTH-FACTOR; RECEPTOR;
   CHEMOATTRACTANT; IDENTIFICATION; NEUTROPHILS; INHIBITION
AB Antimicrobial peptides are an ancient family of molecules that emerged millions of years ago and have been strongly conserved during the evolutionary process of living organisms. Recently, our group described that the human antimicrobial peptide LL-37 migrates to the nucleus, raising the possibility that LL-37 could directly modulate transcription under certain conditions. Here, we showed evidence that LL-37 binds to gene promoter regions, and LL-37 gene silencing changed the transcriptional program of melanoma A375 cells genes associated with histone, metabolism, cellular stress, ubiquitination and mitochondria.
C1 [Munoz, Mindy; Nakaya, Helder I.] Univ Sao Paulo, Inst Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.
   [Craske, Madeleine; Labhart, Paul; Egan, Brian] Act Motif Inc, Carlsbad, CA USA.
   [Severino, Patricia] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa, Sao Paulo, Brazil.
   [de Lima, Thais Martins; Velasco, Irineu Tadeu; Cesar Machado, Marcel Cerqueira; da Silva, Fabiano Pinheiro] Univ Sao Paulo, Fac Med, Dept Emergencias Clin, Sao Paulo, Brazil.
   [Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Oncol, Sao Paulo, Brazil.
RP da Silva, FP (corresponding author), Univ Sao Paulo, Fac Med, Lab Emergencias Clin LIM 51, Av Dr Arnaldo,455 Sala 3189, BR-01246000 Sao Paulo, SP, Brazil.
EM pinheirofabiano@hotmail.com
RI da Silva, Fabiano Pinheiro/F-3464-2011; Severino, Patricia/H-2013-2012;
   Chammas, Roger/A-8004-2011; Nakaya, Helder/AAF-1738-2020; Nakaya, Helder
   I/A-1397-2010; Lima, Thais/C-2767-2012
OI da Silva, Fabiano Pinheiro/0000-0003-2673-2202; Severino,
   Patricia/0000-0002-6682-9343; Chammas, Roger/0000-0003-0342-8726;
   Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Lima, Thais/0000-0003-3175-5281; Munoz Miranda,
   Mindy/0000-0003-4856-2937
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq); Sao Paulo
   Research FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX FPS and HIN are supported by the National Council for Scientific and
   Technological Development and the Sao Paulo Research Foundation.
CR Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005
   Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326
   da Silva FP, 2013, TISSUE CELL, V45, P318, DOI 10.1016/j.tice.2013.04.003
   da Silva FP, 2012, PEPTIDES, V36, P308, DOI 10.1016/j.peptides.2012.05.014
   da Silva FP, 2009, IMMUNOL CELL BIOL, V87, P496, DOI 10.1038/icb.2009.19
   Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239
   Gonzalez-Curiel I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111355
   Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647
   Kim JE, 2010, BRIT J DERMATOL, V163, P959, DOI 10.1111/j.1365-2133.2010.09957.x
   Kuroda K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00144
   LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Nagaoka I., 2012, ISRN MICROBIOL, V2012
   Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x
   Piktel E, 2016, ARCH IMMUNOL THER EX, V64, P33, DOI 10.1007/s00005-015-0359-5
   Ries M, 2013, J LEUKOCYTE BIOL, V94, P123, DOI 10.1189/jlb.0612278
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Salvado MD, 2013, ARTERIOSCL THROM VAS, V33, P1965, DOI 10.1161/ATVBAHA.113.301851
   Salzer S, 2014, J DERMATOL SCI, V76, P173, DOI 10.1016/j.jdermsci.2014.09.002
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Steinstraesser L, 2014, MOL THER, V22, P734, DOI 10.1038/mt.2013.258
   Tjabringa GS, 2006, INT ARCH ALLERGY IMM, V140, P103, DOI 10.1159/000092305
   von Kockritz-Blickwede M, 2008, BLOOD, V111, P3070, DOI 10.1182/blood-2007-07-104018
   Wewers MD, 2009, PURINERG SIGNAL, V5, P189, DOI 10.1007/s11302-009-9131-9
   Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052
   Yin J, 2010, INVEST OPHTH VIS SCI, V51, P1891, DOI 10.1167/iovs.09-3904
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 27
TC 9
Z9 10
U1 1
U2 6
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1837-9664
J9 J CANCER
JI J. Cancer
PY 2016
VL 7
IS 15
BP 2341
EP 2345
DI 10.7150/jca.16947
PG 5
WC Oncology
SC Oncology
GA EJ3DR
UT WOS:000393093300023
PM 27994673
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Hagan, T
   Duraisingham, SS
   Lee, EK
   Kwissa, M
   Rouphael, N
   Frasca, D
   Gersten, M
   Mehta, AK
   Gaujoux, R
   Li, GM
   Gupta, S
   Ahmed, R
   Mulligan, MJ
   Shen-Orr, S
   Blomberg, BB
   Subramaniam, S
   Pulendran, B
AF Nakaya, Helder I.
   Hagan, Thomas
   Duraisingham, Sai S.
   Lee, Eva K.
   Kwissa, Marcin
   Rouphael, Nadine
   Frasca, Daniela
   Gersten, Merril
   Mehta, Aneesh K.
   Gaujoux, Renaud
   Li, Gui-Mei
   Gupta, Shakti
   Ahmed, Rafi
   Mulligan, Mark J.
   Shen-Orr, Shai
   Blomberg, Bonnie B.
   Subramaniam, Shankar
   Pulendran, Bali
TI Systems Analysis of Immunity to Influenza Vaccination across Multiple
   Years and in Diverse Populations Reveals Shared Molecular Signatures
SO IMMUNITY
LA English
DT Article
ID YELLOW-FEVER VACCINE; T-CELL RESPONSES; HUMAN NK-CELLS; SEASONAL
   INFLUENZA; ANTIBODY-RESPONSES; DENDRITIC CELLS; ACTIVATION; HUMANS;
   DECONVOLUTION; MICRORNAS
AB Systems approaches have been used to describe molecular signatures driving immunity to influenza vaccination in humans. Whether such signatures are similar across multiple seasons and in diverse populations is unknown. We applied systems approaches to study immune responses in young, elderly, and diabetic subjects vaccinated with the seasonal influenza vaccine across five consecutive seasons. Signatures of innate immunity and plasmablasts correlated with and predicted influenza antibody titers at 1 month after vaccination with >80% accuracy across multiple seasons but were not associated with the longevity of the response. Baseline signatures of lymphocyte and monocyte inflammation were positively and negatively correlated, respectively, with antibody responses at 1 month. Finally, integrative analysis of microRNAs and transcriptomic profiling revealed potential regulators of vaccine immunity. These results identify shared vaccine-induced signatures across multiple seasons and in diverse populations and might help guide the development of next-generation vaccines that provide persistent immunity against influenza.
C1 [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30307 USA.
   [Hagan, Thomas; Gersten, Merril; Gupta, Shakti; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Duraisingham, Sai S.] Oxford Univ Hosp NHS Trust, Churchill Hosp, Dept Immunol, Oxford OX3 7J, England.
   [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA.
   [Kwissa, Marcin] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.
   [Rouphael, Nadine; Mulligan, Mark J.] Emory Univ, Hope Clin, Atlanta, GA 30030 USA.
   [Frasca, Daniela; Blomberg, Bonnie B.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.
   [Mehta, Aneesh K.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30307 USA.
   [Gaujoux, Renaud; Shen-Orr, Shai] Technion Israel Inst Technol, Fac Med, Dept Immunol, IL-3109601 Haifa, Israel.
   [Li, Gui-Mei; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Li, Gui-Mei; Ahmed, Rafi; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Subramaniam, Shankar] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
   [Subramaniam, Shankar] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.
RP Subramaniam, S (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr MC 0412, La Jolla, CA 92093 USA.
EM shankar@ucsd.edu; bpulend@emory.edu
RI Mehta, Aneesh/B-8054-2012; Mulligan, Mark/V-9275-2019; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Mehta, Aneesh/0000-0002-6552-9162; Nakaya, Helder/0000-0001-5297-9108;
   Nakaya, Helder I/0000-0001-5297-9108; Rouphael,
   Nadine/0000-0002-2512-7919
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI090023, U19AI057266,
   HHSN272201400004C, U54AI057157, R37AI48638, R37DK057665]; NSFNational
   Science Foundation (NSF) [STC-0939370]; CNPq (Brazilian Research
   Council) research fellowship; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U54AI057157, P30AI050409,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   P30AI050409, U54AI057157, U19AI057266, U19AI090023, U54AI057157,
   P30AI050409, P30AI050409, U19AI057266, U54AI057157, U19AI057266,
   P30AI050409, R37AI048638, U19AI090023, U54AI057157, U54AI057157,
   U19AI090023, U54AI057157, P30AI050409, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, P30AI050409, P30AI050409,
   U54AI057157, P30AI050409, U19AI090023, P30AI050409, U19AI090023,
   U19AI090023, U19AI057266, P30AI050409, P30AI050409, U19AI090023,
   U19AI057266, P30AI050409, P30AI050409, U54AI057157, P30AI050409,
   U19AI090023, U19AI090023, U54AI057157, P30AI050409, P30AI050409,
   U54AI057157, P30AI050409, U54AI057157, U19AI057266, P30AI050409,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, R37AI048638, U54AI057157, U19AI057266,
   U19AI090023, P30AI050409, U54AI057157, P30AI050409, P30AI050409,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, P30AI050409,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, P30AI050409, P30AI050409, P30AI050409,
   P30AI050409, U19AI090023, U19AI090023, U54AI057157, U54AI057157,
   U19AI090023, P30AI050409, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266, P30AI050409, U54AI057157, U54AI057157,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157, P30AI050409,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   P30AI050409, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U19AI057266, P30AI050409, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, P30AI050409, U54AI057157, U19AI090023, P30AI050409,
   P30AI050409, P30AI050409, P30AI050409, P30AI050409, U19AI057266,
   P30AI050409, P30AI050409, U19AI057266, U19AI090023, U54AI057157,
   U19AI057266, U19AI090023, P30AI050409, U54AI057157, U19AI090023,
   U19AI090023, U54AI057157, P30AI050409, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, P30AI050409, P30AI050409, U19AI090023, U19AI090023,
   P30AI050409, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, P30AI050409, U19AI057266,
   U54AI057157, U19AI057266, U19AI090023, P30AI050409, U19AI057266,
   U54AI057157, U54AI057157, P30AI050409, U54AI057157, P30AI050409,
   R37AI048638, U19AI057266, U19AI057266, P30AI050409, P30AI050409,
   U54AI057157, P30AI050409, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, P30AI050409,
   U54AI057157, P30AI050409, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, P30AI050409, U54AI057157, U19AI057266,
   R37AI048638, P30AI050409, P30AI050409, U54AI057157, U19AI090023,
   U19AI057266, P30AI050409, U54AI057157, P30AI050409, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   P30AI050409, U54AI057157, U54AI057157, U54AI057157, P30AI050409,
   U54AI057157, U54AI057157, P30AI050409, P30AI050409, R37AI048638,
   U54AI057157, P30AI050409, U19AI057266, P30AI050409, U54AI057157,
   U19AI057266, U54AI057157, P30AI050409, U19AI057266, U19AI090023,
   U54AI057157, U19AI090023, U19AI057266, U19AI090023, U54AI057157,
   U19AI090023, U54AI057157, P30AI050409, P30AI050409, U19AI057266,
   U19AI090023, R37AI048638, U19AI090023, U19AI057266, P30AI050409,
   U54AI057157, U19AI057266, U54AI057157, P30AI050409, R37AI048638,
   P30AI050409, U54AI057157, U54AI057157, P30AI050409, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, P30AI050409, U54AI057157,
   U54AI057157, U54AI057157, R37AI048638, U19AI057266, U54AI057157,
   P30AI050409, U54AI057157, U19AI090023, U19AI057266, P30AI050409,
   U54AI057157, U54AI057157, P30AI050409, P30AI050409, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, P30AI050409, U19AI090023,
   P30AI050409, U54AI057157, U54AI057157, P30AI050409, U19AI057266,
   U54AI057157, P30AI050409, P30AI050409, U54AI057157, U19AI057266,
   P30AI050409, U54AI057157, P30AI050409, U19AI090023, U54AI057157,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, P30AI050409, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   P30AI050409, U19AI090023, U19AI090023, U19AI057266, U54AI057157,
   U19AI090023, P30AI050409, U54AI057157, U54AI057157, P30AI050409,
   U19AI090023, U54AI057157, P30AI050409, U19AI057266, P30AI050409,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, P30AI050409,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   P30AI050409, P30AI050409, U54AI057157, U54AI057157, P30AI050409,
   U54AI057157, P30AI050409, U19AI057266, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U19AI090023,
   U19AI090023, U54AI057157, U54AI057157, P30AI050409, U19AI090023,
   U54AI057157, P30AI050409, U54AI057157, P30AI050409, U54AI057157,
   U54AI057157, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, P30AI050409, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, P30AI050409, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, P30AI050409, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, U54AI057157,
   P30AI050409, U54AI057157, U19AI090023, R37AI048638, U19AI057266,
   U19AI090023, U54AI057157, U19AI057266, U19AI057266, P30AI050409,
   U19AI090023, P30AI050409, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, R37AI048638, P30AI050409, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, P30AI050409] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE ON AGINGUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) [R37AG023717, R37AG023717, R37AG023717, R37AG023717,
   R37AG023717, R37AG023717, R37AG023717, R37AG023717, R37AG023717,
   R37AG023717] Funding Source: NIH RePORTER
FX We are grateful to Mary Bower, Srilatha Edugupanti, and the Hope Clinic
   Staff who assisted with the clinical work. We also thank Emory
   Immunology/Flow Cytometry Core for technical assistance. H.I.N. receives
   a CNPq (Brazilian Research Council) research fellowship. This work was
   supported by NIH grants U19AI090023 (B.P.), U19AI057266 (R.A. and B.P.),
   HHSN272201400004C (B.P.), U54AI057157 (B.P.), R37AI48638 (B.P.), and
   R37DK057665 (B.P.) and NSF Grant STC-0939370 (S.S.).
CR Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098
   Almeida-Oliveira A, 2011, HUM IMMUNOL, V72, P319, DOI 10.1016/j.humimm.2011.01.009
   Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460
   Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330
   Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1
   Brooks JP, 2010, ANN OPER RES, V174, P147, DOI 10.1007/s10479-008-0424-0
   Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156
   Cao RG, 2014, J INFECT DIS, V210, P224, DOI 10.1093/infdis/jiu079
   Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219
   Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195
   Duraisingham SS, 2013, CURR TOP MICROBIOL, V363, P117, DOI 10.1007/82_2012_250
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299
   Frasca D, 2014, EXP GERONTOL, V54, P116, DOI 10.1016/j.exger.2014.01.004
   Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023
   Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15
   Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351
   Gorski KS, 2006, INT IMMUNOL, V18, P1115, DOI 10.1093/intimm/dxl046
   Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576
   Haq K, 2014, CURR OPIN IMMUNOL, V29, P38, DOI 10.1016/j.coi.2014.03.008
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003
   Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252
   Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005
   Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007
   Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]
   Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645
   Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886
   Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834
   Seidman JC, 2012, INFLUENZA OTHER RESP, V6, P52, DOI 10.1111/j.1750-2659.2011.00268.x
   Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015
   Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265
   Solana R, 2014, CURR OPIN IMMUNOL, V29, P56, DOI 10.1016/j.coi.2014.04.002
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sullivan SJ, 2010, EXPERT REV VACCINES, V9, P1127, DOI 10.1586/ERV.10.117
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023698
   Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154
   Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491
NR 52
TC 112
Z9 112
U1 1
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD DEC 15
PY 2015
VL 43
IS 6
BP 1186
EP 1198
DI 10.1016/j.immuni.2015.11.012
PG 13
WC Immunology
SC Immunology
GA CZ1DS
UT WOS:000366846600021
PM 26682988
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Hagan, T
   Nakaya, HI
   Subramaniam, S
   Pulendran, B
AF Hagan, Thomas
   Nakaya, Helder I.
   Subramaniam, Shankar
   Pulendran, Bali
TI Systems vaccinology: Enabling rational vaccine design with systems
   biological approaches
SO VACCINE
LA English
DT Article
DE Vaccines; Systems biology; Systems vaccinology
ID YELLOW-FEVER VACCINE; T-CELL RESPONSES; INACTIVATED INFLUENZA VACCINE;
   ADAPTIVE IMMUNE-RESPONSES; SEASONAL INFLUENZA; GENE-EXPRESSION;
   ANTIBODY; PROTECTION; INFECTION; EFFICACY
AB Vaccines have drastically reduced the mortality and morbidity of many diseases. However, vaccines have historically been developed empirically, and recent development of vaccines against current pandemics such as HIV and malaria has been met with difficulty. The advent of high-throughput technologies, coupled with systems biological methods of data analysis, has enabled researchers to interrogate the entire complement of a variety of molecular components within cells, and characterize the myriad interactions among them in order to model and understand the behavior of the system as a whole. In the context of vaccinology, these tools permit exploration of the molecular mechanisms by which vaccines induce protective immune responses. Here we review the recent advances, challenges, and potential of systems biological approaches in vaccinology. If the challenges facing this developing field can be overcome, systems vaccinology promises to empower the identification of early predictive signatures of vaccine response, as well as novel and robust correlates of protection from infection. Such discoveries, along with the improved understanding of immune responses to vaccination they impart, will play an instrumental role in development of the next generation of rationally designed vaccines. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Hagan, Thomas; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Nakaya, Helder I.; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Dept Pathol, Atlanta, GA 30329 USA.
   [Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.
   [Subramaniam, Shankar] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
   [Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   [Pulendran, Bali] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
RP Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Dept Pathol, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI090023, U19AI090023, R37AI048638, U19AI090023, R37AI048638,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, R37AI048638, U19AI090023, R37AI048638, U19AI090023,
   U19AI090023, R37AI048638, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, R56AI048638, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, R37AI048638,
   U19AI090023, R37AI048638, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, R37AI048638, R37AI048638, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   R37AI048638, U19AI090023, U19AI090023, R37AI048638] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R37 AI048638, R56 AI048638,
   U19 AI090023] Funding Source: Medline
CR Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050
   Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Barouch DH, 2014, CELL, V159, P969, DOI 10.1016/j.cell.2014.10.046
   BEHBEHANI AM, 1983, MICROBIOL REV, V47, P455, DOI 10.1128/MMBR.47.4.455-509.1983
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202
   Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1
   Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5
   Bodhidatta L, 2012, VACCINE, V30, P7040, DOI 10.1016/j.vaccine.2012.09.061
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020
   Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156
   Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642
   CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66
   Duraisingham SS, 2013, CURR TOP MICROBIOL, V363, P117, DOI 10.1007/82_2012_250
   Ehrenfeld E, 2009, EXPERT REV VACCINES, V8, P899, DOI 10.1586/ERV.09.49
   Frey SE, 2015, VACCINE, V33, P163, DOI 10.1016/j.vaccine.2014.10.083
   Funderud A, 2009, CELL SIGNAL, V21, P274, DOI 10.1016/j.cellsig.2008.10.013
   Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15
   Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gelder CM, 2002, J INFECT DIS, V185, P114, DOI 10.1086/338014
   Greenberg DP, 2013, VACCINE, V31, P770, DOI 10.1016/j.vaccine.2012.11.074
   Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425
   Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Inza I, 2000, ARTIF INTELL, V123, P157, DOI 10.1016/S0004-3702(00)00052-7
   Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691
   Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359
   Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Kauffman R E, 2000, Paediatr Drugs, V2, P411, DOI 10.2165/00128072-200002060-00001
   Kominsky DJ, 2010, J IMMUNOL, V184, P4062, DOI 10.4049/jimmunol.0903002
   Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI [10.1007/s10462-007-9052-3, 10.1007/S10462-007-9052-3]
   Lauterbach H, 2005, J GEN VIROL, V86, P2401, DOI 10.1099/vir.0.81104-0
   Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Li ZK, 2013, VACCINE, V31, P4355, DOI 10.1016/j.vaccine.2013.06.108
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260
   Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516
   Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P1423, DOI 10.1001/jama.279.18.1423
   McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333
   Moss AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071376
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   O'Connor D, 2013, CLIN INFECT DIS, V57, P860, DOI 10.1093/cid/cit373
   Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Olotu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115126
   Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041
   Ovsyannikova IG, 2014, HUM GENET, V133, P1083, DOI 10.1007/s00439-014-1449-x
   Ovsyannikova IG, 2011, J INFECT DIS, V203, P1546, DOI 10.1093/infdis/jir167
   Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X
   Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806
   Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314
   Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862
   Poland GA, 1999, VACCINE, V17, P1719, DOI 10.1016/S0264-410X(98)00429-0
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829
   Reif DM, 2009, GENES IMMUN, V10, P112, DOI 10.1038/gene.2008.80
   Reyes-Sandoval A, 2009, CURR OPIN MOL THER, V11, P72
   Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06
   Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834
   Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975
   Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207
   Stephenson I, 2007, VACCINE, V25, P4056, DOI 10.1016/j.vaccine.2007.02.039
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39
   Waddington CS, 2014, CLIN INFECT DIS, V58, P1230, DOI 10.1093/cid/ciu078
   Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023698
   Woods JA, 2006, NEUROL CLIN, V24, P585, DOI 10.1016/j.ncl.2006.03.008
   Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109
NR 86
TC 56
Z9 56
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD SEP 29
PY 2015
VL 33
IS 40
SI SI
BP 5294
EP 5301
DI 10.1016/j.vaccine.2015.03.072
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA CS7ZS
UT WOS:000362306100009
PM 25858860
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Uren, PJ
   Vo, DT
   de Araujo, PR
   Potschke, R
   Burns, SC
   Bahrami-Samani, E
   Qiao, M
   Abreu, RD
   Nakaya, HI
   Correa, BR
   Kuehnoel, C
   Ule, J
   Martindale, JL
   Abdelmohsen, K
   Gorospe, M
   Smith, AD
   Penalva, LOF
AF Uren, Philip J.
   Vo, Dat T.
   de Araujo, Patricia Rosa
   Poetschke, Rebecca
   Burns, Suzanne C.
   Bahrami-Samani, Emad
   Qiao, Mei
   Abreu, Raquel de Sousa
   Nakaya, Helder I.
   Correa, Bruna R.
   Kuehnoel, Caspar
   Ule, Jernej
   Martindale, Jennifer L.
   Abdelmohsen, Kotb
   Gorospe, Myriam
   Smith, Andrew D.
   Penalva, Luiz O. F.
TI RNA-Binding Protein Musashi1 Is a Central Regulator of Adhesion Pathways
   in Glioblastoma
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID EXTRACELLULAR-MATRIX PROTEINS; INTEGRATED GENOMIC ANALYSIS;
   TUMOR-CELL-PROLIFERATION; EXPRESSION ANALYSIS; GLIOMA GROWTH; CANCER;
   MARKER; HUR; IDENTIFICATION; DATABASE
AB The conserved RNA-binding protein Musashi1 (MSI1) has emerged as a key oncogenic factor in numerous solid tumors, including glioblastoma. However, its mechanism of action has not yet been established comprehensively. To identify its target genes comprehensively and determine the main routes by which it influences glioblastoma phenotypes, we conducted individual-nucleotide resolution cross-linking and immunoprecipitation (iCLIP) experiments. We confirmed that MSI1 has a preference for UAG sequences contained in a particular structural context, especially in 3' untranslated regions. Although numerous binding sites were also identified in intronic sequences, our RNA transcriptome sequencing analysis does not favor the idea that MSI1 is a major regulator of splicing in glioblastoma cells. MSI1 target mRNAs encode proteins that function in multiple pathways of cell proliferation and cell adhesion. Since these associations indicate potentially new roles for MSI1, we investigated its impact on glioblastoma cell adhesion, morphology, migration, and invasion. These processes are known to underpin the spread and relapse of glioblastoma, in contrast to other tumors where metastasis is the main driver of recurrence and progression.
C1 [Uren, Philip J.; Bahrami-Samani, Emad; Smith, Andrew D.] Univ So Calif, Div Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.
   [Vo, Dat T.; de Araujo, Patricia Rosa; Burns, Suzanne C.; Qiao, Mei; Abreu, Raquel de Sousa; Correa, Bruna R.; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA.
   [Vo, Dat T.; de Araujo, Patricia Rosa; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   [Poetschke, Rebecca; Kuehnoel, Caspar] Univ Med Ctr, Dept Childrens Hosp, Halle, Saale, Germany.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Nakaya, Helder I.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Dept Pathol, Atlanta, GA USA.
   [Ule, Jernej] UCL, Inst Neurol, Dept Mol Neurosci, London, England.
   [Martindale, Jennifer L.; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA.
RP Smith, AD (corresponding author), Univ So Calif, Div Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA.
EM andrewds@usc.edu
RI Smith, Andrew D./G-4104-2013; Ule, Jernej/C-6315-2013; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Abdelmohsen,
   Kotb/AAX-4191-2020
OI Smith, Andrew D./0000-0002-3337-1970; Ule, Jernej/0000-0002-2452-4277;
   Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Abdelmohsen, Kotb/0000-0001-6240-5810; Penalva,
   Luiz/0000-0003-4491-6769; de Sousa Abreu, Raquel/0000-0002-8211-6052
FU National Institute on Aging Intramural Research Program, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA); Max and Minnie Tomerlin Voelcker Fund; CPRIT (Texas)
   [RP140105]; Voices Against Brain Cancer; IIMS-CTRC (UTHSCSA); NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01HG006015];  [1R21CA175875-01A1]; NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [R21CA175875, R21CA175875, R21CA175875] Funding Source: NIH RePORTER;
   NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Human Genome Research Institute (NHGRI) [R01HG006015,
   R01HG006015, R01HG006015, R01HG006015, R01HG006015, R01HG006015,
   R01HG006015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON
   AGINGUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [ZIAAG000518, ZIAAG000518, ZIAAG000511, ZIAAG000518, ZIAAG000518,
   ZIAAG000518, ZIAAG000518, ZIAAG000518, ZIAAG000518, ZIAAG000518,
   ZIAAG000511, ZIAAG000511, ZIAAG000518, ZIAAG000511, ZIAAG000511,
   ZIAAG000511, ZIAAG000511, ZIAAG000511, ZIAAG000511, ZIAAG000511] Funding
   Source: NIH RePORTER
FX J.L.M., K.A., and M.G. were supported by the National Institute on Aging
   Intramural Research Program, National Institutes of Health. This study
   was supported by the Max and Minnie Tomerlin Voelcker Fund, Voices
   Against Brain Cancer, IIMS-CTRC (UTHSCSA), NIH R01HG006015, and
   1R21CA175875-01A1. P.R.D.A. is supported by CPRIT RP140105 (Texas).
CR Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bahrami-Samani E, 2015, WIRES RNA, V6, P291, DOI 10.1002/wrna.1274
   Bolognani F, 2012, J NEURO-ONCOL, V106, P531, DOI 10.1007/s11060-011-0707-1
   Burke PA, 2002, CANCER RES, V62, P4263
   Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106
   Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029
   Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004
   Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112
   Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385
   Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345
   Chintala SK, 1999, MOL CARCINOGEN, V26, P274, DOI 10.1002/(SICI)1098-2744(199912)26:4<274::AID-MC6>3.0.CO;2-1
   Courtois G, 2008, CELL MOL LIFE SCI, V65, P1123, DOI 10.1007/s00018-007-7465-4
   Cragle C, 2014, J BIOL CHEM, V289, P14239, DOI 10.1074/jbc.M114.548271
   Dahlrot RH, 2013, J NEURO-ONCOL, V115, P453, DOI 10.1007/s11060-013-1246-8
   Dziegiel P, 2010, BRIT J CANCER, V103, P524, DOI 10.1038/sj.bjc.6605750
   Filippova N, 2012, J BIOL CHEM, V287, P32277, DOI 10.1074/jbc.M112.353912
   Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325
   Friedlander DR, 1996, CANCER RES, V56, P1939
   Galante PAF, 2009, RNA BIOL, V6, P426, DOI 10.4161/rna.6.4.8841
   Galland F, 2010, ENDOCR-RELAT CANCER, V17, P361, DOI 10.1677/ERC-10-0018
   Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573
   GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q
   GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516
   Glazer RI, 2012, FRONT BIOSCI-LANDMRK, V17, P54, DOI 10.2741/3915
   Good P, 1998, GENOMICS, V52, P382, DOI 10.1006/geno.1998.5456
   Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200
   Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435
   Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322
   Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838
   Kuersten S, 2013, WIRES RNA, V4, P617, DOI 10.1002/wrna.1173
   Lagadec C, 2014, STEM CELLS, V32, P135, DOI 10.1002/stem.1537
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Loster K, 2001, BIOCHEM J, V356, P233, DOI 10.1042/0264-6021:3560233
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041
   MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621
   Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048
   Mikkelsen T, 2009, INT J CANCER, V124, P2719, DOI 10.1002/ijc.24240
   Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x
   Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431
   Ohyama T, 2012, NUCLEIC ACIDS RES, V40, P3218, DOI 10.1093/nar/gkr1139
   Okano H, 2002, J CELL SCI, V115, P1355
   Onodera T, 2010, SCIENCE, V329, P562, DOI 10.1126/science.1191880
   Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379
   Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736
   Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382
   PAULUS W, 1993, AM J PATHOL, V143, P154
   Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079
   Qin R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086446
   Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011
   Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405
   Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rutledge CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088385
   Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130
   Sakakibara S, 1997, J NEUROSCI, V17, P8300
   Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280
   Skuli N, 2009, CANCER RES, V69, P3308, DOI 10.1158/0008-5472.CAN-08-2158
   Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533
   Strojnik T, 2007, SURG NEUROL, V68, P133, DOI 10.1016/j.surneu.2006.10.050
   Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057
   Tao YM, 2013, HEPATOLOGY, V57, P2326, DOI 10.1002/hep.26268
   Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034
   Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3
   Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569
   Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020
   Vitolo D, 1996, HISTOPATHOLOGY, V28, P521, DOI 10.1046/j.1365-2559.1996.d01-471.x
   Vo DT, 2012, AM J PATHOL, V181, P1762, DOI 10.1016/j.ajpath.2012.07.031
   Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208
   Vo DT, 2011, RNA BIOL, V8, P817, DOI 10.4161/rna.8.5.16041
   Vogetseder A, 2013, INT J CANCER, V133, P2362, DOI 10.1002/ijc.28267
   Wang XY, 2013, ONCOTARGET, V4, P739, DOI 10.18632/oncotarget.1034
   Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221
   Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057
   Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055
NR 81
TC 23
Z9 24
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD SEP
PY 2015
VL 35
IS 17
BP 2965
EP 2978
DI 10.1128/MCB.00410-15
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA CO1TV
UT WOS:000358939200006
PM 26100017
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Almeida, GT
   Lage, RCG
   Anderson, L
   Venancio, TM
   Nakaya, HI
   Miyasato, PA
   Rofatto, HK
   Zerlotini, A
   Nakano, E
   Oliveira, G
   Verjovski-Almeida, S
AF Almeida, Giulliana T.
   Lage, Regina C. G.
   Anderson, Leticia
   Venancio, Thiago M.
   Nakaya, Helder I.
   Miyasato, Patrcia A.
   Rofatto, Henrique K.
   Zerlotini, Adhemar
   Nakano, Eliana
   Oliveira, Guilherme
   Verjovski-Almeida, Sergio
TI Synergy of Omeprazole and Praziquantel In Vitro Treatment against
   Schistosoma mansoni Adult Worms
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID METABOTROPIC GLUTAMATE RECEPTORS; MAP KINASE PHOSPHATASES; MALE-FEMALE
   INTERACTION; HUMAN BLOOD FLUKE; CHRONIC-SCHIZOPHRENIA; DRUG TARGETS;
   INVITRO; TRANSCRIPTOME; RESISTANCE; INHIBITOR
AB Background
   Treatment and morbidity control of schistosomiasis relies on a single drug, praziquantel (PZQ), and the selection of resistant worms under repeated treatment is a concern. Therefore, there is a pressing need to understand the molecular effects of PZQ on schistosomes and to investigate alternative or synergistic drugs against schistosomiasis.
   Methodology
   We used a custom-designed Schistosoma mansoni expression microarray to explore the effects of sublethal doses of PZQ on large-scale gene expression of adult paired males and females and unpaired mature females. We also assessed the efficacy of PZQ, omeprazole (OMP) or their combination against S. mansoni adult worms with a survival in vitro assay.
   Principal Findings
   We identified sets of genes that were affected by PZQ in paired and unpaired mature females, however with opposite gene expression patterns (up-regulated in paired and down-regulated in unpaired mature females), indicating that PZQ effects are heavily influenced by the mating status. We also identified genes that were similarly affected by PZQ in males and females. Functional analyses of gene interaction networks were performed with parasite genes that were differentially expressed upon PZQ treatment, searching for proteins encoded by these genes whose human homologs are targets of different drugs used for other diseases. Based on these results, OMP, a widely prescribed proton pump inhibitor known to target the ATP1A2 gene product, was chosen and tested. Sublethal doses of PZQ combined with OMP significantly increased worm mortality in vitro when compared with PZQ or OMP alone, thus evidencing a synergistic effect.
   Conclusions
   Functional analysis of gene interaction networks is an important approach that can point to possible novel synergistic drug candidates. We demonstrated the potential of this strategy by showing that PZQ in combination with OMP displayed increased efficiency against S. mansoni adult worms in vitro when compared with either drug alone.
C1 [Almeida, Giulliana T.; Anderson, Leticia; Venancio, Thiago M.; Nakaya, Helder I.; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.
   [Lage, Regina C. G.; Zerlotini, Adhemar; Oliveira, Guilherme] Fiocruz MS, Ctr Pesquisas Rene Rachou, Genom & Computat Biol Grp, Belo Horizonte, MG, Brazil.
   [Miyasato, Patrcia A.; Rofatto, Henrique K.; Nakano, Eliana; Verjovski-Almeida, Sergio] Inst Butantan, Sao Paulo, SP, Brazil.
   [Oliveira, Guilherme] Vale Technol Inst, Belem, Para, Brazil.
RP Almeida, GT (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.
EM verjo@iq.usp.br
RI Nakaya, Helder I/A-1397-2010; Venancio, Thiago M/B-5003-2011; Miyasato,
   Patricia/P-8045-2018; Verjovski-Almeida, Sergio/E-4082-2012; Nakaya,
   Helder/AAF-1738-2020; Anderson, Leticia/Q-6935-2016; Zerlotini,
   Adhemar/E-6533-2012; nakano, eliana/D-1542-2011; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Oliveira, Guilherme/E-2624-2014
OI Nakaya, Helder I/0000-0001-5297-9108; Venancio, Thiago
   M/0000-0002-2215-8082; Miyasato, Patricia/0000-0003-4871-5972;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Nakaya,
   Helder/0000-0001-5297-9108; Zerlotini, Adhemar/0000-0002-7739-0284;
   nakano, eliana/0000-0002-7839-9600; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Oliveira, Guilherme/0000-0003-0054-3438;
   Anderson, Leticia/0000-0003-3884-2329
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas Gerais State Research
   Foundation (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP); FAPEMIGMinas Gerais State Research Foundation (FAPEMIG);
   CNPq, BrasilNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by a grant from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) to SVA. GO received funding support from
   Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) and
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq). GTA, TMV, HIN, LA were supported by fellowships from FAPESP, and
   RCGL received a fellowship from FAPEMIG. HIN, TMV, GO and SVA receive
   established investigator fellowship awards from CNPq, Brasil. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Amakye D, 2004, CLIN PHARMACOL THER, V75, pP54, DOI 10.1016/j.clpt.2003.11.203
   BASCH PF, 1981, J PARASITOL, V67, P179, DOI 10.2307/3280632
   BECKER B, 1980, Z PARASITENKD, V63, P113, DOI 10.1007/BF00927527
   BOSCH IB, 1994, MOL BIOCHEM PARASIT, V65, P351, DOI 10.1016/0166-6851(94)90085-X
   Bourguinat C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000072
   Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200
   Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038
   Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031
   Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413
   Cioli D, 2003, PARASITOL RES, V90, pS3, DOI 10.1007/s00436-002-0751-z
   Coeli R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002596
   Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2
   Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205
   de Andrade LF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002949
   De Souza C P, 1979, Rev Bras Pesqui Med Biol, V12, P411
   Derbyshire ER, 2012, P NATL ACAD SCI USA, V109, P8511, DOI 10.1073/pnas.1118370109
   Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266
   Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199
   Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f
   Dufour V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003586
   FALLON PG, 1994, AM J TROP MED HYG, V51, P83, DOI 10.4269/ajtmh.1994.51.83
   FELLENIUS E, 1981, NATURE, V290, P159, DOI 10.1038/290159a0
   Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602
   Gnanasekar M, 2009, ANTIMICROB AGENTS CH, V53, P1054, DOI 10.1128/AAC.01222-08
   Goldstein DM, 2006, J MED CHEM, V49, P1562, DOI 10.1021/jm050736c
   Greenberg RM, 2014, INT J PARASITOL-DRUG, V4, P301, DOI 10.1016/j.ijpddr.2014.09.007
   Greenberg RM, 2013, PARASITOLOGY, V140, P1534, DOI 10.1017/S0031182013000231
   Grevelding CG, 2004, CURR BIOL, V14, pR545, DOI 10.1016/j.cub.2004.07.006
   Grevelding CG, 1997, PARASITOLOGY, V115, P635, DOI 10.1017/S0031182097001728
   HARNETT W, 1986, PARASITOLOGY, V93, P401, DOI 10.1017/S0031182000051568
   Hines-Kay J, 2012, MOL BIOCHEM PARASIT, V186, P87, DOI 10.1016/j.molbiopara.2012.09.006
   Hoffmann KF, 2002, GENOME BIOL, V3
   IWATA H, 1988, JPN J PHARMACOL, V46, P35, DOI 10.1254/jjp.46.35
   Jiang SP, 2002, ANTIMICROB AGENTS CH, V46, P2569, DOI 10.1128/AAC.46.8.2569-2574.2002
   Kapp K, 2004, MOL BIOCHEM PARASIT, V138, P171, DOI 10.1016/j.molbiopara.2004.07.010
   Kasinathan RS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003265
   Kasinathan RS, 2010, FASEB J, V24, P128, DOI 10.1096/fj.09-137091
   KEELING DJ, 1985, BIOCHEM PHARMACOL, V34, P2967, DOI 10.1016/0006-2952(85)90023-1
   Keiser J, 2012, CURR PHARM DESIGN, V18, P3531
   Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936
   KOECHEL DA, 1981, ANNU REV PHARMACOL, V21, P265, DOI 10.1146/annurev.pa.21.040181.001405
   Kohn AB, 2003, INT J PARASITOL, V33, P1303, DOI [10.1016/S0020-7519(03)00209-1, 10.1016/s0020-7519(03)00209-1]
   Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002
   Kunz W, 2001, TRENDS PARASITOL, V17, P227, DOI 10.1016/S1471-4922(01)01893-1
   Langtry HD, 1998, DRUGS, V56, P447, DOI 10.2165/00003495-199856030-00012
   Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688
   Liu S, 2012, MOL BIOCHEM PARASIT, V182, P75, DOI 10.1016/j.molbiopara.2011.12.007
   Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504
   Miller CL, 1996, EXP PARASITOL, V84, P410, DOI 10.1006/expr.1996.0129
   Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126
   Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002
   Pauli-Magnus C, 2001, N-S ARCH PHARMACOL, V364, P551, DOI 10.1007/s00210-001-0489-7
   Peak E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000759
   Peinado JR, 2004, BIOCHEM BIOPH RES CO, V321, P601, DOI 10.1016/j.bbrc.2004.07.012
   Perez-Villanueva J, 2011, BIOORG MED CHEM LETT, V21, P7351, DOI 10.1016/j.bmcl.2011.10.028
   Pica-Mattoccia L, 2004, INT J PARASITOL, V34, P527, DOI 10.1016/j.ijpara.2003.12.003
   POPIEL I, 1984, J EXP ZOOL, V232, P141, DOI 10.1002/jez.1402320117
   Protasio AV, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001455
   Rahimtoola SH, 2004, CIRCULATION, V109, P2942, DOI 10.1161/01.CIR.0000132477.32438.03
   RAMALHOPINTO FJ, 1974, EXP PARASITOL, V36, P360, DOI 10.1016/0014-4894(74)90076-9
   Ribeiro-dos-Santos G, 2006, PARASITOL RES, V99, P505, DOI 10.1007/s00436-006-0175-2
   Riel MA, 2002, ANTIMICROB AGENTS CH, V46, P2627, DOI 10.1128/AAC.46.8.2627-2632.2002
   Rosenheck RA, 2006, AM J PSYCHIAT, V163, P2080, DOI 10.1176/appi.ajp.163.12.2080
   Schussler P, 1997, PARASITOLOGY, V115, P629, DOI 10.1017/S003118209700173X
   Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699
   SHAW MK, 1988, EXP PARASITOL, V65, P31, DOI 10.1016/0014-4894(88)90104-X
   Skinner-Adams T, 1999, ANTIMICROB AGENTS CH, V43, P1304, DOI 10.1128/AAC.43.5.1304
   SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248
   Taman A, 2011, MOL BIOCHEM PARASIT, V176, P42, DOI 10.1016/j.molbiopara.2010.12.001
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237
   Verjovski-Almeida S, 2007, EXP PARASITOL, V117, P236, DOI 10.1016/j.exppara.2007.04.005
   Wang LL, 2006, FEBS LETT, V580, P3677, DOI 10.1016/j.febslet.2006.05.055
   Weiser T, 2005, CNS NEUROL DISORD-DR, V4, P153, DOI 10.2174/1568007053544129
   You H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003254
NR 75
TC 11
Z9 12
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2015
VL 9
IS 9
AR e0004086
DI 10.1371/journal.pntd.0004086
PG 23
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CT7YI
UT WOS:000363031200060
PM 26402251
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Pulendran, B
AF Nakaya, Helder I.
   Pulendran, Bali
TI Vaccinology in the era of high-throughput biology
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Review
DE systems biology; vaccinology; high-throughput biology; immunity
ID YELLOW-FEVER VACCINE; INNATE IMMUNE-RESPONSE; SYSTEMS BIOLOGY; INFLUENZA
   VACCINE; SEASONAL INFLUENZA; ANTIBODY-RESPONSES; MALARIA VACCINE; VIRUS;
   IMMUNOGENICITY; EXPRESSION
AB Vaccination has been tremendously successful saving lives and preventing infections. However, the development of vaccines against global pandemics such as HIV, malaria and tuberculosis has been obstructed by several challenges. A major challenge is the lack of knowledge about the correlates and mechanisms of protective immunity. Recent advances in the application of systems biological approaches to analyse immune responses to vaccination in humans are beginning to yield new insights about mechanisms of vaccine immunity, and to define molecular signatures, induced rapidly after vaccination, that correlate with and predict vaccine induced immunity. Here, we review these advances and discuss the potential of this systems vaccinology approach in defining novel correlates of protection in clinical trials, and in infection-induced 'experimental challenge models' in humans.
C1 [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Pulendran, B (corresponding author), Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R37 DK057665,
   R37 AI048638, U19 AI090023, U19 AI057266, U54 AI057157, N01 AI50019, N01
   AI50025]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U54AI057157,
   U19AI090023, U54AI057157, U19AI090023, U19AI090023, U19AI057266,
   U54AI057157, U54AI057157, R37AI048638, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U19AI090023,
   U54AI057157, U19AI090023, U19AI090023, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, R37AI048638,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   R37AI048638, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, R37AI048638, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   R37AI048638, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U19AI090023, U19AI057266,
   N01AI050025, U54AI057157, R37AI048638, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, R37AI048638,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U19AI090023, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, R37AI048638, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, R37AI048638, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, R37AI048638, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U19AI090023, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, R37AI048638, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665] Funding
   Source: NIH RePORTER
FX This work was supported by grants from the US National Institutes of
   Health (grants nos. R37 DK057665, R37 AI048638, U19 AI090023, U19
   AI057266, U54 AI057157, N01 AI50019 and N01 AI50025) and from the Bill &
   Melinda Gates Foundation to B.P.
CR Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1
   Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668
   Cao RG, 2014, J INFECT DIS, V210, P224, DOI 10.1093/infdis/jiu079
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   CLEMENTS ML, 1990, J INFECT DIS, V161, P869, DOI 10.1093/infdis/161.5.869
   Del Prete A, 2007, BLOOD, V109, P626, DOI 10.1182/blood-2006-02-003665
   Duraisingham SS, 2013, CURR TOP MICROBIOL, V363, P117, DOI 10.1007/82_2012_250
   Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003
   Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299
   Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]
   Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105
   Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6
   Han JDJ, 2008, CELL RES, V18, P224, DOI 10.1038/cr.2008.16
   Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   Ioannidis I, 2012, J VIROL, V86, P5422, DOI 10.1128/JVI.06757-11
   Johnson CH, 2012, J CELL PHYSIOL, V227, P2975, DOI 10.1002/jcp.24002
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336
   Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787
   Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Lee KJ, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00054
   Li GL, UNPUB
   Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789
   Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003
   Liberzon A, 2014, METHODS MOL BIOL, V1150, P153, DOI 10.1007/978-1-4939-0512-6_9
   Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260
   Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198
   Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55
   Marwick C, 1998, JAMA-J AM MED ASSOC, V279, P1423, DOI 10.1001/jama.279.18.1423
   Mooney M, 2013, SEMIN IMMUNOL, V25, P124, DOI 10.1016/j.smim.2013.06.003
   Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nakaya HI, SYSTEMS ANAL I UNPUB
   Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Pache L, 2011, METHODS, V53, P3, DOI 10.1016/j.ymeth.2010.07.009
   Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097
   Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014
   Pulendran B, 2015, ANNU REV IMMUNOL, V33, P563, DOI 10.1146/annurev-immunol-020711-075049
   Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ramautar R, 2013, CURR OPIN CHEM BIOL, V17, P841, DOI 10.1016/j.cbpa.2013.06.015
   Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829
   Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633
   Sack DA, 1998, INFECT IMMUN, V66, P1968, DOI 10.1128/IAI.66.5.1968-1972.1998
   Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902
   Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653
   Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294
   Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437
   Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015
   Spring M, 2014, J INFECT DIS, V209, P540, DOI 10.1093/infdis/jiu063
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tan Y, 2014, EUR J IMMUNOL, V44, P285, DOI 10.1002/eji.201343657
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39
   Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331
   Waddington CS, 2014, CLIN INFECT DIS, V58, P1230, DOI 10.1093/cid/ciu078
   Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x
NR 76
TC 28
Z9 28
U1 0
U2 8
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD JUN 19
PY 2015
VL 370
IS 1671
AR 20140146
DI 10.1098/rstb.2014.0146
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA CJ6AQ
UT WOS:000355575800010
PM 25964458
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Bruna-Romero, O
AF Nakaya, Helder I.
   Bruna-Romero, Oscar
TI Is the gut microbiome key to modulating vaccine efficacy?
SO EXPERT REVIEW OF VACCINES
LA English
DT Editorial Material
DE dysbiosis; immunity; microbiome; systems vaccinology; vaccine efficacy;
   vaccines
ID ANTIBODY-RESPONSES; SEASONAL INFLUENZA; SYSTEMS BIOLOGY; CHOLERA
   VACCINE; IMMUNITY; IMMUNOGENICITY; CHILDREN; HUMANS; INNATE
AB A symbiotic relationship with gut microbes is critical for the normal function of human health. Vaccination, however, tips the symbiotic balance slightly in favor of human health. Recent work has shown that gut bacterial residents can have great (positive) influence over vaccine-induced immunity. With an arsenal of modern high-throughput technologies in the hands of microbiologists and immunologists, it is now easier and more cost-effective than ever to characterize and measure the microbiome of vaccinees. Such data will lead to an understanding of how and to what extent gut microbes can impact vaccine efficacy.
C1 [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.
   [Nakaya, Helder I.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA.
   [Bruna-Romero, Oscar] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Florianopolis, SC, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, Brazil.
EM hnakaya@usp.br
RI BRUNA-ROMERO, OSCAR/B-3918-2010; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020
OI BRUNA-ROMERO, OSCAR/0000-0002-8855-4969; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108
CR Biesbroek G, 2014, EMERG INFECT DIS, V20, P201, DOI 10.3201/eid2002.131220
   Brotman RM, 2014, VACCINE, V32, P1543, DOI 10.1016/j.vaccine.2013.10.010
   Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009
   Didierlaurent A, 2005, CELL MOL LIFE SCI, V62, P1285, DOI 10.1007/s00018-005-5032-4
   Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330
   Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1
   Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8
   Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430
   Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129
   Lopman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041720
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Soh SE, 2010, VACCINE, V28, P2577, DOI 10.1016/j.vaccine.2010.01.020
   Valdezi Y, 2014, TRENDS IMMUNOL, V35, P526, DOI 10.1016/j.it.2014.07.003
NR 16
TC 9
Z9 10
U1 0
U2 26
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD JUN
PY 2015
VL 14
IS 6
BP 777
EP 779
DI 10.1586/14760584.2015.1040395
PG 3
WC Immunology
SC Immunology
GA CI0PV
UT WOS:000354440700001
PM 25915555
OA Green Published
DA 2020-12-17
ER

PT J
AU Navarro, IC
   Ferreira, FM
   Nakaya, HI
   Baron, MA
   Vilar-Pereira, G
   Pereira, IR
   Silva, AMG
   Real, JM
   De Brito, T
   Chevillard, C
   Lannes-Vieira, J
   Kalil, J
   Cunha-Neto, E
   Ferreira, LRP
AF Navarro, Isabela Cunha
   Ferreira, Frederico Moraes
   Nakaya, Helder I.
   Baron, Monique Andrade
   Vilar-Pereira, Glaucia
   Pereira, Isabela Resende
   Goncalves Silva, Ana Maria
   Real, Juliana Monte
   De Brito, Thales
   Chevillard, Christophe
   Lannes-Vieira, Joseli
   Kalil, Jorge
   Cunha-Neto, Edecio
   Pinto Ferreira, Ludmila Rodrigues
TI MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected
   Mice: Parasitological and Cardiological Outcomes
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHAGAS-DISEASE; GENE-EXPRESSION; PARASITE LOAD; CHRONIC PHASE;
   CARDIOMYOPATHY; ABNORMALITIES; PARAMETERS; MORTALITY; RNAS
AB Chagas disease is caused by the parasite Trypanosoma cruzi, and it begins with a short acute phase characterized by high parasitemia followed by a life-long chronic phase with scarce parasitism. Cardiac involvement is the most prominent manifestation, as 30% of infected subjects will develop abnormal ventricular repolarization with myocarditis, fibrosis and cardiomyocyte hypertrophy by undefined mechanisms. Nevertheless, follow-up studies in chagasic patients, as well as studies with murine models, suggest that the intensity of clinical symptoms and pathophysiological events that occur during the acute phase of disease are associated with the severity of cardiac disease observed during the chronic phase. In the present study we investigated the role of microRNAs (miRNAs) in the disease progression in response to T. cruzi infection, as alterations in miRNA levels are known to be associated with many cardiovascular disorders. We screened 641 rodent miRNAs in heart samples of mice during an acute infection with the Colombiana T.cruzi strain and identified multiple miRNAs significantly altered upon infection. Seventeen miRNAs were found significantly deregulated in all three analyzed time points post infection. Among these, six miRNAs had their expression correlated with clinical parameters relevant to the disease, such as parasitemia and maximal heart rate-corrected QT (QTc) interval. Computational analyses identified that the gene targets for these six miRNAs were involved in networks and signaling pathways related to increased ventricular depolarization and repolarization times, important factors for QTc interval prolongation. The data presented here will guide further studies about the contribution of microRNAs to Chagas heart disease pathogenesis.
C1 [Navarro, Isabela Cunha; Ferreira, Frederico Moraes; Baron, Monique Andrade; Kalil, Jorge; Cunha-Neto, Edecio; Pinto Ferreira, Ludmila Rodrigues] Univ Sao Paulo, Heart Inst InCor, Immunol Lab, Sch Med, Sao Paulo, Brazil.
   [Navarro, Isabela Cunha; Ferreira, Frederico Moraes; Baron, Monique Andrade; Kalil, Jorge; Cunha-Neto, Edecio; Pinto Ferreira, Ludmila Rodrigues] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
   [Navarro, Isabela Cunha; Ferreira, Frederico Moraes; Baron, Monique Andrade; Kalil, Jorge; Cunha-Neto, Edecio; Pinto Ferreira, Ludmila Rodrigues] Iii INCT, Inst Investigat Immunol, Sao Paulo, Brazil.
   [Nakaya, Helder I.] Univ Sao Paulo, Dept Clin Anal & Toxicol, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Vilar-Pereira, Glaucia; Pereira, Isabela Resende; Lannes-Vieira, Joseli] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Interact, BR-21045900 Rio De Janeiro, Brazil.
   [Goncalves Silva, Ana Maria; De Brito, Thales] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.
   [Goncalves Silva, Ana Maria; De Brito, Thales] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil.
   [Real, Juliana Monte] Hosp Sirio Libanes, Sao Paulo, Brazil.
   [Chevillard, Christophe] Aix Marseille Univ, Fac Med, INSERM, U906, Marseille, France.
RP Navarro, IC (corresponding author), Univ Sao Paulo, Heart Inst InCor, Immunol Lab, Sch Med, Sao Paulo, Brazil.
EM edecunha@gmail.com
RI KALIL, JORGE/C-8029-2012; Nakaya, Helder/AAF-1738-2020; De Brito,
   Thales/L-2865-2017; Ferreira, Frederico Moraes/A-4622-2013; Ferreira,
   Ludmila Rodrigues Pinto/B-4955-2015; da Silva, Ana Maria
   Goncalves/ABD-3920-2020; Navarro, Isabela Cunha/V-7182-2017; Nakaya,
   Helder I/A-1397-2010; Cunha-Neto, Edecio/B-4157-2009; Ferreira,
   Ludmila/C-4100-2012; chevillard, christophe/A-7087-2015
OI KALIL, JORGE/0000-0001-8415-4274; Nakaya, Helder/0000-0001-5297-9108; De
   Brito, Thales/0000-0003-1106-7254; Ferreira, Ludmila Rodrigues
   Pinto/0000-0001-9944-6691; Navarro, Isabela Cunha/0000-0002-6844-2361;
   Nakaya, Helder I/0000-0001-5297-9108; Cunha-Neto,
   Edecio/0000-0002-3699-3345; Ferreira, Ludmila/0000-0001-9944-6691;
   chevillard, christophe/0000-0002-5269-8813; Silva, Ana
   Maria/0000-0001-7554-0894
FU Sao Paulo state Foundation for Scientific Research (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/08107-6,
   2013/50302-3]; Brazilian National Research Council (CNPq)National
   Council for Scientific and Technological Development (CNPq); National
   Institute of Allergy and Infectious DiseaseUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [1P50AI098461-01]; CNPq fellowshipNational Council for Scientific and
   Technological Development (CNPq) [151045/2013-5]; FAPESP
   fellowshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   Rio de Janeiro Foundation for Scientific Research (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Medical Investigation Laboratory; CNPqNational Council for
   Scientific and Technological Development (CNPq) [474234/20126-Universal,
   302534/2008-3]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [APQ1-E-26/111.756/2008,
   CNE/E-26/101.549/2010, E-26/110.153/2013, E-26/111.709/2013]; National
   Institute for Science and Technology for Vaccines (INCTV/CNPq)
   [403979/2012-9-DECIT]; Institut National de la Sante et de la Recherche
   Medicale (INSERM)Institut National de la Sante et de la Recherche
   Medicale (Inserm); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P50AI098461, P50AI098461, P50AI098461,
   P50AI098461, P50AI098461, P50AI098461, P50AI098461, P50AI098461,
   P50AI098461, P50AI098461, P50AI098461, P50AI098461, P50AI098461,
   P50AI098461, P50AI098461, P50AI098461, P50AI098461, P50AI098461,
   P50AI098461, P50AI098461, P50AI098461, P50AI098461, P50AI098461,
   P50AI098461, P50AI098461] Funding Source: NIH RePORTER
FX This work has been supported by grants of Sao Paulo state Foundation for
   Scientific Research (FAPESP) - Grants number 2012/08107-6 and
   2013/50302-3 - the Brazilian National Research Council (CNPq), National
   Institute of Allergy and Infectious Disease - Grant Number
   1P50AI098461-01. LRPF was recipient of a CNPq fellowship
   (#151045/2013-5); ICN and MAB are recipients of a FAPESP fellowship. GVP
   is recipient of a Coordination of Improvement of Higher Level Personnel
   (CAPES) fellowship, IRP is recipient of a Rio de Janeiro Foundation for
   Scientific Research (FAPERJ) "Bolsa Nota 10" fellowship; AMGS and TDB
   are recipients of a Medical Investigation Laboratory 06 (LIM/06)
   financial support. JLV, ECN and JK are recipients of CNPq productivity
   awards. JLV has also received grants from FAPERJ
   (#APQ1-E-26/111.756/2008, CNE/E-26/101.549/2010, E-26/110.153/2013 and
   E-26/111.709/2013) and CNPq (Grants #474234/20126-Universal and
   #302534/2008-3); National Institute for Science and Technology for
   Vaccines (INCTV/CNPq); (#403979/2012-9-DECIT). CC is a recipient for
   Institut National de la Sante et de la Recherche Medicale (INSERM)
   financial support. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alvarado-Tapias E, 2012, INVEST CLIN, V53, P378
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bern C, 2011, ADV PARASIT, V75, P19, DOI 10.1016/B978-0-12-385863-4.00002-2
   Bilate AM, 2008, J INFECT DIS, V198, P614, DOI 10.1086/590347
   Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001
   Bostjancic E, 2010, FOLIA BIOL-PRAGUE, V56, P27
   BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389
   Caldas IS, 2008, PARASITOL RES, V103, P413, DOI 10.1007/s00436-008-0992-6
   Camandaroba Edson Luiz Paes, 2001, Revista da Sociedade Brasileira de Medicina Tropical, V34, P151, DOI 10.1590/S0037-86822001000200001
   Eickhoff CS, 2010, J PARASITOL, V96, P758, DOI 10.1645/GE-2396.1
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995
   Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800
   Itokawa K, 1999, MOL BRAIN RES, V71, P354, DOI 10.1016/S0169-328X(99)00194-1
   LATRONICO MVG, 2009, NATURE REV, V6, P419, DOI DOI 10.1038/NRCARDIO.2009.56
   Lee CT, 2007, DNA CELL BIOL, V26, P209, DOI 10.1089/dna.2006.0545
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Marinho CRF, 1999, INFECT IMMUN, V67, P308, DOI 10.1128/IAI.67.1.308-318.1999
   Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248
   Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364
   Oliveira-Carvalho V, 2012, ARQ BRAS CARDIOL, V98, P362, DOI 10.1590/S0066-782X2012000400011
   Ferreira LRP, 2014, INT J CARDIOL, V175, P409, DOI 10.1016/j.ijcard.2014.05.019
   Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451
   Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002
   Ribeiro AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002078
   Roman-Campos D, 2013, MEM I OSWALDO CRUZ, V108, P243, DOI 10.1590/0074-0276108022013019
   Roman-Campos D, 2009, BASIC RES CARDIOL, V104, P238, DOI 10.1007/s00395-009-0776-x
   Salles G, 2003, CIRCULATION, V108, P305, DOI 10.1161/01.CIR.0000079174.13444.9C
   Salles GF, 2004, AM J CARDIOL, V93, P1136, DOI 10.1016/j.amjcard.2004.01.040
   Salles GF, 2003, PACE, V26, P1326, DOI 10.1046/j.1460-9592.2003.t01-1-00190.x
   Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Silverio JC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002645
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
   Talvani A, 2000, MICROBES INFECT, V2, P851, DOI 10.1016/S1286-4579(00)00388-9
   Teixeira MM, 2002, TRENDS PARASITOL, V18, P262, DOI 10.1016/S1471-4922(02)02283-3
   Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983
NR 37
TC 21
Z9 21
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2015
VL 9
IS 6
AR e0003828
DI 10.1371/journal.pntd.0003828
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CM0VX
UT WOS:000357398100032
PM 26086673
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Akondy, RS
   Johnson, PLF
   Nakaya, HI
   Edupuganti, S
   Mulligan, MJ
   Lawson, B
   Miller, JD
   Pulendran, B
   Antia, R
   Ahmed, R
AF Akondy, Rama S.
   Johnson, Philip L. F.
   Nakaya, Helder I.
   Edupuganti, Srilatha
   Mulligan, Mark J.
   Lawson, Benton
   Miller, Joseph D.
   Pulendran, Bali
   Antia, Rustom
   Ahmed, Rafi
TI Initial viral load determines the magnitude of the human CD8 T cell
   response to yellow fever vaccination
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE vaccines; human CD8 T cells; viral load; effector T cells; immune memory
ID HIGHLY PATHOGENIC SIV; IMMUNE-RESPONSES; DOUBLE-BLIND; MEMORY; ANTIGEN;
   VIREMIA; INFECTION; EXPANSION; EFFECTOR; ASSOCIATION
AB CD8 T cells are a potent tool for eliminating intracellular pathogens and tumor cells. Thus, eliciting robust CD8 T-cell immunity is the basis for many vaccines under development. However, the relationship between antigen load and the magnitude of the CD8 T-cell response is not well-described in a human immune response. Here we address this issue by quantifying viral load and the CD8 T-cell response in a cohort of 80 individuals immunized with the live attenuated yellow fever vaccine (YFV-17D) by sampling peripheral blood at days 0, 1, 2, 3, 5, 7, 9, 11, 14, 30, and 90. When the virus load was below a threshold (peak virus load < 225 genomes per mL, or integrated virus load < 400 genome days per mL), the magnitude of the CD8 T-cell response correlated strongly with the virus load (R-2 similar to 0.63). As the virus load increased above this threshold, the magnitude of the CD8 T-cell responses saturated. Recent advances in CD8 T-cell-based vaccines have focused on replication-incompetent or single-cycle vectors. However, these approaches deliver relatively limited amounts of antigen after immunization. Our results highlight the requirement that T-cell-based vaccines should deliver sufficient antigen during the initial period of the immune response to elicit a large number of CD8 T cells that may be needed for protection.
C1 [Akondy, Rama S.; Nakaya, Helder I.; Edupuganti, Srilatha; Mulligan, Mark J.; Miller, Joseph D.; Pulendran, Bali; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Akondy, Rama S.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Edupuganti, Srilatha; Mulligan, Mark J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Johnson, Philip L. F.; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA.
   [Lawson, Benton] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508 Sao Paulo, Brazil.
RP Antia, R (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.
EM rantia@emory.edu; rahmed@emory.edu
RI Nakaya, Helder/AAF-1738-2020; DELGADO, RAFAEL/A-2938-2012; Akondy,
   Rama/AAC-4656-2020; Nakaya, Helder I/A-1397-2010; Mulligan,
   Mark/V-9275-2019
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Akondy, Rama/0000-0003-4737-5240
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI057266, R01 AI110720, K99
   GM104158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, R37AI048638, U19AI057266, R37AI048638, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, R01AI110720,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, R37AI048638, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   R01AI110720, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, R01AI110720, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, R37AI048638,
   R01AI110720, U19AI057266, U19AI057266, R37AI048638, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, R37AI048638,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, R01AI110720, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, R37AI048638,
   U19AI057266, R37AI048638, U19AI057266, U19AI057266, U19AI057266,
   R37AI048638, U19AI057266, U19AI057266] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R00GM104158,
   K99GM104158, R00GM104158, K99GM104158, R00GM104158] Funding Source: NIH
   RePORTER
FX We thank the reviewers for helpful comments. This work was supported by
   NIH Grants U19AI057266 (to R. Ahmed), R01 AI110720 (to R. Antia), and
   K99 GM104158 (to P.L.F.J.).
CR Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208
   Asquith B, 2007, IMMUNOL CELL BIOL, V85, P280, DOI 10.1038/sj.icb.7100050
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001
   BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994
   Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3
   Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392
   Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336
   Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x
   Davenport MP, 2007, IMMUNOL REV, V216, P164
   Davenport MP, 2005, J VIROL, V79, P10059, DOI 10.1128/JVI.79.15.10059-10062.2005
   Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004
   Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06
   Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208
   Edupuganti S, 2013, AM J TROP MED HYG, V88, P172, DOI 10.4269/ajtmh.2012.12-0179
   Elemans M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002381
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Harrer T, 1996, AIDS RES HUM RETROV, V12, P585, DOI 10.1089/aid.1996.12.585
   James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13
   Kaech SM, 2001, NAT IMMUNOL, V2, P415
   Kamphorst AO, 2013, CURR OPIN IMMUNOL, V25, P381, DOI 10.1016/j.coi.2013.03.003
   Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520
   KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994
   Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858
   MATIS LA, 1983, P NATL ACAD SCI-BIOL, V80, P6019, DOI 10.1073/pnas.80.19.6019
   Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Monath TP, 2012, VACCINES, P870
   Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7
   Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003
   Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74
   PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0
   Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Pulendran B, 2013, IMMUNOL REV, V255, P243, DOI 10.1111/imr.12099
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105
   Sester M, 2002, J AM SOC NEPHROL, V13, P2577, DOI 10.1097/01.ASN.0000030141.41726.52
   Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sullivan NJ, 2011, NAT MED, V17, P1128, DOI 10.1038/nm.2447
   Swadling L, 2013, EXPERT OPIN BIOL TH, V13, P1109, DOI 10.1517/14712598.2013.791277
   van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423
   Vratskikh O, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003458
NR 50
TC 55
Z9 55
U1 0
U2 19
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 10
PY 2015
VL 112
IS 10
BP 3050
EP 3055
DI 10.1073/pnas.1500475112
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC8VK
UT WOS:000350646500046
PM 25713354
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Nakaya, HI
AF Nakaya, H. I.
TI Systems vaccinology: its promise and challenge for vaccine design
SO IMMUNOLOGY
LA English
DT Meeting Abstract
C1 [Nakaya, H. I.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Nakaya, H. I.] Emory Univ, Atlanta, GA 30322 USA.
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2014
VL 143
SU 2
SI SI
MA 79
BP 19
EP 19
PG 1
WC Immunology
SC Immunology
GA AU6GT
UT WOS:000345702600043
DA 2020-12-17
ER

PT J
AU Loebbermann, J
   Ravindran, R
   Nakaya, H
   Khan, N
   Sharma, P
   Hakimata, P
   Pulendran, B
AF Loebbermann, J.
   Ravindran, R.
   Nakaya, H.
   Khan, N.
   Sharma, P.
   Hakimata, P.
   Pulendran, B.
TI Metabolic control of intestinal inflammation by activation of the
   nutritional sensor GCN2 and the integrated stress response in dendritic
   cells and epithelial cells
SO IMMUNOLOGY
LA English
DT Meeting Abstract
C1 [Loebbermann, J.; Ravindran, R.; Nakaya, H.; Khan, N.; Sharma, P.; Hakimata, P.; Pulendran, B.] Emory Univ, Vaccine Ctr, Atlanta, GA 30322 USA.
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2014
VL 143
SU 2
SI SI
MA 445
BP 102
EP 102
PG 1
WC Immunology
SC Immunology
GA AU6GT
UT WOS:000345702600287
DA 2020-12-17
ER

PT J
AU Poo, YS
   Rudd, PA
   Gardner, J
   Wilson, JAC
   Larcher, T
   Colle, MA
   Le, TT
   Nakaya, HI
   Warrilow, D
   Allcock, R
   Bielefeldt-Ohmann, H
   Schroder, WA
   Khromykh, AA
   Lopez, JA
   Suhrbier, A
AF Poo, Yee Suan
   Rudd, Penny A.
   Gardner, Joy
   Wilson, Jane A. C.
   Larcher, Thibaut
   Colle, Marie-Anne
   Le, Thuy T.
   Nakaya, Helder I.
   Warrilow, David
   Allcock, Richard
   Bielefeldt-Ohmann, Helle
   Schroder, Wayne A.
   Khromykh, Alexander A.
   Lopez, Jose A.
   Suhrbier, Andreas
TI Multiple Immune Factors Are Involved in Controlling Acute and Chronic
   Chikungunya Virus Infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ROSS-RIVER-VIRUS; NATURAL-KILLER-CELLS; ANTIBODY-DEPENDENT ENHANCEMENT;
   WEST NILE VIRUS; CD4(+) T-CELLS; MOUSE MODEL; SINDBIS-VIRUS; NOD MICE;
   MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER
AB The recent epidemic of the arthritogenic alphavirus, chikungunya virus (CHIKV) has prompted a quest to understand the correlates of protection against virus and disease in order to inform development of new interventions. Herein we highlight the propensity of CHIKV infections to persist long term, both as persistent, steady-state, viraemias in multiple B cell deficient mouse strains, and as persistent RNA (including negative-strand RNA) in wild-type mice. The knockout mouse studies provided evidence for a role for T cells (but not NK cells) in viraemia suppression, and confirmed the role of T cells in arthritis promotion, with vaccine-induced T cells also shown to be arthritogenic in the absence of antibody responses. However, MHC class II-restricted T cells were not required for production of anti-viral IgG2c responses post CHIKV infection. The antiviral cytokines, TNF and IFN gamma, were persistently elevated in persistently infected B and T cell deficient mice, with adoptive transfer of anti-CHIKV antibodies unable to clear permanently the viraemia from these, or B cell deficient, mice. The NOD background increased viraemia and promoted arthritis, with B, T and NK deficient NOD mice showing high-levels of persistent viraemia and ultimately succumbing to encephalitic disease. In wild-type mice persistent CHIKV RNA and negative strand RNA (detected for up to 100 days post infection) was associated with persistence of cellular infiltrates, CHIKV antigen and stimulation of IFN alpha/beta and T cell responses. These studies highlight that, secondary to antibodies, several factors are involved in virus control, and suggest that chronic arthritic disease is a consequence of persistent, replicating and transcriptionally active CHIKV RNA.
C1 [Poo, Yee Suan; Rudd, Penny A.; Gardner, Joy; Wilson, Jane A. C.; Le, Thuy T.; Schroder, Wayne A.; Lopez, Jose A.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Poo, Yee Suan; Rudd, Penny A.; Gardner, Joy; Wilson, Jane A. C.; Le, Thuy T.; Schroder, Wayne A.; Lopez, Jose A.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
   [Poo, Yee Suan; Rudd, Penny A.; Wilson, Jane A. C.; Khromykh, Alexander A.; Suhrbier, Andreas] Univ Queensland, Sch Mol & Microbial Sci, Sch Med, Brisbane, Qld, Australia.
   [Larcher, Thibaut; Colle, Marie-Anne] INRA, UMR 703, Oniris, F-44026 Nantes, France.
   [Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Warrilow, David] Queensland Govt, Dept Hlth, Publ Hlth Virol Lab, Brisbane, Qld, Australia.
   [Allcock, Richard] Royal Perth Hosp, Lotterywest State Biomed Facil Genom, Perth, WA 6001, Australia.
   [Bielefeldt-Ohmann, Helle] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.
   [Lopez, Jose A.; Suhrbier, Andreas] Griffith Univ, Sch Nat Sci, Nathan, Qld 4111, Australia.
RP Poo, YS (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
EM Andreas.Suhrbier@qimrberghofer.edu.au
RI Nakaya, Helder/AAF-1738-2020; Lopez, J. Alejandro/P-4129-2019; Lopez, J.
   Alejandro/B-9290-2008; Larcher, Thibaut/X-8500-2019; Khromykh,
   Alexander/X-7200-2018; Nakaya, Helder I/A-1397-2010; Larcher,
   Thibaut/M-9160-2013
OI Nakaya, Helder/0000-0001-5297-9108; Lopez, J.
   Alejandro/0000-0001-9370-1516; Lopez, J. Alejandro/0000-0001-9370-1516;
   Khromykh, Alexander/0000-0001-6206-6935; Nakaya, Helder
   I/0000-0001-5297-9108; Wilson, Jane/0000-0002-7736-9151; Larcher,
   Thibaut/0000-0002-0396-3190
FU National Health and Medical Research Council (NHMRC), AustraliaNational
   Health and Medical Research Council of Australia [APP613622]
FX This work was funded by the National Health and Medical Research Council
   (NHMRC), Australia (APP613622; AS, AAK) (https://www.nhmrc.gov.au) and a
   seed grant from the Australian Infectious Diseases Research Centre
   (http://www.aidrc.org.au). Biosafety level 3 equipment was funded by the
   Queensland Tropical Health Alliance (http://www.qtha.org.au), and a
   donation from Prof. Ed Westaway, Royal Australian Air Force Association.
   YP received an international scholarship and a research scholarship from
   the University of Queensland. JACW received an Australian Postgraduate
   Award. AS is a research fellow with the NHMRC, and PAR was a
   postdoctoral fellow with the Canadian Institutes of Health Research
   (http://www.cihr-irsc.gc.ca). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AASKOV JG, 1987, CLIN EXP IMMUNOL, V68, P23
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Alsharifi M, 2006, EUR J IMMUNOL, V36, P887, DOI 10.1002/eji.200535342
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   BAXTER AG, 1993, DIABETES, V42, P1574, DOI 10.2337/diabetes.42.11.1574
   Berzins SP, 2004, IMMUNOL CELL BIOL, V82, P247, DOI 10.1046/j.1440-1711.2004.01238.x
   BLUSSEVANOUDALBLAS A, 1979, J EXP MED, V149, P1504
   Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002
   Burdeinick-Kerr R, 2007, J VIROL, V81, P5628, DOI 10.1128/JVI.01152-06
   Burrack KAS, 2014, J VIROL, V88, P3719, DOI 10.1128/JVI.02609-13
   Chaaitanya IK, 2011, VIRAL IMMUNOL, V24, P265, DOI 10.1089/vim.2010.0123
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059
   Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1
   Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598
   D'Alise AM, 2011, P NATL ACAD SCI USA, V108, P8737, DOI 10.1073/pnas.1105364108
   Dhanwani R, 2012, VIRUS RES, V163, P563, DOI 10.1016/j.virusres.2011.12.009
   EATON BT, 1976, VIROLOGY, V72, P266, DOI 10.1016/0042-6822(76)90329-9
   Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678
   Fan HL, 2004, J IMMUNOL, V172, P4834, DOI 10.4049/jimmunol.172.8.4834
   Fazakerley JK, 2004, ARCH VIROL, P179
   Ferreira C, 2014, J IMMUNOL, V192, P4145, DOI 10.4049/jimmunol.1301600
   Foged C, 2012, EUR J PHARM SCI, V45, P482, DOI 10.1016/j.ejps.2011.08.016
   Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897
   FRASER JRE, 1981, AUST NZ J MED, V11, P168, DOI 10.1111/j.1445-5994.1981.tb04226.x
   Fric J, 2013, J INFECT DIS, V207, P319, DOI 10.1093/infdis/jis674
   Frolov I, 2004, ARCH VIROL, P139
   Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10
   Furze RC, 2005, PARASITE IMMUNOL, V27, P181, DOI 10.1111/j.1365-3024.2005.00761.x
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07
   Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422
   Griffin DE, 2005, CURR TOP MICROBIOL, V289, P57
   Griffin DE, 1998, NEUROSCI BIOBEHAV R, V22, P721, DOI 10.1016/S0149-7634(98)00010-4
   Griffin DE, 2010, IMMUNOL RES, V47, P123, DOI 10.1007/s12026-009-8143-4
   Gunn BM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002586
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13
   Hoarau JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084695
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   JOURNEAUX SF, 1987, J GEN VIROL, V68, P3165, DOI 10.1099/0022-1317-68-12-3165
   Kim D, 2011, EXPERT REV CLIN IMMU, V7, P557, DOI [10.1586/eci.11.48, 10.1586/ECI.11.48]
   Kim HS, 2012, BIOCHEM BIOPH RES CO, V421, P145, DOI 10.1016/j.bbrc.2012.04.017
   Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011
   Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178
   Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12
   La Linn M, 1998, J VIROL, V72, P5146, DOI 10.1128/JVI.72.6.5146-5153.1998
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lee CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002390
   Lee MS, 2012, J CLIN IMMUNOL, V32, P753, DOI 10.1007/s10875-012-9682-3
   Lidbury BA, 2000, J VIROL, V74, P8376, DOI 10.1128/JVI.74.18.8376-8381.2000
   Lidbury BA, 2011, J VIROL, V85, P5651, DOI 10.1128/JVI.01189-10
   Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304
   Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338
   Mahalingam S, 2002, P NATL ACAD SCI USA, V99, P13819, DOI 10.1073/pnas.202415999
   Maier LM, 2008, J IMMUNOL, V181, P7073, DOI 10.4049/jimmunol.181.10.7073
   Markine-Goriaynoff D, 2000, INT IMMUNOL, V12, P223, DOI 10.1093/intimm/12.2.223
   Mateo L, 2000, INTERVIROLOGY, V43, P55, DOI 10.1159/000025023
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Metcalf TU, 2011, J VIROL, V85, P11490, DOI 10.1128/JVI.05379-11
   Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124
   Mohan JF, 2013, MOL IMMUNOL, V55, P166, DOI 10.1016/j.molimm.2012.10.024
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08
   Morrison TE, 2011, AM J PATHOL, V178, P32, DOI 10.1016/j.ajpath.2010.11.018
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Namekar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045851
   Padmakumar B, 2009, INDIAN J RHEUMATOL, V4, P94, DOI DOI 10.1016/S0973-3698(10)60189-6
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   PECK R, 1979, INFECT IMMUN, V25, P320, DOI 10.1128/IAI.25.1.320-327.1979
   PECK R, 1979, J IMMUNOL, V123, P1763
   PECK RD, 1975, J IMMUNOL, V114, P581
   Petkova DS, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00426
   Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468
   Poo YS, 2014, J VIROL, V88, P6862, DOI 10.1128/JVI.03364-13
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Prentice HA, 2012, VIRUSES-BASEL, V4, P2080, DOI 10.3390/v4102080
   Prow TW, 2010, SMALL, V6, P1776, DOI 10.1002/smll.201000331
   RAHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213, DOI 10.1002/eji.1830240942
   Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031
   Rouzaire P, 2012, EUR J IMMUNOL, V42, P80, DOI 10.1002/eji.201141820
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x
   Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   SEAY AR, 1983, ANN NEUROL, V14, P559, DOI 10.1002/ana.410140511
   Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423
   Shiraishi D, 2012, BIOCHEM BIOPH RES CO, V425, P304, DOI 10.1016/j.bbrc.2012.07.086
   SINGH V K, 1987, Journal of Experimental Pathology (New York), V3, P19
   SMEE DF, 1990, ANTIVIR RES, V13, P91, DOI 10.1016/0166-3542(90)90025-3
   Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E
   Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003
   Stoermer KA, 2012, J IMMUNOL, V189, P4047, DOI 10.4049/jimmunol.1201240
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005
   Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152
   Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Thon-Hon VG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-213
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054
   Wuthrich M, 2005, INFECT IMMUN, V73, P7436, DOI 10.1128/IAI.73.11.7436-7441.2005
   Yun NE, 2009, VACCINE, V27, P4064, DOI 10.1016/j.vaccine.2009.04.015
   Zaid A, 2011, ARTHRITIS RHEUM-US, V63, P488, DOI 10.1002/art.30112
   Zhang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065896
   ZHDANOV V M, 1976, Molekulyarnaya Biologiya (Moscow), V10, P1296
   Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133
NR 119
TC 83
Z9 84
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2014
VL 8
IS 12
AR e3354
DI 10.1371/journal.pntd.0003354
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AX1IM
UT WOS:000346701000033
PM 25474568
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Oh, JZ
   Ravindran, R
   Chassaing, B
   Carvalho, FA
   Maddur, MS
   Bower, M
   Hakimpour, P
   Gill, KP
   Nakaya, HI
   Yarovinsky, F
   Sartor, RB
   Gewirtz, AT
   Pulendran, B
AF Oh, Jason Z.
   Ravindran, Rajesh
   Chassaing, Benoit
   Carvalho, Frederic A.
   Maddur, Mohan S.
   Bower, Maureen
   Hakimpour, Paul
   Gill, Kiran P.
   Nakaya, Helder I.
   Yarovinsky, Felix
   Sartor, R. Balfour
   Gewirtz, Andrew T.
   Pulendran, Bali
TI TLR5-Mediated Sensing of Gut Microbiota Is Necessary for Antibody
   Responses to Seasonal Influenza Vaccination
SO IMMUNITY
LA English
DT Article
ID BACTERIAL FLAGELLIN; SYSTEMS BIOLOGY; CELL RESPONSES; T-CELLS;
   RECOGNITION; DIFFERENTIATION; EXPRESSION; ADJUVANT; IMMUNITY; VIRUS
AB Systems biological analysis of immunity to the trivalent inactivated influenza vaccine (TIV) in humans revealed a correlation between early expression of TLR5 and the magnitude of the antibody response. Vaccination of Trl5(-/-) mice resulted in reduced antibody titers and lower frequencies of plasma cells, demonstrating a role for TLR5 in immunity to TIV. This was due to a failure to sense host microbiota. Thus, antibody responses in germ-free or antibiotic-treated mice were impaired, but restored by oral reconstitution with a flagellated, but not aflagellated, strain of E. coli. TLR5-mediated sensing of flagellin promoted plasma cell differentiation directly and by stimulating lymph node macrophages to produce plasma cell growth factors. Finally, TLR5-mediated sensing of the microbiota also impacted antibody responses to the inactivated polio vaccine, but not to adjuvanted vaccines or the live-attenuated yellow fever vaccine. These results reveal an unappreciated role for gut microbiota in promoting immunity to vaccination.
C1 [Oh, Jason Z.; Ravindran, Rajesh; Maddur, Mohan S.; Gill, Kiran P.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Oh, Jason Z.; Ravindran, Rajesh; Maddur, Mohan S.; Hakimpour, Paul; Gill, Kiran P.; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Ctr, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30329 USA.
   [Chassaing, Benoit; Carvalho, Frederic A.; Gewirtz, Andrew T.] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30302 USA.
   [Carvalho, Frederic A.] Univ Auvergne, INSERM U1107, F-63001 Clermont Ferrand 1, France.
   [Bower, Maureen; Sartor, R. Balfour] Univ N Carolina, Natl Gnotobiot Rodent Resource Ctr, Chapel Hill, NC 27514 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Inst Pharmaceut Sci, Dept Clin & Toxicol Analyses, BR-05508000 Sao Paulo, Brazil.
   [Yarovinsky, Felix] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75235 USA.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder I/A-1397-2010; Chassaing, Benoit/R-3819-2017; Maddur,
   Mohan/E-4763-2015; Carvalho, Frederic A/K-2204-2015; Nakaya,
   Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Chassaing,
   Benoit/0000-0002-4285-769X; Nakaya, Helder/0000-0001-5297-9108;
   Yarovinsky, Felix/0000-0001-5825-8002
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HHSN272201400004C, U19AI090023,
   U54AI057157, R37AI48638, R37DK057665, U19AI057266, AI100663-02,
   DK099071, DK083890, AI085263, P40 OD010995, P30 DK34987]; Bill and
   Melinda Gates FoundationBill & Melinda Gates Foundation; Crohn's and
   Colitis Foundation of America; Burroughs Wellcome FundBurroughs Wellcome
   Fund; Influenza Pathogenesis and Immunology Research Center - CEIRS;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U54AI057157, U19AI090023, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, UM1AI100663,
   U19AI057266, U19AI057266, U19AI090023, R37AI048638, UM1AI100663,
   U19AI057266, U19AI057266, U54AI057157, UM1AI100663, UM1AI100663,
   U19AI057266, U54AI057157, UM1AI100663, U19AI057266, UM1AI100663,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, UM1AI100663, U54AI057157,
   U19AI090023, UM1AI100663, U19AI057266, U19AI057266, U54AI057157,
   UM1AI100663, UM1AI100663, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, UM1AI100663, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U19AI090023, U54AI057157, UM1AI100663,
   U54AI057157, U54AI057157, UM1AI100663, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   R37AI048638, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, UM1AI100663, R56AI048638,
   U54AI057157, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, UM1AI100663, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, UM1AI100663, U19AI057266,
   R01AI085263, U54AI057157, U54AI057157, U19AI090023, UM1AI100663,
   UM1AI100663, U19AI057266, U19AI057266, U54AI057157, UM1AI100663,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, UM1AI100663,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   UM1AI100663, U19AI057266, U19AI057266, UM1AI100663, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, R37AI048638,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, UM1AI100663, UM1AI100663, U19AI090023,
   R37AI048638, UM1AI100663, U19AI090023, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, U54AI057157, U19AI090023,
   U54AI057157, U54AI057157, UM1AI100663, U19AI090023, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, R01AI085263, U54AI057157, U19AI090023,
   U19AI057266, R01AI085263, U54AI057157, U54AI057157, U54AI057157,
   UM1AI100663, U54AI057157, U54AI057157, UM1AI100663, UM1AI100663,
   U54AI057157, R37AI048638, U54AI057157, U19AI090023, U19AI090023,
   U54AI057157, R37AI048638, U54AI057157, U19AI090023, U19AI090023,
   U19AI057266, U54AI057157, UM1AI100663, R37AI048638, U19AI057266,
   U54AI057157, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   UM1AI100663, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   UM1AI100663, U19AI090023, UM1AI100663, UM1AI100663, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, R01AI085263, U19AI090023, U19AI090023, U19AI090023,
   U54AI057157, U19AI090023, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   UM1AI100663, UM1AI100663, UM1AI100663, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   UM1AI100663, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   UM1AI100663, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, UM1AI100663, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, UM1AI100663, R37AI048638, U19AI057266,
   UM1AI100663, UM1AI100663, U54AI057157, U19AI057266, UM1AI100663,
   U19AI057266, UM1AI100663, R37AI048638, UM1AI100663, U54AI057157,
   U19AI090023, U54AI057157, U54AI057157, UM1AI100663, U19AI090023,
   U19AI090023, U54AI057157, U54AI057157, UM1AI100663, R01AI085263,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, R37AI048638, U19AI057266, U19AI057266, U19AI090023,
   U54AI057157, U19AI090023, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, UM1AI100663,
   U54AI057157, UM1AI100663, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, UM1AI100663,
   U19AI057266, U54AI057157, UM1AI100663, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, U19AI090023,
   U54AI057157, U54AI057157, U19AI090023, R56AI085263, U19AI090023,
   U19AI057266, U54AI057157, UM1AI100663, U54AI057157, U54AI057157,
   U19AI090023, UM1AI100663, U19AI057266, U54AI057157, UM1AI100663,
   U54AI057157, R37AI048638, U19AI057266, U54AI057157, UM1AI100663,
   UM1AI100663, UM1AI100663, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, R01DK083890,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, R01DK099071,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, R37DK057665, R37DK057665,
   P30DK034987, P30DK034987, R01DK083890, P30DK034987, P30DK034987,
   P30DK034987, R01DK099071, P30DK034987, P30DK034987, R01DK099071,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, R37DK057665, R37DK057665, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   R37DK057665, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, R01DK083890,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   R37DK057665, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   R01DK083890, R01DK099071, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, R37DK057665, P30DK034987, R37DK057665,
   R01DK099071, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   R01DK099071, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, R01DK083890, R01DK099071, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, R01DK083890, P30DK034987,
   P30DK034987, P30DK034987, R01DK083890, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, R01DK083890, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, R01DK099071, R37DK057665,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, R01DK099071, P30DK034987, P30DK034987,
   P30DK034987, P30DK034987, P30DK034987, R01DK083890, R37DK057665,
   P30DK034987, P30DK034987, P30DK034987, P30DK034987, P30DK034987,
   P30DK034987] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR,
   NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51OD011132,
   P40OD010995, P40OD010995, P51OD011132, P51OD011132, P51OD011132,
   P40OD010995, P51OD011132, P51OD011132, P40OD010995, P51OD011132,
   P40OD010995, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P40OD010995, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P40OD010995, P40OD010995] Funding Source: NIH RePORTER
FX We thank A. Darfeuille-Michaud for providing LF82 strains; R. L.
   Toennisson and M. Bower for technical assistance with gnotobiotic
   studies; and B. Cervasi for macrophage and B cell sorting. This work was
   supported by NIH grants HHSN272201400004C, U19AI090023, U54AI057157,
   R37AI48638, R37DK057665, U19AI057266, and AI100663-02 (to B. P.) and a
   grant from the Bill and Melinda Gates Foundation (to B. P.). Additional
   support was provided by grants from the NIH (DK099071 and DK083890) (A.
   T. G.), Research Fellowship award from the Crohn's and Colitis
   Foundation of America (B. C.), NIH (AI085263) and the Burroughs Wellcome
   Fund (F. Y.), NIH (P40 OD010995, P30 DK34987) and Crohn's and Colitis
   Foundation of America (R. B. S., NGRRC), and Research Fellowship award
   from the Influenza Pathogenesis and Immunology Research Center - CEIRS
   (J.Z.O.).
CR Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707
   Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005
   Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469
   Carvalho FA, 2012, CELL HOST MICROBE, V12, P139, DOI 10.1016/j.chom.2012.07.004
   Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x
   Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882
   Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007
   Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863
   Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014
   He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107
   Kostova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066312
   Letran SE, 2011, J IMMUNOL, V186, P5406, DOI 10.4049/jimmunol.1003576
   Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914
   Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975
   Sirard JC, 2009, BBA-GENE REGUL MECH, V1789, P386, DOI 10.1016/j.bbagrm.2009.03.001
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   Vijay-Kumar M, 2010, EUR J IMMUNOL, V40, P3528, DOI 10.1002/eji.201040421
   Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721
NR 36
TC 212
Z9 218
U1 2
U2 51
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD SEP 18
PY 2014
VL 41
IS 3
BP 478
EP 492
DI 10.1016/j.immuni.2014.08.009
PG 15
WC Immunology
SC Immunology
GA AQ2ON
UT WOS:000342626500017
PM 25220212
OA Bronze, Green Accepted, Green Published
DA 2020-12-17
ER

PT J
AU Kwissa, M
   Nakaya, HI
   Onlamoon, N
   Wrammert, J
   Villinger, F
   Perng, GC
   Yoksan, S
   Pattanapanyasat, K
   Chokephaibulkit, K
   Ahmed, R
   Pulendran, B
AF Kwissa, Marcin
   Nakaya, Helder I.
   Onlamoon, Nattawat
   Wrammert, Jens
   Villinger, Francois
   Perng, Guey Chuen
   Yoksan, Sutee
   Pattanapanyasat, Kovit
   Chokephaibulkit, Kulkanya
   Ahmed, Rafi
   Pulendran, Bali
TI Dengue Virus Infection Induces Expansion of a CD14(+)CD16(+) Monocyte
   Population that Stimulates Plasmablast Differentiation
SO CELL HOST & MICROBE
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; SUBCAPSULAR SINUS MACROPHAGES; GENE
   TRANSCRIPT ABUNDANCE; BLOOD MONONUCLEAR-CELLS; HUMAN DENDRITIC CELLS;
   HEMORRHAGIC-FEVER; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; DISEASE SEVERITY;
   SYSTEMS BIOLOGY
AB Dengue virus (DENV) infection induces the expansion of plasmablasts, which produce antibodies that can neutralize DENV but also enhance disease upon secondary infection with another DENV serotype. To understand how these immune responses are generated, we used a systems biological approach to analyze immune responses to dengue in humans. Transcriptomic analysis of whole blood revealed that genes encoding proinflammatory mediators and type I interferon-related proteins were associated with high DENV levels during initial symptomatic disease. Additionally, CD14(+)CD16(+) monocytes increased in the blood. Similarly, in a nonhuman primate model, DENV infection boosted CD14(+)CD16(+) monocyte numbers in the blood and lymph nodes. Upon DENV infection in vitro, monocytes upregulated CD16 and mediated differentiation of resting B cells to plasmablasts as well as immunoglobulin G (IgG) and IgM secretion. These findings provide a detailed picture of innate responses to dengue and highlight a role for CD14(+)CD16(+) monocytes in promoting plasmablast differentiation and anti-DENV antibody responses.
C1 [Kwissa, Marcin; Nakaya, Helder I.; Wrammert, Jens; Villinger, Francois; Ahmed, Rafi; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Onlamoon, Nattawat; Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Fac Med, Off Res & Dev, Bangkok 10700, Thailand.
   [Wrammert, Jens; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Villinger, Francois] Emory Univ, Yerkes Natl Primate Res Ctr, Div Pathol, Atlanta, GA 30329 USA.
   [Perng, Guey Chuen] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan.
   [Perng, Guey Chuen] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan.
   [Yoksan, Sutee] Mahidol Univ, Siriraj Hosp, Fac Med, Inst Mol Biosci, Bangkok 10700, Thailand.
   [Chokephaibulkit, Kulkanya] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat, Bangkok 10700, Thailand.
RP Pulendran, B (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder I/A-1397-2010; Onlamoon, Nattawat/AAR-8390-2020; Nakaya,
   Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Onlamoon, Nattawat/0000-0002-8784-3005;
   Perng, Oscar/0000-0001-7510-4486
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R37 DK057665, R37 AI048638, U19
   AI090023, U19 AI057266, U54 AI057157, N01 AI50019, N01 AI50025]; Bill &
   Melinda Gates FoundationBill & Melinda Gates Foundation;  [PS10D11132];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI090023, R37AI048638, U54AI057157, R37AI048638, U54AI057157,
   U54AI057157, U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, R37AI048638,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U54AI057157, U19AI090023, U19AI090023, R37AI048638, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, R37AI048638, U54AI057157, U54AI057157,
   U19AI057266, U19AI090023, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   R37AI048638, U54AI057157, R37AI048638, U19AI090023, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U19AI090023, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266, U19AI090023, U19AI057266, U54AI057157,
   U19AI090023, U54AI057157, U19AI090023, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI090023, R37AI048638, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, U54AI057157, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI090023, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, R37AI048638, U54AI057157,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   N01AI050025, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   R37AI048638, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI090023, U19AI090023, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND
   KIDNEY DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665] Funding Source: NIH
   RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132] Funding Source: NIH RePORTER
FX We acknowledge the expert help of the clinical and supporting staff at
   the Siriraj Hospital, Bangkok, Thailand. We warmly acknowledge the
   exceptional assistance of Stephanie Ehnert, Elizabeth Strobert, and all
   Yerkes NPRC personnel for their excellent care of the animals and sample
   collections. We are very grateful to Jean-Francois Pare from Yerkes NPRC
   for the outstanding expertise in EM specimen preparation and imaging. We
   appreciate the great help of Mohan Maddur Sathyanarayana from EVC with
   MDDC preparation and Hui-Mien Hsiao from Emory University for the RT-PCR
   and NS-1 ELISA. We also thank Kiran Gill and Barbara Cervasi from the
   EVC Flow Cytometry Core for excellent technical support. The authors
   declare no financial conflict of interest that might be construed to
   influence the results or interpretation of the manuscript. This work was
   supported by grants from the NIH (R37 DK057665, R37 AI048638, U19
   AI090023, U19 AI057266, U54 AI057157, N01 AI50019, and N01 AI50025) and
   the Bill & Melinda Gates Foundation to B.P. and PS10D11132 to Yerkes.
CR Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557
   Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012
   Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946
   Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671
   Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P804, DOI 10.1093/aje/152.9.804
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499
   Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001
   Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287
   Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863
   Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579
   Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829
   Loke P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000710
   Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507
   Long TH, 2010, J VIROL, V84, P12982, DOI 10.1128/JVI.01224-10
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572
   Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745
   Popper SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001966
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509
   Saha P, 2011, IMMUNOL CELL BIOL, V89, P2, DOI 10.1038/icb.2010.130
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Serbina NV, 2009, J IMMUNOL, V183, P2678, DOI 10.4049/jimmunol.0803398
   Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Sun PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002298
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699
   Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435
   Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Xu W, 2012, J EXP MED, V209, P1813, DOI 10.1084/jem.20112142
   Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023
NR 58
TC 104
Z9 104
U1 0
U2 16
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUL 9
PY 2014
VL 16
IS 1
BP 115
EP 127
DI 10.1016/j.chom.2014.06.001
PG 13
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA AO2IG
UT WOS:000341142600014
PM 24981333
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Poo, YS
   Nakaya, H
   Gardner, J
   Larcher, T
   Schroder, WA
   Le, TT
   Major, LD
   Suhrbier, A
AF Poo, Yee Suan
   Nakaya, Helder
   Gardner, Joy
   Larcher, Thibaut
   Schroder, Wayne A.
   Le, Thuy T.
   Major, Lee D.
   Suhrbier, Andreas
TI CCR2 Deficiency Promotes Exacerbated Chronic Erosive
   Neutrophil-Dominated Chikungunya Virus Arthritis
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; MOUSE MODEL; INFLAMMATORY MONOCYTES;
   RHEUMATOID-ARTHRITIS; RECEPTOR FUNCTION; DENDRITIC CELLS; IN-VITRO;
   T-CELLS; MACROPHAGES; MICE
AB Chikungunya virus (CHIKV) is a member of a globally distributed group of arthritogenic alphaviruses that cause weeks to months of debilitating polyarthritis/arthralgia, which is often poorly managed with current treatments. Arthritic disease is usually characterized by high levels of the chemokine CCL2 and a prodigious monocyte/macrophage infiltrate. Several inhibitors of CCL2 and its receptor CCR2 are in development and may find application for treatment of certain inflammatory conditions, including autoimmune and viral arthritides. Here we used CCR2(-/-) mice to determine the effect of CCR2 deficiency on CHIKV infection and arthritis. Although there were no significant changes in viral load or RNA persistence and only marginal changes in antiviral immunity, arthritic disease was substantially increased and prolonged in CCR2(-/-) mice compared to wild-type mice. The monocyte/macrophage infiltrate was replaced in CCR2(-/-) mice by a severe neutrophil (followed by an eosinophil) infiltrate and was associated with changes in the expression levels of multiple inflammatory mediators (including CXCL1, CXCL2, granulocyte colony-stimulating factor [G-CSF], interleukin-1 beta [IL-1 beta], and IL-10). The loss of anti-inflammatory macrophages and their activities (e. g., efferocytosis) was also implicated in exacerbated inflammation. Clear evidence of cartilage damage was also seen in CHIKV-infected CCR2(-/-) mice, a feature not normally associated with alphaviral arthritides. Although recruitment of CCR2(+) monocytes/macrophages can contribute to inflammation, it also appears to be critical for preventing excessive pathology and resolving inflammation following alphavirus infection. Caution might thus be warranted when considering therapeutic targeting of CCR2/CCL2 for the treatment of alphaviral arthritides.
C1 [Poo, Yee Suan; Gardner, Joy; Schroder, Wayne A.; Le, Thuy T.; Major, Lee D.; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Poo, Yee Suan; Gardner, Joy; Schroder, Wayne A.; Le, Thuy T.; Major, Lee D.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.
   [Poo, Yee Suan] Univ Queensland, Sch Med, Brisbane, Qld, Australia.
   [Nakaya, Helder] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil.
   [Nakaya, Helder] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA USA.
   [Nakaya, Helder] Emory Univ, Atlanta, GA 30322 USA.
   [Larcher, Thibaut] Oniris, Inst Natl Rech Agron, Unite Mixte Rech 703, Nantes, France.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
EM Andreas.Suhrbier@qimrberghofer.edu.au
RI Larcher, Thibaut/X-8500-2019; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020; Larcher, Thibaut/M-9160-2013
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Larcher, Thibaut/0000-0002-0396-3190
FU National Health and Medical Research Council, AustraliaNational Health
   and Medical Research Council of Australia; Australian Infectious
   Diseases Research Centre; University of QueenslandUniversity of
   Queensland; Queensland Tropical Health Alliance, an initiative of the
   Queensland government; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132] Funding Source: NIH RePORTER
FX This work was funded by a project grant from the National Health and
   Medical Research Council, Australia, and the Australian Infectious
   Diseases Research Centre. Yee Suan Poo received a University of
   Queensland international scholarship and a University of Queensland
   research scholarship. Biosafety level 3 equipment was funded by the
   Queensland Tropical Health Alliance, an initiative of the Queensland
   government.
CR Ajuebor MN, 1999, J IMMUNOL, V162, P1685
   Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004
   Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798
   BREWER JM, 1994, CLIN EXP IMMUNOL, V97, P164
   Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890
   Brzoza-Lewis KL, 2012, CELL IMMUNOL, V273, P41, DOI 10.1016/j.cellimm.2011.11.008
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chaaitanya IK, 2011, VIRAL IMMUNOL, V24, P265, DOI 10.1089/vim.2010.0123
   Cote CH, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-359
   Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09
   Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535
   FUJII H, 2012, INFLAMM REGEN, V32, P124
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131
   Guabiraba R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015680
   Hankey PA, 2009, FRONT BIOSCI-LANDMRK, V14, P5273, DOI 10.2741/3597
   Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549
   Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108
   Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200
   Katayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062231
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   LALINN M, 1995, J VIROL METHODS, V52, P51
   Lebre MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021772
   Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841
   Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003
   Lin KL, 2011, J IMMUNOL, V186, P508, DOI 10.4049/jimmunol.1001002
   Lipscomb MW, 2009, J IMMUNOL, V183, P7250, DOI 10.4049/jimmunol.0901477
   London A, 2013, J IMMUNOL, V190, P3570, DOI 10.4049/jimmunol.1202076
   Lotfi R, 2009, J IMMUNOL, V183, P5023, DOI 10.4049/jimmunol.0900504
   MCGARRY MP, 1991, J LEUKOCYTE BIOL, V50, P471
   Min SH, 2010, BIOCHEM BIOPH RES CO, V391, P1080, DOI 10.1016/j.bbrc.2009.12.025
   Miyake Y, 2012, ADV EXP MED BIOL, V738, P144, DOI 10.1007/978-1-4614-1680-7_9
   Montgomery RR, 2007, INFECT IMMUN, V75, P613, DOI 10.1128/IAI.00685-06
   Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631
   Nikbakht N, 2013, J IMMUNOL, V190, P4923, DOI 10.4049/jimmunol.1300350
   Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382
   Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018
   Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451
   Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126
   Rampersad RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025833
   Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470
   Rulli NE, 2009, ARTHRITIS RHEUM-US, V60, P2513, DOI 10.1002/art.24682
   Sadik CD, 2012, P NATL ACAD SCI USA, V109, pE3177, DOI 10.1073/pnas.1213797109
   Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205
   Sawanobori Y, 2008, BLOOD, V111, P5457, DOI 10.1182/blood-2008-01-136895
   Schroder WA, 2010, J IMMUNOL, V184, P2663, DOI 10.4049/jimmunol.0902187
   Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322
   Shahrara S, 2008, J IMMUNOL, V180, P3447, DOI 10.4049/jimmunol.180.5.3447
   Souto FO, 2011, AM J RESP CRIT CARE, V183, P234, DOI 10.1164/rccm.201003-0416OC
   Stoermer KA, 2012, J IMMUNOL, V189, P4047, DOI 10.4049/jimmunol.1201240
   Subasinghe NL, 2013, BIOORG MED CHEM LETT, V23, P1063, DOI 10.1016/j.bmcl.2012.12.017
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005
   Tanaka T, 2010, BIOCHEM BIOPH RES CO, V399, P677, DOI 10.1016/j.bbrc.2010.07.141
   Thomas CJ, 2013, TRENDS IMMUNOL, V34, P317, DOI 10.1016/j.it.2013.02.008
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Vazquez-Trinanes C, 2013, RHEUMATOLOGY, V52, P346, DOI 10.1093/rheumatology/kes236
   Wang BM, 2012, CELL IMMUNOL, V278, P103, DOI 10.1016/j.cellimm.2012.07.005
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wisniewski T, 2010, J IMMUNOL METHODS, V352, P101, DOI 10.1016/j.jim.2009.10.010
   Xin LJ, 2010, J IMMUNOL, V184, P7047, DOI 10.4049/jimmunol.0903273
   Zhao QH, 2010, J LEUKOCYTE BIOL, V88, P41, DOI 10.1189/jlb.1009671
   Zollo M, 2012, CLIN EXP METASTAS, V29, P585, DOI 10.1007/s10585-012-9473-5
NR 66
TC 66
Z9 66
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2014
VL 88
IS 12
BP 6862
EP 6872
DI 10.1128/JVI.03364-13
PG 11
WC Virology
SC Virology
GA AI5HF
UT WOS:000336895600028
PM 24696480
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Li, S
   Rouphael, N
   Duraisingham, S
   Romero-Steiner, S
   Presnell, S
   Davis, C
   Schmidt, DS
   Johnson, SE
   Milton, A
   Rajam, G
   Kasturi, S
   Carlone, GM
   Quinn, C
   Chaussabel, D
   Palucka, AK
   Mulligan, MJ
   Ahmed, R
   Stephens, DS
   Nakaya, HI
   Pulendran, B
AF Li, Shuzhao
   Rouphael, Nadine
   Duraisingham, Sai
   Romero-Steiner, Sandra
   Presnell, Scott
   Davis, Carl
   Schmidt, Daniel S.
   Johnson, Scott E.
   Milton, Andrea
   Rajam, Gowrisankar
   Kasturi, Sudhir
   Carlone, George M.
   Quinn, Charlie
   Chaussabel, Damien
   Palucka, A. Karolina
   Mulligan, Mark J.
   Ahmed, Rafi
   Stephens, David S.
   Nakaya, Helder I.
   Pulendran, Bali
TI Molecular signatures of antibody responses derived from a systems
   biology study of five human vaccines
SO NATURE IMMUNOLOGY
LA English
DT Article
ID REGULATORY NETWORKS; IMMUNE-SYSTEM; EXPRESSION; INFLUENZA; VACCINATION;
   ACTIVATION; PROTECTION
AB Many vaccines induce protective immunity via antibodies. Systems biology approaches have been used to determine signatures that can be used to predict vaccine-induced immunity in humans, but whether there is a 'universal signature' that can be used to predict antibody responses to any vaccine is unknown. Here we did systems analyses of immune responses to the polysaccharide and conjugate vaccines against meningococcus in healthy adults, in the broader context of published studies of vaccines against yellow fever virus and influenza virus. To achieve this, we did a large-scale network integration of publicly available human blood transcriptomes and systems-scale databases in specific biological contexts and deduced a set of transcription modules in blood. Those modules revealed distinct transcriptional signatures of antibody responses to different classes of vaccines, which provided key insights into primary viral, protein recall and anti-polysaccharide responses. Our results elucidate the early transcriptional programs that orchestrate vaccine immunity in humans and demonstrate the power of integrative network modeling.
C1 [Li, Shuzhao; Rouphael, Nadine; Duraisingham, Sai; Davis, Carl; Kasturi, Sudhir; Mulligan, Mark J.; Ahmed, Rafi; Stephens, David S.; Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Li, Shuzhao; Duraisingham, Sai; Kasturi, Sudhir; Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
   [Rouphael, Nadine; Mulligan, Mark J.] Emory Univ, Div Infect Dis, Emory Vaccine Ctr, Hope Clin, Decatur, GA USA.
   [Romero-Steiner, Sandra; Schmidt, Daniel S.; Johnson, Scott E.; Milton, Andrea; Rajam, Gowrisankar; Carlone, George M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA USA.
   [Presnell, Scott; Quinn, Charlie; Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA.
   [Presnell, Scott; Quinn, Charlie; Chaussabel, Damien; Palucka, A. Karolina] Baylor Res Inst, Baylor Inst Immunol Res, Dallas, TX USA.
   [Davis, Carl; Mulligan, Mark J.; Stephens, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
EM bpulend@emory.edu
RI Mulligan, Mark/V-9275-2019; Chaussabel, Damien/AAX-1909-2020; Nakaya,
   Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Rouphael, Nadine/0000-0002-2512-7919;
   Romero-Steiner, Sandra/0000-0003-4128-7768; Chaussabel,
   Damien/0000-0002-6131-7242; Li, Shuzhao/0000-0002-7386-2539; Presnell,
   Scott/0000-0001-9203-6403
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U19AI090023,
   U54AI057157, R37AI48638, R37DK057665, U19AI057266, AI100663-02]; Georgia
   Research Alliance GRA and Emory University Research Committee; Clinical
   and Translational Science Award Program (National Center for Research
   Resources of the US National Institutes of Health); NATIONAL CENTER FOR
   ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR000454,
   UL1TR000454, UL1TR000454, UL1TR000454, UL1TR000454, UL1TR000454,
   UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH
   RESOURCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, UL1RR025008, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, UL1RR025008, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, UL1RR025008,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, UL1RR025008, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, UL1RR025008, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, UL1RR025008,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, UL1RR025008,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, UL1RR025008,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, UL1RR025008, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, UL1RR025008,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, UL1RR025008, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, UL1RR025008,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, UL1RR025008, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, UL1RR025008, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   UL1RR025008, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [UM1AI100663, U19AI057266, UM1AI100663, R37AI048638, UM1AI100663,
   UM1AI100663, U19AI057266, UM1AI100663, U19AI090023, U54AI057157,
   UM1AI100663, UM1AI100663, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U19AI090023, U19AI096187, U19AI090023, U19AI057266,
   UM1AI100663, U19AI057266, U54AI057157, UM1AI100663, U19AI096187,
   U54AI057157, U19AI096187, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, UM1AI100663, U54AI057157, U19AI057266,
   U19AI096187, U54AI057157, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, UM1AI100663, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, UM1AI100663, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U54AI057157, UM1AI100663, U19AI057266,
   U19AI096187, U54AI057157, U19AI096187, U19AI057266, U19AI057266,
   UM1AI100663, U54AI057157, U54AI057157, U19AI057266, U19AI096187,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   UM1AI100663, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U19AI096187, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI096187, U19AI057266, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, R37AI048638, U54AI057157, U54AI057157,
   R37AI048638, UM1AI100663, UM1AI100663, U19AI090023, U19AI090023,
   UM1AI100663, U54AI057157, UM1AI100663, U19AI090023, U19AI090023,
   UM1AI100663, U54AI057157, U54AI057157, U19AI096187, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, UM1AI100663, U19AI057266,
   U54AI057157, U19AI096187, U19AI057266, UM1AI100663, U19AI057266,
   U54AI057157, U19AI090023, R37AI048638, U54AI057157, U19AI096187,
   U19AI057266, U19AI096187, U19AI096187, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, UM1AI100663, U19AI096187,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, UM1AI100663,
   UM1AI100663, U54AI057157, U19AI057266, U19AI096187, U54AI057157,
   R37AI048638, U19AI057266, U19AI096187, U19AI057266, U54AI057157,
   UM1AI100663, U19AI090023, U54AI057157, U54AI057157, U19AI096187,
   U19AI057266, U19AI096187, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   R37AI048638, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U19AI090023, UM1AI100663, U54AI057157, U19AI096187, U19AI090023,
   U19AI096187, U54AI057157, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI096187, U54AI057157, U19AI090023, U54AI057157,
   U19AI096187, U54AI057157, R37AI048638, U19AI096187, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI096187, U19AI096187, U19AI096187,
   U19AI057266, U54AI057157, UM1AI100663, U54AI057157, U54AI057157,
   U54AI057157, R37AI048638, UM1AI100663, U54AI057157, R37AI048638,
   U54AI057157, U19AI096187, U19AI057266, U54AI057157, U54AI057157,
   UM1AI100663, U54AI057157, UM1AI100663, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, UM1AI100663, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U19AI096187, U19AI090023,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI096187, U54AI057157, U19AI096187, U54AI057157, U54AI057157,
   U19AI057266, U19AI090023, U19AI096187, UM1AI100663, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI096187, U54AI057157,
   U19AI090023, U54AI057157, U19AI057266, U19AI057266, UM1AI100663,
   U19AI096187, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, UM1AI100663, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, UM1AI100663, U19AI090023,
   U19AI090023, U19AI096187, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI090023, U19AI057266, UM1AI100663,
   U19AI057266, U54AI057157, U19AI057266, U19AI096187, U19AI090023,
   U54AI057157, U19AI090023, U19AI057266, U19AI090023, U54AI057157,
   U19AI090023, UM1AI100663, U19AI090023, U54AI057157, UM1AI100663,
   U19AI090023, R37AI048638, UM1AI100663, U19AI057266, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   UM1AI100663, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U19AI096187,
   U19AI096187, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI096187, U19AI057266, U54AI057157, U19AI096187,
   UM1AI100663, U19AI057266, UM1AI100663, U54AI057157, U19AI096187,
   U54AI057157, UM1AI100663, U19AI096187, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, UM1AI100663, UM1AI100663, U19AI057266, UM1AI100663,
   UM1AI100663, UM1AI100663, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI096187, U19AI090023, U54AI057157, U54AI057157,
   R37AI048638, U54AI057157, UM1AI100663, U19AI090023, UM1AI100663,
   UM1AI100663, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI096187,
   U19AI057266, U54AI057157, U54AI057157, U19AI096187, UM1AI100663,
   U19AI057266, U54AI057157, U19AI096187, U19AI057266, U54AI057157,
   U19AI090023, U19AI090023, U19AI096187, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U19AI096187, U19AI090023, U19AI057266,
   U19AI057266, UM1AI100663, U54AI057157, U19AI096187, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   UM1AI100663, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U54AI057157, UM1AI100663, U19AI057266, U54AI057157,
   UM1AI100663, U19AI096187, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, UM1AI100663, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK) [R37DK057665, R37DK057665, R01DK057665, R37DK057665,
   R01DK057665, R01DK057665, R01DK057665, R01DK057665, R01DK057665,
   R37DK057665, R37DK057665, R01DK057665, R37DK057665, R01DK057665,
   R37DK057665, R37DK057665, R01DK057665, R37DK057665, R37DK057665,
   R01DK057665, R01DK057665] Funding Source: NIH RePORTER; OFFICE OF THE
   DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132] Funding
   Source: NIH RePORTER
FX We thank B. Weaver and the Hope Clinic staff for assistance with the
   clinical study. Supported by the US National Institutes of Health
   (U19AI090023, U54AI057157, R37AI48638, R37DK057665, U19AI057266 and
   AI100663-02 to the B.P. laboratory), the Georgia Research Alliance GRA
   and Emory University Research Committee and the Clinical and
   Translational Science Award Program (National Center for Research
   Resources of the US National Institutes of Health; to N.R.). The
   findings and conclusions in this report are those of the author(s) and
   do not necessarily represent the views of the Centers for Disease
   Control and Prevention.
CR Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535
   Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532
   Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051
   Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156
   Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84
   Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09
   Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180
   Findlow H, 2006, CLIN VACCINE IMMUNOL, V13, P507, DOI 10.1128/CVI.13.4.507-510.2006
   Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711
   Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105
   Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068
   Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307
   Haining WN, 2012, CURR OPIN IMMUNOL, V24, P332, DOI 10.1016/j.coi.2012.03.010
   Jokhdar H, 2004, CLIN DIAGN LAB IMMUN, V11, P83, DOI 10.1128/CDLI.11.1.83-88.2004
   KAYHTY H, 1980, J INFECT DIS, V142, P861, DOI 10.1093/infdis/142.6.861
   Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375
   Klein SL, 2013, VACCINE, V31, P2599, DOI 10.1016/j.vaccine.2013.02.070
   Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759
   Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000
   Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70
   Lefebvre C, 2012, WIRES SYST BIOL MED, V4, P311, DOI 10.1002/wsbm.1159
   Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31
   Li SZ, 2013, SEMIN IMMUNOL, V25, P209, DOI 10.1016/j.smim.2013.05.003
   Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nibbe RK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000639
   Oberg AL, 2011, CURR OPIN IMMUNOL, V23, P436, DOI 10.1016/j.coi.2011.04.005
   Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ravindran R., SCIENCE IN PRESS
   Rouphael NG, 2012, METHODS MOL BIOL, V799, P1, DOI 10.1007/978-1-61779-346-2_1
   Sales G, 2011, BIOINFORMATICS, V27, P1876, DOI 10.1093/bioinformatics/btr274
   Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653
   Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Trautmann L, 2011, NAT IMMUNOL, V12, P729, DOI 10.1038/ni.2078
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275
   Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109
   Zhang WQ, 2010, MOL BIOL CELL, V21, P2500, DOI 10.1091/mbc.E09-08-0715
   Zughaier SM, 2011, J LEUKOCYTE BIOL, V89, P469, DOI 10.1189/jlb.0610369
NR 51
TC 305
Z9 305
U1 1
U2 76
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD FEB
PY 2014
VL 15
IS 2
BP 195
EP 204
DI 10.1038/ni.2789
PG 10
WC Immunology
SC Immunology
GA 295XV
UT WOS:000330150600014
PM 24336226
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Tamim, S
   Vo, DT
   Uren, PJ
   Qiao, M
   Bindewald, E
   Kasprzak, WK
   Shapiro, BA
   Nakaya, HI
   Burns, SC
   Araujo, PR
   Nakano, I
   Radek, AJ
   Kuersten, S
   Smith, AD
   Penalva, LOF
AF Tamim, Saleh
   Vo, Dat T.
   Uren, Philip J.
   Qiao, Mei
   Bindewald, Eckart
   Kasprzak, Wojciech K.
   Shapiro, Bruce A.
   Nakaya, Helder I.
   Burns, Suzanne C.
   Araujo, Patricia R.
   Nakano, Ichiro
   Radek, Agnes J.
   Kuersten, Scott
   Smith, Andrew D.
   Penalva, Luiz O. F.
TI Genomic Analyses Reveal Broad Impact of miR-137 on Genes Associated with
   Malignant Transformation and Neuronal Differentiation in Glioblastoma
   Cells
SO PLOS ONE
LA English
DT Article
ID RNA-BINDING PROTEIN; MICRORNA REPLACEMENT THERAPY; EMBRYONIC STEM-CELLS;
   MIB1 LABELING INDEX; DOUBLECORTIN-LIKE; GLIOMA-CELLS; MESSENGER-RNAS;
   INTEGRATIVE ANALYSIS; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE
AB miR-137 plays critical roles in the nervous system and tumor development; an increase in its expression is required for neuronal differentiation while its reduction is implicated in gliomagenesis. To evaluate the potential of miR-137 in glioblastoma therapy, we conducted genome-wide target mapping in glioblastoma cells by measuring the level of association between PABP and mRNAs in cells transfected with miR-137 mimics vs. controls via RIPSeq. Impact on mRNA levels was also measured by RNASeq. By combining the results of both experimental approaches, 1468 genes were found to be negatively impacted by miR-137 - among them, 595 (40%) contain miR-137 predicted sites. The most relevant targets include oncogenic proteins and key players in neurogenesis like c-KIT, YBX1, AKT2, CDC42, CDK6 and TGF beta 2. Interestingly, we observed that several identified miR-137 targets are also predicted to be regulated by miR-124, miR-128 and miR-7, which are equally implicated in neuronal differentiation and gliomagenesis. We suggest that the concomitant increase of these four miRNAs in neuronal stem cells or their repression in tumor cells could produce a robust regulatory effect with major consequences to neuronal differentiation and tumorigenesis.
C1 [Tamim, Saleh; Vo, Dat T.; Qiao, Mei; Burns, Suzanne C.; Araujo, Patricia R.; Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA.
   [Uren, Philip J.; Smith, Andrew D.] Univ So Calif, Div Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA USA.
   [Bindewald, Eckart; Kasprzak, Wojciech K.] SAIC Frederick Inc, Basic Sci Program, Ctr Canc Res Nanobiol Program, Frederick Natl Lab Canc Res, Frederick, MD USA.
   [Shapiro, Bruce A.] NCI, Ctr Canc Res, Nanobiol Program, Frederick, MD 21701 USA.
   [Nakaya, Helder I.] Univ Sao Paulo, Inst Pharmaceut Sci, Dept Clin Anal & Toxicol, Sao Paulo, Brazil.
   [Nakano, Ichiro] Ohio State Univ, Dept Neurol Surg, James Comprehens Canc Ctr, Columbus, OH 43210 USA.
   [Radek, Agnes J.; Kuersten, Scott] Epicentre, Madison, WI USA.
   [Penalva, Luiz O. F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
RP Penalva, LOF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Childrens Canc Res Inst, San Antonio, TX 78229 USA.
EM penalva@uthscsa.edu
RI Nakano, Ichiro/AAR-9562-2020; Nakaya, Helder I/A-1397-2010; Tamim,
   Saleh/ABH-1777-2020; Nakano, Ichiro/F-2076-2014; Smith, Andrew
   D./G-4104-2013; Nakaya, Helder/AAF-1738-2020
OI Nakano, Ichiro/0000-0002-0916-3207; Nakaya, Helder
   I/0000-0001-5297-9108; Nakano, Ichiro/0000-0002-6734-3468; Smith, Andrew
   D./0000-0002-3337-1970; Nakaya, Helder/0000-0001-5297-9108; Penalva,
   Luiz/0000-0003-4491-6769
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HG006015]; IIMS; CTSA
   (UTHSCSA); Center for Biomedical Neuroscience (CBN) (UTHSCSA); Max and
   Minnie Tomerlin Voelcker Fund; Frederick National Laboratory for Cancer
   Research, National Institutes of Health [HHSN261200800001E]; Intramural
   Research Program of NIH, Frederick National Laboratory for Cancer
   Research, Center for Cancer Research; NATIONAL CANCER INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, ZIABC008382, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, ZIABC008382, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   ZIABC008382, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, ZIABC008382, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   ZIABC008382, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, ZIABC008382, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, ZIABC008382, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, ZIABC008382, P30CA016058,
   ZIABC008382, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, ZIABC008382, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058, P30CA016058, P30CA016058,
   P30CA016058, P30CA016058, P30CA016058] Funding Source: NIH RePORTER;
   NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001120, UL1TR001120, UL1TR001120, UL1TR001120, KL2TR001118,
   UL1TR001120, KL2TR001118, KL2TR001118, KL2TR001118, UL1TR001120,
   UL1TR000149, KL2TR001118, UL1TR001120, UL1TR000149] Funding Source: NIH
   RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI) [R01HG006015,
   R01HG006015, R01HG006015, R01HG006015, R01HG006015, R01HG006015,
   R01HG006015] Funding Source: NIH RePORTER
FX This work was supported by the National Institutes of Health [HG006015
   to A.D.S. and L.O.F.P.], IIMS and CTSA (UTHSCSA) [to L.O.F.P.], Center
   for Biomedical Neuroscience (CBN) (UTHSCSA) [to L.O.F.P.], and the Max
   and Minnie Tomerlin Voelcker Fund [to L.O.F.P.]. This project has been
   funded in whole or in part with Federal funds from the Frederick
   National Laboratory for Cancer Research, National Institutes of Health,
   under contract HHSN261200800001E. The content of this publication does
   not necessarily reflect the views or policies of the Department of
   Health and Human Services, nor does mention of trade names, commercial
   products or organizations imply endorsement by the US Government. This
   research was supported [in part] by the Intramural Research Program of
   NIH, Frederick National Laboratory for Cancer Research, Center for
   Cancer Research. Funding for open access charge: National Institutes of
   Health. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200
   Ahluwalia MS, 2010, CANCER LETT, V298, P139, DOI 10.1016/j.canlet.2010.08.014
   Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P591, DOI 10.1007/s10549-010-1028-3
   Althoff K, 2013, INT J CANCER, V133, P1064, DOI 10.1002/ijc.28091
   Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001
   Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928
   Boutz DR, 2011, J BIOL CHEM, V286, P18066, DOI 10.1074/jbc.M110.196451
   Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095
   Ch'ng ES, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-251
   Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910
   Chen LC, 2012, EUR J CANCER, V48, P3104, DOI 10.1016/j.ejca.2012.02.007
   Chen QJ, 2011, DIGEST DIS SCI, V56, P2009, DOI 10.1007/s10620-010-1536-3
   Chen XY, 2011, INVEST OPHTH VIS SCI, V52, P1193, DOI 10.1167/iovs.10-5272
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408
   Costello JF, 1997, CANCER RES, V57, P1250
   Cui Y, 2012, BRAIN RES, V1469, P1, DOI 10.1016/j.brainres.2012.06.043
   Deng JP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/517172
   Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049
   Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752
   Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296
   Featherstone DE, 2011, GLIA, V59, P1351, DOI 10.1002/glia.21085
   Fitzsimons CP, 2008, MOL ENDOCRINOL, V22, P248, DOI 10.1210/me.2007-0233
   Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616
   Fotovati A, 2011, CANCER RES, V71, P5569, DOI 10.1158/0008-5472.CAN-10-2805
   Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088
   Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478
   Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517
   Glazer RI, 2012, FRONT BIOSCI-LANDMRK, V17, P54, DOI 10.2741/3915
   Gomes AL, 2007, CELL ONCOL, V29, P399
   Gonzalez-Gomez P, 2011, MOL NEUROBIOL, V44, P235, DOI 10.1007/s12035-011-8196-y
   Hau P, 2011, CURR PHARM BIOTECHNO, V12, P2150, DOI 10.2174/138920111798808347
   Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126
   Henry JC, 2011, PHARM RES-DORDR, V28, P3030, DOI 10.1007/s11095-011-0548-9
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huveldt D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056505
   Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17
   Kanemura Y, 2001, DIFFERENTIATION, V68, P141, DOI 10.1046/j.1432-0436.2001.680208.x
   Kang K, 2012, J BIOL CHEM
   Kelleher FC, 2012, CANCER J, V18, P132, DOI 10.1097/PPO.0b013e31824ba4df
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117
   Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194
   Kwon E, 2011, MOL PSYCHIAT
   Lam PYP, 2000, BRIT J NEUROSURG, V14, P28
   Langevin SM, 2011, CANCER-AM CANCER SOC, V117, P1454, DOI 10.1002/cncr.25689
   Langevin SM, 2010, CARCINOGENESIS, V31, P864, DOI 10.1093/carcin/bgq051
   Lee SG, 2011, CANCER RES, V71, P6514, DOI 10.1158/0008-5472.CAN-11-0782
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li B, 2012, ONCOL REP, V28, P909, DOI 10.3892/or.2012.1884
   Li KK, 2012, BRAIN PATHOL
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347
   Milano V, 2009, MOL CANCER THER, V8, P394, DOI 10.1158/1535-7163.MCT-08-0669
   Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309
   Nagamine T, 2011, J BIOCHEM, V149, P619, DOI 10.1093/jb/mvr013
   Nielsen S, 1997, J NEUROSCI, V17, P171
   O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034
   Penalva LOF, 2004, BIOTECHNIQUES, V37, P604, DOI 10.2144/04374ST05
   Perruisseau-Carrier C, 2011, MOL NEUROBIOL, V43, P215, DOI 10.1007/s12035-011-8179-z
   Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59
   Pittoni P, 2011, ONCOGENE, V30, P757, DOI 10.1038/onc.2010.494
   Pu PY, 2004, TUMOR BIOL, V25, P172, DOI 10.1159/000081099
   Quintero A, 2006, J CLIN PATHOL, V59, P83, DOI 10.1136/jcp.2004.022939
   Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680
   Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144
   Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280
   Schmitt A, 2006, HISTOPATHOLOGY, V49, P298, DOI 10.1111/j.1365-2559.2006.02505.x
   Schneider T, 2006, J NEURO-ONCOL, V79, P61, DOI 10.1007/s11060-005-9116-7
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Senner V, 1999, J NEUROPATH EXP NEUR, V58, P795, DOI 10.1097/00005072-199908000-00002
   Setty M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.37
   Sharma S, 2004, APPL IMMUNOHISTO M M, V12, P290, DOI 10.1097/00129039-200412000-00002
   Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039
   Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14
   Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533
   Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431
   Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344
   Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041
   Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532
   Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151
   Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207
   Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034
   Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301
   Vo DT, 2012, AM J PATHOL, V181, P1762, DOI 10.1016/j.ajpath.2012.07.031
   Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208
   Vo DT, 2011, RNA BIOL, V8, P817, DOI 10.4161/rna.8.5.16041
   Warth A, 2007, J NEUROSCI RES, V85, P1336, DOI 10.1002/jnr.21224
   Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832
   Yiin JJ, 2009, NEURO-ONCOLOGY, V11, P779, DOI 10.1215/15228517-2008-017
   Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008
   Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314
   Zhang DY, 2011, ONCOL REP, V26, P901, DOI 10.3892/or.2011.1362
   Zhang JX, 2010, ONCOL REP, V24, P65, DOI 10.3892/or_00000829
   Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102
   ZHU X, 2012, FEBS LETT
NR 104
TC 28
Z9 28
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 22
PY 2014
VL 9
IS 1
AR e85591
DI 10.1371/journal.pone.0085591
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 297VL
UT WOS:000330283100048
PM 24465609
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ravindran, R
   Khan, N
   Nakaya, HI
   Li, SZ
   Loebbermann, J
   Maddur, MS
   Park, Y
   Jones, DP
   Chappert, P
   Davoust, J
   Weiss, DS
   Virgin, HW
   Ron, D
   Pulendran, B
AF Ravindran, Rajesh
   Khan, Nooruddin
   Nakaya, Helder I.
   Li, Shuzhao
   Loebbermann, Jens
   Maddur, Mohan S.
   Park, Youngja
   Jones, Dean P.
   Chappert, Pascal
   Davoust, Jean
   Weiss, David S.
   Virgin, Herbert W.
   Ron, David
   Pulendran, Bali
TI Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells
   Enhances Antigen Presentation
SO SCIENCE
LA English
DT Article
ID INITIATION-FACTOR 2-ALPHA; YELLOW-FEVER VACCINE; CD8(+) T-CELLS;
   TRANSLATIONAL CONTROL; AUTOPHAGY; KINASE; STRESS; MICE; RNA;
   PHOSPHORYLATION
AB The yellow fever vaccine YF-17D is one of the most successful vaccines ever developed in humans. Despite its efficacy and widespread use in more than 600 million people, the mechanisms by which it stimulates protective immunity remain poorly understood. Recent studies using systems biology approaches in humans have revealed that YF-17D-induced early expression of general control nonderepressible 2 kinase (GCN2) in the blood strongly correlates with the magnitude of the later CD8(+) T cell response. We demonstrate a key role for virus-induced GCN2 activation in programming dendritic cells to initiate autophagy and enhanced antigen presentation to both CD4(+) and CD8(+) T cells. These results reveal an unappreciated link between virus-induced integrated stress response in dendritic cells and the adaptive immune response.
C1 [Ravindran, Rajesh; Khan, Nooruddin; Nakaya, Helder I.; Li, Shuzhao; Loebbermann, Jens; Maddur, Mohan S.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Khan, Nooruddin] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500046, Andhra Pradesh, India.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Park, Youngja] Korea Univ, Coll Pharm, Seoul 339700, South Korea.
   [Jones, Dean P.] Emory Univ, Dept Med, Div Pulm Allergy & Crit Care, Atlanta, GA 30322 USA.
   [Chappert, Pascal; Davoust, Jean] INSERM, U1013, Paris, France.
   [Chappert, Pascal; Davoust, Jean] Univ Paris 05, Sorbonne Paris Cite, F-75743 Paris 15, France.
   [Weiss, David S.] Emory Univ, Div Infect Dis, Dept Med, Atlanta, GA 30329 USA.
   [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Ron, David] Univ Cambridge, Cambridge Metab Res Labs, Cambridge CB2 0QQ, England.
   [Ron, David] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Maddur, Mohan/E-4763-2015; Davoust,
   Jean/ABB-6720-2020; Khan, Nooruddin/AAF-5417-2019; Loebbermann,
   Jens/K-8327-2014; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; chappert, pascal/0000-0002-9799-4608; Maddur,
   Mohan/0000-0002-7085-1762; Ron, David/0000-0002-3014-5636; Davoust,
   Jean/0000-0002-3098-7665; Virgin, Herbert/0000-0001-8580-7628; Li,
   Shuzhao/0000-0002-7386-2539
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R37 DK057665,
   R37 AI048638, U19 AI090023, U19 AI057266, U54 AI057157, N01 AI50019, N01
   AI50025]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation; Wellcome TrustWellcome Trust [084812/Z/08/Z]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U54 AI057160]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U19AI090023, U54AI057160,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057160, U54AI057157, U54AI057160, U19AI057266,
   U54AI057160, U19AI057266, U54AI057160, U54AI057157, U19AI057266,
   R37AI048638, U54AI057160, U19AI057266, U54AI057157, U19AI057266,
   U54AI057160, U54AI057160, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057160, U19AI057266, U54AI057160,
   U54AI057157, U54AI057157, U54AI057157, U54AI057160, U54AI057160,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U54AI057160, U54AI057160, N01AI050025, U19AI057266, U54AI057157,
   U19AI090023, R37AI048638, U54AI057160, U54AI057160, U54AI057157,
   U19AI090023, U54AI057157, U19AI090023, U54AI057160, U54AI057160,
   U54AI057160, U54AI057157, U19AI057266, U54AI057160, U54AI057157,
   U54AI057160, U54AI057160, U19AI057266, U54AI057160, U54AI057160,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U54AI057160,
   U54AI057160, U19AI057266, U54AI057160, U54AI057160, U54AI057160,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI090023, U19AI057266, U54AI057160, U54AI057157, U19AI057266,
   U54AI057160, U54AI057157, U54AI057157, U54AI057160, U54AI057157,
   U54AI057157, U54AI057160, U19AI057266, U54AI057160, U19AI057266,
   U54AI057160, U54AI057157, U19AI057266, U19AI057266, U54AI057160,
   U19AI057266, U54AI057160, U54AI057160, U54AI057160, U54AI057157,
   U54AI057157, U54AI057160, U54AI057160, U54AI057157, U54AI057160,
   U54AI057160, U54AI057157, U19AI090023, U19AI090023, R37AI048638,
   U54AI057157, U54AI057160, U54AI057160, U19AI057266, U19AI057266,
   U19AI057266, U54AI057160, U54AI057160, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U54AI057160, U19AI090023,
   U54AI057160, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U54AI057160, U54AI057160, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI090023, U54AI057160,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057160,
   U19AI057266, U54AI057160, U54AI057157, U54AI057157, U19AI057266,
   U54AI057160, U54AI057160, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057160, U54AI057157, U54AI057157,
   U54AI057157, U54AI057160, U19AI057266, U54AI057157, U54AI057157,
   U54AI057160, U54AI057157, U19AI057266, U54AI057160, U19AI090023,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, U54AI057160,
   U19AI090023, U54AI057157, U54AI057157, U54AI057160, U19AI090023,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057160, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057160, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   R37AI048638, U54AI057157, U54AI057160, U19AI057266, U54AI057157,
   U19AI057266, U54AI057160, U19AI057266, U19AI057266, U54AI057160,
   U54AI057160, U54AI057157, U54AI057160, U54AI057157, U19AI057266,
   U54AI057160, U19AI090023, U19AI090023, U19AI057266, U54AI057160,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057160, U54AI057160, U54AI057157, U54AI057157,
   U19AI090023, U54AI057157, U54AI057160, U19AI090023, U19AI057266,
   U54AI057157, U54AI057160, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057160, U54AI057160, U54AI057157,
   U19AI090023, R37AI048638, U19AI057266, U54AI057160, U54AI057157,
   R37AI048638, R37AI048638, U54AI057160, U54AI057160, U19AI057266,
   U54AI057160, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI090023, U54AI057160, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057160, U19AI090023,
   U54AI057157, U19AI057266, U19AI090023, U19AI057266, U54AI057160,
   U54AI057157, U19AI057266, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U54AI057157, U54AI057160, U19AI090023, U19AI090023,
   U54AI057160, U54AI057160, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057160, U54AI057160, U54AI057160, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U54AI057160, U19AI090023, U54AI057157,
   U54AI057160, U54AI057157, U54AI057160, U54AI057160, U19AI057266,
   U54AI057160, U54AI057160, U54AI057160, U19AI090023, U54AI057157,
   U54AI057157, U54AI057160, U54AI057160, U54AI057157, U54AI057160,
   U19AI090023, U19AI090023, U54AI057157, U19AI090023, U54AI057160,
   U54AI057160, U19AI057266, U54AI057160, U19AI090023, U54AI057157,
   U19AI057266, U19AI090023, U19AI057266, U54AI057160, U19AI057266,
   U54AI057160, U19AI090023, U54AI057160, U54AI057157, U54AI057160,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, U19AI057266, U54AI057157, U19AI057266, U54AI057160,
   U54AI057157, U54AI057160, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U54AI057160, U19AI090023, U19AI090023, U54AI057157,
   U54AI057157, U54AI057160, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057160, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U19AI057266, U54AI057160, U54AI057160,
   U19AI057266, U54AI057157, U19AI057266, R56AI048638, U54AI057160,
   U54AI057157, U19AI057266, U54AI057157, U19AI090023, U19AI090023,
   U54AI057157, U54AI057160, R37AI048638, U54AI057160, R37AI048638,
   U54AI057160, U19AI057266, U54AI057157, U54AI057160, U54AI057160,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, R37AI048638,
   U19AI057266, U19AI057266, R37AI048638, U54AI057157, U54AI057160,
   U54AI057160, U54AI057157, U19AI057266, U54AI057160, U54AI057160,
   U19AI057266, U19AI090023, U54AI057160, U54AI057160, U54AI057157,
   U19AI057266, U19AI090023, U54AI057160, U19AI090023, U19AI090023,
   U54AI057160, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U19AI090023, U54AI057160, U54AI057160, U54AI057157, U54AI057160,
   U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665] Funding
   Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132] Funding Source: NIH RePORTER
FX This work was supported by grants from the U.S. National Institutes of
   Health (grants R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266,
   U54 AI057157, N01 AI50019, and N01 AI50025) and from the Bill & Melinda
   Gates Foundation to B. P., a Wellcome Trust Principal Research
   Fellowship (084812/Z/08/Z) to D. R, and NIH grant U54 AI057160 to H. W.
   V. We thank B. Cervasi and K. Gill for help with sorting and D.
   Levesque, D. Bonenberger, and colleagues for animal husbandry. The data
   presented in this manuscript are tabulated in the main paper and the
   supplementary materials.
CR Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2
   Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073
   Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363
   Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106
   Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458
   den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7
   English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720
   Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882
   HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Krishnamoorthy J, 2008, CELL CYCLE, V7, P2346, DOI 10.4161/cc.6323
   Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029
   Lee HK, 2010, IMMUNITY, V32, P227, DOI 10.1016/j.immuni.2009.12.006
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198
   Martinez J, 2013, CELL METAB, V17, P895, DOI 10.1016/j.cmet.2013.05.012
   McAllister A, 2000, J VIROL, V74, P9197, DOI 10.1128/JVI.74.19.9197-9205.2000
   Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7
   Munz C, 2011, VIRUSES-BASEL, V3, P1166, DOI 10.3390/v3071166
   Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784
   Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018
   Sood R, 2000, GENETICS, V154, P787
   Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299
   Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404
   Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8
   Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007
   Won S, 2012, J VIROL, V86, P1802, DOI 10.1128/JVI.05660-11
NR 31
TC 124
Z9 127
U1 1
U2 50
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JAN 17
PY 2014
VL 343
IS 6168
BP 313
EP 317
DI 10.1126/science.1246829
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 289YN
UT WOS:000329718600040
PM 24310610
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Medina-Acosta, E
   Nakaya, HTI
   Pontillo, A
   Fernandes, RCDC
AF Medina-Acosta, Enrique
   Nakaya, Helder Takashi Imoto
   Pontillo, Alessandra
   de Souza Campos Fernandes, Regina Celia
TI Genetic Control of Immune Response and Susceptibility to Infectious
   Diseases
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Editorial Material
C1 [Medina-Acosta, Enrique] State Univ Norte Fluminense Darcy Ribeiro, Ctr Biosci & Biotechnol, Dept Biotechnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Nakaya, Helder Takashi Imoto] Emory Univ, Emory Vaccine Ctr, Primate Res Ctr, Atlanta, GA 30329 USA.
   [Pontillo, Alessandra] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Immunogenet Lab, BR-05508900 Sao Paulo, Brazil.
   [de Souza Campos Fernandes, Regina Celia] Alvaro Alvim Sch Hosp, Sch Med Campos, Dept Pediat, BR-28035211 Campos Dos Goytacazes, RJ, Brazil.
RP Medina-Acosta, E (corresponding author), State Univ Norte Fluminense Darcy Ribeiro, Ctr Biosci & Biotechnol, Dept Biotechnol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM quique@uenf.br
RI Pontillo, ALESSANDRA/D-4352-2012; Medina-Acosta, Enrique/G-3041-2010;
   Pontillo, Alessandra/AAD-4790-2019; Nakaya, Helder I/A-1397-2010;
   Nakaya, Helder/AAF-1738-2020; Pontillo, Alessandra/ABC-6266-2020
OI Pontillo, ALESSANDRA/0000-0002-7883-0640; Medina-Acosta,
   Enrique/0000-0002-2529-0548; Pontillo, Alessandra/0000-0002-7883-0640;
   Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Pontillo, Alessandra/0000-0002-7883-0640
NR 0
TC 0
Z9 0
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 796073
DI 10.1155/2014/796073
PG 3
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AB4GA
UT WOS:000331746400001
PM 24689057
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Tan, Y
   Tamayo, P
   Nakaya, H
   Pulendran, B
   Mesirov, JP
   Haining, WN
AF Tan, Yan
   Tamayo, Pablo
   Nakaya, Helder
   Pulendran, Bali
   Mesirov, Jill P.
   Haining, W. Nicholas
TI Gene signatures related to B-cell proliferation predict influenza
   vaccine-induced antibody response
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID YELLOW-FEVER VACCINE; SYSTEMS VACCINOLOGY; T-CELLS; EXPRESSION;
   IMMUNITY; BIOLOGY; HUMANS
C1 [Tan, Yan; Tamayo, Pablo; Mesirov, Jill P.; Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Tan, Yan; Mesirov, Jill P.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA.
   [Nakaya, Helder; Pulendran, Bali] Yerkes Natl Primate Ctr, Dept Pathol, Emory Vaccine Ctr, Atlanta, GA USA.
   [Haining, W. Nicholas] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Haining, W. Nicholas] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp, Boston, MA 02115 USA.
RP Haining, WN (corresponding author), Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, 44 Binney St,Dana 640, Boston, MA 02115 USA.
EM mesirov@broad.mit.edu; nicholas_haining@dfci.harvard.edu
RI Nakaya, Helder/AAF-1738-2020; Tan, Yan/N-5672-2017; Nakaya, Helder
   I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU Infrastructure and Opportunity Fund Grant from the Human Immune
   Phenotyping Consortium; Bill and Melinda Gates FoundationBill & Melinda
   Gates Foundation [OPP50092];  [R01AI091493];  [U19AI090023]; NATIONAL
   CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA121941, R01CA121941, R01CA121941, R01CA121941,
   R01CA121941, R01CA121941, R01CA121941, R01CA121941, R01CA121941,
   R01CA121941, R01CA121941] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI090023, U19AI057266, U19AI057266, U19AI057266, R01AI091493,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, R37AI048638,
   U19AI090023, U19AI090023, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, R01AI091493,
   U19AI057266, R37AI048638, U19AI090023, U19AI057266, U19AI057266,
   R37AI048638, U19AI090023, R37AI048638, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   R01AI091493, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, R37AI048638, U19AI090023, U19AI057266, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, U19AI090023, U19AI057266, R37AI048638, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   R01AI091493, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI057266, R37AI048638, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI057266, R56AI048638,
   U19AI090023, R37AI048638, U19AI090023, R01AI091493, U19AI057266,
   U19AI057266, R37AI048638, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI090023, U19AI090023, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI090023,
   R01AI091493, U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U19AI090023, U19AI090023, U19AI057266, U19AI057266, U19AI090023,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI057266, U19AI090023, U19AI090023, U19AI090023,
   R37AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665] Funding
   Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132, P51OD011132, P51OD011132, P51OD011132,
   P51OD011132, P51OD011132] Funding Source: NIH RePORTER
FX Supported by R01AI091493 to W.N.H.; U19AI090023 to B.P. and W.N.H, by an
   Infrastructure and Opportunity Fund Grant from the Human Immune
   Phenotyping Consortium to W.N.H. and J.M.; and by the Bill and Melinda
   Gates Foundation OPP50092 to J.M.
CR Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109
   Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   de Leeuw J, 2009, J STAT SOFTW, V31, P1
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Haining WN, 2012, CURR OPIN IMMUNOL, V24, P332, DOI 10.1016/j.coi.2012.03.010
   Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260
   Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232
   Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500
   Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273
   Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]
   Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665
   Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tamayo P, 2011, J CLIN ONCOL, V29, P1415, DOI 10.1200/JCO.2010.28.1675
   US Department of Health and Human Services, 2007, GUID IND CLIN DAT NE
   Vinh NX, 2010, J MACH LEARN RES, V11, P2837
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
NR 31
TC 42
Z9 42
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD JAN
PY 2014
VL 44
IS 1
BP 285
EP 295
DI 10.1002/eji.201343657
PG 11
WC Immunology
SC Immunology
GA AA0RA
UT WOS:000330803400028
PM 24136404
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Li, SZ
   Nakaya, HI
   Kazmin, DA
   Oh, JZ
   Pulendran, B
AF Li, Shuzhao
   Nakaya, Helder I.
   Kazmin, Dmitri A.
   Oh, Jason Z.
   Pulendran, Bali
TI Systems biological approaches to measure and understand vaccine immunity
   in humans
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Vaccines; Systems biology; Systems vaccinology
ID DIFFERENTIAL EXPRESSION ANALYSIS; REGULATORY T-CELLS; GENE-EXPRESSION;
   MINIMUM INFORMATION; MOLECULAR NETWORKS; ANTIBODY-RESPONSE; INNATE
   IMMUNITY; DATA-MANAGEMENT; FATTY-ACIDS; MICROARRAY
AB Recent studies have demonstrated the utility of using systems approaches to identify molecular signatures that can be used to predict vaccine immunity in humans. Such approaches are now being used extensively in vaccinology, and are beginning to yield novel insights about the molecular networks driving vaccine immunity. In this review, we present a broad review of the methodologies involved in these studies, and discuss the promise and challenges involved in this emerging field of "systems vaccinology." (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Li, Shuzhao; Nakaya, Helder I.; Kazmin, Dmitri A.; Oh, Jason Z.; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
RP Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Ibrahim,
   Essam H./G-1960-2018
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Ibrahim, Essam H./0000-0003-0130-2257; Li,
   Shuzhao/0000-0002-7386-2539
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R37 AI048638, U54 AI057157, U19 AI057266,
   U19 AI090023, U19 AI096187] Funding Source: Medline; NIDDK NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R37 DK057665] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U54AI057157, U54AI057157, U19AI096187, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI096187,
   U54AI057157, U54AI057157, U54AI057157, U19AI096187, U19AI096187,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI096187, U54AI057157, U54AI057157, U54AI057157,
   U19AI096187, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI096187, U54AI057157,
   U54AI057157, U54AI057157, U19AI096187, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, R37AI048638, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U19AI096187, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U19AI096187, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI096187, U54AI057157, U54AI057157, U19AI090023, U19AI096187,
   U19AI090023, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   R37AI048638, U19AI090023, U19AI090023, U54AI057157, U54AI057157,
   U19AI096187, U54AI057157, U19AI057266, U19AI057266, R37AI048638,
   U19AI090023, U19AI057266, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI096187, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U19AI096187, U54AI057157, U19AI096187, U54AI057157, U19AI057266,
   U19AI090023, U19AI057266, U19AI090023, U54AI057157, U19AI057266,
   U19AI090023, U19AI090023, U19AI090023, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U19AI096187,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U19AI090023, U19AI057266, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI096187, U54AI057157, U54AI057157,
   U19AI090023, U19AI096187, U19AI090023, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U19AI090023, U19AI096187, U19AI090023, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U19AI096187,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U19AI096187, U19AI090023, U19AI057266,
   U54AI057157, U54AI057157, R37AI048638, U19AI057266, U54AI057157,
   U54AI057157, U19AI096187, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U19AI096187,
   U19AI057266, U19AI057266, U54AI057157, U19AI096187, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U54AI057157, U19AI096187, U19AI096187, U54AI057157,
   U54AI057157, U19AI096187, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U19AI096187, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI057266, U19AI057266, U54AI057157, U19AI096187,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   R37AI048638, U54AI057157, U19AI057266, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI096187, U19AI096187, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI096187, U19AI057266,
   U19AI096187, U19AI057266, U19AI096187, U19AI057266, U54AI057157,
   U54AI057157, U19AI090023, U19AI096187, U19AI057266, U19AI057266,
   U19AI057266, U19AI096187, U19AI096187, U54AI057157, R37AI048638,
   U54AI057157, U19AI096187, R37AI048638, R37AI048638, R37AI048638,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   R37AI048638, U19AI057266, U19AI096187, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI090023,
   U19AI096187, U19AI090023, U54AI057157, U19AI090023, U19AI096187,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI096187, U19AI090023, U19AI057266,
   U19AI096187, U19AI096187, U19AI057266, U19AI096187, U19AI057266,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, U19AI096187, U19AI057266,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   U19AI096187, R37AI048638, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U19AI096187, U19AI090023,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI096187, U54AI057157, U19AI090023] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665] Funding Source: NIH RePORTER
CR Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098
   Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173
   Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Al-Abed Y, 2011, P NATL ACAD SCI USA, V108, P8224, DOI 10.1073/pnas.1017624108
   Al-Mubarak R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001303
   Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356
   Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550
   Antunes LCM, 2011, INFECT IMMUN, V79, P1759, DOI 10.1128/IAI.01373-10
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240
   Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469
   Auffray C, 2009, GENOME MED, V1, DOI 10.1186/gm2
   Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bolen CR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-258
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Carvalho FA, 2012, GUT, V61, P373, DOI 10.1136/gut.2011.240556
   Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84
   Chaussabel D, 2009, NAT IMMUNOL, V10, P1225, DOI 10.1038/ni1209-1225
   Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009
   Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757
   Chikina MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000417
   CHUANG HY, 2007, MOL SYSTEMS BIOL, P2007
   Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617
   Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010
   Davis NA, 2010, GENES IMMUN, V11, P630, DOI 10.1038/gene.2010.37
   de Bakker PIW, 2010, NAT GENET, V42, P731, DOI 10.1038/ng0910-731
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512
   DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032
   Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3
   Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042
   Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018
   Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758
   Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205
   Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791
   Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961
   Fritsche K, 2006, ANNU REV NUTR, V26, P45, DOI 10.1146/annurev.nutr.25.050304.092610
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317
   Germain RN, 2010, IMMUNITY, V33, P441, DOI 10.1016/j.immuni.2010.09.014
   GOTTFRIED E, 2012, SEMINARS CANC BIOL
   Haining WN, 2012, CURR OPIN IMMUNOL, V24, P332, DOI 10.1016/j.coi.2012.03.010
   Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009
   Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184
   Hansen AM, 2010, NAT MED, V16, P856, DOI 10.1038/nm0810-856
   Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132
   Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657
   HUANG Y, 2011, PLOS GENET, V7
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007
   Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857
   Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   KENNEDY RB, 2012, HUM GENET, P1
   Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375
   Kirschner DE, 2007, IMMUNOL REV, V216, P93
   KOHLER PF, 1985, J CLIN INVEST, V75, P883, DOI 10.1172/JCI111787
   Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217
   Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09
   Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623
   Lee KK, 2009, LECT NOTES COMPUT SC, V5547, P1, DOI 10.1007/978-3-642-01929-6_1
   Lee SI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r76
   Lee YC, 2006, VACCINE, V24, P5335, DOI 10.1016/j.vaccine.2006.04.021
   Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123
   Li SZ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r115
   Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721
   Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100
   Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x
   LYNN DJ, 2008, MOL SYSTEMS BIOL, P2008
   Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   Meier-Schellersheim M, 2009, WIRES SYST BIOL MED, V1, P4, DOI 10.1002/wsbm.33
   Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002
   Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565
   Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004
   O'Donnell VB, 2012, BLOOD, V120, P1985, DOI 10.1182/blood-2012-04-402826
   Oberg AL, 2011, CURR OPIN IMMUNOL, V23, P436, DOI 10.1016/j.coi.2011.04.005
   OBERHARDT MA, 2009, MOL SYSTEMS BIOL, P2009
   Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301
   Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004
   Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055
   Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695
   Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115
   Pandey G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000928
   Parry RM, 2010, PHARMACOGENOMICS J, V10, P292, DOI 10.1038/tpj.2010.56
   Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221
   Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314
   Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097
   Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700
   Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271
   PLATA G, 2010, MOL SYSTEMS BIOL, P2010
   Plotkin SA, 2011, NAT REV MICROBIOL, V9, P889, DOI 10.1038/nrmicro2668
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI [10.2217/pgs.09.25, 10.2217/PGS.09.25]
   Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124
   Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809
   Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857
   Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454
   Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653
   SCIAMMAS R, 2011, MOL SYSTEMS BIOL, P2011
   Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]
   Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665
   Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002
   Spidlen Josef, 2011, BMC Res Notes, V4, P50, DOI 10.1186/1756-0500-4-50
   Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0
   Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383
   Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trautmann L, 2011, NAT IMMUNOL, V12, P729, DOI 10.1038/ni.2078
   Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39
   Veenstra TD, 2012, GENOME MED, V4, DOI 10.1186/gm339
   Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328
   WELLEN ME, 2012, NATURE REV MOL CELL
   Wikoff WR, 2009, J PROTEOME RES, V8, P3578, DOI 10.1021/pr900275p
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Xing H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001105
   Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364
   Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325
   Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337
   Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319
   Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919
   Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006
   Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109
   Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x
   Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753
NR 159
TC 36
Z9 36
U1 1
U2 12
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
EI 1096-3618
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD OCT 31
PY 2013
VL 25
IS 3
BP 209
EP 218
DI 10.1016/j.smim.2013.05.003
PG 10
WC Immunology
SC Immunology
GA 257WS
UT WOS:000327419100004
PM 23796714
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Pulendran, B
   Oh, JZ
   Nakaya, HI
   Ravindran, R
   Kazmin, DA
AF Pulendran, Bali
   Oh, Jason Z.
   Nakaya, Helder I.
   Ravindran, Rajesh
   Kazmin, Dmitri A.
TI Immunity to viruses: learning from successful human vaccines
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review
DE dendritic cells; Toll-like receptors; vaccination
ID YELLOW-FEVER VACCINE; ENDOPLASMIC-RETICULUM STRESS; T-CELL RESPONSES;
   PROTEIN-SYNTHESIS; DENDRITIC CELLS; INNATE IMMUNITY; TRANSLATIONAL
   REGULATION; INFLUENZA VACCINATION; SYSTEMS BIOLOGY; CUTTING EDGE
AB For more than a century, immunologists and vaccinologists have existed in parallel universes. Immunologists have for long reveled in using model antigens', such as chicken egg ovalbumin or nitrophenyl haptens, to study immune responses in model organisms such as mice. Such studies have yielded many seminal insights about the mechanisms of immune regulation, but their relevance to humans has been questioned. In another universe, vaccinologists have relied on human clinical trials to assess vaccine efficacy, but have done little to take advantage of such trials for studying the nature of immune responses to vaccination. The human model provides a nexus between these two universes, and recent studies have begun to use this model to study the molecular profile of innate and adaptive responses to vaccination. Such systems vaccinology' studies are beginning to provide mechanistic insights about innate and adaptive immunity in humans. Here, we present an overview of such studies, with particular examples from studies with the yellow fever and the seasonal influenza vaccines. Vaccination with the yellow fever vaccine causes a systemic acute viral infection and thus provides an attractive model to study innate and adaptive responses to a primary viral challenge. Vaccination with the live attenuated influenza vaccine causes a localized acute viral infection in mucosal tissues and induces a recall response, since most vaccinees have had prior exposure to influenza, and thus provides a unique opportunity to study innate and antigen-specific memory responses in mucosal tissues and in the blood. Vaccination with the inactivated influenza vaccine offers a model to study immune responses to an inactivated immunogen. Studies with these and other vaccines are beginning to reunite the estranged fields of immunology and vaccinology, yielding unexpected insights about mechanisms of viral immunity. Vaccines that have been proven to be of immense benefit in saving lives offer us a new fringe benefit: lessons in viral immunology.
C1 [Pulendran, Bali; Oh, Jason Z.; Nakaya, Helder I.; Ravindran, Rajesh; Kazmin, Dmitri A.] Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Pulendran, Bali; Oh, Jason Z.; Nakaya, Helder I.; Ravindran, Rajesh; Kazmin, Dmitri A.] Emory Univ, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA.
   [Pulendran, Bali; Nakaya, Helder I.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.
   [Pulendran, Bali] Emory Univ, Sch Med, Atlanta, GA USA.
RP Pulendran, B (corresponding author), Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Ibrahim, Essam H./G-1960-2018; Nakaya, Helder/AAF-1738-2020; Nakaya,
   Helder I/A-1397-2010
OI Ibrahim, Essam H./0000-0003-0130-2257; Nakaya,
   Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U19AI090023,
   U54AI057157, R37AI48638, R37DK057665, U19AI057266, PO1A1096187]; Scripps
   CHAVI-ID Award [UM1AI100663]; Bill and Melinda Gates FoundationBill &
   Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI090023, U54AI057157, UM1AI100663,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, R37AI048638, UM1AI100663, U54AI057157,
   UM1AI100663, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   UM1AI100663, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   UM1AI100663, U54AI057157, U54AI057157, UM1AI100663, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, R37AI048638,
   U19AI096187, U54AI057157, UM1AI100663, U19AI057266, U19AI096187,
   U19AI096187, UM1AI100663, U19AI057266, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI096187, U19AI096187, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI096187, UM1AI100663, UM1AI100663,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, UM1AI100663,
   U19AI057266, UM1AI100663, U54AI057157, U19AI096187, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, UM1AI100663,
   U54AI057157, U54AI057157, U19AI096187, U19AI096187, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, UM1AI100663,
   U54AI057157, U19AI057266, U19AI096187, UM1AI100663, UM1AI100663,
   U19AI057266, U19AI090023, U19AI057266, UM1AI100663, U19AI090023,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, UM1AI100663, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, UM1AI100663,
   U19AI057266, U19AI090023, U19AI096187, U54AI057157, U54AI057157,
   U19AI057266, U19AI096187, U54AI057157, U19AI057266, UM1AI100663,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, UM1AI100663, U19AI096187,
   U19AI057266, U19AI096187, UM1AI100663, U19AI057266, U19AI096187,
   U54AI057157, U19AI090023, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, UM1AI100663, UM1AI100663, U54AI057157,
   U54AI057157, U54AI057157, U19AI096187, U19AI090023, U19AI096187,
   UM1AI100663, R37AI048638, U54AI057157, U54AI057157, U19AI096187,
   U19AI057266, U19AI090023, U19AI096187, U19AI057266, U19AI096187,
   U19AI057266, U54AI057157, U19AI090023, UM1AI100663, UM1AI100663,
   U19AI096187, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI090023,
   UM1AI100663, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U19AI096187, U19AI096187, U54AI057157, UM1AI100663, U19AI096187,
   U19AI090023, U19AI057266, U19AI096187, U19AI090023, R37AI048638,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, UM1AI100663, R37AI048638, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI096187, U54AI057157, U19AI090023,
   U19AI090023, U19AI057266, UM1AI100663, U19AI057266, U19AI090023,
   UM1AI100663, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   UM1AI100663, UM1AI100663, U54AI057157, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, UM1AI100663, U19AI057266,
   U54AI057157, U19AI057266, UM1AI100663, U19AI096187, U54AI057157,
   UM1AI100663, U54AI057157, U19AI057266, UM1AI100663, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, UM1AI100663, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157, UM1AI100663,
   U54AI057157, U19AI090023, U19AI096187, U54AI057157, U19AI057266,
   UM1AI100663, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI096187, U54AI057157, U19AI096187, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, R37AI048638,
   U54AI057157, U19AI096187, U19AI090023, U19AI096187, U19AI096187,
   U19AI096187, U19AI057266, UM1AI100663, U54AI057157, UM1AI100663,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, U54AI057157,
   U19AI096187, U19AI057266, U19AI057266, U54AI057157, UM1AI100663,
   U54AI057157, UM1AI100663, R37AI048638, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, UM1AI100663,
   UM1AI100663, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U19AI096187, U19AI096187, U19AI057266,
   U54AI057157, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U19AI096187, U19AI090023, U19AI096187, UM1AI100663, U19AI096187,
   U54AI057157, R37AI048638, UM1AI100663, U19AI090023, UM1AI100663,
   R37AI048638, U54AI057157, U19AI057266, U19AI090023, U19AI090023,
   U19AI096187, R37AI048638, U54AI057157, U54AI057157, U19AI090023,
   U19AI096187, U19AI096187, U54AI057157, U19AI090023, U19AI096187,
   U19AI057266, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U19AI096187, U54AI057157, U54AI057157, U54AI057157, UM1AI100663,
   U19AI057266, UM1AI100663, U54AI057157, U19AI090023, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, UM1AI100663, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   R37AI048638, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI096187, U19AI096187, U19AI057266,
   U19AI057266, U19AI090023, UM1AI100663, U54AI057157, U54AI057157,
   UM1AI100663, U19AI057266, U19AI090023, U54AI057157, U19AI096187,
   U19AI057266, U54AI057157, U19AI057266, UM1AI100663, U19AI057266,
   U54AI057157, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, UM1AI100663, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U19AI096187, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI096187, UM1AI100663] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665] Funding Source: NIH RePORTER
FX Research in the Pulendran laboratory is supported by the US National
   Institutes of Health (U19AI090023, U54AI057157, R37AI48638, R37DK057665,
   U19AI057266, PO1A1096187, Scripps CHAVI-ID Award (UM1AI100663) and the
   Bill and Melinda Gates Foundation. B. P., J. Z. O., H. I. N., R. R., D.
   A. Z. have no conflicts of interest to declare.
CR Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011
   Ahmed R, 2011, IMMUNOL CELL BIOL, V89, P340, DOI 10.1038/icb.2010.155
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109
   Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050
   Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002
   Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2
   Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200
   Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259
   Barouch DH, 2001, CURR OPIN IMMUNOL, V13, P479, DOI 10.1016/S0952-7915(00)00244-2
   Barrett Alan D, 2003, Adv Virus Res, V61, P291, DOI 10.1016/S0065-3527(03)61007-9
   Belsher JL, 2007, VACCINE, V25, P8480, DOI 10.1016/j.vaccine.2007.08.061
   Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191
   Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156
   Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   CHEFALO PJ, 1994, J BIOL CHEM, V269, P25788
   Chefalo PJ, 1998, EUR J BIOCHEM, V258, P820, DOI 10.1046/j.1432-1327.1998.2580820.x
   CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6
   Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009
   Crosby JS, 2000, BLOOD, V96, P3241
   Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969
   Darce JR, 2007, J IMMUNOL, V178, P5612, DOI 10.4049/jimmunol.178.9.5612
   Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6
   Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138
   Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569
   GERIN JL, 1969, NATURE, V221, P1255, DOI 10.1038/2211255a0
   Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407
   Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917
   Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961
   Harding HP, 1999, NATURE, V397, P271
   Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI200522854
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200
   Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711
   Koyama S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000759
   Lauer GM, 2002, J VIROL, V76, P6104, DOI 10.1128/JVI.76.12.6104-6113.2002
   Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499
   Li S, 2013, SEMIN IMMUNOL
   Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829
   Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290
   Lu JF, 1999, J BIOL CHEM, V274, P32198, DOI 10.1074/jbc.274.45.32198
   Luke CJ, 2012, VACCINES, P294
   MACK TM, 1972, AM J TROP MED HYG, V21, P214, DOI 10.4269/ajtmh.1972.21.214
   Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128
   McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Monath TP., 1996, MICROBE HUNTERS NOW, P456
   Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260
   Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Niwa M, 2000, P NATL ACAD SCI USA, V97, P12396, DOI 10.1073/pnas.250476097
   Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008
   Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2007, ADV EXP MED BIOL, V590, P43
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rahman ZSM, 2003, J EXP MED, V198, P1157, DOI 10.1084/jem.20030495
   Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378
   REIMER C. B., 1967, J VIROL, V1, P1207
   Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000
   Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784
   Roos MTL, 2000, J INFECT DIS, V182, P451, DOI 10.1086/315737
   Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924
   Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001
   Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008
   Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007
   Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06
   Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975
   Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964
   Shapira SD, 2011, CURR OPIN IMMUNOL, V23, P71, DOI 10.1016/j.coi.2010.10.022
   Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499
   Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   Sood R, 2000, GENETICS, V154, P787
   Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001
   Tan LC, 1999, J IMMUNOL, V162, P1827
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004
   Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359
   Urbani S, 2002, J VIROL, V76, P12423, DOI 10.1128/JVI.76.24.12423-12434.2002
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   van Leeuwen EM, 2002, J IMMUNOL, V169, P5838, DOI 10.4049/jimmunol.169.10.5838
   Vora KA, 2003, J IMMUNOL, V171, P547, DOI 10.4049/jimmunol.171.2.547
   Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007
   Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003
   Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612
   Yan MH, 2000, NAT IMMUNOL, V1, P37
   Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109
   Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b
   Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002
   Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002
NR 115
TC 41
Z9 41
U1 1
U2 44
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-2896
EI 1600-065X
J9 IMMUNOL REV
JI Immunol. Rev.
PD SEP
PY 2013
VL 255
IS 1
SI SI
BP 243
EP 255
DI 10.1111/imr.12099
PG 13
WC Immunology
SC Immunology
GA 201OM
UT WOS:000323150900018
PM 23947360
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Beckedorff, FC
   Ayupe, AC
   Crocci-Souza, R
   Amaral, MS
   Nakaya, HI
   Soltys, DT
   Menck, CFM
   Reis, EM
   Verjovski-Almeida, S
AF Beckedorff, Felipe C.
   Ayupe, Ana C.
   Crocci-Souza, Renan
   Amaral, Murilo S.
   Nakaya, Helder I.
   Soltys, Daniela T.
   Menck, Carlos F. M.
   Reis, Eduardo M.
   Verjovski-Almeida, Sergio
TI The Intronic Long Noncoding RNA ANRASSF1 Recruits PRC2 to the RASSF1A
   Promoter, Reducing the Expression of RASSF1A and Increasing Cell
   Proliferation
SO PLOS GENETICS
LA English
DT Article
ID TUMOR-SUPPRESSOR GENE; LUNG-CANCER; EPIGENETIC INACTIVATION;
   HUMAN-DISEASE; HUMAN GENOME; TRANSCRIPTION; CHROMATIN; PROTEIN; DOMAIN;
   DIFFERENTIATION
AB The down-regulation of the tumor-suppressor gene RASSF1A has been shown to increase cell proliferation in several tumors. RASSF1A expression is regulated through epigenetic events involving the polycomb repressive complex 2 (PRC2); however, the molecular mechanisms modulating the recruitment of this epigenetic modifier to the RASSF1 locus remain largely unknown. Here, we identify and characterize ANRASSF1, an endogenous unspliced long noncoding RNA (lncRNA) that is transcribed from the opposite strand on the RASSF1 gene locus in several cell lines and tissues and binds PRC2. ANRASSF1 is transcribed through RNA polymerase II and is 5'-capped and polyadenylated; it exhibits nuclear localization and has a shorter half-life compared with other lncRNAs that bind PRC2. ANRASSF1 endogenous expression is higher in breast and prostate tumor cell lines compared with non-tumor, and an opposite pattern is observed for RASSF1A. ANRASSF1 ectopic overexpression reduces RASSF1A abundance and increases the proliferation of HeLa cells, whereas ANRASSF1 silencing causes the opposite effects. These changes in ANRASSF1 levels do not affect the RASSF1C isoform abundance. ANRASSF1 overexpression causes a marked increase in both PRC2 occupancy and histone H3K27me3 repressive marks, specifically at the RASSF1A promoter region. No effect of ANRASSF1 overexpression was detected on PRC2 occupancy and histone H3K27me3 at the promoter regions of RASSF1C and the four other neighboring genes, including two well-characterized tumor suppressor genes. Additionally, we demonstrated that ANRASSF1 forms an RNA/DNA hybrid and recruits PRC2 to the RASSF1A promoter. Together, these results demonstrate a novel mechanism of epigenetic repression of the RASSF1A tumor suppressor gene involving antisense unspliced lncRNA, in which ANRASSF1 selectively represses the expression of the RASSF1 isoform overlapping the antisense transcript in a location-specific manner. In a broader perspective, our findings suggest that other non-characterized unspliced intronic lncRNAs transcribed in the human genome might contribute to a location-specific epigenetic modulation of genes.
C1 [Beckedorff, Felipe C.; Ayupe, Ana C.; Crocci-Souza, Renan; Amaral, Murilo S.; Nakaya, Helder I.; Reis, Eduardo M.; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.
   [Soltys, Daniela T.; Menck, Carlos F. M.] Univ Sao Paulo, Dept Microbiol, Inst Ciencias Biomed, BR-01498 Sao Paulo, Brazil.
   [Reis, Eduardo M.; Verjovski-Almeida, Sergio] Inst Nacl Ciencia & Tecnol Oncogen, Sao Paulo, Brazil.
RP Beckedorff, FC (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.
EM verjo@iq.usp.br
RI Beckedorff, Felipe/AAJ-9930-2020; Amaral, Murilo S/G-5769-2013; Reis,
   Eduardo M/H-2008-2011; Menck, Carlos FM/G-6321-2011; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Verjovski-Almeida, Sergio/E-4082-2012; Beckedorff,
   Felipe C/E-6288-2012; Nakaya, Helder/AAF-1738-2020; Reis, Eduardo Moraes
   Rego/AAF-3553-2020; Nakaya, Helder I/A-1397-2010; Soltys, Daniela
   Tathiana Tathiana/E-6283-2012
OI Beckedorff, Felipe/0000-0001-6735-6851; Reis, Eduardo
   M/0000-0002-9556-3070; Menck, Carlos FM/0000-0003-1941-0694;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Beckedorff, Felipe C/0000-0001-6735-6851;
   Nakaya, Helder/0000-0001-5297-9108; Reis, Eduardo Moraes
   Rego/0000-0002-9556-3070; Nakaya, Helder I/0000-0001-5297-9108; Soltys,
   Daniela Tathiana Tathiana/0000-0002-1024-3108
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Instituto Nacional de
   Ciencia e Tecnologia em Oncogenomica; FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); (CNPq)National Council
   for Scientific and Technological Development (CNPq)
FX This work was supported by grants from Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) (SVA and EMR) and from Instituto Nacional
   de Ciencia e Tecnologia em Oncogenomica (SVA and EMR), by fellowships
   from FAPESP (FCB, RCS, HIN, DTS, ACA) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (MSA) and by
   investigator fellowship awards (CNPq) (SVA, CFMM and EMR). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088
   Amin Karishma S, 2012, J Carcinog, V11, P3, DOI 10.4103/1477-3163.93000
   Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200
   Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106
   Calipel A, 2011, MOL CANCER RES, V9, P1187, DOI 10.1158/1541-7786.MCR-10-0437
   Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020
   Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849
   Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755
   Dammann R, 2000, NAT GENET, V25, P315
   Dammann R, 2003, HISTOL HISTOPATHOL, V18, P665, DOI 10.14670/HH-18.665
   Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389
   Engelhardt J, 2012, THEOR BIOSCI, V131, P49, DOI 10.1007/s12064-012-0151-6
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Fernandes MS, 2013, INT J CANCER, V132, P251, DOI 10.1002/ijc.27696
   Giovinazzi S, 2012, ONCOGENE, V31, P13, DOI 10.1038/onc.2011.211
   Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305
   Guil S, 2012, NAT STRUCT MOL BIOL, V19, P664, DOI 10.1038/nsmb.2315
   Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481
   Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398
   Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672
   Hoque MO, 2010, J THORAC ONCOL, V5, P1887, DOI 10.1097/JTO.0b013e3181f77a53
   Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298
   Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928
   Jiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036780
   Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341
   Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016
   Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106
   Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391
   Kurata A, 2008, CANCER SCI, V99, P1827, DOI 10.1111/j.1349-7006.2008.00874.x
   Lewis-Wambi JS, 2008, EUR J CANCER, V44, P1770, DOI 10.1016/j.ejca.2008.05.016
   Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009
   Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008
   Mattick JS, 2012, EMBO J, V31, P515, DOI 10.1038/emboj.2011.479
   Mondal T, 2010, GENOME RES, V20, P899, DOI 10.1101/gr.103473.109
   Moraes MCS, 2012, CANCER LETT, V314, P108, DOI 10.1016/j.canlet.2011.09.019
   Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43
   Palakurthy RK, 2009, MOL CELL, V36, P219, DOI 10.1016/j.molcel.2009.10.009
   Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022
   Pellegrini Matteo, 2008, BMC Cancer, V8, P264, DOI 10.1186/1471-2407-8-264
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209
   Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328
   Reis Eduardo M., 2012, Frontiers in Genetics, V3, P32, DOI 10.3389/fgene.2012.00032
   Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022
   Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902
   Sambrook J F, 2001, MOL CLONING LAB MANU
   Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621
   Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Uno F, 2004, CANCER RES, V64, P2969, DOI 10.1158/0008-5472.CAN-03-3702
   Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992
   Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756
   Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001
   Zhang XD, 2004, MOL CANCER THER, V3, P187
   Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011
NR 60
TC 113
Z9 115
U1 1
U2 31
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD AUG
PY 2013
VL 9
IS 8
AR e1003705
DI 10.1371/journal.pgen.1003705
PG 15
WC Genetics & Heredity
SC Genetics & Heredity
GA 210KB
UT WOS:000323830300055
PM 23990798
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Norris, BA
   Uebelhoer, LS
   Nakaya, HI
   Price, AA
   Grakoui, A
   Pulendran, B
AF Norris, Brian A.
   Uebelhoer, Luke S.
   Nakaya, Helder I.
   Price, Aryn A.
   Grakoui, Arash
   Pulendran, Bali
TI Chronic but Not Acute Virus Infection Induces Sustained Expansion of
   Myeloid Suppressor Cell Numbers that Inhibit Viral-Specific T Cell
   Immunity
SO IMMUNITY
LA English
DT Article
ID LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PLASMACYTOID DENDRITIC CELLS;
   ANTIGEN-PRESENTING CELLS; PERSISTENCE IN-VIVO; SUBSETS;
   IMMUNOSUPPRESSION; CD8(+); MICE; MONOCYTES; SYSTEM
AB Resolution of acute and chronic viral infections requires activation of innate cells to initiate and maintain adaptive immune responses. Here we report that infection with acute Armstrong (ARM) or chronic Clone 13 (C13) strains of lymphocytic choriomeningitis virus (LCMV) led to two distinct phases of innate immune response. During the first 72 hr of infection, dendritic cells upregulated activation markers and stimulated antiviral CD8(+) T cells, independent of viral strain. Seven days after infection, there was an increase in Ly6C(hi) monocytic and Gr-1(hi) neutrophilic cells in lymphoid organs and blood. This expansion in cell numbers was enhanced and sustained in C13 infection, whereas it occurred only transiently with ARM infection. These cells resembled myeloid-derived suppressor cells and potently suppressed T cell proliferation. The reduction of monocytic cells in Ccr2(-/-) mice or after Gr-1 antibody depletion enhanced antiviral T cell function. Thus, innate cells have an important immunomodulatory role throughout chronic infection.
C1 [Norris, Brian A.; Uebelhoer, Luke S.; Nakaya, Helder I.; Price, Aryn A.; Grakoui, Arash; Pulendran, Bali] Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA.
   [Norris, Brian A.; Uebelhoer, Luke S.; Nakaya, Helder I.; Price, Aryn A.; Grakoui, Arash; Pulendran, Bali] Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA.
   [Norris, Brian A.; Uebelhoer, Luke S.; Nakaya, Helder I.; Price, Aryn A.; Grakoui, Arash; Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
RP Pulendran, B (corresponding author), Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U54AI057157,
   R37AI48638, R37DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025,
   U19AI090023]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation; Yerkes Research Center Base Grant [RR-00165]; Public Health
   ServiceUnited States Public Health Service [DK083356, AI070101];
   NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R37AI048638, U19AI057266, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, U54AI057157, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   U19AI090023, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   R01AI070101, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, R37AI048638, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U19AI090023,
   R37AI048638, U19AI057266, U19AI090023, R01AI070101, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U19AI090023, U19AI090023,
   U19AI057266, U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, T32AI007610, T32AI007610,
   U19AI057266, U19AI090023, U54AI057157, R01AI070101, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, T32AI007610, U19AI090023, U19AI090023, T32AI007610,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   R01AI070101, U54AI057157, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, T32AI007610, U19AI057266, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, R01AI070101, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, U54AI057157,
   U54AI057157, U19AI090023, R37AI048638, R37AI048638, U19AI057266,
   N01AI050025, U54AI057157, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, R01AI070101, U19AI057266,
   U54AI057157, T32AI007610, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, T32AI007610, U54AI057157, U19AI090023, U19AI090023,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, T32AI007610, U19AI090023,
   U19AI090023, R01AI070101, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, R01AI070101, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, R37AI048638, U54AI057157,
   U19AI057266, U54AI057157, T32AI007610, U54AI057157, U19AI090023,
   U19AI090023, U19AI090023, R01AI070101, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, R01AI070101, U54AI057157,
   U54AI057157, U19AI057266, T32AI007610, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, T32AI007610, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, U54AI057157, U19AI057266, T32AI007610, T32AI007610,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, T32AI007610, U19AI057266,
   R37AI048638, R37AI048638, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, R37AI048638,
   U19AI057266, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, T32AI007610, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U54AI057157, U19AI090023, U54AI057157,
   U54AI057157, R37AI048638, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND
   KIDNEY DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37DK057665,
   R01DK083356, R01DK083356, R37DK057665, R37DK057665, R37DK057665,
   R01DK083356, R01DK083356, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665] Funding Source: NIH RePORTER
FX We gratefully acknowledge R. Ahmed for advice and discussion; B.
   Evavold, J. Jacob, and R. Napier for comments on the paper; B. Cervasi
   and K. Gill for outstanding help with myeloid cell sorting; and J.
   Connolly's core laboratory at the Baylor Institute (Dallas, TX) for
   luminex analysis. This work was supported by grants U54AI057157,
   R37AI48638, R37DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025,
   and U19AI090023 from the National Institutes of Health and a grant from
   the Bill & Melinda Gates Foundation. Additional support was provided by
   the Yerkes Research Center Base Grant RR-00165 and Public Health Service
   DK083356 and AI070101 (A.G.).
CR AHMED R, 1988, J VIROL, V62, P3301, DOI 10.1128/JVI.62.9.3301-3308.1988
   AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521
   Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Bergthaler A, 2010, P NATL ACAD SCI USA, V107, P21641, DOI 10.1073/pnas.1011998107
   BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995
   Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492
   Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0
   Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349
   Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247
   Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602
   den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685
   Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783
   Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203
   Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506
   Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828
   Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2
   Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299
   Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012
   Jung A, 2008, J VIROL, V82, P196, DOI 10.1128/JVI.01640-07
   Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591
   Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241
   Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989
   Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792
   Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06
   MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993
   Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935
   MELILLO G, 1994, J BIOL CHEM, V269, P8128
   Montoya M, 2005, J IMMUNOL, V174, P1851, DOI 10.4049/jimmunol.174.4.1851
   Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104
   Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106
   ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252
   Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036
   Ribechini E, 2009, EUR J IMMUNOL, V39, P3538, DOI 10.1002/eji.200939530
   Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326
   Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309
   Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249
   Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243
   Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727
   Smelt SC, 2001, J VIROL, V75, P448, DOI 10.1128/JVI.75.1.448-457.2001
   Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746
   Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015
   Voisin MB, 2004, INFECT IMMUN, V72, P5487, DOI 10.1128/IAI.72.9.5487-5492.2004
   Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889
   Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003
   Yang RC, 2006, CANCER RES, V66, P6807, DOI 10.1158/0008-5472.CAN-05-3755
   Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791
   Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205
   Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228
   Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016
NR 50
TC 70
Z9 72
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD FEB 21
PY 2013
VL 38
IS 2
BP 309
EP 321
DI 10.1016/j.immuni.2012.10.022
PG 13
WC Immunology
SC Immunology
GA AA2RC
UT WOS:000330940800013
PM 23438822
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT S
AU Varani, AM
   Monteiro-Vitorello, CB
   Nakaya, HI
   Van Sluys, MA
AF Varani, Alessandro M.
   Monteiro-Vitorello, Claudia Barros
   Nakaya, Helder I.
   Van Sluys, Marie-Anne
BE VanAlfen, NK
TI The Role of Prophage in Plant-Pathogenic Bacteria
SO ANNUAL REVIEW OF PHYTOPATHOLOGY, VOL 51
SE Annual Review of Phytopathology
LA English
DT Review; Book Chapter
DE mobile genetic elements; genome evolution; genome plasticity;
   bacteriophage; recombination; plant-pathogen interaction
ID HORIZONTAL GENE-TRANSFER; RESTRICTION-MODIFICATION SYSTEMS;
   RALSTONIA-SOLANACEARUM STRAINS; BURKHOLDERIA-CENOCEPACIA J2315; PROVIDES
   ACQUIRED-RESISTANCE; COMPLETE NUCLEOTIDE-SEQUENCE; COMPARATIVE GENOMIC
   ANALYSIS; PSEUDOMONAS-AERUGINOSA; VIRULENCE DETERMINANTS; EPIDEMIC
   PATHOGEN
AB A diverse set of phage lineages is associated with the bacterial plant-pathogen genomes sequenced to date. Analysis of 37 genomes revealed 5,169 potential genes (approximately 4.3 Mbp) of phage origin, and at least 50% had no function assigned or are nonessential to phage biology. Some phytopathogens have transcriptionally active prophage genes under conditions that mimic plant infection, suggesting an association between plant disease and prophage transcriptional modulation. The role of prophages within genomes for cell biology varies. For pathogens such as Pectobacterium, Pseudomonas, Ralstonia, and Streptomyces, involvement of prophage in disease symptoms has been demonstrated. In Xylella and Xanthomonas, prophage activity is associated with genome rearrangements and strain differentiation. For other pathogens, prophage roles are yet to be established. This review integrates available information in a unique interface (http://propnav.esalq.usp.br) that may be assessed to improve research in prophage biology and its association with genome evolution and pathogenicity.
C1 [Varani, Alessandro M.; Monteiro-Vitorello, Claudia Barros] Univ Sao Paulo, Dept Genet LGN, Escola Super Agr Luiz de Queiroz, BR-13418900 Piracicaba, SP, Brazil.
   [Nakaya, Helder I.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Van Sluys, Marie-Anne] Univ Sao Paulo, GaTE Lab, Dept Bot, Inst Biociencias, BR-05508090 Sao Paulo, Brazil.
   [Varani, Alessandro M.] UNESP Univ Estadual Paulista, Fac Ciencias Agr & Vet, Dept Tecnol, Jaboticabal, SP, Brazil.
RP Varani, AM (corresponding author), Univ Sao Paulo, Dept Genet LGN, Escola Super Agr Luiz de Queiroz, BR-13418900 Piracicaba, SP, Brazil.
EM mavsluys@usp.br
RI Monteiro-Vitorello, Claudia B/F-2436-2012; Nakaya, Helder I/A-1397-2010;
   Nakaya, Helder/AAF-1738-2020; de Mello Varani, Alessandro/AAH-5718-2019;
   Monteiro-Vitorello, Claudia Barros/ABG-5101-2020; Van Sluys,
   Marie-Anne/A-8483-2012; Varani, Alessandro M/F-6887-2011
OI Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; de Mello
   Varani, Alessandro/0000-0002-8876-3269; Monteiro-Vitorello, Claudia
   Barros/0000-0002-1238-9354; Van Sluys, Marie-Anne/0000-0002-6506-2734;
   Varani, Alessandro M/0000-0002-8876-3269
CR Addy HS, 2012, PHYTOPATHOLOGY, V102, P244, DOI 10.1094/PHYTO-10-11-0277
   Adriaenssens EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033227
   Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Balogh B, 2010, CURR PHARM BIOTECHNO, V11, P48, DOI 10.2174/138920110790725302
   Balogh B, 2008, PLANT DIS, V92, P1048, DOI 10.1094/PDIS-92-7-1048
   BALTCH AL, 1994, TOXICON, V32, P27, DOI 10.1016/0041-0101(94)90018-3
   Baltz RH, 2011, J IND MICROBIOL BIOT, V39, P661
   Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140
   Battle SE, 2009, FEMS MICROBIOL LETT, V290, P70, DOI 10.1111/j.1574-6968.2008.01406.x
   Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269
   Bentley SD, 2008, J BACTERIOL, V190, P2150, DOI 10.1128/JB.01598-07
   Bertolla F, 1997, APPL ENVIRON MICROB, V63, P4965, DOI 10.1128/AEM.63.12.4965-4968.1997
   Bignell DRD, 2010, MOL PLANT MICROBE IN, V23, P161, DOI 10.1094/MPMI-23-2-0161
   Binnewies Tim T., 2006, Functional & Integrative Genomics, V6, P165, DOI 10.1007/s10142-006-0027-2
   Born Y, 2011, APPL ENVIRON MICROB, V77, P5945, DOI 10.1128/AEM.03022-10
   Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209
   Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004
   Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100
   BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358
   Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x
   Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003
   Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x
   Ceyssens PJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-134
   Chaturvedi D, 2003, BIOCHEM BIOPH RES CO, V303, P884, DOI 10.1016/S0006-291X(03)00421-2
   Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-75
   CHENG XD, 1995, CURR OPIN STRUC BIOL, V5, P4, DOI 10.1016/0959-440X(95)80003-J
   CIVEROLO EL, 1974, PHYTOPATHOLOGY, V64, P1248, DOI 10.1094/Phyto-64-1248
   da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a
   Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123
   Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812
   Dreier J, 1997, MOL PLANT MICROBE IN, V10, P195, DOI 10.1094/MPMI.1997.10.2.195
   ECHANDI E, 1973, PHYTOPATHOLOGY, V63, P1398, DOI 10.1094/Phyto-63-1398
   EDLIN G, 1975, NATURE, V255, P735, DOI 10.1038/255735a0
   Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258
   Evans TJ, 2010, FEMS MICROBIOL LETT, V304, P195, DOI 10.1111/j.1574-6968.2010.01901.x
   EXPERT D, 1982, VIROLOGY, V121, P82, DOI 10.1016/0042-6822(82)90119-2
   Fang KC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-83
   Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102
   Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106
   Forde A, 1999, ANTON LEEUW INT J G, V76, P89, DOI 10.1023/A:1002027321171
   Frampton Rebekah A, 2012, Int J Microbiol, V2012, P326452, DOI 10.1155/2012/326452
   FREEMAN VJ, 1951, J BACTERIOL, V61, P675, DOI 10.1128/JB.61.6.675-688.1951
   Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235
   Fujiwara A, 2008, J BACTERIOL, V190, P143, DOI 10.1128/JB.01158-07
   Genin S, 2012, ANNU REV PHYTOPATHOL, V50, P67, DOI 10.1146/annurev-phyto-081211-173000
   Godfrey SAC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002010
   Goudie AD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-615
   Grenier AM, 2006, APPL ENVIRON MICROB, V72, P1956, DOI 10.1128/AEM.72.3.1956-1965.2006
   Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172
   Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06
   Guidot A, 2009, ISME J, V3, P549, DOI 10.1038/ismej.2009.14
   Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x
   Hamilton JP, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar053
   Hatfull GF, 2008, CURR OPIN MICROBIOL, V11, P447, DOI 10.1016/j.mib.2008.09.004
   HAYASHI T, 1994, FEMS MICROBIOL LETT, V122, P239, DOI 10.1016/0378-1097(94)00329-7
   Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157
   Hendrix RW, 1999, CURR BIOL, V9, pR914, DOI 10.1016/S0960-9822(00)80103-7
   Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08
   Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875
   Jacobs JM, 2012, MBIO, V3, DOI 10.1128/mBio.00114-12
   Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411
   Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x
   Kai T, 2009, PULM PHARMACOL THER, V22, P483, DOI 10.1016/j.pupt.2009.04.004
   Kenna DT, 2003, FEMS IMMUNOL MED MIC, V35, P87, DOI 10.1016/S0928-8244(02)00442-X
   Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x
   KIDAMBI SP, 1994, APPL ENVIRON MICROB, V60, P496, DOI 10.1128/AEM.60.2.496-500.1994
   Killiny N, 2009, P NATL ACAD SCI USA, V106, P22416, DOI 10.1073/pnas.0908562106
   Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7
   Kobayashi I, 1999, CURR OPIN GENET DEV, V9, P649, DOI 10.1016/S0959-437X(99)00026-X
   Koide T, 2004, J BACTERIOL, V186, P5442, DOI 10.1128/JB.186.16.5442-5449.2004
   Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10
   KUO TT, 1994, ARCH VIROL, V135, P253, DOI 10.1007/BF01310012
   KUO TT, 1991, NUCLEIC ACIDS RES, V19, P2498, DOI 10.1093/nar/19.9.2498
   Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001
   Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315
   Lan LF, 2006, MOL PLANT MICROBE IN, V19, P976, DOI 10.1094/MPMI-19-0976
   Lang AS, 2012, NAT REV MICROBIOL, V10, P472, DOI 10.1038/nrmicro2802
   Langley R, 2003, J MED MICROBIOL, V52, P483, DOI 10.1099/jmm.0.05099-0
   LENSKI RE, 1984, J THEOR BIOL, V108, P319, DOI 10.1016/S0022-5193(84)80035-1
   Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822
   Levin BR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001171
   Lim J, 2009, J BACTERIOL, V191, P3758, DOI 10.1128/JB.00349-09
   Lima-Mendez G, 2007, VIROLOGY, V365, P241, DOI 10.1016/j.virol.2007.03.047
   Lindeberg M, 2008, MOL PLANT MICROBE IN, V21, P685, DOI 10.1094/MPMI-21-6-0685
   Loria R, 2006, ANNU REV PHYTOPATHOL, V44, P469, DOI 10.1146/annurev.phyto.44.032905.091147
   Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x
   Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x
   Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x
   Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703
   Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105
   MATSUMOTO H, 1986, J GEN MICROBIOL, V132, P2583
   Mattinen L, 2008, MICROBIOL-SGM, V154, P2387, DOI 10.1099/mic.0.2008/017582-0
   McKenna F, 2002, LETT APPL MICROBIOL, V35, P107, DOI 10.1046/j.1472-765X.2002.01136.x
   Monteiro-Vitorello CB, 2005, OMICS, V9, P146, DOI 10.1089/omi.2005.9.146
   Monteiro-Vitorello CB, 2004, MOL PLANT MICROBE IN, V17, P827, DOI 10.1094/MPMI.2004.17.8.827
   Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113
   Murugaiyan S, 2011, J APPL MICROBIOL, V110, P296, DOI 10.1111/j.1365-2672.2010.04882.x
   Nagy JK, 2012, CENT EUR J BIOL, V7, P1, DOI 10.2478/s11535-011-0093-x
   Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x
   Nunes LR, 2003, GENOME RES, V13, P570, DOI 10.1101/gr.930803
   Nzula S, 2000, FEMS IMMUNOL MED MIC, V28, P307, DOI 10.1111/j.1574-695X.2000.tb01491.x
   O'Brien HE, 2011, ANNU REV PHYTOPATHOL, V49, P269, DOI 10.1146/annurev-phyto-072910-095242
   Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35
   Pemberton CL, 2005, MOL PLANT MICROBE IN, V18, P343, DOI 10.1094/MPMI-18-0343
   Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131
   Ravensdale M, 2007, CAN J PLANT PATHOL, V29, P121, DOI 10.1080/07060660709507448
   Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109
   Riley SA, 2002, J MAGN RESON, V159, P82, DOI 10.1016/S1090-7807(02)00004-6
   RITTER A, 1995, MOL MICROBIOL, V17, P109, DOI 10.1111/j.1365-2958.1995.mmi_17010109.x
   Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874
   Rocha EPC, 2001, GENOME RES, V11, P946, DOI 10.1101/gr.GR-1531RR
   Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004
   Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102
   Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0
   Schell MA, 2000, ANNU REV PHYTOPATHOL, V38, P263, DOI 10.1146/annurev.phyto.38.1.263
   Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10
   Semenova E, 2009, FEMS MICROBIOL LETT, V296, P110, DOI 10.1111/j.1574-6968.2009.01626.x
   Setubal JC, 2005, CURR OPIN MICROBIOL, V8, P595, DOI 10.1016/j.mib.2005.08.015
   Sharma N, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn298
   Shen K, 2006, INFECT IMMUN, V74, P5272, DOI 10.1128/IAI.00546-06
   SHINOMIYA T, 1989, J BACTERIOL, V171, P2287, DOI 10.1128/jb.171.5.2287-2292.1989
   Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x
   Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793
   Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053
   Summer EJ, 2010, J BACTERIOL, V192, P179, DOI 10.1128/JB.01174-09
   Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437
   Tampakaki AP, 2010, ANNU REV PHYTOPATHOL, V48, P347, DOI 10.1146/annurev-phyto-073009-114407
   Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444
   Toussaint A, 2012, METHODS MOL BIOL, V804, P57, DOI 10.1007/978-1-61779-361-5_4
   Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003
   Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559
   Varani AD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004059
   Varani AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r30
   VIDAVER AK, 1976, ANNU REV PHYTOPATHOL, V14, P451, DOI 10.1146/annurev.py.14.090176.002315
   Walcott RR, 2003, PHYTOPATHOLOGY, V93, P528, DOI 10.1094/PHYTO.2003.93.5.528
   Weir TL, 2008, APPL ENVIRON MICROB, V74, P5784, DOI 10.1128/AEM.00860-08
   Wicker E, 2007, APPL ENVIRON MICROB, V73, P6790, DOI 10.1128/AEM.00841-07
   WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101
   Wittmann Johannes, 2011, Bacteriophage, V1, P6, DOI 10.4161/bact.1.1.13873
   Wittmann J, 2010, MICROBIOL-SGM, V156, P2366, DOI 10.1099/mic.0.037291-0
   Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100
   Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000
   Woods DE, 2004, TRENDS MICROBIOL, V12, P437, DOI 10.1016/j.tim.2004.08.003
   Yamada T, 2007, MICROBIOL-SGM, V153, P2630, DOI 10.1099/mic.0.2006/001453-0
   Yoder-Himes DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008724
NR 150
TC 35
Z9 35
U1 5
U2 63
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0066-4286
EI 1545-2107
BN 978-0-8243-1351-7
J9 ANNU REV PHYTOPATHOL
JI Annu. Rev. Phytopathol.
PY 2013
VL 51
BP 429
EP +
DI 10.1146/annurev-phyto-081211-173010
PG 27
WC Plant Sciences
SC Plant Sciences
GA BGR36
UT WOS:000323889000020
PM 23725471
DA 2020-12-17
ER

PT S
AU Duraisingham, SS
   Rouphael, N
   Cavanagh, MM
   Nakaya, HI
   Goronzy, JJ
   Pulendran, B
AF Duraisingham, Sai S.
   Rouphael, Nadine
   Cavanagh, Mary M.
   Nakaya, Helder I.
   Goronzy, Jorg J.
   Pulendran, Bali
BE Katze, MG
TI Systems Biology of Vaccination in the Elderly
SO SYSTEMS BIOLOGY
SE Current Topics in Microbiology and Immunology
LA English
DT Review; Book Chapter
ID YELLOW-FEVER VACCINE; PNEUMOCOCCAL POLYSACCHARIDE VACCINE;
   HEPATITIS-B-VACCINE; TETANUS-ACELLULAR PERTUSSIS;
   VARICELLA-ZOSTER-VIRUS; T-CELL RESPONSES; INFLUENZA VACCINE;
   IMMUNE-RESPONSES; OLDER-ADULTS; STREPTOCOCCUS-PNEUMONIAE
AB Aging population demographics, combined with suboptimal vaccine responses in the elderly, make the improvement of vaccination strategies in the elderly a developing public health issue. The immune system changes with age, with innate and adaptive cell components becoming increasingly dysfunctional. As such, vaccine responses in the elderly are impaired in ways that differ depending on the type of vaccine (e. g., live attenuated, polysaccharide, conjugate, or subunit) and the mediators of protection (e. g., antibody and/or T cell). The rapidly progressing field of systems biology has been shown to be useful in predicting immunogenicity and offering insights into potential mechanisms of protection in young adults. Future application of systems biology to vaccination in the elderly may help to identify gene signatures that predict suboptimal responses and help to identify more accurate correlates of protection. Moreover, the identification of specific defects may be used to target novel vaccination strategies that improve efficacy in elderly populations.
C1 [Duraisingham, Sai S.; Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Rouphael, Nadine] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30329 USA.
   [Cavanagh, Mary M.; Goronzy, Jorg J.] Stanford Univ, Dept Med, Stanford, CA 94305 USA.
   [Goronzy, Jorg J.] Palo Alto Vet Adm Hlth Care Syst, Dept Med, Palo Alto, CA 94304 USA.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Rouphael, Nadine/0000-0002-2512-7919
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI057266, U54AI057157, U19AI057266, U19AI090019, U19AI090019,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, R37AI048638, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI090019, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U19AI090019, U54AI057157,
   U54AI057157, U54AI057157, U19AI090019, U19AI090023, U19AI090023,
   U19AI090023, U19AI057266, U19AI090019, U19AI090019, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U19AI090023, U19AI090023,
   U19AI090019, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, U54AI057157,
   U19AI090023, U54AI057157, U19AI090019, U54AI057157, U54AI057157,
   U19AI090023, U54AI057157, R37AI048638, U19AI057266, U19AI057266,
   U19AI090023, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI090019, U19AI090019,
   U19AI090023, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI090019, U19AI090023, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, R37AI048638, U54AI057157, U19AI057266,
   U19AI090019, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI090019, U19AI057266, U19AI090019, U19AI090023, R37AI048638,
   U19AI090023, U54AI057157, U19AI057266, U54AI057157, U19AI090019,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U19AI090019, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, U19AI090019, U19AI090023, U19AI090023, U54AI057157,
   U54AI057157, U54AI057157, U19AI090019, U54AI057157, U19AI090023,
   U19AI057266, U19AI090023, U54AI057157, U19AI057266, U19AI090019,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U19AI057266, U19AI090023, U19AI090019, U19AI090023,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI090019, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI090019, U19AI090019, U54AI057157,
   U19AI090019, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI090019, U19AI090019, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI090019, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   R37AI048638, U19AI090019, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U19AI090019, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U19AI090019,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI090019, R37AI048638,
   U19AI057266, U54AI057157, U19AI090019, U19AI090019, U54AI057157,
   U19AI057266, R37AI048638, U19AI057266, U19AI090023, U19AI057266,
   U54AI057157, U19AI090023, U19AI090019, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI090019, U19AI057266, U19AI090019,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI090019, U19AI090019, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U19AI090023, U54AI057157, U19AI090019,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI090019, U54AI057157, U19AI090023,
   U54AI057157, U19AI090023, U19AI090019, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057157,
   U19AI090023, U19AI090019, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U19AI090019, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U19AI090023, U19AI090019, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U19AI090019, U54AI057157,
   U54AI057157, R37AI048638, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   U19AI090019, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, R37AI048638, U19AI057266, U54AI057157, R37AI048638,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI090019,
   U54AI057157, U19AI057266, U19AI057266, R37AI048638, U19AI057266,
   U19AI057266, U19AI090023, U19AI090019, U19AI057266, N01AI050025,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI090019, U19AI057266, U19AI090019, U19AI057266, U54AI057157,
   U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R37AI48638, U19
   AI090019, U19 AI057266, U19AI090023, U19AI057266, N01AI50025,
   U54AI057157] Funding Source: Medline; NIDDK NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK) [R37DK057665] Funding Source: Medline; PHS HHSUnited States
   Public Health Service [HHSN266200700006C] Funding Source: Medline
CR Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108
   Ademokun A, 2010, BIOGERONTOLOGY, V11, P125, DOI 10.1007/s10522-009-9256-9
   Ageing W.P., 2002, WORLD POP AG 1950 20, V26, P11
   Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896
   Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912
   Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091
   Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535
   Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704
   Cavanagh MM, 2011, AGING DIS, V2, P398
   Chapman RS, 2003, VACCINE, V21, P2541, DOI 10.1016/S0264-410X(03)00034-3
   Chen WH, 2011, VACCINE, V29, P2865, DOI 10.1016/j.vaccine.2011.02.017
   Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212
   Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042
   Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002
   de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142
   Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012
   den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006
   Eidex RB, 2004, LANCET, V364, P936, DOI 10.1016/S0140-6736(04)17017-7
   Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020
   Feng JQ, 2009, VACCINE, V27, P6358, DOI 10.1016/j.vaccine.2009.06.090
   Finlay D, 2011, NAT REV IMMUNOL, V11, P109, DOI 10.1038/nri2888
   Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283
   Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123
   Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023
   Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x
   Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105
   Goronzy J. J., 2012, SEMIN IMMUN IN PRESS
   GUCKIAN JC, 1980, J INFECT DIS, V142, P175, DOI 10.1093/infdis/142.2.175
   Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075
   Hirota Y, 1997, VACCINE, V15, P962, DOI 10.1016/S0264-410X(96)00302-7
   Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466
   Honda M, 2001, CLIN IMMUNOL, V99, P211, DOI 10.1006/clim.2001.5023
   Hutchins WA, 1999, J INFECT DIS, V179, P1433, DOI 10.1086/314750
   Ikematsu H, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18469
   Jackson LA, 2007, VACCINE, V25, P4029, DOI 10.1016/j.vaccine.2007.02.062
   Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005
   Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5
   Johnson SE, 1999, J INFECT DIS, V180, P133, DOI 10.1086/314845
   Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325
   Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089
   Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254
   Kolibab K, 2005, INFECT IMMUN, V73, P7465, DOI 10.1128/IAI.73.11.7465-7476.2005
   Lee WW, 2008, REJUV RES, V11, P1001, DOI 10.1089/rej.2008.0747
   Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008
   Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009
   Longo DM, 2012, J IMMUNOL, V188, P1717, DOI 10.4049/jimmunol.1102514
   Martin M, 2001, EMERG INFECT DIS, V7, P945, DOI 10.3201/eid0706.010605
   Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956
   McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333
   McKenna RW, 2001, BLOOD, V98, P2498, DOI 10.1182/blood.V98.8.2498
   MCMAHON BJ, 1995, J INFECT DIS, V171, P676, DOI 10.1093/infdis/171.3.676
   MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103
   Melegaro A, 2004, EUR J EPIDEMIOL, V19, P353, DOI 10.1023/B:EJEP.0000024701.94769.98
   MILLER RA, 1987, J CELL PHYSIOL, V132, P337, DOI 10.1002/jcp.1041320220
   Monath TP, 2005, HUM VACCINES, V1, P207, DOI 10.4161/hv.1.5.2221
   Musher DM, 2000, J INFECT DIS, V182, P158, DOI 10.1086/315697
   Nakaya HI, 2012, WIRES SYST BIOL MED, V4, P193, DOI 10.1002/wsbm.163
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446
   Nikolich-Zugich J, 2012, SEMIN IMMUN IN PRESS
   Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102
   Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8
   O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014
   Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3
   Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X
   Ouyang Qin, 2003, Experimental Gerontology, V38, P911, DOI 10.1016/S0531-5565(03)00134-7
   Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016
   PALACHE AM, 1993, VACCINE, V11, P892, DOI 10.1016/0264-410X(93)90375-8
   Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022
   Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108
   Park S, 2011, INFECT IMMUN, V79, P314, DOI 10.1128/IAI.00768-10
   Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097
   Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Reuman PD, 1997, VACCINE, V15, P1157, DOI 10.1016/S0264-410X(96)00310-6
   Rogers PR, 1999, J IMMUNOL, V163, P1205
   Romero-Steiner S, 1999, CLIN INFECT DIS, V29, P281, DOI 10.1086/520200
   Rossi MID, 2003, BLOOD, V101, P576, DOI 10.1182/blood-2002-03-0896
   Roukens AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027753
   Rubins JB, 1998, J INFECT DIS, V178, P431, DOI 10.1086/515644
   Rudd BD, 2011, P NATL ACAD SCI USA, V108, P13694, DOI 10.1073/pnas.1107594108
   Sablan BP, 2012, VACCINE, V30, P2689, DOI 10.1016/j.vaccine.2012.02.001
   Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834
   Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975
   Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269
   Schenkein JG, 2008, VACCINE, V26, P5521, DOI 10.1016/j.vaccine.2008.07.071
   SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101
   Shi YH, 2005, J IMMUNOL, V175, P3262, DOI 10.4049/jimmunol.175.5.3262
   Snelgrove RJ, 2012, J INFECT DIS, V205, P975, DOI 10.1093/infdis/jir868
   Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Stiasny K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034145
   Tarazona R, 2000, MECH AGEING DEV, V121, P77
   Theeten H, 2007, CURR MED RES OPIN, V23, P2729, DOI 10.1185/03007X233034
   Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057
   Tohme RA, 2011, VACCINE, V29, P9316, DOI 10.1016/j.vaccine.2011.10.011
   Torling J, 2003, VACCINE, V22, P96, DOI 10.1016/S0264-410X(03)00521-8
   Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271
   Van Damme P, 2004, VACCINE, V22, P305, DOI 10.1016/j.vaccine.2003.08.012
   VAZIRI H, 1993, AM J HUM GENET, V52, P661
   Vermeulen JN, 2012, VACCINE, V30, P904, DOI 10.1016/j.vaccine.2011.11.096
   Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657
   Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023698
   Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040
   Weinberg A, 2009, J INFECT DIS, V200, P1068, DOI 10.1086/605611
   West DJ, 1996, VACCINE, V14, P1019, DOI 10.1016/0264-410X(96)00062-X
   Weston WM, 2012, VACCINE, V30, P1721, DOI 10.1016/j.vaccine.2011.12.055
   Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135
   Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612
   Wolters B, 2003, VACCINE, V21, P3623, DOI 10.1016/S0264-410X(03)00399-2
   Xu J, 2005, J BIOL CHEM, V280, P24277, DOI 10.1074/jbc.M500727200
   Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140
   Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109
NR 117
TC 24
Z9 25
U1 0
U2 5
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
EI 2196-9965
BN 978-3-642-33099-5; 978-3-642-33098-8
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2013
VL 363
BP 117
EP 142
DI 10.1007/82_2012_250
D2 10.1007/978-3-642-33099-5
PG 26
WC Mathematical & Computational Biology; Immunology; Microbiology
SC Mathematical & Computational Biology; Immunology; Microbiology
GA BJU56
UT WOS:000330590200008
PM 22903566
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Gardner, J
   Poo, YS
   Major, L
   Pulendran, B
   Suhrbier, A
AF Nakaya, Helder I.
   Gardner, Joy
   Poo, Yee-Suan
   Major, Lee
   Pulendran, Bali
   Suhrbier, Andreas
TI Gene profiling of chikungunya virus arthritis in a mouse model reveals
   significant overlap with rheumatoid arthritis
SO ARTHRITIS AND RHEUMATISM
LA English
DT Article
ID ROSS-RIVER-VIRUS; ALPHAVIRAL ARTHRITIS; INNATE IMMUNITY; ACUTE-PHASE;
   INFECTION; MICE; MYOSITIS; DISEASE; THERAPY; CELLS
AB Objective Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that causes a chronic debilitating polyarthralgia/polyarthritis, for which current treatments are often inadequate. To assess whether new drugs being developed for rheumatoid arthritis (RA) might find utility in the treatment of alphaviral arthritides, we sought to determine whether the inflammatory gene expression signature of CHIKV arthritis shows any similarities with RA or collagen-induced arthritis (CIA), a mouse model of RA.
   Methods Using a recently developed animal model of CHIKV arthritis in adult wild-type mice, we generated a consensus CHIKV arthritis gene expression signature, which was used to interrogate publicly available microarray studies of RA and CIA. Pathway analyses were then performed using the overlapping gene signatures.
   Results Gene set enrichment analysis showed that there was a highly significant overlap in the differentially expressed genes in the CHIKV arthritis model and in RA. This concordance also increased with the severity of RA, as measured by the inflammation score. A highly significant overlap was also seen between CHIKV arthritis and CIA. Pathway analysis revealed that the overlap between these arthritides was spread over a range of different inflammatory processes. Involvement of T cells and interferon-gamma (IFN gamma) in CHIKV arthritis was confirmed in studies of MHCII-deficient mice and IFN gamma-deficient mice, respectively.
   Conclusion These results suggest that RA, a chronic autoimmune arthritis, and CHIKV disease, usually a self-limiting viral arthropathy, share multiple inflammatory processes. New drugs and biologic therapies being developed for RA may thus find application in the treatment of alphaviral arthritides.
C1 [Gardner, Joy; Poo, Yee-Suan; Major, Lee; Suhrbier, Andreas] Univ Queensland, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.
   [Gardner, Joy; Poo, Yee-Suan; Major, Lee; Suhrbier, Andreas] Australian Ctr Vaccine Dev, Brisbane, Qld, Australia.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Atlanta, GA 30322 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA USA.
RP Suhrbier, A (corresponding author), Univ Queensland, Queensland Inst Med Res, PO Royal Brisbane Hosp, Brisbane, Qld 4029, Australia.
EM andreasS@qimr.edu.au
RI Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108
FU International Alliance Program of the Government of Queensland;
   Australian Centre for Vaccine Development; NATIONAL CENTER FOR RESEARCH
   RESOURCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165, P51RR000165, P51RR000165, P51RR000165, P51RR000165,
   P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R37AI048638, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, R37AI048638, U19AI090023, U19AI090023, R37AI048638,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, R37AI048638, R37AI048638, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, R37AI048638,
   R37AI048638, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, R37AI048638, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, R37AI048638, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, R37AI048638, U19AI090023,
   R37AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665] Funding
   Source: NIH RePORTER
FX Supported by a grant from the International Alliance Program of the
   Government of Queensland for collaboration between the Australian Centre
   for Vaccine Development and Emory Vaccine Center. Dr. Nakaya was
   recipient of a travel award from the Australian Centre for Vaccine
   Development.
CR Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6
   Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005
   Buch MH, 2011, CURR OPIN RHEUMATOL, V23, P245, DOI 10.1097/BOR.0b013e3283454124
   Chao CC, 2011, AUTOIMMUNITY, V44, P243, DOI 10.3109/08916934.2010.517815
   Chopra A, 2008, ARTHRITIS RHEUM, V58, P2921, DOI 10.1002/art.23753
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Bonilla-Hernan MG, 2011, RHEUMATOLOGY, V50, P1542, DOI 10.1093/rheumatology/ker192
   Geurts J, 2009, MOL THER, V17, P1877, DOI 10.1038/mt.2009.182
   Gorchakov R, 2005, J VIROL, V79, P9397, DOI 10.1128/JVI.79.15.9397-9409.2005
   Hammamieh R, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-82
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lebre MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021772
   Lidbury BA, 2000, J INFECT DIS, V181, P27, DOI 10.1086/315164
   Lidbury BA, 2008, J INFECT DIS, V197, P1585, DOI 10.1086/587841
   Ling ZQ, 2010, BIOINFORMATICS, V26, P1431, DOI 10.1093/bioinformatics/btq163
   Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338
   Martinez-Lostao L, 2010, ARTHRITIS RHEUM-US, V62, P2272, DOI 10.1002/art.27501
   Morrison TE, 2006, J VIROL, V80, P737, DOI 10.1128/JVI.80.2.737-749.2006
   Morrison TE, 2008, J VIROL, V82, P11263, DOI 10.1128/JVI.01352-08
   Mylonas AD, 2004, JCR-J CLIN RHEUMATOL, V10, P326, DOI 10.1097/01.rhu.0000147052.11190.36
   Mylonas AD, 2002, MED J AUSTRALIA, V177, P356, DOI 10.5694/j.1326-5377.2002.tb04837.x
   Nasonova VA, 2008, TERAPEVT ARKH, V80, P30
   Padmakumar B, 2010, SE ASIAN J TROP MED, V41, P85
   Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Rulli NE, 2011, J INFECT DIS, V204, P1026, DOI 10.1093/infdis/jir470
   Scheinecker C, 2011, NAT REV RHEUMATOL, V7, P73, DOI 10.1038/nrrheum.2010.226
   SEAY AR, 1981, NEUROLOGY, V31, P656, DOI 10.1212/WNL.31.6.656
   Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2
   Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445
   Sozzani S, 2010, AUTOIMMUNITY, V43, P196, DOI 10.3109/08916930903510872
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suhrbier A, 2004, CURR OPIN RHEUMATOL, V16, P374, DOI 10.1097/01.bor.0000130537.76808.26
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Suhrbier A, 2009, PHARMACOL THERAPEUT, V124, P301, DOI 10.1016/j.pharmthera.2009.09.005
   Tak PP, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3096, 10.1186/1478-6354-13-S1-S5]
   Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010
   Warter L, 2011, J IMMUNOL, V186, P3258, DOI 10.4049/jimmunol.1003139
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014
   Yamada H, 2011, J RHEUMATOL, V38, P1569, DOI 10.3899/jrheum.101355
   Zaid A, 2011, ARTHRITIS RHEUM-US, V63, P488, DOI 10.1002/art.30112
NR 50
TC 73
Z9 74
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0004-3591
EI 1529-0131
J9 ARTHRITIS RHEUM-US
JI Arthritis Rheum.
PD NOV
PY 2012
VL 64
IS 11
BP 3553
EP 3563
DI 10.1002/art.34631
PG 11
WC Rheumatology
SC Rheumatology
GA 030CC
UT WOS:000310544500009
PM 22833339
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Jones, CL
   Sampson, TR
   Nakaya, HI
   Pulendran, B
   Weiss, DS
AF Jones, Crystal L.
   Sampson, Timothy R.
   Nakaya, Helder I.
   Pulendran, Bali
   Weiss, David S.
TI Repression of bacterial lipoprotein production by Francisella novicida
   facilitates evasion of innate immune recognition
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID LIVE VACCINE STRAIN; TOLL-LIKE RECEPTORS; TULARENSIS SCHU S4;
   BORRELIA-BURGDORFERI; MURINE MACROPHAGES; HOST-DEFENSE; IFN-GAMMA;
   INFECTION; VIRULENCE; IDENTIFICATION
AB Innate recognition systems, including the Toll-like receptors (TLRs), play a critical role in activating host defences and proinflammatory pathways in response to infection. Pathogens have developed strategies to subvert TLRs in order to survive and replicate within the host. The model intracellular pathogen, Francisella novicida, modulates host defences to promote survival and replication in macrophages. TLR2, which recognizes bacterial lipoproteins (BLPs), is critical for activating host defences and proinflammatory cytokine production in response to Francisella infection. Here we show that the F.?novicida protein FTN_0757 acts to repress BLP production, dampening TLR2 activation. The ?FTN_0757 mutant strain induced robust TLR2-dependent cytokine production in macrophages compared with wild-type bacteria, and produced increased amounts of BLPs. The deletion of one BLP (FTN_1103) from ?FTN_0757 decreased the total BLP concentration to near wild-type level sand correlated with a decrease in the inductionof TLR2 signalling. The overproduction of BLPs also contributed to the in vivo attenuation of the ?FTN_0757 mutant, which was significantly rescued when FTN_1103 was deleted. Taken together, these data reveal a novel mechanism of immune evasion by the downregulation of BLP expression to subvert TLR2 activation, which is likely used by numerous other intracellular bacterial pathogens.
C1 [Jones, Crystal L.; Sampson, Timothy R.; Nakaya, Helder I.; Pulendran, Bali; Weiss, David S.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Jones, Crystal L.; Sampson, Timothy R.] Emory Univ, Microbiol & Mol Genet Program, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Jones, Crystal L.; Sampson, Timothy R.; Nakaya, Helder I.; Pulendran, Bali; Weiss, David S.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
   [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Weiss, David S.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
RP Weiss, DS (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
EM david.weiss@emory.edu
RI Sampson, Tim/B-9061-2013; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Sampson, Timothy/0000-0002-2486-8766
FU NIH from the Southeastern Regional Center of Excellence for Emerging
   Infections and Biodefense [U54 AI057157]; National Science Foundation
   Graduate Research FellowshipNational Science Foundation (NSF); ARCS
   Foundation; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt
   Digestive Disease Center [P30 DK58404]; Vanderbilt Vision Center [P30
   EY08126]; NIH/NCRRUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [G20 RR030956]; Proteomics Core of the Emory
   Neuroscience NINDS Core Facilities grant [P30NS055077]; NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485,
   P30CA068485, P30CA068485, P30CA068485, P30CA068485, P30CA068485] Funding
   Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [G20RR030956] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Eye Institute (NEI) [P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126,
   P30EY008126, P30EY008126, P30EY008126, P30EY008126, P30EY008126] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R56AI087673, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404, P30DK058404, P30DK058404, P30DK058404, P30DK058404,
   P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077, P30NS055077, P30NS055077,
   P30NS055077, P30NS055077, P30NS055077] Funding Source: NIH RePORTER
FX We thank Brooke Napier and Dr Thomas Henry for critical reading of this
   manuscript. The project described was supported by NIH Grant #U54
   AI057157 from the Southeastern Regional Center of Excellence for
   Emerging Infections and Biodefense. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the NIH. This research was also supported by the
   National Science Foundation Graduate Research Fellowship (C. L. J. and
   T. R. S.), as well as the ARCS Foundation (T. R. S.). We are grateful to
   the Vanderbilt Genome Sciences Resource which is supported by the
   Vanderbilt Ingram Cancer Center (P30 CA68485), the Vanderbilt Digestive
   Disease Center (P30 DK58404), the Vanderbilt Vision Center (P30 EY08126)
   and NIH/NCRR (G20 RR030956), for microarray processing. The Resource
   collaborates with the Computational Genomics Core of the Center Human
   Genetic Research and the Center for Quantitative Sciences. We thank the
   Emory Proteomics Core, which is supported in part by the Proteomics Core
   of the Emory Neuroscience NINDS Core Facilities grant (P30NS055077). The
   authors declare no conflicts of interest.
CR Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736
   Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102
   ANTHONY LSD, 1991, J GEN MICROBIOL, V137, P2697, DOI 10.1099/00221287-137-12-2697
   ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991
   Bagos PG, 2008, J PROTEOME RES, V7, P5082, DOI 10.1021/pr800162c
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06
   Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06
   Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888
   De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08
   Dickinson GS, 2010, INFECT IMMUN, V78, P4579, DOI 10.1128/IAI.00438-10
   Embers ME, 2008, INFECT IMMUN, V76, P3984, DOI 10.1128/IAI.00387-08
   FOLLETT EAC, 1963, J GEN MICROBIOL, V32, P235, DOI 10.1099/00221287-32-2-235
   Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08
   Gozal YM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-82
   Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   JONES JD, 1995, INFECT IMMUN, V63, P2424, DOI 10.1128/IAI.63.7.2424-2434.1995
   Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463
   Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024
   Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002
   Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08
   Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062
   Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294
   Liang FT, 2002, J EXP MED, V195, P415, DOI 10.1084/jem.20011870
   Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541
   Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004
   Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05
   Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998
   Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743
   Parsa KVL, 2008, MOL IMMUNOL, V45, P3428, DOI 10.1016/j.molimm.2008.04.006
   Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x
   Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200
   Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102
   Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021
   Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x
   Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08
   SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779
   Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779
   Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06
   Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149
   Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x
   Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200
   Vidal V, 1998, NAT MED, V4, P1416, DOI 10.1038/4007
   Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104
   Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104
   Winter SE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001060
   Yoon SS, 2008, INFECT IMMUN, V76, P1282, DOI 10.1128/IAI.00736-07
NR 51
TC 24
Z9 24
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
J9 CELL MICROBIOL
JI Cell Microbiol.
PD OCT
PY 2012
VL 14
IS 10
BP 1531
EP 1543
DI 10.1111/j.1462-5822.2012.01816.x
PG 13
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 007IF
UT WOS:000308881300004
PM 22632124
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Kwissa, M
   Nakaya, HI
   Oluoch, H
   Pulendran, B
AF Kwissa, Marcin
   Nakaya, Helder I.
   Oluoch, Herold
   Pulendran, Bali
TI Distinct TLR adjuvants differentially stimulate systemic and local
   innate immune responses in nonhuman primates
SO BLOOD
LA English
DT Article
ID PATTERN-RECOGNITION RECEPTORS; YELLOW-FEVER VACCINE; T-CELL RESPONSES;
   DENDRITIC CELLS; AGONIST; IMMUNIZATION; MAGNITUDE; NEUTROPHILS;
   INFLUENZA; MONOCYTES
AB TLR ligands (TLR-Ls) represent novel vaccine adjuvants, but their immunologic effects in humans remain poorly defined in vivo. In the present study, we analyzed the innate responses stimulated by different TLR-Ls in rhesus macaques. MPL (TLR4-L), R-848 (TLR7/8-L), or cytosine-phosphate-guanine oligodeoxynucleotide (TLR9-L) induced a rapid and robust expansion of blood neutrophils, with a concomitant reduction in PBMCs. Furthermore, all TLR-Ls induced rapid (3-8 hours) expansion of CD14(+) monocytes, but only TLR7/8-L and TLR9-L mobilized the CD14(+) CD16(+) and CD14(dim)CD16(++) monocytes, and only TLR7/8-L and TLR9-L induced activation of myeloid dendritic cells (mDCs) and plasmacytoid DCs (pDCs), production of IP-10 and type-I IFN, and expression of type-I IFN-related and chemokine genes in the blood. In the draining lymph nodes (LNs), consistent with the effects in blood, all TLR-Ls induced expansion of CD14(+) monocytes, but only TLR7/8-L and TLR9-L expanded the activated CD14(+)CD16(+) cells. TLR4-L and TLR9-L differentially induced the expansion of mDCs and pDCs (1-3 days), but did not activate DCs. In contrast, TLR7/8-L did not induce DC expansion, but did activate mDCs. Finally, both TLR9-L and TLR7/8-L induced the expression of genes related to chemokines and type-I IFNs in LNs. Thus different TLR-Ls mediate distinct signatures of early innate responses both locally and systemically. (Blood. 2012; 119(9): 2044-2055)
C1 [Kwissa, Marcin; Nakaya, Helder I.; Oluoch, Herold; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Kwissa, Marcin; Nakaya, Helder I.; Oluoch, Herold; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30329 USA.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5U19 AI057266-05,
   1P01AI096187-01]; Bill and Melinda Gates Foundation (Fred Hutchinson
   Cancer Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI096187,
   U19AI057266, U19AI057266, U19AI057266, U19AI096187, U19AI057266,
   U19AI096187, U19AI096187, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI096187, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI096187, U19AI096187, U19AI096187,
   U19AI096187, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI096187, U19AI057266, U19AI057266, U19AI096187, U19AI057266,
   U19AI057266, U19AI096187, U19AI057266, U19AI096187, U19AI057266,
   U19AI096187, U19AI057266, U19AI057266, U19AI096187, U19AI096187,
   U19AI057266, U19AI057266, U19AI096187, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI096187, U19AI057266, U19AI096187,
   U19AI096187, U19AI096187, U19AI057266, U19AI096187, U19AI096187,
   U19AI096187, U19AI057266, U19AI096187, U19AI057266, U19AI096187,
   U19AI096187, U19AI096187, U19AI057266, U19AI096187, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI096187, U19AI057266, U19AI057266, U19AI096187,
   U19AI057266, U19AI057266, U19AI096187, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI096187, U19AI057266, U19AI057266, U19AI057266,
   U19AI096187, U19AI057266, U19AI096187, U19AI057266, U19AI096187,
   U19AI057266, U19AI057266, U19AI096187, U19AI096187, U19AI096187,
   U19AI057266, U19AI057266, U19AI096187, U19AI057266, U19AI096187,
   U19AI057266, U19AI057266, U19AI096187, U19AI057266, U19AI096187,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI096187, U19AI096187, U19AI096187, U19AI096187,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI096187, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI096187, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI096187] Funding Source: NIH RePORTER
FX This study was supported by grants from the National Institutes of
   Health (grants 5U19 AI057266-05 and 1P01AI096187-01) and the Bill and
   Melinda Gates Foundation (subcontract from the Fred Hutchinson Cancer
   Institute).
CR Ahmed SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002302
   Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348
   Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/ERV.10.174, 10.1586/erv.10.174]
   Bogunovic D, 2011, CANCER RES, V71, P5467, DOI 10.1158/0008-5472.CAN-10-3988
   Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011
   Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333
   Crane MJ, 2009, J IMMUNOL, V183, P2810, DOI 10.4049/jimmunol.0900205
   Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012
   Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474
   Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]
   Gnjatic S, 2010, CANCER J, V16, P382, DOI 10.1097/PPO.0b013e3181eaca65
   Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001
   Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028
   Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140
   Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863
   Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416
   Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336
   Klaschik S, 2009, J LEUKOCYTE BIOL, V85, P788, DOI 10.1189/jlb.1008671
   Kwissa M, 2007, J EXP MED, V204, P2733, DOI 10.1084/jem.20071211
   Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963
   Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004
   Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   O'Hagan DT, 2011, EXPERT REV VACCINES, V10, P447, DOI [10.1586/ERV.11.23, 10.1586/erv.11.23]
   Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6
   Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006
   Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304
   Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326
   Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Tomai MA, 2011, EXPERT REV VACCINES, V10, P405, DOI [10.1586/ERV.11.26, 10.1586/erv.11.26]
   Tritto E, 2009, VACCINE, V27, P3331, DOI 10.1016/j.vaccine.2009.01.084
   Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135
   Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102
   Wille-Reece U, 2005, J IMMUNOL, V174, P7676, DOI 10.4049/jimmunol.174.12.7676
   Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433
   Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355
   Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827
   Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558
NR 51
TC 82
Z9 85
U1 0
U2 13
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD MAR 1
PY 2012
VL 119
IS 9
BP 2044
EP 2055
DI 10.1182/blood-2011-10-388579
PG 12
WC Hematology
SC Hematology
GA 901GA
UT WOS:000300949500014
PM 22246032
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Li, SZ
   Pulendran, B
AF Nakaya, Helder I.
   Li, Shuzhao
   Pulendran, Bali
TI Systems vaccinology: learning to compute the behavior of vaccine induced
   immunity
SO WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE
LA English
DT Article
ID YELLOW-FEVER VACCINE; GENE-EXPRESSION PATTERNS; MICROARRAY DATA;
   MOLECULAR NETWORKS; INNATE IMMUNITY; SET ANALYSIS; CLASSIFICATION;
   VIRUS; BIOLOGY; TOOL
AB The goal of systems biology is to access and integrate information about the parts (e.g., genes, proteins, cells) of a biological system with a view to computing and predicting the behavior of the system. The past decade has witnessed technological revolutions in the capacity to make high throughput measurements about the behavior of genes, proteins, and cells. Such technologies are widely used in biological research and in medicine, such as toward prognosis and therapy response prediction in cancer patients. More recently, systems biology is being applied to vaccinology, with the goal of: (1) understanding the mechanisms by which vaccines stimulate protective immunity, and (2) predicting the immunogenicity or efficacy of vaccines. Here, we review the recent advances in this area, and highlight the biological and computational challenges posed. WIREs Syst Biol Med 2012, 4:193205. doi: 10.1002/wsbm.163
C1 [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Nakaya, Helder I.; Li, Shuzhao] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA USA.
RP Pulendran, B (corresponding author), Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
EM bpulend@emory.edu
RI Nakaya, Helder I/A-1397-2010; Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Li, Shuzhao/0000-0002-7386-2539
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R37AI048638, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   R37AI048638, U19AI090023, R37AI048638, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   R56AI048638, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, R37AI048638, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, R37AI048638,
   U19AI090023, U19AI090023, R37AI048638, R37AI048638, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, R37AI048638,
   U19AI090023, U19AI090023, R37AI048638, R37AI048638, U19AI090023,
   R37AI048638, U19AI090023, U19AI090023, U19AI090023] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665] Funding Source: NIH RePORTER;
   NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI090023-03, R37 AI048638-12, R56
   AI048638-09, R56 AI048638, R37 AI048638, U19 AI090023, U19 AI090023-01,
   R37 AI048638-11, U19 AI090023-02] Funding Source: Medline; NIDDK NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37 DK057665, R37 DK057665-13, R37
   DK057665-14, R37 DK057665-12] Funding Source: Medline
CR Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098
   Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749
   Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262
   Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84
   Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681
   Dhiman N, 2009, EXPERT REV VACCINES, V8, P963, DOI 10.1586/ERV.09.67
   Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3
   Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242
   Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042
   Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103
   Garcia-Pineres AJ, 2009, J IMMUNOL, V182, P1706, DOI 10.4049/jimmunol.182.3.1706
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278
   Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001
   Han JDJ, 2008, CELL RES, V18, P224, DOI 10.1038/cr.2008.16
   Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118
   Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926
   Hyatt G, 2006, NAT IMMUNOL, V7, P686, DOI 10.1038/ni0706-686
   Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126
   Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009
   Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896
   Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7
   Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347
   Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017
   Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31
   Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721
   Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005
   Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862
   Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09
   Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477
   Reif DM, 2009, GENES IMMUN, V10, P112, DOI 10.1038/gene.2008.80
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Russell RB, 2008, NAT CHEM BIOL, V4, P666, DOI 10.1038/nchembio.119
   Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454
   Scherer CA, 2007, VACCINE, V25, P6458, DOI 10.1016/j.vaccine.2007.06.035
   Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359
   Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]
   Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665
   Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   Vytvytska O, 2002, PROTEOMICS, V2, P580, DOI 10.1002/1615-9861(200205)2:5<580::AID-PROT580>3.0.CO;2-G
   Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09
   Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001
   Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0
NR 73
TC 53
Z9 53
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-5094
EI 1939-005X
J9 WIRES SYST BIOL MED
JI Wiley Interdiscip. Rev.-Syst. Biol
PD MAR-APR
PY 2012
VL 4
IS 2
BP 193
EP 205
DI 10.1002/wsbm.163
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 896LZ
UT WOS:000300569300006
PM 22012654
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Pulendran, B
AF Nakaya, Helder I.
   Pulendran, Bali
TI Systems vaccinology: its promise and challenge for HIV vaccine
   development
SO CURRENT OPINION IN HIV AND AIDS
LA English
DT Review
DE blood transcriptomics; systems biology; systems vaccinology; vaccinology
ID PROTEIN-KINASE-IV; YELLOW-FEVER VACCINE; GENE-EXPRESSION; BREAST-CANCER;
   MICROARRAY EXPERIMENTS; LUPUS-ERYTHEMATOSUS; IMMUNE-RESPONSES; RNA-SEQ;
   BIOLOGY; PATHWAY
AB Purpose of review
   The use of systems biology approaches to understand and predict vaccine-induced immunity promises to revolutionize vaccinology. For centuries vaccines were developed empirically, with very little understanding of the mechanisms by which they mediate protective immunity. The so-called systems vaccinology approach employs high-throughput technologies (e. g. microarrays, RNA-seq and mass spectrometry-based proteomics and metabolomics) and computational modeling to describe the complex interactions between all the parts of immune system, with a view to elucidating new biological rules capable of predicting the behavior of the system.
   Recent findings
   Systems biology successfully applied to yellow-fever and influenza vaccines has led to the discovery of signatures that predict vaccine immunogenicity, and promises to advance basic immunology research by providing novel mechanistic insights about immune regulation. However a major challenge of systems vaccinology concerns the analyses and interpretation of the large and noisy data sets generated by high-throughput techniques. Overcoming these issues, we envision that systems vaccinology will have a potential impact on vaccine development, including HIV vaccines.
   Summary
   High-throughput technologies allow the investigation of vaccine-induced immune responses at system and molecular levels. These are currently being used to unravel new molecular insights about the immune system, and are on the verge of being integrated into clinical trials to enable rational vaccine design and development.
C1 [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30329 USA.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Sch Med, Atlanta, GA 30329 USA.
   [Pulendran, Bali] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA 30329 USA.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Sch Med, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder/0000-0001-5297-9108
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; Bill and Melinda
   Gates FoundationBill & Melinda Gates Foundation; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI090023, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   R56AI048638, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI090023, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665] Funding Source: NIH RePORTER
FX We are very grateful for the generous support offered by the National
   Institutes of Health and the Bill and Melinda Gates Foundation for their
   very generous support of our work.
CR Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098
   Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016
   Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002
   Arkin A, 1998, GENETICS, V149, P1633
   Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030
   Balazsi Gabor, 2007, Methods Mol Biol, V377, P153
   Barla A, 2008, BRIEF BIOINFORM, V9, P119, DOI 10.1093/bib/bbn008
   Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247
   Bolen CR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-258
   Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725
   Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262
   Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437
   Chandra H, 2011, EXPERT REV PROTEOMIC, V8, P61, DOI 10.1586/EPR.10.99
   Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84
   Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010
   Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681
   Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3
   Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326
   FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Germain RN, 2010, IMMUNITY, V33, P441, DOI 10.1016/j.immuni.2010.09.014
   Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750
   Grigoryev YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013358
   HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610
   Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620
   Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173
   Jiang LC, 2011, GENOME RES, V21, P1543, DOI 10.1101/gr.121095.111
   Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7
   Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004
   Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac
   Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200
   Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032
   Krebs J, 1997, BIOCHEM BIOPH RES CO, V241, P383, DOI 10.1006/bbrc.1997.7823
   Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264
   Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108
   Marot G, 2009, BIOINFORMATICS, V25, P2692, DOI 10.1093/bioinformatics/btp444
   McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814
   McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333
   Mettetal JT, 2006, P NATL ACAD SCI USA, V103, P7304, DOI 10.1073/pnas.0509874103
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Oberg AL, 2011, CURR OPIN IMMUNOL, V23, P436, DOI 10.1016/j.coi.2011.04.005
   Pache L, 2011, METHODS, V53, P3, DOI 10.1016/j.ymeth.2010.07.009
   Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588
   Painter MW, 2011, J IMMUNOL, V186, P3047, DOI 10.4049/jimmunol.1002695
   Plikaytis BD, 2005, VACCINE, V23, P1606, DOI 10.1016/j.vaccine.2004.06.047
   Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477
   Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Rhodes DR, 2002, CANCER RES, V62, P4427
   Ribeiro AS, 2010, MATH BIOSCI, V223, P1, DOI 10.1016/j.mbs.2009.10.007
   Ricciardi-Castagnoli P, 2002, NAT REV IMMUNOL, V2, P881, DOI 10.1038/nri936
   Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205
   Rolland M, 2011, AIDS RES HUM RETROVI
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515
   Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]
   Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665
   SHOUVAL D, 1993, VACCINE, V11, pS9, DOI 10.1016/0264-410X(93)90151-M
   Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052
   Suarez-Farinas M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-99
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sullivan SJ, 2010, EXPERT REV VACCINES, V9, P1127, DOI 10.1586/ERV.10.117
   Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   Tong TJ, 2008, STAT MED, V27, P1960, DOI 10.1002/sim.3237
   Van Schaeybroeck S, 2011, NAT REV CLIN ONCOL, V8, P222, DOI 10.1038/nrclinonc.2011.15
   van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a
   Wang SL, 2001, CELL GROWTH DIFFER, V12, P351
   Watterson S, 2008, DRUG DISCOV TODAY, V13, P447, DOI 10.1016/j.drudis.2008.03.019
   Watterson S, 2010, FUTURE MICROBIOL, V5, P163, DOI 10.2217/fmb.10.8
   Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x
   Zhang Z, 2010, CANCER EPIDEM BIOMAR, V19, P2995, DOI 10.1158/1055-9965.EPI-10-0580
   Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004
NR 82
TC 36
Z9 36
U1 0
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1746-630X
EI 1746-6318
J9 CURR OPIN HIV AIDS
JI Curr. Opin. HIV AIDS
PD JAN
PY 2012
VL 7
IS 1
BP 24
EP 31
DI 10.1097/COH.0b013e32834dc37b
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 863GS
UT WOS:000298151400005
PM 22156839
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Wrammert, J
   Lee, EK
   Racioppi, L
   Marie-Kunze, S
   Haining, WN
   Means, AR
   Kasturi, SP
   Khan, N
   Li, GM
   McCausland, M
   Kanchan, V
   Kokko, KE
   Li, SZ
   Elbein, R
   Mehta, AK
   Aderem, A
   Subbarao, K
   Ahmed, R
   Pulendran, B
AF Nakaya, Helder I.
   Wrammert, Jens
   Lee, Eva K.
   Racioppi, Luigi
   Marie-Kunze, Stephanie
   Haining, W. Nicholas
   Means, Anthony R.
   Kasturi, Sudhir P.
   Khan, Nooruddin
   Li, Gui-Mei
   McCausland, Megan
   Kanchan, Vibhu
   Kokko, Kenneth E.
   Li, Shuzhao
   Elbein, Rivka
   Mehta, Aneesh K.
   Aderem, Alan
   Subbarao, Kanta
   Ahmed, Rafi
   Pulendran, Bali
TI Systems biology of vaccination for seasonal influenza in humans
SO NATURE IMMUNOLOGY
LA English
DT Article
ID YELLOW-FEVER VACCINE; PROTEIN-KINASE-IV; PLASMA-CELL DIFFERENTIATION;
   IMMUNE-RESPONSES; TRANSCRIPTION FACTOR; ANTIBODY-RESPONSES; CUTTING
   EDGE; T-CELLS; LIVE; CHILDREN
AB Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated with trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV). TIV induced higher antibody titers and more plasmablasts than LAIV did. In subjects vaccinated with TIV, early molecular signatures correlated with and could be used to accurately predict later antibody titers in two independent trials. Notably, expression of the kinase CaMKIV at day 3 was inversely correlated with later antibody titers. Vaccination of CaMKIV-deficient mice with TIV induced enhanced antigen-specific antibody titers, which demonstrated an unappreciated role for CaMKIV in the regulation of antibody responses. Thus, systems approaches can be used to predict immunogenicity and provide new mechanistic insights about vaccines.
C1 [Nakaya, Helder I.; Wrammert, Jens; Marie-Kunze, Stephanie; Kasturi, Sudhir P.; Khan, Nooruddin; Li, Gui-Mei; McCausland, Megan; Kanchan, Vibhu; Li, Shuzhao; Ahmed, Rafi; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
   [Nakaya, Helder I.; Marie-Kunze, Stephanie; Kasturi, Sudhir P.; Khan, Nooruddin; Li, Shuzhao; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
   [Wrammert, Jens; Li, Gui-Mei; McCausland, Megan; Kanchan, Vibhu; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA.
   [Racioppi, Luigi] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA.
   [Racioppi, Luigi; Means, Anthony R.] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy.
   [Haining, W. Nicholas] Dana Farber Canc Inst, Boston, MA 02115 USA.
   [Kokko, Kenneth E.] Emory Univ, Sch Med, Dept Med, Div Nephrol, Atlanta, GA USA.
   [Elbein, Rivka; Mehta, Aneesh K.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Aderem, Alan] Inst Syst Biol, Seattle, WA USA.
   [Subbarao, Kanta] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.
   [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.
EM bpulend@emory.edu
RI Khan, Nooruddin/AAF-5417-2019; Nakaya, Helder/AAF-1738-2020; Mehta,
   Aneesh/B-8054-2012; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Mehta, Aneesh/0000-0002-6552-9162;
   Nakaya, Helder I/0000-0001-5297-9108; Subbarao,
   Kanta/0000-0003-1713-3056; Li, Shuzhao/0000-0002-7386-2539; racioppi,
   luigi/0000-0002-9207-6752
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U19AI090023,
   HHSN266200700006C, U54AI057157, R37AI48638, R01DK057665, U19AI057266,
   N01 AI50025, AI30048, AI057266, DK074701, UL1 RR025008]; Bill & Melinda
   Gates FoundationBill & Melinda Gates Foundation [38645]; National
   Science Foundation (E.K.L. laboratory)National Science Foundation (NSF);
   Centers for Disease Control (E.K.L. laboratory)United States Department
   of Health & Human ServicesCenters for Disease Control & Prevention -
   USA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR000454, UL1TR000454, UL1TR000454, UL1TR000454, UL1TR000454,
   UL1TR000454, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER
   FOR RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, R01AI030048,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, R37AI048638,
   U19AI090023, U54AI057157, U19AI057266, U19AI090023, U19AI057266,
   U54AI057157, U19AI090023, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, R01AI030048, U54AI057157, R01AI030048,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, R01AI030048, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, U54AI057157, U54AI057157,
   R01AI030048, R01AI030048, R01AI030048, R37AI048638, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   R01AI030048, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U19AI090023, U54AI057157, U19AI090023, R01AI030048,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, R37AI048638, U54AI057157, U19AI057266,
   U54AI057157, R37AI048638, U54AI057157, R37AI048638, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   R37AI030048, U54AI057157, U54AI057157, R01AI030048, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, R37AI048638, U19AI057266,
   U54AI057157, U19AI057266, R37AI048638, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI090023, U19AI090023, U19AI057266, N01AI050025, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   R01AI030048, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, R01AI030048, U19AI090023, U19AI057266, R01AI030048,
   U54AI057157, U54AI057157, R01AI030048, U54AI057157, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI090023, U19AI090023, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, R01AI030048,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, R37AI030048,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI090023, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   R37AI048638, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, R37AI030048, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, R37AI030048, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, R37AI048638,
   U54AI057157, U19AI057266, U19AI090023, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, U54AI057157, U19AI090023, R01AI030048, U19AI090023,
   U19AI090023, U19AI090023, R37AI030048, U54AI057157, R37AI030048,
   U54AI057157, U19AI057266, R37AI030048, R37AI030048, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U54AI057157, R37AI030048,
   U54AI057157, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, R37AI048638, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U19AI090023,
   U54AI057157, U19AI090023, U19AI057266, U19AI090023, U19AI090023,
   U54AI057157, R37AI030048, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, R01AI030048, U19AI090023, U54AI057157,
   R37AI048638, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R01DK074701, R01DK057665, R01DK057665,
   R01DK057665, R37DK057665, R01DK057665, R37DK057665, R01DK074701,
   R01DK057665, R01DK074701, R37DK057665, R37DK057665, R01DK074701,
   R37DK057665, R37DK057665, R37DK057665, R01DK074701, R01DK057665,
   R37DK057665, R37DK057665, R01DK057665, R01DK057665, R01DK057665,
   R01DK057665, R37DK057665, R01DK057665] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM033976,
   R01GM033976, R01GM033976, R01GM033976, R01GM033976, R01GM033976,
   R01GM033976, R01GM033976, R01GM033976, R01GM033976, R01GM033976,
   R01GM033976, R01GM033976, R01GM033976, R01GM033976, R01GM033976,
   R01GM033976, R01GM033976, R01GM033976, R01GM033976, R01GM033976,
   R01GM033976, R01GM033976, R01GM033976, R01GM033976, R01GM033976,
   R01GM033976, R01GM033976, R01GM033976, R01GM033976, R01GM033976] Funding
   Source: NIH RePORTER
FX We thank B.T. Rouse and R. Compans for discussion and comments on the
   manuscript, and H. Oluoch for technical assistance. Supported the US
   National Institutes of Health (U19AI090023, HHSN266200700006C,
   U54AI057157, R37AI48638, R01DK057665, U19AI057266 and N01 AI50025 for
   the B. P. laboratory; AI30048 and AI057266 for the R.A. laboratory;
   DK074701 for the A.R.M. laboratory; Intramural Research Program of the
   National Institute of Allergy and Infectious Diseases for the K.S.
   laboratory; and UL1 RR025008 from the Clinical and Translational Science
   Award program, National Center for Research Resources for clinical
   work), the Bill & Melinda Gates Foundation (Collaboration for AIDS
   Vaccine Discovery 38645 to the R.A. and B.P. laboratories), the National
   Science Foundation (E.K.L. laboratory) and the Centers for Disease
   Control (E.K.L. laboratory).
CR Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002
   Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x
   Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001
   Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Belshe RB, 2004, VIRUS RES, V103, P177, DOI 10.1016/j.virusres.2004.02.031
   Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6
   Brooks JP, 2010, ANN OPER RES, V174, P147, DOI 10.1007/s10479-008-0424-0
   Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x
   Chen GL, 2010, VIROLOGY, V398, P109, DOI 10.1016/j.virol.2009.12.003
   CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986
   Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969
   Deaglio S, 2001, LEUKEMIA RES, V25, P1, DOI 10.1016/S0145-2126(00)00093-X
   Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06
   Hirota Y, 1997, VACCINE, V15, P962, DOI 10.1016/S0264-410X(96)00302-7
   Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062
   Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173
   Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907
   Iwakoshi NN, 2003, IMMUNOL REV, V194, P29, DOI 10.1034/j.1600-065X.2003.00057.x
   JOHNSON PR, 1985, J MED VIROL, V17, P325, DOI 10.1002/jmv.1890170405
   Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200
   Krebs J, 1997, BIOCHEM BIOPH RES CO, V241, P383, DOI 10.1006/bbrc.1997.7823
   Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107
   MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099
   POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06
   Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975
   Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515
   Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]
   Shubinsky G, 1997, IMMUNITY, V7, P315, DOI 10.1016/S1074-7613(00)80353-2
   Sullivan SJ, 2010, EXPERT REV VACCINES, V9, P1127, DOI 10.1586/ERV.10.117
   Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x
   Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442
   Thomas R, 2010, CLIN REV ALLERG IMMU, V38, P159, DOI 10.1007/s12016-009-8148-8
   Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Ueda Y, 2003, HUM IMMUNOL, V64, P1144, DOI 10.1016/j.humimm.2003.08.342
   *US DEP HLTH HUM S, 2007, GUID IND CLIN DAT NE
   Wang SL, 2001, CELL GROWTH DIFFER, V12, P351
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153
   Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b
NR 54
TC 490
Z9 493
U1 2
U2 95
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD AUG
PY 2011
VL 12
IS 8
BP 786
EP U149
DI 10.1038/ni.2067
PG 11
WC Immunology
SC Immunology
GA 794BT
UT WOS:000292870700017
PM 21743478
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Duraiswamy, J
   Ibegbu, CC
   Masopust, D
   Miller, JD
   Araki, K
   Doho, GH
   Tata, P
   Gupta, S
   Zilliox, MJ
   Nakaya, HI
   Pulendran, B
   Haining, WN
   Freeman, GJ
   Ahmed, R
AF Duraiswamy, Jaikumar
   Ibegbu, Chris C.
   Masopust, David
   Miller, Joseph D.
   Araki, Koichi
   Doho, Gregory H.
   Tata, Pramila
   Gupta, Satish
   Zilliox, Michael J.
   Nakaya, Helder I.
   Pulendran, Bali
   Haining, W. Nicholas
   Freeman, Gordon J.
   Ahmed, Rafi
TI Phenotype, Function, and Gene Expression Profiles of Programmed
   Death-1(hi) CD8 T Cells in Healthy Human Adults
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID CHRONIC VIRAL-INFECTION; INTERLEUKIN-7 RECEPTOR-ALPHA; C
   VIRUS-INFECTION; HUMAN EFFECTOR; UP-REGULATION; PROLIFERATIVE CAPACITY;
   INHIBITORY RECEPTORS; DISEASE PROGRESSION; HIV-INFECTION; PD-1 PATHWAY
AB T cell dysfunction is an important feature of many chronic viral infections. In particular, it was shown that programmed death-1 (PD-1) regulates T cell dysfunction during chronic lymphocytic choriomeningitis virus infection in mice, and PD-1(hi) cells exhibit an intense exhausted gene signature. These findings were extended to human chronic infections such as HIV, hepatitis C virus, and hepatitis B virus. However, it is not known if PD-1(hi) cells of healthy humans have the traits of exhausted cells. In this study, we provide a comprehensive description of phenotype, function, and gene expression profiles of PD-1(hi) versus PD-1(lo) CD8 T cells in the peripheral blood of healthy human adults as follows: 1) the percentage of naive and memory CD8 T cells varied widely in the peripheral blood cells of healthy humans, and PD-1 was expressed by the memory CD8 T cells; 2) PD-1(hi) CD8 T cells in healthy humans did not significantly correlate with the PD-1(hi) exhausted gene signature of HIV-specific human CD8 T cells or chronic lymphocytic choriomeningitis virus-specific CD8 T cells from mice; 3) PD-1 expression did not directly affect the ability of CD8 T cells to secrete cytokines in healthy adults; 4) PD-1 was expressed by the effector memory compared with terminally differentiated effector CD8 T cells; and 5) finally, an interesting inverse relationship between CD45RA and PD-1 expression was observed. In conclusion, our study shows that most PD-1(hi) CD8 T cells in healthy adult humans are effector memory cells rather than exhausted cells. The Journal of Immunology, 2011, 186: 4200-4212.
C1 [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Rollins Res Ctr, Atlanta, GA 30322 USA.
   [Duraiswamy, Jaikumar; Ibegbu, Chris C.; Masopust, David; Miller, Joseph D.; Araki, Koichi; Zilliox, Michael J.; Ahmed, Rafi] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Doho, Gregory H.] Emory Univ, Emory Biomarker Serv Ctr, Atlanta, GA 30322 USA.
   [Tata, Pramila; Gupta, Satish] Strand Life Sci, Bangalore 560024, Karnataka, India.
   [Nakaya, Helder I.; Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.
   [Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.
   [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.
RP Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Rollins Res Ctr, 1510 Clifton Rd,G211, Atlanta, GA 30322 USA.
EM rahmed@emory.edu
RI masopust, david/B-5027-2008; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020; Freeman, Gordon/AAC-5380-2019; Gupta,
   Satish/B-9934-2009
OI Nakaya, Helder I/0000-0001-5297-9108; Nakaya,
   Helder/0000-0001-5297-9108; Freeman, Gordon/0000-0002-7210-5616; Gupta,
   Satish/0000-0003-3717-0436
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P01 AI080192-01];
   Grand Challenges in Global Health Initiative [05GCGH0]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R37AI048638, U54AI057157, U19AI057266, P01AI080192, U54AI057157,
   U54AI057157, U19AI090023, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI090023, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   P01AI080192, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI090023, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, R37AI048638, U19AI057266,
   R37AI048638, U54AI057157, U19AI057266, U54AI057157, U19AI090023,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   P01AI080192, U19AI057266, P01AI080192, P01AI080192, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U19AI090023, P01AI080192, R37AI048638, R37AI048638, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U19AI090023, U19AI090023, U54AI057157, U19AI090023,
   U19AI057266, U19AI057266, U54AI057157, U19AI090023, P01AI080192,
   U19AI057266, U19AI090023, U19AI057266, U54AI057157, U19AI090023,
   U19AI057266, U19AI057266, U19AI090023, P01AI080192, U19AI090023,
   U54AI057157, P01AI080192, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U54AI057157, P01AI080192, U54AI057157, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   R37AI048638, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U19AI090023, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, P01AI080192, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI090023,
   U19AI057266, U19AI090023, P01AI080192, P01AI080192, U54AI057157,
   U54AI057157, U19AI057266, P01AI080192, U54AI057157, P01AI080192,
   U19AI090023, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   U19AI057266, U19AI090023, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, P01AI080192, U54AI057157, U19AI057266, P01AI080192,
   U19AI057266, U54AI057157, P01AI080192, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, P01AI080192, P01AI080192, U19AI057266, U19AI057266,
   P01AI080192, U54AI057157, U54AI057157, R37AI048638, U54AI057157,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, P01AI080192,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   R37AI048638, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   P01AI080192, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI090023, U19AI090023, U54AI057157,
   U19AI090023, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   P01AI080192, U19AI057266, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, P01AI080192, U54AI057157,
   P01AI080192, P01AI080192, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, R37AI048638, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, U54AI057157, U19AI090023,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U54AI057157,
   U19AI090023, U19AI057266, P01AI080192, U54AI057157, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, P01AI080192, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, P01AI080192, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U19AI090023, U19AI090023,
   U54AI057157, U54AI057157, U54AI057157, P01AI080192, U19AI057266,
   U19AI090023, U54AI057157, P01AI080192, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, P01AI080192, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, P01AI080192,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U19AI090023, P01AI080192, U54AI057157, U19AI057266, U54AI057157,
   P01AI080192, P01AI080192, U54AI057157, P01AI080192, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, P01AI080192, U54AI057157,
   U19AI057266, U19AI090023, U54AI057157, U19AI057266, U19AI090023,
   U19AI057266, U54AI057157, R37AI048638, U19AI057266, P01AI080192,
   U54AI057157, U19AI090023, R37AI048638, U54AI057157] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665, R37DK057665, R37DK057665,
   R37DK057665, R37DK057665, R37DK057665] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health Grant P01
   AI080192-01 (to R.A.) and Grand Challenges in Global Health Initiative
   Grant 05GCGH0 (to R.A.).
CR Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Ansari MJI, 2003, J EXP MED, V198, P63, DOI 10.1084/jem.20022125
   Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643
   Arlettaz L, 2004, EUR J IMMUNOL, V34, P3413, DOI 10.1002/eji.200324756
   Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444
   Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679
   Boettler T, 2006, J VIROL, V80, P3532, DOI 10.1128/JVI.80.7.3532-3540.2006
   Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06
   Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257
   Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554
   Carrasco J, 2006, BLOOD, V108, P2897, DOI 10.1182/blood-2005-11-007237
   Carrington M, 2006, CURR TOP MICROBIOL, V298, P225
   Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945
   Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349
   Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x
   Freeman GJ, 2003, MOL B INT U, P59
   Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800
   GERDES J, 1984, J IMMUNOL, V133, P1710
   Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09
   Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859
   Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001
   Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407
   Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088
   Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009
   Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515
   Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776
   Lazuardi L, 2009, BIOGERONTOLOGY, V10, P191, DOI 10.1007/s10522-008-9167-1
   Lefrancois L, 1999, J EXP MED, V189, P1631, DOI 10.1084/jem.189.10.1631
   Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858
   McNerney ME, 2005, MOL IMMUNOL, V42, P489, DOI 10.1016/j.molimm.2004.07.032
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106
   Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1
   Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319
   Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8
   Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001
   Okazaki T, 2006, CELL, V124, P459, DOI 10.1016/j.cell.2006.01.022
   Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496
   Petrovas C, 2009, J IMMUNOL, V183, P1120, DOI 10.4049/jimmunol.0900182
   Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232
   Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06
   Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84
   Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112
   Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385
   Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641
   Sauce D, 2009, J VIROL, V83, P9068, DOI 10.1128/JVI.00141-09
   Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868
   Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727
   Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443
   Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Thompson RH, 2007, CLIN CANCER RES, V13, p709S, DOI 10.1158/1078-0432.CCR-06-1868
   Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482
   Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001
   Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662
   Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657
   Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006
   Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004
   Williams AP, 2005, MOL INTERV, V5, P226, DOI 10.1124/mi.5.4.6
   Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895
   Zhang JY, 2007, BLOOD, V109, P4671, DOI 10.1182/blood-2006-09-044826
NR 64
TC 133
Z9 138
U1 0
U2 14
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD APR 1
PY 2011
VL 186
IS 7
BP 4200
EP 4212
DI 10.4049/jimmunol.1001783
PG 13
WC Immunology
SC Immunology
GA 739WH
UT WOS:000288751200045
PM 21383243
OA Green Accepted, Bronze
DA 2020-12-17
ER

PT J
AU Kasturi, SP
   Skountzou, I
   Albrecht, RA
   Koutsonanos, D
   Hua, T
   Nakaya, HI
   Ravindran, R
   Stewart, S
   Alam, M
   Kwissa, M
   Villinger, F
   Murthy, N
   Steel, J
   Jacob, J
   Hogan, RJ
   Garcia-Sastre, A
   Compans, R
   Pulendran, B
AF Kasturi, Sudhir Pai
   Skountzou, Ioanna
   Albrecht, Randy A.
   Koutsonanos, Dimitrios
   Hua, Tang
   Nakaya, Helder I.
   Ravindran, Rajesh
   Stewart, Shelley
   Alam, Munir
   Kwissa, Marcin
   Villinger, Francois
   Murthy, Niren
   Steel, John
   Jacob, Joshy
   Hogan, Robert J.
   Garcia-Sastre, Adolfo
   Compans, Richard
   Pulendran, Bali
TI Programming the magnitude and persistence of antibody responses with
   innate immunity
SO NATURE
LA English
DT Article
ID MEMORY B-CELLS; YELLOW-FEVER VACCINE; DERMAL DENDRITIC CELLS; TOLL-LIKE
   RECEPTORS; GERMINAL CENTER; IN-VIVO; T-CELLS; LANGERHANS CELLS;
   EXPRESSION; ANTIGEN
AB Many successful vaccines induce persistent antibody responses that can last a lifetime. The mechanisms by which they do so remain unclear, but emerging evidence indicates that they activate dendritic cells via Toll-like receptors (TLRs)(1,2). For example, the yellow fever vaccine YF-17D, one of the most successful empiric vaccines ever developed(3), activates dendritic cells via multiple TLRs to stimulate proinflammatory cytokines(4,5). Triggering specific combinations of TLRs in dendritic cells can induce synergistic production of cytokines(6), which results in enhanced T-cell responses, but its impact on antibody responses remain unknown. Learning the critical parameters of innate immunity that program such antibody responses remains a major challenge in vaccinology. Here we demonstrate that immunization of mice with synthetic nanoparticles containing antigens plus ligands that signal through TLR4 and TLR7 induces synergistic increases in antigen-specific, neutralizing antibodies compared to immunization with nanoparticles containing antigens plus a single TLR ligand. Consistent with this there was enhanced persistence of germinal centres and of plasma-cell responses, which persisted in the lymph nodes for >1.5 years. Surprisingly, there was no enhancement of the early short-lived plasma-cell response relative to that observed with single TLR ligands. Molecular profiling of activated B cells, isolated 7 days after immunization, indicated that there was early programming towards B-cell memory. Antibody responses were dependent on direct triggering of both TLRs on B cells and dendritic cells, as well as on T-cell help. Immunization protected completely against lethal avian and swine influenza virus strains in mice, and induced robust immunity against pandemic H1N1 influenza in rhesus macaques.
C1 [Kasturi, Sudhir Pai; Skountzou, Ioanna; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Compans, Richard; Pulendran, Bali] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Kasturi, Sudhir Pai; Hua, Tang; Nakaya, Helder I.; Ravindran, Rajesh; Kwissa, Marcin; Villinger, Francois; Jacob, Joshy; Pulendran, Bali] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Skountzou, Ioanna; Koutsonanos, Dimitrios; Jacob, Joshy; Compans, Richard] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.
   [Albrecht, Randy A.; Steel, John; Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.
   [Stewart, Shelley; Alam, Munir] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA.
   [Villinger, Francois; Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
   [Murthy, Niren] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Hogan, Robert J.] Univ Georgia, Dept Anat & Radiol, Coll Vet Med, Athens, GA 30602 USA.
   [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Div Infect Dis, Dept Med, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
RP Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Alam, S. Munir/AAC-6711-2019; Skountzou, Ioanna/A-4454-2010; Nakaya,
   Helder I/A-1397-2010; Albrecht, Randy A./H-5119-2019; Compans,
   Richard/I-4087-2013; Nakaya, Helder/AAF-1738-2020
OI Skountzou, Ioanna/0000-0002-6429-244X; Nakaya, Helder
   I/0000-0001-5297-9108; Albrecht, Randy A./0000-0003-4008-503X; Compans,
   Richard/0000-0003-2360-335X; Nakaya, Helder/0000-0001-5297-9108;
   Garcia-Sastre, Adolfo/0000-0002-6551-1827
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U54AI057157,
   R37AI48638, R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025,
   U19AI090023, HHSN266200700010C, U54AI57158, U01AI070469]; Bill & Melinda
   Gates FoundationBill & Melinda Gates Foundation; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U54AI057158,
   U54AI057157, U54AI057157, U54AI057158, U54AI057158, U19AI090023,
   U54AI057157, U54AI057158, U54AI057158, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, R37AI048638, U54AI057158, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057158, U19AI057266,
   U54AI057157, U54AI057157, U54AI057158, U54AI057158, U19AI090023,
   U54AI057157, U54AI057157, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U19AI057266, U54AI057158, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U54AI057158, U19AI090023, U19AI090023,
   U54AI057158, U19AI090023, U54AI057157, U54AI057157, U54AI057158,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057158, U19AI090023, U54AI057157, U19AI057266,
   U54AI057157, U54AI057158, U54AI057158, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057158, U54AI057157,
   U54AI057158, U19AI090023, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, U54AI057158, U54AI057157, U54AI057158, R01AI048638,
   U54AI057157, U54AI057158, U54AI057158, U54AI057157, U54AI057157,
   U19AI057266, U19AI090023, U54AI057158, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057158, U54AI057158, U54AI057158,
   U19AI057266, U19AI057266, U54AI057157, U54AI057158, U54AI057158,
   U54AI057157, U19AI057266, U19AI057266, U54AI057158, U54AI057157,
   U54AI057157, R56AI048638, R37AI048638, U19AI090023, U19AI057266,
   U54AI057158, U54AI057157, U54AI057157, R37AI048638, U19AI057266,
   U19AI057266, U54AI057158, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U19AI090023, U54AI057158, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U19AI090023, U54AI057158,
   U54AI057158, U19AI057266, U54AI057157, U54AI057158, U54AI057158,
   U54AI057158, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057158, U54AI057158, U54AI057158, U54AI057158,
   U54AI057158, U19AI090023, U19AI057266, U54AI057157, U19AI090023,
   U54AI057158, U19AI057266, U54AI057158, U54AI057158, U54AI057157,
   U54AI057158, U54AI057157, U54AI057158, U54AI057158, U54AI057157,
   U54AI057158, U54AI057158, U54AI057157, U19AI057266, U54AI057158,
   U19AI057266, U54AI057158, R37AI048638, U54AI057158, U54AI057158,
   U54AI057158, U19AI057266, U54AI057157, U19AI090023, U54AI057157,
   U19AI090023, U19AI057266, U54AI057157, U54AI057157, U54AI057158,
   U19AI090023, U54AI057157, U19AI057266, U54AI057158, U54AI057158,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U54AI057158,
   U54AI057158, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057158, U54AI057158, U54AI057158, U19AI090023, U54AI057157,
   U19AI090023, U19AI090023, U54AI057157, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U54AI057158, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057158, U19AI057266,
   U54AI057157, U54AI057158, U54AI057158, U54AI057158, U19AI057266,
   U54AI057157, U54AI057158, U54AI057157, U19AI090023, U54AI057158,
   U54AI057158, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U54AI057158, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U54AI057157, U19AI057266, U54AI057158, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI090023, U54AI057158, U19AI057266,
   U54AI057158, U54AI057158, R01AI048638, U19AI057266, U54AI057157,
   U54AI057158, U54AI057158, U54AI057157, U54AI057157, U19AI057266,
   R37AI048638, U54AI057157, U54AI057158, U54AI057158, U19AI090023,
   U54AI057157, U19AI057266, U54AI057157, U54AI057158, U01AI070469,
   U54AI057158, U54AI057158, U54AI057157, U54AI057158, U54AI057158,
   U54AI057157, U19AI057266, R01AI048638, U19AI090023, U19AI057266,
   U19AI057266, U54AI057158, U01AI070469, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U54AI057158, U54AI057157, U54AI057157, U19AI090023, R01AI048638,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U19AI090023,
   U19AI057266, R01AI048638, U19AI057266, U54AI057158, U54AI057157,
   U54AI057158, U19AI090023, U19AI057266, U54AI057157, R01AI048638,
   U54AI057157, U54AI057158, U19AI057266, U54AI057158, U54AI057158,
   R37AI048638, U54AI057157, U19AI090023, U19AI057266, U54AI057158,
   U19AI057266, U54AI057157, R37AI048638, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057158, R01AI048638,
   U54AI057158, U19AI057266, U54AI057157, U19AI057266, U54AI057158,
   U54AI057158, U54AI057157, U54AI057158, U54AI057158, U54AI057157,
   U19AI057266, U54AI057157, U54AI057158, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057158, U54AI057158,
   U54AI057157, R37AI048638, U54AI057157, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057158,
   U54AI057157, U54AI057158, U54AI057158, U54AI057157, U54AI057158,
   U54AI057157, U54AI057158, U54AI057158, U19AI057266, U54AI057158,
   U54AI057157, U19AI057266, U54AI057157, U54AI057158, N01AI050025,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, R37AI048638,
   U19AI090023, U19AI090023, U19AI090023, U54AI057158, U54AI057157,
   U19AI090023, U19AI057266, U19AI057266, U19AI090023, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057158, U54AI057158,
   U19AI057266, U19AI090023, U19AI090023, U54AI057157, U19AI090023,
   U54AI057157, U19AI057266, U54AI057158, U54AI057157, U01AI070469,
   U54AI057158, R01AI048638, U54AI057157, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U54AI057158, U54AI057157, U19AI057266,
   U54AI057158, U54AI057157, U19AI090023, U01AI070469, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057158, U19AI057266,
   U54AI057158, U54AI057157, U19AI057266, U19AI057266, U54AI057158,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI090023, U54AI057158, U54AI057158,
   U54AI057158, U54AI057157, U54AI057157, U54AI057157, U54AI057158,
   U54AI057157, U54AI057158, U19AI057266, U19AI057266, R37AI048638,
   U54AI057157, U19AI057266, U19AI057266, U54AI057158, R37AI048638,
   U19AI057266, U54AI057157, U19AI090023, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057158, U19AI057266, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U54AI057158,
   U19AI090023, U54AI057157, U54AI057157, U01AI070469, U54AI057157,
   U19AI090023, U54AI057157, U19AI057266, U19AI090023, U19AI090023,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI090023] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND
   KIDNEY DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK057665,
   R01DK057665, R01DK057665, R01DK057665, R01DK057665, R01DK057665,
   R01DK057665, R01DK057665, R01DK057665, R01DK057665, R01DK057665] Funding
   Source: NIH RePORTER
FX We thank R. Ahmed and B. Rouse for discussion and comments on the
   manuscript. We thank B. Norris for assistance with FACS analysis, and H.
   Oluoch for assistance with cryostat sectioning. The work in the
   laboratory of B. P. was supported by grants U54AI057157, R37AI48638,
   R01DK057665, U19AI057266, HHSN266200700006C, NO1 AI50025 and U19AI090023
   from the National Institutes of Health and a grant from the Bill &
   Melinda Gates Foundation. Work in A.G.-S. laboratories was partly funded
   by grants HHSN266200700010C, U54AI57158) and U01AI070469 from the
   National Institutes of Health.
CR Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107
   Airoldi I, 2004, CLIN CANCER RES, V10, P144, DOI 10.1158/1078-0432.CCR-1026-3
   Airoldi I, 2000, J IMMUNOL, V165, P6880, DOI 10.4049/jimmunol.165.12.6880
   Bachmann MF, 1996, J EXP MED, V183, P2259, DOI 10.1084/jem.183.5.2259
   Badr G, 2010, CELL IMMUNOL, V263, P31, DOI 10.1016/j.cellimm.2010.02.012
   Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8
   Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043
   Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071
   Chen GL, 2009, CURR TOP MICROBIOL, V333, P109, DOI 10.1007/978-3-540-92165-3_5
   Chin AID, 1999, MOL CELL BIOL, V19, P6665
   Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650
   COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974
   den Haan JMM, 2007, J IMMUNOL, V178, P5429, DOI 10.4049/jimmunol.178.9.5429
   Dorner M, 2009, IMMUNOLOGY, V128, P573, DOI 10.1111/j.1365-2567.2009.03143.x
   Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1
   Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783
   Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964
   Hikida M, 2009, J EXP MED, V206, P681, DOI 10.1084/jem.20082100
   Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5
   Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499
   Kano G, 2008, LEUKEMIA LYMPHOMA, V49, P965, DOI 10.1080/10428190801993462
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010
   Ke N, 2001, J BIOL CHEM, V276, P12481, DOI 10.1074/jbc.C000871200
   Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004
   Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18
   Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103
   Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963
   McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732
   MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295
   Mitchison NA, 2004, NAT REV IMMUNOL, V4, P308, DOI 10.1038/nri1334
   Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107
   Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223
   Nera KP, 2006, SCAND J IMMUNOL, V64, P190, DOI 10.1111/j.1365-3083.2006.01809.x
   Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267
   Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017
   POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545
   Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sah HK, 1997, J PHARM SCI, V86, P1315, DOI 10.1021/js960363q
   Singh M, 2007, EXPERT REV VACCINES, V6, P797, DOI 10.1586/14760584.6.5.797
   Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5
   Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475
   Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07
   Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08
   Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695
   Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065
   Tovey MG, 2008, BIOL CHEM, V389, P541, DOI 10.1515/BC.2008.051
   van Essen D, 2000, J IMMUNOL, V165, P3640
   Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102
   Young JAT, 2002, SCI AM, V286, P48, DOI 10.1038/scientificamerican0302-48
   Zhou G, 2005, EXP MOL PATHOL, V78, P25, DOI 10.1016/j.yexmp.2004.08.008
   Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106
NR 56
TC 573
Z9 581
U1 9
U2 174
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD FEB 24
PY 2011
VL 470
IS 7335
BP 543
EP U136
DI 10.1038/nature09737
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 725NT
UT WOS:000287652900044
PM 21350488
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Pulendran, B
   Li, SZ
   Nakaya, HI
AF Pulendran, Bali
   Li, Shuzhao
   Nakaya, Helder I.
TI Systems Vaccinology
SO IMMUNITY
LA English
DT Review
ID YELLOW-FEVER VIRUS; GENE-EXPRESSION PATTERNS; VARICELLA-ZOSTER-VIRUS;
   INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTORS; CD8(+) T-CELLS; DENDRITIC
   CELLS; NALP3 INFLAMMASOME; IN-VIVO; B-CELLS
AB Vaccination is one of the greatest triumphs of modern medicine, yet we remain largely ignorant of the mechanisms by which successful vaccines stimulate protective immunity Two recent advances are beginning to illuminate such mechanisms realization of the pivotal role of the innate immune system in sensing microbes and stimulating adaptive immunity, and advances in systems biology Recent studies have used systems biology approaches to obtain a global picture of the immune responses to vaccination in humans This has enabled the identification of early innate signatures that predict the immunogenicity of vaccines, and identification of potentially novel mechanisms of immune regulation Here, we review these advances and critically examine the potential opportunities and challenges posed by systems biology in vaccine development
C1 [Pulendran, Bali; Li, Shuzhao; Nakaya, Helder I.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Pulendran, Bali] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA.
RP Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Li, Shuzhao/0000-0002-7386-2539
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023, U19AI090023, U19AI090023, U19AI090023,
   U19AI090023, U19AI090023] Funding Source: NIH RePORTER; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI090023] Funding Source: Medline
CR Aderem A, 2001, NAT IMMUNOL, V2, P373
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501
   ANDREONI J, 1993, J INFECT DIS, V168, P227, DOI 10.1093/infdis/168.1.227
   Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379
   Arvin AM, 2008, J INFECT DIS, V197, pS58, DOI 10.1086/522123
   Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025
   Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120
   Brenner S, 1997, CURR BIOL, V7, pR58, DOI 10.1016/S0960-9822(06)00031-5
   Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384
   Buonaguro L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S5
   Callan MFC, 1998, J EXP MED, V187, P1395, DOI 10.1084/jem.187.9.1395
   Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012
   Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757
   Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180
   Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002
   DAVIES K, 2008, BIO IT WORLD MAG MAY
   De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648
   Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042
   Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109
   DOWDLE WR, 1973, POSTGRAD MED J, V49, P159, DOI 10.1136/pgmj.49.569.159
   EIN DL, 2006, P NATL ACAD SCI USA, V103, P5923
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000
   Gardner EM, 2006, VACCINE, V24, P1609, DOI 10.1016/j.vaccine.2005.09.058
   Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569
   Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946
   Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768
   Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07
   Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859
   Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001
   Harari A, 2004, EUR J IMMUNOL, V34, P3525, DOI 10.1002/eji.200425324
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203
   Hoft DF, 2008, LANCET, V372, P164, DOI 10.1016/S0140-6736(08)61036-3
   Huttenhower C, 2009, GENOME RES, V19, P1093, DOI 10.1101/gr.082214.108
   Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   IPSEN J, 1946, J IMMUNOL, V54, P325
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578
   Jiang BM, 2008, VACCINE, V26, P6754, DOI 10.1016/j.vaccine.2008.10.008
   Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857
   Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7
   Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254
   Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755
   Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045
   Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217
   Letvin NL, 2007, IMMUNITY, V27, P366, DOI 10.1016/j.immuni.2007.09.001
   Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696
   Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17
   Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x
   LOONEY JM, 1956, NEW ENGL J MED, V254, P6, DOI 10.1056/NEJM195601052540102
   Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55
   Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004
   McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333
   Morgan C, 2008, PLOS MED, V5, P1200, DOI 10.1371/journal.pmed.0050173
   Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105
   MOSTOW SR, 1973, POSTGRAD MED J, V49, P152, DOI 10.1136/pgmj.49.569.152
   Nagarajan T, 2008, CURR TOP MICROBIOL, V317, P67
   Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223
   *NAT I ALL INF DIS, 2010, NIH LAUNCH EFF DEF M
   Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309
   OUEREC T, 2006, J EXP MED, V203, P413
   Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806
   Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221
   Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862
   Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019
   Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477
   Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652
   Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B
   REYES SA, 2009, CURR OPIN MOL THER, V11, P72
   Romero-Steiner S, 2006, CLIN VACCINE IMMUNOL, V13, P165, DOI 10.1128/CVI.13.2.165-169.2006
   Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385
   Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008
   Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589
   Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061
   SHEN OSS, 2010, NAT METHODS, V7, P287
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001
   Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107
   Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004
   Tong JC, 2009, DRUG DISCOV TODAY, V14, P684, DOI 10.1016/j.drudis.2009.04.001
   Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310
   Van Damme Pierre, 2007, Travel Med Infect Dis, V5, P79, DOI 10.1016/j.tmaid.2006.04.004
   Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007
   Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92
   WHEELOCK EF, 1965, NEW ENGL J MED, V273, P194, DOI 10.1056/NEJM196507222730404
   Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006
   Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003
   Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x
NR 99
TC 226
Z9 230
U1 0
U2 27
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD OCT 29
PY 2010
VL 33
IS 4
BP 516
EP 529
DI 10.1016/j.immuni.2010.10.006
PG 14
WC Immunology
SC Immunology
GA 681GU
UT WOS:000284300200008
PM 21029962
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Manicassamy, S
   Reizis, B
   Ravindran, R
   Nakaya, H
   Salazar-Gonzalez, RM
   Wang, YC
   Pulendran, B
AF Manicassamy, Santhakumar
   Reizis, Boris
   Ravindran, Rajesh
   Nakaya, Helder
   Salazar-Gonzalez, Rosa Maria
   Wang, Yi-chong
   Pulendran, Bali
TI Activation of beta-Catenin in Dendritic Cells Regulates Immunity Versus
   Tolerance in the Intestine
SO SCIENCE
LA English
DT Article
ID TOLL-LIKE RECEPTORS; T-HELPER-CELLS; RETINOIC-ACID; INNATE IMMUNITY;
   RESPONSES; DIFFERENTIATION; MACROPHAGES; DISEASE; EXPRESSION; INDUCTION
AB Dendritic cells (DCs) play a vital role in initiating robust immunity against pathogens as well as maintaining immunological tolerance to self antigens. However, the intracellular signaling networks that program DCs to become tolerogenic remain unknown. We report here that the Wnt-beta-catenin signaling in intestinal dendritic cells regulates the balance between inflammatory versus regulatory responses in the gut. beta-catenin in intestinal dendritic cells was required for the expression of anti-inflammatory mediators such as retinoic acid-metabolizing enzymes, interleukin-10, and transforming growth factor-beta, and the stimulation of regulatory T cell induction while suppressing inflammatory effector T cells. Furthermore, ablation of beta-catenin expression in DCs enhanced inflammatory responses and disease in a mouse model of inflammatory bowel disease. Thus, beta-catenin signaling programs DCs to a tolerogenic state, limiting the inflammatory response.
C1 [Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.
   [Salazar-Gonzalez, Rosa Maria] Cincinnati Childrens Hosp, Med Ctr, Mol Immunol Div, Cincinnati, OH 45229 USA.
   [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.
RP Pulendran, B (corresponding author), Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@emory.edu
RI Sharry, John A Mac/B-5509-2011; Nakaya, Helder I/A-1397-2010; Nakaya,
   Helder/AAF-1738-2020
OI Sharry, John A Mac/0000-0002-9528-6261; Nakaya, Helder
   I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Reizis,
   Boris/0000-0003-1140-7853
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U54AI057157,
   R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019,
   NO1 AI50025]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   R01AI048638, U19AI057266, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, R01AI048638, U54AI057157,
   R01AI056499, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   R37AI048638, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, R01AI048638, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, R37AI048638,
   R01AI056499, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, R01AI056499, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, R01AI048638,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, R37AI048638, U54AI057157,
   U19AI057266, U19AI057266, R01AI048638, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, R01AI048638,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, R37AI048638, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   R37AI048638, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, R37AI048638,
   R37AI048638, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, R01AI048638,
   U54AI057157, R01AI056499, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   R37AI048638, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, R01AI048638, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, N01AI050025,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   R37AI048638, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   R37AI048638, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R37DK057665, R01DK057665, R01DK057665, R01DK057665, R01DK057665,
   R37DK057665, R37DK057665, R01DK057665, R01DK057665, R37DK057665,
   R37DK057665, R01DK057665, R37DK057665, R01DK057665, R37DK057665,
   R01DK057665, R01DK057665, R01DK057665, R37DK057665, R37DK057665,
   R37DK057665] Funding Source: NIH RePORTER
FX We thank S. A. Mertens and L. Bronner for assistance with cell sorting
   and D. Levesque (Emory Vaccine Center) and D. Bonenberger for assistance
   with maintenance of mice strains at the Emory Vaccine Center vivarium.
   The work in the laboratory of BP was supported by grants U54AI057157,
   R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019,
   and NO1 AI50025 from the National Institutes of Health and a grant from
   the Bill & Melinda Gates Foundation. Microarray accession number is
   GSE2213 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22136).
CR Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240
   Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723
   Brault V, 2001, DEVELOPMENT, V128, P1253
   Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648
   Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239
   Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032
   Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590
   Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511
   Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569
   Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035
   Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657
   Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194
   Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005
   Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925
   Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007
   Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100
   Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108
   Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x
   Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007
   Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017
   Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602
   Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622
   Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720
   Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021
NR 34
TC 346
Z9 354
U1 2
U2 53
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD AUG 13
PY 2010
VL 329
IS 5993
BP 849
EP 853
DI 10.1126/science.1188510
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 637ID
UT WOS:000280809900053
PM 20705860
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Tang, H
   Cao, WP
   Kasturi, SP
   Ravindran, R
   Nakaya, HI
   Kundu, K
   Murthy, N
   Kepler, TB
   Malissen, B
   Pulendran, B
AF Tang, Hua
   Cao, Weiping
   Kasturi, Sudhir Pai
   Ravindran, Rajesh
   Nakaya, Helder I.
   Kundu, Kousik
   Murthy, Niren
   Kepler, Thomas B.
   Malissen, Bernard
   Pulendran, Bali
TI The T helper type 2 response to cysteine proteases requires dendritic
   cell-basophil cooperation via ROS-mediated signaling
SO NATURE IMMUNOLOGY
LA English
DT Article
ID THYMIC STROMAL LYMPHOPOIETIN; IN-VIVO DEPLETION; CUTTING EDGE; OXIDATIVE
   STRESS; IMMUNE-RESPONSE; IL-4 PRODUCTION; DISTINCT; ANTIGEN; INNATE;
   DIFFERENTIATION
AB The mechanisms that initiate T helper type 2 (T(H)2) responses are poorly understood. Here we demonstrate that cysteine protease-induced T(H)2 responses occur via 'cooperation' between migratory dermal dendritic cells (DCs) and basophils positive for interleukin 4 (IL-4). Subcutaneous immunization with papain plus antigen induced reactive oxygen species (ROS) in lymph node DCs and in dermal DCs and epithelial cells of the skin. ROS orchestrated T(H)2 responses by inducing oxidized lipids that triggered the induction of thymic stromal lymphopoietin (TSLP) by epithelial cells mediated by Toll-like receptor 4 (TLR4) and the adaptor protein TRIF; by suppressing production of the T(H)1-inducing molecules IL-12 and CD70 in lymph node DCs; and by inducing the DC-derived chemokine CCL7, which mediated recruitment of IL-4(+) basophils to the lymph node. Thus, the T(H)2 response to cysteine proteases requires DC-basophil cooperation via ROS-mediated signaling.
C1 [Tang, Hua; Cao, Weiping; Kasturi, Sudhir Pai; Ravindran, Rajesh; Nakaya, Helder I.; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA USA.
   [Kundu, Kousik; Murthy, Niren] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Kepler, Thomas B.] Duke Univ, Ctr Computat Immunol, Durham, NC USA.
   [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.
   [Malissen, Bernard] Univ Mediterranee, INSERM, U631,UMR 6102, CNRS,Ctr Immunol Marseille Luminy, Marseille, France.
RP Pulendran, B (corresponding author), Emory Vaccine Ctr, Atlanta, GA USA.
EM bpulend@emory.edu
RI Nakaya, Helder I/A-1397-2010; Malissen, Bernard/AAK-4659-2020; Nakaya,
   Helder/AAF-1738-2020
OI Nakaya, Helder I/0000-0001-5297-9108; Malissen,
   Bernard/0000-0003-1340-9342; Nakaya, Helder/0000-0001-5297-9108; Kepler,
   Thomas/0000-0002-1383-6865
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U54AI057157,
   R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, N01 AI50019,
   N01 AI50025]; Bill & Melinda Gates FoundationBill & Melinda Gates
   Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL096796,
   R01HL096796, R01HL096796, R01HL096796, R01HL096796] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   N01AI050025, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, R37AI048638, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, R37AI048638,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, R37AI048638, U54AI057157, R37AI048638,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   R37AI048638, U19AI057266, U54AI057157, R37AI048638, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   R37AI048638, U54AI057157, U54AI057157, U54AI057157, R37AI048638,
   U19AI057266, U19AI057266, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   R37AI048638, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U19AI057266,
   U19AI057266, U19AI057266, U19AI057266, R37AI048638, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   R37AI048638, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R01DK057665, R01DK057665,
   R01DK057665, R01DK057665, R01DK057665, R01DK057665, R01DK057665,
   R01DK057665, R01DK057665, R01DK057665, R01DK057665] Funding Source: NIH
   RePORTER
FX We thank S. A. Mertens, L. Bronner and Y. Wang for assistance with cell
   sorting; Y. Wang, D. Levesque and D. Bonenberger for assistance with the
   maintenance of mice at the Emory Vaccine Center vivarium; S. Akira
   (Osaka University) for Tlr2<SUP>-/-</SUP>, Tlr3<SUP>-/-</SUP>,
   Tlr4<SUP>-/-</SUP>, Tlr6<SUP>-/-</SUP>, Tlr7<SUP>-/-</SUP>,
   Tlr9<SUP>-/-</SUP>, Myd88<SUP>-/-</SUP> and Ticam1<SUP>lps-2/lps-2</SUP>
   mice; V. Dixit (Genentech) for Nalp3<SUP>-/-</SUP>, Ipaf<SUP>-/-</SUP>
   and Asc<SUP>-/-</SUP> mice; K. A. Hogquist (University of Minnesota) for
   Langerin-EGFP-DTR mice; and J. Witztum (University of California at San
   Diego) for EO6. Supported by the National Institutes of Health
   (U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C,
   N01 AI50019, N01 AI50025) and the Bill & Melinda Gates Foundation.
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017
   Allenspach EJ, 2008, IMMUNITY, V29, P795, DOI 10.1016/j.immuni.2008.08.013
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724
   Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218
   Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6
   Bogunovic M, 2006, J EXP MED, V203, P2627, DOI 10.1084/jem.20060667
   Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751
   Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621
   Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733
   Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340
   Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009
   Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158
   Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935
   Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733
   Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822
   Heffernan MJ, 2009, BIOMATERIALS, V30, P910, DOI 10.1016/j.biomaterials.2008.10.034
   Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741
   Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043
   Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4
   Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598
   Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851
   Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718
   Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587
   McGowen AL, 2009, VACCINE, V27, P3544, DOI 10.1016/j.vaccine.2009.03.069
   Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004
   Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200
   Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590
   Min B, 2008, NAT IMMUNOL, V9, P223, DOI 10.1038/ni0308-223
   Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8
   MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045
   Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022
   Niu N, 2009, J IMMUNOL, V183, P1523, DOI 10.4049/jimmunol.0901349
   Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740
   Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724
   Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036
   Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739
   Riedl MA, 2008, CURR OPIN ALLERGY CL, V8, P49, DOI 10.1097/ACI.0b013e3282f3d913
   Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176
   Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558
   Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738
   Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   URBAN JF, 1992, IMMUNOL REV, V127, P205, DOI 10.1111/j.1600-065X.1992.tb01415.x
   van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311
   Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027
   Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737
   Zhai Y, 2004, J IMMUNOL, V173, P7115, DOI 10.4049/jimmunol.173.12.7115
   Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212
   Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360
NR 58
TC 221
Z9 230
U1 0
U2 30
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD JUL
PY 2010
VL 11
IS 7
BP 608
EP U80
DI 10.1038/ni.1883
PG 12
WC Immunology
SC Immunology
GA 612TO
UT WOS:000278926400017
PM 20495560
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Lage, RC
   Pereira, RA
   Almeida, GT
   Nakaya, H
   Verjovski-Almeida, S
   Oliveira, GC
AF Lage, Regina C.
   Pereira, Rosiane Aparecida
   Almeida, Giulliana Tessarini
   Nakaya, Helder
   Verjovski-Almeida, Sergio
   Oliveira, Guilherme Correa
TI IDENTIFICATION OF GENES AND PROTEINS DIFFERENTIALLY EXPRESSED IN
   SCHISTOSOMA MANSONI ADULT WORMS TREATED WITH PRAZIQUANTEL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 18-22, 2009
CL Washington, DC
SP Amer Soc Trop Med & Hyg
C1 [Lage, Regina C.; Pereira, Rosiane Aparecida; Oliveira, Guilherme Correa] Fiocruz MS, Belo Horizonte, MG, Brazil.
   [Almeida, Giulliana Tessarini; Nakaya, Helder; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Quim, BR-09500900 Sao Paulo, Brazil.
RI Verjovski-Almeida, Sergio/E-4082-2012; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Oliveira, Guilherme/E-2624-2014; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Oliveira, Guilherme/0000-0003-0054-3438;
   Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2009
VL 81
IS 5
SU S
MA 643
BP 183
EP 183
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 521WK
UT WOS:000271956701059
DA 2020-12-17
ER

PT J
AU Moreira, Y
   Nakaya, H
   Egidio, C
   Venancio, T
   Leite, K
   Camara-Lopes, L
   Reis, E
   Verjovski-Almeida, S
AF Moreira, Yuri
   Nakaya, Helder
   Egidio, Camila
   Venancio, Thiago
   Leite, Katia
   Camara-Lopes, Luiz
   Reis, Eduardo
   Verjovski-Almeida, Sergio
TI Identification of noncoding RNAs as marker candidates for prostate
   cancer recurrence prognosis
SO CANCER RESEARCH
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, Sao Paulo, Brazil.
   Hosp SEDrio Libans, Lab Patol Cirurg & Mol, Sao Paulo, Brazil.
RI Nakaya, Helder I/A-1397-2010; LEITE, KATIA RM/C-2055-2008; Nakaya,
   Helder/AAF-1738-2020; Verjovski-Almeida, Sergio/E-4082-2012
OI Nakaya, Helder I/0000-0001-5297-9108; LEITE, KATIA
   RM/0000-0002-2615-7730; Nakaya, Helder/0000-0001-5297-9108;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD MAY 1
PY 2009
VL 69
SU 9
MA 1386
PG 1
WC Oncology
SC Oncology
GA V43ST
UT WOS:000209701803197
DA 2020-12-17
ER

PT J
AU Querec, TD
   Akondy, RS
   Lee, EK
   Cao, WP
   Nakaya, HI
   Teuwen, D
   Pirani, A
   Gernert, K
   Deng, JS
   Marzolf, B
   Kennedy, K
   Wu, HY
   Bennouna, S
   Oluoch, H
   Miller, J
   Vencio, RZ
   Mulligan, M
   Aderem, A
   Ahmed, R
   Pulendran, B
AF Querec, Troy D.
   Akondy, Rama S.
   Lee, Eva K.
   Cao, Weiping
   Nakaya, Helder I.
   Teuwen, Dirk
   Pirani, Ali
   Gernert, Kim
   Deng, Jiusheng
   Marzolf, Bruz
   Kennedy, Kathleen
   Wu, Haiyan
   Bennouna, Soumaya
   Oluoch, Herold
   Miller, Joseph
   Vencio, Ricardo Z.
   Mulligan, Mark
   Aderem, Alan
   Ahmed, Rafi
   Pulendran, Bali
TI Systems biology approach predicts immunogenicity of the yellow fever
   vaccine in humans
SO NATURE IMMUNOLOGY
LA English
DT Article
ID GENE-EXPRESSION PATTERNS; WEST-NILE-VIRUS; ENDOPLASMIC-RETICULUM; CELL;
   CLASSIFICATION; TRANSLATION; RESPONSES; MEDICINE; IMMUNITY; TARGETS
AB A major challenge in vaccinology is to prospectively determine vaccine efficacy. Here we have used a systems biology approach to identify early gene 'signatures' that predicted immune responses in humans vaccinated with yellow fever vaccine YF-17D. Vaccination induced genes that regulate virus innate sensing and type I interferon production. Computational analyses identified a gene signature, including complement protein C1qB and eukaryotic translation initiation factor 2 alpha kinase 4-an orchestrator of the integrated stress response-that correlated with and predicted YF-17D CD8(+) T cell responses with up to 90% accuracy in an independent, blinded trial. A distinct signature, including B cell growth factor TNFRS17, predicted the neutralizing antibody response with up to 100% accuracy. These data highlight the utility of systems biology approaches in predicting vaccine efficacy.
C1 [Querec, Troy D.; Akondy, Rama S.; Cao, Weiping; Nakaya, Helder I.; Deng, Jiusheng; Bennouna, Soumaya; Oluoch, Herold; Miller, Joseph; Mulligan, Mark; Ahmed, Rafi; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Lee, Eva K.] Georgia Inst Technol, Sch Ind & Syst Engn, Ctr Operat Res Med & Healthcare, Atlanta, GA 30332 USA.
   [Teuwen, Dirk] Sanofi Pasteur, Lyon 07, France.
   [Pirani, Ali; Gernert, Kim] Emory Univ, Sch Med, Atlanta, GA 30322 USA.
   [Marzolf, Bruz; Kennedy, Kathleen; Wu, Haiyan; Vencio, Ricardo Z.; Aderem, Alan] Inst Syst Biol, Seattle, WA 98103 USA.
   [Mulligan, Mark] Hope Clin, Decatur, GA 30030 USA.
   [Pulendran, Bali] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
RP Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.
EM bpulend@rmy.emory.edu
RI Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Mulligan,
   Mark/V-9275-2019; Vencio, Ricardo ZN/A-1426-2008; Akondy,
   Rama/AAC-4656-2020
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; Vencio, Ricardo ZN/0000-0003-0425-7877; Querec,
   Troy/0000-0002-3787-6271; Akondy, Rama/0000-0003-4737-5240
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; Sanofi Pasteur;
   Bill & Melinda Gates FoundationBill & Melinda Gates Foundation;  [U19
   AI057266];  [R01 AI048638];  [R01 DK057665];  [U54 AI057157];  [N01
   AI50019];  [N01 AI50025]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR000454, UL1TR000454, UL1TR000454,
   UL1TR000454, UL1TR000454, UL1TR000454, UL1TR000454] Funding Source: NIH
   RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Research Resources (NCRR) [UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008,
   UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008, UL1RR025008] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   R01AI048638, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, R01AI048638,
   U19AI090023, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U19AI090023, U19AI057266, U54AI057157, U19AI090023, U54AI057157,
   U19AI090023, U54AI057157, U19AI057266, U19AI090023, U19AI090023,
   U54AI057157, U54AI057157, U19AI090023, U19AI057266, U19AI057266,
   U54AI057157, U19AI057266, U54AI057157, U19AI090023, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, R01AI048638, U54AI057157, U19AI057266, U54AI057157,
   R01AI048638, U19AI090023, U19AI057266, U54AI057157, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, N01AI050025, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI057266, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, U19AI090023, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U19AI090023, U19AI090023, U19AI090023, U19AI057266,
   U54AI057157, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI057266, U19AI057266, U19AI057266, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U19AI057266, U54AI057157,
   U54AI057157, U54AI057157, U19AI090023, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI057266, U19AI057266, U19AI090023, U19AI057266, U19AI090023,
   U54AI057157, U54AI057157, U19AI090023, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U54AI057157, U19AI057266, U19AI057266,
   U54AI057157, U54AI057157, U54AI057157, U54AI057157, U19AI057266,
   U19AI090023, U54AI057157, U19AI057266, U19AI057266, U54AI057157,
   U54AI057157, U19AI057266, U19AI090023, U19AI057266, U19AI057266,
   U19AI057266, U19AI090023, U54AI057157, U54AI057157, U19AI090023,
   U54AI057157, U19AI090023, U54AI057157, U54AI057157, R01AI048638,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, U19AI057266,
   U19AI090023, U19AI057266, U19AI057266, U19AI057266, U19AI090023,
   U19AI090023, U19AI090023, U54AI057157, U19AI057266, U19AI057266,
   U19AI057266, R01AI048638, U19AI057266, U54AI057157, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U54AI057157,
   U54AI057157, U19AI090023, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U54AI057157, U54AI057157, U54AI057157,
   U54AI057157, U54AI057157, U54AI057157, U19AI090023, U19AI057266,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U54AI057157,
   U19AI090023, U54AI057157, U54AI057157, U19AI090023, U54AI057157,
   U54AI057157, R01AI048638, U19AI090023, U54AI057157, U54AI057157,
   U54AI057157, U19AI057266, U19AI057266, U19AI090023, U19AI057266,
   U19AI057266, U54AI057157, U54AI057157, U19AI090023, U54AI057157,
   U19AI057266, U54AI057157, U19AI057266, U54AI057157, U19AI057266,
   U54AI057157, U54AI057157, R01AI048638, U19AI057266, U54AI057157,
   U19AI057266, U19AI057266, U54AI057157, U54AI057157, U19AI090023,
   U19AI090023, U54AI057157, U54AI057157, U54AI057157] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37DK057665, R01DK057665,
   R01DK057665, R37DK057665, R01DK057665, R37DK057665, R01DK057665,
   R01DK057665, R37DK057665, R01DK057665, R37DK057665, R37DK057665,
   R37DK057665, R01DK057665, R01DK057665, R37DK057665, R01DK057665,
   R37DK057665, R37DK057665, R01DK057665, R01DK057665] Funding Source: NIH
   RePORTER
FX We thank J. Connolly at the Luminex Core at Baylor Institute for
   Immunology Research for doing Luminex analyses, and N. Kozyr (CFAR
   Virology Core, Emory University) for doing RT-PCR. Supported by the US
   National Institutes of Health (U19 AI057266, R01 AI048638, R01 DK057665,
   U54 AI057157, N01 AI50019, N01 AI50025), Sanofi Pasteur and the Bill &
   Melinda Gates Foundation.
CR Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501
   Arimoto KI, 2008, MOL IMMUNOL, V45, P1078, DOI 10.1016/j.molimm.2007.07.021
   Atrasheuskaya AV, 2003, CLIN EXP IMMUNOL, V131, P148, DOI 10.1046/j.1365-2249.2003.02050.x
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073
   Brooks JP, 2008, ANN OPER RES, V164, P1
   Cancro MP, 2006, ANN RHEUM DIS, V65, P34, DOI 10.1136/ard.2006.058412
   Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185
   Dabney AR, 2005, BIOINFORMATICS, V21, P4148, DOI 10.1093/bioinformatics/bti681
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0
   Gallagher RJ, 1997, ANN OPER RES, V74, P65, DOI 10.1023/A:1018943025993
   Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211
   Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7
   Lee EK, 2007, ANN BIOMED ENG, V35, P1095, DOI 10.1007/s10439-007-9317-7
   Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388
   Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Monath TP CM, 2008, VACCINES
   Pantaleo G, 2008, LANCET INFECT DIS, V8, P82, DOI 10.1016/S1473-3099(07)70266-9
   Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491
   Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720
   Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477
   Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260
   Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   STAUB O, 2004, SCI STKE, pPE43
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x
   Theiler M, 2000, Rev Med Virol, V10, P6
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   THEILER M, 2000, REV MED VIROL, V10, P13
   Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103
   Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001
   Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187
NR 37
TC 686
Z9 698
U1 0
U2 89
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
EI 1529-2916
J9 NAT IMMUNOL
JI Nat. Immunol.
PD JAN
PY 2009
VL 10
IS 1
BP 116
EP 125
DI 10.1038/ni.1688
PG 10
WC Immunology
SC Immunology
GA 385BV
UT WOS:000261788800019
PM 19029902
OA Green Accepted
DA 2020-12-17
ER

PT J
AU Varani, AD
   Souza, RC
   Nakaya, HI
   de Lima, WC
   de Almeida, LGP
   Kitajima, EW
   Chen, J
   Civerolo, E
   Vasconcelos, ATR
   Van Sluys, MA
AF Varani, Alessandro de Mello
   Souza, Rangel Celso
   Nakaya, Helder I.
   de Lima, Wanessa Cristina
   Paula de Almeida, Luiz Gonzaga
   Kitajima, Elliot Watanabe
   Chen, Jianchi
   Civerolo, Edwin
   Ribeiro Vasconcelos, Ana Tereza
   Van Sluys, Marie-Anne
TI Origins of the Xylella fastidiosa Prophage-Like Regions and Their Impact
   in Genome Differentiation
SO PLOS ONE
LA English
DT Article
AB Xylella fastidiosa is a Gram negative plant pathogen causing many economically important diseases, and analyses of completely sequenced X. fastidiosa genome strains allowed the identification of many prophage-like elements and possibly phage remnants, accounting for up to 15% of the genome composition. To better evaluate the recent evolution of the X. fastidiosa chromosome backbone among distinct pathovars, the number and location of prophage-like regions on two finished genomes (9a5c and Temecula1), and in two candidate molecules (Ann1 and Dixon) were assessed. Based on comparative best bidirectional hit analyses, the majority (51%) of the predicted genes in the X. fastidiosa prophage-like regions are related to structural phage genes belonging to the Siphoviridae family. Electron micrograph reveals the existence of putative viral particles with similar morphology to lambda phages in the bacterial cell in planta. Moreover, analysis of microarray data indicates that 9a5c strain cultivated under stress conditions presents enhanced expression of phage anti-repressor genes, suggesting switches from lysogenic to lytic cycle of phages under stress-induced situations. Furthermore, virulence-associated proteins and toxins are found within these prophage-like elements, thus suggesting an important role in host adaptation. Finally, clustering analyses of phage integrase genes based on multiple alignment patterns reveal they group in five lineages, all possessing a tyrosine recombinase catalytic domain, and phylogenetically close to other integrases found in phages that are genetic mosaics and able to perform generalized and specialized transduction. Integration sites and tRNA association is also evidenced. In summary, we present comparative and experimental evidence supporting the association and contribution of phage activity on the differentiation of Xylella genomes.
C1 [Varani, Alessandro de Mello; de Lima, Wanessa Cristina; Van Sluys, Marie-Anne] Univ Sao Paulo, Inst Biociencias, Dept Bot, Genome & Transposable Elements Lab GaTE Lab, Sao Paulo, Brazil.
   [Souza, Rangel Celso; Paula de Almeida, Luiz Gonzaga; Ribeiro Vasconcelos, Ana Tereza] Lab Nacl Comput Cient, LABINFO, Rio De Janeiro, Brazil.
   [Nakaya, Helder I.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA USA.
   [Kitajima, Elliot Watanabe] Univ Sao Paulo, ESALQ, Sao Paulo, Brazil.
   [Chen, Jianchi; Civerolo, Edwin] San Joaquin Valley Agr Sci Ctr, Agr Res Serv, USDA, Parlier, CA USA.
RP Varani, AD (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Genome & Transposable Elements Lab GaTE Lab, Sao Paulo, Brazil.
EM mavsluys@gmail.com
RI Nakaya, Helder/AAF-1738-2020; Almeida, Luiz GP/G-5829-2012; Kitajima,
   Elliot W/C-2764-2012; Varani, Alessandro M/F-6887-2011; de Mello Varani,
   Alessandro/AAH-5718-2019; Van Sluys, Marie-Anne/A-8483-2012; Nakaya,
   Helder I/A-1397-2010; Vasconcelos, Ana Tereza R/I-1011-2012
OI Nakaya, Helder/0000-0001-5297-9108; Almeida, Luiz
   GP/0000-0002-7124-2715; Kitajima, Elliot W/0000-0002-9138-2918; Varani,
   Alessandro M/0000-0002-8876-3269; de Mello Varani,
   Alessandro/0000-0002-8876-3269; Van Sluys,
   Marie-Anne/0000-0002-6506-2734; Nakaya, Helder I/0000-0001-5297-9108;
   Vasconcelos, Ana Tereza R/0000-0002-4632-2086
FU CAPESCAPES [PhD fellowship]; FAPESPFundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [fellowship]; USDA-ARSUnited States
   Department of Agriculture (USDA); CNPqNational Council for Scientific
   and Technological Development (CNPq)
FX AMV was recipient of a CAPES PhD fellowship. WCL was recipient of a TT-5
   FAPESP fellowship. The present work was supported by grants from
   USDA-ARS, FAPESP and CNPq to MAVS. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1
   Almeida LGP, 2004, BIOINFORMATICS, V20, P2832, DOI 10.1093/bioinformatics/bth273
   Almeida Luiz G P, 2004, Genet Mol Res, V3, P26
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37
   Asakura M, 2007, P NATL ACAD SCI USA, V104, P14483, DOI 10.1073/pnas.0706695104
   Attwood Terri K, 2002, Brief Bioinform, V3, P252, DOI 10.1093/bib/3.3.252
   Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591
   Berg G, 1996, MICROBIOL RES, V151, P19, DOI 10.1016/S0944-5013(96)80051-6
   Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6
   Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004
   Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9
   Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003
   Casas V, 2007, METHOD ENZYMOL, V421, P259, DOI 10.1016/S0076-6879(06)21020-6
   Chang KH, 1998, BIOCHEM BIOPH RES CO, V245, P313, DOI 10.1006/bbrc.1998.8432
   Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-75
   da Silva JF, 2007, J BACTERIOL, V189, P551, DOI 10.1128/JB.00986-06
   da Silva VS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-474
   Davis BM, 2003, CURR OPIN MICROBIOL, V6, P35, DOI 10.1016/S1369-5274(02)00005-X
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Felsenstein J, 2005, PHYLIP PHYLOGENY INF
   Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908
   Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082
   Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641
   Hagemann M, 2006, ARCH MICROBIOL, V185, P449, DOI 10.1007/s00203-006-0115-7
   Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092
   Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004
   Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590
   Holden BJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-289
   JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x
   Koide T, 2006, GENET MOL RES, V5, P93
   Koide T, 2006, J BACTERIOL, V188, P5821, DOI 10.1128/JB.00182-06
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002
   Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07
   Manson JM, 2006, MOL MICROBIOL, V61, P555, DOI 10.1111/j.1365-2958.2006.05262.x
   Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X
   Ohnishi M, 2001, TRENDS MICROBIOL, V9, P481, DOI 10.1016/S0966-842X(01)02173-4
   Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896
   Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248
   Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2
   Resch G, 2004, J BACTERIOL, V186, P5523, DOI 10.1128/JB.186.16.5523-5528.2004
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33
   Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103
   Treangen TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-433
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902
   Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003
   Vencio RZN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-86
   Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866
   Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000
NR 57
TC 33
Z9 33
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2008
VL 3
IS 12
AR e4059
DI 10.1371/journal.pone.0004059
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437DO
UT WOS:000265466600002
PM 19116666
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Louro, R
   El-Jundi, T
   Nakaya, HI
   Reis, EM
   Verjovski-Almeida, S
AF Louro, Rodrigo
   El-Jundi, Tarik
   Nakaya, Helder I.
   Reis, Eduardo M.
   Verjovski-Almeida, Sergio
TI Conserved tissue expression signatures of intronic noncoding RNAs
   transcribed from human and mouse loci
SO GENOMICS
LA English
DT Article
DE noncoding RNAs; tissue-specific gene expression; evolutionary
   conservation; human-mouse transcripts; cross-species microarray
ID ANTISENSE TRANSCRIPTION; IDENTIFICATION; SEQUENCE; MICROARRAY;
   EVOLUTION; GENOME; GENES; MICRORNAS; ELEMENTS; REVEAL
AB It has been postulated that noncoding RNAs (ncRNAs) are involved in the posttranscriptional control of gene expression, and may have contributed to the emergence of the complex attributes observed in mammalians. We show here that the complement of ncRNAs expressed from intronic regions of the human and mouse genomes comprises at least 78,147 and 39,660 transcriptional units, respectively. To identify conserved intronic sequences expressed in both humans and mice, we used custom-designed human cDNA microarrays to separately interrogate RNA from mouse and human liver, kidney, and prostate tissues. An overlapping tissue expression signature was detected for both species, comprising 198 transcripts; among these, 22 RNAs map to intronic regions with evidence of evolutionary conservation in humans and mice. Transcription of selected human-mouse intronic ncRNAs was confirmed using strand-specific RT-PCR. Altogether, these results support an evolutionarily conserved role of intronic ncRNAs in human and mouse, which are likely to be involved in the fine tuning of gene expression regulation in different mammalian tissues. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Louro, Rodrigo; El-Jundi, Tarik; Nakaya, Helder I.; Reis, Eduardo M.; Verjovski-Almeida, Sergio] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
RP Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
EM verjo@iq.usp.br
RI Verjovski-Almeida, Sergio/E-4082-2012; Reis, Eduardo M/H-2008-2011;
   Nakaya, Helder I/A-1397-2010; Reis, Eduardo Moraes Rego/AAF-3553-2020;
   Verjovski-Almeida, Sergio/AAI-2728-2020; Nakaya, Helder/AAF-1738-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Reis, Eduardo
   M/0000-0002-9556-3070; Nakaya, Helder I/0000-0001-5297-9108; Reis,
   Eduardo Moraes Rego/0000-0002-9556-3070; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Nakaya, Helder/0000-0001-5297-9108
CR Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887
   Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388
   Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Carninci P, 2007, CURR OPIN GENET DEV, V17, P139, DOI 10.1016/j.gde.2007.02.008
   Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818
   Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527
   DeSilva U, 2002, GENOME RES, V12, P3, DOI 10.1101/gr.214802
   DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315
   Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429
   Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959
   Hill AE, 2006, FRONT BIOSCI-LANDMRK, V11, P1998, DOI 10.2741/1941
   Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104
   Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136
   Louro R, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-4
   Makalowski W, 1996, GENOME RES, V6, P846, DOI 10.1101/gr.6.9.846
   Manzella L, 2000, EXP CELL RES, V256, P248, DOI 10.1006/excr.1999.4794
   Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203
   Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046
   Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951
   Misra S., 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0083, DOI 10.1186/GB-2002-3-12-RESEARCH0083]
   Moody DE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-27
   Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43
   Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603
   Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266
   Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504
   Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003
   Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206
   Reis EM, 2005, OMICS, V9, P2, DOI 10.1089/omi.2005.9.2
   Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880
   Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203
   Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204
   Ryan D, 2006, MOL VIS, V12, P1175
   Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99
   Torarinsson E, 2006, GENOME RES, V16, P885, DOI 10.1101/gr.5226606
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Vallee M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-113
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009
   Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007
   Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808
NR 46
TC 46
Z9 50
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0888-7543
EI 1089-8646
J9 GENOMICS
JI Genomics
PD JUL
PY 2008
VL 92
IS 1
BP 18
EP 25
DI 10.1016/j.ygeno.2008.03.013
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 323TK
UT WOS:000257471100003
PM 18495418
DA 2020-12-17
ER

PT J
AU Zaini, PA
   Fogaca, AC
   Lupo, FGN
   Nakaya, HI
   Vencio, RZN
   da Silva, AM
AF Zaini, Paulo A.
   Fogaca, Andrea C.
   Lupo, Fernanda G. N.
   Nakaya, Helder I.
   Vencio, Ricardo Z. N.
   da Silva, Aline M.
TI The iron stimulon of Xylella fastidiosa includes genes for type IV pilus
   and colicin V-like bacteriocins
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID CITRUS VARIEGATED CHLOROSIS; FERRIC UPTAKE REGULATOR; HEAT-SHOCK
   RESPONSE; PSEUDOMONAS-AERUGINOSA; CAMPYLOBACTER-JEJUNI;
   HELICOBACTER-PYLORI; STAPHYLOCOCCUS-AUREUS; NEISSERIA-GONORRHOEAE;
   TWITCHING MOTILITY; BIOFILM FORMATION
AB Xylella fastidiosa is the etiologic agent of a wide range of plant diseases, including citrus variegated chlorosis (CVC), a major threat to citrus industry. The genomes of several strains of this phytopathogen were completely sequenced, enabling large-scale functional studies. DNA microarrays representing 2,608 (91.6%) coding sequences (CDS) of X. fastidiosa CVC strain 9a5c were used to investigate transcript levels during growth with different iron availabilities. When treated with the iron chelator 2,2'-dipyridyl, 193 CDS were considered up-regulated and 216 were considered down-regulated. Upon incubation with 100 mu M ferric pyrophosphate, 218 and 256 CDS were considered up- and down-regulated, respectively. Differential expression for a subset of 44 CDS was further evaluated by reverse transcription-quantitative PCR. Several CDS involved with regulatory functions, pathogenicity, and cell structure were modulated under both conditions assayed, suggesting that major changes in cell architecture and metabolism occur when X. fastidiosa cells are exposed to extreme variations in iron concentration. Interestingly, the modulated CDS include those related to colicin V-like bacteriocin synthesis and secretion and to functions of pili/fimbriae. We also investigated the contribution of the ferric uptake regulator Fur to the iron stimulon of X. fastidiosa. The promoter regions of the strain 9a5c genome were screened for putative Fur boxes, and candidates were analyzed by electrophoretic mobility shift assays. Taken together, our data support the hypothesis that Fur is not solely responsible for the modulation of the iron stimulon of X fastidiosa, and they present novel evidence for iron regulation of pathogenicity determinants.
C1 [Zaini, Paulo A.; Fogaca, Andrea C.; Lupo, Fernanda G. N.; Nakaya, Helder I.; da Silva, Aline M.] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, Brazil.
   [Vencio, Ricardo Z. N.] Univ Sao Paulo, Programa Posgrad Interunidades Bioinformat, BR-05508000 Sao Paulo, Brazil.
RP da Silva, AM (corresponding author), Univ Sao Paulo, Dept Bioquim, Inst Quim, Av Prof Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil.
EM almsilva@iq.usp.br
RI Nakaya, Helder/AAF-1738-2020; Fogaca, Andrea/C-1322-2012; Nakaya, Helder
   I/A-1397-2010; da Silva, Aline M./C-3649-2012; Vencio, Ricardo
   ZN/A-1426-2008; Fogaca, Andrea C/M-4267-2013
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder
   I/0000-0001-5297-9108; da Silva, Aline M./0000-0001-9249-4922; Vencio,
   Ricardo ZN/0000-0003-0425-7877; Fogaca, Andrea/0000-0002-0890-6136
CR Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X
   Ausubel F. M., 1995, CURRENT PROTOCOLS MO
   Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x
   Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x
   Basler M, 2006, PROTEOMICS, V6, P6194, DOI 10.1002/pmic.200600312
   Bereswill S, 2000, J BACTERIOL, V182, P5948, DOI 10.1128/JB.182.21.5948-5953.2000
   BERISH SA, 1993, INFECT IMMUN, V61, P4599, DOI 10.1128/IAI.61.11.4599-4606.1993
   Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003
   Boyer AE, 1998, J BACTERIOL, V180, P1662, DOI 10.1128/JB.180.7.1662-1672.1998
   CHAUHAN S, 1993, J BACTERIOL, V175, P7222, DOI 10.1128/JB.175.22.7222-7227.1993
   Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x
   Simionato AVC, 2007, J MASS SPECTROM, V42, P490, DOI 10.1002/jms.1181
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Cui YY, 2005, J BACTERIOL, V187, P4792, DOI 10.1128/JB.187.14.4792-4803.2005
   da Silva JF, 2007, J BACTERIOL, V189, P551, DOI 10.1128/JB.00986-06
   DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883
   de Peredo AG, 2001, J MOL BIOL, V310, P83, DOI 10.1006/jmbi.2001.4769
   de Souza AA, 2003, MOL PLANT MICROBE IN, V16, P867, DOI 10.1094/MPMI.2003.16.10.867
   Delany I, 2003, J BACTERIOL, V185, P6032, DOI 10.1128/JB.185.20.6032-6041.2003
   DELORENZO V, 1988, J MOL BIOL, V203, P875, DOI 10.1016/0022-2836(88)90113-1
   Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05
   DeReuse H, 1997, RES MICROBIOL, V148, P289, DOI 10.1016/S0923-2508(97)81585-9
   Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72
   Ducey TF, 2005, J BACTERIOL, V187, P4865, DOI 10.1128/JB.187.14.4865-4874.2005
   Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005
   Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0
   Expert D, 1999, ANNU REV PHYTOPATHOL, V37, P307, DOI 10.1146/annurev.phyto.37.1.307
   FATH MJ, 1989, J BACTERIOL, V171, P3158, DOI 10.1128/jb.171.6.3158-3161.1989
   Feil H, 2003, PHYTOPATHOLOGY, V93, P675, DOI 10.1094/PHYTO.2003.93.6.675
   GILSON L, 1987, J BACTERIOL, V169, P2466, DOI 10.1128/jb.169.6.2466-2470.1987
   Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856
   Hamza I, 2000, MICROBIOL-SGM, V146, P669, DOI 10.1099/00221287-146-3-669
   HAVARSTEIN LS, 1994, MICROBIOL-SGM, V140, P2383, DOI 10.1099/13500872-140-9-2383
   Hendrickson EL, 2001, J BACTERIOL, V183, P7126, DOI 10.1128/JB.183.24.7126-7134.2001
   Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0
   Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001
   Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003
   Juhas M, 2004, MICROBIOL-SGM, V150, P831, DOI 10.1099/mic.0.26906-0
   KAHN D, 1991, MOL MICROBIOL, V5, P987, DOI 10.1111/j.1365-2958.1991.tb00774.x
   Koide T, 2004, J BACTERIOL, V186, P5442, DOI 10.1128/JB.186.16.5442-5449.2004
   Koide T, 2006, J BACTERIOL, V188, P5821, DOI 10.1128/JB.00182-06
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003
   Li WB, 1999, CURR MICROBIOL, V39, P106, DOI 10.1007/s002849900428
   Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LORY S, 1986, J BACTERIOL, V168, P1451, DOI 10.1128/jb.168.3.1451-1456.1986
   Luke NR, 2004, INFECT IMMUN, V72, P6262, DOI 10.1128/IAI.72.11.6262-6270.2004
   Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454
   Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599
   Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103
   Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938
   Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005
   Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003
   Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005
   Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06
   Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x
   Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06
   Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100
   Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003
   Ocaktan A, 1997, J BIOL CHEM, V272, P21964, DOI 10.1074/jbc.272.35.21964
   OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995
   Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x
   Osiro D, 2004, FEMS MICROBIOL LETT, V236, P313, DOI 10.1016/j.femsle.2004.06.003
   Osorio CR, 2004, BIOMETALS, V17, P725, DOI 10.1007/s10534-004-1652-7
   Palyada K, 2004, J BACTERIOL, V186, P4714, DOI 10.1128/JB.186.14.4714-4729.2004
   Parker D, 2006, J BACTERIOL, V188, P4801, DOI 10.1128/JB.00255-06
   Pashalidis S, 2005, OMICS, V9, P77, DOI 10.1089/omi.2005.9.77
   Poole K, 2003, FRONT BIOSCI-LANDMRK, V8, pD661, DOI 10.2741/1051
   POOLE K, 1993, MOL MICROBIOL, V10, P529, DOI 10.1111/j.1365-2958.1993.tb00925.x
   POSTLE K, 1990, J BACTERIOL, V172, P2287, DOI 10.1128/jb.172.5.2287-2293.1990
   Quatrini R, 2005, MICROBIOL-SGM, V151, P2005, DOI 10.1099/mic.0.27581-0
   Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881
   Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001
   SACCO M, 1995, J BACTERIOL, V177, P372, DOI 10.1128/jb.177.2.372-377.1995
   SAUVAGE C, 1994, MOL PLANT MICROBE IN, V7, P71, DOI 10.1094/MPMI-7-0071
   Scarpari LM, 2003, FEMS MICROBIOL LETT, V222, P83, DOI 10.1016/S0378-1097(03)00251-9
   Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046
   Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003
   SITNIKOV DM, 1995, MOL MICROBIOL, V17, P801, DOI 10.1111/j.1365-2958.1995.mmi_17050801.x
   Thomson NR, 1997, MOL MICROBIOL, V26, P531, DOI 10.1046/j.1365-2958.1997.5981976.x
   Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003
   Vencio RZN, 2005, DNA RES, V12, P211, DOI 10.1093/dnares/dsi007
   Wan XF, 2004, J BACTERIOL, V186, P8385, DOI 10.1128/JB.186.24.8385-8400.2004
   WATERS VL, 1991, MICROBIOL REV, V55, P437, DOI 10.1128/MMBR.55.3.437-450.1991
   Whitmire JM, 2007, CURR MED CHEM, V14, P469, DOI 10.2174/092986707779941069
   Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101
   Wolfe AJ, 2004, APPL ENVIRON MICROB, V70, P2520, DOI 10.1128/AEM.70.4.2520-2524.2004
   Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200
NR 91
TC 29
Z9 29
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD APR
PY 2008
VL 190
IS 7
BP 2368
EP 2378
DI 10.1128/JB.01495-07
PG 11
WC Microbiology
SC Microbiology
GA 278YX
UT WOS:000254323300015
PM 18223091
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Beckedorff, FC
   Baldini, ML
   Fachel, AA
   Reis, EM
   Verjovski-Almeida, S
AF Nakaya, Helder I.
   Beckedorff, Felipe C.
   Baldini, Maria L.
   Fachel, Angela A.
   Reis, Eduardo M.
   Verjovski-Almeida, Sergio
TI Splice variants of TLE family genes and up-regulation of a TLE3 isoform
   in prostate tumors
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Groucho/Transducin-like enhancer of split (TLE) gene family; alternative
   splicing; non-coding RNA; microarray; transcription analysis; introns;
   prostate cancer
ID TRANSCRIPTIONAL REPRESSOR; GROUCHO; PROTEIN; SEGMENTATION; NEUROGENESIS;
   INTERACTS; ENHANCER
AB The TLE genes constitute a family of important transcriptional co-repressors involved in many cellular processes. We found evidence of alternatively spliced mRNAs for human TLE1-4 containing premature stop codons, thus encoding putative shortened proteins. Microarray experiments and Real-time RT-PCR assays showed that alternatively spliced isoforms of TLE1, TLE2 and TLE3 were preferentially expressed in prostate in comparison to liver and kidney tissues. We identified by orientation-specific RT-PCR an antisense partially intronic non-coding RNA that overlaps a novel exon of the TLE3 gene, raising the possibility of regulation of alternative splicing by this non-coding transcript. The alternatively spliced isoform of TLE3 was up-regulated (6- to 17-fold) in prostate tumors in comparison to matched non-tumor adjacent tissue from 7 out of 11 (64%) patients and in four prostate tumor cell lines in comparison to a normal prostate cell line. These results demonstrate that different isoforms of TLE genes are commonly transcribed in human tissues and suggest that TLE3 could be involved in prostate cancer development. (C) 2007 Elsevier Inc. All rights reserved.
C1 Univ Sao Paulo, Dept Biochim, Inst Quim, BR-05508900 Sao Paulo, Brazil.
RP Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Dept Biochim, Inst Quim, BR-05508900 Sao Paulo, Brazil.
EM verjo@iq.usp.br
RI Verjovski-Almeida, Sergio/E-4082-2012; Beckedorff, Felipe C/E-6288-2012;
   Reis, Eduardo M/H-2008-2011; Fachel, Angela/C-6944-2012; Nakaya, Helder
   I/A-1397-2010; Reis, Eduardo Moraes Rego/AAF-3553-2020; Nakaya,
   Helder/AAF-1738-2020; Beckedorff, Felipe/AAJ-9930-2020;
   Verjovski-Almeida, Sergio/AAI-2728-2020
OI Verjovski-Almeida, Sergio/0000-0002-6356-2401; Beckedorff, Felipe
   C/0000-0001-6735-6851; Reis, Eduardo M/0000-0002-9556-3070; Fachel,
   Angela/0000-0003-4271-8240; Nakaya, Helder I/0000-0001-5297-9108; Reis,
   Eduardo Moraes Rego/0000-0002-9556-3070; Nakaya,
   Helder/0000-0001-5297-9108; Beckedorff, Felipe/0000-0001-6735-6851;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401
CR Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8
   Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X
   DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1
   Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476
   Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x
   Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019
   Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138
   Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024
   Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4
   Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200
   Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590
   Li ZY, 2006, CURR MED CHEM, V13, P1693, DOI 10.2174/092986706777441995
   Milili M, 2002, IMMUNOLOGY, V106, P447, DOI 10.1046/j.1365-2567.2002.01456.x
   Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43
   PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1
   Peixoto BR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-35
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880
   Shendure J, 2002, GENOME BIOL, V3
   Swingler TE, 2004, J BIOL CHEM, V279, P34938, DOI 10.1074/jbc.M404488200
   Yan MD, 2005, HUM MOL GENET, V14, P1465, DOI 10.1093/hmg/ddi156
NR 21
TC 10
Z9 11
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 28
PY 2007
VL 364
IS 4
BP 918
EP 923
DI 10.1016/j.bbrc.2007.10.097
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 237FB
UT WOS:000251358500034
PM 18273443
DA 2020-12-17
ER

PT J
AU Louro, R
   Nakaya, HI
   Amaral, PP
   Festa, F
   Sogayar, MC
   da Silva, AM
   Verjovski-Almeida, S
   Reis, EM
AF Louro, Rodrigo
   Nakaya, Helder I.
   Amaral, Paulo P.
   Festa, Fernanda
   Sogayar, Mari C.
   da Silva, Aline M.
   Verjovski-Almeida, Sergio
   Reis, Eduardo M.
TI Androgen responsive intronic non-coding RNAs
SO BMC BIOLOGY
LA English
DT Article
ID ANTISENSE TRANSCRIPTION; MYOSIN-VA; EXPRESSION; GENE; IDENTIFICATION;
   BINDING; HUMAN-CHROMOSOME-21; DATABASE; GENOME; SENSE
AB Background: Transcription of large numbers of non-coding RNAs originating from intronic regions of human genes has been recently reported, but mechanisms governing their biosynthesis and biological functions are largely unknown. In this work, we evaluated the existence of a common mechanism of transcription regulation shared by protein-coding mRNAs and intronic RNAs by measuring the effect of androgen on the transcriptional profile of a prostate cancer cell line.
   Results: Using a custom-built cDNA microarray enriched in intronic transcribed sequences, we found 39 intronic non-coding RNAs for which levels were significantly regulated by androgen exposure. Orientation-specific reverse transcription-PCR indicated that 10 of the 13 were transcribed in the antisense direction. These transcripts are long (0.5-5 kb), unspliced and apparently do not code for proteins. Interestingly, we found that the relative levels of androgen-regulated intronic transcripts could be correlated with the levels of the corresponding protein-coding gene (asGAS6 and asDNAJC3) or with the alternative usage of exons (asKDELR2 and asITGA6) in the corresponding protein-coding transcripts. Binding of the androgen receptor to a putative regulatory region upstream from asMYO5A, an androgen-regulated antisense intronic transcript, was confirmed by chromatin immunoprecipitation.
   Conclusion: Altogether, these results indicate that at least a fraction of naturally transcribed intronic non-coding RNAs may be regulated by common physiological signals such as hormones, and further corroborate the notion that the intronic complement of the transcriptome play functional roles in the human gene-expression program.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
RP Reis, EM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
EM rolouro@iq.usp.br; hnakaya@iq.usp.br; ppamaral@iq.usp.br;
   fernanda@cecm.usp.br; mcsoga@iq.usp.br; almsilva@iq.usp.br;
   verjo@iq.usp.br; emreis@iq.usp.br
RI Reis, Eduardo Moraes Rego/AAF-3553-2020; Sogayar, Mari C/B-3980-2017;
   Reis, Eduardo M/H-2008-2011; Nakaya, Helder/AAF-1738-2020;
   Verjovski-Almeida, Sergio/AAI-2728-2020; Nakaya, Helder I/A-1397-2010;
   da Silva, Aline M./C-3649-2012; Verjovski-Almeida, Sergio/E-4082-2012
OI Reis, Eduardo Moraes Rego/0000-0002-9556-3070; Sogayar, Mari
   C/0000-0003-4805-4609; Reis, Eduardo M/0000-0002-9556-3070; Nakaya,
   Helder/0000-0001-5297-9108; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Nakaya, Helder I/0000-0001-5297-9108; da
   Silva, Aline M./0000-0001-9249-4922; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; de Paiva Amaral, Paulo/0000-0002-6696-5142;
   Festa, Fernanda/0000-0002-2822-823X
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Au JSY, 2002, CELL MOTIL CYTOSKEL, V53, P89, DOI 10.1002/cm.10061
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8
   Chen H, 2003, J BIOL CHEM, V278, P3121, DOI 10.1074/jbc.M208230200
   Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   DePrimo SE, 2002, GENOME BIOL, V3
   Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004
   Geck P, 1997, J STEROID BIOCHEM, V63, P211, DOI 10.1016/S0960-0760(97)00122-2
   Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023
   Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159
   ISAACS JT, 1992, J ANDROL, V13, P457
   Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138
   Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928
   Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009
   Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104
   Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305
   Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009
   Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265
   Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3
   Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903
   Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734
   Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Ma J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r22
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069
   Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321
   Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299
   Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491
   Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266
   Peixoto BR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-35
   Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0
   Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206
   Reis EM, 2005, OMICS, V9, P2, DOI 10.1089/omi.2005.9.2
   Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880
   Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704
   Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265
   Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101
   Shendure J, 2002, GENOME BIOL, V3
   Shim M, 2005, J BIOL CHEM, V280, P18636, DOI 10.1074/jbc.M414613200
   Swinnen JV, 1998, J STEROID BIOCHEM, V65, P191, DOI 10.1016/S0960-0760(97)00187-8
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252
   Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009
   Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214
   Xu LL, 2001, INT J CANCER, V92, P322, DOI 10.1002/ijc.1196
   Yan MD, 2005, HUM MOL GENET, V14, P1465, DOI 10.1093/hmg/ddi156
   Yang CC, 2006, MOL PHARMACOL, V69, P1564, DOI 10.1124/mol.105.018333
   Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808
NR 57
TC 50
Z9 55
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD JAN 30
PY 2007
VL 5
AR 4
DI 10.1186/1741-7007-5-4
PG 14
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 136VP
UT WOS:000244252500001
PM 17263875
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Nakaya, HI
   Amaral, PP
   Louro, R
   Lopes, A
   Fachel, AA
   Moreira, YB
   El-Jundi, TA
   da Silva, AM
   Reis, EM
   Verjovski-Almeida, S
AF Nakaya, Helder I.
   Amaral, Paulo P.
   Louro, Rodrigo
   Lopes, Andre
   Fachel, Angela A.
   Moreira, Yuri B.
   El-Jundi, Tarik A.
   da Silva, Aline M.
   Reis, Eduardo M.
   Verjovski-Almeida, Sergio
TI Genome mapping and expression analyses of human intronic noncoding RNAs
   reveal tissue-specific patterns and enrichment in genes related to
   regulation of transcription
SO GENOME BIOLOGY
LA English
DT Article
ID ANTISENSE TRANSCRIPTS; TILING ARRAYS; IDENTIFICATION; MICROARRAYS;
   SEQUENCES; MICRORNA; ELEMENTS; MOUSE; CANCER; HUMAN-CHROMOSOME-21
AB Background: RNAs transcribed from intronic regions of genes are involved in a number of processes related to post-transcriptional control of gene expression. However, the complement of human genes in which introns are transcribed, and the number of intronic transcriptional units and their tissue expression patterns are not known.
   Results: A survey of mRNA and EST public databases revealed more than 55,000 totally intronic noncoding (TIN) RNAs transcribed from the introns of 74% of all unique RefSeq genes. Guided by this information, we designed an oligoarray platform containing sense and antisense probes for each of 7,135 randomly selected TIN transcripts plus the corresponding protein-coding genes. We identified exonic and intronic tissue-specific expression signatures for human liver, prostate and kidney. The most highly expressed antisense TIN RNAs were transcribed from introns of proteincoding genes significantly enriched (p = 0.002 to 0.022) in the 'Regulation of transcription' Gene Ontology category. RNA polymerase II inhibition resulted in increased expression of a fraction of intronic RNAs in cell cultures, suggesting that other RNA polymerases may be involved in their biosynthesis. Members of a subset of intronic and protein-coding signatures transcribed from the same genomic loci have correlated expression patterns, suggesting that intronic RNAs regulate the abundance or the pattern of exon usage in protein-coding messages.
   Conclusion: We have identified diverse intronic RNA expression patterns, pointing to distinct regulatory roles. This gene-oriented approach, using a combined intron-exon oligoarray, should permit further comparative analysis of intronic transcription under various physiological and pathological conditions, thus advancing current knowledge about the biological functions of these noncoding RNAs.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
RP Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
EM verjo@iq.usp.br
RI Reis, Eduardo Moraes Rego/AAF-3553-2020; Nakaya, Helder/AAF-1738-2020;
   da Silva, Aline M./C-3649-2012; Fachel, Angela/C-6944-2012; Nakaya,
   Helder I/A-1397-2010; Reis, Eduardo M/H-2008-2011; Verjovski-Almeida,
   Sergio/E-4082-2012; Verjovski-Almeida, Sergio/AAI-2728-2020
OI Reis, Eduardo Moraes Rego/0000-0002-9556-3070; Nakaya,
   Helder/0000-0001-5297-9108; da Silva, Aline M./0000-0001-9249-4922;
   Fachel, Angela/0000-0003-4271-8240; Nakaya, Helder
   I/0000-0001-5297-9108; Reis, Eduardo M/0000-0002-9556-3070;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; de Paiva Amaral, Paulo/0000-0002-6696-5142
CR Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119
   Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388
   Bruno IG, 2004, HUM MOL GENET, V13, P2409, DOI 10.1093/hmg/ddh272
   Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8
   Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818
   Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625
   Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451
   Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001
   Dahary D, 2005, GENOME RES, V15, P364, DOI 10.1101/gr.3308405
   De Angelis FG, 2002, P NATL ACAD SCI USA, V99, P9456, DOI 10.1073/pnas.142302299
   Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070
   Ferguson DA, 2005, GENE EXPR PATTERNS, V5, P619, DOI 10.1016/j.modgep.2005.03.003
   Geirsson A, 2003, BIOCHEM BIOPH RES CO, V301, P718, DOI 10.1016/S0006-291X(03)00028-7
   Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531
   Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946
   Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081
   Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023
   Gupta S, 2004, BIOINFORMATICS, V20, P2579, DOI 10.1093/bioinformatics/bth288
   Hill AE, 2006, FRONT BIOSCI-LANDMRK, V11, P1998, DOI 10.2741/1941
   Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730
   Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138
   Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100
   Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104
   Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001
   Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305
   Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597
   KHOCHBIN S, 1989, EMBO J, V8, P4107, DOI 10.1002/j.1460-2075.1989.tb08595.x
   Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3
   Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903
   Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848
   KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538
   Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321
   Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046
   Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028
   McClorey G, 2005, CURR OPIN PHARMACOL, V5, P529, DOI 10.1016/j.coph.2005.06.001
   Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159
   Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266
   Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089
   Peixoto BR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-35
   Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113
   Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899
   Reis EM, 2005, CANCER RES, V65, P1693, DOI 10.1158/0008-5472.CAN-04-3506
   Reis EM, 2005, OMICS, V9, P2, DOI 10.1089/omi.2005.9.2
   Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880
   Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103
   Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203
   Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704
   Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705
   Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shendure J, 2002, GENOME BIOL, V3
   Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306
   Sironi M, 2005, HUM MOL GENET, V14, P2533, DOI 10.1093/hmg/ddi257
   Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028
   Thanaraj TA, 2003, NUCLEIC ACIDS RES, V31, P2544, DOI 10.1093/nar/gkg355
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Vinogradov AE, 2006, GENOME RES, V16, P347, DOI 10.1101/gr.4318206
   Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006
   Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901
   Yan MD, 2005, HUM MOL GENET, V14, P1465, DOI 10.1093/hmg/ddi156
   Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808
NR 64
TC 146
Z9 158
U1 1
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2007
VL 8
IS 3
AR R43
DI 10.1186/gb-2007-8-3-r43
PG 25
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 162IX
UT WOS:000246081600012
PM 17386095
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Reis, EM
   Louro, R
   Nakaya, HI
   Verjovski-Almeida, S
AF Reis, EM
   Louro, R
   Nakaya, HI
   Verjovski-Almeida, S
TI As antisense RNA gets intronic
SO OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
LA English
DT Review
ID MESSENGER-RNA; TRANSCRIPTIONAL ACTIVITY; MICRORNA GENES; BINDING SITES;
   EXPRESSION; SEQUENCES; GENOME; IDENTIFICATION; HUMAN-CHROMOSOME-21;
   DIFFERENTIATION
AB Recent work describing the transcriptional output of the human genome points to the existence of a significant number of non-coding RNA transcripts coming from intronic regions, with a fraction of these being oriented antisense relative to the protein-coding mRNA of the known gene. In this article, we survey the main findings of the large-scale expression analysis projects that led to the identification of antisense intronic messages and which demonstrate their ubiquitous expression in the human genome. We review the current knowledge on long, unspliced, intronic antisense transcripts, a new class of non-coding RNAs, recently described by our group to be correlated with the degree of tumor differentiation in prostate cancer, which we postulate is involved in the fine tuning of gene expression in eukaryotes. Possible mechanisms of antisense intronic transcript biogenesis and function in gene expression regulation are discussed, as is their involvement in human diseases. While there is still no conclusive evidence demonstrating a functional role for these long, intronic antisense messages, the far-reaching implications of their existence for the mechanisms regulating gene expression certainly warrant further experimentation.
C1 Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
RP Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
EM verjo@iq.usp.br
RI Reis, Eduardo Moraes Rego/AAF-3553-2020; Verjovski-Almeida,
   Sergio/E-4082-2012; Nakaya, Helder/AAF-1738-2020; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Reis, Eduardo M/H-2008-2011; Nakaya, Helder
   I/A-1397-2010
OI Reis, Eduardo Moraes Rego/0000-0002-9556-3070; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Nakaya, Helder/0000-0001-5297-9108;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Reis, Eduardo
   M/0000-0002-9556-3070; Nakaya, Helder I/0000-0001-5297-9108
CR Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169
   Akker SA, 2001, J MOL ENDOCRINOL, V27, P123, DOI 10.1677/jme.0.0270123
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501
   Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388
   Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720
   Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4
   Bruno IG, 2004, HUM MOL GENET, V13, P2409, DOI 10.1093/hmg/ddh272
   Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101
   Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101
   Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8
   Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004
   FARRELL CM, 1995, J BIOL CHEM, V270, P3400, DOI 10.1074/jbc.270.7.3400
   Friedman KJ, 1999, J BIOL CHEM, V274, P36193, DOI 10.1074/jbc.274.51.36193
   Gebuhr TC, 2000, GENESIS, V26, P189, DOI 10.1002/(SICI)1526-968X(200003)26:3<189::AID-GENE4>3.0.CO;2-5
   Hastings ML, 1997, NUCLEIC ACIDS RES, V25, P4296, DOI 10.1093/nar/25.21.4296
   Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507
   Huang C, 2003, CURR OPIN GENET DEV, V13, P246, DOI 10.1016/S0959-437X(03)00054-6
   Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159
   Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E
   Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104
   Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597
   Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903
   KRYSTAL GW, 1990, MOL CELL BIOL, V10, P4180, DOI 10.1128/MCB.10.8.4180
   Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542
   Lacerra G, 2000, P NATL ACAD SCI USA, V97, P9591, DOI 10.1073/pnas.97.17.9591
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100
   Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321
   Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332
   Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872
   Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200
   MUNROE SH, 1991, J BIOL CHEM, V266, P22083
   NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x
   NOGUCHI M, 1994, J BIOL CHEM, V269, P29161
   Pelissier T, 2000, RNA, V6, P55, DOI 10.1017/S135583820099201X
   Peters NT, 2003, RNA, V9, P698, DOI 10.1261/rna.2120703
   Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899
   Reis EM, 2004, ONCOGENE, V23, P6684, DOI 10.1038/sj.onc.1207880
   Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203
   Shendure J, 2002, GENOME BIOL, V3
   Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141
   Sierakowska H, 1996, P NATL ACAD SCI USA, V93, P12840, DOI 10.1073/pnas.93.23.12840
   SILVERMAN TA, 1992, J BIOL CHEM, V267, P9738
   Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a
   Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9
   Sorek R, 2003, NUCLEIC ACIDS RES, V31, P1067, DOI 10.1093/nar/gkg170
   Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312
   Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157
   van der Vlag J, 1999, NAT GENET, V23, P474
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8
   Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631
   Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808
   Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4
NR 60
TC 26
Z9 29
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1536-2310
EI 1557-8100
J9 OMICS
JI OMICS
PD MAR
PY 2005
VL 9
IS 1
BP 2
EP 12
DI 10.1089/omi.2005.9.2
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 919VO
UT WOS:000228645900002
PM 15805775
DA 2020-12-17
ER

PT J
AU Reis, EM
   Nakaya, HI
   Louro, R
   Canavez, FC
   Flatschart, AVF
   Almeida, GT
   Egidio, CM
   Paquola, AC
   Machado, AA
   Festa, F
   Yamamoto, D
   Alvarenga, R
   da Silva, CC
   Brito, GC
   Simon, SD
   Moreira, CA
   Leite, KR
   Camara-Lopes, LH
   Campos, FS
   Gimba, E
   Vignal, GM
   El-Dorry, H
   Sogayar, MC
   Barcinski, MA
   da Silva, AM
   Verjovski-Almeida, S
AF Reis, EM
   Nakaya, HI
   Louro, R
   Canavez, FC
   Flatschart, AVF
   Almeida, GT
   Egidio, CM
   Paquola, AC
   Machado, AA
   Festa, F
   Yamamoto, D
   Alvarenga, R
   da Silva, CC
   Brito, GC
   Simon, SD
   Moreira, CA
   Leite, KR
   Camara-Lopes, LH
   Campos, FS
   Gimba, E
   Vignal, GM
   El-Dorry, H
   Sogayar, MC
   Barcinski, MA
   da Silva, AM
   Verjovski-Almeida, S
TI Antisense intronic non-coding RNA levels correlate to the degree of
   tumor differentiation in prostate cancer
SO ONCOGENE
LA English
DT Article
DE prostate cancer; Gleason score; intronic transcripts; antisense RNA;
   microarray
ID GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; SEQUENCE;
   HUMAN-CHROMOSOME-21; SITES
AB A large fraction of transcripts are expressed antisense to introns of known genes in the human genome. Here we show the construction and use of a cDNA microarray platform enriched in intronic transcripts to assess their biological relevance in pathological conditions. To validate the approach, prostate cancer was used as a model, and 27 patient tumor samples with Gleason scores ranging from 5 to 10 were analyzed. We find that a considerably higher fraction (6.6%,[23/346]) of intronic transcripts are significantly correlated (Pless than or equal to0.001) to the degree of prostate tumor differentiation ( Gleason score) when compared to transcripts from unannotated genomic regions (1%,[6/539]) or from exons of known genes (2%,[27/1369]). Among the top twelve transcripts most correlated to tumor differentiation, six are antisense intronic messages as shown by orientation-specific RTPCR or Northern blot analysis with strand-specific riboprobe. Orientation-specific real-time RT-PCR with six tumor samples, confirmed the correlation ( P = 0.024) between the low/high degrees of tumor differentiation and antisense intronic RASSF1 transcript levels. The need to use intron arrays to reveal the transcriptome profile of antisense intronic RNA in cancer has clearly emerged.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Quim, Lab Bioinformat, BR-05508900 Sao Paulo, Brazil.
   Hosp Israelita Albert Einstein, Div Oncol, BR-05651901 Sao Paulo, Brazil.
   Hosp Sirio Libanes, Lab Patol Cirurg & Mol, BR-01308050 Sao Paulo, Brazil.
   Inst Nacl Canc MS, BR-20230130 Rio De Janeiro, Brazil.
RP Verjovski-Almeida, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
EM verjo@iq.usp.br
RI Tesaarin e Almeida, Giulliana/F-5936-2013; Gimba, Etel/B-4473-2016;
   Brito, Glauber/C-4415-2013; Reis, Eduardo Moraes Rego/AAF-3553-2020;
   Verjovski-Almeida, Sergio/AAI-2728-2020; moreira-filho, carlos
   alberto/J-2551-2014; Gimba, Etel/H-7195-2012; LEITE, KATIA
   RM/C-2055-2008; Reis, Eduardo M/H-2008-2011; Nakaya,
   Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Sogayar, Mari
   C/B-3980-2017; Verjovski-Almeida, Sergio/E-4082-2012; da Silva, Aline
   M./C-3649-2012
OI Brito, Glauber/0000-0002-9887-3939; Reis, Eduardo Moraes
   Rego/0000-0002-9556-3070; Verjovski-Almeida, Sergio/0000-0002-6356-2401;
   moreira-filho, carlos alberto/0000-0003-3433-4714; LEITE, KATIA
   RM/0000-0002-2615-7730; Reis, Eduardo M/0000-0002-9556-3070; Nakaya,
   Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108;
   Sogayar, Mari C/0000-0003-4805-4609; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; da Silva, Aline M./0000-0001-9249-4922;
   Festa, Fernanda/0000-0002-2822-823X
CR Best CJM, 2003, DIAGN MOL PATHOL, V12, P63, DOI 10.1097/00019606-200306000-00001
   Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100
   Brunschwig EB, 2003, CANCER RES, V63, P1568
   Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101
   Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798
   Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8
   Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X
   Epstein JI, 1996, AM J SURG PATHOL, V20, P286, DOI 10.1097/00000478-199603000-00004
   Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572
   Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171
   Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138
   Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104
   Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597
   KHOCHBIN S, 1989, EMBO J, V8, P4107, DOI 10.1002/j.1460-2075.1989.tb08595.x
   Kiyosawa H, 2003, GENOME RES, V13, P1324, DOI 10.1101/gr.982903
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101
   Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734
   Liu LM, 2002, ONCOGENE, V21, P6835, DOI 10.1038/sj.onc.1205814
   Liu YL, 1996, GENOMICS, V31, P58, DOI 10.1006/geno.1996.0009
   McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5
   NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x
   Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491
   Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060
   Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203
   Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973
   Shendure J, 2002, GENOME BIOL, V3
   Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141
   Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2
   Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9
   Sorek R, 2003, NUCLEIC ACIDS RES, V31, P1067, DOI 10.1093/nar/gkg170
   Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907
   TASHEVA ES, 1995, GENE DEV, V9, P304, DOI 10.1101/gad.9.3.304
   Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157
   van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808
NR 37
TC 110
Z9 126
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD AUG 26
PY 2004
VL 23
IS 39
BP 6684
EP 6692
DI 10.1038/sj.onc.1207880
PG 9
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 849IB
UT WOS:000223530800017
PM 15221013
OA Bronze
DA 2020-12-17
ER

PT J
AU Louro, R
   Nakaya, HI
   Paquola, ACM
   Martins, EAL
   da Silva, AM
   Verjovski-Almeida, S
   Reis, EM
AF Louro, R
   Nakaya, HI
   Paquola, ACM
   Martins, EAL
   da Silva, AM
   Verjovski-Almeida, S
   Reis, EM
TI RASL11A, member of a novel small monomeric GTPase gene family, is
   down-regulated in prostate tumors
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE tumor suppressor; Ras-related GTPases; prostate cancer
ID SMALL G-PROTEIN; ENDOPLASMIC-RETICULUM; HUMAN TRANSCRIPTOME; SEQUENCE
   TAGS; CANCER; BINDING; GROWTH; SUPPRESSOR; RESOURCES; PROJECT
AB We performed a genome-wide search for novel loci encoding for Ras-related proteins based on the genome mapping coordinates of the cancer-derived EST dataset at GenBank. Partial sequences from two novel human genes were identified and subsequently used for full length transcript cloning. RASL11A and ARL9 belong to two novel subfamilies coding for small GTPases that we found to be highly conserved among eukaryotes. The Ar19/Awr110 subfamily displays a conserved interswitch toggle that places it evolutionarily closer to the Arf family. Ras111 proteins are more closely related to the Ras branch of GTPases. All orthologues newly identified here exhibit an Asn residue in place of the highly conserved Thr35 of the G domain, suggesting that the universal switch mechanism of small GTPases may be structurally different in this subfamily. We determined by Northern blot that RASL11A is transcribed in several human tissues and that it is down-regulated in prostate tumors as measured by quantitative real-time PCR. These results highlight a previously uncharacterized subfamily of Ras-related genes that may have a tumor suppressor role in prostate cancer. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
   Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil.
RP Reis, EM (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil.
EM emreis@iq.usp.br
RI Reis, Eduardo Moraes Rego/AAF-3553-2020; da Silva, Aline M./C-3649-2012;
   Nakaya, Helder/AAF-1738-2020; Reis, Eduardo M/H-2008-2011; Martins,
   Elizabeth AL/B-7135-2015; Verjovski-Almeida, Sergio/AAI-2728-2020;
   Verjovski-Almeida, Sergio/E-4082-2012; Nakaya, Helder I/A-1397-2010
OI Reis, Eduardo Moraes Rego/0000-0002-9556-3070; da Silva, Aline
   M./0000-0001-9249-4922; Nakaya, Helder/0000-0001-5297-9108; Reis,
   Eduardo M/0000-0002-9556-3070; Martins, Elizabeth
   AL/0000-0002-2333-9379; Verjovski-Almeida, Sergio/0000-0002-6356-2401;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Nakaya, Helder
   I/0000-0001-5297-9108
CR Adjei AA, 2003, J CLIN ONCOL, V21, P1760, DOI 10.1200/JCO.2003.09.075
   Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062
   BOECK R, 1994, EMBO J, V13, P3017
   Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2
   BOS JL, 1997, BIOCHIM BIOPHYS ACTA, V1333, P19
   Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100
   Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798
   Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306
   Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030
   Eckley DM, 2003, MOL BIOL CELL, V14, P2645, DOI 10.1091/mbc.E03-01-0049
   Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799
   Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200
   KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51
   Lee CHJ, 1996, J NEUROSCI, V16, P6784
   Luo RZ, 2003, ONCOGENE, V22, P2897, DOI 10.1038/sj.onc.1206380
   Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4
   Paduch M, 2001, ACTA BIOCHIM POL, V48, P829
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   Paquola ACM, 2003, BIOINFORMATICS, V19, P1035, DOI 10.1093/bioinformatics/btg122
   Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221
   Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X
   Sinensky M, 2000, BBA-MOL CELL BIOL L, V1484, P93, DOI 10.1016/S1388-1981(00)00009-3
   Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398
   Strausberg RL, 2003, NAT REV GENET, V4, P409, DOI 10.1038/nrg1085
   Strausberg RL, 2001, J PATHOL, V195, P31, DOI 10.1002/1096-9896(200109)195:1<31::AID-PATH920>3.0.CO;2-W
   Tee MK, 2001, BIOCHEM J, V359, P219, DOI 10.1042/0264-6021:3590219
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023
   Wani MA, 1997, SOMAT CELL MOLEC GEN, V23, P123, DOI 10.1007/BF02679971
   Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033
   Wistow G, 2002, MOL VIS, V8, P185
   Yu YH, 1999, P NATL ACAD SCI USA, V96, P214, DOI 10.1073/pnas.96.1.214
   Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181
NR 33
TC 19
Z9 31
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 9
PY 2004
VL 316
IS 3
BP 618
EP 627
DI 10.1016/j.bbrc.2004.02.091
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 808OU
UT WOS:000220579200005
PM 15033445
DA 2020-12-17
ER

EF